drugbank-id,description,name,parent_key
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Reteplase.,Picotamide,DB00015
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Reteplase.,Cloricromen,DB00015
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Reteplase.,Linsidomine,DB00015
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Reteplase.,Buflomedil,DB00015
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Reteplase.,Relcovaptan,DB00015
DB00374,The risk or severity of adverse effects can be increased when Reteplase is combined with Treprostinil.,Treprostinil,DB00015
DB03404,Hemin may increase the anticoagulant activities of Reteplase.,Hemin,DB00015
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Reteplase.,Acemetacin,DB00015
DB00624,Testosterone may increase the anticoagulant activities of Reteplase.,Testosterone,DB00015
DB01420,Testosterone propionate may increase the anticoagulant activities of Reteplase.,Testosterone propionate,DB00015
DB01481,1-Testosterone may increase the anticoagulant activities of Reteplase.,1-Testosterone,DB00015
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Reteplase.,4-Hydroxytestosterone,DB00015
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Reteplase.,Dehydrochloromethyltestosterone,DB00015
DB01541,Boldenone may increase the anticoagulant activities of Reteplase.,Boldenone,DB00015
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Reteplase.,18-methyl-19-nortestosterone,DB00015
DB01564,Calusterone may increase the anticoagulant activities of Reteplase.,Calusterone,DB00015
DB01569,Formebolone may increase the anticoagulant activities of Reteplase.,Formebolone,DB00015
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Reteplase.,Methyl-1-testosterone,DB00015
DB02901,Stanolone may increase the anticoagulant activities of Reteplase.,Stanolone,DB00015
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Reteplase.,5beta-dihydrotestosterone,DB00015
DB08619,Testosterone succinate may increase the anticoagulant activities of Reteplase.,Testosterone succinate,DB00015
DB11429,Mibolerone may increase the anticoagulant activities of Reteplase.,Mibolerone,DB00015
DB13943,Testosterone cypionate may increase the anticoagulant activities of Reteplase.,Testosterone cypionate,DB00015
DB13944,Testosterone enanthate may increase the anticoagulant activities of Reteplase.,Testosterone enanthate,DB00015
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Reteplase.,Testosterone undecanoate,DB00015
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Reteplase.,Testosterone enantate benzilic acid hydrazone,DB00015
DB13951,Stanolone acetate may increase the anticoagulant activities of Reteplase.,Stanolone acetate,DB00015
DB13958,Trestolone acetate may increase the anticoagulant activities of Reteplase.,Trestolone acetate,DB00015
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Reteplase.","(1,2,6,7-3H)Testosterone",DB00015
DB14655,Drostanolone propionate may increase the anticoagulant activities of Reteplase.,Drostanolone propionate,DB00015
DB11051,The risk or severity of adverse effects can be increased when Reteplase is combined with Azficel-T.,Azficel-T,DB00015
DB09568,The therapeutic efficacy of Reteplase can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids,DB00015
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Reteplase.,Calcium acetate,DB00015
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Reteplase.,Calcium chloride,DB00015
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Reteplase.,Calcium,DB00015
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Reteplase.,Calcium gluconate,DB00015
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Reteplase.,Eftrenonacog alfa,DB00015
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Reteplase.,Albutrepenonacog alfa,DB00015
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Reteplase.,Emicizumab,DB00015
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Reteplase.,Turoctocog alfa pegol,DB00015
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Reteplase.","Antihemophilic factor, human recombinant",DB00015
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Reteplase.,Coagulation factor VIIa Recombinant Human,DB00015
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Reteplase.,Coagulation Factor IX (Recombinant),DB00015
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Reteplase.,Pantothenic acid,DB00015
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Reteplase.,Formic acid,DB00015
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Reteplase.,Platelet Activating Factor,DB00015
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Reteplase.,Calcium carbonate,DB00015
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Reteplase.,Turoctocog alfa,DB00015
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Reteplase.,Fibrinogen human,DB00015
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Reteplase.,Catridecacog,DB00015
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Reteplase.","Antihemophilic Factor (Recombinant), PEGylated",DB00015
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Reteplase.,Calcium citrate,DB00015
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Reteplase.,Calcium threonate,DB00015
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Reteplase.,Prothrombin,DB00015
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Reteplase.,Factor IX Complex (Human),DB00015
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Reteplase.,Calcium Phosphate,DB00015
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Reteplase.,Susoctocog alfa,DB00015
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Reteplase.,Rusalatide acetate,DB00015
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Reteplase.,Vatreptacog alfa,DB00015
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Reteplase.,Factor XIII (human),DB00015
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Reteplase.,Von Willebrand Factor Human,DB00015
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Reteplase.,Coagulation factor X human,DB00015
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Reteplase.,Coagulation factor VII human,DB00015
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Reteplase.,Anti-inhibitor coagulant complex,DB00015
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Reteplase.,Coagulation Factor IX Human,DB00015
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Reteplase.,Antihemophilic factor human,DB00015
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Reteplase.,Kallidinogenase,DB00015
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Reteplase.,Trenonacog alfa,DB00015
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Reteplase.,Nonacog beta pegol,DB00015
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Reteplase.,Moroctocog alfa,DB00015
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Reteplase.,Beroctocog alfa,DB00015
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Reteplase.,Andexanet alfa,DB00015
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Reteplase.,Calcium cation,DB00015
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Reteplase.,Damoctocog alfa pegol,DB00015
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Reteplase.,Fluvoxamine,DB00015
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Reteplase.,Citalopram,DB00015
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Reteplase.,Fluoxetine,DB00015
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Reteplase.,Paroxetine,DB00015
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Reteplase.,Nefazodone,DB00015
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Reteplase.,Zimelidine,DB00015
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Reteplase.,Dapoxetine,DB00015
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Reteplase.,Seproxetine,DB00015
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Reteplase.,Indalpine,DB00015
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Reteplase.,Ritanserin,DB00015
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Reteplase.,Alaproclate,DB00015
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Reteplase.,Duloxetine,DB00015
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Reteplase.,Sibutramine,DB00015
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Reteplase.,Milnacipran,DB00015
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Reteplase.,Desvenlafaxine,DB00015
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Reteplase.,Levomilnacipran,DB00015
DB00285,Venlafaxine may increase the antiplatelet activities of Reteplase.,Venlafaxine,DB00015
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Reteplase.,Amphetamine,DB00015
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Reteplase.,Linezolid,DB00015
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Reteplase.,Furazolidone,DB00015
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Reteplase.,Procaine,DB00015
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Reteplase.,Tranylcypromine,DB00015
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Reteplase.,Phenelzine,DB00015
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Reteplase.,Minaprine,DB00015
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Reteplase.,Selegiline,DB00015
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Reteplase.,Procarbazine,DB00015
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Reteplase.,Moclobemide,DB00015
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Reteplase.,Isocarboxazid,DB00015
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Reteplase.,Rasagiline,DB00015
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Reteplase.,Pargyline,DB00015
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Reteplase.,Clorgiline,DB00015
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Reteplase.,Iproniazid,DB00015
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Reteplase.,Nialamide,DB00015
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Reteplase.,Safinamide,DB00015
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Reteplase.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",DB00015
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Reteplase.,Methylene blue,DB00015
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Reteplase.,Hydracarbazine,DB00015
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Reteplase.,Pirlindole,DB00015
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Reteplase.,Toloxatone,DB00015
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Reteplase.,Benmoxin,DB00015
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Reteplase.,Mebanazine,DB00015
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Reteplase.,Octamoxin,DB00015
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Reteplase.,Pheniprazine,DB00015
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Reteplase.,Phenoxypropazine,DB00015
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Reteplase.,Pivhydrazine,DB00015
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Reteplase.,Safrazine,DB00015
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Reteplase.,Caroxazone,DB00015
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Reteplase.,Harmaline,DB00015
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Reteplase.,Brofaromine,DB00015
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Reteplase.,Bivalirudin,DB00015
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Reteplase.,Dicoumarol,DB00015
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Reteplase.,Argatroban,DB00015
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Reteplase.,Ardeparin,DB00015
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Reteplase.,Phenindione,DB00015
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Reteplase.,Fondaparinux,DB00015
DB00682,The risk or severity of bleeding can be increased when Warfarin is combined with Reteplase.,Warfarin,DB00015
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Reteplase.,Phenprocoumon,DB00015
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Reteplase.,Edetic acid,DB00015
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Reteplase.,Heparin,DB00015
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Reteplase.,Enoxaparin,DB00015
DB01418,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Reteplase.,Acenocoumarol,DB00015
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Reteplase.,Ximelagatran,DB00015
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Reteplase.,Ancrod,DB00015
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Reteplase.,Sulodexide,DB00015
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Reteplase.,Idraparinux,DB00015
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Reteplase.,Otamixaban,DB00015
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Reteplase.,Danaparoid,DB00015
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Reteplase.,Dalteparin,DB00015
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Reteplase.,Ferulic acid,DB00015
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Reteplase.,Ethyl biscoumacetate,DB00015
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Reteplase.,Nadroparin,DB00015
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Reteplase.,Dextran,DB00015
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Reteplase.,Reviparin,DB00015
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Reteplase.,Certoparin,DB00015
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Reteplase.,Desirudin,DB00015
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Reteplase.,Protocatechualdehyde,DB00015
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Reteplase.,Protein C,DB00015
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Reteplase.,Antithrombin III human,DB00015
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Reteplase.,Letaxaban,DB00015
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Reteplase.,Darexaban,DB00015
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Reteplase.,Nafamostat,DB00015
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Reteplase.,Gabexate,DB00015
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Reteplase.,Troxerutin,DB00015
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Reteplase.,Fluindione,DB00015
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Reteplase.,Protein S human,DB00015
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Reteplase.,Melagatran,DB00015
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Reteplase.,Potassium citrate,DB00015
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Reteplase.,Sodium citrate,DB00015
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Reteplase.,Tenecteplase,DB00015
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Reteplase.,Drotrecogin alfa,DB00015
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Reteplase.,Tinzaparin,DB00015
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Reteplase.,Brinase,DB00015
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Reteplase.,Saruplase,DB00015
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Reteplase.,Streptokinase,DB00015
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Reteplase.,Desmoteplase,DB00015
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Reteplase.,Fibrinolysin,DB00015
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Reteplase.,Astaxanthin,DB00015
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Reteplase.,Ditazole,DB00015
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Reteplase.,Bemiparin,DB00015
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Reteplase.,Parnaparin,DB00015
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Reteplase.,Clorindione,DB00015
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Reteplase.,Diphenadione,DB00015
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Reteplase.,Tioclomarol,DB00015
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Reteplase.,Lepirudin,DB00015
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Reteplase.,Alteplase,DB00015
DB00029,The risk or severity of bleeding can be increased when Reteplase is combined with Anistreplase.,Anistreplase,DB00015
DB14094,The risk or severity of bleeding can be increased when Reteplase is combined with Tocopherylquinone.,Tocopherylquinone,DB00015
DB06679,The risk or severity of bleeding can be increased when Reteplase is combined with Amediplase.,Amediplase,DB00015
DB03410,The risk or severity of bleeding can be increased when Reteplase is combined with 4-hydroxycoumarin.,4-hydroxycoumarin,DB00015
DB08496,The risk or severity of bleeding can be increased when Reteplase is combined with (R)-warfarin.,(R)-warfarin,DB00015
DB14055,The risk or severity of bleeding can be increased when Reteplase is combined with (S)-Warfarin.,(S)-Warfarin,DB00015
DB12364,The risk or severity of bleeding can be increased when Reteplase is combined with Betrixaban.,Betrixaban,DB00015
DB14598,The risk or severity of bleeding can be increased when Reteplase is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous,DB00015
DB11154,The risk or severity of bleeding can be increased when Reteplase is combined with Zinc citrate.,Zinc citrate,DB00015
DB11166,The risk or severity of bleeding can be increased when Reteplase is combined with Antithrombin Alfa.,Antithrombin Alfa,DB00015
DB04665,The risk or severity of bleeding can be increased when Reteplase is combined with Coumarin.,Coumarin,DB00015
DB14726,The risk or severity of bleeding can be increased when Reteplase is combined with Dabigatran.,Dabigatran,DB00015
DB06294,The risk or severity of bleeding can be increased when Reteplase is combined with Semuloparin.,Semuloparin,DB00015
DB12726,The risk or severity of bleeding can be increased when Reteplase is combined with Monteplase.,Monteplase,DB00015
DB00177,The risk or severity of angioedema can be increased when Reteplase is combined with Valsartan.,Valsartan,DB00015
DB00178,The risk or severity of angioedema can be increased when Reteplase is combined with Ramipril.,Ramipril,DB00015
DB00230,The risk or severity of angioedema can be increased when Reteplase is combined with Pregabalin.,Pregabalin,DB00015
DB00492,The risk or severity of angioedema can be increased when Reteplase is combined with Fosinopril.,Fosinopril,DB00015
DB00519,The risk or severity of angioedema can be increased when Reteplase is combined with Trandolapril.,Trandolapril,DB00015
DB00542,The risk or severity of angioedema can be increased when Reteplase is combined with Benazepril.,Benazepril,DB00015
DB00584,The risk or severity of angioedema can be increased when Reteplase is combined with Enalapril.,Enalapril,DB00015
DB00678,The risk or severity of angioedema can be increased when Reteplase is combined with Losartan.,Losartan,DB00015
DB00691,The risk or severity of angioedema can be increased when Reteplase is combined with Moexipril.,Moexipril,DB00015
DB00722,The risk or severity of angioedema can be increased when Reteplase is combined with Lisinopril.,Lisinopril,DB00015
DB00790,The risk or severity of angioedema can be increased when Reteplase is combined with Perindopril.,Perindopril,DB00015
DB00876,The risk or severity of angioedema can be increased when Reteplase is combined with Eprosartan.,Eprosartan,DB00015
DB00877,The risk or severity of angioedema can be increased when Reteplase is combined with Sirolimus.,Sirolimus,DB00015
DB00881,The risk or severity of angioedema can be increased when Reteplase is combined with Quinapril.,Quinapril,DB00015
DB00886,The risk or severity of angioedema can be increased when Reteplase is combined with Omapatrilat.,Omapatrilat,DB00015
DB00966,The risk or severity of angioedema can be increased when Reteplase is combined with Telmisartan.,Telmisartan,DB00015
DB01050,The risk or severity of angioedema can be increased when Reteplase is combined with Ibuprofen.,Ibuprofen,DB00015
DB01180,The risk or severity of angioedema can be increased when Reteplase is combined with Rescinnamine.,Rescinnamine,DB00015
DB01197,The risk or severity of angioedema can be increased when Reteplase is combined with Captopril.,Captopril,DB00015
DB01261,The risk or severity of angioedema can be increased when Reteplase is combined with Sitagliptin.,Sitagliptin,DB00015
DB01340,The risk or severity of angioedema can be increased when Reteplase is combined with Cilazapril.,Cilazapril,DB00015
DB01342,The risk or severity of angioedema can be increased when Reteplase is combined with Forasartan.,Forasartan,DB00015
DB01347,The risk or severity of angioedema can be increased when Reteplase is combined with Saprisartan.,Saprisartan,DB00015
DB01348,The risk or severity of angioedema can be increased when Reteplase is combined with Spirapril.,Spirapril,DB00015
DB04876,The risk or severity of angioedema can be increased when Reteplase is combined with Vildagliptin.,Vildagliptin,DB00015
DB06011,The risk or severity of angioedema can be increased when Reteplase is combined with AMG-222.,AMG-222,DB00015
DB06127,The risk or severity of angioedema can be increased when Reteplase is combined with Bisegliptin.,Bisegliptin,DB00015
DB06196,The risk or severity of angioedema can be increased when Reteplase is combined with Icatibant.,Icatibant,DB00015
DB06203,The risk or severity of angioedema can be increased when Reteplase is combined with Alogliptin.,Alogliptin,DB00015
DB06245,The risk or severity of angioedema can be increased when Reteplase is combined with Lanoteplase.,Lanoteplase,DB00015
DB06287,The risk or severity of angioedema can be increased when Reteplase is combined with Temsirolimus.,Temsirolimus,DB00015
DB06335,The risk or severity of angioedema can be increased when Reteplase is combined with Saxagliptin.,Saxagliptin,DB00015
DB08382,The risk or severity of angioedema can be increased when Reteplase is combined with Gosogliptin.,Gosogliptin,DB00015
DB08822,The risk or severity of angioedema can be increased when Reteplase is combined with Azilsartan medoxomil.,Azilsartan medoxomil,DB00015
DB08836,The risk or severity of angioedema can be increased when Reteplase is combined with Temocapril.,Temocapril,DB00015
DB08882,The risk or severity of angioedema can be increased when Reteplase is combined with Linagliptin.,Linagliptin,DB00015
DB09292,The risk or severity of angioedema can be increased when Reteplase is combined with Sacubitril.,Sacubitril,DB00015
DB09477,The risk or severity of angioedema can be increased when Reteplase is combined with Enalaprilat.,Enalaprilat,DB00015
DB11723,The risk or severity of angioedema can be increased when Reteplase is combined with Dutogliptin.,Dutogliptin,DB00015
DB11783,The risk or severity of angioedema can be increased when Reteplase is combined with Imidapril.,Imidapril,DB00015
DB11950,The risk or severity of angioedema can be increased when Reteplase is combined with Teneligliptin.,Teneligliptin,DB00015
DB11992,The risk or severity of angioedema can be increased when Reteplase is combined with Omarigliptin.,Omarigliptin,DB00015
DB12268,The risk or severity of angioedema can be increased when Reteplase is combined with Carmegliptin.,Carmegliptin,DB00015
DB12412,The risk or severity of angioedema can be increased when Reteplase is combined with Gemigliptin.,Gemigliptin,DB00015
DB12417,The risk or severity of angioedema can be increased when Reteplase is combined with Anagliptin.,Anagliptin,DB00015
DB12625,The risk or severity of angioedema can be increased when Reteplase is combined with Evogliptin.,Evogliptin,DB00015
DB13166,The risk or severity of angioedema can be increased when Reteplase is combined with Zofenopril.,Zofenopril,DB00015
DB13312,The risk or severity of angioedema can be increased when Reteplase is combined with Delapril.,Delapril,DB00015
DB14125,The risk or severity of angioedema can be increased when Reteplase is combined with Benazeprilat.,Benazeprilat,DB00015
DB14207,The risk or severity of angioedema can be increased when Reteplase is combined with Fosinoprilat.,Fosinoprilat,DB00015
DB14208,The risk or severity of angioedema can be increased when Reteplase is combined with Ramiprilat.,Ramiprilat,DB00015
DB14209,The risk or severity of angioedema can be increased when Reteplase is combined with Trandolaprilat.,Trandolaprilat,DB00015
DB14210,The risk or severity of angioedema can be increased when Reteplase is combined with Moexiprilat.,Moexiprilat,DB00015
DB14213,The risk or severity of angioedema can be increased when Reteplase is combined with Perindoprilat.,Perindoprilat,DB00015
DB14217,The risk or severity of angioedema can be increased when Reteplase is combined with Quinaprilat.,Quinaprilat,DB00015
DB14231,The risk or severity of angioedema can be increased when Reteplase is combined with Quinoline Yellow WS.,Quinoline Yellow WS,DB00015
DB00203,The risk or severity of hemorrhage can be increased when Reteplase is combined with Sildenafil.,Sildenafil,DB00015
DB00008,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a,DB00015
DB00011,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-n1.,Interferon alfa-n1,DB00015
DB00018,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-n3.,Interferon alfa-n3,DB00015
DB00022,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b,DB00015
DB00033,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00015
DB00034,"The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00015
DB00041,The risk or severity of bleeding can be increased when Reteplase is combined with Aldesleukin.,Aldesleukin,DB00015
DB00056,The risk or severity of bleeding can be increased when Reteplase is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00015
DB00068,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon beta-1b.,Interferon beta-1b,DB00015
DB00069,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00015
DB00073,The risk or severity of bleeding can be increased when Reteplase is combined with Rituximab.,Rituximab,DB00015
DB00078,The risk or severity of bleeding can be increased when Reteplase is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00015
DB00087,The risk or severity of bleeding can be increased when Reteplase is combined with Alemtuzumab.,Alemtuzumab,DB00015
DB00105,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00015
DB00120,The risk or severity of bleeding can be increased when Reteplase is combined with Phenylalanine.,Phenylalanine,DB00015
DB00188,The risk or severity of bleeding can be increased when Reteplase is combined with Bortezomib.,Bortezomib,DB00015
DB00242,The risk or severity of bleeding can be increased when Reteplase is combined with Cladribine.,Cladribine,DB00015
DB00262,The risk or severity of bleeding can be increased when Reteplase is combined with Carmustine.,Carmustine,DB00015
DB00276,The risk or severity of bleeding can be increased when Reteplase is combined with Amsacrine.,Amsacrine,DB00015
DB00291,The risk or severity of bleeding can be increased when Reteplase is combined with Chlorambucil.,Chlorambucil,DB00015
DB00293,The risk or severity of bleeding can be increased when Reteplase is combined with Raltitrexed.,Raltitrexed,DB00015
DB00305,The risk or severity of bleeding can be increased when Reteplase is combined with Mitomycin.,Mitomycin,DB00015
DB00307,The risk or severity of bleeding can be increased when Reteplase is combined with Bexarotene.,Bexarotene,DB00015
DB00309,The risk or severity of bleeding can be increased when Reteplase is combined with Vindesine.,Vindesine,DB00015
DB00322,The risk or severity of bleeding can be increased when Reteplase is combined with Floxuridine.,Floxuridine,DB00015
DB00352,The risk or severity of bleeding can be increased when Reteplase is combined with Tioguanine.,Tioguanine,DB00015
DB00361,The risk or severity of bleeding can be increased when Reteplase is combined with Vinorelbine.,Vinorelbine,DB00015
DB00380,The risk or severity of bleeding can be increased when Reteplase is combined with Dexrazoxane.,Dexrazoxane,DB00015
DB00398,The risk or severity of bleeding can be increased when Reteplase is combined with Sorafenib.,Sorafenib,DB00015
DB00428,The risk or severity of bleeding can be increased when Reteplase is combined with Streptozocin.,Streptozocin,DB00015
DB00441,The risk or severity of bleeding can be increased when Reteplase is combined with Gemcitabine.,Gemcitabine,DB00015
DB00444,The risk or severity of bleeding can be increased when Reteplase is combined with Teniposide.,Teniposide,DB00015
DB00445,The risk or severity of bleeding can be increased when Reteplase is combined with Epirubicin.,Epirubicin,DB00015
DB00446,The risk or severity of bleeding can be increased when Reteplase is combined with Chloramphenicol.,Chloramphenicol,DB00015
DB00480,The risk or severity of bleeding can be increased when Reteplase is combined with Lenalidomide.,Lenalidomide,DB00015
DB00488,The risk or severity of bleeding can be increased when Reteplase is combined with Altretamine.,Altretamine,DB00015
DB00495,The risk or severity of bleeding can be increased when Reteplase is combined with Zidovudine.,Zidovudine,DB00015
DB00515,The risk or severity of bleeding can be increased when Reteplase is combined with Cisplatin.,Cisplatin,DB00015
DB00526,The risk or severity of bleeding can be increased when Reteplase is combined with Oxaliplatin.,Oxaliplatin,DB00015
DB00531,The risk or severity of bleeding can be increased when Reteplase is combined with Cyclophosphamide.,Cyclophosphamide,DB00015
DB00544,The risk or severity of bleeding can be increased when Reteplase is combined with Fluorouracil.,Fluorouracil,DB00015
DB00552,The risk or severity of bleeding can be increased when Reteplase is combined with Pentostatin.,Pentostatin,DB00015
DB00563,The risk or severity of bleeding can be increased when Reteplase is combined with Methotrexate.,Methotrexate,DB00015
DB00564,The risk or severity of bleeding can be increased when Reteplase is combined with Carbamazepine.,Carbamazepine,DB00015
DB00570,The risk or severity of bleeding can be increased when Reteplase is combined with Vinblastine.,Vinblastine,DB00015
DB00619,The risk or severity of bleeding can be increased when Reteplase is combined with Imatinib.,Imatinib,DB00015
DB00631,The risk or severity of bleeding can be increased when Reteplase is combined with Clofarabine.,Clofarabine,DB00015
DB00642,The risk or severity of bleeding can be increased when Reteplase is combined with Pemetrexed.,Pemetrexed,DB00015
DB00694,The risk or severity of bleeding can be increased when Reteplase is combined with Daunorubicin.,Daunorubicin,DB00015
DB00762,The risk or severity of bleeding can be increased when Reteplase is combined with Irinotecan.,Irinotecan,DB00015
DB00773,The risk or severity of bleeding can be increased when Reteplase is combined with Etoposide.,Etoposide,DB00015
DB00851,The risk or severity of bleeding can be increased when Reteplase is combined with Dacarbazine.,Dacarbazine,DB00015
DB00853,The risk or severity of bleeding can be increased when Reteplase is combined with Temozolomide.,Temozolomide,DB00015
DB00859,The risk or severity of bleeding can be increased when Reteplase is combined with Penicillamine.,Penicillamine,DB00015
DB00864,The risk or severity of bleeding can be increased when Reteplase is combined with Tacrolimus.,Tacrolimus,DB00015
DB00888,The risk or severity of bleeding can be increased when Reteplase is combined with Mechlorethamine.,Mechlorethamine,DB00015
DB00928,The risk or severity of bleeding can be increased when Reteplase is combined with Azacitidine.,Azacitidine,DB00015
DB00958,The risk or severity of bleeding can be increased when Reteplase is combined with Carboplatin.,Carboplatin,DB00015
DB00970,The risk or severity of bleeding can be increased when Reteplase is combined with Dactinomycin.,Dactinomycin,DB00015
DB00987,The risk or severity of bleeding can be increased when Reteplase is combined with Cytarabine.,Cytarabine,DB00015
DB00997,The risk or severity of bleeding can be increased when Reteplase is combined with Doxorubicin.,Doxorubicin,DB00015
DB01005,The risk or severity of bleeding can be increased when Reteplase is combined with Hydroxyurea.,Hydroxyurea,DB00015
DB01008,The risk or severity of bleeding can be increased when Reteplase is combined with Busulfan.,Busulfan,DB00015
DB01030,The risk or severity of bleeding can be increased when Reteplase is combined with Topotecan.,Topotecan,DB00015
DB01033,The risk or severity of bleeding can be increased when Reteplase is combined with Mercaptopurine.,Mercaptopurine,DB00015
DB01041,The risk or severity of bleeding can be increased when Reteplase is combined with Thalidomide.,Thalidomide,DB00015
DB01042,The risk or severity of bleeding can be increased when Reteplase is combined with Melphalan.,Melphalan,DB00015
DB01073,The risk or severity of bleeding can be increased when Reteplase is combined with Fludarabine.,Fludarabine,DB00015
DB01099,The risk or severity of bleeding can be increased when Reteplase is combined with Flucytosine.,Flucytosine,DB00015
DB01101,The risk or severity of bleeding can be increased when Reteplase is combined with Capecitabine.,Capecitabine,DB00015
DB01169,The risk or severity of bleeding can be increased when Reteplase is combined with Arsenic trioxide.,Arsenic trioxide,DB00015
DB01177,The risk or severity of bleeding can be increased when Reteplase is combined with Idarubicin.,Idarubicin,DB00015
DB01204,The risk or severity of bleeding can be increased when Reteplase is combined with Mitoxantrone.,Mitoxantrone,DB00015
DB01206,The risk or severity of bleeding can be increased when Reteplase is combined with Lomustine.,Lomustine,DB00015
DB01229,The risk or severity of bleeding can be increased when Reteplase is combined with Paclitaxel.,Paclitaxel,DB00015
DB01248,The risk or severity of bleeding can be increased when Reteplase is combined with Docetaxel.,Docetaxel,DB00015
DB01262,The risk or severity of bleeding can be increased when Reteplase is combined with Decitabine.,Decitabine,DB00015
DB01280,The risk or severity of bleeding can be increased when Reteplase is combined with Nelarabine.,Nelarabine,DB00015
DB01590,The risk or severity of bleeding can be increased when Reteplase is combined with Everolimus.,Everolimus,DB00015
DB02546,The risk or severity of bleeding can be increased when Reteplase is combined with Vorinostat.,Vorinostat,DB00015
DB04572,The risk or severity of bleeding can be increased when Reteplase is combined with Thiotepa.,Thiotepa,DB00015
DB04845,The risk or severity of bleeding can be increased when Reteplase is combined with Ixabepilone.,Ixabepilone,DB00015
DB04868,The risk or severity of bleeding can be increased when Reteplase is combined with Nilotinib.,Nilotinib,DB00015
DB05015,The risk or severity of bleeding can be increased when Reteplase is combined with Belinostat.,Belinostat,DB00015
DB05109,The risk or severity of bleeding can be increased when Reteplase is combined with Trabectedin.,Trabectedin,DB00015
DB05258,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa.,Interferon alfa,DB00015
DB05472,The risk or severity of bleeding can be increased when Reteplase is combined with omega interferon.,omega interferon,DB00015
DB05773,The risk or severity of bleeding can be increased when Reteplase is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00015
DB06616,The risk or severity of bleeding can be increased when Reteplase is combined with Bosutinib.,Bosutinib,DB00015
DB06769,The risk or severity of bleeding can be increased when Reteplase is combined with Bendamustine.,Bendamustine,DB00015
DB06772,The risk or severity of bleeding can be increased when Reteplase is combined with Cabazitaxel.,Cabazitaxel,DB00015
DB08871,The risk or severity of bleeding can be increased when Reteplase is combined with Eribulin.,Eribulin,DB00015
DB08877,The risk or severity of bleeding can be increased when Reteplase is combined with Ruxolitinib.,Ruxolitinib,DB00015
DB08889,The risk or severity of bleeding can be increased when Reteplase is combined with Carfilzomib.,Carfilzomib,DB00015
DB08895,The risk or severity of bleeding can be increased when Reteplase is combined with Tofacitinib.,Tofacitinib,DB00015
DB08901,The risk or severity of bleeding can be increased when Reteplase is combined with Ponatinib.,Ponatinib,DB00015
DB08910,The risk or severity of bleeding can be increased when Reteplase is combined with Pomalidomide.,Pomalidomide,DB00015
DB09042,The risk or severity of bleeding can be increased when Reteplase is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00015
DB09052,The risk or severity of bleeding can be increased when Reteplase is combined with Blinatumomab.,Blinatumomab,DB00015
DB09073,The risk or severity of bleeding can be increased when Reteplase is combined with Palbociclib.,Palbociclib,DB00015
DB09074,The risk or severity of bleeding can be increased when Reteplase is combined with Olaparib.,Olaparib,DB00015
DB09077,The risk or severity of bleeding can be increased when Reteplase is combined with Dinutuximab.,Dinutuximab,DB00015
DB09122,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00015
DB12814,The risk or severity of bleeding can be increased when Reteplase is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00015
DB00229,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefotiam.,Cefotiam,DB00015
DB00267,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefmenoxime.,Cefmenoxime,DB00015
DB00274,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefmetazole.,Cefmetazole,DB00015
DB00430,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefpiramide.,Cefpiramide,DB00015
DB00438,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftazidime.,Ceftazidime,DB00015
DB00447,The therapeutic efficacy of Reteplase can be decreased when used in combination with Loracarbef.,Loracarbef,DB00015
DB00456,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefalotin.,Cefalotin,DB00015
DB00493,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefotaxime.,Cefotaxime,DB00015
DB00535,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefdinir.,Cefdinir,DB00015
DB00567,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cephalexin.,Cephalexin,DB00015
DB00671,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefixime.,Cefixime,DB00015
DB00689,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cephaloglycin.,Cephaloglycin,DB00015
DB00833,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefaclor.,Cefaclor,DB00015
DB00923,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceforanide.,Ceforanide,DB00015
DB01066,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefditoren.,Cefditoren,DB00015
DB01112,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefuroxime.,Cefuroxime,DB00015
DB01139,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefapirin.,Cefapirin,DB00015
DB01140,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefadroxil.,Cefadroxil,DB00015
DB01150,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefprozil.,Cefprozil,DB00015
DB01212,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftriaxone.,Ceftriaxone,DB00015
DB01326,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefamandole.,Cefamandole,DB00015
DB01327,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefazolin.,Cefazolin,DB00015
DB01328,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefonicid.,Cefonicid,DB00015
DB01329,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefoperazone.,Cefoperazone,DB00015
DB01330,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefotetan.,Cefotetan,DB00015
DB01331,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefoxitin.,Cefoxitin,DB00015
DB01332,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftizoxime.,Ceftizoxime,DB00015
DB01333,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefradine.,Cefradine,DB00015
DB01413,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefepime.,Cefepime,DB00015
DB01414,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefacetrile.,Cefacetrile,DB00015
DB01415,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftibuten.,Ceftibuten,DB00015
DB01416,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefpodoxime.,Cefpodoxime,DB00015
DB04570,The therapeutic efficacy of Reteplase can be decreased when used in combination with Latamoxef.,Latamoxef,DB00015
DB04918,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftobiprole.,Ceftobiprole,DB00015
DB06590,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil,DB00015
DB09008,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefaloridine.,Cefaloridine,DB00015
DB09050,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftolozane.,Ceftolozane,DB00015
DB09062,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefminox.,Cefminox,DB00015
DB11367,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefroxadine.,Cefroxadine,DB00015
DB11935,The therapeutic efficacy of Reteplase can be decreased when used in combination with Flomoxef.,Flomoxef,DB00015
DB13266,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefatrizine.,Cefatrizine,DB00015
DB13461,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefcapene.,Cefcapene,DB00015
DB13470,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefodizime.,Cefodizime,DB00015
DB13499,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefsulodin.,Cefsulodin,DB00015
DB13504,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefetamet.,Cefetamet,DB00015
DB13638,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefbuperazone.,Cefbuperazone,DB00015
DB13667,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefozopran.,Cefozopran,DB00015
DB13682,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefpirome.,Cefpirome,DB00015
DB13778,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefazedone.,Cefazedone,DB00015
DB13821,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftezole.,Ceftezole,DB00015
DB14725,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate,DB00015
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Reteplase.,Doxycycline,DB00015
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Reteplase.,Azithromycin,DB00015
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Reteplase.,Omega-3-acid ethyl esters,DB00015
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Reteplase.,Acetylsalicylic acid,DB00015
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Reteplase.,Tazobactam,DB00015
DB00727,The therapeutic efficacy of Reteplase can be decreased when used in combination with Nitroglycerin.,Nitroglycerin,DB00015
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Reteplase.,Erythromycin,DB00015
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Reteplase.,Trazodone,DB00015
DB00620,The therapeutic efficacy of Reteplase can be decreased when used in combination with Triamcinolone.,Triamcinolone,DB00015
DB09079,The risk or severity of bleeding can be increased when Reteplase is combined with Nintedanib.,Nintedanib,DB00015
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Reteplase.,Escitalopram,DB00015
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Reteplase.,Sertraline,DB00015
DB00232,The therapeutic efficacy of Reteplase can be decreased when used in combination with Methyclothiazide.,Methyclothiazide,DB00015
DB00436,The therapeutic efficacy of Reteplase can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide,DB00015
DB00562,The therapeutic efficacy of Reteplase can be decreased when used in combination with Benzthiazide.,Benzthiazide,DB00015
DB00606,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cyclothiazide.,Cyclothiazide,DB00015
DB00774,The therapeutic efficacy of Reteplase can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide,DB00015
DB00880,The therapeutic efficacy of Reteplase can be decreased when used in combination with Chlorothiazide.,Chlorothiazide,DB00015
DB00999,The therapeutic efficacy of Reteplase can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide,DB00015
DB01021,The therapeutic efficacy of Reteplase can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide,DB00015
DB01324,The therapeutic efficacy of Reteplase can be decreased when used in combination with Polythiazide.,Polythiazide,DB00015
DB13430,The therapeutic efficacy of Reteplase can be decreased when used in combination with Mebutizide.,Mebutizide,DB00015
DB13532,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide,DB00015
DB00480,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lenalidomide.,Lenalidomide,DB00016
DB01041,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thalidomide.,Thalidomide,DB00016
DB08910,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pomalidomide.,Pomalidomide,DB00016
DB00002,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cetuximab.,Cetuximab,DB00016
DB00004,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Denileukin diftitox.,Denileukin diftitox,DB00016
DB00007,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Leuprolide.,Leuprolide,DB00016
DB00008,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a,DB00016
DB00014,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Goserelin.,Goserelin,DB00016
DB00023,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Asparaginase Escherichia coli.,Asparaginase Escherichia coli,DB00016
DB00041,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aldesleukin.,Aldesleukin,DB00016
DB00056,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00016
DB00059,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pegaspargase.,Pegaspargase,DB00016
DB00072,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trastuzumab.,Trastuzumab,DB00016
DB00073,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rituximab.,Rituximab,DB00016
DB00081,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tositumomab.,Tositumomab,DB00016
DB00087,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alemtuzumab.,Alemtuzumab,DB00016
DB00104,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Octreotide.,Octreotide,DB00016
DB00105,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00016
DB00112,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bevacizumab.,Bevacizumab,DB00016
DB00179,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Masoprocol.,Masoprocol,DB00016
DB00188,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bortezomib.,Bortezomib,DB00016
DB00236,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pipobroman.,Pipobroman,DB00016
DB00242,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cladribine.,Cladribine,DB00016
DB00248,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cabergoline.,Cabergoline,DB00016
DB00261,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anagrelide.,Anagrelide,DB00016
DB00262,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carmustine.,Carmustine,DB00016
DB00269,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Chlorotrianisene.,Chlorotrianisene,DB00016
DB00276,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Amsacrine.,Amsacrine,DB00016
DB00282,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pamidronic acid.,Pamidronic acid,DB00016
DB00290,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bleomycin.,Bleomycin,DB00016
DB00291,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Chlorambucil.,Chlorambucil,DB00016
DB00293,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Raltitrexed.,Raltitrexed,DB00016
DB00305,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitomycin.,Mitomycin,DB00016
DB00307,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bexarotene.,Bexarotene,DB00016
DB00313,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Valproic acid.,Valproic acid,DB00016
DB00317,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gefitinib.,Gefitinib,DB00016
DB00322,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Floxuridine.,Floxuridine,DB00016
DB00351,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Megestrol acetate.,Megestrol acetate,DB00016
DB00352,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tioguanine.,Tioguanine,DB00016
DB00357,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aminoglutethimide.,Aminoglutethimide,DB00016
DB00385,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Valrubicin.,Valrubicin,DB00016
DB00398,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sorafenib.,Sorafenib,DB00016
DB00428,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Streptozocin.,Streptozocin,DB00016
DB00432,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trifluridine.,Trifluridine,DB00016
DB00441,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gemcitabine.,Gemcitabine,DB00016
DB00444,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Teniposide.,Teniposide,DB00016
DB00445,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epirubicin.,Epirubicin,DB00016
DB00488,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Altretamine.,Altretamine,DB00016
DB00499,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Flutamide.,Flutamide,DB00016
DB00515,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cisplatin.,Cisplatin,DB00016
DB00523,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alitretinoin.,Alitretinoin,DB00016
DB00526,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oxaliplatin.,Oxaliplatin,DB00016
DB00530,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Erlotinib.,Erlotinib,DB00016
DB00539,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Toremifene.,Toremifene,DB00016
DB00544,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fluorouracil.,Fluorouracil,DB00016
DB00552,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pentostatin.,Pentostatin,DB00016
DB00563,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methotrexate.,Methotrexate,DB00016
DB00603,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Medroxyprogesterone acetate.,Medroxyprogesterone acetate,DB00016
DB00619,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Imatinib.,Imatinib,DB00016
DB00631,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Clofarabine.,Clofarabine,DB00016
DB00635,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednisone.,Prednisone,DB00016
DB00642,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pemetrexed.,Pemetrexed,DB00016
DB00648,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitotane.,Mitotane,DB00016
DB00665,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nilutamide.,Nilutamide,DB00016
DB00675,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tamoxifen.,Tamoxifen,DB00016
DB00694,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daunorubicin.,Daunorubicin,DB00016
DB00707,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Porfimer sodium.,Porfimer sodium,DB00016
DB00755,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tretinoin.,Tretinoin,DB00016
DB00762,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Irinotecan.,Irinotecan,DB00016
DB00773,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etoposide.,Etoposide,DB00016
DB00791,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Uracil mustard.,Uracil mustard,DB00016
DB00851,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dacarbazine.,Dacarbazine,DB00016
DB00853,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Temozolomide.,Temozolomide,DB00016
DB00855,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aminolevulinic acid.,Aminolevulinic acid,DB00016
DB00860,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednisolone.,Prednisolone,DB00016
DB00888,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mechlorethamine.,Mechlorethamine,DB00016
DB00894,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Testolactone.,Testolactone,DB00016
DB00928,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Azacitidine.,Azacitidine,DB00016
DB00947,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fulvestrant.,Fulvestrant,DB00016
DB00958,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carboplatin.,Carboplatin,DB00016
DB00959,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methylprednisolone.,Methylprednisolone,DB00016
DB00970,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dactinomycin.,Dactinomycin,DB00016
DB00987,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cytarabine.,Cytarabine,DB00016
DB00990,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Exemestane.,Exemestane,DB00016
DB00997,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Doxorubicin.,Doxorubicin,DB00016
DB01005,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hydroxyurea.,Hydroxyurea,DB00016
DB01006,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Letrozole.,Letrozole,DB00016
DB01008,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Busulfan.,Busulfan,DB00016
DB01030,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Topotecan.,Topotecan,DB00016
DB01033,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mercaptopurine.,Mercaptopurine,DB00016
DB01042,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Melphalan.,Melphalan,DB00016
DB01073,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fludarabine.,Fludarabine,DB00016
DB01101,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Capecitabine.,Capecitabine,DB00016
DB01108,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trilostane.,Trilostane,DB00016
DB01128,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bicalutamide.,Bicalutamide,DB00016
DB01157,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trimetrexate.,Trimetrexate,DB00016
DB01168,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Procarbazine.,Procarbazine,DB00016
DB01169,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Arsenic trioxide.,Arsenic trioxide,DB00016
DB01177,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Idarubicin.,Idarubicin,DB00016
DB01181,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ifosfamide.,Ifosfamide,DB00016
DB01196,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Estramustine.,Estramustine,DB00016
DB01204,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitoxantrone.,Mitoxantrone,DB00016
DB01206,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lomustine.,Lomustine,DB00016
DB01217,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anastrozole.,Anastrozole,DB00016
DB01229,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Paclitaxel.,Paclitaxel,DB00016
DB01234,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dexamethasone.,Dexamethasone,DB00016
DB01248,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Docetaxel.,Docetaxel,DB00016
DB01254,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dasatinib.,Dasatinib,DB00016
DB01259,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lapatinib.,Lapatinib,DB00016
DB01262,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Decitabine.,Decitabine,DB00016
DB01268,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sunitinib.,Sunitinib,DB00016
DB01269,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Panitumumab.,Panitumumab,DB00016
DB01280,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nelarabine.,Nelarabine,DB00016
DB01590,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Everolimus.,Everolimus,DB00016
DB01645,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Genistein.,Genistein,DB00016
DB01667,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 8-azaguanine.,8-azaguanine,DB00016
DB01873,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epothilone D.,Epothilone D,DB00016
DB01933,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 7-Hydroxystaurosporine.,7-Hydroxystaurosporine,DB00016
DB02109,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hadacidin.,Hadacidin,DB00016
DB02342,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-Methoxyestradiol.,2-Methoxyestradiol,DB00016
DB02424,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Geldanamycin.,Geldanamycin,DB00016
DB02546,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vorinostat.,Vorinostat,DB00016
DB02640,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fumagillin.,Fumagillin,DB00016
DB03010,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Patupilone.,Patupilone,DB00016
DB03172,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tubercidin.,Tubercidin,DB00016
DB03459,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sparfosic acid.,Sparfosic acid,DB00016
DB03496,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alvocidib.,Alvocidib,DB00016
DB03509,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide.,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,DB00016
DB03523,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brequinar.,Brequinar,DB00016
DB03695,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Piritrexim.,Piritrexim,DB00016
DB03825,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rhodamine 6G.,Rhodamine 6G,DB00016
DB03880,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Batimastat.,Batimastat,DB00016
DB03946,"The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 3,4-Dihydroxybenzoic Acid.","3,4-Dihydroxybenzoic Acid",DB00016
DB04106,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fotemustine.,Fotemustine,DB00016
DB04222,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sparsomycin.,Sparsomycin,DB00016
DB04253,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tretazicar.,Tretazicar,DB00016
DB04258,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Seocalcitol.,Seocalcitol,DB00016
DB04331,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Monastrol.,Monastrol,DB00016
DB04440,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nebularine.,Nebularine,DB00016
DB04468,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Afimoxifene.,Afimoxifene,DB00016
DB04572,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thiotepa.,Thiotepa,DB00016
DB04576,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fleroxacin.,Fleroxacin,DB00016
DB04655,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Metoprine.,Metoprine,DB00016
DB04690,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Camptothecin.,Camptothecin,DB00016
DB04786,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Suramin.,Suramin,DB00016
DB04827,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Urethane.,Urethane,DB00016
DB04839,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cyproterone acetate.,Cyproterone acetate,DB00016
DB04845,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ixabepilone.,Ixabepilone,DB00016
DB04849,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cediranib.,Cediranib,DB00016
DB04858,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tirapazamine.,Tirapazamine,DB00016
DB04865,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate,DB00016
DB04866,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Halofuginone.,Halofuginone,DB00016
DB04868,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nilotinib.,Nilotinib,DB00016
DB04894,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vapreotide.,Vapreotide,DB00016
DB04900,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thymalfasin.,Thymalfasin,DB00016
DB04901,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Galiximab.,Galiximab,DB00016
DB04907,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sitimagene ceradenovec.,Sitimagene ceradenovec,DB00016
DB04950,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ranpirnase.,Ranpirnase,DB00016
DB04951,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pirfenidone.,Pirfenidone,DB00016
DB04958,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epratuzumab.,Epratuzumab,DB00016
DB04960,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tipifarnib.,Tipifarnib,DB00016
DB04961,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Troxacitabine.,Troxacitabine,DB00016
DB04964,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oregovomab.,Oregovomab,DB00016
DB04975,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Banoxantrone.,Banoxantrone,DB00016
DB04977,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Plitidepsin.,Plitidepsin,DB00016
DB04996,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Satraplatin.,Satraplatin,DB00016
DB05015,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Belinostat.,Belinostat,DB00016
DB05022,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Amonafide.,Amonafide,DB00016
DB05076,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fenretinide.,Fenretinide,DB00016
DB05088,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tetrathiomolybdate.,Tetrathiomolybdate,DB00016
DB05097,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Labetuzumab.,Labetuzumab,DB00016
DB05109,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trabectedin.,Trabectedin,DB00016
DB05129,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Elsamitrucin.,Elsamitrucin,DB00016
DB05136,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bavituximab.,Bavituximab,DB00016
DB05223,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pracinostat.,Pracinostat,DB00016
DB05239,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cobimetinib.,Cobimetinib,DB00016
DB05260,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gallium nitrate.,Gallium nitrate,DB00016
DB05265,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ecabet.,Ecabet,DB00016
DB05294,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vandetanib.,Vandetanib,DB00016
DB05374,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rindopepimut.,Rindopepimut,DB00016
DB05424,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Canertinib.,Canertinib,DB00016
DB05428,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Motexafin gadolinium.,Motexafin gadolinium,DB00016
DB05482,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 7-ethyl-10-hydroxycamptothecin.,7-ethyl-10-hydroxycamptothecin,DB00016
DB05524,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pelitinib.,Pelitinib,DB00016
DB05540,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alanosine.,Alanosine,DB00016
DB05578,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ramucirumab.,Ramucirumab,DB00016
DB05595,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Farletuzumab.,Farletuzumab,DB00016
DB05656,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Veltuzumab.,Veltuzumab,DB00016
DB05668,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Palifosfamide.,Palifosfamide,DB00016
DB05697,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with AP 12009.,AP 12009,DB00016
DB05773,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00016
DB05779,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oglufanide.,Oglufanide,DB00016
DB05786,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Irofulven.,Irofulven,DB00016
DB05812,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abiraterone.,Abiraterone,DB00016
DB05889,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin,DB00016
DB05903,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with KOS-1584.,KOS-1584,DB00016
DB05916,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CT-011.,CT-011,DB00016
DB05974,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Transcrocetinate.,Transcrocetinate,DB00016
DB05996,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Glembatumumab vedotin.,Glembatumumab vedotin,DB00016
DB06013,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aldoxorubicin.,Aldoxorubicin,DB00016
DB06021,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with AV-412.,AV-412,DB00016
DB06040,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Filanesib.,Filanesib,DB00016
DB06043,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olaratumab.,Olaratumab,DB00016
DB06159,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rubitecan.,Rubitecan,DB00016
DB06160,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Garenoxacin.,Garenoxacin,DB00016
DB06163,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Plevitrexed.,Plevitrexed,DB00016
DB06171,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Paclitaxel trevatide.,Paclitaxel trevatide,DB00016
DB06176,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Romidepsin.,Romidepsin,DB00016
DB06181,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with IMO-2055.,IMO-2055,DB00016
DB06186,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ipilimumab.,Ipilimumab,DB00016
DB06192,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nimotuzumab.,Nimotuzumab,DB00016
DB06193,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pixantrone.,Pixantrone,DB00016
DB06195,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Seliciclib.,Seliciclib,DB00016
DB06199,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Atrasentan.,Atrasentan,DB00016
DB06233,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ridaforolimus.,Ridaforolimus,DB00016
DB06235,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vadimezan.,Vadimezan,DB00016
DB06246,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Exisulind.,Exisulind,DB00016
DB06263,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Amrubicin.,Amrubicin,DB00016
DB06266,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lonidamine.,Lonidamine,DB00016
DB06272,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Maxacalcitol.,Maxacalcitol,DB00016
DB06287,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Temsirolimus.,Temsirolimus,DB00016
DB06317,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Elotuzumab.,Elotuzumab,DB00016
DB06334,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tucidinostat.,Tucidinostat,DB00016
DB06365,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sapacitabine.,Sapacitabine,DB00016
DB06366,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pertuzumab.,Pertuzumab,DB00016
DB06370,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Indisulam.,Indisulam,DB00016
DB06420,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Annamycin.,Annamycin,DB00016
DB06423,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Endostatin.,Endostatin,DB00016
DB06433,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tezacitabine.,Tezacitabine,DB00016
DB06436,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Semaxanib.,Semaxanib,DB00016
DB06445,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Diethylnorspermine.,Diethylnorspermine,DB00016
DB06461,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Squalamine.,Squalamine,DB00016
DB06478,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Porfiromycin.,Porfiromycin,DB00016
DB06517,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with MLN576.,MLN576,DB00016
DB06589,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pazopanib.,Pazopanib,DB00016
DB06595,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Midostaurin.,Midostaurin,DB00016
DB06603,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Panobinostat.,Panobinostat,DB00016
DB06607,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Catumaxomab.,Catumaxomab,DB00016
DB06616,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bosutinib.,Bosutinib,DB00016
DB06626,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Axitinib.,Axitinib,DB00016
DB06647,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Volociximab.,Volociximab,DB00016
DB06650,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ofatumumab.,Ofatumumab,DB00016
DB06699,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Degarelix.,Degarelix,DB00016
DB06710,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methyltestosterone.,Methyltestosterone,DB00016
DB06719,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Buserelin.,Buserelin,DB00016
DB06748,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ginsenoside C.,Ginsenoside C,DB00016
DB06769,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bendamustine.,Bendamustine,DB00016
DB06772,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cabazitaxel.,Cabazitaxel,DB00016
DB06789,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hydroxyprogesterone caproate.,Hydroxyprogesterone caproate,DB00016
DB06791,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lanreotide.,Lanreotide,DB00016
DB06810,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Plicamycin.,Plicamycin,DB00016
DB06813,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pralatrexate.,Pralatrexate,DB00016
DB06825,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Triptorelin.,Triptorelin,DB00016
DB07232,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Veliparib.,Veliparib,DB00016
DB07931,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hexestrol.,Hexestrol,DB00016
DB08313,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nocodazole.,Nocodazole,DB00016
DB08437,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Puromycin.,Puromycin,DB00016
DB08486,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Efaproxiral.,Efaproxiral,DB00016
DB08633,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with TNP-470.,TNP-470,DB00016
DB08828,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vismodegib.,Vismodegib,DB00016
DB08865,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Crizotinib.,Crizotinib,DB00016
DB08870,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brentuximab vedotin.,Brentuximab vedotin,DB00016
DB08871,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Eribulin.,Eribulin,DB00016
DB08875,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cabozantinib.,Cabozantinib,DB00016
DB08877,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ruxolitinib.,Ruxolitinib,DB00016
DB08881,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vemurafenib.,Vemurafenib,DB00016
DB08886,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Asparaginase Erwinia chrysanthemi.,Asparaginase Erwinia chrysanthemi,DB00016
DB08889,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carfilzomib.,Carfilzomib,DB00016
DB08896,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Regorafenib.,Regorafenib,DB00016
DB08899,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Enzalutamide.,Enzalutamide,DB00016
DB08901,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ponatinib.,Ponatinib,DB00016
DB08905,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Formestane.,Formestane,DB00016
DB08911,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trametinib.,Trametinib,DB00016
DB08912,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dabrafenib.,Dabrafenib,DB00016
DB08913,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Radium Ra 223 dichloride.,Radium Ra 223 dichloride,DB00016
DB08916,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Afatinib.,Afatinib,DB00016
DB08935,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Obinutuzumab.,Obinutuzumab,DB00016
DB08972,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Flumequine.,Flumequine,DB00016
DB09010,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carmofur.,Carmofur,DB00016
DB09031,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Miltefosine.,Miltefosine,DB00016
DB09035,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nivolumab.,Nivolumab,DB00016
DB09036,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Siltuximab.,Siltuximab,DB00016
DB09037,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pembrolizumab.,Pembrolizumab,DB00016
DB09052,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Blinatumomab.,Blinatumomab,DB00016
DB09053,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ibrutinib.,Ibrutinib,DB00016
DB09054,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Idelalisib.,Idelalisib,DB00016
DB09063,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ceritinib.,Ceritinib,DB00016
DB09073,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Palbociclib.,Palbociclib,DB00016
DB09074,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olaparib.,Olaparib,DB00016
DB09077,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dinutuximab.,Dinutuximab,DB00016
DB09078,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lenvatinib.,Lenvatinib,DB00016
DB09079,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nintedanib.,Nintedanib,DB00016
DB09123,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dienogest.,Dienogest,DB00016
DB09143,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sonidegib.,Sonidegib,DB00016
DB09239,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Niguldipine.,Niguldipine,DB00016
DB09256,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tegafur.,Tegafur,DB00016
DB09274,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Artesunate.,Artesunate,DB00016
DB09298,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Silibinin.,Silibinin,DB00016
DB09330,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Osimertinib.,Osimertinib,DB00016
DB09331,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daratumumab.,Daratumumab,DB00016
DB09559,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Necitumumab.,Necitumumab,DB00016
DB09570,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ixazomib.,Ixazomib,DB00016
DB11363,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alectinib.,Alectinib,DB00016
DB11366,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Roquinimex.,Roquinimex,DB00016
DB11526,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Masitinib.,Masitinib,DB00016
DB11581,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Venetoclax.,Venetoclax,DB00016
DB11595,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Atezolizumab.,Atezolizumab,DB00016
DB11616,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pirarubicin.,Pirarubicin,DB00016
DB11617,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aclarubicin.,Aclarubicin,DB00016
DB11618,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Zorubicin.,Zorubicin,DB00016
DB11630,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Temoporfin.,Temoporfin,DB00016
DB11646,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Conatumumab.,Conatumumab,DB00016
DB11651,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dactolisib.,Dactolisib,DB00016
DB11662,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rabusertib.,Rabusertib,DB00016
DB11669,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ortataxel.,Ortataxel,DB00016
DB11678,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Treosulfan.,Treosulfan,DB00016
DB11688,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-chloroethyl-3-sarcosinamide-1-nitrosourea.,2-chloroethyl-3-sarcosinamide-1-nitrosourea,DB00016
DB11694,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ilorasertib.,Ilorasertib,DB00016
DB11714,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Durvalumab.,Durvalumab,DB00016
DB11716,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Misonidazole.,Misonidazole,DB00016
DB11717,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epacadostat.,Epacadostat,DB00016
DB11718,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Encorafenib.,Encorafenib,DB00016
DB11727,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Endostar.,Endostar,DB00016
DB11730,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ribociclib.,Ribociclib,DB00016
DB11737,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Icotinib.,Icotinib,DB00016
DB11752,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bryostatin 1.,Bryostatin 1,DB00016
DB11760,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Talazoparib.,Talazoparib,DB00016
DB11771,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tremelimumab.,Tremelimumab,DB00016
DB11793,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Niraparib.,Niraparib,DB00016
DB11795,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with GSK-2636771.,GSK-2636771,DB00016
DB11800,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tivozanib.,Tivozanib,DB00016
DB11805,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Saracatinib.,Saracatinib,DB00016
DB11812,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Talaporfin.,Talaporfin,DB00016
DB11828,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Neratinib.,Neratinib,DB00016
DB11830,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mocetinostat.,Mocetinostat,DB00016
DB11832,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Crenolanib.,Crenolanib,DB00016
DB11841,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Entinostat.,Entinostat,DB00016
DB11880,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Acridine Carboxamide.,Acridine Carboxamide,DB00016
DB11886,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Infigratinib.,Infigratinib,DB00016
DB11891,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CUDC-907.,CUDC-907,DB00016
DB11894,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Efatutazone.,Efatutazone,DB00016
DB11901,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Apalutamide.,Apalutamide,DB00016
DB11907,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rociletinib.,Rociletinib,DB00016
DB11918,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Guadecitabine.,Guadecitabine,DB00016
DB11919,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 6-O-benzylguanine.,6-O-benzylguanine,DB00016
DB11945,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Avelumab.,Avelumab,DB00016
DB11960,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carboxyamidotriazole.,Carboxyamidotriazole,DB00016
DB11963,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dacomitinib.,Dacomitinib,DB00016
DB11967,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Binimetinib.,Binimetinib,DB00016
DB11972,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rilotumumab.,Rilotumumab,DB00016
DB11973,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tesevatinib.,Tesevatinib,DB00016
DB11978,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Glasdegib.,Glasdegib,DB00016
DB11986,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Entrectinib.,Entrectinib,DB00016
DB11999,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vosaroxin.,Vosaroxin,DB00016
DB12001,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abemaciclib.,Abemaciclib,DB00016
DB12015,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alpelisib.,Alpelisib,DB00016
DB12025,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Triptolide.,Triptolide,DB00016
DB12028,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Broxuridine.,Broxuridine,DB00016
DB12036,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Naquotinib.,Naquotinib,DB00016
DB12056,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trebananib.,Trebananib,DB00016
DB12081,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anecortave.,Anecortave,DB00016
DB12082,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vesnarinone.,Vesnarinone,DB00016
DB12083,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mafosfamide.,Mafosfamide,DB00016
DB12085,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with LCL-161.,LCL-161,DB00016
DB12089,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine,DB00016
DB12108,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Taselisib.,Taselisib,DB00016
DB12124,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Namitecan.,Namitecan,DB00016
DB12130,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lorlatinib.,Lorlatinib,DB00016
DB12141,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gilteritinib.,Gilteritinib,DB00016
DB12142,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Duligotuzumab.,Duligotuzumab,DB00016
DB12146,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rigosertib.,Rigosertib,DB00016
DB12147,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Erdafitinib.,Erdafitinib,DB00016
DB12156,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cordycepin.,Cordycepin,DB00016
DB12174,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CUDC-101.,CUDC-101,DB00016
DB12182,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Binetrakin.,Binetrakin,DB00016
DB12185,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Exatecan.,Exatecan,DB00016
DB12202,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Zalutumumab.,Zalutumumab,DB00016
DB12222,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lurtotecan.,Lurtotecan,DB00016
DB12232,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with KRN-7000.,KRN-7000,DB00016
DB12257,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Platinum.,Platinum,DB00016
DB12259,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CG-200745.,CG-200745,DB00016
DB12266,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epofolate.,Epofolate,DB00016
DB12267,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brigatinib.,Brigatinib,DB00016
DB12279,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with OBP-801.,OBP-801,DB00016
DB12332,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rucaparib.,Rucaparib,DB00016
DB12340,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Navitoclax.,Navitoclax,DB00016
DB12352,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bizelesin.,Bizelesin,DB00016
DB12376,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ricolinostat.,Ricolinostat,DB00016
DB12379,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Indirubin.,Indirubin,DB00016
DB12381,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Merestinib.,Merestinib,DB00016
DB12382,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with R-306465.,R-306465,DB00016
DB12385,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 10-hydroxycamptothecin.,10-hydroxycamptothecin,DB00016
DB12391,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sagopilone.,Sagopilone,DB00016
DB12422,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sulforaphane.,Sulforaphane,DB00016
DB12459,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Belotecan.,Belotecan,DB00016
DB12473,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Taurolidine.,Taurolidine,DB00016
DB12480,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Betulinic Acid.,Betulinic Acid,DB00016
DB12483,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Copanlisib.,Copanlisib,DB00016
DB12498,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mogamulizumab.,Mogamulizumab,DB00016
DB12515,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 9-aminocamptothecin.,9-aminocamptothecin,DB00016
DB12525,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Molgramostim.,Molgramostim,DB00016
DB12539,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oltipraz.,Oltipraz,DB00016
DB12549,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pyrazoloacridine.,Pyrazoloacridine,DB00016
DB12565,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abexinostat.,Abexinostat,DB00016
DB12577,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fosbretabulin.,Fosbretabulin,DB00016
DB12589,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dacetuzumab.,Dacetuzumab,DB00016
DB12593,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Apaziquone.,Apaziquone,DB00016
DB12596,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Combretastatin.,Combretastatin,DB00016
DB12617,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mizoribine.,Mizoribine,DB00016
DB12637,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Onapristone.,Onapristone,DB00016
DB12638,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with PU-H71.,PU-H71,DB00016
DB12645,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Givinostat.,Givinostat,DB00016
DB12671,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Beloranib.,Beloranib,DB00016
DB12677,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Soblidotin.,Soblidotin,DB00016
DB12681,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Salirasib.,Salirasib,DB00016
DB12688,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Moxetumomab Pasudotox.,Moxetumomab Pasudotox,DB00016
DB12692,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gusperimus.,Gusperimus,DB00016
DB12695,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Phenethyl Isothiocyanate.,Phenethyl Isothiocyanate,DB00016
DB12697,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methylselenocysteine.,Methylselenocysteine,DB00016
DB12701,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Intetumumab.,Intetumumab,DB00016
DB12730,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dolastatin 10.,Dolastatin 10,DB00016
DB12736,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etanidazole.,Etanidazole,DB00016
DB12769,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lometrexol.,Lometrexol,DB00016
DB12797,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ecromeximab.,Ecromeximab,DB00016
DB12832,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednimustine.,Prednimustine,DB00016
DB12870,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Buthionine Sulfoximine.,Buthionine Sulfoximine,DB00016
DB12873,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dianhydrogalactitol.,Dianhydrogalactitol,DB00016
DB12881,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Indole-3-carbinol.,Indole-3-carbinol,DB00016
DB12901,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fiacitabine.,Fiacitabine,DB00016
DB12902,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trofosfamide.,Trofosfamide,DB00016
DB12912,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nolatrexed.,Nolatrexed,DB00016
DB12916,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitolactol.,Mitolactol,DB00016
DB12920,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pinometostat.,Pinometostat,DB00016
DB12947,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Doxifluridine.,Doxifluridine,DB00016
DB12948,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Didox.,Didox,DB00016
DB12967,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitoguazone.,Mitoguazone,DB00016
DB12978,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pexidartinib.,Pexidartinib,DB00016
DB12987,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Penclomedine.,Penclomedine,DB00016
DB12991,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Deoxyspergualin.,Deoxyspergualin,DB00016
DB12996,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Acteoside.,Acteoside,DB00016
DB13005,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rebastinib.,Rebastinib,DB00016
DB13014,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hypericin.,Hypericin,DB00016
DB13046,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tocladesine.,Tocladesine,DB00016
DB13066,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Liarozole.,Liarozole,DB00016
DB13069,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nimustine.,Nimustine,DB00016
DB13104,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with X-396.,X-396,DB00016
DB13128,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sizofiran.,Sizofiran,DB00016
DB13145,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nedaplatin.,Nedaplatin,DB00016
DB13164,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olmutinib.,Olmutinib,DB00016
DB13182,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daidzein.,Daidzein,DB00016
DB13243,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tiazofurine.,Tiazofurine,DB00016
DB13304,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Triaziquone.,Triaziquone,DB00016
DB13318,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Demecolcine.,Demecolcine,DB00016
DB13334,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mannosulfan.,Mannosulfan,DB00016
DB13339,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etoglucid.,Etoglucid,DB00016
DB13375,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Edrecolomab.,Edrecolomab,DB00016
DB13480,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lentinan.,Lentinan,DB00016
DB13543,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitobronitol.,Mitobronitol,DB00016
DB13627,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oxolinic acid.,Oxolinic acid,DB00016
DB13647,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Semustine.,Semustine,DB00016
DB13677,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carboquone.,Carboquone,DB00016
DB13767,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vorozole.,Vorozole,DB00016
DB13809,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Paclitaxel poliglumex.,Paclitaxel poliglumex,DB00016
DB13811,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oblimersen.,Oblimersen,DB00016
DB13832,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ranimustine.,Ranimustine,DB00016
DB13874,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Enasidenib.,Enasidenib,DB00016
DB13877,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Iniparib.,Iniparib,DB00016
DB13896,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Talimogene laherparepvec.,Talimogene laherparepvec,DB00016
DB13912,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Coumermycin A1.,Coumermycin A1,DB00016
DB13916,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Toyocamycin.,Toyocamycin,DB00016
DB14031,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tretamine.,Tretamine,DB00016
DB14066,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tetrandrine.,Tetrandrine,DB00016
DB14067,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dofequidar.,Dofequidar,DB00016
DB14068,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dexniguldipine.,Dexniguldipine,DB00016
DB14568,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ivosidenib.,Ivosidenib,DB00016
DB14644,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methylprednisolone hemisuccinate.,Methylprednisolone hemisuccinate,DB00016
DB14646,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednisone acetate.,Prednisone acetate,DB00016
DB14680,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Combretastatin A4.,Combretastatin A4,DB00016
DB14707,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cemiplimab.,Cemiplimab,DB00016
DB14723,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Larotrectinib.,Larotrectinib,DB00016
DB14731,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tagraxofusp.,Tagraxofusp,DB00016
DB14765,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rivoceranib.,Rivoceranib,DB00016
DB14792,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with AZD-5991.,AZD-5991,DB00016
DB14844,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with ONC-201.,ONC-201,DB00016
DB14860,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ensartinib.,Ensartinib,DB00016
DB14865,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Human interleukin-2.,Human interleukin-2,DB00016
DB14877,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lintuzumab.,Lintuzumab,DB00016
DB14947,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bermekimab.,Bermekimab,DB00016
DB14951,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etirinotecan pegol.,Etirinotecan pegol,DB00016
DB15035,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Zanubrutinib.,Zanubrutinib,DB00016
DB15057,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with NUC-1031.,NUC-1031,DB00016
DB15157,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Voruciclib.,Voruciclib,DB00016
DB15215,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with KRN-5500.,KRN-5500,DB00016
DB15289,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Perillyl alcohol.,Perillyl alcohol,DB00016
DB15321,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tefinostat.,Tefinostat,DB00016
DB15334,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Biochanin A.,Biochanin A,DB00016
DB15351,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dihematoporphyrin ether.,Dihematoporphyrin ether,DB00016
DB15366,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with SOR-C13.,SOR-C13,DB00016
DB15383,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pidilizumab.,Pidilizumab,DB00016
DB15419,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nanatinostat.,Nanatinostat,DB00016
DB15466,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tallimustine.,Tallimustine,DB00016
DB12062,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Volasertib.,Volasertib,DB00016
DB14811,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Isatuximab.,Isatuximab,DB00016
DB15102,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pemigatinib.,Pemigatinib,DB00016
DB11791,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Capmatinib.,Capmatinib,DB00016
DB15685,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Selpercatinib.,Selpercatinib,DB00016
DB00531,The risk or severity of pulmonary toxicity can be increased when Erythropoietin is combined with Cyclophosphamide.,Cyclophosphamide,DB00016
DB00984,The therapeutic efficacy of Erythropoietin can be increased when used in combination with Nandrolone phenpropionate.,Nandrolone phenpropionate,DB00016
DB08804,The therapeutic efficacy of Erythropoietin can be increased when used in combination with Nandrolone decanoate.,Nandrolone decanoate,DB00016
DB13169,The therapeutic efficacy of Erythropoietin can be increased when used in combination with Nandrolone.,Nandrolone,DB00016
DB00178,The serum concentration of Erythropoietin can be decreased when it is combined with Ramipril.,Ramipril,DB00016
DB00492,The serum concentration of Erythropoietin can be decreased when it is combined with Fosinopril.,Fosinopril,DB00016
DB00519,The serum concentration of Erythropoietin can be decreased when it is combined with Trandolapril.,Trandolapril,DB00016
DB00542,The serum concentration of Erythropoietin can be decreased when it is combined with Benazepril.,Benazepril,DB00016
DB00584,The serum concentration of Erythropoietin can be decreased when it is combined with Enalapril.,Enalapril,DB00016
DB00691,The serum concentration of Erythropoietin can be decreased when it is combined with Moexipril.,Moexipril,DB00016
DB00722,The serum concentration of Erythropoietin can be decreased when it is combined with Lisinopril.,Lisinopril,DB00016
DB00790,The serum concentration of Erythropoietin can be decreased when it is combined with Perindopril.,Perindopril,DB00016
DB00881,The serum concentration of Erythropoietin can be decreased when it is combined with Quinapril.,Quinapril,DB00016
DB00886,The serum concentration of Erythropoietin can be decreased when it is combined with Omapatrilat.,Omapatrilat,DB00016
DB01180,The serum concentration of Erythropoietin can be decreased when it is combined with Rescinnamine.,Rescinnamine,DB00016
DB01197,The serum concentration of Erythropoietin can be decreased when it is combined with Captopril.,Captopril,DB00016
DB01340,The serum concentration of Erythropoietin can be decreased when it is combined with Cilazapril.,Cilazapril,DB00016
DB01348,The serum concentration of Erythropoietin can be decreased when it is combined with Spirapril.,Spirapril,DB00016
DB08836,The serum concentration of Erythropoietin can be decreased when it is combined with Temocapril.,Temocapril,DB00016
DB09477,The serum concentration of Erythropoietin can be decreased when it is combined with Enalaprilat.,Enalaprilat,DB00016
DB11783,The serum concentration of Erythropoietin can be decreased when it is combined with Imidapril.,Imidapril,DB00016
DB13166,The serum concentration of Erythropoietin can be decreased when it is combined with Zofenopril.,Zofenopril,DB00016
DB13312,The serum concentration of Erythropoietin can be decreased when it is combined with Delapril.,Delapril,DB00016
DB14125,The serum concentration of Erythropoietin can be decreased when it is combined with Benazeprilat.,Benazeprilat,DB00016
DB14207,The serum concentration of Erythropoietin can be decreased when it is combined with Fosinoprilat.,Fosinoprilat,DB00016
DB14208,The serum concentration of Erythropoietin can be decreased when it is combined with Ramiprilat.,Ramiprilat,DB00016
DB14209,The serum concentration of Erythropoietin can be decreased when it is combined with Trandolaprilat.,Trandolaprilat,DB00016
DB14210,The serum concentration of Erythropoietin can be decreased when it is combined with Moexiprilat.,Moexiprilat,DB00016
DB14213,The serum concentration of Erythropoietin can be decreased when it is combined with Perindoprilat.,Perindoprilat,DB00016
DB14217,The serum concentration of Erythropoietin can be decreased when it is combined with Quinaprilat.,Quinaprilat,DB00016
DB14231,The serum concentration of Erythropoietin can be decreased when it is combined with Quinoline Yellow WS.,Quinoline Yellow WS,DB00016
DB15565,The serum concentration of Erythropoietin can be decreased when it is combined with Cilazaprilat.,Cilazaprilat,DB00016
DB00309,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vindesine.,Vindesine,DB00016
DB00361,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinorelbine.,Vinorelbine,DB00016
DB00541,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vincristine.,Vincristine,DB00016
DB00570,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinblastine.,Vinblastine,DB00016
DB05168,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vintafolide.,Vintafolide,DB00016
DB11641,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinflunine.,Vinflunine,DB00016
DB13374,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vincamine.,Vincamine,DB00016
DB00215,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Citalopram.,Citalopram,DB00017
DB00472,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Fluoxetine.,Fluoxetine,DB00017
DB00656,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Trazodone.,Trazodone,DB00017
DB01104,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Sertraline.,Sertraline,DB00017
DB01175,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Escitalopram.,Escitalopram,DB00017
DB04832,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Zimelidine.,Zimelidine,DB00017
DB04884,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dapoxetine.,Dapoxetine,DB00017
DB06731,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Seproxetine.,Seproxetine,DB00017
DB08953,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Indalpine.,Indalpine,DB00017
DB12693,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ritanserin.,Ritanserin,DB00017
DB13233,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Alaproclate.,Alaproclate,DB00017
DB00715,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Paroxetine.,Paroxetine,DB00017
DB00399,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Zoledronic acid.,Zoledronic acid,DB00017
DB00630,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Alendronic acid.,Alendronic acid,DB00017
DB00710,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Ibandronate.,Ibandronate,DB00017
DB00720,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Clodronic acid.,Clodronic acid,DB00017
DB00884,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Risedronic acid.,Risedronic acid,DB00017
DB01077,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Etidronic acid.,Etidronic acid,DB00017
DB06255,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Incadronic acid.,Incadronic acid,DB00017
DB00282,The risk or severity of hypocalcemia can be increased when Pamidronic acid is combined with Salmon calcitonin.,Pamidronic acid,DB00017
DB01133,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Tiludronic acid.,Tiludronic acid,DB00017
DB01356,Salmon calcitonin may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy.,Lithium cation,DB00017
DB14507,Salmon calcitonin may increase the excretion rate of Lithium citrate which could result in a lower serum level and potentially a reduction in efficacy.,Lithium citrate,DB00017
DB14509,Salmon calcitonin may increase the excretion rate of Lithium carbonate which could result in a lower serum level and potentially a reduction in efficacy.,Lithium carbonate,DB00017
DB14506,Salmon calcitonin may increase the excretion rate of Lithium hydroxide which could result in a lower serum level and potentially a reduction in efficacy.,Lithium hydroxide,DB00017
DB00091,Cyclosporine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cyclosporine,DB00017
DB00159,Icosapent may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Icosapent,DB00017
DB00229,Cefotiam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefotiam,DB00017
DB00244,Mesalazine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Mesalazine,DB00017
DB00267,Cefmenoxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefmenoxime,DB00017
DB00274,Cefmetazole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefmetazole,DB00017
DB00300,Tenofovir disoproxil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tenofovir disoproxil,DB00017
DB00328,Indomethacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Indomethacin,DB00017
DB00369,Cidofovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cidofovir,DB00017
DB00384,Triamterene may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Triamterene,DB00017
DB00430,Cefpiramide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefpiramide,DB00017
DB00438,Ceftazidime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftazidime,DB00017
DB00447,Loracarbef may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Loracarbef,DB00017
DB00456,Cefalotin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefalotin,DB00017
DB00461,Nabumetone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Nabumetone,DB00017
DB00465,Ketorolac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ketorolac,DB00017
DB00469,Tenoxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tenoxicam,DB00017
DB00482,Celecoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Celecoxib,DB00017
DB00493,Cefotaxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefotaxime,DB00017
DB00500,Tolmetin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tolmetin,DB00017
DB00529,Foscarnet may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Foscarnet,DB00017
DB00533,Rofecoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Rofecoxib,DB00017
DB00554,Piroxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Piroxicam,DB00017
DB00563,Methotrexate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Methotrexate,DB00017
DB00567,Cephalexin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cephalexin,DB00017
DB00573,Fenoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Fenoprofen,DB00017
DB00577,Valaciclovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Valaciclovir,DB00017
DB00580,Valdecoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Valdecoxib,DB00017
DB00586,Diclofenac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Diclofenac,DB00017
DB00605,Sulindac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Sulindac,DB00017
DB00626,Bacitracin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Bacitracin,DB00017
DB00681,Amphotericin B may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Amphotericin B,DB00017
DB00689,Cephaloglycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cephaloglycin,DB00017
DB00712,Flurbiprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Flurbiprofen,DB00017
DB00718,Adefovir dipivoxil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Adefovir dipivoxil,DB00017
DB00738,Pentamidine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Pentamidine,DB00017
DB00742,Mannitol may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Mannitol,DB00017
DB00749,Etodolac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Etodolac,DB00017
DB00784,Mefenamic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Mefenamic acid,DB00017
DB00787,Acyclovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Acyclovir,DB00017
DB00788,Naproxen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Naproxen,DB00017
DB00795,Sulfasalazine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Sulfasalazine,DB00017
DB00812,Phenylbutazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Phenylbutazone,DB00017
DB00814,Meloxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Meloxicam,DB00017
DB00821,Carprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Carprofen,DB00017
DB00833,Cefaclor may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefaclor,DB00017
DB00861,Diflunisal may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Diflunisal,DB00017
DB00864,Tacrolimus may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tacrolimus,DB00017
DB00903,Etacrynic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Etacrynic acid,DB00017
DB00923,Ceforanide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceforanide,DB00017
DB00936,Salicylic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Salicylic acid,DB00017
DB00939,Meclofenamic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Meclofenamic acid,DB00017
DB00945,Acetylsalicylic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Acetylsalicylic acid,DB00017
DB00958,Carboplatin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Carboplatin,DB00017
DB00991,Oxaprozin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Oxaprozin,DB00017
DB00999,Hydrochlorothiazide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Hydrochlorothiazide,DB00017
DB01009,Ketoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ketoprofen,DB00017
DB01014,Balsalazide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Balsalazide,DB00017
DB01050,Ibuprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ibuprofen,DB00017
DB01066,Cefditoren may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefditoren,DB00017
DB01072,Atazanavir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Atazanavir,DB00017
DB01111,Colistimethate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Colistimethate,DB00017
DB01112,Cefuroxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefuroxime,DB00017
DB01139,Cefapirin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefapirin,DB00017
DB01140,Cefadroxil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefadroxil,DB00017
DB01150,Cefprozil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefprozil,DB00017
DB01212,Ceftriaxone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftriaxone,DB00017
DB01250,Olsalazine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Olsalazine,DB00017
DB01283,Lumiracoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Lumiracoxib,DB00017
DB01326,Cefamandole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefamandole,DB00017
DB01327,Cefazolin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefazolin,DB00017
DB01328,Cefonicid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefonicid,DB00017
DB01329,Cefoperazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefoperazone,DB00017
DB01330,Cefotetan may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefotetan,DB00017
DB01331,Cefoxitin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefoxitin,DB00017
DB01332,Ceftizoxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftizoxime,DB00017
DB01333,Cefradine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefradine,DB00017
DB01397,Magnesium salicylate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Magnesium salicylate,DB00017
DB01399,Salsalate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Salsalate,DB00017
DB01401,Choline magnesium trisalicylate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Choline magnesium trisalicylate,DB00017
DB01413,Cefepime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefepime,DB00017
DB01414,Cefacetrile may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefacetrile,DB00017
DB01415,Ceftibuten may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftibuten,DB00017
DB01416,Cefpodoxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefpodoxime,DB00017
DB01419,Antrafenine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Antrafenine,DB00017
DB01424,Aminophenazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Aminophenazone,DB00017
DB01435,Antipyrine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Antipyrine,DB00017
DB01600,Tiaprofenic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tiaprofenic acid,DB00017
DB01601,Lopinavir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Lopinavir,DB00017
DB01628,Etoricoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Etoricoxib,DB00017
DB02247,Hydrolyzed Cephalothin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Hydrolyzed Cephalothin,DB00017
DB03450,Cephalothin Group may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cephalothin Group,DB00017
DB03585,Oxyphenbutazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Oxyphenbutazone,DB00017
DB04552,Niflumic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Niflumic acid,DB00017
DB04570,Latamoxef may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Latamoxef,DB00017
DB04743,Nimesulide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Nimesulide,DB00017
DB04812,Benoxaprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Benoxaprofen,DB00017
DB04817,Metamizole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Metamizole,DB00017
DB04828,Zomepirac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Zomepirac,DB00017
DB04918,Ceftobiprole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftobiprole,DB00017
DB05095,Cimicoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cimicoxib,DB00017
DB06590,Ceftaroline fosamil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftaroline fosamil,DB00017
DB06725,Lornoxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Lornoxicam,DB00017
DB06736,Aceclofenac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Aceclofenac,DB00017
DB06737,Zaltoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Zaltoprofen,DB00017
DB07402,Azapropazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Azapropazone,DB00017
DB07477,Felbinac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Felbinac,DB00017
DB08439,Parecoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Parecoxib,DB00017
DB08797,Salicylamide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Salicylamide,DB00017
DB08940,Kebuzone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Kebuzone,DB00017
DB08942,Isoxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Isoxicam,DB00017
DB08951,Indoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Indoprofen,DB00017
DB08955,Ibuproxam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ibuproxam,DB00017
DB08976,Floctafenine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Floctafenine,DB00017
DB08981,Fenbufen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Fenbufen,DB00017
DB08984,Etofenamate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Etofenamate,DB00017
DB08991,Epirizole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Epirizole,DB00017
DB09008,Cefaloridine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefaloridine,DB00017
DB09062,Cefminox may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefminox,DB00017
DB09084,Benzydamine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Benzydamine,DB00017
DB09212,Loxoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Loxoprofen,DB00017
DB09213,Dexibuprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Dexibuprofen,DB00017
DB09214,Dexketoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Dexketoprofen,DB00017
DB09215,Droxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Droxicam,DB00017
DB09216,Tolfenamic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tolfenamic acid,DB00017
DB09217,Firocoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Firocoxib,DB00017
DB09218,Clonixin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Clonixin,DB00017
DB09285,Morniflumate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Morniflumate,DB00017
DB09288,Propacetamol may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Propacetamol,DB00017
DB09295,Talniflumate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Talniflumate,DB00017
DB09299,Tenofovir alafenamide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tenofovir alafenamide,DB00017
DB11367,Cefroxadine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefroxadine,DB00017
DB11455,Robenacoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Robenacoxib,DB00017
DB11466,Tepoxalin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tepoxalin,DB00017
DB11518,Flunixin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Flunixin,DB00017
DB11935,Flomoxef may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Flomoxef,DB00017
DB12151,Brincidofovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Brincidofovir,DB00017
DB12445,Nitroaspirin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Nitroaspirin,DB00017
DB12545,Indobufen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Indobufen,DB00017
DB13001,Tinoridine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tinoridine,DB00017
DB13167,Alclofenac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Alclofenac,DB00017
DB13217,Fentiazac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Fentiazac,DB00017
DB13232,Suxibuzone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Suxibuzone,DB00017
DB13266,Cefatrizine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefatrizine,DB00017
DB13286,Bumadizone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Bumadizone,DB00017
DB13314,Alminoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Alminoprofen,DB00017
DB13317,Flunoxaprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Flunoxaprofen,DB00017
DB13364,Feprazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Feprazone,DB00017
DB13371,Difenpiramide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Difenpiramide,DB00017
DB13407,Nifenazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Nifenazone,DB00017
DB13432,Lonazolac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Lonazolac,DB00017
DB13461,Cefcapene may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefcapene,DB00017
DB13470,Cefodizime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefodizime,DB00017
DB13481,Tenidap may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tenidap,DB00017
DB13499,Cefsulodin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefsulodin,DB00017
DB13501,Bendazac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Bendazac,DB00017
DB13504,Cefetamet may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefetamet,DB00017
DB13514,Pranoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Pranoprofen,DB00017
DB13524,Propyphenazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Propyphenazone,DB00017
DB13527,Proglumetacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Proglumetacin,DB00017
DB13538,Guacetisal may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Guacetisal,DB00017
DB13544,Ethenzamide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ethenzamide,DB00017
DB13612,Carbaspirin calcium may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Carbaspirin calcium,DB00017
DB13629,Mofebutazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Mofebutazone,DB00017
DB13638,Cefbuperazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefbuperazone,DB00017
DB13649,Proquazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Proquazone,DB00017
DB13657,Benorilate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Benorilate,DB00017
DB13667,Cefozopran may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefozopran,DB00017
DB13682,Cefpirome may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefpirome,DB00017
DB13722,Pirprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Pirprofen,DB00017
DB13778,Cefazedone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefazedone,DB00017
DB13783,Acemetacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Acemetacin,DB00017
DB13821,Ceftezole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftezole,DB00017
DB13860,Imidazole salicylate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Imidazole salicylate,DB00017
DB13868,Adefovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Adefovir,DB00017
DB14059,SC-236 may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,SC-236,DB00017
DB14060,NS-398 may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,NS-398,DB00017
DB14126,Tenofovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tenofovir,DB00017
DB14713,Inotersen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Inotersen,DB00017
DB01438,Phenazopyridine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Phenazopyridine,DB00017
DB15066,Givosiran may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Givosiran,DB00017
DB00007,Leuprolide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Leuprolide,DB00017
DB00014,Goserelin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Goserelin,DB00017
DB00035,Salmon calcitonin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Desmopressin,DB00017
DB00080,Salmon calcitonin may decrease the excretion rate of Daptomycin which could result in a higher serum level.,Daptomycin,DB00017
DB00081,Salmon calcitonin may decrease the excretion rate of Tositumomab which could result in a higher serum level.,Tositumomab,DB00017
DB00115,Salmon calcitonin may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.,Cyanocobalamin,DB00017
DB00158,Salmon calcitonin may decrease the excretion rate of Folic acid which could result in a higher serum level.,Folic acid,DB00017
DB00165,Salmon calcitonin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,Pyridoxine,DB00017
DB00176,Salmon calcitonin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,Fluvoxamine,DB00017
DB00181,Salmon calcitonin may decrease the excretion rate of Baclofen which could result in a higher serum level.,Baclofen,DB00017
DB00185,Salmon calcitonin may decrease the excretion rate of Cevimeline which could result in a higher serum level.,Cevimeline,DB00017
DB00186,Salmon calcitonin may decrease the excretion rate of Lorazepam which could result in a higher serum level.,Lorazepam,DB00017
DB00190,Salmon calcitonin may decrease the excretion rate of Carbidopa which could result in a higher serum level.,Carbidopa,DB00017
DB00193,Salmon calcitonin may decrease the excretion rate of Tramadol which could result in a higher serum level.,Tramadol,DB00017
DB00196,Salmon calcitonin may decrease the excretion rate of Fluconazole which could result in a higher serum level.,Fluconazole,DB00017
DB00198,Salmon calcitonin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,Oseltamivir,DB00017
DB00200,Salmon calcitonin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,Hydroxocobalamin,DB00017
DB00206,Salmon calcitonin may decrease the excretion rate of Reserpine which could result in a higher serum level.,Reserpine,DB00017
DB00208,Salmon calcitonin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,Ticlopidine,DB00017
DB00213,Salmon calcitonin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.,Pantoprazole,DB00017
DB00225,Salmon calcitonin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,Gadodiamide,DB00017
DB00230,Salmon calcitonin may decrease the excretion rate of Pregabalin which could result in a higher serum level.,Pregabalin,DB00017
DB00231,Salmon calcitonin may decrease the excretion rate of Temazepam which could result in a higher serum level.,Temazepam,DB00017
DB00235,Salmon calcitonin may decrease the excretion rate of Milrinone which could result in a higher serum level.,Milrinone,DB00017
DB00237,Salmon calcitonin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,Butabarbital,DB00017
DB00243,Salmon calcitonin may decrease the excretion rate of Ranolazine which could result in a higher serum level.,Ranolazine,DB00017
DB00245,Salmon calcitonin may decrease the excretion rate of Benzatropine which could result in a higher serum level.,Benzatropine,DB00017
DB00254,Salmon calcitonin may decrease the excretion rate of Doxycycline which could result in a higher serum level.,Doxycycline,DB00017
DB00262,Salmon calcitonin may decrease the excretion rate of Carmustine which could result in a higher serum level.,Carmustine,DB00017
DB00264,Salmon calcitonin may decrease the excretion rate of Metoprolol which could result in a higher serum level.,Metoprolol,DB00017
DB00270,Salmon calcitonin may decrease the excretion rate of Isradipine which could result in a higher serum level.,Isradipine,DB00017
DB00271,Salmon calcitonin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,Diatrizoate,DB00017
DB00273,Salmon calcitonin may decrease the excretion rate of Topiramate which could result in a higher serum level.,Topiramate,DB00017
DB00279,Salmon calcitonin may decrease the excretion rate of Liothyronine which could result in a higher serum level.,Liothyronine,DB00017
DB00280,Salmon calcitonin may decrease the excretion rate of Disopyramide which could result in a higher serum level.,Disopyramide,DB00017
DB00284,Salmon calcitonin may decrease the excretion rate of Acarbose which could result in a higher serum level.,Acarbose,DB00017
DB00285,Salmon calcitonin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,Venlafaxine,DB00017
DB00286,Salmon calcitonin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,Conjugated estrogens,DB00017
DB00289,Salmon calcitonin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.,Atomoxetine,DB00017
DB00290,Salmon calcitonin may decrease the excretion rate of Bleomycin which could result in a higher serum level.,Bleomycin,DB00017
DB00292,Salmon calcitonin may decrease the excretion rate of Etomidate which could result in a higher serum level.,Etomidate,DB00017
DB00294,Salmon calcitonin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,Etonogestrel,DB00017
DB00296,Salmon calcitonin may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,Ropivacaine,DB00017
DB00303,Salmon calcitonin may decrease the excretion rate of Ertapenem which could result in a higher serum level.,Ertapenem,DB00017
DB00308,Salmon calcitonin may decrease the excretion rate of Ibutilide which could result in a higher serum level.,Ibutilide,DB00017
DB00312,Salmon calcitonin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,Pentobarbital,DB00017
DB00316,Salmon calcitonin may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,Acetaminophen,DB00017
DB00319,Salmon calcitonin may decrease the excretion rate of Piperacillin which could result in a higher serum level.,Piperacillin,DB00017
DB00322,Salmon calcitonin may decrease the excretion rate of Floxuridine which could result in a higher serum level.,Floxuridine,DB00017
DB00323,Salmon calcitonin may decrease the excretion rate of Tolcapone which could result in a higher serum level.,Tolcapone,DB00017
DB00325,Salmon calcitonin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,Nitroprusside,DB00017
DB00327,Salmon calcitonin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,Hydromorphone,DB00017
DB00330,Salmon calcitonin may decrease the excretion rate of Ethambutol which could result in a higher serum level.,Ethambutol,DB00017
DB00331,Salmon calcitonin may decrease the excretion rate of Metformin which could result in a higher serum level.,Metformin,DB00017
DB00333,Salmon calcitonin may decrease the excretion rate of Methadone which could result in a higher serum level.,Methadone,DB00017
DB00339,Salmon calcitonin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,Pyrazinamide,DB00017
DB00341,Salmon calcitonin may decrease the excretion rate of Cetirizine which could result in a higher serum level.,Cetirizine,DB00017
DB00349,Salmon calcitonin may decrease the excretion rate of Clobazam which could result in a higher serum level.,Clobazam,DB00017
DB00351,Salmon calcitonin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,Megestrol acetate,DB00017
DB00355,Salmon calcitonin may decrease the excretion rate of Aztreonam which could result in a higher serum level.,Aztreonam,DB00017
DB00356,Salmon calcitonin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,Chlorzoxazone,DB00017
DB00359,Salmon calcitonin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,Sulfadiazine,DB00017
DB00363,Salmon calcitonin may decrease the excretion rate of Clozapine which could result in a higher serum level.,Clozapine,DB00017
DB00364,Salmon calcitonin may decrease the excretion rate of Sucralfate which could result in a higher serum level.,Sucralfate,DB00017
DB00372,Salmon calcitonin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,Thiethylperazine,DB00017
DB00373,Salmon calcitonin may decrease the excretion rate of Timolol which could result in a higher serum level.,Timolol,DB00017
DB00377,Salmon calcitonin may decrease the excretion rate of Palonosetron which could result in a higher serum level.,Palonosetron,DB00017
DB00380,Salmon calcitonin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,Dexrazoxane,DB00017
DB00401,Salmon calcitonin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,Nisoldipine,DB00017
DB00402,Salmon calcitonin may decrease the excretion rate of Eszopiclone which could result in a higher serum level.,Eszopiclone,DB00017
DB00404,Salmon calcitonin may decrease the excretion rate of Alprazolam which could result in a higher serum level.,Alprazolam,DB00017
DB00412,Salmon calcitonin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,Rosiglitazone,DB00017
DB00413,Salmon calcitonin may decrease the excretion rate of Pramipexole which could result in a higher serum level.,Pramipexole,DB00017
DB00415,Salmon calcitonin may decrease the excretion rate of Ampicillin which could result in a higher serum level.,Ampicillin,DB00017
DB00418,Salmon calcitonin may decrease the excretion rate of Secobarbital which could result in a higher serum level.,Secobarbital,DB00017
DB00422,Salmon calcitonin may decrease the excretion rate of Methylphenidate which could result in a higher serum level.,Methylphenidate,DB00017
DB00432,Salmon calcitonin may decrease the excretion rate of Trifluridine which could result in a higher serum level.,Trifluridine,DB00017
DB00435,Salmon calcitonin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,Nitric Oxide,DB00017
DB00437,Salmon calcitonin may decrease the excretion rate of Allopurinol which could result in a higher serum level.,Allopurinol,DB00017
DB00440,Salmon calcitonin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.,Trimethoprim,DB00017
DB00441,Salmon calcitonin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,Gemcitabine,DB00017
DB00476,Salmon calcitonin may decrease the excretion rate of Duloxetine which could result in a higher serum level.,Duloxetine,DB00017
DB00477,Salmon calcitonin may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.,Chlorpromazine,DB00017
DB00480,Salmon calcitonin may decrease the excretion rate of Lenalidomide which could result in a higher serum level.,Lenalidomide,DB00017
DB00490,Salmon calcitonin may decrease the excretion rate of Buspirone which could result in a higher serum level.,Buspirone,DB00017
DB00492,Salmon calcitonin may decrease the excretion rate of Fosinopril which could result in a higher serum level.,Fosinopril,DB00017
DB00499,Salmon calcitonin may decrease the excretion rate of Flutamide which could result in a higher serum level.,Flutamide,DB00017
DB00501,Salmon calcitonin may decrease the excretion rate of Cimetidine which could result in a higher serum level.,Cimetidine,DB00017
DB00502,Salmon calcitonin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,Haloperidol,DB00017
DB00535,Salmon calcitonin may decrease the excretion rate of Cefdinir which could result in a higher serum level.,Cefdinir,DB00017
DB00537,Salmon calcitonin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.,Ciprofloxacin,DB00017
DB00548,Salmon calcitonin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.,Azelaic acid,DB00017
DB00553,Salmon calcitonin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.,Methoxsalen,DB00017
DB00555,Salmon calcitonin may decrease the excretion rate of Lamotrigine which could result in a higher serum level.,Lamotrigine,DB00017
DB00558,Salmon calcitonin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,Zanamivir,DB00017
DB00569,Salmon calcitonin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.,Fondaparinux,DB00017
DB00571,Salmon calcitonin may decrease the excretion rate of Propranolol which could result in a higher serum level.,Propranolol,DB00017
DB00583,Salmon calcitonin may decrease the excretion rate of Levocarnitine which could result in a higher serum level.,Levocarnitine,DB00017
DB00591,Salmon calcitonin may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.,Fluocinolone acetonide,DB00017
DB00597,Salmon calcitonin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,Gadoteridol,DB00017
DB00603,Salmon calcitonin may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.,Medroxyprogesterone acetate,DB00017
DB00608,Salmon calcitonin may decrease the excretion rate of Chloroquine which could result in a higher serum level.,Chloroquine,DB00017
DB00612,Salmon calcitonin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,Bisoprolol,DB00017
DB00624,Salmon calcitonin may decrease the excretion rate of Testosterone which could result in a higher serum level.,Testosterone,DB00017
DB00628,Salmon calcitonin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.,Clorazepic acid,DB00017
DB00631,Salmon calcitonin may decrease the excretion rate of Clofarabine which could result in a higher serum level.,Clofarabine,DB00017
DB00633,Salmon calcitonin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.,Dexmedetomidine,DB00017
DB00635,Salmon calcitonin may decrease the excretion rate of Prednisone which could result in a higher serum level.,Prednisone,DB00017
DB00651,Salmon calcitonin may decrease the excretion rate of Dyphylline which could result in a higher serum level.,Dyphylline,DB00017
DB00657,Salmon calcitonin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.,Mecamylamine,DB00017
DB00660,Salmon calcitonin may decrease the excretion rate of Metaxalone which could result in a higher serum level.,Metaxalone,DB00017
DB00661,Salmon calcitonin may decrease the excretion rate of Verapamil which could result in a higher serum level.,Verapamil,DB00017
DB00665,Salmon calcitonin may decrease the excretion rate of Nilutamide which could result in a higher serum level.,Nilutamide,DB00017
DB00669,Salmon calcitonin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.,Sumatriptan,DB00017
DB00683,Salmon calcitonin may decrease the excretion rate of Midazolam which could result in a higher serum level.,Midazolam,DB00017
DB00688,Salmon calcitonin may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.,Mycophenolate mofetil,DB00017
DB00690,Salmon calcitonin may decrease the excretion rate of Flurazepam which could result in a higher serum level.,Flurazepam,DB00017
DB00692,Salmon calcitonin may decrease the excretion rate of Phentolamine which could result in a higher serum level.,Phentolamine,DB00017
DB00698,Salmon calcitonin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,Nitrofurantoin,DB00017
DB00706,Salmon calcitonin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.,Tamsulosin,DB00017
DB00709,Salmon calcitonin may decrease the excretion rate of Lamivudine which could result in a higher serum level.,Lamivudine,DB00017
DB00713,Salmon calcitonin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,Oxacillin,DB00017
DB00716,Salmon calcitonin may decrease the excretion rate of Nedocromil which could result in a higher serum level.,Nedocromil,DB00017
DB00722,Salmon calcitonin may decrease the excretion rate of Lisinopril which could result in a higher serum level.,Lisinopril,DB00017
DB00730,Salmon calcitonin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.,Thiabendazole,DB00017
DB00731,Salmon calcitonin may decrease the excretion rate of Nateglinide which could result in a higher serum level.,Nateglinide,DB00017
DB00733,Salmon calcitonin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.,Pralidoxime,DB00017
DB00743,Salmon calcitonin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,Gadobenic acid,DB00017
DB00759,Salmon calcitonin may decrease the excretion rate of Tetracycline which could result in a higher serum level.,Tetracycline,DB00017
DB00760,Salmon calcitonin may decrease the excretion rate of Meropenem which could result in a higher serum level.,Meropenem,DB00017
DB00761,Salmon calcitonin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.,Potassium chloride,DB00017
DB00763,Salmon calcitonin may decrease the excretion rate of Methimazole which could result in a higher serum level.,Methimazole,DB00017
DB00775,Salmon calcitonin may decrease the excretion rate of Tirofiban which could result in a higher serum level.,Tirofiban,DB00017
DB00780,Salmon calcitonin may decrease the excretion rate of Phenelzine which could result in a higher serum level.,Phenelzine,DB00017
DB00782,Salmon calcitonin may decrease the excretion rate of Propantheline which could result in a higher serum level.,Propantheline,DB00017
DB00783,Salmon calcitonin may decrease the excretion rate of Estradiol which could result in a higher serum level.,Estradiol,DB00017
DB00789,Salmon calcitonin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,Gadopentetic acid,DB00017
DB00790,Salmon calcitonin may decrease the excretion rate of Perindopril which could result in a higher serum level.,Perindopril,DB00017
DB00800,Salmon calcitonin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.,Fenoldopam,DB00017
DB00804,Salmon calcitonin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.,Dicyclomine,DB00017
DB00806,Salmon calcitonin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.,Pentoxifylline,DB00017
DB00811,Salmon calcitonin may decrease the excretion rate of Ribavirin which could result in a higher serum level.,Ribavirin,DB00017
DB00820,Salmon calcitonin may decrease the excretion rate of Tadalafil which could result in a higher serum level.,Tadalafil,DB00017
DB00828,Salmon calcitonin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.,Fosfomycin,DB00017
DB00842,Salmon calcitonin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,Oxazepam,DB00017
DB00851,Salmon calcitonin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,Dacarbazine,DB00017
DB00853,Salmon calcitonin may decrease the excretion rate of Temozolomide which could result in a higher serum level.,Temozolomide,DB00017
DB00863,Salmon calcitonin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,Ranitidine,DB00017
DB00894,Salmon calcitonin may decrease the excretion rate of Testolactone which could result in a higher serum level.,Testolactone,DB00017
DB00897,Salmon calcitonin may decrease the excretion rate of Triazolam which could result in a higher serum level.,Triazolam,DB00017
DB00900,Salmon calcitonin may decrease the excretion rate of Didanosine which could result in a higher serum level.,Didanosine,DB00017
DB00911,Salmon calcitonin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,Tinidazole,DB00017
DB00915,Salmon calcitonin may decrease the excretion rate of Amantadine which could result in a higher serum level.,Amantadine,DB00017
DB00918,Salmon calcitonin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,Almotriptan,DB00017
DB00928,Salmon calcitonin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,Azacitidine,DB00017
DB00934,Salmon calcitonin may decrease the excretion rate of Maprotiline which could result in a higher serum level.,Maprotiline,DB00017
DB00951,Salmon calcitonin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,Isoniazid,DB00017
DB00953,Salmon calcitonin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,Rizatriptan,DB00017
DB00960,Salmon calcitonin may decrease the excretion rate of Pindolol which could result in a higher serum level.,Pindolol,DB00017
DB00961,Salmon calcitonin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,Mepivacaine,DB00017
DB00962,Salmon calcitonin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,Zaleplon,DB00017
DB00968,Salmon calcitonin may decrease the excretion rate of Methyldopa which could result in a higher serum level.,Methyldopa,DB00017
DB00980,Salmon calcitonin may decrease the excretion rate of Ramelteon which could result in a higher serum level.,Ramelteon,DB00017
DB00993,Salmon calcitonin may decrease the excretion rate of Azathioprine which could result in a higher serum level.,Azathioprine,DB00017
DB00995,Salmon calcitonin may decrease the excretion rate of Auranofin which could result in a higher serum level.,Auranofin,DB00017
DB01001,Salmon calcitonin may decrease the excretion rate of Salbutamol which could result in a higher serum level.,Salbutamol,DB00017
DB01002,Salmon calcitonin may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,Levobupivacaine,DB00017
DB01004,Salmon calcitonin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,Ganciclovir,DB00017
DB01010,Salmon calcitonin may decrease the excretion rate of Edrophonium which could result in a higher serum level.,Edrophonium,DB00017
DB01011,Salmon calcitonin may decrease the excretion rate of Metyrapone which could result in a higher serum level.,Metyrapone,DB00017
DB01015,Salmon calcitonin may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,Sulfamethoxazole,DB00017
DB01018,Salmon calcitonin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,Guanfacine,DB00017
DB01020,Salmon calcitonin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,Isosorbide mononitrate,DB00017
DB01022,Salmon calcitonin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,Phylloquinone,DB00017
DB01024,Salmon calcitonin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,Mycophenolic acid,DB00017
DB01030,Salmon calcitonin may decrease the excretion rate of Topotecan which could result in a higher serum level.,Topotecan,DB00017
DB01032,Salmon calcitonin may decrease the excretion rate of Probenecid which could result in a higher serum level.,Probenecid,DB00017
DB01036,Salmon calcitonin may decrease the excretion rate of Tolterodine which could result in a higher serum level.,Tolterodine,DB00017
DB01039,Salmon calcitonin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.,Fenofibrate,DB00017
DB01043,Salmon calcitonin may decrease the excretion rate of Memantine which could result in a higher serum level.,Memantine,DB00017
DB01046,Salmon calcitonin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.,Lubiprostone,DB00017
DB01048,Salmon calcitonin may decrease the excretion rate of Abacavir which could result in a higher serum level.,Abacavir,DB00017
DB01060,Salmon calcitonin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.,Amoxicillin,DB00017
DB01068,Salmon calcitonin may decrease the excretion rate of Clonazepam which could result in a higher serum level.,Clonazepam,DB00017
DB01069,Salmon calcitonin may decrease the excretion rate of Promethazine which could result in a higher serum level.,Promethazine,DB00017
DB01093,Salmon calcitonin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.,Dimethyl sulfoxide,DB00017
DB01099,Salmon calcitonin may decrease the excretion rate of Flucytosine which could result in a higher serum level.,Flucytosine,DB00017
DB01101,Salmon calcitonin may decrease the excretion rate of Capecitabine which could result in a higher serum level.,Capecitabine,DB00017
DB01105,Salmon calcitonin may decrease the excretion rate of Sibutramine which could result in a higher serum level.,Sibutramine,DB00017
DB01115,Salmon calcitonin may decrease the excretion rate of Nifedipine which could result in a higher serum level.,Nifedipine,DB00017
DB01129,Salmon calcitonin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.,Rabeprazole,DB00017
DB01135,Salmon calcitonin may decrease the excretion rate of Doxacurium which could result in a higher serum level.,Doxacurium,DB00017
DB01137,Salmon calcitonin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.,Levofloxacin,DB00017
DB01148,Salmon calcitonin may decrease the excretion rate of Flavoxate which could result in a higher serum level.,Flavoxate,DB00017
DB01149,Salmon calcitonin may decrease the excretion rate of Nefazodone which could result in a higher serum level.,Nefazodone,DB00017
DB01156,Salmon calcitonin may decrease the excretion rate of Bupropion which could result in a higher serum level.,Bupropion,DB00017
DB01157,Salmon calcitonin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.,Trimetrexate,DB00017
DB01166,Salmon calcitonin may decrease the excretion rate of Cilostazol which could result in a higher serum level.,Cilostazol,DB00017
DB01169,Salmon calcitonin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,Arsenic trioxide,DB00017
DB01170,Salmon calcitonin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,Guanethidine,DB00017
DB01181,Salmon calcitonin may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,Ifosfamide,DB00017
DB01183,Salmon calcitonin may decrease the excretion rate of Naloxone which could result in a higher serum level.,Naloxone,DB00017
DB01203,Salmon calcitonin may decrease the excretion rate of Nadolol which could result in a higher serum level.,Nadolol,DB00017
DB01205,Salmon calcitonin may decrease the excretion rate of Flumazenil which could result in a higher serum level.,Flumazenil,DB00017
DB01213,Salmon calcitonin may decrease the excretion rate of Fomepizole which could result in a higher serum level.,Fomepizole,DB00017
DB01215,Salmon calcitonin may decrease the excretion rate of Estazolam which could result in a higher serum level.,Estazolam,DB00017
DB01221,Salmon calcitonin may decrease the excretion rate of Ketamine which could result in a higher serum level.,Ketamine,DB00017
DB01222,Salmon calcitonin may decrease the excretion rate of Budesonide which could result in a higher serum level.,Budesonide,DB00017
DB01224,Salmon calcitonin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,Quetiapine,DB00017
DB01240,Salmon calcitonin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,Epoprostenol,DB00017
DB01241,Salmon calcitonin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,Gemfibrozil,DB00017
DB01249,Salmon calcitonin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,Iodixanol,DB00017
DB01261,Salmon calcitonin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,Sitagliptin,DB00017
DB01267,Salmon calcitonin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,Paliperidone,DB00017
DB01273,Salmon calcitonin may decrease the excretion rate of Varenicline which could result in a higher serum level.,Varenicline,DB00017
DB01274,Salmon calcitonin may decrease the excretion rate of Arformoterol which could result in a higher serum level.,Arformoterol,DB00017
DB01275,Salmon calcitonin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,Hydralazine,DB00017
DB01359,Salmon calcitonin may decrease the excretion rate of Penbutolol which could result in a higher serum level.,Penbutolol,DB00017
DB01367,Salmon calcitonin may decrease the excretion rate of Rasagiline which could result in a higher serum level.,Rasagiline,DB00017
DB01394,Salmon calcitonin may decrease the excretion rate of Colchicine which could result in a higher serum level.,Colchicine,DB00017
DB01409,Salmon calcitonin may decrease the excretion rate of Tiotropium which could result in a higher serum level.,Tiotropium,DB00017
DB01420,Salmon calcitonin may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.,Testosterone propionate,DB00017
DB01427,Salmon calcitonin may decrease the excretion rate of Amrinone which could result in a higher serum level.,Amrinone,DB00017
DB01428,Salmon calcitonin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,Oxybenzone,DB00017
DB01431,Salmon calcitonin may decrease the excretion rate of Allylestrenol which could result in a higher serum level.,Allylestrenol,DB00017
DB01550,Salmon calcitonin may decrease the excretion rate of Fenproporex which could result in a higher serum level.,Fenproporex,DB00017
DB01558,Salmon calcitonin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,Bromazepam,DB00017
DB01563,Salmon calcitonin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.,Chloral hydrate,DB00017
DB01587,Salmon calcitonin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,Ketazolam,DB00017
DB01610,Salmon calcitonin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,Valganciclovir,DB00017
DB01638,Salmon calcitonin may decrease the excretion rate of Sorbitol which could result in a higher serum level.,Sorbitol,DB00017
DB01656,Salmon calcitonin may decrease the excretion rate of Roflumilast which could result in a higher serum level.,Roflumilast,DB00017
DB01685,Salmon calcitonin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,Topiroxostat,DB00017
DB04574,Salmon calcitonin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,Estrone sulfate,DB00017
DB04871,Salmon calcitonin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,Lorcaserin,DB00017
DB04895,Salmon calcitonin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,Pegaptanib,DB00017
DB04896,Salmon calcitonin may decrease the excretion rate of Milnacipran which could result in a higher serum level.,Milnacipran,DB00017
DB04920,Salmon calcitonin may decrease the excretion rate of Clevidipine which could result in a higher serum level.,Clevidipine,DB00017
DB04948,Salmon calcitonin may decrease the excretion rate of Lofexidine which could result in a higher serum level.,Lofexidine,DB00017
DB04953,Salmon calcitonin may decrease the excretion rate of Ezogabine which could result in a higher serum level.,Ezogabine,DB00017
DB05018,Salmon calcitonin may decrease the excretion rate of Migalastat which could result in a higher serum level.,Migalastat,DB00017
DB05541,Salmon calcitonin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,Brivaracetam,DB00017
DB05676,Salmon calcitonin may decrease the excretion rate of Apremilast which could result in a higher serum level.,Apremilast,DB00017
DB06154,Salmon calcitonin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,Pentaerythritol tetranitrate,DB00017
DB06186,Salmon calcitonin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,Ipilimumab,DB00017
DB06196,Salmon calcitonin may decrease the excretion rate of Icatibant which could result in a higher serum level.,Icatibant,DB00017
DB06203,Salmon calcitonin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,Alogliptin,DB00017
DB06209,Salmon calcitonin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,Prasugrel,DB00017
DB06211,Salmon calcitonin may decrease the excretion rate of Doripenem which could result in a higher serum level.,Doripenem,DB00017
DB06228,Salmon calcitonin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,Rivaroxaban,DB00017
DB06230,Salmon calcitonin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,Nalmefene,DB00017
DB06262,Salmon calcitonin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,Droxidopa,DB00017
DB06282,Salmon calcitonin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,Levocetirizine,DB00017
DB06335,Salmon calcitonin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,Saxagliptin,DB00017
DB06402,Salmon calcitonin may decrease the excretion rate of Telavancin which could result in a higher serum level.,Telavancin,DB00017
DB06480,Salmon calcitonin may decrease the excretion rate of Prucalopride which could result in a higher serum level.,Prucalopride,DB00017
DB06623,Salmon calcitonin may decrease the excretion rate of Flupirtine which could result in a higher serum level.,Flupirtine,DB00017
DB06637,Salmon calcitonin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,Dalfampridine,DB00017
DB06695,Salmon calcitonin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,Dabigatran etexilate,DB00017
DB06700,Salmon calcitonin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.,Desvenlafaxine,DB00017
DB06702,Salmon calcitonin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,Fesoterodine,DB00017
DB06705,Salmon calcitonin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,Gadofosveset trisodium,DB00017
DB06710,Salmon calcitonin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,Methyltestosterone,DB00017
DB06767,Salmon calcitonin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,Ammonium chloride,DB00017
DB06782,Salmon calcitonin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,Dimercaprol,DB00017
DB06796,Salmon calcitonin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,Mangafodipir,DB00017
DB06800,Salmon calcitonin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,Methylnaltrexone,DB00017
DB06809,Salmon calcitonin may decrease the excretion rate of Plerixafor which could result in a higher serum level.,Plerixafor,DB00017
DB06813,Salmon calcitonin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,Pralatrexate,DB00017
DB06823,Salmon calcitonin may decrease the excretion rate of Tiopronin which could result in a higher serum level.,Tiopronin,DB00017
DB06824,Salmon calcitonin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,Triethylenetetramine,DB00017
DB08824,Salmon calcitonin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,Ioflupane I-123,DB00017
DB08826,Salmon calcitonin may decrease the excretion rate of Deferiprone which could result in a higher serum level.,Deferiprone,DB00017
DB08840,Salmon calcitonin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,N-methylnicotinamide,DB00017
DB08872,Salmon calcitonin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,Gabapentin enacarbil,DB00017
DB08893,Salmon calcitonin may decrease the excretion rate of Mirabegron which could result in a higher serum level.,Mirabegron,DB00017
DB08894,Salmon calcitonin may decrease the excretion rate of Peginesatide which could result in a higher serum level.,Peginesatide,DB00017
DB08897,Salmon calcitonin may decrease the excretion rate of Aclidinium which could result in a higher serum level.,Aclidinium,DB00017
DB08899,Salmon calcitonin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,Enzalutamide,DB00017
DB08900,Salmon calcitonin may decrease the excretion rate of Teduglutide which could result in a higher serum level.,Teduglutide,DB00017
DB08904,Salmon calcitonin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,Certolizumab pegol,DB00017
DB08905,Salmon calcitonin may decrease the excretion rate of Formestane which could result in a higher serum level.,Formestane,DB00017
DB08909,Salmon calcitonin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,Glycerol phenylbutyrate,DB00017
DB08910,Salmon calcitonin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,Pomalidomide,DB00017
DB08911,Salmon calcitonin may decrease the excretion rate of Trametinib which could result in a higher serum level.,Trametinib,DB00017
DB08918,Salmon calcitonin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,Levomilnacipran,DB00017
DB08932,Salmon calcitonin may decrease the excretion rate of Macitentan which could result in a higher serum level.,Macitentan,DB00017
DB08934,Salmon calcitonin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,Sofosbuvir,DB00017
DB08964,Salmon calcitonin may decrease the excretion rate of Gemeprost which could result in a higher serum level.,Gemeprost,DB00017
DB09027,Salmon calcitonin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,Ledipasvir,DB00017
DB09050,Salmon calcitonin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,Ceftolozane,DB00017
DB09066,Salmon calcitonin may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,Corifollitropin alfa,DB00017
DB09068,Salmon calcitonin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,Vortioxetine,DB00017
DB09071,Salmon calcitonin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,Tasimelteon,DB00017
DB09075,Salmon calcitonin may decrease the excretion rate of Edoxaban which could result in a higher serum level.,Edoxaban,DB00017
DB09081,Salmon calcitonin may decrease the excretion rate of Idebenone which could result in a higher serum level.,Idebenone,DB00017
DB09082,Salmon calcitonin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,Vilanterol,DB00017
DB09089,Salmon calcitonin may decrease the excretion rate of Trimebutine which could result in a higher serum level.,Trimebutine,DB00017
DB09091,Salmon calcitonin may decrease the excretion rate of Tixocortol which could result in a higher serum level.,Tixocortol,DB00017
DB09103,Salmon calcitonin may decrease the excretion rate of Ancestim which could result in a higher serum level.,Ancestim,DB00017
DB09104,Salmon calcitonin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.,Magnesium hydroxide,DB00017
DB09106,Salmon calcitonin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,Hydroxyethyl Starch,DB00017
DB09111,Salmon calcitonin may decrease the excretion rate of Pentastarch which could result in a higher serum level.,Pentastarch,DB00017
DB09118,Salmon calcitonin may decrease the excretion rate of Stiripentol which could result in a higher serum level.,Stiripentol,DB00017
DB09121,Salmon calcitonin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.,Aurothioglucose,DB00017
DB09123,Salmon calcitonin may decrease the excretion rate of Dienogest which could result in a higher serum level.,Dienogest,DB00017
DB09129,Salmon calcitonin may decrease the excretion rate of Chromic chloride which could result in a higher serum level.,Chromic chloride,DB00017
DB09132,Salmon calcitonin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,Gadoteric acid,DB00017
DB09133,Salmon calcitonin may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.,Iothalamic acid,DB00017
DB09134,Salmon calcitonin may decrease the excretion rate of Ioversol which could result in a higher serum level.,Ioversol,DB00017
DB09135,Salmon calcitonin may decrease the excretion rate of Ioxilan which could result in a higher serum level.,Ioxilan,DB00017
DB09136,Salmon calcitonin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.,Isosulfan blue,DB00017
DB09137,Salmon calcitonin may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.,Technetium Tc-99m mebrofenin,DB00017
DB09139,Salmon calcitonin may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.,Technetium Tc-99m oxidronate,DB00017
DB09148,Salmon calcitonin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.,Florbetaben (18F),DB00017
DB09149,Salmon calcitonin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.,Florbetapir (18F),DB00017
DB09156,Salmon calcitonin may decrease the excretion rate of Iopromide which could result in a higher serum level.,Iopromide,DB00017
DB09163,Salmon calcitonin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.,Technetium Tc-99m exametazime,DB00017
DB09165,Salmon calcitonin may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.,Technetium Tc-99m pyrophosphate,DB00017
DB09185,Salmon calcitonin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,Viloxazine,DB00017
DB09194,Salmon calcitonin may decrease the excretion rate of Etoperidone which could result in a higher serum level.,Etoperidone,DB00017
DB09195,Salmon calcitonin may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.,Lorpiprazole,DB00017
DB09204,Salmon calcitonin may decrease the excretion rate of Arotinolol which could result in a higher serum level.,Arotinolol,DB00017
DB09205,Salmon calcitonin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.,Moxisylyte,DB00017
DB09209,Salmon calcitonin may decrease the excretion rate of Pholcodine which could result in a higher serum level.,Pholcodine,DB00017
DB09210,Salmon calcitonin may decrease the excretion rate of Piracetam which could result in a higher serum level.,Piracetam,DB00017
DB09219,Salmon calcitonin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,Bisoxatin,DB00017
DB09220,Salmon calcitonin may decrease the excretion rate of Nicorandil which could result in a higher serum level.,Nicorandil,DB00017
DB09223,Salmon calcitonin may decrease the excretion rate of Blonanserin which could result in a higher serum level.,Blonanserin,DB00017
DB09224,Salmon calcitonin may decrease the excretion rate of Melperone which could result in a higher serum level.,Melperone,DB00017
DB09241,Salmon calcitonin may decrease the excretion rate of Methylene blue which could result in a higher serum level.,Methylene blue,DB00017
DB09244,Salmon calcitonin may decrease the excretion rate of Pirlindole which could result in a higher serum level.,Pirlindole,DB00017
DB09245,Salmon calcitonin may decrease the excretion rate of Toloxatone which could result in a higher serum level.,Toloxatone,DB00017
DB09255,Salmon calcitonin may decrease the excretion rate of Dextran which could result in a higher serum level.,Dextran,DB00017
DB09256,Salmon calcitonin may decrease the excretion rate of Tegafur which could result in a higher serum level.,Tegafur,DB00017
DB09257,Salmon calcitonin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,Gimeracil,DB00017
DB09262,Salmon calcitonin may decrease the excretion rate of Imidafenacin which could result in a higher serum level.,Imidafenacin,DB00017
DB09264,Salmon calcitonin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.,Idarucizumab,DB00017
DB09265,Salmon calcitonin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.,Lixisenatide,DB00017
DB09268,Salmon calcitonin may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.,Picosulfuric acid,DB00017
DB09276,Salmon calcitonin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.,Sodium aurothiomalate,DB00017
DB09277,Salmon calcitonin may decrease the excretion rate of Choline C 11 which could result in a higher serum level.,Choline C 11,DB00017
DB09281,Salmon calcitonin may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.,Magnesium trisilicate,DB00017
DB09292,Salmon calcitonin may decrease the excretion rate of Sacubitril which could result in a higher serum level.,Sacubitril,DB00017
DB09301,Salmon calcitonin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.,Chondroitin sulfate,DB00017
DB09317,"Salmon calcitonin may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.","Synthetic Conjugated Estrogens, A",DB00017
DB09318,"Salmon calcitonin may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.","Synthetic Conjugated Estrogens, B",DB00017
DB09320,Salmon calcitonin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.,Procaine benzylpenicillin,DB00017
DB09324,Salmon calcitonin may decrease the excretion rate of Sulbactam which could result in a higher serum level.,Sulbactam,DB00017
DB09325,Salmon calcitonin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.,Sodium fluoride,DB00017
DB09329,"Salmon calcitonin may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.","Antihemophilic Factor (Recombinant), PEGylated",DB00017
DB09344,Salmon calcitonin may decrease the excretion rate of Invert sugar which could result in a higher serum level.,Invert sugar,DB00017
DB09357,Salmon calcitonin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.,Dexpanthenol,DB00017
DB09394,Salmon calcitonin may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.,Phosphoric acid,DB00017
DB09395,Salmon calcitonin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.,Sodium acetate,DB00017
DB09407,Salmon calcitonin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.,Magnesium chloride,DB00017
DB09418,Salmon calcitonin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.,Potassium perchlorate,DB00017
DB09472,Salmon calcitonin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.,Sodium sulfate,DB00017
DB09477,Salmon calcitonin may decrease the excretion rate of Enalaprilat which could result in a higher serum level.,Enalaprilat,DB00017
DB09481,Salmon calcitonin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.,Magnesium carbonate,DB00017
DB09488,Salmon calcitonin may decrease the excretion rate of Acrivastine which could result in a higher serum level.,Acrivastine,DB00017
DB09496,Salmon calcitonin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,Octinoxate,DB00017
DB09502,Salmon calcitonin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.,Fludeoxyglucose (18F),DB00017
DB09546,Salmon calcitonin may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.,Iobenguane sulfate I-123,DB00017
DB09570,Salmon calcitonin may decrease the excretion rate of Ixazomib which could result in a higher serum level.,Ixazomib,DB00017
DB11077,Salmon calcitonin may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.,Polyethylene glycol 400,DB00017
DB11090,Salmon calcitonin may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.,Potassium nitrate,DB00017
DB11098,Salmon calcitonin may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.,Potassium bicarbonate,DB00017
DB11102,Salmon calcitonin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,N-acetyltyrosine,DB00017
DB11114,Salmon calcitonin may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.,Eucalyptus oil,DB00017
DB11127,Salmon calcitonin may decrease the excretion rate of Selenious acid which could result in a higher serum level.,Selenious acid,DB00017
DB11130,Salmon calcitonin may decrease the excretion rate of Opium which could result in a higher serum level.,Opium,DB00017
DB11135,Salmon calcitonin may decrease the excretion rate of Selenium which could result in a higher serum level.,Selenium,DB00017
DB11136,Salmon calcitonin may decrease the excretion rate of Chromium which could result in a higher serum level.,Chromium,DB00017
DB11145,Salmon calcitonin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,Oxyquinoline,DB00017
DB11156,Salmon calcitonin may decrease the excretion rate of Pyrantel which could result in a higher serum level.,Pyrantel,DB00017
DB11164,Salmon calcitonin may decrease the excretion rate of Bicisate which could result in a higher serum level.,Bicisate,DB00017
DB11251,Salmon calcitonin may decrease the excretion rate of Tocopherol which could result in a higher serum level.,Tocopherol,DB00017
DB11278,Salmon calcitonin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.,DL-Methylephedrine,DB00017
DB11328,Salmon calcitonin may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.,Tetradecyl hydrogen sulfate (ester),DB00017
DB11338,Salmon calcitonin may decrease the excretion rate of Clove oil which could result in a higher serum level.,Clove oil,DB00017
DB11358,Salmon calcitonin may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.,Evening primrose oil,DB00017
DB11364,Salmon calcitonin may decrease the excretion rate of Pidotimod which could result in a higher serum level.,Pidotimod,DB00017
DB11560,Salmon calcitonin may decrease the excretion rate of Lesinurad which could result in a higher serum level.,Lesinurad,DB00017
DB11577,Salmon calcitonin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.,Indigotindisulfonic acid,DB00017
DB11587,Salmon calcitonin may decrease the excretion rate of Etafedrine which could result in a higher serum level.,Etafedrine,DB00017
DB11598,Salmon calcitonin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.,Antithrombin III human,DB00017
DB11642,Salmon calcitonin may decrease the excretion rate of Pitolisant which could result in a higher serum level.,Pitolisant,DB00017
DB11691,Salmon calcitonin may decrease the excretion rate of Naldemedine which could result in a higher serum level.,Naldemedine,DB00017
DB11699,Salmon calcitonin may decrease the excretion rate of Tropisetron which could result in a higher serum level.,Tropisetron,DB00017
DB11817,Salmon calcitonin may decrease the excretion rate of Baricitinib which could result in a higher serum level.,Baricitinib,DB00017
DB11901,Salmon calcitonin may decrease the excretion rate of Apalutamide which could result in a higher serum level.,Apalutamide,DB00017
DB11915,Salmon calcitonin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,Valbenazine,DB00017
DB11943,Salmon calcitonin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.,Delafloxacin,DB00017
DB11989,Salmon calcitonin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,Benznidazole,DB00017
DB12007,Salmon calcitonin may decrease the excretion rate of Isoflavone which could result in a higher serum level.,Isoflavone,DB00017
DB12107,Salmon calcitonin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,Vaborbactam,DB00017
DB12161,Salmon calcitonin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.,Deutetrabenazine,DB00017
DB12278,Salmon calcitonin may decrease the excretion rate of Propiverine which could result in a higher serum level.,Propiverine,DB00017
DB12783,Salmon calcitonin may decrease the excretion rate of Benserazide which could result in a higher serum level.,Benserazide,DB00017
DB13025,Salmon calcitonin may decrease the excretion rate of Tiapride which could result in a higher serum level.,Tiapride,DB00017
DB13139,Salmon calcitonin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,Levosalbutamol,DB00017
DB13156,Salmon calcitonin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.,Inosine pranobex,DB00017
DB13178,Salmon calcitonin may decrease the excretion rate of Inositol which could result in a higher serum level.,Inositol,DB00017
DB13185,Salmon calcitonin may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.,Oxabolone cipionate,DB00017
DB13191,Salmon calcitonin may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.,Phosphocreatine,DB00017
DB13269,Salmon calcitonin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.,Dichlorobenzyl alcohol,DB00017
DB13293,Salmon calcitonin may decrease the excretion rate of Ipecac which could result in a higher serum level.,Ipecac,DB00017
DB13595,Salmon calcitonin may decrease the excretion rate of Almasilate which could result in a higher serum level.,Almasilate,DB00017
DB13873,Salmon calcitonin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.,Fenofibric acid,DB00017
DB13884,Salmon calcitonin may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.,Albutrepenonacog alfa,DB00017
DB13909,Salmon calcitonin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,Bismuth subgallate,DB00017
DB13943,Salmon calcitonin may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.,Testosterone cypionate,DB00017
DB13944,Salmon calcitonin may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.,Testosterone enanthate,DB00017
DB13946,Salmon calcitonin may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.,Testosterone undecanoate,DB00017
DB13952,Salmon calcitonin may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.,Estradiol acetate,DB00017
DB13954,Salmon calcitonin may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.,Estradiol cypionate,DB00017
DB13955,Salmon calcitonin may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.,Estradiol dienanthate,DB00017
DB13956,Salmon calcitonin may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.,Estradiol valerate,DB00017
DB13967,Salmon calcitonin may decrease the excretion rate of Patent Blue which could result in a higher serum level.,Patent Blue,DB00017
DB14006,Salmon calcitonin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.,Choline salicylate,DB00017
DB14007,Salmon calcitonin may decrease the excretion rate of Pentetic acid which could result in a higher serum level.,Pentetic acid,DB00017
DB14498,Salmon calcitonin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.,Potassium acetate,DB00017
DB14499,Salmon calcitonin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.,Potassium sulfate,DB00017
DB14526,Salmon calcitonin may decrease the excretion rate of Chromic citrate which could result in a higher serum level.,Chromic citrate,DB00017
DB14527,Salmon calcitonin may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.,Chromic nitrate,DB00017
DB14528,Salmon calcitonin may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.,Chromium gluconate,DB00017
DB14529,Salmon calcitonin may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.,Chromium nicotinate,DB00017
DB14530,Salmon calcitonin may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.,Chromous sulfate,DB00017
DB14754,Salmon calcitonin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,Solriamfetol,DB00017
DB06815,Salmon calcitonin may decrease the excretion rate of Pyrithione which could result in a higher serum level.,Pyrithione,DB00017
DB11121,Salmon calcitonin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.,Chloroxylenol,DB00017
DB15593,Salmon calcitonin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,Golodirsen,DB00017
DB00318,Salmon calcitonin may decrease the excretion rate of Codeine which could result in a higher serum level.,Codeine,DB00017
DB00454,Salmon calcitonin may decrease the excretion rate of Meperidine which could result in a higher serum level.,Meperidine,DB00017
DB00813,Salmon calcitonin may decrease the excretion rate of Fentanyl which could result in a higher serum level.,Fentanyl,DB00017
DB00879,Salmon calcitonin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.,Emtricitabine,DB00017
DB00452,Framycetin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Framycetin,DB00017
DB00479,Amikacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Amikacin,DB00017
DB00684,Tobramycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tobramycin,DB00017
DB00798,Gentamicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Gentamicin,DB00017
DB00955,Netilmicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Netilmicin,DB00017
DB00994,Neomycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Neomycin,DB00017
DB01082,Streptomycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Streptomycin,DB00017
DB01172,Kanamycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Kanamycin,DB00017
DB01421,Paromomycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Paromomycin,DB00017
DB03615,Ribostamycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ribostamycin,DB00017
DB04263,Geneticin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Geneticin,DB00017
DB04626,Apramycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Apramycin,DB00017
DB04729,Gentamicin C1a may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Gentamicin C1a,DB00017
DB04808,Neamine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Neamine,DB00017
DB06696,Arbekacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Arbekacin,DB00017
DB08437,Puromycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Puromycin,DB00017
DB11512,Dihydrostreptomycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Dihydrostreptomycin,DB00017
DB11520,Hygromycin B may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Hygromycin B,DB00017
DB12604,Sisomicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Sisomicin,DB00017
DB13270,Dibekacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Dibekacin,DB00017
DB13274,Micronomicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Micronomicin,DB00017
DB13540,Isepamicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Isepamicin,DB00017
DB13673,Bekanamycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Bekanamycin,DB00017
DB00552,Salmon calcitonin may decrease the excretion rate of Pentostatin which could result in a higher serum level.,Pentostatin,DB00017
DB13145,Salmon calcitonin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,Nedaplatin,DB00017
DB00314,Salmon calcitonin may decrease the excretion rate of Capreomycin which could result in a higher serum level.,Capreomycin,DB00017
DB00390,Salmon calcitonin may decrease the excretion rate of Digoxin which could result in a higher serum level.,Digoxin,DB00017
DB00512,Salmon calcitonin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,Vancomycin,DB00017
DB00515,Salmon calcitonin may decrease the excretion rate of Cisplatin which could result in a higher serum level.,Cisplatin,DB00017
DB00564,Salmon calcitonin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.,Carbamazepine,DB00017
DB00642,Salmon calcitonin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.,Pemetrexed,DB00017
DB00682,Salmon calcitonin may decrease the excretion rate of Warfarin which could result in a higher serum level.,Warfarin,DB00017
DB00908,Salmon calcitonin may decrease the excretion rate of Quinidine which could result in a higher serum level.,Quinidine,DB00017
DB00982,Salmon calcitonin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,Isotretinoin,DB00017
DB01035,Salmon calcitonin may decrease the excretion rate of Procainamide which could result in a higher serum level.,Procainamide,DB00017
DB12615,Salmon calcitonin may decrease the excretion rate of Plazomicin which could result in a higher serum level.,Plazomicin,DB00017
DB00524,Salmon calcitonin may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.,Metolazone,DB00017
DB00695,Salmon calcitonin may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.,Furosemide,DB00017
DB00808,Salmon calcitonin may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.,Indapamide,DB00017
DB00887,Salmon calcitonin may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,Bumetanide,DB00017
DB00909,Salmon calcitonin may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,Zonisamide,DB00017
DB08907,Salmon calcitonin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.,Canagliflozin,DB00017
DB09338,Salmon calcitonin may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.,Mersalyl,DB00017
DB00214,Torasemide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Torasemide,DB00017
DB00232,Methyclothiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Methyclothiazide,DB00017
DB00310,Chlorthalidone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Chlorthalidone,DB00017
DB00311,Ethoxzolamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Ethoxzolamide,DB00017
DB00421,Spironolactone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Spironolactone,DB00017
DB00436,Bendroflumethiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Bendroflumethiazide,DB00017
DB00562,Benzthiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Benzthiazide,DB00017
DB00594,Amiloride may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Amiloride,DB00017
DB00606,Cyclothiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Cyclothiazide,DB00017
DB00700,Eplerenone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Eplerenone,DB00017
DB00703,Methazolamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Methazolamide,DB00017
DB00774,Hydroflumethiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Hydroflumethiazide,DB00017
DB00819,Acetazolamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Acetazolamide,DB00017
DB00872,Conivaptan may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Conivaptan,DB00017
DB00880,Chlorothiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Chlorothiazide,DB00017
DB01021,Trichlormethiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Trichlormethiazide,DB00017
DB01119,Diazoxide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Diazoxide,DB00017
DB01144,Diclofenamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Diclofenamide,DB00017
DB01324,Polythiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Polythiazide,DB00017
DB01325,Quinethazone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Quinethazone,DB00017
DB01395,Drospirenone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Drospirenone,DB00017
DB01412,Theobromine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Theobromine,DB00017
DB02925,Piretanide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Piretanide,DB00017
DB04831,Tienilic acid may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Tienilic acid,DB00017
DB05034,Ularitide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Ularitide,DB00017
DB06212,Tolvaptan may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Tolvaptan,DB00017
DB06292,Dapagliflozin may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Dapagliflozin,DB00017
DB06370,Indisulam may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Indisulam,DB00017
DB08961,Azosemide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Azosemide,DB00017
DB09015,Canrenoic acid may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenoic acid,DB00017
DB09125,Potassium citrate may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium citrate,DB00017
DB09235,Efonidipine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Efonidipine,DB00017
DB09401,Isosorbide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Isosorbide,DB00017
DB11827,Ertugliflozin may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Ertugliflozin,DB00017
DB12221,Canrenone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenone,DB00017
DB12670,Rolofylline may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Rolofylline,DB00017
DB12704,Spiradoline may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Spiradoline,DB00017
DB12766,Cicletanine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Cicletanine,DB00017
DB13284,Meticrane may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Meticrane,DB00017
DB13316,Ibopamine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Ibopamine,DB00017
DB13405,Mefruside may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Mefruside,DB00017
DB13430,Mebutizide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Mebutizide,DB00017
DB13532,Cyclopenthiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Cyclopenthiazide,DB00017
DB13617,Clorexolone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Clorexolone,DB00017
DB13663,Clofenamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Clofenamide,DB00017
DB13708,Fenquizone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Fenquizone,DB00017
DB13792,Clopamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Clopamide,DB00017
DB13801,Muzolimine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Muzolimine,DB00017
DB13803,Xipamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Xipamide,DB00017
DB13989,Epitizide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Epitizide,DB00017
DB14018,Bromotheophylline may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Bromotheophylline,DB00017
DB14500,Potassium may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium,DB00017
DB00191,The risk or severity of adverse effects can be increased when Phentermine is combined with Salmon calcitonin.,Phentermine,DB00017
DB00211,The risk or severity of adverse effects can be increased when Midodrine is combined with Salmon calcitonin.,Midodrine,DB00017
DB00368,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Salmon calcitonin.,Norepinephrine,DB00017
DB00388,The risk or severity of adverse effects can be increased when Phenylephrine is combined with Salmon calcitonin.,Phenylephrine,DB00017
DB00397,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Salmon calcitonin.,Phenylpropanolamine,DB00017
DB00610,The risk or severity of adverse effects can be increased when Metaraminol is combined with Salmon calcitonin.,Metaraminol,DB00017
DB00668,The risk or severity of adverse effects can be increased when Epinephrine is combined with Salmon calcitonin.,Epinephrine,DB00017
DB00723,The risk or severity of adverse effects can be increased when Methoxamine is combined with Salmon calcitonin.,Methoxamine,DB00017
DB00816,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Salmon calcitonin.,Orciprenaline,DB00017
DB00830,The risk or severity of adverse effects can be increased when Phenmetrazine is combined with Salmon calcitonin.,Phenmetrazine,DB00017
DB00852,The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Salmon calcitonin.,Pseudoephedrine,DB00017
DB00865,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Salmon calcitonin.,Benzphetamine,DB00017
DB00867,The risk or severity of adverse effects can be increased when Ritodrine is combined with Salmon calcitonin.,Ritodrine,DB00017
DB00935,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Salmon calcitonin.,Oxymetazoline,DB00017
DB00937,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Salmon calcitonin.,Diethylpropion,DB00017
DB01064,The risk or severity of adverse effects can be increased when Isoprenaline is combined with Salmon calcitonin.,Isoprenaline,DB00017
DB01255,The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Salmon calcitonin.,Lisdexamfetamine,DB00017
DB01288,The risk or severity of adverse effects can be increased when Fenoterol is combined with Salmon calcitonin.,Fenoterol,DB00017
DB01364,The risk or severity of adverse effects can be increased when Ephedrine is combined with Salmon calcitonin.,Ephedrine,DB00017
DB01365,The risk or severity of adverse effects can be increased when Mephentermine is combined with Salmon calcitonin.,Mephentermine,DB00017
DB01366,The risk or severity of adverse effects can be increased when Procaterol is combined with Salmon calcitonin.,Procaterol,DB00017
DB01407,The risk or severity of adverse effects can be increased when Clenbuterol is combined with Salmon calcitonin.,Clenbuterol,DB00017
DB01442,The risk or severity of adverse effects can be increased when MMDA is combined with Salmon calcitonin.,MMDA,DB00017
DB01454,The risk or severity of adverse effects can be increased when Midomafetamine is combined with Salmon calcitonin.,Midomafetamine,DB00017
DB01467,"The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Salmon calcitonin.","2,5-Dimethoxy-4-ethylamphetamine",DB00017
DB01484,"The risk or severity of adverse effects can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Salmon calcitonin.","4-Bromo-2,5-dimethoxyamphetamine",DB00017
DB01509,The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Salmon calcitonin.,Tenamfetamine,DB00017
DB01556,The risk or severity of adverse effects can be increased when Chlorphentermine is combined with Salmon calcitonin.,Chlorphentermine,DB00017
DB01566,The risk or severity of adverse effects can be increased when Methylenedioxyethamphetamine is combined with Salmon calcitonin.,Methylenedioxyethamphetamine,DB00017
DB01576,The risk or severity of adverse effects can be increased when Dextroamphetamine is combined with Salmon calcitonin.,Dextroamphetamine,DB00017
DB06152,The risk or severity of adverse effects can be increased when Nylidrin is combined with Salmon calcitonin.,Nylidrin,DB00017
DB06764,The risk or severity of adverse effects can be increased when Tetryzoline is combined with Salmon calcitonin.,Tetryzoline,DB00017
DB08841,The risk or severity of adverse effects can be increased when Tyramine is combined with Salmon calcitonin.,Tyramine,DB00017
DB08941,The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Salmon calcitonin.,Isoxsuprine,DB00017
DB08985,The risk or severity of adverse effects can be increased when Etilefrine is combined with Salmon calcitonin.,Etilefrine,DB00017
DB09203,The risk or severity of adverse effects can be increased when Synephrine is combined with Salmon calcitonin.,Synephrine,DB00017
DB09480,The risk or severity of adverse effects can be increased when Iofetamine I-123 is combined with Salmon calcitonin.,Iofetamine I-123,DB00017
DB11124,The risk or severity of adverse effects can be increased when Racepinephrine is combined with Salmon calcitonin.,Racepinephrine,DB00017
DB12080,The risk or severity of adverse effects can be increased when Ritobegron is combined with Salmon calcitonin.,Ritobegron,DB00017
DB13064,The risk or severity of adverse effects can be increased when Tramazoline is combined with Salmon calcitonin.,Tramazoline,DB00017
DB13108,The risk or severity of adverse effects can be increased when Mephedrone is combined with Salmon calcitonin.,Mephedrone,DB00017
DB13341,The risk or severity of adverse effects can be increased when Fenozolone is combined with Salmon calcitonin.,Fenozolone,DB00017
DB13624,The risk or severity of adverse effects can be increased when Methoxyphenamine is combined with Salmon calcitonin.,Methoxyphenamine,DB00017
DB13692,The risk or severity of adverse effects can be increased when Tretoquinol is combined with Salmon calcitonin.,Tretoquinol,DB00017
DB13703,The risk or severity of adverse effects can be increased when Gepefrine is combined with Salmon calcitonin.,Gepefrine,DB00017
DB13777,The risk or severity of adverse effects can be increased when Prenalterol is combined with Salmon calcitonin.,Prenalterol,DB00017
DB13852,The risk or severity of adverse effects can be increased when Mefenorex is combined with Salmon calcitonin.,Mefenorex,DB00017
DB13940,"The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylthioamphetamine is combined with Salmon calcitonin.","2,5-Dimethoxy-4-ethylthioamphetamine",DB00017
DB00182,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Amphetamine.,Amphetamine,DB00017
DB00598,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Labetalol.,Labetalol,DB00017
DB00841,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Dobutamine.,Dobutamine,DB00017
DB00871,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Terbutaline.,Terbutaline,DB00017
DB00988,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Dopamine.,Dopamine,DB00017
DB01577,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Metamfetamine.,Metamfetamine,DB00017
DB01193,The risk or severity of adverse effects can be increased when Acebutolol is combined with Salmon calcitonin.,Acebutolol,DB00017
DB04846,The risk or severity of adverse effects can be increased when Celiprolol is combined with Salmon calcitonin.,Celiprolol,DB00017
DB12752,The risk or severity of adverse effects can be increased when Bucindolol is combined with Salmon calcitonin.,Bucindolol,DB00017
DB13757,The risk or severity of adverse effects can be increased when Epanolol is combined with Salmon calcitonin.,Epanolol,DB00017
DB00317,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Gefitinib.,Gefitinib,DB00017
DB00530,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Erlotinib.,Erlotinib,DB00017
DB00619,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Imatinib.,Imatinib,DB00017
DB01254,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dasatinib.,Dasatinib,DB00017
DB01259,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Lapatinib.,Lapatinib,DB00017
DB01268,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Sunitinib.,Sunitinib,DB00017
DB01645,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Genistein.,Genistein,DB00017
DB02058,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.,3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone,DB00017
DB02424,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Geldanamycin.,Geldanamycin,DB00017
DB02567,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with PD173955.,PD173955,DB00017
DB03758,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Radicicol.,Radicicol,DB00017
DB04849,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Cediranib.,Cediranib,DB00017
DB04868,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Nilotinib.,Nilotinib,DB00017
DB04879,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Vatalanib.,Vatalanib,DB00017
DB05294,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Vandetanib.,Vandetanib,DB00017
DB05424,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Canertinib.,Canertinib,DB00017
DB05465,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Tandutinib.,Tandutinib,DB00017
DB05575,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Motesanib.,Motesanib,DB00017
DB05928,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dovitinib.,Dovitinib,DB00017
DB06302,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Glesatinib.,Glesatinib,DB00017
DB06469,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Lestaurtinib.,Lestaurtinib,DB00017
DB06589,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Pazopanib.,Pazopanib,DB00017
DB06595,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Midostaurin.,Midostaurin,DB00017
DB06616,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Bosutinib.,Bosutinib,DB00017
DB06626,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Axitinib.,Axitinib,DB00017
DB08399,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Piceatannol.,Piceatannol,DB00017
DB08865,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Crizotinib.,Crizotinib,DB00017
DB08875,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Cabozantinib.,Cabozantinib,DB00017
DB08881,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Vemurafenib.,Vemurafenib,DB00017
DB08896,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Regorafenib.,Regorafenib,DB00017
DB08901,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ponatinib.,Ponatinib,DB00017
DB08916,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Afatinib.,Afatinib,DB00017
DB09053,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ibrutinib.,Ibrutinib,DB00017
DB09063,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ceritinib.,Ceritinib,DB00017
DB09078,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Lenvatinib.,Lenvatinib,DB00017
DB09079,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Nintedanib.,Nintedanib,DB00017
DB09330,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Osimertinib.,Osimertinib,DB00017
DB11363,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Alectinib.,Alectinib,DB00017
DB11689,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Selumetinib.,Selumetinib,DB00017
DB11697,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Pacritinib.,Pacritinib,DB00017
DB11703,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Acalabrutinib.,Acalabrutinib,DB00017
DB11737,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Icotinib.,Icotinib,DB00017
DB11805,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Saracatinib.,Saracatinib,DB00017
DB11828,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Neratinib.,Neratinib,DB00017
DB11832,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Crenolanib.,Crenolanib,DB00017
DB11904,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Flumatinib.,Flumatinib,DB00017
DB11963,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dacomitinib.,Dacomitinib,DB00017
DB11973,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Tesevatinib.,Tesevatinib,DB00017
DB11986,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Entrectinib.,Entrectinib,DB00017
DB12010,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Fostamatinib.,Fostamatinib,DB00017
DB12048,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Savolitinib.,Savolitinib,DB00017
DB12141,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Gilteritinib.,Gilteritinib,DB00017
DB12147,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Erdafitinib.,Erdafitinib,DB00017
DB12267,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Brigatinib.,Brigatinib,DB00017
DB12307,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Foretinib.,Foretinib,DB00017
DB12323,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Radotinib.,Radotinib,DB00017
DB14723,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Larotrectinib.,Larotrectinib,DB00017
DB00398,The therapeutic efficacy of Sorafenib can be decreased when used in combination with Salmon calcitonin.,Sorafenib,DB00017
DB08877,The therapeutic efficacy of Ruxolitinib can be decreased when used in combination with Salmon calcitonin.,Ruxolitinib,DB00017
DB12978,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Pexidartinib.,Pexidartinib,DB00017
DB12500,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Fedratinib.,Fedratinib,DB00017
DB11652,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Tucatinib.,Tucatinib,DB00017
DB11791,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Capmatinib.,Capmatinib,DB00017
DB15685,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Selpercatinib.,Selpercatinib,DB00017
DB05258,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Interferon alfa.,Interferon alfa,DB00017
DB00041,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Aldesleukin.,Aldesleukin,DB00017
DB00227,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Lovastatin.,Lovastatin,DB00017
DB00609,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ethionamide.,Ethionamide,DB00017
DB00850,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Perphenazine.,Perphenazine,DB00017
DB14651,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Perphenazine enanthate.,Perphenazine enanthate,DB00017
DB00829,The therapeutic efficacy of Diazepam can be decreased when used in combination with Salmon calcitonin.,Diazepam,DB00017
DB01233,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Salmon calcitonin.,Metoclopramide,DB00017
DB00233,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Aminosalicylic acid.,Aminosalicylic acid,DB00017
DB11085,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Resorcinol.,Resorcinol,DB00017
DB00672,The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Salmon calcitonin.,Chlorpropamide,DB00017
DB00839,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Salmon calcitonin.,Tolazamide,DB00017
DB01067,The therapeutic efficacy of Glipizide can be decreased when used in combination with Salmon calcitonin.,Glipizide,DB00017
DB01124,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Salmon calcitonin.,Tolbutamide,DB00017
DB00222,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Salmon calcitonin.,Glimepiride,DB00017
DB00414,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Salmon calcitonin.,Acetohexamide,DB00017
DB01016,The therapeutic efficacy of Glyburide can be decreased when used in combination with Salmon calcitonin.,Glyburide,DB00017
DB01120,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Salmon calcitonin.,Gliclazide,DB00017
DB01251,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Salmon calcitonin.,Gliquidone,DB00017
DB01289,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Salmon calcitonin.,Glisoxepide,DB00017
DB08962,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Salmon calcitonin.,Glibornuride,DB00017
DB13406,The therapeutic efficacy of Carbutamide can be decreased when used in combination with Salmon calcitonin.,Carbutamide,DB00017
DB13675,The therapeutic efficacy of Metahexamide can be decreased when used in combination with Salmon calcitonin.,Metahexamide,DB00017
DB01151,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Desipramine.,Desipramine,DB00017
DB01242,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Clomipramine.,Clomipramine,DB00017
DB08996,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Dimetacrine.,Dimetacrine,DB00017
DB00540,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Nortriptyline.,Nortriptyline,DB00017
DB00321,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Amitriptyline.,Amitriptyline,DB00017
DB00344,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Protriptyline.,Protriptyline,DB00017
DB00458,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Imipramine.,Imipramine,DB00017
DB00543,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Amoxapine.,Amoxapine,DB00017
DB00726,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Trimipramine.,Trimipramine,DB00017
DB01142,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Doxepin.,Doxepin,DB00017
DB04836,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Amineptine.,Amineptine,DB00017
DB09016,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Butriptyline.,Butriptyline,DB00017
DB09167,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Dosulepin.,Dosulepin,DB00017
DB09289,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Tianeptine.,Tianeptine,DB00017
DB09307,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Oxaprotiline.,Oxaprotiline,DB00017
DB12930,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Opipramol.,Opipramol,DB00017
DB13114,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Amitriptylinoxide.,Amitriptylinoxide,DB00017
DB13225,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Dibenzepin.,Dibenzepin,DB00017
DB13246,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Quinupramine.,Quinupramine,DB00017
DB13384,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Melitracen.,Melitracen,DB00017
DB13411,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Lofepramine.,Lofepramine,DB00017
DB13496,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Iprindole.,Iprindole,DB00017
DB13782,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Imipramine oxide.,Imipramine oxide,DB00017
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Interferon alfa-n3.,Denosumab,DB00018
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-n3.,Etanercept,DB00018
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-n3.,Peginterferon alfa-2a,DB00018
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa-n3.,Interferon alfa-n1,DB00018
DB00022,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b,DB00018
DB00026,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Anakinra.,Anakinra,DB00018
DB00033,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00018
DB00034,"The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00018
DB00051,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Adalimumab.,Adalimumab,DB00018
DB00056,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00018
DB00059,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pegaspargase.,Pegaspargase,DB00018
DB00065,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Infliximab.,Infliximab,DB00018
DB00068,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon beta-1b.,Interferon beta-1b,DB00018
DB00069,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00018
DB00073,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Rituximab.,Rituximab,DB00018
DB00074,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Basiliximab.,Basiliximab,DB00018
DB00075,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Muromonab.,Muromonab,DB00018
DB00078,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00018
DB00081,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tositumomab.,Tositumomab,DB00018
DB00087,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Alemtuzumab.,Alemtuzumab,DB00018
DB00092,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Alefacept.,Alefacept,DB00018
DB00095,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Efalizumab.,Efalizumab,DB00018
DB00098,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit),DB00018
DB00105,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00018
DB00111,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Daclizumab.,Daclizumab,DB00018
DB00112,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bevacizumab.,Bevacizumab,DB00018
DB00120,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Phenylalanine.,Phenylalanine,DB00018
DB00180,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Flunisolide.,Flunisolide,DB00018
DB00188,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bortezomib.,Bortezomib,DB00018
DB00242,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cladribine.,Cladribine,DB00018
DB00262,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Carmustine.,Carmustine,DB00018
DB00276,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Amsacrine.,Amsacrine,DB00018
DB00290,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bleomycin.,Bleomycin,DB00018
DB00291,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Chlorambucil.,Chlorambucil,DB00018
DB00293,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Raltitrexed.,Raltitrexed,DB00018
DB00305,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mitomycin.,Mitomycin,DB00018
DB00307,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bexarotene.,Bexarotene,DB00018
DB00309,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vindesine.,Vindesine,DB00018
DB00322,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Floxuridine.,Floxuridine,DB00018
DB00328,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Indomethacin.,Indomethacin,DB00018
DB00352,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tioguanine.,Tioguanine,DB00018
DB00361,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vinorelbine.,Vinorelbine,DB00018
DB00380,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dexrazoxane.,Dexrazoxane,DB00018
DB00394,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate,DB00018
DB00398,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sorafenib.,Sorafenib,DB00018
DB00428,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Streptozocin.,Streptozocin,DB00018
DB00432,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trifluridine.,Trifluridine,DB00018
DB00441,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gemcitabine.,Gemcitabine,DB00018
DB00443,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Betamethasone.,Betamethasone,DB00018
DB00444,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Teniposide.,Teniposide,DB00018
DB00445,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Epirubicin.,Epirubicin,DB00018
DB00446,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Chloramphenicol.,Chloramphenicol,DB00018
DB00480,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Lenalidomide.,Lenalidomide,DB00018
DB00488,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Altretamine.,Altretamine,DB00018
DB00495,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Zidovudine.,Zidovudine,DB00018
DB00515,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cisplatin.,Cisplatin,DB00018
DB00526,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Oxaliplatin.,Oxaliplatin,DB00018
DB00531,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cyclophosphamide.,Cyclophosphamide,DB00018
DB00541,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vincristine.,Vincristine,DB00018
DB00544,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluorouracil.,Fluorouracil,DB00018
DB00550,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Propylthiouracil.,Propylthiouracil,DB00018
DB00552,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pentostatin.,Pentostatin,DB00018
DB00563,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Methotrexate.,Methotrexate,DB00018
DB00564,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Carbamazepine.,Carbamazepine,DB00018
DB00570,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vinblastine.,Vinblastine,DB00018
DB00588,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluticasone propionate.,Fluticasone propionate,DB00018
DB00591,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluocinolone acetonide.,Fluocinolone acetonide,DB00018
DB00601,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Linezolid.,Linezolid,DB00018
DB00619,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Imatinib.,Imatinib,DB00018
DB00620,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Triamcinolone.,Triamcinolone,DB00018
DB00631,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Clofarabine.,Clofarabine,DB00018
DB00635,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Prednisone.,Prednisone,DB00018
DB00642,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pemetrexed.,Pemetrexed,DB00018
DB00687,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fludrocortisone.,Fludrocortisone,DB00018
DB00688,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mycophenolate mofetil.,Mycophenolate mofetil,DB00018
DB00694,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Daunorubicin.,Daunorubicin,DB00018
DB00755,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tretinoin.,Tretinoin,DB00018
DB00762,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Irinotecan.,Irinotecan,DB00018
DB00763,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Methimazole.,Methimazole,DB00018
DB00764,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mometasone.,Mometasone,DB00018
DB00773,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Etoposide.,Etoposide,DB00018
DB00795,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sulfasalazine.,Sulfasalazine,DB00018
DB00851,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dacarbazine.,Dacarbazine,DB00018
DB00853,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Temozolomide.,Temozolomide,DB00018
DB00859,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Penicillamine.,Penicillamine,DB00018
DB00860,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Prednisolone.,Prednisolone,DB00018
DB00877,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sirolimus.,Sirolimus,DB00018
DB00888,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mechlorethamine.,Mechlorethamine,DB00018
DB00928,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Azacitidine.,Azacitidine,DB00018
DB00958,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Carboplatin.,Carboplatin,DB00018
DB00959,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Methylprednisolone.,Methylprednisolone,DB00018
DB00970,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dactinomycin.,Dactinomycin,DB00018
DB00987,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cytarabine.,Cytarabine,DB00018
DB00993,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Azathioprine.,Azathioprine,DB00018
DB00997,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Doxorubicin.,Doxorubicin,DB00018
DB01005,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydroxyurea.,Hydroxyurea,DB00018
DB01008,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Busulfan.,Busulfan,DB00018
DB01024,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mycophenolic acid.,Mycophenolic acid,DB00018
DB01030,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Topotecan.,Topotecan,DB00018
DB01033,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mercaptopurine.,Mercaptopurine,DB00018
DB01041,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Thalidomide.,Thalidomide,DB00018
DB01042,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Melphalan.,Melphalan,DB00018
DB01073,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fludarabine.,Fludarabine,DB00018
DB01099,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Flucytosine.,Flucytosine,DB00018
DB01101,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Capecitabine.,Capecitabine,DB00018
DB01108,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trilostane.,Trilostane,DB00018
DB01168,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Procarbazine.,Procarbazine,DB00018
DB01169,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Arsenic trioxide.,Arsenic trioxide,DB00018
DB01177,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Idarubicin.,Idarubicin,DB00018
DB01181,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ifosfamide.,Ifosfamide,DB00018
DB01196,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Estramustine.,Estramustine,DB00018
DB01204,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mitoxantrone.,Mitoxantrone,DB00018
DB01206,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Lomustine.,Lomustine,DB00018
DB01222,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Budesonide.,Budesonide,DB00018
DB01229,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Paclitaxel.,Paclitaxel,DB00018
DB01234,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dexamethasone.,Dexamethasone,DB00018
DB01248,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Docetaxel.,Docetaxel,DB00018
DB01254,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dasatinib.,Dasatinib,DB00018
DB01257,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Eculizumab.,Eculizumab,DB00018
DB01262,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Decitabine.,Decitabine,DB00018
DB01268,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sunitinib.,Sunitinib,DB00018
DB01280,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Nelarabine.,Nelarabine,DB00018
DB01281,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Abatacept.,Abatacept,DB00018
DB01285,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Corticotropin.,Corticotropin,DB00018
DB01380,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cortisone acetate.,Cortisone acetate,DB00018
DB01384,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Paramethasone.,Paramethasone,DB00018
DB01394,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Colchicine.,Colchicine,DB00018
DB01410,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ciclesonide.,Ciclesonide,DB00018
DB01423,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Stepronin.,Stepronin,DB00018
DB01590,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Everolimus.,Everolimus,DB00018
DB01611,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydroxychloroquine.,Hydroxychloroquine,DB00018
DB01816,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Castanospermine.,Castanospermine,DB00018
DB02546,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vorinostat.,Vorinostat,DB00018
DB02806,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with 2-Methoxyethanol.,2-Methoxyethanol,DB00018
DB03523,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Brequinar.,Brequinar,DB00018
DB04572,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Thiotepa.,Thiotepa,DB00018
DB04630,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Aldosterone.,Aldosterone,DB00018
DB04845,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ixabepilone.,Ixabepilone,DB00018
DB04868,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Nilotinib.,Nilotinib,DB00018
DB04951,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pirfenidone.,Pirfenidone,DB00018
DB04956,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Afelimomab.,Afelimomab,DB00018
DB05015,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Belinostat.,Belinostat,DB00018
DB05109,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trabectedin.,Trabectedin,DB00018
DB05258,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfa.,Interferon alfa,DB00018
DB05259,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Glatiramer.,Glatiramer,DB00018
DB05260,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gallium nitrate.,Gallium nitrate,DB00018
DB05459,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Briakinumab.,Briakinumab,DB00018
DB05472,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with omega interferon.,omega interferon,DB00018
DB05676,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Apremilast.,Apremilast,DB00018
DB05773,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00018
DB06168,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Canakinumab.,Canakinumab,DB00018
DB06273,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tocilizumab.,Tocilizumab,DB00018
DB06287,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Temsirolimus.,Temsirolimus,DB00018
DB06372,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Rilonacept.,Rilonacept,DB00018
DB06589,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pazopanib.,Pazopanib,DB00018
DB06603,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Panobinostat.,Panobinostat,DB00018
DB06612,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mepolizumab.,Mepolizumab,DB00018
DB06616,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bosutinib.,Bosutinib,DB00018
DB06662,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Abetimus.,Abetimus,DB00018
DB06674,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Golimumab.,Golimumab,DB00018
DB06681,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Belatacept.,Belatacept,DB00018
DB06769,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bendamustine.,Bendamustine,DB00018
DB06772,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cabazitaxel.,Cabazitaxel,DB00018
DB06813,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pralatrexate.,Pralatrexate,DB00018
DB08059,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Wortmannin.,Wortmannin,DB00018
DB08870,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Brentuximab vedotin.,Brentuximab vedotin,DB00018
DB08871,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Eribulin.,Eribulin,DB00018
DB08877,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ruxolitinib.,Ruxolitinib,DB00018
DB08879,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Belimumab.,Belimumab,DB00018
DB08880,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Teriflunomide.,Teriflunomide,DB00018
DB08889,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Carfilzomib.,Carfilzomib,DB00018
DB08901,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ponatinib.,Ponatinib,DB00018
DB08904,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Certolizumab pegol.,Certolizumab pegol,DB00018
DB08906,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluticasone furoate.,Fluticasone furoate,DB00018
DB08908,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dimethyl fumarate.,Dimethyl fumarate,DB00018
DB08910,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pomalidomide.,Pomalidomide,DB00018
DB08935,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Obinutuzumab.,Obinutuzumab,DB00018
DB08970,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluprednidene.,Fluprednidene,DB00018
DB08971,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluocortolone.,Fluocortolone,DB00018
DB09029,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Secukinumab.,Secukinumab,DB00018
DB09033,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vedolizumab.,Vedolizumab,DB00018
DB09036,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Siltuximab.,Siltuximab,DB00018
DB09052,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Blinatumomab.,Blinatumomab,DB00018
DB09053,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ibrutinib.,Ibrutinib,DB00018
DB09054,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Idelalisib.,Idelalisib,DB00018
DB09073,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Palbociclib.,Palbociclib,DB00018
DB09074,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Olaparib.,Olaparib,DB00018
DB09077,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dinutuximab.,Dinutuximab,DB00018
DB09082,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vilanterol.,Vilanterol,DB00018
DB09091,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tixocortol.,Tixocortol,DB00018
DB09122,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00018
DB09312,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse),DB00018
DB09378,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluprednisolone.,Fluprednisolone,DB00018
DB09383,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Meprednisone.,Meprednisone,DB00018
DB11466,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tepoxalin.,Tepoxalin,DB00018
DB11487,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate,DB00018
DB11529,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Melengestrol.,Melengestrol,DB00018
DB11569,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ixekizumab.,Ixekizumab,DB00018
DB11580,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ravulizumab.,Ravulizumab,DB00018
DB11616,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pirarubicin.,Pirarubicin,DB00018
DB11693,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Voclosporin.,Voclosporin,DB00018
DB11708,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Peficitinib.,Peficitinib,DB00018
DB11750,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Clobetasol.,Clobetasol,DB00018
DB11767,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sarilumab.,Sarilumab,DB00018
DB11776,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Brodalumab.,Brodalumab,DB00018
DB11803,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sirukumab.,Sirukumab,DB00018
DB11817,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Baricitinib.,Baricitinib,DB00018
DB11834,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Guselkumab.,Guselkumab,DB00018
DB11921,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Deflazacort.,Deflazacort,DB00018
DB11988,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ocrelizumab.,Ocrelizumab,DB00018
DB12025,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Triptolide.,Triptolide,DB00018
DB12371,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Siponimod.,Siponimod,DB00018
DB12612,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ozanimod.,Ozanimod,DB00018
DB12617,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mizoribine.,Mizoribine,DB00018
DB12692,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gusperimus.,Gusperimus,DB00018
DB12814,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00018
DB12902,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trofosfamide.,Trofosfamide,DB00018
DB12947,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Doxifluridine.,Doxifluridine,DB00018
DB12991,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Deoxyspergualin.,Deoxyspergualin,DB00018
DB12996,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Acteoside.,Acteoside,DB00018
DB13003,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cortivazol.,Cortivazol,DB00018
DB13014,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hypericin.,Hypericin,DB00018
DB13068,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A,DB00018
DB13208,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Prednylidene.,Prednylidene,DB00018
DB13223,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluocortin.,Fluocortin,DB00018
DB13241,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Begelomab.,Begelomab,DB00018
DB13491,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluperolone.,Fluperolone,DB00018
DB13664,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Formocortal.,Formocortal,DB00018
DB13728,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Halometasone.,Halometasone,DB00018
DB13843,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cloprednol.,Cloprednol,DB00018
DB13856,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluclorolone.,Fluclorolone,DB00018
DB13867,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluticasone.,Fluticasone,DB00018
DB14066,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tetrandrine.,Tetrandrine,DB00018
DB14219,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Monomethyl fumarate.,Monomethyl fumarate,DB00018
DB14512,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mometasone furoate.,Mometasone furoate,DB00018
DB14538,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydrocortisone aceponate.,Hydrocortisone aceponate,DB00018
DB14539,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydrocortisone acetate.,Hydrocortisone acetate,DB00018
DB14545,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydrocortisone succinate.,Hydrocortisone succinate,DB00018
DB14724,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Emapalumab.,Emapalumab,DB00018
DB14762,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Risankizumab.,Risankizumab,DB00018
DB14919,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Rozanolixizumab.,Rozanolixizumab,DB00018
DB15253,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bleselumab.,Bleselumab,DB00018
DB00108,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Natalizumab.,Natalizumab,DB00018
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfa-n3.,Pimecrolimus,DB00018
DB01656,Roflumilast may increase the immunosuppressive activities of Interferon alfa-n3.,Roflumilast,DB00018
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Interferon alfa-n3.,Sipuleucel-T,DB00018
DB00041,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Aldesleukin.,Aldesleukin,DB00018
DB00363,The risk or severity of neutropenia can be increased when Interferon alfa-n3 is combined with Clozapine.,Clozapine,DB00018
DB00333,The serum concentration of Methadone can be increased when it is combined with Interferon alfa-n3.,Methadone,DB00018
DB00811,The risk or severity of anemia can be increased when Interferon alfa-n3 is combined with Ribavirin.,Ribavirin,DB00018
DB00315,The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-n3.,Zolmitriptan,DB00018
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Interferon alfa-n3.,Sulfamethoxazole,DB00018
DB01265,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Telbivudine.,Telbivudine,DB00018
DB01097,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Leflunomide.,Leflunomide,DB00018
DB08895,Interferon alfa-n3 may increase the immunosuppressive activities of Tofacitinib.,Tofacitinib,DB00018
DB00072,Trastuzumab may increase the neutropenic activities of Interferon alfa-n3.,Trastuzumab,DB00018
DB08868,Interferon alfa-n3 may increase the immunosuppressive activities of Fingolimod.,Fingolimod,DB00018
DB00864,Tacrolimus may increase the immunosuppressive activities of Interferon alfa-n3.,Tacrolimus,DB00018
DB00201,The metabolism of Caffeine can be decreased when combined with Interferon alfa-n3.,Caffeine,DB00018
DB00651,The metabolism of Dyphylline can be decreased when combined with Interferon alfa-n3.,Dyphylline,DB00018
DB00806,The metabolism of Pentoxifylline can be decreased when combined with Interferon alfa-n3.,Pentoxifylline,DB00018
DB01303,The metabolism of Oxtriphylline can be decreased when combined with Interferon alfa-n3.,Oxtriphylline,DB00018
DB01412,The metabolism of Theobromine can be decreased when combined with Interferon alfa-n3.,Theobromine,DB00018
DB01482,The metabolism of Fenethylline can be decreased when combined with Interferon alfa-n3.,Fenethylline,DB00018
DB01667,The metabolism of 8-azaguanine can be decreased when combined with Interferon alfa-n3.,8-azaguanine,DB00018
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Interferon alfa-n3.","7,9-Dimethylguanine",DB00018
DB02134,The metabolism of Xanthine can be decreased when combined with Interferon alfa-n3.,Xanthine,DB00018
DB02245,The metabolism of 7-Deazaguanine can be decreased when combined with Interferon alfa-n3.,7-Deazaguanine,DB00018
DB02377,The metabolism of Guanine can be decreased when combined with Interferon alfa-n3.,Guanine,DB00018
DB02489,The metabolism of 9-Methylguanine can be decreased when combined with Interferon alfa-n3.,9-Methylguanine,DB00018
DB02568,The metabolism of Peldesine can be decreased when combined with Interferon alfa-n3.,Peldesine,DB00018
DB04076,The metabolism of Hypoxanthine can be decreased when combined with Interferon alfa-n3.,Hypoxanthine,DB00018
DB04356,The metabolism of 9-Deazaguanine can be decreased when combined with Interferon alfa-n3.,9-Deazaguanine,DB00018
DB06479,The metabolism of Propentofylline can be decreased when combined with Interferon alfa-n3.,Propentofylline,DB00018
DB06575,The metabolism of Valomaciclovir can be decreased when combined with Interferon alfa-n3.,Valomaciclovir,DB00018
DB07954,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Interferon alfa-n3.,3-isobutyl-1-methyl-7H-xanthine,DB00018
DB08844,The metabolism of Uric acid can be decreased when combined with Interferon alfa-n3.,Uric acid,DB00018
DB09273,The metabolism of Doxofylline can be decreased when combined with Interferon alfa-n3.,Doxofylline,DB00018
DB11919,The metabolism of 6-O-benzylguanine can be decreased when combined with Interferon alfa-n3.,6-O-benzylguanine,DB00018
DB12406,The metabolism of Lisofylline can be decreased when combined with Interferon alfa-n3.,Lisofylline,DB00018
DB12531,The metabolism of Lobucavir can be decreased when combined with Interferon alfa-n3.,Lobucavir,DB00018
DB12926,The metabolism of Cafedrine can be decreased when combined with Interferon alfa-n3.,Cafedrine,DB00018
DB12927,The metabolism of Theodrenaline can be decreased when combined with Interferon alfa-n3.,Theodrenaline,DB00018
DB13203,The metabolism of Bamifylline can be decreased when combined with Interferon alfa-n3.,Bamifylline,DB00018
DB13449,The metabolism of Proxyphylline can be decreased when combined with Interferon alfa-n3.,Proxyphylline,DB00018
DB13573,The metabolism of Acefylline can be decreased when combined with Interferon alfa-n3.,Acefylline,DB00018
DB13592,The metabolism of Etamiphylline can be decreased when combined with Interferon alfa-n3.,Etamiphylline,DB00018
DB13634,The metabolism of Pentifylline can be decreased when combined with Interferon alfa-n3.,Pentifylline,DB00018
DB13812,The metabolism of Bufylline can be decreased when combined with Interferon alfa-n3.,Bufylline,DB00018
DB14018,The metabolism of Bromotheophylline can be decreased when combined with Interferon alfa-n3.,Bromotheophylline,DB00018
DB14029,The metabolism of Furafylline can be decreased when combined with Interferon alfa-n3.,Furafylline,DB00018
DB14132,The metabolism of 8-chlorotheophylline can be decreased when combined with Interferon alfa-n3.,8-chlorotheophylline,DB00018
DB15122,The metabolism of PCS-499 can be decreased when combined with Interferon alfa-n3.,PCS-499,DB00018
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Interferon alfa-n3.,G17DT,DB00018
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Interferon alfa-n3.,PEV3A,DB00018
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Interferon alfa-n3.,INGN 225,DB00018
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Interferon alfa-n3.,Rindopepimut,DB00018
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Interferon alfa-n3.,SRP 299,DB00018
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Interferon alfa-n3.,GI-5005,DB00018
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Interferon alfa-n3.,Vitespen,DB00018
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Interferon alfa-n3.,TG4010,DB00018
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Interferon alfa-n3.,Anthrax immune globulin human,DB00018
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Interferon alfa-n3.","Rabies virus inactivated antigen, B",DB00018
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-n3.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen,DB00018
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Interferon alfa-n3.,Rotavirus vaccine,DB00018
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Interferon alfa-n3.","Rabies virus inactivated antigen, A",DB00018
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Interferon alfa-n3.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen,DB00018
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Clostridium tetani toxoid antigen (formaldehyde inactivated),DB00018
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated),DB00018
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated),DB00018
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),DB00018
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated),DB00018
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Interferon alfa-n3.,Typhoid Vi polysaccharide vaccine,DB00018
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfa-n3.,Hepatitis A Vaccine,DB00018
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-n3.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,DB00018
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated),DB00018
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated),DB00018
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated),DB00018
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated),DB00018
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Interferon alfa-n3.,Human rabies virus immune globulin,DB00018
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-n3.,Hepatitis B Vaccine (Recombinant),DB00018
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Interferon alfa-n3.,Tecemotide,DB00018
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Interferon alfa-n3.,Typhoid vaccine,DB00018
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated),DB00018
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated),DB00018
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen,DB00018
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated),DB00018
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen,DB00018
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated),DB00018
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated),DB00018
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Interferon alfa-n3.,Vaccinia virus strain new york city board of health live antigen,DB00018
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Interferon alfa-n3.,Pertussis vaccine,DB00018
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Yersinia pestis 195/p antigen (formaldehyde inactivated),DB00018
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-n3.,Varicella Zoster Vaccine (Recombinant),DB00018
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Interferon alfa-n3.,Modified vaccinia ankara,DB00018
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Interferon alfa-n3.","Ebola Zaire vaccine (live, attenuated)",DB00018
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-n3.,Abciximab,DB00018
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Interferon alfa-n3.,Eptifibatide,DB00018
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Interferon alfa-n3.,Ticlopidine,DB00018
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Interferon alfa-n3.,Tirofiban,DB00018
DB00945,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon alfa-n3.,Acetylsalicylic acid,DB00018
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Interferon alfa-n3.,Dipyridamole,DB00018
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Interferon alfa-n3.,Iloprost,DB00018
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon alfa-n3.,Sulfinpyrazone,DB00018
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Interferon alfa-n3.,Ridogrel,DB00018
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Interferon alfa-n3.,Sevoflurane,DB00018
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfa-n3.,Epoprostenol,DB00018
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Interferon alfa-n3.,Nimesulide,DB00018
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Interferon alfa-n3.,Tesmilifene,DB00018
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Interferon alfa-n3.,Defibrotide,DB00018
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Interferon alfa-n3.,Beraprost,DB00018
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Interferon alfa-n3.,Ibudilast,DB00018
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Interferon alfa-n3.,Andrographolide,DB00018
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Interferon alfa-n3.,Caplacizumab,DB00018
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Interferon alfa-n3.,Prasugrel,DB00018
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Interferon alfa-n3.,Cangrelor,DB00018
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Interferon alfa-n3.,Tranilast,DB00018
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Interferon alfa-n3.,Triflusal,DB00018
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Interferon alfa-n3.,Ticagrelor,DB00018
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Interferon alfa-n3.,Icosapent ethyl,DB00018
DB09030,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfa-n3.,Vorapaxar,DB00018
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Interferon alfa-n3.,Trapidil,DB00018
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Interferon alfa-n3.,Naftopidil,DB00018
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Interferon alfa-n3.,Sarpogrelate,DB00018
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Interferon alfa-n3.,Ifetroban,DB00018
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Interferon alfa-n3.,Nitroaspirin,DB00018
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Interferon alfa-n3.,Ketanserin,DB00018
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Interferon alfa-n3.,Indobufen,DB00018
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Interferon alfa-n3.,Butylphthalide,DB00018
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Interferon alfa-n3.,Hydroxytyrosol,DB00018
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Interferon alfa-n3.,Ramatroban,DB00018
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Interferon alfa-n3.,Picotamide,DB00018
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Interferon alfa-n3.,Cloricromen,DB00018
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Interferon alfa-n3.,Linsidomine,DB00018
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Interferon alfa-n3.,Buflomedil,DB00018
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Interferon alfa-n3.,Relcovaptan,DB00018
DB13200,Interferon alfa-n3 may increase the myelosuppressive activities of Lipegfilgrastim.,Lipegfilgrastim,DB00018
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Interferon alfa-n3.,Rubella virus vaccine,DB00018
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Interferon alfa-n3.,Varicella Zoster Vaccine (Live/attenuated),DB00018
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Interferon alfa-n3.,Bacillus calmette-guerin substrain tice live antigen,DB00018
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Interferon alfa-n3.,Bacillus calmette-guerin substrain connaught live antigen,DB00018
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Interferon alfa-n3.,Yellow Fever Vaccine,DB00018
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Interferon alfa-n3.,Anthrax vaccine,DB00018
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Interferon alfa-n3.,Typhoid Vaccine Live,DB00018
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Interferon alfa-n3.,Bacillus calmette-guerin substrain danish 1331 live antigen,DB00018
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Interferon alfa-n3.,BCG vaccine,DB00018
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfa-n3.,Human adenovirus e serotype 4 strain cl-68578 antigen,DB00018
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Interferon alfa-n3.,Vibrio cholerae CVD 103-HgR strain live antigen,DB00018
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Interferon alfa-n3.,Adenovirus type 7 vaccine live,DB00018
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-n3.,Palifermin,DB00018
DB00176,The metabolism of Fluvoxamine can be decreased when combined with Interferon alfa-n3.,Fluvoxamine,DB00018
DB00184,The metabolism of Nicotine can be decreased when combined with Interferon alfa-n3.,Nicotine,DB00018
DB00195,The metabolism of Betaxolol can be decreased when combined with Interferon alfa-n3.,Betaxolol,DB00018
DB00261,The metabolism of Anagrelide can be decreased when combined with Interferon alfa-n3.,Anagrelide,DB00018
DB00280,The metabolism of Disopyramide can be decreased when combined with Interferon alfa-n3.,Disopyramide,DB00018
DB00281,The metabolism of Lidocaine can be decreased when combined with Interferon alfa-n3.,Lidocaine,DB00018
DB00286,The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-n3.,Conjugated estrogens,DB00018
DB00296,The metabolism of Ropivacaine can be decreased when combined with Interferon alfa-n3.,Ropivacaine,DB00018
DB00316,The metabolism of Acetaminophen can be decreased when combined with Interferon alfa-n3.,Acetaminophen,DB00018
DB00334,The metabolism of Olanzapine can be decreased when combined with Interferon alfa-n3.,Olanzapine,DB00018
DB00356,The metabolism of Chlorzoxazone can be decreased when combined with Interferon alfa-n3.,Chlorzoxazone,DB00018
DB00365,The metabolism of Grepafloxacin can be decreased when combined with Interferon alfa-n3.,Grepafloxacin,DB00018
DB00370,The metabolism of Mirtazapine can be decreased when combined with Interferon alfa-n3.,Mirtazapine,DB00018
DB00379,The metabolism of Mexiletine can be decreased when combined with Interferon alfa-n3.,Mexiletine,DB00018
DB00382,The metabolism of Tacrine can be decreased when combined with Interferon alfa-n3.,Tacrine,DB00018
DB00384,The metabolism of Triamterene can be decreased when combined with Interferon alfa-n3.,Triamterene,DB00018
DB00420,The metabolism of Promazine can be decreased when combined with Interferon alfa-n3.,Promazine,DB00018
DB00425,The metabolism of Zolpidem can be decreased when combined with Interferon alfa-n3.,Zolpidem,DB00018
DB00442,The metabolism of Entecavir can be decreased when combined with Interferon alfa-n3.,Entecavir,DB00018
DB00461,The metabolism of Nabumetone can be decreased when combined with Interferon alfa-n3.,Nabumetone,DB00018
DB00468,The metabolism of Quinine can be decreased when combined with Interferon alfa-n3.,Quinine,DB00018
DB00472,The metabolism of Fluoxetine can be decreased when combined with Interferon alfa-n3.,Fluoxetine,DB00018
DB00476,The metabolism of Duloxetine can be decreased when combined with Interferon alfa-n3.,Duloxetine,DB00018
DB00477,The metabolism of Chlorpromazine can be decreased when combined with Interferon alfa-n3.,Chlorpromazine,DB00018
DB00499,The metabolism of Flutamide can be decreased when combined with Interferon alfa-n3.,Flutamide,DB00018
DB00502,The metabolism of Haloperidol can be decreased when combined with Interferon alfa-n3.,Haloperidol,DB00018
DB00518,The metabolism of Albendazole can be decreased when combined with Interferon alfa-n3.,Albendazole,DB00018
DB00533,The metabolism of Rofecoxib can be decreased when combined with Interferon alfa-n3.,Rofecoxib,DB00018
DB00568,The metabolism of Cinnarizine can be decreased when combined with Interferon alfa-n3.,Cinnarizine,DB00018
DB00571,The metabolism of Propranolol can be decreased when combined with Interferon alfa-n3.,Propranolol,DB00018
DB00586,The metabolism of Diclofenac can be decreased when combined with Interferon alfa-n3.,Diclofenac,DB00018
DB00629,The metabolism of Guanabenz can be decreased when combined with Interferon alfa-n3.,Guanabenz,DB00018
DB00661,The metabolism of Verapamil can be decreased when combined with Interferon alfa-n3.,Verapamil,DB00018
DB00715,The metabolism of Paroxetine can be decreased when combined with Interferon alfa-n3.,Paroxetine,DB00018
DB00730,The metabolism of Thiabendazole can be decreased when combined with Interferon alfa-n3.,Thiabendazole,DB00018
DB00740,The metabolism of Riluzole can be decreased when combined with Interferon alfa-n3.,Riluzole,DB00018
DB00744,The metabolism of Zileuton can be decreased when combined with Interferon alfa-n3.,Zileuton,DB00018
DB00758,The metabolism of Clopidogrel can be decreased when combined with Interferon alfa-n3.,Clopidogrel,DB00018
DB00783,The metabolism of Estradiol can be decreased when combined with Interferon alfa-n3.,Estradiol,DB00018
DB00787,The metabolism of Acyclovir can be decreased when combined with Interferon alfa-n3.,Acyclovir,DB00018
DB00788,The metabolism of Naproxen can be decreased when combined with Interferon alfa-n3.,Naproxen,DB00018
DB00831,The metabolism of Trifluoperazine can be decreased when combined with Interferon alfa-n3.,Trifluoperazine,DB00018
DB00850,The metabolism of Perphenazine can be decreased when combined with Interferon alfa-n3.,Perphenazine,DB00018
DB00857,The metabolism of Terbinafine can be decreased when combined with Interferon alfa-n3.,Terbinafine,DB00018
DB00863,The metabolism of Ranitidine can be decreased when combined with Interferon alfa-n3.,Ranitidine,DB00018
DB00898,The metabolism of Ethanol can be decreased when combined with Interferon alfa-n3.,Ethanol,DB00018
DB00934,The metabolism of Maprotiline can be decreased when combined with Interferon alfa-n3.,Maprotiline,DB00018
DB00969,The metabolism of Alosetron can be decreased when combined with Interferon alfa-n3.,Alosetron,DB00018
DB00978,The metabolism of Lomefloxacin can be decreased when combined with Interferon alfa-n3.,Lomefloxacin,DB00018
DB00980,The metabolism of Ramelteon can be decreased when combined with Interferon alfa-n3.,Ramelteon,DB00018
DB00998,The metabolism of Frovatriptan can be decreased when combined with Interferon alfa-n3.,Frovatriptan,DB00018
DB01002,The metabolism of Levobupivacaine can be decreased when combined with Interferon alfa-n3.,Levobupivacaine,DB00018
DB01012,The metabolism of Cinacalcet can be decreased when combined with Interferon alfa-n3.,Cinacalcet,DB00018
DB01037,The metabolism of Selegiline can be decreased when combined with Interferon alfa-n3.,Selegiline,DB00018
DB01056,The metabolism of Tocainide can be decreased when combined with Interferon alfa-n3.,Tocainide,DB00018
DB01058,The metabolism of Praziquantel can be decreased when combined with Interferon alfa-n3.,Praziquantel,DB00018
DB01065,The metabolism of Melatonin can be decreased when combined with Interferon alfa-n3.,Melatonin,DB00018
DB01087,The metabolism of Primaquine can be decreased when combined with Interferon alfa-n3.,Primaquine,DB00018
DB01094,The metabolism of Hesperetin can be decreased when combined with Interferon alfa-n3.,Hesperetin,DB00018
DB01115,The metabolism of Nifedipine can be decreased when combined with Interferon alfa-n3.,Nifedipine,DB00018
DB01136,The metabolism of Carvedilol can be decreased when combined with Interferon alfa-n3.,Carvedilol,DB00018
DB01166,The metabolism of Cilostazol can be decreased when combined with Interferon alfa-n3.,Cilostazol,DB00018
DB01182,The metabolism of Propafenone can be decreased when combined with Interferon alfa-n3.,Propafenone,DB00018
DB01184,The metabolism of Domperidone can be decreased when combined with Interferon alfa-n3.,Domperidone,DB00018
DB01191,The metabolism of Dexfenfluramine can be decreased when combined with Interferon alfa-n3.,Dexfenfluramine,DB00018
DB01367,The metabolism of Rasagiline can be decreased when combined with Interferon alfa-n3.,Rasagiline,DB00018
DB01405,The metabolism of Temafloxacin can be decreased when combined with Interferon alfa-n3.,Temafloxacin,DB00018
DB01424,The metabolism of Aminophenazone can be decreased when combined with Interferon alfa-n3.,Aminophenazone,DB00018
DB01435,The metabolism of Antipyrine can be decreased when combined with Interferon alfa-n3.,Antipyrine,DB00018
DB01558,The metabolism of Bromazepam can be decreased when combined with Interferon alfa-n3.,Bromazepam,DB00018
DB01623,The metabolism of Thiothixene can be decreased when combined with Interferon alfa-n3.,Thiothixene,DB00018
DB01628,The metabolism of Etoricoxib can be decreased when combined with Interferon alfa-n3.,Etoricoxib,DB00018
DB01645,The metabolism of Genistein can be decreased when combined with Interferon alfa-n3.,Genistein,DB00018
DB02709,The metabolism of Resveratrol can be decreased when combined with Interferon alfa-n3.,Resveratrol,DB00018
DB03783,The metabolism of Phenacetin can be decreased when combined with Interferon alfa-n3.,Phenacetin,DB00018
DB04574,The metabolism of Estrone sulfate can be decreased when combined with Interferon alfa-n3.,Estrone sulfate,DB00018
DB04841,The metabolism of Flunarizine can be decreased when combined with Interferon alfa-n3.,Flunarizine,DB00018
DB04871,The metabolism of Lorcaserin can be decreased when combined with Interferon alfa-n3.,Lorcaserin,DB00018
DB04948,The metabolism of Lofexidine can be decreased when combined with Interferon alfa-n3.,Lofexidine,DB00018
DB06148,The metabolism of Mianserin can be decreased when combined with Interferon alfa-n3.,Mianserin,DB00018
DB06210,The metabolism of Eltrombopag can be decreased when combined with Interferon alfa-n3.,Eltrombopag,DB00018
DB06216,The metabolism of Asenapine can be decreased when combined with Interferon alfa-n3.,Asenapine,DB00018
DB06235,The metabolism of Vadimezan can be decreased when combined with Interferon alfa-n3.,Vadimezan,DB00018
DB06292,The metabolism of Dapagliflozin can be decreased when combined with Interferon alfa-n3.,Dapagliflozin,DB00018
DB06594,The metabolism of Agomelatine can be decreased when combined with Interferon alfa-n3.,Agomelatine,DB00018
DB06626,The metabolism of Axitinib can be decreased when combined with Interferon alfa-n3.,Axitinib,DB00018
DB06770,The metabolism of Benzyl alcohol can be decreased when combined with Interferon alfa-n3.,Benzyl alcohol,DB00018
DB06774,The metabolism of Capsaicin can be decreased when combined with Interferon alfa-n3.,Capsaicin,DB00018
DB08496,The metabolism of (R)-warfarin can be decreased when combined with Interferon alfa-n3.,(R)-warfarin,DB00018
DB08883,The metabolism of Perampanel can be decreased when combined with Interferon alfa-n3.,Perampanel,DB00018
DB09071,The metabolism of Tasimelteon can be decreased when combined with Interferon alfa-n3.,Tasimelteon,DB00018
DB09118,The metabolism of Stiripentol can be decreased when combined with Interferon alfa-n3.,Stiripentol,DB00018
DB09225,The metabolism of Zotepine can be decreased when combined with Interferon alfa-n3.,Zotepine,DB00018
DB09288,The metabolism of Propacetamol can be decreased when combined with Interferon alfa-n3.,Propacetamol,DB00018
DB09290,The metabolism of Ramosetron can be decreased when combined with Interferon alfa-n3.,Ramosetron,DB00018
DB11967,The metabolism of Binimetinib can be decreased when combined with Interferon alfa-n3.,Binimetinib,DB00018
DB12026,The metabolism of Voxilaprevir can be decreased when combined with Interferon alfa-n3.,Voxilaprevir,DB00018
DB12245,The metabolism of Triclabendazole can be decreased when combined with Interferon alfa-n3.,Triclabendazole,DB00018
DB12332,The metabolism of Rucaparib can be decreased when combined with Interferon alfa-n3.,Rucaparib,DB00018
DB12945,The metabolism of Dihydralazine can be decreased when combined with Interferon alfa-n3.,Dihydralazine,DB00018
DB13952,The metabolism of Estradiol acetate can be decreased when combined with Interferon alfa-n3.,Estradiol acetate,DB00018
DB13953,The metabolism of Estradiol benzoate can be decreased when combined with Interferon alfa-n3.,Estradiol benzoate,DB00018
DB13954,The metabolism of Estradiol cypionate can be decreased when combined with Interferon alfa-n3.,Estradiol cypionate,DB00018
DB13955,The metabolism of Estradiol dienanthate can be decreased when combined with Interferon alfa-n3.,Estradiol dienanthate,DB00018
DB13956,The metabolism of Estradiol valerate can be decreased when combined with Interferon alfa-n3.,Estradiol valerate,DB00018
DB11757,The metabolism of Istradefylline can be decreased when combined with Interferon alfa-n3.,Istradefylline,DB00018
DB00972,The metabolism of Azelastine can be decreased when combined with Interferon alfa-n3.,Azelastine,DB00018
DB00625,The metabolism of Efavirenz can be decreased when combined with Interferon alfa-n3.,Efavirenz,DB00018
DB01233,The metabolism of Metoclopramide can be decreased when combined with Interferon alfa-n3.,Metoclopramide,DB00018
DB04889,The metabolism of Bicifadine can be decreased when combined with Interferon alfa-n3.,Bicifadine,DB00018
DB05708,The metabolism of GTS-21 can be decreased when combined with Interferon alfa-n3.,GTS-21,DB00018
DB01195,The metabolism of Flecainide can be decreased when combined with Interferon alfa-n3.,Flecainide,DB00018
DB00977,The metabolism of Ethinylestradiol can be decreased when combined with Interferon alfa-n3.,Ethinylestradiol,DB00018
DB00321,The metabolism of Amitriptyline can be decreased when combined with Interferon alfa-n3.,Amitriptyline,DB00018
DB00458,The metabolism of Imipramine can be decreased when combined with Interferon alfa-n3.,Imipramine,DB00018
DB01142,The metabolism of Doxepin can be decreased when combined with Interferon alfa-n3.,Doxepin,DB00018
DB00532,The metabolism of Mephenytoin can be decreased when combined with Interferon alfa-n3.,Mephenytoin,DB00018
DB00540,The metabolism of Nortriptyline can be decreased when combined with Interferon alfa-n3.,Nortriptyline,DB00018
DB00575,The metabolism of Clonidine can be decreased when combined with Interferon alfa-n3.,Clonidine,DB00018
DB00924,The metabolism of Cyclobenzaprine can be decreased when combined with Interferon alfa-n3.,Cyclobenzaprine,DB00018
DB01151,The metabolism of Desipramine can be decreased when combined with Interferon alfa-n3.,Desipramine,DB00018
DB01242,The metabolism of Clomipramine can be decreased when combined with Interferon alfa-n3.,Clomipramine,DB00018
DB11689,The metabolism of Selumetinib can be decreased when combined with Interferon alfa-n3.,Selumetinib,DB00018
DB00277,The metabolism of Theophylline can be decreased when combined with Interferon alfa-n3.,Theophylline,DB00018
DB00682,The metabolism of Warfarin can be decreased when combined with Interferon alfa-n3.,Warfarin,DB00018
DB00697,The metabolism of Tizanidine can be decreased when combined with Interferon alfa-n3.,Tizanidine,DB00018
DB01100,The metabolism of Pimozide can be decreased when combined with Interferon alfa-n3.,Pimozide,DB00018
DB01223,The metabolism of Aminophylline can be decreased when combined with Interferon alfa-n3.,Aminophylline,DB00018
DB01418,The metabolism of Acenocoumarol can be decreased when combined with Interferon alfa-n3.,Acenocoumarol,DB00018
DB00530,The metabolism of Erlotinib can be decreased when combined with Interferon alfa-n3.,Erlotinib,DB00018
DB09256,The metabolism of Tegafur can be decreased when combined with Interferon alfa-n3.,Tegafur,DB00018
DB13874,The metabolism of Enasidenib can be decreased when combined with Interferon alfa-n3.,Enasidenib,DB00018
DB00675,The metabolism of Tamoxifen can be decreased when combined with Interferon alfa-n3.,Tamoxifen,DB00018
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n3.,Lepirudin,DB00018
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-n3.,Bivalirudin,DB00018
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-n3.,Alteplase,DB00018
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-n3.,Urokinase,DB00018
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-n3.,Reteplase,DB00018
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-n3.,Anistreplase,DB00018
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-n3.,Tenecteplase,DB00018
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Interferon alfa-n3.,Drotrecogin alfa,DB00018
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Interferon alfa-n3.,Streptokinase,DB00018
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Interferon alfa-n3.,Dicoumarol,DB00018
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Interferon alfa-n3.,Argatroban,DB00018
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Interferon alfa-n3.,Ardeparin,DB00018
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Interferon alfa-n3.,Phenindione,DB00018
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Interferon alfa-n3.,Fondaparinux,DB00018
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Interferon alfa-n3.,Pentosan polysulfate,DB00018
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Interferon alfa-n3.,Phenprocoumon,DB00018
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfa-n3.,Heparin,DB00018
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Interferon alfa-n3.,Enoxaparin,DB00018
DB03410,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Interferon alfa-n3.,4-hydroxycoumarin,DB00018
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Interferon alfa-n3.,Coumarin,DB00018
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfa-n3.,Ximelagatran,DB00018
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Interferon alfa-n3.,Desmoteplase,DB00018
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Interferon alfa-n3.,Ancrod,DB00018
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Interferon alfa-n3.,Fibrinolysin,DB00018
DB06228,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon alfa-n3.,Rivaroxaban,DB00018
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Interferon alfa-n3.,Sulodexide,DB00018
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Interferon alfa-n3.,Semuloparin,DB00018
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Interferon alfa-n3.,Idraparinux,DB00018
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Interferon alfa-n3.,Astaxanthin,DB00018
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Interferon alfa-n3.,Apixaban,DB00018
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Interferon alfa-n3.,Otamixaban,DB00018
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Interferon alfa-n3.,Amediplase,DB00018
DB06695,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Interferon alfa-n3.,Dabigatran etexilate,DB00018
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Interferon alfa-n3.,Danaparoid,DB00018
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Interferon alfa-n3.,Dalteparin,DB00018
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Interferon alfa-n3.,Tinzaparin,DB00018
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Interferon alfa-n3.,Ferulic acid,DB00018
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Interferon alfa-n3.,Ethyl biscoumacetate,DB00018
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Interferon alfa-n3.,Nadroparin,DB00018
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Interferon alfa-n3.,Ditazole,DB00018
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Interferon alfa-n3.,Edoxaban,DB00018
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Interferon alfa-n3.,Potassium citrate,DB00018
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Interferon alfa-n3.,Sodium citrate,DB00018
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Interferon alfa-n3.,Dextran,DB00018
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Interferon alfa-n3.,Bemiparin,DB00018
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Interferon alfa-n3.,Reviparin,DB00018
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Interferon alfa-n3.,Parnaparin,DB00018
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Interferon alfa-n3.,Certoparin,DB00018
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Interferon alfa-n3.,Desirudin,DB00018
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Interferon alfa-n3.,Zinc citrate,DB00018
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Interferon alfa-n3.,Antithrombin Alfa,DB00018
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Interferon alfa-n3.,Protein C,DB00018
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Interferon alfa-n3.,Antithrombin III human,DB00018
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Interferon alfa-n3.,Letaxaban,DB00018
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Interferon alfa-n3.,Darexaban,DB00018
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Interferon alfa-n3.,Betrixaban,DB00018
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfa-n3.,Nafamostat,DB00018
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Interferon alfa-n3.,Monteplase,DB00018
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Interferon alfa-n3.,Gabexate,DB00018
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Interferon alfa-n3.,Fluindione,DB00018
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfa-n3.,Protein S human,DB00018
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Interferon alfa-n3.,Brinase,DB00018
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Interferon alfa-n3.,Clorindione,DB00018
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Interferon alfa-n3.,Diphenadione,DB00018
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Interferon alfa-n3.,Tioclomarol,DB00018
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Interferon alfa-n3.,Melagatran,DB00018
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Interferon alfa-n3.,Saruplase,DB00018
DB14055,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Interferon alfa-n3.,(S)-Warfarin,DB00018
DB14094,The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Interferon alfa-n3.,Tocopherylquinone,DB00018
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Interferon alfa-n3.,Edetate calcium disodium anhydrous,DB00018
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Interferon alfa-n3.,Dabigatran,DB00018
DB00232,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Interferon alfa-n3.,Methyclothiazide,DB00018
DB00436,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Interferon alfa-n3.,Bendroflumethiazide,DB00018
DB00562,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Interferon alfa-n3.,Benzthiazide,DB00018
DB00606,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Interferon alfa-n3.,Cyclothiazide,DB00018
DB00774,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfa-n3.,Hydroflumethiazide,DB00018
DB00880,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Interferon alfa-n3.,Chlorothiazide,DB00018
DB00999,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfa-n3.,Hydrochlorothiazide,DB00018
DB01021,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Interferon alfa-n3.,Trichlormethiazide,DB00018
DB01324,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Interferon alfa-n3.,Polythiazide,DB00018
DB13430,The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Interferon alfa-n3.,Mebutizide,DB00018
DB13532,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Interferon alfa-n3.,Cyclopenthiazide,DB00018
DB09042,The risk or severity of myelosuppression can be increased when Interferon alfa-n3 is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00018
DB00091,Interferon alfa-n3 may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine,DB00018
DB00268,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ropinirole.,Ropinirole,DB00018
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Interferon alfa-n3.,Cyanocobalamin,DB00018
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon alfa-n3.,Allopurinol,DB00018
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Interferon alfa-n3.,Magnesium,DB00018
DB01601,The serum concentration of Interferon alfa-n3 can be increased when it is combined with Lopinavir.,Lopinavir,DB00018
DB12530,The risk or severity of infection can be increased when Interferon alfa-n3 is combined with Inebilizumab.,Inebilizumab,DB00018
DB00531,The risk or severity of pulmonary toxicity can be increased when Pegfilgrastim is combined with Cyclophosphamide.,Cyclophosphamide,DB00019
DB01030,The risk or severity of neutropenia can be increased when Pegfilgrastim is combined with Topotecan.,Topotecan,DB00019
DB00008,The therapeutic efficacy of Pegfilgrastim can be decreased when used in combination with Peginterferon alfa-2a.,Peginterferon alfa-2a,DB00019
DB00022,The therapeutic efficacy of Peginterferon alfa-2b can be decreased when used in combination with Pegfilgrastim.,Peginterferon alfa-2b,DB00019
DB00059,The therapeutic efficacy of Pegaspargase can be decreased when used in combination with Pegfilgrastim.,Pegaspargase,DB00019
DB00061,The therapeutic efficacy of Pegademase can be decreased when used in combination with Pegfilgrastim.,Pegademase,DB00019
DB00082,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Pegfilgrastim.,Pegvisomant,DB00019
DB01839,The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Pegfilgrastim.,Propylene glycol,DB00019
DB03394,The therapeutic efficacy of Heptaethylene glycol can be decreased when used in combination with Pegfilgrastim.,Heptaethylene glycol,DB00019
DB04895,The therapeutic efficacy of Pegaptanib can be decreased when used in combination with Pegfilgrastim.,Pegaptanib,DB00019
DB05202,The therapeutic efficacy of Egaptivon pegol can be decreased when used in combination with Pegfilgrastim.,Egaptivon pegol,DB00019
DB05321,The therapeutic efficacy of PEG-uricase can be decreased when used in combination with Pegfilgrastim.,PEG-uricase,DB00019
DB05860,The therapeutic efficacy of Peginterferon alfacon-1 can be decreased when used in combination with Pegfilgrastim.,Peginterferon alfacon-1,DB00019
DB06022,The therapeutic efficacy of GlycoPEG-GCSF can be decreased when used in combination with Pegfilgrastim.,GlycoPEG-GCSF,DB00019
DB06293,The therapeutic efficacy of Pegnivacogin can be decreased when used in combination with Pegfilgrastim.,Pegnivacogin,DB00019
DB06325,The therapeutic efficacy of Pegpleranib can be decreased when used in combination with Pegfilgrastim.,Pegpleranib,DB00019
DB06611,The therapeutic efficacy of Pegsunercept can be decreased when used in combination with Pegfilgrastim.,Pegsunercept,DB00019
DB06811,The therapeutic efficacy of Polidocanol can be decreased when used in combination with Pegfilgrastim.,Polidocanol,DB00019
DB08894,The therapeutic efficacy of Peginesatide can be decreased when used in combination with Pegfilgrastim.,Peginesatide,DB00019
DB08904,The therapeutic efficacy of Certolizumab pegol can be decreased when used in combination with Pegfilgrastim.,Certolizumab pegol,DB00019
DB09107,The therapeutic efficacy of Methoxy polyethylene glycol-epoetin beta can be decreased when used in combination with Pegfilgrastim.,Methoxy polyethylene glycol-epoetin beta,DB00019
DB09122,The therapeutic efficacy of Peginterferon beta-1a can be decreased when used in combination with Pegfilgrastim.,Peginterferon beta-1a,DB00019
DB09208,The therapeutic efficacy of Pegloticase can be decreased when used in combination with Pegfilgrastim.,Pegloticase,DB00019
DB09287,The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegfilgrastim.,Polyethylene glycol,DB00019
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Pegfilgrastim.","Antihemophilic Factor (Recombinant), PEGylated",DB00019
DB11077,The therapeutic efficacy of Polyethylene glycol 400 can be decreased when used in combination with Pegfilgrastim.,Polyethylene glycol 400,DB00019
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegfilgrastim.,Insulin peglispro,DB00019
DB11661,The therapeutic efficacy of Eptacog alfa pegol (activated) can be decreased when used in combination with Pegfilgrastim.,Eptacog alfa pegol (activated),DB00019
DB11707,The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Pegfilgrastim.,Olaptesed Pegol,DB00019
DB12258,The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Pegfilgrastim.,Abicipar Pegol,DB00019
DB12578,The therapeutic efficacy of Lexaptepid Pegol can be decreased when used in combination with Pegfilgrastim.,Lexaptepid Pegol,DB00019
DB12814,The therapeutic efficacy of Cepeginterferon alfa-2B can be decreased when used in combination with Pegfilgrastim.,Cepeginterferon alfa-2B,DB00019
DB12839,The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Pegfilgrastim.,Pegvaliase,DB00019
DB12842,The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Pegfilgrastim.,Pegamotecan,DB00019
DB13200,The therapeutic efficacy of Lipegfilgrastim can be decreased when used in combination with Pegfilgrastim.,Lipegfilgrastim,DB00019
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Pegfilgrastim.,Nonacog beta pegol,DB00019
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Pegfilgrastim.,Damoctocog alfa pegol,DB00019
DB14712,The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegfilgrastim.,Elapegademase,DB00019
DB00309,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vindesine.,Vindesine,DB00019
DB00361,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinorelbine.,Vinorelbine,DB00019
DB00541,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vincristine.,Vincristine,DB00019
DB00570,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinblastine.,Vinblastine,DB00019
DB05168,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vintafolide.,Vintafolide,DB00019
DB11641,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinflunine.,Vinflunine,DB00019
DB13374,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vincamine.,Vincamine,DB00019
DB00290,The risk or severity of adverse effects can be increased when Sargramostim is combined with Bleomycin.,Bleomycin,DB00020
DB00531,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Sargramostim.,Cyclophosphamide,DB00020
DB00309,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vindesine.,Vindesine,DB00020
DB00361,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinorelbine.,Vinorelbine,DB00020
DB00541,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vincristine.,Vincristine,DB00020
DB00570,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinblastine.,Vinblastine,DB00020
DB05168,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vintafolide.,Vintafolide,DB00020
DB11641,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinflunine.,Vinflunine,DB00020
DB13374,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vincamine.,Vincamine,DB00020
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Peginterferon alfa-2b.,Denosumab,DB00022
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon alfa-2b.,Etanercept,DB00022
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Peginterferon alfa-2b.,Peginterferon alfa-2a,DB00022
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Peginterferon alfa-2b.,Interferon alfa-n1,DB00022
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Peginterferon alfa-2b.,Interferon alfa-n3,DB00022
DB00026,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Anakinra.,Anakinra,DB00022
DB00033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00022
DB00034,"The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00022
DB00051,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Adalimumab.,Adalimumab,DB00022
DB00056,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00022
DB00059,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Pegaspargase.,Pegaspargase,DB00022
DB00065,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Infliximab.,Infliximab,DB00022
DB00068,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon beta-1b.,Interferon beta-1b,DB00022
DB00069,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00022
DB00073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Rituximab.,Rituximab,DB00022
DB00074,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Basiliximab.,Basiliximab,DB00022
DB00075,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Muromonab.,Muromonab,DB00022
DB00078,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00022
DB00081,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tositumomab.,Tositumomab,DB00022
DB00087,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Alemtuzumab.,Alemtuzumab,DB00022
DB00092,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Alefacept.,Alefacept,DB00022
DB00095,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Efalizumab.,Efalizumab,DB00022
DB00098,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit),DB00022
DB00105,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00022
DB00111,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Daclizumab.,Daclizumab,DB00022
DB00112,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bevacizumab.,Bevacizumab,DB00022
DB00120,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Phenylalanine.,Phenylalanine,DB00022
DB00180,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Flunisolide.,Flunisolide,DB00022
DB00242,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cladribine.,Cladribine,DB00022
DB00276,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Amsacrine.,Amsacrine,DB00022
DB00290,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bleomycin.,Bleomycin,DB00022
DB00291,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Chlorambucil.,Chlorambucil,DB00022
DB00293,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Raltitrexed.,Raltitrexed,DB00022
DB00305,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mitomycin.,Mitomycin,DB00022
DB00307,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bexarotene.,Bexarotene,DB00022
DB00309,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vindesine.,Vindesine,DB00022
DB00322,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Floxuridine.,Floxuridine,DB00022
DB00328,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Indomethacin.,Indomethacin,DB00022
DB00352,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tioguanine.,Tioguanine,DB00022
DB00361,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vinorelbine.,Vinorelbine,DB00022
DB00380,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dexrazoxane.,Dexrazoxane,DB00022
DB00394,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate,DB00022
DB00428,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Streptozocin.,Streptozocin,DB00022
DB00432,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Trifluridine.,Trifluridine,DB00022
DB00441,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gemcitabine.,Gemcitabine,DB00022
DB00443,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Betamethasone.,Betamethasone,DB00022
DB00444,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Teniposide.,Teniposide,DB00022
DB00445,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Epirubicin.,Epirubicin,DB00022
DB00446,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Chloramphenicol.,Chloramphenicol,DB00022
DB00480,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Lenalidomide.,Lenalidomide,DB00022
DB00488,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Altretamine.,Altretamine,DB00022
DB00515,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cisplatin.,Cisplatin,DB00022
DB00526,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Oxaliplatin.,Oxaliplatin,DB00022
DB00531,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cyclophosphamide.,Cyclophosphamide,DB00022
DB00541,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vincristine.,Vincristine,DB00022
DB00550,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Propylthiouracil.,Propylthiouracil,DB00022
DB00552,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Pentostatin.,Pentostatin,DB00022
DB00563,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Methotrexate.,Methotrexate,DB00022
DB00570,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vinblastine.,Vinblastine,DB00022
DB00588,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluticasone propionate.,Fluticasone propionate,DB00022
DB00591,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluocinolone acetonide.,Fluocinolone acetonide,DB00022
DB00601,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Linezolid.,Linezolid,DB00022
DB00620,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Triamcinolone.,Triamcinolone,DB00022
DB00631,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Clofarabine.,Clofarabine,DB00022
DB00635,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Prednisone.,Prednisone,DB00022
DB00687,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fludrocortisone.,Fludrocortisone,DB00022
DB00688,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mycophenolate mofetil.,Mycophenolate mofetil,DB00022
DB00694,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Daunorubicin.,Daunorubicin,DB00022
DB00755,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tretinoin.,Tretinoin,DB00022
DB00762,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Irinotecan.,Irinotecan,DB00022
DB00763,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Methimazole.,Methimazole,DB00022
DB00764,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mometasone.,Mometasone,DB00022
DB00795,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sulfasalazine.,Sulfasalazine,DB00022
DB00853,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Temozolomide.,Temozolomide,DB00022
DB00859,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Penicillamine.,Penicillamine,DB00022
DB00860,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Prednisolone.,Prednisolone,DB00022
DB00877,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sirolimus.,Sirolimus,DB00022
DB00888,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mechlorethamine.,Mechlorethamine,DB00022
DB00928,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Azacitidine.,Azacitidine,DB00022
DB00958,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Carboplatin.,Carboplatin,DB00022
DB00959,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Methylprednisolone.,Methylprednisolone,DB00022
DB00970,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dactinomycin.,Dactinomycin,DB00022
DB00987,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cytarabine.,Cytarabine,DB00022
DB00997,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Doxorubicin.,Doxorubicin,DB00022
DB01005,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydroxyurea.,Hydroxyurea,DB00022
DB01008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Busulfan.,Busulfan,DB00022
DB01024,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mycophenolic acid.,Mycophenolic acid,DB00022
DB01030,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Topotecan.,Topotecan,DB00022
DB01033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mercaptopurine.,Mercaptopurine,DB00022
DB01041,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Thalidomide.,Thalidomide,DB00022
DB01042,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Melphalan.,Melphalan,DB00022
DB01073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fludarabine.,Fludarabine,DB00022
DB01099,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Flucytosine.,Flucytosine,DB00022
DB01108,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Trilostane.,Trilostane,DB00022
DB01168,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Procarbazine.,Procarbazine,DB00022
DB01169,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Arsenic trioxide.,Arsenic trioxide,DB00022
DB01177,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Idarubicin.,Idarubicin,DB00022
DB01181,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ifosfamide.,Ifosfamide,DB00022
DB01196,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Estramustine.,Estramustine,DB00022
DB01204,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mitoxantrone.,Mitoxantrone,DB00022
DB01206,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Lomustine.,Lomustine,DB00022
DB01222,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Budesonide.,Budesonide,DB00022
DB01229,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Paclitaxel.,Paclitaxel,DB00022
DB01234,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dexamethasone.,Dexamethasone,DB00022
DB01248,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Docetaxel.,Docetaxel,DB00022
DB01257,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Eculizumab.,Eculizumab,DB00022
DB01262,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Decitabine.,Decitabine,DB00022
DB01268,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sunitinib.,Sunitinib,DB00022
DB01280,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Nelarabine.,Nelarabine,DB00022
DB01281,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Abatacept.,Abatacept,DB00022
DB01285,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Corticotropin.,Corticotropin,DB00022
DB01380,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cortisone acetate.,Cortisone acetate,DB00022
DB01384,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Paramethasone.,Paramethasone,DB00022
DB01394,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Colchicine.,Colchicine,DB00022
DB01410,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ciclesonide.,Ciclesonide,DB00022
DB01423,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Stepronin.,Stepronin,DB00022
DB01590,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Everolimus.,Everolimus,DB00022
DB01611,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydroxychloroquine.,Hydroxychloroquine,DB00022
DB01816,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Castanospermine.,Castanospermine,DB00022
DB02546,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vorinostat.,Vorinostat,DB00022
DB02806,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with 2-Methoxyethanol.,2-Methoxyethanol,DB00022
DB03523,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Brequinar.,Brequinar,DB00022
DB04572,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Thiotepa.,Thiotepa,DB00022
DB04630,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Aldosterone.,Aldosterone,DB00022
DB04845,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ixabepilone.,Ixabepilone,DB00022
DB04868,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Nilotinib.,Nilotinib,DB00022
DB04956,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Afelimomab.,Afelimomab,DB00022
DB05258,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfa.,Interferon alfa,DB00022
DB05259,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Glatiramer.,Glatiramer,DB00022
DB05260,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gallium nitrate.,Gallium nitrate,DB00022
DB05459,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Briakinumab.,Briakinumab,DB00022
DB05472,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with omega interferon.,omega interferon,DB00022
DB05773,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00022
DB06168,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Canakinumab.,Canakinumab,DB00022
DB06273,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tocilizumab.,Tocilizumab,DB00022
DB06287,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Temsirolimus.,Temsirolimus,DB00022
DB06372,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Rilonacept.,Rilonacept,DB00022
DB06603,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Panobinostat.,Panobinostat,DB00022
DB06612,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mepolizumab.,Mepolizumab,DB00022
DB06616,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bosutinib.,Bosutinib,DB00022
DB06662,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Abetimus.,Abetimus,DB00022
DB06674,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Golimumab.,Golimumab,DB00022
DB06681,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Belatacept.,Belatacept,DB00022
DB06772,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cabazitaxel.,Cabazitaxel,DB00022
DB06813,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Pralatrexate.,Pralatrexate,DB00022
DB08059,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Wortmannin.,Wortmannin,DB00022
DB08870,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Brentuximab vedotin.,Brentuximab vedotin,DB00022
DB08871,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Eribulin.,Eribulin,DB00022
DB08877,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ruxolitinib.,Ruxolitinib,DB00022
DB08879,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Belimumab.,Belimumab,DB00022
DB08880,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Teriflunomide.,Teriflunomide,DB00022
DB08889,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Carfilzomib.,Carfilzomib,DB00022
DB08901,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ponatinib.,Ponatinib,DB00022
DB08904,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Certolizumab pegol.,Certolizumab pegol,DB00022
DB08906,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluticasone furoate.,Fluticasone furoate,DB00022
DB08908,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dimethyl fumarate.,Dimethyl fumarate,DB00022
DB08935,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Obinutuzumab.,Obinutuzumab,DB00022
DB08970,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluprednidene.,Fluprednidene,DB00022
DB08971,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluocortolone.,Fluocortolone,DB00022
DB09029,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Secukinumab.,Secukinumab,DB00022
DB09033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vedolizumab.,Vedolizumab,DB00022
DB09036,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Siltuximab.,Siltuximab,DB00022
DB09052,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Blinatumomab.,Blinatumomab,DB00022
DB09053,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ibrutinib.,Ibrutinib,DB00022
DB09054,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Idelalisib.,Idelalisib,DB00022
DB09073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Palbociclib.,Palbociclib,DB00022
DB09074,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Olaparib.,Olaparib,DB00022
DB09077,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dinutuximab.,Dinutuximab,DB00022
DB09082,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vilanterol.,Vilanterol,DB00022
DB09091,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tixocortol.,Tixocortol,DB00022
DB09122,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00022
DB09312,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse),DB00022
DB09378,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluprednisolone.,Fluprednisolone,DB00022
DB09383,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Meprednisone.,Meprednisone,DB00022
DB11466,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tepoxalin.,Tepoxalin,DB00022
DB11487,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate,DB00022
DB11529,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Melengestrol.,Melengestrol,DB00022
DB11569,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ixekizumab.,Ixekizumab,DB00022
DB11580,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ravulizumab.,Ravulizumab,DB00022
DB11616,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Pirarubicin.,Pirarubicin,DB00022
DB11693,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Voclosporin.,Voclosporin,DB00022
DB11708,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Peficitinib.,Peficitinib,DB00022
DB11750,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Clobetasol.,Clobetasol,DB00022
DB11767,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sarilumab.,Sarilumab,DB00022
DB11776,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Brodalumab.,Brodalumab,DB00022
DB11803,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sirukumab.,Sirukumab,DB00022
DB11817,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Baricitinib.,Baricitinib,DB00022
DB11834,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Guselkumab.,Guselkumab,DB00022
DB11921,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Deflazacort.,Deflazacort,DB00022
DB11988,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ocrelizumab.,Ocrelizumab,DB00022
DB12025,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Triptolide.,Triptolide,DB00022
DB12612,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ozanimod.,Ozanimod,DB00022
DB12617,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mizoribine.,Mizoribine,DB00022
DB12692,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gusperimus.,Gusperimus,DB00022
DB12814,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00022
DB12902,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Trofosfamide.,Trofosfamide,DB00022
DB12947,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Doxifluridine.,Doxifluridine,DB00022
DB12991,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Deoxyspergualin.,Deoxyspergualin,DB00022
DB12996,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Acteoside.,Acteoside,DB00022
DB13003,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cortivazol.,Cortivazol,DB00022
DB13014,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hypericin.,Hypericin,DB00022
DB13068,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A,DB00022
DB13208,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Prednylidene.,Prednylidene,DB00022
DB13223,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluocortin.,Fluocortin,DB00022
DB13241,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Begelomab.,Begelomab,DB00022
DB13491,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluperolone.,Fluperolone,DB00022
DB13664,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Formocortal.,Formocortal,DB00022
DB13728,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Halometasone.,Halometasone,DB00022
DB13843,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cloprednol.,Cloprednol,DB00022
DB13856,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluclorolone.,Fluclorolone,DB00022
DB13867,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluticasone.,Fluticasone,DB00022
DB14066,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tetrandrine.,Tetrandrine,DB00022
DB14219,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Monomethyl fumarate.,Monomethyl fumarate,DB00022
DB14512,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mometasone furoate.,Mometasone furoate,DB00022
DB14538,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydrocortisone aceponate.,Hydrocortisone aceponate,DB00022
DB14539,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydrocortisone acetate.,Hydrocortisone acetate,DB00022
DB14545,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydrocortisone succinate.,Hydrocortisone succinate,DB00022
DB14724,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Emapalumab.,Emapalumab,DB00022
DB14762,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Risankizumab.,Risankizumab,DB00022
DB14919,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Rozanolixizumab.,Rozanolixizumab,DB00022
DB15253,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bleselumab.,Bleselumab,DB00022
DB12371,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Siponimod.,Siponimod,DB00022
DB00108,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Natalizumab.,Natalizumab,DB00022
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Peginterferon alfa-2b.,Pimecrolimus,DB00022
DB01656,Roflumilast may increase the immunosuppressive activities of Peginterferon alfa-2b.,Roflumilast,DB00022
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Peginterferon alfa-2b.,Sipuleucel-T,DB00022
DB00041,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Aldesleukin.,Aldesleukin,DB00022
DB00363,The risk or severity of neutropenia can be increased when Peginterferon alfa-2b is combined with Clozapine.,Clozapine,DB00022
DB00333,The serum concentration of Methadone can be increased when it is combined with Peginterferon alfa-2b.,Methadone,DB00022
DB00495,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Zidovudine.,Zidovudine,DB00022
DB00472,The serum concentration of Fluoxetine can be decreased when it is combined with Peginterferon alfa-2b.,Fluoxetine,DB00022
DB01265,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Telbivudine.,Telbivudine,DB00022
DB00675,The serum concentration of Tamoxifen can be increased when it is combined with Peginterferon alfa-2b.,Tamoxifen,DB00022
DB00972,The serum concentration of Azelastine can be increased when it is combined with Peginterferon alfa-2b.,Azelastine,DB00022
DB00176,The serum concentration of Fluvoxamine can be increased when it is combined with Peginterferon alfa-2b.,Fluvoxamine,DB00022
DB00184,The serum concentration of Nicotine can be increased when it is combined with Peginterferon alfa-2b.,Nicotine,DB00022
DB00188,The serum concentration of Bortezomib can be increased when it is combined with Peginterferon alfa-2b.,Bortezomib,DB00022
DB00195,The serum concentration of Betaxolol can be increased when it is combined with Peginterferon alfa-2b.,Betaxolol,DB00022
DB00201,The serum concentration of Caffeine can be increased when it is combined with Peginterferon alfa-2b.,Caffeine,DB00022
DB00261,The serum concentration of Anagrelide can be increased when it is combined with Peginterferon alfa-2b.,Anagrelide,DB00022
DB00262,The serum concentration of Carmustine can be increased when it is combined with Peginterferon alfa-2b.,Carmustine,DB00022
DB00277,The serum concentration of Theophylline can be increased when it is combined with Peginterferon alfa-2b.,Theophylline,DB00022
DB00280,The serum concentration of Disopyramide can be increased when it is combined with Peginterferon alfa-2b.,Disopyramide,DB00022
DB00281,The serum concentration of Lidocaine can be increased when it is combined with Peginterferon alfa-2b.,Lidocaine,DB00022
DB00286,The serum concentration of Conjugated estrogens can be increased when it is combined with Peginterferon alfa-2b.,Conjugated estrogens,DB00022
DB00296,The serum concentration of Ropivacaine can be increased when it is combined with Peginterferon alfa-2b.,Ropivacaine,DB00022
DB00316,The serum concentration of Acetaminophen can be increased when it is combined with Peginterferon alfa-2b.,Acetaminophen,DB00022
DB00334,The serum concentration of Olanzapine can be increased when it is combined with Peginterferon alfa-2b.,Olanzapine,DB00022
DB00356,The serum concentration of Chlorzoxazone can be increased when it is combined with Peginterferon alfa-2b.,Chlorzoxazone,DB00022
DB00365,The serum concentration of Grepafloxacin can be increased when it is combined with Peginterferon alfa-2b.,Grepafloxacin,DB00022
DB00370,The serum concentration of Mirtazapine can be increased when it is combined with Peginterferon alfa-2b.,Mirtazapine,DB00022
DB00379,The serum concentration of Mexiletine can be increased when it is combined with Peginterferon alfa-2b.,Mexiletine,DB00022
DB00382,The serum concentration of Tacrine can be increased when it is combined with Peginterferon alfa-2b.,Tacrine,DB00022
DB00384,The serum concentration of Triamterene can be increased when it is combined with Peginterferon alfa-2b.,Triamterene,DB00022
DB00398,The serum concentration of Sorafenib can be increased when it is combined with Peginterferon alfa-2b.,Sorafenib,DB00022
DB00420,The serum concentration of Promazine can be increased when it is combined with Peginterferon alfa-2b.,Promazine,DB00022
DB00425,The serum concentration of Zolpidem can be increased when it is combined with Peginterferon alfa-2b.,Zolpidem,DB00022
DB00442,The serum concentration of Entecavir can be increased when it is combined with Peginterferon alfa-2b.,Entecavir,DB00022
DB00458,The serum concentration of Imipramine can be increased when it is combined with Peginterferon alfa-2b.,Imipramine,DB00022
DB00461,The serum concentration of Nabumetone can be increased when it is combined with Peginterferon alfa-2b.,Nabumetone,DB00022
DB00468,The serum concentration of Quinine can be increased when it is combined with Peginterferon alfa-2b.,Quinine,DB00022
DB00476,The serum concentration of Duloxetine can be increased when it is combined with Peginterferon alfa-2b.,Duloxetine,DB00022
DB00477,The serum concentration of Chlorpromazine can be increased when it is combined with Peginterferon alfa-2b.,Chlorpromazine,DB00022
DB00499,The serum concentration of Flutamide can be increased when it is combined with Peginterferon alfa-2b.,Flutamide,DB00022
DB00518,The serum concentration of Albendazole can be increased when it is combined with Peginterferon alfa-2b.,Albendazole,DB00022
DB00530,The serum concentration of Erlotinib can be increased when it is combined with Peginterferon alfa-2b.,Erlotinib,DB00022
DB00532,The serum concentration of Mephenytoin can be increased when it is combined with Peginterferon alfa-2b.,Mephenytoin,DB00022
DB00533,The serum concentration of Rofecoxib can be increased when it is combined with Peginterferon alfa-2b.,Rofecoxib,DB00022
DB00540,The serum concentration of Nortriptyline can be increased when it is combined with Peginterferon alfa-2b.,Nortriptyline,DB00022
DB00544,The serum concentration of Fluorouracil can be increased when it is combined with Peginterferon alfa-2b.,Fluorouracil,DB00022
DB00564,The serum concentration of Carbamazepine can be increased when it is combined with Peginterferon alfa-2b.,Carbamazepine,DB00022
DB00568,The serum concentration of Cinnarizine can be increased when it is combined with Peginterferon alfa-2b.,Cinnarizine,DB00022
DB00571,The serum concentration of Propranolol can be increased when it is combined with Peginterferon alfa-2b.,Propranolol,DB00022
DB00575,The serum concentration of Clonidine can be increased when it is combined with Peginterferon alfa-2b.,Clonidine,DB00022
DB00586,The serum concentration of Diclofenac can be increased when it is combined with Peginterferon alfa-2b.,Diclofenac,DB00022
DB00619,The serum concentration of Imatinib can be increased when it is combined with Peginterferon alfa-2b.,Imatinib,DB00022
DB00629,The serum concentration of Guanabenz can be increased when it is combined with Peginterferon alfa-2b.,Guanabenz,DB00022
DB00642,The serum concentration of Pemetrexed can be increased when it is combined with Peginterferon alfa-2b.,Pemetrexed,DB00022
DB00661,The serum concentration of Verapamil can be increased when it is combined with Peginterferon alfa-2b.,Verapamil,DB00022
DB00682,The serum concentration of Warfarin can be increased when it is combined with Peginterferon alfa-2b.,Warfarin,DB00022
DB00697,The serum concentration of Tizanidine can be increased when it is combined with Peginterferon alfa-2b.,Tizanidine,DB00022
DB00715,The serum concentration of Paroxetine can be increased when it is combined with Peginterferon alfa-2b.,Paroxetine,DB00022
DB00730,The serum concentration of Thiabendazole can be increased when it is combined with Peginterferon alfa-2b.,Thiabendazole,DB00022
DB00740,The serum concentration of Riluzole can be increased when it is combined with Peginterferon alfa-2b.,Riluzole,DB00022
DB00744,The serum concentration of Zileuton can be increased when it is combined with Peginterferon alfa-2b.,Zileuton,DB00022
DB00758,The serum concentration of Clopidogrel can be increased when it is combined with Peginterferon alfa-2b.,Clopidogrel,DB00022
DB00773,The serum concentration of Etoposide can be increased when it is combined with Peginterferon alfa-2b.,Etoposide,DB00022
DB00783,The serum concentration of Estradiol can be increased when it is combined with Peginterferon alfa-2b.,Estradiol,DB00022
DB00787,The serum concentration of Acyclovir can be increased when it is combined with Peginterferon alfa-2b.,Acyclovir,DB00022
DB00788,The serum concentration of Naproxen can be increased when it is combined with Peginterferon alfa-2b.,Naproxen,DB00022
DB00806,The serum concentration of Pentoxifylline can be increased when it is combined with Peginterferon alfa-2b.,Pentoxifylline,DB00022
DB00831,The serum concentration of Trifluoperazine can be increased when it is combined with Peginterferon alfa-2b.,Trifluoperazine,DB00022
DB00850,The serum concentration of Perphenazine can be increased when it is combined with Peginterferon alfa-2b.,Perphenazine,DB00022
DB00851,The serum concentration of Dacarbazine can be increased when it is combined with Peginterferon alfa-2b.,Dacarbazine,DB00022
DB00857,The serum concentration of Terbinafine can be increased when it is combined with Peginterferon alfa-2b.,Terbinafine,DB00022
DB00863,The serum concentration of Ranitidine can be increased when it is combined with Peginterferon alfa-2b.,Ranitidine,DB00022
DB00898,The serum concentration of Ethanol can be increased when it is combined with Peginterferon alfa-2b.,Ethanol,DB00022
DB00924,The serum concentration of Cyclobenzaprine can be increased when it is combined with Peginterferon alfa-2b.,Cyclobenzaprine,DB00022
DB00934,The serum concentration of Maprotiline can be increased when it is combined with Peginterferon alfa-2b.,Maprotiline,DB00022
DB00969,The serum concentration of Alosetron can be increased when it is combined with Peginterferon alfa-2b.,Alosetron,DB00022
DB00978,The serum concentration of Lomefloxacin can be increased when it is combined with Peginterferon alfa-2b.,Lomefloxacin,DB00022
DB00980,The serum concentration of Ramelteon can be increased when it is combined with Peginterferon alfa-2b.,Ramelteon,DB00022
DB00993,The serum concentration of Azathioprine can be increased when it is combined with Peginterferon alfa-2b.,Azathioprine,DB00022
DB00998,The serum concentration of Frovatriptan can be increased when it is combined with Peginterferon alfa-2b.,Frovatriptan,DB00022
DB01002,The serum concentration of Levobupivacaine can be increased when it is combined with Peginterferon alfa-2b.,Levobupivacaine,DB00022
DB01012,The serum concentration of Cinacalcet can be increased when it is combined with Peginterferon alfa-2b.,Cinacalcet,DB00022
DB01037,The serum concentration of Selegiline can be increased when it is combined with Peginterferon alfa-2b.,Selegiline,DB00022
DB01056,The serum concentration of Tocainide can be increased when it is combined with Peginterferon alfa-2b.,Tocainide,DB00022
DB01058,The serum concentration of Praziquantel can be increased when it is combined with Peginterferon alfa-2b.,Praziquantel,DB00022
DB01065,The serum concentration of Melatonin can be increased when it is combined with Peginterferon alfa-2b.,Melatonin,DB00022
DB01087,The serum concentration of Primaquine can be increased when it is combined with Peginterferon alfa-2b.,Primaquine,DB00022
DB01094,The serum concentration of Hesperetin can be increased when it is combined with Peginterferon alfa-2b.,Hesperetin,DB00022
DB01100,The serum concentration of Pimozide can be increased when it is combined with Peginterferon alfa-2b.,Pimozide,DB00022
DB01115,The serum concentration of Nifedipine can be increased when it is combined with Peginterferon alfa-2b.,Nifedipine,DB00022
DB01136,The serum concentration of Carvedilol can be increased when it is combined with Peginterferon alfa-2b.,Carvedilol,DB00022
DB01142,The serum concentration of Doxepin can be increased when it is combined with Peginterferon alfa-2b.,Doxepin,DB00022
DB01151,The serum concentration of Desipramine can be increased when it is combined with Peginterferon alfa-2b.,Desipramine,DB00022
DB01166,The serum concentration of Cilostazol can be increased when it is combined with Peginterferon alfa-2b.,Cilostazol,DB00022
DB01182,The serum concentration of Propafenone can be increased when it is combined with Peginterferon alfa-2b.,Propafenone,DB00022
DB01184,The serum concentration of Domperidone can be increased when it is combined with Peginterferon alfa-2b.,Domperidone,DB00022
DB01191,The serum concentration of Dexfenfluramine can be increased when it is combined with Peginterferon alfa-2b.,Dexfenfluramine,DB00022
DB01223,The serum concentration of Aminophylline can be increased when it is combined with Peginterferon alfa-2b.,Aminophylline,DB00022
DB01242,The serum concentration of Clomipramine can be increased when it is combined with Peginterferon alfa-2b.,Clomipramine,DB00022
DB01254,The serum concentration of Dasatinib can be increased when it is combined with Peginterferon alfa-2b.,Dasatinib,DB00022
DB01303,The serum concentration of Oxtriphylline can be increased when it is combined with Peginterferon alfa-2b.,Oxtriphylline,DB00022
DB01367,The serum concentration of Rasagiline can be increased when it is combined with Peginterferon alfa-2b.,Rasagiline,DB00022
DB01405,The serum concentration of Temafloxacin can be increased when it is combined with Peginterferon alfa-2b.,Temafloxacin,DB00022
DB01412,The serum concentration of Theobromine can be increased when it is combined with Peginterferon alfa-2b.,Theobromine,DB00022
DB01418,The serum concentration of Acenocoumarol can be increased when it is combined with Peginterferon alfa-2b.,Acenocoumarol,DB00022
DB01424,The serum concentration of Aminophenazone can be increased when it is combined with Peginterferon alfa-2b.,Aminophenazone,DB00022
DB01435,The serum concentration of Antipyrine can be increased when it is combined with Peginterferon alfa-2b.,Antipyrine,DB00022
DB01482,The serum concentration of Fenethylline can be increased when it is combined with Peginterferon alfa-2b.,Fenethylline,DB00022
DB01558,The serum concentration of Bromazepam can be increased when it is combined with Peginterferon alfa-2b.,Bromazepam,DB00022
DB01623,The serum concentration of Thiothixene can be increased when it is combined with Peginterferon alfa-2b.,Thiothixene,DB00022
DB01628,The serum concentration of Etoricoxib can be increased when it is combined with Peginterferon alfa-2b.,Etoricoxib,DB00022
DB01645,The serum concentration of Genistein can be increased when it is combined with Peginterferon alfa-2b.,Genistein,DB00022
DB01667,The serum concentration of 8-azaguanine can be increased when it is combined with Peginterferon alfa-2b.,8-azaguanine,DB00022
DB02134,The serum concentration of Xanthine can be increased when it is combined with Peginterferon alfa-2b.,Xanthine,DB00022
DB02489,The serum concentration of 9-Methylguanine can be increased when it is combined with Peginterferon alfa-2b.,9-Methylguanine,DB00022
DB02568,The serum concentration of Peldesine can be increased when it is combined with Peginterferon alfa-2b.,Peldesine,DB00022
DB02709,The serum concentration of Resveratrol can be increased when it is combined with Peginterferon alfa-2b.,Resveratrol,DB00022
DB03783,The serum concentration of Phenacetin can be increased when it is combined with Peginterferon alfa-2b.,Phenacetin,DB00022
DB04076,The serum concentration of Hypoxanthine can be increased when it is combined with Peginterferon alfa-2b.,Hypoxanthine,DB00022
DB04356,The serum concentration of 9-Deazaguanine can be increased when it is combined with Peginterferon alfa-2b.,9-Deazaguanine,DB00022
DB04574,The serum concentration of Estrone sulfate can be increased when it is combined with Peginterferon alfa-2b.,Estrone sulfate,DB00022
DB04841,The serum concentration of Flunarizine can be increased when it is combined with Peginterferon alfa-2b.,Flunarizine,DB00022
DB04871,The serum concentration of Lorcaserin can be increased when it is combined with Peginterferon alfa-2b.,Lorcaserin,DB00022
DB04948,The serum concentration of Lofexidine can be increased when it is combined with Peginterferon alfa-2b.,Lofexidine,DB00022
DB04951,The serum concentration of Pirfenidone can be increased when it is combined with Peginterferon alfa-2b.,Pirfenidone,DB00022
DB05676,The serum concentration of Apremilast can be increased when it is combined with Peginterferon alfa-2b.,Apremilast,DB00022
DB06148,The serum concentration of Mianserin can be increased when it is combined with Peginterferon alfa-2b.,Mianserin,DB00022
DB06210,The serum concentration of Eltrombopag can be increased when it is combined with Peginterferon alfa-2b.,Eltrombopag,DB00022
DB06216,The serum concentration of Asenapine can be increased when it is combined with Peginterferon alfa-2b.,Asenapine,DB00022
DB06235,The serum concentration of Vadimezan can be increased when it is combined with Peginterferon alfa-2b.,Vadimezan,DB00022
DB06292,The serum concentration of Dapagliflozin can be increased when it is combined with Peginterferon alfa-2b.,Dapagliflozin,DB00022
DB06479,The serum concentration of Propentofylline can be increased when it is combined with Peginterferon alfa-2b.,Propentofylline,DB00022
DB06589,The serum concentration of Pazopanib can be increased when it is combined with Peginterferon alfa-2b.,Pazopanib,DB00022
DB06594,The serum concentration of Agomelatine can be increased when it is combined with Peginterferon alfa-2b.,Agomelatine,DB00022
DB06626,The serum concentration of Axitinib can be increased when it is combined with Peginterferon alfa-2b.,Axitinib,DB00022
DB06769,The serum concentration of Bendamustine can be increased when it is combined with Peginterferon alfa-2b.,Bendamustine,DB00022
DB06770,The serum concentration of Benzyl alcohol can be increased when it is combined with Peginterferon alfa-2b.,Benzyl alcohol,DB00022
DB06774,The serum concentration of Capsaicin can be increased when it is combined with Peginterferon alfa-2b.,Capsaicin,DB00022
DB08496,The serum concentration of (R)-warfarin can be increased when it is combined with Peginterferon alfa-2b.,(R)-warfarin,DB00022
DB08883,The serum concentration of Perampanel can be increased when it is combined with Peginterferon alfa-2b.,Perampanel,DB00022
DB08910,The serum concentration of Pomalidomide can be increased when it is combined with Peginterferon alfa-2b.,Pomalidomide,DB00022
DB09071,The serum concentration of Tasimelteon can be increased when it is combined with Peginterferon alfa-2b.,Tasimelteon,DB00022
DB09118,The serum concentration of Stiripentol can be increased when it is combined with Peginterferon alfa-2b.,Stiripentol,DB00022
DB09225,The serum concentration of Zotepine can be increased when it is combined with Peginterferon alfa-2b.,Zotepine,DB00022
DB09256,The serum concentration of Tegafur can be increased when it is combined with Peginterferon alfa-2b.,Tegafur,DB00022
DB09273,The serum concentration of Doxofylline can be increased when it is combined with Peginterferon alfa-2b.,Doxofylline,DB00022
DB09288,The serum concentration of Propacetamol can be increased when it is combined with Peginterferon alfa-2b.,Propacetamol,DB00022
DB09290,The serum concentration of Ramosetron can be increased when it is combined with Peginterferon alfa-2b.,Ramosetron,DB00022
DB11919,The serum concentration of 6-O-benzylguanine can be increased when it is combined with Peginterferon alfa-2b.,6-O-benzylguanine,DB00022
DB11967,The serum concentration of Binimetinib can be increased when it is combined with Peginterferon alfa-2b.,Binimetinib,DB00022
DB12026,The serum concentration of Voxilaprevir can be increased when it is combined with Peginterferon alfa-2b.,Voxilaprevir,DB00022
DB12245,The serum concentration of Triclabendazole can be increased when it is combined with Peginterferon alfa-2b.,Triclabendazole,DB00022
DB12332,The serum concentration of Rucaparib can be increased when it is combined with Peginterferon alfa-2b.,Rucaparib,DB00022
DB12406,The serum concentration of Lisofylline can be increased when it is combined with Peginterferon alfa-2b.,Lisofylline,DB00022
DB12531,The serum concentration of Lobucavir can be increased when it is combined with Peginterferon alfa-2b.,Lobucavir,DB00022
DB12926,The serum concentration of Cafedrine can be increased when it is combined with Peginterferon alfa-2b.,Cafedrine,DB00022
DB12927,The serum concentration of Theodrenaline can be increased when it is combined with Peginterferon alfa-2b.,Theodrenaline,DB00022
DB12945,The serum concentration of Dihydralazine can be increased when it is combined with Peginterferon alfa-2b.,Dihydralazine,DB00022
DB13203,The serum concentration of Bamifylline can be increased when it is combined with Peginterferon alfa-2b.,Bamifylline,DB00022
DB13449,The serum concentration of Proxyphylline can be increased when it is combined with Peginterferon alfa-2b.,Proxyphylline,DB00022
DB13573,The serum concentration of Acefylline can be increased when it is combined with Peginterferon alfa-2b.,Acefylline,DB00022
DB13592,The serum concentration of Etamiphylline can be increased when it is combined with Peginterferon alfa-2b.,Etamiphylline,DB00022
DB13634,The serum concentration of Pentifylline can be increased when it is combined with Peginterferon alfa-2b.,Pentifylline,DB00022
DB13812,The serum concentration of Bufylline can be increased when it is combined with Peginterferon alfa-2b.,Bufylline,DB00022
DB13874,The serum concentration of Enasidenib can be increased when it is combined with Peginterferon alfa-2b.,Enasidenib,DB00022
DB13952,The serum concentration of Estradiol acetate can be increased when it is combined with Peginterferon alfa-2b.,Estradiol acetate,DB00022
DB13953,The serum concentration of Estradiol benzoate can be increased when it is combined with Peginterferon alfa-2b.,Estradiol benzoate,DB00022
DB13954,The serum concentration of Estradiol cypionate can be increased when it is combined with Peginterferon alfa-2b.,Estradiol cypionate,DB00022
DB13955,The serum concentration of Estradiol dienanthate can be increased when it is combined with Peginterferon alfa-2b.,Estradiol dienanthate,DB00022
DB13956,The serum concentration of Estradiol valerate can be increased when it is combined with Peginterferon alfa-2b.,Estradiol valerate,DB00022
DB14018,The serum concentration of Bromotheophylline can be increased when it is combined with Peginterferon alfa-2b.,Bromotheophylline,DB00022
DB14132,The serum concentration of 8-chlorotheophylline can be increased when it is combined with Peginterferon alfa-2b.,8-chlorotheophylline,DB00022
DB01195,The serum concentration of Flecainide can be increased when it is combined with Peginterferon alfa-2b.,Flecainide,DB00022
DB01233,The serum concentration of Metoclopramide can be increased when it is combined with Peginterferon alfa-2b.,Metoclopramide,DB00022
DB11757,The serum concentration of Istradefylline can be increased when it is combined with Peginterferon alfa-2b.,Istradefylline,DB00022
DB00625,The serum concentration of Efavirenz can be increased when it is combined with Peginterferon alfa-2b.,Efavirenz,DB00022
DB04889,The serum concentration of Bicifadine can be increased when it is combined with Peginterferon alfa-2b.,Bicifadine,DB00022
DB05708,The serum concentration of GTS-21 can be increased when it is combined with Peginterferon alfa-2b.,GTS-21,DB00022
DB00977,The serum concentration of Ethinylestradiol can be increased when it is combined with Peginterferon alfa-2b.,Ethinylestradiol,DB00022
DB11689,The serum concentration of Selumetinib can be increased when it is combined with Peginterferon alfa-2b.,Selumetinib,DB00022
DB00315,The metabolism of Zolmitriptan can be decreased when combined with Peginterferon alfa-2b.,Zolmitriptan,DB00022
DB00289,The metabolism of Atomoxetine can be decreased when combined with Peginterferon alfa-2b.,Atomoxetine,DB00022
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Peginterferon alfa-2b.,Sulfamethoxazole,DB00022
DB04817,The risk or severity of myelosuppression can be increased when Metamizole is combined with Peginterferon alfa-2b.,Metamizole,DB00022
DB01097,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Leflunomide.,Leflunomide,DB00022
DB08895,Peginterferon alfa-2b may increase the immunosuppressive activities of Tofacitinib.,Tofacitinib,DB00022
DB00072,Trastuzumab may increase the neutropenic activities of Peginterferon alfa-2b.,Trastuzumab,DB00022
DB00019,The therapeutic efficacy of Peginterferon alfa-2b can be decreased when used in combination with Pegfilgrastim.,Pegfilgrastim,DB00022
DB00061,The therapeutic efficacy of Pegademase can be decreased when used in combination with Peginterferon alfa-2b.,Pegademase,DB00022
DB00082,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Peginterferon alfa-2b.,Pegvisomant,DB00022
DB01839,The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Peginterferon alfa-2b.,Propylene glycol,DB00022
DB03394,The therapeutic efficacy of Heptaethylene glycol can be decreased when used in combination with Peginterferon alfa-2b.,Heptaethylene glycol,DB00022
DB04895,The therapeutic efficacy of Pegaptanib can be decreased when used in combination with Peginterferon alfa-2b.,Pegaptanib,DB00022
DB05202,The therapeutic efficacy of Egaptivon pegol can be decreased when used in combination with Peginterferon alfa-2b.,Egaptivon pegol,DB00022
DB05321,The therapeutic efficacy of PEG-uricase can be decreased when used in combination with Peginterferon alfa-2b.,PEG-uricase,DB00022
DB05860,The therapeutic efficacy of Peginterferon alfacon-1 can be decreased when used in combination with Peginterferon alfa-2b.,Peginterferon alfacon-1,DB00022
DB06022,The therapeutic efficacy of GlycoPEG-GCSF can be decreased when used in combination with Peginterferon alfa-2b.,GlycoPEG-GCSF,DB00022
DB06293,The therapeutic efficacy of Pegnivacogin can be decreased when used in combination with Peginterferon alfa-2b.,Pegnivacogin,DB00022
DB06325,The therapeutic efficacy of Pegpleranib can be decreased when used in combination with Peginterferon alfa-2b.,Pegpleranib,DB00022
DB06611,The therapeutic efficacy of Pegsunercept can be decreased when used in combination with Peginterferon alfa-2b.,Pegsunercept,DB00022
DB06811,The therapeutic efficacy of Polidocanol can be decreased when used in combination with Peginterferon alfa-2b.,Polidocanol,DB00022
DB08894,The therapeutic efficacy of Peginesatide can be decreased when used in combination with Peginterferon alfa-2b.,Peginesatide,DB00022
DB09107,The therapeutic efficacy of Methoxy polyethylene glycol-epoetin beta can be decreased when used in combination with Peginterferon alfa-2b.,Methoxy polyethylene glycol-epoetin beta,DB00022
DB09208,The therapeutic efficacy of Pegloticase can be decreased when used in combination with Peginterferon alfa-2b.,Pegloticase,DB00022
DB09287,The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Peginterferon alfa-2b.,Polyethylene glycol,DB00022
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Peginterferon alfa-2b.","Antihemophilic Factor (Recombinant), PEGylated",DB00022
DB11077,The therapeutic efficacy of Polyethylene glycol 400 can be decreased when used in combination with Peginterferon alfa-2b.,Polyethylene glycol 400,DB00022
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Peginterferon alfa-2b.,Insulin peglispro,DB00022
DB11661,The therapeutic efficacy of Eptacog alfa pegol (activated) can be decreased when used in combination with Peginterferon alfa-2b.,Eptacog alfa pegol (activated),DB00022
DB11707,The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Peginterferon alfa-2b.,Olaptesed Pegol,DB00022
DB12258,The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Peginterferon alfa-2b.,Abicipar Pegol,DB00022
DB12578,The therapeutic efficacy of Lexaptepid Pegol can be decreased when used in combination with Peginterferon alfa-2b.,Lexaptepid Pegol,DB00022
DB12839,The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Peginterferon alfa-2b.,Pegvaliase,DB00022
DB12842,The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Peginterferon alfa-2b.,Pegamotecan,DB00022
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Peginterferon alfa-2b.,Nonacog beta pegol,DB00022
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Peginterferon alfa-2b.,Damoctocog alfa pegol,DB00022
DB14712,The therapeutic efficacy of Elapegademase can be decreased when used in combination with Peginterferon alfa-2b.,Elapegademase,DB00022
DB08868,Peginterferon alfa-2b may increase the immunosuppressive activities of Fingolimod.,Fingolimod,DB00022
DB00864,Tacrolimus may increase the immunosuppressive activities of Peginterferon alfa-2b.,Tacrolimus,DB00022
DB00651,The metabolism of Dyphylline can be decreased when combined with Peginterferon alfa-2b.,Dyphylline,DB00022
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Peginterferon alfa-2b.","7,9-Dimethylguanine",DB00022
DB02245,The metabolism of 7-Deazaguanine can be decreased when combined with Peginterferon alfa-2b.,7-Deazaguanine,DB00022
DB02377,The metabolism of Guanine can be decreased when combined with Peginterferon alfa-2b.,Guanine,DB00022
DB06575,The metabolism of Valomaciclovir can be decreased when combined with Peginterferon alfa-2b.,Valomaciclovir,DB00022
DB07954,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Peginterferon alfa-2b.,3-isobutyl-1-methyl-7H-xanthine,DB00022
DB08844,The metabolism of Uric acid can be decreased when combined with Peginterferon alfa-2b.,Uric acid,DB00022
DB14029,The metabolism of Furafylline can be decreased when combined with Peginterferon alfa-2b.,Furafylline,DB00022
DB15122,The metabolism of PCS-499 can be decreased when combined with Peginterferon alfa-2b.,PCS-499,DB00022
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Peginterferon alfa-2b.,G17DT,DB00022
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Peginterferon alfa-2b.,PEV3A,DB00022
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Peginterferon alfa-2b.,INGN 225,DB00022
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Peginterferon alfa-2b.,Rindopepimut,DB00022
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Peginterferon alfa-2b.,SRP 299,DB00022
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Peginterferon alfa-2b.,GI-5005,DB00022
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Peginterferon alfa-2b.,Vitespen,DB00022
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Peginterferon alfa-2b.,TG4010,DB00022
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Peginterferon alfa-2b.,Anthrax immune globulin human,DB00022
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Peginterferon alfa-2b.","Rabies virus inactivated antigen, B",DB00022
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Peginterferon alfa-2b.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen,DB00022
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Peginterferon alfa-2b.,Rotavirus vaccine,DB00022
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Peginterferon alfa-2b.","Rabies virus inactivated antigen, A",DB00022
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Peginterferon alfa-2b.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen,DB00022
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Clostridium tetani toxoid antigen (formaldehyde inactivated),DB00022
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated),DB00022
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated),DB00022
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),DB00022
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated),DB00022
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Peginterferon alfa-2b.,Typhoid Vi polysaccharide vaccine,DB00022
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Peginterferon alfa-2b.,Hepatitis A Vaccine,DB00022
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Peginterferon alfa-2b.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,DB00022
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated),DB00022
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated),DB00022
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated),DB00022
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated),DB00022
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Peginterferon alfa-2b.,Human rabies virus immune globulin,DB00022
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Peginterferon alfa-2b.,Hepatitis B Vaccine (Recombinant),DB00022
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Peginterferon alfa-2b.,Tecemotide,DB00022
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Peginterferon alfa-2b.,Typhoid vaccine,DB00022
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated),DB00022
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated),DB00022
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen,DB00022
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated),DB00022
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen,DB00022
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated),DB00022
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated),DB00022
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Peginterferon alfa-2b.,Vaccinia virus strain new york city board of health live antigen,DB00022
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Peginterferon alfa-2b.,Pertussis vaccine,DB00022
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Yersinia pestis 195/p antigen (formaldehyde inactivated),DB00022
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Peginterferon alfa-2b.,Varicella Zoster Vaccine (Recombinant),DB00022
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Peginterferon alfa-2b.,Modified vaccinia ankara,DB00022
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Peginterferon alfa-2b.","Ebola Zaire vaccine (live, attenuated)",DB00022
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2b.,Abciximab,DB00022
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Peginterferon alfa-2b.,Eptifibatide,DB00022
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Peginterferon alfa-2b.,Ticlopidine,DB00022
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Peginterferon alfa-2b.,Tirofiban,DB00022
DB00945,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Peginterferon alfa-2b.,Acetylsalicylic acid,DB00022
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Peginterferon alfa-2b.,Dipyridamole,DB00022
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Peginterferon alfa-2b.,Iloprost,DB00022
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Peginterferon alfa-2b.,Sulfinpyrazone,DB00022
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Peginterferon alfa-2b.,Ridogrel,DB00022
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Peginterferon alfa-2b.,Sevoflurane,DB00022
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Peginterferon alfa-2b.,Epoprostenol,DB00022
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Peginterferon alfa-2b.,Nimesulide,DB00022
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Peginterferon alfa-2b.,Tesmilifene,DB00022
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Peginterferon alfa-2b.,Defibrotide,DB00022
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Peginterferon alfa-2b.,Beraprost,DB00022
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Peginterferon alfa-2b.,Ibudilast,DB00022
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Peginterferon alfa-2b.,Andrographolide,DB00022
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Peginterferon alfa-2b.,Caplacizumab,DB00022
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Peginterferon alfa-2b.,Prasugrel,DB00022
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Peginterferon alfa-2b.,Cangrelor,DB00022
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Peginterferon alfa-2b.,Tranilast,DB00022
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Peginterferon alfa-2b.,Triflusal,DB00022
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Peginterferon alfa-2b.,Ticagrelor,DB00022
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Peginterferon alfa-2b.,Icosapent ethyl,DB00022
DB09030,The risk or severity of bleeding can be increased when Vorapaxar is combined with Peginterferon alfa-2b.,Vorapaxar,DB00022
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Peginterferon alfa-2b.,Trapidil,DB00022
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Peginterferon alfa-2b.,Naftopidil,DB00022
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Peginterferon alfa-2b.,Sarpogrelate,DB00022
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Peginterferon alfa-2b.,Ifetroban,DB00022
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Peginterferon alfa-2b.,Nitroaspirin,DB00022
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Peginterferon alfa-2b.,Ketanserin,DB00022
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Peginterferon alfa-2b.,Indobufen,DB00022
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Peginterferon alfa-2b.,Butylphthalide,DB00022
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Peginterferon alfa-2b.,Hydroxytyrosol,DB00022
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Peginterferon alfa-2b.,Ramatroban,DB00022
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Peginterferon alfa-2b.,Picotamide,DB00022
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Peginterferon alfa-2b.,Cloricromen,DB00022
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Peginterferon alfa-2b.,Linsidomine,DB00022
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Peginterferon alfa-2b.,Buflomedil,DB00022
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Peginterferon alfa-2b.,Relcovaptan,DB00022
DB13200,Peginterferon alfa-2b may increase the myelosuppressive activities of Lipegfilgrastim.,Lipegfilgrastim,DB00022
DB10318,The risk or severity of infection can be increased when Peginterferon alfa-2b is combined with Varicella Zoster Vaccine (Live/attenuated).,Varicella Zoster Vaccine (Live/attenuated),DB00022
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Peginterferon alfa-2b.,Rubella virus vaccine,DB00022
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Peginterferon alfa-2b.,Bacillus calmette-guerin substrain tice live antigen,DB00022
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Peginterferon alfa-2b.,Bacillus calmette-guerin substrain connaught live antigen,DB00022
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Peginterferon alfa-2b.,Yellow Fever Vaccine,DB00022
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Peginterferon alfa-2b.,Anthrax vaccine,DB00022
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Peginterferon alfa-2b.,Typhoid Vaccine Live,DB00022
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Peginterferon alfa-2b.,Bacillus calmette-guerin substrain danish 1331 live antigen,DB00022
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Peginterferon alfa-2b.,BCG vaccine,DB00022
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Peginterferon alfa-2b.,Human adenovirus e serotype 4 strain cl-68578 antigen,DB00022
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Peginterferon alfa-2b.,Vibrio cholerae CVD 103-HgR strain live antigen,DB00022
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Peginterferon alfa-2b.,Adenovirus type 7 vaccine live,DB00022
DB01238,The metabolism of Aripiprazole can be decreased when combined with Peginterferon alfa-2b.,Aripiprazole,DB00022
DB14185,The metabolism of Aripiprazole lauroxil can be decreased when combined with Peginterferon alfa-2b.,Aripiprazole lauroxil,DB00022
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2b.,Palifermin,DB00022
DB00757,The metabolism of Dolasetron can be decreased when combined with Peginterferon alfa-2b.,Dolasetron,DB00022
DB00182,The metabolism of Amphetamine can be decreased when combined with Peginterferon alfa-2b.,Amphetamine,DB00022
DB00185,The metabolism of Cevimeline can be decreased when combined with Peginterferon alfa-2b.,Cevimeline,DB00022
DB00187,The metabolism of Esmolol can be decreased when combined with Peginterferon alfa-2b.,Esmolol,DB00022
DB00215,The metabolism of Citalopram can be decreased when combined with Peginterferon alfa-2b.,Citalopram,DB00022
DB00243,The metabolism of Ranolazine can be decreased when combined with Peginterferon alfa-2b.,Ranolazine,DB00022
DB00245,The metabolism of Benzatropine can be decreased when combined with Peginterferon alfa-2b.,Benzatropine,DB00022
DB00264,The metabolism of Metoprolol can be decreased when combined with Peginterferon alfa-2b.,Metoprolol,DB00022
DB00297,The metabolism of Bupivacaine can be decreased when combined with Peginterferon alfa-2b.,Bupivacaine,DB00022
DB00317,The metabolism of Gefitinib can be decreased when combined with Peginterferon alfa-2b.,Gefitinib,DB00022
DB00318,The metabolism of Codeine can be decreased when combined with Peginterferon alfa-2b.,Codeine,DB00022
DB00335,The metabolism of Atenolol can be decreased when combined with Peginterferon alfa-2b.,Atenolol,DB00022
DB00342,The metabolism of Terfenadine can be decreased when combined with Peginterferon alfa-2b.,Terfenadine,DB00022
DB00377,The metabolism of Palonosetron can be decreased when combined with Peginterferon alfa-2b.,Palonosetron,DB00022
DB00409,The metabolism of Remoxipride can be decreased when combined with Peginterferon alfa-2b.,Remoxipride,DB00022
DB00433,The metabolism of Prochlorperazine can be decreased when combined with Peginterferon alfa-2b.,Prochlorperazine,DB00022
DB00490,The metabolism of Buspirone can be decreased when combined with Peginterferon alfa-2b.,Buspirone,DB00022
DB00496,The metabolism of Darifenacin can be decreased when combined with Peginterferon alfa-2b.,Darifenacin,DB00022
DB00497,The metabolism of Oxycodone can be decreased when combined with Peginterferon alfa-2b.,Oxycodone,DB00022
DB00503,The metabolism of Ritonavir can be decreased when combined with Peginterferon alfa-2b.,Ritonavir,DB00022
DB00589,The metabolism of Lisuride can be decreased when combined with Peginterferon alfa-2b.,Lisuride,DB00022
DB00592,The metabolism of Piperazine can be decreased when combined with Peginterferon alfa-2b.,Piperazine,DB00022
DB00608,The metabolism of Chloroquine can be decreased when combined with Peginterferon alfa-2b.,Chloroquine,DB00022
DB00637,The metabolism of Astemizole can be decreased when combined with Peginterferon alfa-2b.,Astemizole,DB00022
DB00641,The metabolism of Simvastatin can be decreased when combined with Peginterferon alfa-2b.,Simvastatin,DB00022
DB00647,The metabolism of Dextropropoxyphene can be decreased when combined with Peginterferon alfa-2b.,Dextropropoxyphene,DB00022
DB00656,The metabolism of Trazodone can be decreased when combined with Peginterferon alfa-2b.,Trazodone,DB00022
DB00674,The metabolism of Galantamine can be decreased when combined with Peginterferon alfa-2b.,Galantamine,DB00022
DB00679,The metabolism of Thioridazine can be decreased when combined with Peginterferon alfa-2b.,Thioridazine,DB00022
DB00699,The metabolism of Nicergoline can be decreased when combined with Peginterferon alfa-2b.,Nicergoline,DB00022
DB00705,The metabolism of Delavirdine can be decreased when combined with Peginterferon alfa-2b.,Delavirdine,DB00022
DB00706,The metabolism of Tamsulosin can be decreased when combined with Peginterferon alfa-2b.,Tamsulosin,DB00022
DB00734,The metabolism of Risperidone can be decreased when combined with Peginterferon alfa-2b.,Risperidone,DB00022
DB00737,The metabolism of Meclizine can be decreased when combined with Peginterferon alfa-2b.,Meclizine,DB00022
DB00738,The metabolism of Pentamidine can be decreased when combined with Peginterferon alfa-2b.,Pentamidine,DB00022
DB00805,The metabolism of Minaprine can be decreased when combined with Peginterferon alfa-2b.,Minaprine,DB00022
DB00836,The metabolism of Loperamide can be decreased when combined with Peginterferon alfa-2b.,Loperamide,DB00022
DB00866,The metabolism of Alprenolol can be decreased when combined with Peginterferon alfa-2b.,Alprenolol,DB00022
DB00914,The metabolism of Phenformin can be decreased when combined with Peginterferon alfa-2b.,Phenformin,DB00022
DB00918,The metabolism of Almotriptan can be decreased when combined with Peginterferon alfa-2b.,Almotriptan,DB00022
DB00932,The metabolism of Tipranavir can be decreased when combined with Peginterferon alfa-2b.,Tipranavir,DB00022
DB00933,The metabolism of Mesoridazine can be decreased when combined with Peginterferon alfa-2b.,Mesoridazine,DB00022
DB00956,The metabolism of Hydrocodone can be decreased when combined with Peginterferon alfa-2b.,Hydrocodone,DB00022
DB00960,The metabolism of Pindolol can be decreased when combined with Peginterferon alfa-2b.,Pindolol,DB00022
DB01069,The metabolism of Promethazine can be decreased when combined with Peginterferon alfa-2b.,Promethazine,DB00022
DB01071,The metabolism of Mequitazine can be decreased when combined with Peginterferon alfa-2b.,Mequitazine,DB00022
DB01074,The metabolism of Perhexiline can be decreased when combined with Peginterferon alfa-2b.,Perhexiline,DB00022
DB01079,The metabolism of Tegaserod can be decreased when combined with Peginterferon alfa-2b.,Tegaserod,DB00022
DB01114,The metabolism of Chlorpheniramine can be decreased when combined with Peginterferon alfa-2b.,Chlorpheniramine,DB00022
DB01149,The metabolism of Nefazodone can be decreased when combined with Peginterferon alfa-2b.,Nefazodone,DB00022
DB01175,The metabolism of Escitalopram can be decreased when combined with Peginterferon alfa-2b.,Escitalopram,DB00022
DB01192,The metabolism of Oxymorphone can be decreased when combined with Peginterferon alfa-2b.,Oxymorphone,DB00022
DB01193,The metabolism of Acebutolol can be decreased when combined with Peginterferon alfa-2b.,Acebutolol,DB00022
DB01203,The metabolism of Nadolol can be decreased when combined with Peginterferon alfa-2b.,Nadolol,DB00022
DB01224,The metabolism of Quetiapine can be decreased when combined with Peginterferon alfa-2b.,Quetiapine,DB00022
DB01228,The metabolism of Encainide can be decreased when combined with Peginterferon alfa-2b.,Encainide,DB00022
DB01244,The metabolism of Bepridil can be decreased when combined with Peginterferon alfa-2b.,Bepridil,DB00022
DB01255,The metabolism of Lisdexamfetamine can be decreased when combined with Peginterferon alfa-2b.,Lisdexamfetamine,DB00022
DB01267,The metabolism of Paliperidone can be decreased when combined with Peginterferon alfa-2b.,Paliperidone,DB00022
DB01295,The metabolism of Bevantolol can be decreased when combined with Peginterferon alfa-2b.,Bevantolol,DB00022
DB01297,The metabolism of Practolol can be decreased when combined with Peginterferon alfa-2b.,Practolol,DB00022
DB01359,The metabolism of Penbutolol can be decreased when combined with Peginterferon alfa-2b.,Penbutolol,DB00022
DB01392,The metabolism of Yohimbine can be decreased when combined with Peginterferon alfa-2b.,Yohimbine,DB00022
DB01403,The metabolism of Methotrimeprazine can be decreased when combined with Peginterferon alfa-2b.,Methotrimeprazine,DB00022
DB01409,The metabolism of Tiotropium can be decreased when combined with Peginterferon alfa-2b.,Tiotropium,DB00022
DB01429,The metabolism of Aprindine can be decreased when combined with Peginterferon alfa-2b.,Aprindine,DB00022
DB01454,The metabolism of Midomafetamine can be decreased when combined with Peginterferon alfa-2b.,Midomafetamine,DB00022
DB01466,The metabolism of Ethylmorphine can be decreased when combined with Peginterferon alfa-2b.,Ethylmorphine,DB00022
DB01472,The metabolism of 4-Methoxyamphetamine can be decreased when combined with Peginterferon alfa-2b.,4-Methoxyamphetamine,DB00022
DB01551,The metabolism of Dihydrocodeine can be decreased when combined with Peginterferon alfa-2b.,Dihydrocodeine,DB00022
DB01576,The metabolism of Dextroamphetamine can be decreased when combined with Peginterferon alfa-2b.,Dextroamphetamine,DB00022
DB01577,The metabolism of Metamfetamine can be decreased when combined with Peginterferon alfa-2b.,Metamfetamine,DB00022
DB01580,The metabolism of Oxprenolol can be decreased when combined with Peginterferon alfa-2b.,Oxprenolol,DB00022
DB01591,The metabolism of Solifenacin can be decreased when combined with Peginterferon alfa-2b.,Solifenacin,DB00022
DB01621,The metabolism of Pipotiazine can be decreased when combined with Peginterferon alfa-2b.,Pipotiazine,DB00022
DB01624,The metabolism of Zuclopenthixol can be decreased when combined with Peginterferon alfa-2b.,Zuclopenthixol,DB00022
DB02703,The metabolism of Fusidic acid can be decreased when combined with Peginterferon alfa-2b.,Fusidic acid,DB00022
DB04829,The metabolism of Lysergic acid diethylamide can be decreased when combined with Peginterferon alfa-2b.,Lysergic acid diethylamide,DB00022
DB04840,The metabolism of Debrisoquine can be decreased when combined with Peginterferon alfa-2b.,Debrisoquine,DB00022
DB04844,The metabolism of Tetrabenazine can be decreased when combined with Peginterferon alfa-2b.,Tetrabenazine,DB00022
DB04846,The metabolism of Celiprolol can be decreased when combined with Peginterferon alfa-2b.,Celiprolol,DB00022
DB04861,The metabolism of Nebivolol can be decreased when combined with Peginterferon alfa-2b.,Nebivolol,DB00022
DB04884,The metabolism of Dapoxetine can be decreased when combined with Peginterferon alfa-2b.,Dapoxetine,DB00022
DB04920,The metabolism of Clevidipine can be decreased when combined with Peginterferon alfa-2b.,Clevidipine,DB00022
DB04946,The metabolism of Iloperidone can be decreased when combined with Peginterferon alfa-2b.,Iloperidone,DB00022
DB05271,The metabolism of Rotigotine can be decreased when combined with Peginterferon alfa-2b.,Rotigotine,DB00022
DB06016,The metabolism of Cariprazine can be decreased when combined with Peginterferon alfa-2b.,Cariprazine,DB00022
DB06144,The metabolism of Sertindole can be decreased when combined with Peginterferon alfa-2b.,Sertindole,DB00022
DB06203,The metabolism of Alogliptin can be decreased when combined with Peginterferon alfa-2b.,Alogliptin,DB00022
DB06217,The metabolism of Vernakalant can be decreased when combined with Peginterferon alfa-2b.,Vernakalant,DB00022
DB06506,The metabolism of Repinotan can be decreased when combined with Peginterferon alfa-2b.,Repinotan,DB00022
DB06608,The metabolism of Tafenoquine can be decreased when combined with Peginterferon alfa-2b.,Tafenoquine,DB00022
DB06678,The metabolism of Esmirtazapine can be decreased when combined with Peginterferon alfa-2b.,Esmirtazapine,DB00022
DB06684,The metabolism of Vilazodone can be decreased when combined with Peginterferon alfa-2b.,Vilazodone,DB00022
DB06702,The metabolism of Fesoterodine can be decreased when combined with Peginterferon alfa-2b.,Fesoterodine,DB00022
DB06726,The metabolism of Bufuralol can be decreased when combined with Peginterferon alfa-2b.,Bufuralol,DB00022
DB06727,The metabolism of Sparteine can be decreased when combined with Peginterferon alfa-2b.,Sparteine,DB00022
DB06735,The metabolism of Enclomiphene can be decreased when combined with Peginterferon alfa-2b.,Enclomiphene,DB00022
DB08807,The metabolism of Bopindolol can be decreased when combined with Peginterferon alfa-2b.,Bopindolol,DB00022
DB08808,The metabolism of Bupranolol can be decreased when combined with Peginterferon alfa-2b.,Bupranolol,DB00022
DB08893,The metabolism of Mirabegron can be decreased when combined with Peginterferon alfa-2b.,Mirabegron,DB00022
DB08918,The metabolism of Levomilnacipran can be decreased when combined with Peginterferon alfa-2b.,Levomilnacipran,DB00022
DB08922,The metabolism of Perospirone can be decreased when combined with Peginterferon alfa-2b.,Perospirone,DB00022
DB08952,The metabolism of Indenolol can be decreased when combined with Peginterferon alfa-2b.,Indenolol,DB00022
DB09013,The metabolism of Befunolol can be decreased when combined with Peginterferon alfa-2b.,Befunolol,DB00022
DB09039,The metabolism of Eliglustat can be decreased when combined with Peginterferon alfa-2b.,Eliglustat,DB00022
DB09076,The metabolism of Umeclidinium can be decreased when combined with Peginterferon alfa-2b.,Umeclidinium,DB00022
DB09128,The metabolism of Brexpiprazole can be decreased when combined with Peginterferon alfa-2b.,Brexpiprazole,DB00022
DB09183,The metabolism of Dasabuvir can be decreased when combined with Peginterferon alfa-2b.,Dasabuvir,DB00022
DB09195,The metabolism of Lorpiprazole can be decreased when combined with Peginterferon alfa-2b.,Lorpiprazole,DB00022
DB09204,The metabolism of Arotinolol can be decreased when combined with Peginterferon alfa-2b.,Arotinolol,DB00022
DB09351,The metabolism of Levobetaxolol can be decreased when combined with Peginterferon alfa-2b.,Levobetaxolol,DB00022
DB09555,The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Peginterferon alfa-2b.,Dexchlorpheniramine maleate,DB00022
DB11130,The metabolism of Opium can be decreased when combined with Peginterferon alfa-2b.,Opium,DB00022
DB11770,The metabolism of Talinolol can be decreased when combined with Peginterferon alfa-2b.,Talinolol,DB00022
DB11785,The metabolism of Anisodamine can be decreased when combined with Peginterferon alfa-2b.,Anisodamine,DB00022
DB11855,The metabolism of Revefenacin can be decreased when combined with Peginterferon alfa-2b.,Revefenacin,DB00022
DB11915,The metabolism of Valbenazine can be decreased when combined with Peginterferon alfa-2b.,Valbenazine,DB00022
DB11979,The metabolism of Elagolix can be decreased when combined with Peginterferon alfa-2b.,Elagolix,DB00022
DB12070,The metabolism of Letermovir can be decreased when combined with Peginterferon alfa-2b.,Letermovir,DB00022
DB12161,The metabolism of Deutetrabenazine can be decreased when combined with Peginterferon alfa-2b.,Deutetrabenazine,DB00022
DB12212,The metabolism of Landiolol can be decreased when combined with Peginterferon alfa-2b.,Landiolol,DB00022
DB12752,The metabolism of Bucindolol can be decreased when combined with Peginterferon alfa-2b.,Bucindolol,DB00022
DB13293,The metabolism of Ipecac can be decreased when combined with Peginterferon alfa-2b.,Ipecac,DB00022
DB13443,The metabolism of Esatenolol can be decreased when combined with Peginterferon alfa-2b.,Esatenolol,DB00022
DB13508,The metabolism of Cloranolol can be decreased when combined with Peginterferon alfa-2b.,Cloranolol,DB00022
DB13530,The metabolism of Mepindolol can be decreased when combined with Peginterferon alfa-2b.,Mepindolol,DB00022
DB13679,The metabolism of Dexchlorpheniramine can be decreased when combined with Peginterferon alfa-2b.,Dexchlorpheniramine,DB00022
DB13757,The metabolism of Epanolol can be decreased when combined with Peginterferon alfa-2b.,Epanolol,DB00022
DB13775,The metabolism of Tertatolol can be decreased when combined with Peginterferon alfa-2b.,Tertatolol,DB00022
DB09173,The metabolism of Butyrfentanyl can be decreased when combined with Peginterferon alfa-2b.,Butyrfentanyl,DB00022
DB00598,The metabolism of Labetalol can be decreased when combined with Peginterferon alfa-2b.,Labetalol,DB00022
DB14010,"The metabolism of 5-methoxy-N,N-dimethyltryptamine can be decreased when combined with Peginterferon alfa-2b.","5-methoxy-N,N-dimethyltryptamine",DB00022
DB11642,The metabolism of Pitolisant can be decreased when combined with Peginterferon alfa-2b.,Pitolisant,DB00022
DB00344,The metabolism of Protriptyline can be decreased when combined with Peginterferon alfa-2b.,Protriptyline,DB00022
DB00454,The metabolism of Meperidine can be decreased when combined with Peginterferon alfa-2b.,Meperidine,DB00022
DB00543,The metabolism of Amoxapine can be decreased when combined with Peginterferon alfa-2b.,Amoxapine,DB00022
DB12930,The metabolism of Opipramol can be decreased when combined with Peginterferon alfa-2b.,Opipramol,DB00022
DB05109,The metabolism of Trabectedin can be decreased when combined with Peginterferon alfa-2b.,Trabectedin,DB00022
DB11963,The metabolism of Dacomitinib can be decreased when combined with Peginterferon alfa-2b.,Dacomitinib,DB00022
DB00489,The metabolism of Sotalol can be decreased when combined with Peginterferon alfa-2b.,Sotalol,DB00022
DB01035,The metabolism of Procainamide can be decreased when combined with Peginterferon alfa-2b.,Procainamide,DB00022
DB09167,The metabolism of Dosulepin can be decreased when combined with Peginterferon alfa-2b.,Dosulepin,DB00022
DB11718,The metabolism of Encorafenib can be decreased when combined with Peginterferon alfa-2b.,Encorafenib,DB00022
DB01118,The metabolism of Amiodarone can be decreased when combined with Peginterferon alfa-2b.,Amiodarone,DB00022
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2b.,Lepirudin,DB00022
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon alfa-2b.,Bivalirudin,DB00022
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon alfa-2b.,Alteplase,DB00022
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Peginterferon alfa-2b.,Urokinase,DB00022
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon alfa-2b.,Reteplase,DB00022
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon alfa-2b.,Anistreplase,DB00022
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon alfa-2b.,Tenecteplase,DB00022
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Peginterferon alfa-2b.,Drotrecogin alfa,DB00022
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Peginterferon alfa-2b.,Streptokinase,DB00022
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Peginterferon alfa-2b.,Argatroban,DB00022
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Peginterferon alfa-2b.,Ardeparin,DB00022
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Peginterferon alfa-2b.,Phenindione,DB00022
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Peginterferon alfa-2b.,Fondaparinux,DB00022
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Peginterferon alfa-2b.,Pentosan polysulfate,DB00022
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Peginterferon alfa-2b.,Heparin,DB00022
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Peginterferon alfa-2b.,Enoxaparin,DB00022
DB03410,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Peginterferon alfa-2b.,4-hydroxycoumarin,DB00022
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Peginterferon alfa-2b.,Coumarin,DB00022
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Peginterferon alfa-2b.,Ximelagatran,DB00022
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Peginterferon alfa-2b.,Desmoteplase,DB00022
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Peginterferon alfa-2b.,Ancrod,DB00022
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Peginterferon alfa-2b.,Fibrinolysin,DB00022
DB06228,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Peginterferon alfa-2b.,Rivaroxaban,DB00022
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Peginterferon alfa-2b.,Sulodexide,DB00022
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Peginterferon alfa-2b.,Semuloparin,DB00022
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Peginterferon alfa-2b.,Idraparinux,DB00022
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Peginterferon alfa-2b.,Astaxanthin,DB00022
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Peginterferon alfa-2b.,Apixaban,DB00022
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Peginterferon alfa-2b.,Otamixaban,DB00022
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Peginterferon alfa-2b.,Amediplase,DB00022
DB06695,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Peginterferon alfa-2b.,Dabigatran etexilate,DB00022
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Peginterferon alfa-2b.,Danaparoid,DB00022
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Peginterferon alfa-2b.,Dalteparin,DB00022
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Peginterferon alfa-2b.,Tinzaparin,DB00022
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Peginterferon alfa-2b.,Ferulic acid,DB00022
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Peginterferon alfa-2b.,Ethyl biscoumacetate,DB00022
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Peginterferon alfa-2b.,Nadroparin,DB00022
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Peginterferon alfa-2b.,Ditazole,DB00022
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Peginterferon alfa-2b.,Edoxaban,DB00022
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Peginterferon alfa-2b.,Potassium citrate,DB00022
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Peginterferon alfa-2b.,Sodium citrate,DB00022
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Peginterferon alfa-2b.,Dextran,DB00022
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Peginterferon alfa-2b.,Bemiparin,DB00022
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Peginterferon alfa-2b.,Reviparin,DB00022
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Peginterferon alfa-2b.,Parnaparin,DB00022
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Peginterferon alfa-2b.,Certoparin,DB00022
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Peginterferon alfa-2b.,Desirudin,DB00022
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Peginterferon alfa-2b.,Zinc citrate,DB00022
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Peginterferon alfa-2b.,Antithrombin Alfa,DB00022
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Peginterferon alfa-2b.,Protein C,DB00022
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Peginterferon alfa-2b.,Antithrombin III human,DB00022
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Peginterferon alfa-2b.,Letaxaban,DB00022
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Peginterferon alfa-2b.,Darexaban,DB00022
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Peginterferon alfa-2b.,Betrixaban,DB00022
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Peginterferon alfa-2b.,Nafamostat,DB00022
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Peginterferon alfa-2b.,Monteplase,DB00022
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Peginterferon alfa-2b.,Gabexate,DB00022
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Peginterferon alfa-2b.,Protein S human,DB00022
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Peginterferon alfa-2b.,Brinase,DB00022
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Peginterferon alfa-2b.,Clorindione,DB00022
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Peginterferon alfa-2b.,Diphenadione,DB00022
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Peginterferon alfa-2b.,Tioclomarol,DB00022
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Peginterferon alfa-2b.,Melagatran,DB00022
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Peginterferon alfa-2b.,Saruplase,DB00022
DB14055,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Peginterferon alfa-2b.,(S)-Warfarin,DB00022
DB14094,The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Peginterferon alfa-2b.,Tocopherylquinone,DB00022
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Peginterferon alfa-2b.,Edetate calcium disodium anhydrous,DB00022
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Peginterferon alfa-2b.,Dabigatran,DB00022
DB00177,The metabolism of Valsartan can be increased when combined with Peginterferon alfa-2b.,Valsartan,DB00022
DB00197,The metabolism of Troglitazone can be increased when combined with Peginterferon alfa-2b.,Troglitazone,DB00022
DB00203,The metabolism of Sildenafil can be increased when combined with Peginterferon alfa-2b.,Sildenafil,DB00022
DB00214,The metabolism of Torasemide can be increased when combined with Peginterferon alfa-2b.,Torasemide,DB00022
DB00216,The metabolism of Eletriptan can be increased when combined with Peginterferon alfa-2b.,Eletriptan,DB00022
DB00222,The metabolism of Glimepiride can be increased when combined with Peginterferon alfa-2b.,Glimepiride,DB00022
DB00238,The metabolism of Nevirapine can be increased when combined with Peginterferon alfa-2b.,Nevirapine,DB00022
DB00250,The metabolism of Dapsone can be increased when combined with Peginterferon alfa-2b.,Dapsone,DB00022
DB00285,The metabolism of Venlafaxine can be increased when combined with Peginterferon alfa-2b.,Venlafaxine,DB00022
DB00304,The metabolism of Desogestrel can be increased when combined with Peginterferon alfa-2b.,Desogestrel,DB00022
DB00327,The metabolism of Hydromorphone can be increased when combined with Peginterferon alfa-2b.,Hydromorphone,DB00022
DB00338,The metabolism of Omeprazole can be increased when combined with Peginterferon alfa-2b.,Omeprazole,DB00022
DB00343,The metabolism of Diltiazem can be increased when combined with Peginterferon alfa-2b.,Diltiazem,DB00022
DB00347,The metabolism of Trimethadione can be increased when combined with Peginterferon alfa-2b.,Trimethadione,DB00022
DB00374,The metabolism of Treprostinil can be increased when combined with Peginterferon alfa-2b.,Treprostinil,DB00022
DB00396,The metabolism of Progesterone can be increased when combined with Peginterferon alfa-2b.,Progesterone,DB00022
DB00404,The metabolism of Alprazolam can be increased when combined with Peginterferon alfa-2b.,Alprazolam,DB00022
DB00412,The metabolism of Rosiglitazone can be increased when combined with Peginterferon alfa-2b.,Rosiglitazone,DB00022
DB00414,The metabolism of Acetohexamide can be increased when combined with Peginterferon alfa-2b.,Acetohexamide,DB00022
DB00440,The metabolism of Trimethoprim can be increased when combined with Peginterferon alfa-2b.,Trimethoprim,DB00022
DB00448,The metabolism of Lansoprazole can be increased when combined with Peginterferon alfa-2b.,Lansoprazole,DB00022
DB00469,The metabolism of Tenoxicam can be increased when combined with Peginterferon alfa-2b.,Tenoxicam,DB00022
DB00470,The metabolism of Dronabinol can be increased when combined with Peginterferon alfa-2b.,Dronabinol,DB00022
DB00471,The metabolism of Montelukast can be increased when combined with Peginterferon alfa-2b.,Montelukast,DB00022
DB00482,The metabolism of Celecoxib can be increased when combined with Peginterferon alfa-2b.,Celecoxib,DB00022
DB00514,The metabolism of Dextromethorphan can be increased when combined with Peginterferon alfa-2b.,Dextromethorphan,DB00022
DB00549,The metabolism of Zafirlukast can be increased when combined with Peginterferon alfa-2b.,Zafirlukast,DB00022
DB00554,The metabolism of Piroxicam can be increased when combined with Peginterferon alfa-2b.,Piroxicam,DB00022
DB00559,The metabolism of Bosentan can be increased when combined with Peginterferon alfa-2b.,Bosentan,DB00022
DB00580,The metabolism of Valdecoxib can be increased when combined with Peginterferon alfa-2b.,Valdecoxib,DB00022
DB00582,The metabolism of Voriconazole can be increased when combined with Peginterferon alfa-2b.,Voriconazole,DB00022
DB00590,The metabolism of Doxazosin can be increased when combined with Peginterferon alfa-2b.,Doxazosin,DB00022
DB00617,The metabolism of Paramethadione can be increased when combined with Peginterferon alfa-2b.,Paramethadione,DB00022
DB00624,The metabolism of Testosterone can be increased when combined with Peginterferon alfa-2b.,Testosterone,DB00022
DB00672,The metabolism of Chlorpropamide can be increased when combined with Peginterferon alfa-2b.,Chlorpropamide,DB00022
DB00678,The metabolism of Losartan can be increased when combined with Peginterferon alfa-2b.,Losartan,DB00022
DB00701,The metabolism of Amprenavir can be increased when combined with Peginterferon alfa-2b.,Amprenavir,DB00022
DB00712,The metabolism of Flurbiprofen can be increased when combined with Peginterferon alfa-2b.,Flurbiprofen,DB00022
DB00731,The metabolism of Nateglinide can be increased when combined with Peginterferon alfa-2b.,Nateglinide,DB00022
DB00749,The metabolism of Etodolac can be increased when combined with Peginterferon alfa-2b.,Etodolac,DB00022
DB00784,The metabolism of Mefenamic acid can be increased when combined with Peginterferon alfa-2b.,Mefenamic acid,DB00022
DB00794,The metabolism of Primidone can be increased when combined with Peginterferon alfa-2b.,Primidone,DB00022
DB00796,The metabolism of Candesartan cilexetil can be increased when combined with Peginterferon alfa-2b.,Candesartan cilexetil,DB00022
DB00812,The metabolism of Phenylbutazone can be increased when combined with Peginterferon alfa-2b.,Phenylbutazone,DB00022
DB00814,The metabolism of Meloxicam can be increased when combined with Peginterferon alfa-2b.,Meloxicam,DB00022
DB00818,The metabolism of Propofol can be increased when combined with Peginterferon alfa-2b.,Propofol,DB00022
DB00829,The metabolism of Diazepam can be increased when combined with Peginterferon alfa-2b.,Diazepam,DB00022
DB00839,The metabolism of Tolazamide can be increased when combined with Peginterferon alfa-2b.,Tolazamide,DB00022
DB00843,The metabolism of Donepezil can be increased when combined with Peginterferon alfa-2b.,Donepezil,DB00022
DB00904,The metabolism of Ondansetron can be increased when combined with Peginterferon alfa-2b.,Ondansetron,DB00022
DB00921,The metabolism of Buprenorphine can be increased when combined with Peginterferon alfa-2b.,Buprenorphine,DB00022
DB00936,The metabolism of Salicylic acid can be increased when combined with Peginterferon alfa-2b.,Salicylic acid,DB00022
DB00983,The metabolism of Formoterol can be increased when combined with Peginterferon alfa-2b.,Formoterol,DB00022
DB01016,The metabolism of Glyburide can be increased when combined with Peginterferon alfa-2b.,Glyburide,DB00022
DB01028,The metabolism of Methoxyflurane can be increased when combined with Peginterferon alfa-2b.,Methoxyflurane,DB00022
DB01029,The metabolism of Irbesartan can be increased when combined with Peginterferon alfa-2b.,Irbesartan,DB00022
DB01036,The metabolism of Tolterodine can be increased when combined with Peginterferon alfa-2b.,Tolterodine,DB00022
DB01050,The metabolism of Ibuprofen can be increased when combined with Peginterferon alfa-2b.,Ibuprofen,DB00022
DB01067,The metabolism of Glipizide can be increased when combined with Peginterferon alfa-2b.,Glipizide,DB00022
DB01072,The metabolism of Atazanavir can be increased when combined with Peginterferon alfa-2b.,Atazanavir,DB00022
DB01075,The metabolism of Diphenhydramine can be increased when combined with Peginterferon alfa-2b.,Diphenhydramine,DB00022
DB01095,The metabolism of Fluvastatin can be increased when combined with Peginterferon alfa-2b.,Fluvastatin,DB00022
DB01098,The metabolism of Rosuvastatin can be increased when combined with Peginterferon alfa-2b.,Rosuvastatin,DB00022
DB01104,The metabolism of Sertraline can be increased when combined with Peginterferon alfa-2b.,Sertraline,DB00022
DB01120,The metabolism of Gliclazide can be increased when combined with Peginterferon alfa-2b.,Gliclazide,DB00022
DB01124,The metabolism of Tolbutamide can be increased when combined with Peginterferon alfa-2b.,Tolbutamide,DB00022
DB01131,The metabolism of Proguanil can be increased when combined with Peginterferon alfa-2b.,Proguanil,DB00022
DB01154,The metabolism of Thiamylal can be increased when combined with Peginterferon alfa-2b.,Thiamylal,DB00022
DB01156,The metabolism of Bupropion can be increased when combined with Peginterferon alfa-2b.,Bupropion,DB00022
DB01159,The metabolism of Halothane can be increased when combined with Peginterferon alfa-2b.,Halothane,DB00022
DB01171,The metabolism of Moclobemide can be increased when combined with Peginterferon alfa-2b.,Moclobemide,DB00022
DB01174,The metabolism of Phenobarbital can be increased when combined with Peginterferon alfa-2b.,Phenobarbital,DB00022
DB01198,The metabolism of Zopiclone can be increased when combined with Peginterferon alfa-2b.,Zopiclone,DB00022
DB01221,The metabolism of Ketamine can be increased when combined with Peginterferon alfa-2b.,Ketamine,DB00022
DB01251,The metabolism of Gliquidone can be increased when combined with Peginterferon alfa-2b.,Gliquidone,DB00022
DB01274,The metabolism of Arformoterol can be increased when combined with Peginterferon alfa-2b.,Arformoterol,DB00022
DB01283,The metabolism of Lumiracoxib can be increased when combined with Peginterferon alfa-2b.,Lumiracoxib,DB00022
DB01289,The metabolism of Glisoxepide can be increased when combined with Peginterferon alfa-2b.,Glisoxepide,DB00022
DB01355,The metabolism of Hexobarbital can be increased when combined with Peginterferon alfa-2b.,Hexobarbital,DB00022
DB01357,The metabolism of Mestranol can be increased when combined with Peginterferon alfa-2b.,Mestranol,DB00022
DB01544,The metabolism of Flunitrazepam can be increased when combined with Peginterferon alfa-2b.,Flunitrazepam,DB00022
DB01589,The metabolism of Quazepam can be increased when combined with Peginterferon alfa-2b.,Quazepam,DB00022
DB03756,The metabolism of Doconexent can be increased when combined with Peginterferon alfa-2b.,Doconexent,DB00022
DB04557,The metabolism of Arachidonic Acid can be increased when combined with Peginterferon alfa-2b.,Arachidonic Acid,DB00022
DB04725,The metabolism of Licofelone can be increased when combined with Peginterferon alfa-2b.,Licofelone,DB00022
DB04938,The metabolism of Ospemifene can be increased when combined with Peginterferon alfa-2b.,Ospemifene,DB00022
DB05541,The metabolism of Brivaracetam can be increased when combined with Peginterferon alfa-2b.,Brivaracetam,DB00022
DB06204,The metabolism of Tapentadol can be increased when combined with Peginterferon alfa-2b.,Tapentadol,DB00022
DB06218,The metabolism of Lacosamide can be increased when combined with Peginterferon alfa-2b.,Lacosamide,DB00022
DB06268,The metabolism of Sitaxentan can be increased when combined with Peginterferon alfa-2b.,Sitaxentan,DB00022
DB06370,The metabolism of Indisulam can be increased when combined with Peginterferon alfa-2b.,Indisulam,DB00022
DB06414,The metabolism of Etravirine can be increased when combined with Peginterferon alfa-2b.,Etravirine,DB00022
DB06652,The metabolism of Vicriviroc can be increased when combined with Peginterferon alfa-2b.,Vicriviroc,DB00022
DB06697,The metabolism of Artemether can be increased when combined with Peginterferon alfa-2b.,Artemether,DB00022
DB06725,The metabolism of Lornoxicam can be increased when combined with Peginterferon alfa-2b.,Lornoxicam,DB00022
DB06737,The metabolism of Zaltoprofen can be increased when combined with Peginterferon alfa-2b.,Zaltoprofen,DB00022
DB06738,The metabolism of Ketobemidone can be increased when combined with Peginterferon alfa-2b.,Ketobemidone,DB00022
DB06739,The metabolism of Seratrodast can be increased when combined with Peginterferon alfa-2b.,Seratrodast,DB00022
DB06803,The metabolism of Niclosamide can be increased when combined with Peginterferon alfa-2b.,Niclosamide,DB00022
DB08439,The metabolism of Parecoxib can be increased when combined with Peginterferon alfa-2b.,Parecoxib,DB00022
DB08828,The metabolism of Vismodegib can be increased when combined with Peginterferon alfa-2b.,Vismodegib,DB00022
DB08860,The metabolism of Pitavastatin can be increased when combined with Peginterferon alfa-2b.,Pitavastatin,DB00022
DB08875,The metabolism of Cabozantinib can be increased when combined with Peginterferon alfa-2b.,Cabozantinib,DB00022
DB08899,The metabolism of Enzalutamide can be increased when combined with Peginterferon alfa-2b.,Enzalutamide,DB00022
DB08962,The metabolism of Glibornuride can be increased when combined with Peginterferon alfa-2b.,Glibornuride,DB00022
DB09048,The metabolism of Netupitant can be increased when combined with Peginterferon alfa-2b.,Netupitant,DB00022
DB09061,The metabolism of Cannabidiol can be increased when combined with Peginterferon alfa-2b.,Cannabidiol,DB00022
DB09068,The metabolism of Vortioxetine can be increased when combined with Peginterferon alfa-2b.,Vortioxetine,DB00022
DB09080,The metabolism of Olodaterol can be increased when combined with Peginterferon alfa-2b.,Olodaterol,DB00022
DB11560,The metabolism of Lesinurad can be increased when combined with Peginterferon alfa-2b.,Lesinurad,DB00022
DB11586,The metabolism of Asunaprevir can be increased when combined with Peginterferon alfa-2b.,Asunaprevir,DB00022
DB11614,The metabolism of Rupatadine can be increased when combined with Peginterferon alfa-2b.,Rupatadine,DB00022
DB11823,The metabolism of Esketamine can be increased when combined with Peginterferon alfa-2b.,Esketamine,DB00022
DB12474,The metabolism of Lynestrenol can be increased when combined with Peginterferon alfa-2b.,Lynestrenol,DB00022
DB13406,The metabolism of Carbutamide can be increased when combined with Peginterferon alfa-2b.,Carbutamide,DB00022
DB13675,The metabolism of Metahexamide can be increased when combined with Peginterferon alfa-2b.,Metahexamide,DB00022
DB13919,The metabolism of Candesartan can be increased when combined with Peginterferon alfa-2b.,Candesartan,DB00022
DB13941,The metabolism of Piperaquine can be increased when combined with Peginterferon alfa-2b.,Piperaquine,DB00022
DB13943,The metabolism of Testosterone cypionate can be increased when combined with Peginterferon alfa-2b.,Testosterone cypionate,DB00022
DB13944,The metabolism of Testosterone enanthate can be increased when combined with Peginterferon alfa-2b.,Testosterone enanthate,DB00022
DB13946,The metabolism of Testosterone undecanoate can be increased when combined with Peginterferon alfa-2b.,Testosterone undecanoate,DB00022
DB14009,The metabolism of Medical Cannabis can be increased when combined with Peginterferon alfa-2b.,Medical Cannabis,DB00022
DB14011,The metabolism of Nabiximols can be increased when combined with Peginterferon alfa-2b.,Nabiximols,DB00022
DB09213,The metabolism of Dexibuprofen can be increased when combined with Peginterferon alfa-2b.,Dexibuprofen,DB00022
DB00465,The metabolism of Ketorolac can be increased when combined with Peginterferon alfa-2b.,Ketorolac,DB00022
DB14975,The metabolism of Voxelotor can be increased when combined with Peginterferon alfa-2b.,Voxelotor,DB00022
DB15233,The metabolism of Avapritinib can be increased when combined with Peginterferon alfa-2b.,Avapritinib,DB00022
DB00726,The metabolism of Trimipramine can be increased when combined with Peginterferon alfa-2b.,Trimipramine,DB00022
DB01101,The metabolism of Capecitabine can be increased when combined with Peginterferon alfa-2b.,Capecitabine,DB00022
DB05015,The metabolism of Belinostat can be increased when combined with Peginterferon alfa-2b.,Belinostat,DB00022
DB00252,The metabolism of Phenytoin can be increased when combined with Peginterferon alfa-2b.,Phenytoin,DB00022
DB00266,The metabolism of Dicoumarol can be increased when combined with Peginterferon alfa-2b.,Dicoumarol,DB00022
DB00313,The metabolism of Valproic acid can be increased when combined with Peginterferon alfa-2b.,Valproic acid,DB00022
DB00908,The metabolism of Quinidine can be increased when combined with Peginterferon alfa-2b.,Quinidine,DB00022
DB00946,The metabolism of Phenprocoumon can be increased when combined with Peginterferon alfa-2b.,Phenprocoumon,DB00022
DB01320,The metabolism of Fosphenytoin can be increased when combined with Peginterferon alfa-2b.,Fosphenytoin,DB00022
DB13136,The metabolism of Fluindione can be increased when combined with Peginterferon alfa-2b.,Fluindione,DB00022
DB12147,The metabolism of Erdafitinib can be increased when combined with Peginterferon alfa-2b.,Erdafitinib,DB00022
DB00232,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Peginterferon alfa-2b.,Methyclothiazide,DB00022
DB00436,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Peginterferon alfa-2b.,Bendroflumethiazide,DB00022
DB00562,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Peginterferon alfa-2b.,Benzthiazide,DB00022
DB00606,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Peginterferon alfa-2b.,Cyclothiazide,DB00022
DB00774,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Peginterferon alfa-2b.,Hydroflumethiazide,DB00022
DB00880,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Peginterferon alfa-2b.,Chlorothiazide,DB00022
DB00999,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Peginterferon alfa-2b.,Hydrochlorothiazide,DB00022
DB01021,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Peginterferon alfa-2b.,Trichlormethiazide,DB00022
DB01324,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Peginterferon alfa-2b.,Polythiazide,DB00022
DB13430,The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Peginterferon alfa-2b.,Mebutizide,DB00022
DB13532,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Peginterferon alfa-2b.,Cyclopenthiazide,DB00022
DB09042,The risk or severity of myelosuppression can be increased when Peginterferon alfa-2b is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00022
DB00091,Peginterferon alfa-2b may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine,DB00022
DB00268,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ropinirole.,Ropinirole,DB00022
DB00321,The metabolism of Amitriptyline can be decreased when combined with Peginterferon alfa-2b.,Amitriptyline,DB00022
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Peginterferon alfa-2b.,Cyanocobalamin,DB00022
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Peginterferon alfa-2b.,Allopurinol,DB00022
DB00373,The metabolism of Timolol can be decreased when combined with Peginterferon alfa-2b.,Timolol,DB00022
DB00193,The metabolism of Tramadol can be decreased when combined with Peginterferon alfa-2b.,Tramadol,DB00022
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Peginterferon alfa-2b.,Magnesium,DB00022
DB01601,The serum concentration of Peginterferon alfa-2b can be increased when it is combined with Lopinavir.,Lopinavir,DB00022
DB00502,The serum concentration of Haloperidol can be increased when it is combined with Peginterferon alfa-2b.,Haloperidol,DB00022
DB12530,The risk or severity of infection can be increased when Peginterferon alfa-2b is combined with Inebilizumab.,Inebilizumab,DB00022
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Asparaginase Escherichia coli.,Darbepoetin alfa,DB00023
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Asparaginase Escherichia coli.,Erythropoietin,DB00023
DB08894,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Asparaginase Escherichia coli.,Peginesatide,DB00023
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Asparaginase Escherichia coli.,Methoxy polyethylene glycol-epoetin beta,DB00023
DB01234,The serum concentration of Dexamethasone can be increased when it is combined with Asparaginase Escherichia coli.,Dexamethasone,DB00023
DB00563,The therapeutic efficacy of Methotrexate can be decreased when used in combination with Asparaginase Escherichia coli.,Methotrexate,DB00023
DB00619,The risk or severity of liver damage can be increased when Asparaginase Escherichia coli is combined with Imatinib.,Imatinib,DB00023
DB00252,The therapeutic efficacy of Phenytoin can be increased when used in combination with Asparaginase Escherichia coli.,Phenytoin,DB00023
DB00279,The therapeutic efficacy of Liothyronine can be increased when used in combination with Asparaginase Escherichia coli.,Liothyronine,DB00023
DB00451,The therapeutic efficacy of Levothyroxine can be increased when used in combination with Asparaginase Escherichia coli.,Levothyroxine,DB00023
DB00532,The therapeutic efficacy of Mephenytoin can be increased when used in combination with Asparaginase Escherichia coli.,Mephenytoin,DB00023
DB00564,The therapeutic efficacy of Carbamazepine can be increased when used in combination with Asparaginase Escherichia coli.,Carbamazepine,DB00023
DB00695,The therapeutic efficacy of Furosemide can be increased when used in combination with Asparaginase Escherichia coli.,Furosemide,DB00023
DB00698,The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Asparaginase Escherichia coli.,Nitrofurantoin,DB00023
DB00754,The therapeutic efficacy of Ethotoin can be increased when used in combination with Asparaginase Escherichia coli.,Ethotoin,DB00023
DB00939,The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Asparaginase Escherichia coli.,Meclofenamic acid,DB00023
DB01109,The therapeutic efficacy of Heparin can be increased when used in combination with Asparaginase Escherichia coli.,Heparin,DB00023
DB01219,The therapeutic efficacy of Dantrolene can be increased when used in combination with Asparaginase Escherichia coli.,Dantrolene,DB00023
DB01320,The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Asparaginase Escherichia coli.,Fosphenytoin,DB00023
DB01583,The therapeutic efficacy of Liotrix can be increased when used in combination with Asparaginase Escherichia coli.,Liotrix,DB00023
DB08899,The therapeutic efficacy of Enzalutamide can be increased when used in combination with Asparaginase Escherichia coli.,Enzalutamide,DB00023
DB08984,The therapeutic efficacy of Etofenamate can be increased when used in combination with Asparaginase Escherichia coli.,Etofenamate,DB00023
DB12425,The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Asparaginase Escherichia coli.,Liothyronine I-131,DB00023
DB13396,The therapeutic efficacy of Neocitrullamon can be increased when used in combination with Asparaginase Escherichia coli.,Neocitrullamon,DB00023
DB01344,Tolevamer can cause a decrease in the absorption of Thyrotropin alfa resulting in a reduced serum concentration and potentially a decrease in efficacy.,Tolevamer,DB00024
DB00255,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Diethylstilbestrol.,Diethylstilbestrol,DB00024
DB00269,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Chlorotrianisene.,Chlorotrianisene,DB00024
DB00286,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Conjugated estrogens.,Conjugated estrogens,DB00024
DB00783,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol.,Estradiol,DB00024
DB00977,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ethinylestradiol.,Ethinylestradiol,DB00024
DB01357,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Mestranol.,Mestranol,DB00024
DB04573,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estriol.,Estriol,DB00024
DB04574,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estrone sulfate.,Estrone sulfate,DB00024
DB04575,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Quinestrol.,Quinestrol,DB00024
DB07931,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Hexestrol.,Hexestrol,DB00024
DB09070,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tibolone.,Tibolone,DB00024
DB09317,"The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Synthetic Conjugated Estrogens, A.","Synthetic Conjugated Estrogens, A",DB00024
DB09318,"The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Synthetic Conjugated Estrogens, B.","Synthetic Conjugated Estrogens, B",DB00024
DB09369,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Polyestradiol phosphate.,Polyestradiol phosphate,DB00024
DB09381,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Esterified estrogens.,Esterified estrogens,DB00024
DB11478,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Zeranol.,Zeranol,DB00024
DB11674,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Equol.,Equol,DB00024
DB12487,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Promestriene.,Promestriene,DB00024
DB13143,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Methallenestril.,Methallenestril,DB00024
DB13386,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Epimestrol.,Epimestrol,DB00024
DB13418,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Moxestrol.,Moxestrol,DB00024
DB13952,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol acetate.,Estradiol acetate,DB00024
DB13953,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol benzoate.,Estradiol benzoate,DB00024
DB13954,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol cypionate.,Estradiol cypionate,DB00024
DB13956,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol valerate.,Estradiol valerate,DB00024
DB15334,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Biochanin A.,Biochanin A,DB00024
DB15335,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Formononetin.,Formononetin,DB00024
DB00176,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluvoxamine.,Fluvoxamine,DB00024
DB00215,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Citalopram.,Citalopram,DB00024
DB00472,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluoxetine.,Fluoxetine,DB00024
DB00476,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Duloxetine.,Duloxetine,DB00024
DB00656,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Trazodone.,Trazodone,DB00024
DB00715,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Paroxetine.,Paroxetine,DB00024
DB01104,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sertraline.,Sertraline,DB00024
DB01105,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sibutramine.,Sibutramine,DB00024
DB01149,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nefazodone.,Nefazodone,DB00024
DB01175,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Escitalopram.,Escitalopram,DB00024
DB04832,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Zimelidine.,Zimelidine,DB00024
DB04884,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dapoxetine.,Dapoxetine,DB00024
DB04896,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Milnacipran.,Milnacipran,DB00024
DB06700,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Desvenlafaxine.,Desvenlafaxine,DB00024
DB06731,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Seproxetine.,Seproxetine,DB00024
DB08918,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Levomilnacipran.,Levomilnacipran,DB00024
DB08953,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Indalpine.,Indalpine,DB00024
DB12693,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ritanserin.,Ritanserin,DB00024
DB13233,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Alaproclate.,Alaproclate,DB00024
DB00930,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Colesevelam.,Colesevelam,DB00024
DB00258,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium acetate.,Calcium acetate,DB00024
DB00326,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium glucoheptonate.,Calcium glucoheptonate,DB00024
DB01164,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium chloride.,Calcium chloride,DB00024
DB01373,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium.,Calcium,DB00024
DB06724,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium carbonate.,Calcium carbonate,DB00024
DB11093,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium citrate.,Calcium citrate,DB00024
DB11126,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium gluconate.,Calcium gluconate,DB00024
DB11348,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium Phosphate.,Calcium Phosphate,DB00024
DB13142,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium glubionate anhydrous.,Calcium glubionate anhydrous,DB00024
DB13231,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium lactate.,Calcium lactate,DB00024
DB13365,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium lactate gluconate.,Calcium lactate gluconate,DB00024
DB13590,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium pangamate.,Calcium pangamate,DB00024
DB13800,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium levulinate.,Calcium levulinate,DB00024
DB14577,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium cation.,Calcium cation,DB00024
DB14684,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium polycarbophil.,Calcium polycarbophil,DB00024
DB06792,Lanthanum carbonate can cause a decrease in the absorption of Thyrotropin alfa resulting in a reduced serum concentration and potentially a decrease in efficacy.,Lanthanum carbonate,DB00024
DB09210,"The risk or severity of confusion, irritability, and sleep disorders can be increased when Thyrotropin alfa is combined with Piracetam.",Piracetam,DB00024
DB00331,The therapeutic efficacy of Metformin can be decreased when used in combination with Thyrotropin alfa.,Metformin,DB00024
DB00067,Thyrotropin alfa may increase the vasoconstricting activities of Vasopressin.,Vasopressin,DB00024
DB00093,Thyrotropin alfa may increase the vasoconstricting activities of Felypressin.,Felypressin,DB00024
DB00247,Thyrotropin alfa may increase the vasoconstricting activities of Methysergide.,Methysergide,DB00024
DB00320,Thyrotropin alfa may increase the vasoconstricting activities of Dihydroergotamine.,Dihydroergotamine,DB00024
DB00669,Thyrotropin alfa may increase the vasoconstricting activities of Sumatriptan.,Sumatriptan,DB00024
DB00696,Thyrotropin alfa may increase the vasoconstricting activities of Ergotamine.,Ergotamine,DB00024
DB00907,Thyrotropin alfa may increase the vasoconstricting activities of Cocaine.,Cocaine,DB00024
DB00952,Thyrotropin alfa may increase the vasoconstricting activities of Naratriptan.,Naratriptan,DB00024
DB02234,Thyrotropin alfa may increase the vasoconstricting activities of S-Ethylisothiourea.,S-Ethylisothiourea,DB00024
DB02638,Thyrotropin alfa may increase the vasoconstricting activities of Terlipressin.,Terlipressin,DB00024
DB02860,Thyrotropin alfa may increase the vasoconstricting activities of Calyculin A.,Calyculin A,DB00024
DB06694,Thyrotropin alfa may increase the vasoconstricting activities of Xylometazoline.,Xylometazoline,DB00024
DB06707,Thyrotropin alfa may increase the vasoconstricting activities of Levonordefrin.,Levonordefrin,DB00024
DB06711,Thyrotropin alfa may increase the vasoconstricting activities of Naphazoline.,Naphazoline,DB00024
DB09202,Thyrotropin alfa may increase the vasoconstricting activities of Cirazoline.,Cirazoline,DB00024
DB11842,Thyrotropin alfa may increase the vasoconstricting activities of Angiotensin II.,Angiotensin II,DB00024
DB13251,Thyrotropin alfa may increase the vasoconstricting activities of Octopamine.,Octopamine,DB00024
DB13394,Thyrotropin alfa may increase the vasoconstricting activities of Adrenalone.,Adrenalone,DB00024
DB13464,Thyrotropin alfa may increase the vasoconstricting activities of Ornipressin.,Ornipressin,DB00024
DB13517,Thyrotropin alfa may increase the vasoconstricting activities of Angiotensinamide.,Angiotensinamide,DB00024
DB14642,Thyrotropin alfa may increase the vasoconstricting activities of Lypressin.,Lypressin,DB00024
DB00233,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Aminosalicylic acid.,Aminosalicylic acid,DB00024
DB00244,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Mesalazine.,Mesalazine,DB00024
DB00795,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Sulfasalazine.,Sulfasalazine,DB00024
DB00861,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Diflunisal.,Diflunisal,DB00024
DB00936,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Salicylic acid.,Salicylic acid,DB00024
DB00945,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Acetylsalicylic acid.,Acetylsalicylic acid,DB00024
DB01014,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Balsalazide.,Balsalazide,DB00024
DB01250,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Olsalazine.,Olsalazine,DB00024
DB01294,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Bismuth subsalicylate.,Bismuth subsalicylate,DB00024
DB06251,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Dersalazine.,Dersalazine,DB00024
DB06807,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Phenyl aminosalicylate.,Phenyl aminosalicylate,DB00024
DB09543,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Methyl salicylate.,Methyl salicylate,DB00024
DB12445,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Nitroaspirin.,Nitroaspirin,DB00024
DB13509,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Aloxiprin.,Aloxiprin,DB00024
DB13538,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Guacetisal.,Guacetisal,DB00024
DB13612,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Carbaspirin calcium.,Carbaspirin calcium,DB00024
DB14006,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Choline salicylate.,Choline salicylate,DB00024
DB14026,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Thiosalicylic acid.,Thiosalicylic acid,DB00024
DB00187,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Esmolol.,Esmolol,DB00024
DB00195,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Betaxolol.,Betaxolol,DB00024
DB00264,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Metoprolol.,Metoprolol,DB00024
DB00335,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Atenolol.,Atenolol,DB00024
DB00373,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Timolol.,Timolol,DB00024
DB00489,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sotalol.,Sotalol,DB00024
DB00571,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Propranolol.,Propranolol,DB00024
DB00598,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Labetalol.,Labetalol,DB00024
DB00612,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bisoprolol.,Bisoprolol,DB00024
DB00866,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Alprenolol.,Alprenolol,DB00024
DB00960,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Pindolol.,Pindolol,DB00024
DB01136,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Carvedilol.,Carvedilol,DB00024
DB01182,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Propafenone.,Propafenone,DB00024
DB01193,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Acebutolol.,Acebutolol,DB00024
DB01203,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nadolol.,Nadolol,DB00024
DB01295,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bevantolol.,Bevantolol,DB00024
DB01297,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Practolol.,Practolol,DB00024
DB01359,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Penbutolol.,Penbutolol,DB00024
DB01580,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Oxprenolol.,Oxprenolol,DB00024
DB03322,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dexpropranolol.,Dexpropranolol,DB00024
DB04846,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Celiprolol.,Celiprolol,DB00024
DB04861,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nebivolol.,Nebivolol,DB00024
DB06726,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bufuralol.,Bufuralol,DB00024
DB08807,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bopindolol.,Bopindolol,DB00024
DB08808,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bupranolol.,Bupranolol,DB00024
DB08952,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Indenolol.,Indenolol,DB00024
DB09013,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Befunolol.,Befunolol,DB00024
DB09204,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Arotinolol.,Arotinolol,DB00024
DB09351,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Levobetaxolol.,Levobetaxolol,DB00024
DB11770,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Talinolol.,Talinolol,DB00024
DB11785,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Anisodamine.,Anisodamine,DB00024
DB12212,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Landiolol.,Landiolol,DB00024
DB12752,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bucindolol.,Bucindolol,DB00024
DB13443,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Esatenolol.,Esatenolol,DB00024
DB13508,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cloranolol.,Cloranolol,DB00024
DB13530,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Mepindolol.,Mepindolol,DB00024
DB13757,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Epanolol.,Epanolol,DB00024
DB13775,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tertatolol.,Tertatolol,DB00024
DB00394,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Beclomethasone dipropionate.,Beclomethasone dipropionate,DB00024
DB00443,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Betamethasone.,Betamethasone,DB00024
DB00620,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Triamcinolone.,Triamcinolone,DB00024
DB00635,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednisone.,Prednisone,DB00024
DB00764,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Mometasone.,Mometasone,DB00024
DB01380,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cortisone acetate.,Cortisone acetate,DB00024
DB01384,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Paramethasone.,Paramethasone,DB00024
DB01410,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ciclesonide.,Ciclesonide,DB00024
DB08906,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluticasone furoate.,Fluticasone furoate,DB00024
DB08970,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluprednidene.,Fluprednidene,DB00024
DB08971,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluocortolone.,Fluocortolone,DB00024
DB09383,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Meprednisone.,Meprednisone,DB00024
DB11487,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dexamethasone isonicotinate.,Dexamethasone isonicotinate,DB00024
DB11750,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Clobetasol.,Clobetasol,DB00024
DB11921,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Deflazacort.,Deflazacort,DB00024
DB13003,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cortivazol.,Cortivazol,DB00024
DB13208,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednylidene.,Prednylidene,DB00024
DB13728,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Halometasone.,Halometasone,DB00024
DB13843,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cloprednol.,Cloprednol,DB00024
DB13867,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluticasone.,Fluticasone,DB00024
DB14512,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Mometasone furoate.,Mometasone furoate,DB00024
DB14631,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednisolone phosphate.,Prednisolone phosphate,DB00024
DB14633,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednisolone hemisuccinate.,Prednisolone hemisuccinate,DB00024
DB14634,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluprednidene acetate.,Fluprednidene acetate,DB00024
DB14644,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Methylprednisolone hemisuccinate.,Methylprednisolone hemisuccinate,DB00024
DB14646,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednisone acetate.,Prednisone acetate,DB00024
DB14652,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Clocortolone acetate.,Clocortolone acetate,DB00024
DB14659,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Melengestrol acetate.,Melengestrol acetate,DB00024
DB14669,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Betamethasone phosphate.,Betamethasone phosphate,DB00024
DB14681,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cortisone.,Cortisone,DB00024
DB01118,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Amiodarone.,Amiodarone,DB00024
DB00182,The risk or severity of adverse effects can be increased when Amphetamine is combined with Thyrotropin alfa.,Amphetamine,DB00024
DB00191,The risk or severity of adverse effects can be increased when Phentermine is combined with Thyrotropin alfa.,Phentermine,DB00024
DB00211,The risk or severity of adverse effects can be increased when Midodrine is combined with Thyrotropin alfa.,Midodrine,DB00024
DB00368,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Thyrotropin alfa.,Norepinephrine,DB00024
DB00388,The risk or severity of adverse effects can be increased when Phenylephrine is combined with Thyrotropin alfa.,Phenylephrine,DB00024
DB00397,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Thyrotropin alfa.,Phenylpropanolamine,DB00024
DB00610,The risk or severity of adverse effects can be increased when Metaraminol is combined with Thyrotropin alfa.,Metaraminol,DB00024
DB00668,The risk or severity of adverse effects can be increased when Epinephrine is combined with Thyrotropin alfa.,Epinephrine,DB00024
DB00723,The risk or severity of adverse effects can be increased when Methoxamine is combined with Thyrotropin alfa.,Methoxamine,DB00024
DB00816,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Thyrotropin alfa.,Orciprenaline,DB00024
DB00830,The risk or severity of adverse effects can be increased when Phenmetrazine is combined with Thyrotropin alfa.,Phenmetrazine,DB00024
DB00841,The risk or severity of adverse effects can be increased when Dobutamine is combined with Thyrotropin alfa.,Dobutamine,DB00024
DB00852,The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Thyrotropin alfa.,Pseudoephedrine,DB00024
DB00865,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Thyrotropin alfa.,Benzphetamine,DB00024
DB00867,The risk or severity of adverse effects can be increased when Ritodrine is combined with Thyrotropin alfa.,Ritodrine,DB00024
DB00871,The risk or severity of adverse effects can be increased when Terbutaline is combined with Thyrotropin alfa.,Terbutaline,DB00024
DB00935,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Thyrotropin alfa.,Oxymetazoline,DB00024
DB00937,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Thyrotropin alfa.,Diethylpropion,DB00024
DB00988,The risk or severity of adverse effects can be increased when Dopamine is combined with Thyrotropin alfa.,Dopamine,DB00024
DB01064,The risk or severity of adverse effects can be increased when Isoprenaline is combined with Thyrotropin alfa.,Isoprenaline,DB00024
DB01255,The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Thyrotropin alfa.,Lisdexamfetamine,DB00024
DB01288,The risk or severity of adverse effects can be increased when Fenoterol is combined with Thyrotropin alfa.,Fenoterol,DB00024
DB01364,The risk or severity of adverse effects can be increased when Ephedrine is combined with Thyrotropin alfa.,Ephedrine,DB00024
DB01365,The risk or severity of adverse effects can be increased when Mephentermine is combined with Thyrotropin alfa.,Mephentermine,DB00024
DB01366,The risk or severity of adverse effects can be increased when Procaterol is combined with Thyrotropin alfa.,Procaterol,DB00024
DB01407,The risk or severity of adverse effects can be increased when Clenbuterol is combined with Thyrotropin alfa.,Clenbuterol,DB00024
DB01442,The risk or severity of adverse effects can be increased when MMDA is combined with Thyrotropin alfa.,MMDA,DB00024
DB01454,The risk or severity of adverse effects can be increased when Midomafetamine is combined with Thyrotropin alfa.,Midomafetamine,DB00024
DB01467,"The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Thyrotropin alfa.","2,5-Dimethoxy-4-ethylamphetamine",DB00024
DB01484,"The risk or severity of adverse effects can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Thyrotropin alfa.","4-Bromo-2,5-dimethoxyamphetamine",DB00024
DB01509,The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Thyrotropin alfa.,Tenamfetamine,DB00024
DB01556,The risk or severity of adverse effects can be increased when Chlorphentermine is combined with Thyrotropin alfa.,Chlorphentermine,DB00024
DB01566,The risk or severity of adverse effects can be increased when Methylenedioxyethamphetamine is combined with Thyrotropin alfa.,Methylenedioxyethamphetamine,DB00024
DB01576,The risk or severity of adverse effects can be increased when Dextroamphetamine is combined with Thyrotropin alfa.,Dextroamphetamine,DB00024
DB01577,The risk or severity of adverse effects can be increased when Metamfetamine is combined with Thyrotropin alfa.,Metamfetamine,DB00024
DB06152,The risk or severity of adverse effects can be increased when Nylidrin is combined with Thyrotropin alfa.,Nylidrin,DB00024
DB06764,The risk or severity of adverse effects can be increased when Tetryzoline is combined with Thyrotropin alfa.,Tetryzoline,DB00024
DB08841,The risk or severity of adverse effects can be increased when Tyramine is combined with Thyrotropin alfa.,Tyramine,DB00024
DB08941,The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Thyrotropin alfa.,Isoxsuprine,DB00024
DB08985,The risk or severity of adverse effects can be increased when Etilefrine is combined with Thyrotropin alfa.,Etilefrine,DB00024
DB09203,The risk or severity of adverse effects can be increased when Synephrine is combined with Thyrotropin alfa.,Synephrine,DB00024
DB09480,The risk or severity of adverse effects can be increased when Iofetamine I-123 is combined with Thyrotropin alfa.,Iofetamine I-123,DB00024
DB11124,The risk or severity of adverse effects can be increased when Racepinephrine is combined with Thyrotropin alfa.,Racepinephrine,DB00024
DB12080,The risk or severity of adverse effects can be increased when Ritobegron is combined with Thyrotropin alfa.,Ritobegron,DB00024
DB13064,The risk or severity of adverse effects can be increased when Tramazoline is combined with Thyrotropin alfa.,Tramazoline,DB00024
DB13108,The risk or severity of adverse effects can be increased when Mephedrone is combined with Thyrotropin alfa.,Mephedrone,DB00024
DB13341,The risk or severity of adverse effects can be increased when Fenozolone is combined with Thyrotropin alfa.,Fenozolone,DB00024
DB13624,The risk or severity of adverse effects can be increased when Methoxyphenamine is combined with Thyrotropin alfa.,Methoxyphenamine,DB00024
DB13692,The risk or severity of adverse effects can be increased when Tretoquinol is combined with Thyrotropin alfa.,Tretoquinol,DB00024
DB13703,The risk or severity of adverse effects can be increased when Gepefrine is combined with Thyrotropin alfa.,Gepefrine,DB00024
DB13777,The risk or severity of adverse effects can be increased when Prenalterol is combined with Thyrotropin alfa.,Prenalterol,DB00024
DB13852,The risk or severity of adverse effects can be increased when Mefenorex is combined with Thyrotropin alfa.,Mefenorex,DB00024
DB13940,"The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylthioamphetamine is combined with Thyrotropin alfa.","2,5-Dimethoxy-4-ethylthioamphetamine",DB00024
DB00317,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Gefitinib.,Gefitinib,DB00024
DB00398,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sorafenib.,Sorafenib,DB00024
DB00530,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Erlotinib.,Erlotinib,DB00024
DB00619,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Imatinib.,Imatinib,DB00024
DB01254,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dasatinib.,Dasatinib,DB00024
DB01259,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Lapatinib.,Lapatinib,DB00024
DB01268,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sunitinib.,Sunitinib,DB00024
DB01645,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Genistein.,Genistein,DB00024
DB02058,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.,3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone,DB00024
DB02424,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Geldanamycin.,Geldanamycin,DB00024
DB02567,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with PD173955.,PD173955,DB00024
DB03758,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Radicicol.,Radicicol,DB00024
DB04849,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cediranib.,Cediranib,DB00024
DB04868,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nilotinib.,Nilotinib,DB00024
DB04879,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Vatalanib.,Vatalanib,DB00024
DB05294,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Vandetanib.,Vandetanib,DB00024
DB05424,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Canertinib.,Canertinib,DB00024
DB05465,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tandutinib.,Tandutinib,DB00024
DB05575,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Motesanib.,Motesanib,DB00024
DB05928,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dovitinib.,Dovitinib,DB00024
DB06302,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Glesatinib.,Glesatinib,DB00024
DB06469,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Lestaurtinib.,Lestaurtinib,DB00024
DB06589,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Pazopanib.,Pazopanib,DB00024
DB06595,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Midostaurin.,Midostaurin,DB00024
DB06616,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bosutinib.,Bosutinib,DB00024
DB06626,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Axitinib.,Axitinib,DB00024
DB08399,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Piceatannol.,Piceatannol,DB00024
DB08865,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Crizotinib.,Crizotinib,DB00024
DB08875,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cabozantinib.,Cabozantinib,DB00024
DB08877,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ruxolitinib.,Ruxolitinib,DB00024
DB08881,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Vemurafenib.,Vemurafenib,DB00024
DB08896,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Regorafenib.,Regorafenib,DB00024
DB08901,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ponatinib.,Ponatinib,DB00024
DB08916,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Afatinib.,Afatinib,DB00024
DB09053,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ibrutinib.,Ibrutinib,DB00024
DB09063,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ceritinib.,Ceritinib,DB00024
DB09078,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Lenvatinib.,Lenvatinib,DB00024
DB09079,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nintedanib.,Nintedanib,DB00024
DB09330,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Osimertinib.,Osimertinib,DB00024
DB11363,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Alectinib.,Alectinib,DB00024
DB11689,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Selumetinib.,Selumetinib,DB00024
DB11697,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Pacritinib.,Pacritinib,DB00024
DB11703,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Acalabrutinib.,Acalabrutinib,DB00024
DB11737,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Icotinib.,Icotinib,DB00024
DB11805,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Saracatinib.,Saracatinib,DB00024
DB11828,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Neratinib.,Neratinib,DB00024
DB11832,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Crenolanib.,Crenolanib,DB00024
DB11904,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Flumatinib.,Flumatinib,DB00024
DB11963,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dacomitinib.,Dacomitinib,DB00024
DB11973,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tesevatinib.,Tesevatinib,DB00024
DB11986,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Entrectinib.,Entrectinib,DB00024
DB12010,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fostamatinib.,Fostamatinib,DB00024
DB12048,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Savolitinib.,Savolitinib,DB00024
DB12141,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Gilteritinib.,Gilteritinib,DB00024
DB12147,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Erdafitinib.,Erdafitinib,DB00024
DB12267,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Brigatinib.,Brigatinib,DB00024
DB12307,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Foretinib.,Foretinib,DB00024
DB12323,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Radotinib.,Radotinib,DB00024
DB14723,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Larotrectinib.,Larotrectinib,DB00024
DB12978,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Pexidartinib.,Pexidartinib,DB00024
DB12500,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fedratinib.,Fedratinib,DB00024
DB11652,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tucatinib.,Tucatinib,DB00024
DB11791,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Capmatinib.,Capmatinib,DB00024
DB15685,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Selpercatinib.,Selpercatinib,DB00024
DB05258,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Interferon alfa.,Interferon alfa,DB00024
DB00041,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Aldesleukin.,Aldesleukin,DB00024
DB00227,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Lovastatin.,Lovastatin,DB00024
DB00609,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ethionamide.,Ethionamide,DB00024
DB00829,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Diazepam.,Diazepam,DB00024
DB00850,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Perphenazine.,Perphenazine,DB00024
DB01233,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Metoclopramide.,Metoclopramide,DB00024
DB14651,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Perphenazine enanthate.,Perphenazine enanthate,DB00024
DB11085,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Resorcinol.,Resorcinol,DB00024
DB00201,Thyrotropin alfa may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.,Caffeine,DB00024
DB00277,Thyrotropin alfa may increase the excretion rate of Theophylline which could result in a lower serum level and potentially a reduction in efficacy.,Theophylline,DB00024
DB00651,Thyrotropin alfa may increase the excretion rate of Dyphylline which could result in a lower serum level and potentially a reduction in efficacy.,Dyphylline,DB00024
DB00806,Thyrotropin alfa may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.,Pentoxifylline,DB00024
DB01033,Thyrotropin alfa may increase the excretion rate of Mercaptopurine which could result in a lower serum level and potentially a reduction in efficacy.,Mercaptopurine,DB00024
DB01223,Thyrotropin alfa may increase the excretion rate of Aminophylline which could result in a lower serum level and potentially a reduction in efficacy.,Aminophylline,DB00024
DB01303,Thyrotropin alfa may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,Oxtriphylline,DB00024
DB01412,Thyrotropin alfa may increase the excretion rate of Theobromine which could result in a lower serum level and potentially a reduction in efficacy.,Theobromine,DB00024
DB01482,Thyrotropin alfa may increase the excretion rate of Fenethylline which could result in a lower serum level and potentially a reduction in efficacy.,Fenethylline,DB00024
DB01667,Thyrotropin alfa may increase the excretion rate of 8-azaguanine which could result in a lower serum level and potentially a reduction in efficacy.,8-azaguanine,DB00024
DB01978,"Thyrotropin alfa may increase the excretion rate of 7,9-Dimethylguanine which could result in a lower serum level and potentially a reduction in efficacy.","7,9-Dimethylguanine",DB00024
DB02134,Thyrotropin alfa may increase the excretion rate of Xanthine which could result in a lower serum level and potentially a reduction in efficacy.,Xanthine,DB00024
DB02245,Thyrotropin alfa may increase the excretion rate of 7-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,7-Deazaguanine,DB00024
DB02377,Thyrotropin alfa may increase the excretion rate of Guanine which could result in a lower serum level and potentially a reduction in efficacy.,Guanine,DB00024
DB02489,Thyrotropin alfa may increase the excretion rate of 9-Methylguanine which could result in a lower serum level and potentially a reduction in efficacy.,9-Methylguanine,DB00024
DB02568,Thyrotropin alfa may increase the excretion rate of Peldesine which could result in a lower serum level and potentially a reduction in efficacy.,Peldesine,DB00024
DB04076,Thyrotropin alfa may increase the excretion rate of Hypoxanthine which could result in a lower serum level and potentially a reduction in efficacy.,Hypoxanthine,DB00024
DB04356,Thyrotropin alfa may increase the excretion rate of 9-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,9-Deazaguanine,DB00024
DB06479,Thyrotropin alfa may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.,Propentofylline,DB00024
DB06575,Thyrotropin alfa may increase the excretion rate of Valomaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,Valomaciclovir,DB00024
DB07954,Thyrotropin alfa may increase the excretion rate of 3-isobutyl-1-methyl-7H-xanthine which could result in a lower serum level and potentially a reduction in efficacy.,3-isobutyl-1-methyl-7H-xanthine,DB00024
DB08844,Thyrotropin alfa may increase the excretion rate of Uric acid which could result in a lower serum level and potentially a reduction in efficacy.,Uric acid,DB00024
DB09273,Thyrotropin alfa may increase the excretion rate of Doxofylline which could result in a lower serum level and potentially a reduction in efficacy.,Doxofylline,DB00024
DB11919,Thyrotropin alfa may increase the excretion rate of 6-O-benzylguanine which could result in a lower serum level and potentially a reduction in efficacy.,6-O-benzylguanine,DB00024
DB12406,Thyrotropin alfa may increase the excretion rate of Lisofylline which could result in a lower serum level and potentially a reduction in efficacy.,Lisofylline,DB00024
DB12531,Thyrotropin alfa may increase the excretion rate of Lobucavir which could result in a lower serum level and potentially a reduction in efficacy.,Lobucavir,DB00024
DB12926,Thyrotropin alfa may increase the excretion rate of Cafedrine which could result in a lower serum level and potentially a reduction in efficacy.,Cafedrine,DB00024
DB12927,Thyrotropin alfa may increase the excretion rate of Theodrenaline which could result in a lower serum level and potentially a reduction in efficacy.,Theodrenaline,DB00024
DB13203,Thyrotropin alfa may increase the excretion rate of Bamifylline which could result in a lower serum level and potentially a reduction in efficacy.,Bamifylline,DB00024
DB13449,Thyrotropin alfa may increase the excretion rate of Proxyphylline which could result in a lower serum level and potentially a reduction in efficacy.,Proxyphylline,DB00024
DB13573,Thyrotropin alfa may increase the excretion rate of Acefylline which could result in a lower serum level and potentially a reduction in efficacy.,Acefylline,DB00024
DB13592,Thyrotropin alfa may increase the excretion rate of Etamiphylline which could result in a lower serum level and potentially a reduction in efficacy.,Etamiphylline,DB00024
DB13634,Thyrotropin alfa may increase the excretion rate of Pentifylline which could result in a lower serum level and potentially a reduction in efficacy.,Pentifylline,DB00024
DB13812,Thyrotropin alfa may increase the excretion rate of Bufylline which could result in a lower serum level and potentially a reduction in efficacy.,Bufylline,DB00024
DB14018,Thyrotropin alfa may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,Bromotheophylline,DB00024
DB14029,Thyrotropin alfa may increase the excretion rate of Furafylline which could result in a lower serum level and potentially a reduction in efficacy.,Furafylline,DB00024
DB14132,Thyrotropin alfa may increase the excretion rate of 8-chlorotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,8-chlorotheophylline,DB00024
DB15122,Thyrotropin alfa may increase the excretion rate of PCS-499 which could result in a lower serum level and potentially a reduction in efficacy.,PCS-499,DB00024
DB01432,Cholestyramine can cause a decrease in the absorption of Thyrotropin alfa resulting in a reduced serum concentration and potentially a decrease in efficacy.,Cholestyramine,DB00024
DB00375,Colestipol can cause a decrease in the absorption of Thyrotropin alfa resulting in a reduced serum concentration and potentially a decrease in efficacy.,Colestipol,DB00024
DB00658,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sevelamer.,Sevelamer,DB00024
DB00390,The serum concentration of Digoxin can be decreased when it is combined with Thyrotropin alfa.,Digoxin,DB00024
DB13401,The serum concentration of Metildigoxin can be decreased when it is combined with Thyrotropin alfa.,Metildigoxin,DB00024
DB13691,The serum concentration of Acetyldigoxin can be decreased when it is combined with Thyrotropin alfa.,Acetyldigoxin,DB00024
DB00266,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Dicoumarol.,Dicoumarol,DB00024
DB00498,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Phenindione.,Phenindione,DB00024
DB00682,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Warfarin.,Warfarin,DB00024
DB00946,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Phenprocoumon.,Phenprocoumon,DB00024
DB01418,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Acenocoumarol.,Acenocoumarol,DB00024
DB03410,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with 4-hydroxycoumarin.,4-hydroxycoumarin,DB00024
DB04665,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Coumarin.,Coumarin,DB00024
DB08496,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with (R)-warfarin.,(R)-warfarin,DB00024
DB08794,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Ethyl biscoumacetate.,Ethyl biscoumacetate,DB00024
DB13136,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Fluindione.,Fluindione,DB00024
DB13275,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Clorindione.,Clorindione,DB00024
DB13347,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Diphenadione.,Diphenadione,DB00024
DB13451,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Tioclomarol.,Tioclomarol,DB00024
DB14055,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with (S)-Warfarin.,(S)-Warfarin,DB00024
DB00222,Thyrotropin alfa may decrease the hypoglycemic activities of Glimepiride.,Glimepiride,DB00024
DB00414,Thyrotropin alfa may decrease the hypoglycemic activities of Acetohexamide.,Acetohexamide,DB00024
DB00672,Thyrotropin alfa may decrease the hypoglycemic activities of Chlorpropamide.,Chlorpropamide,DB00024
DB00839,Thyrotropin alfa may decrease the hypoglycemic activities of Tolazamide.,Tolazamide,DB00024
DB01016,Thyrotropin alfa may decrease the hypoglycemic activities of Glyburide.,Glyburide,DB00024
DB01067,Thyrotropin alfa may decrease the hypoglycemic activities of Glipizide.,Glipizide,DB00024
DB01120,Thyrotropin alfa may decrease the hypoglycemic activities of Gliclazide.,Gliclazide,DB00024
DB01124,Thyrotropin alfa may decrease the hypoglycemic activities of Tolbutamide.,Tolbutamide,DB00024
DB01251,Thyrotropin alfa may decrease the hypoglycemic activities of Gliquidone.,Gliquidone,DB00024
DB01289,Thyrotropin alfa may decrease the hypoglycemic activities of Glisoxepide.,Glisoxepide,DB00024
DB08962,Thyrotropin alfa may decrease the hypoglycemic activities of Glibornuride.,Glibornuride,DB00024
DB13406,Thyrotropin alfa may decrease the hypoglycemic activities of Carbutamide.,Carbutamide,DB00024
DB13675,Thyrotropin alfa may decrease the hypoglycemic activities of Metahexamide.,Metahexamide,DB00024
DB00030,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin human.,Insulin human,DB00024
DB00046,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin lispro.,Insulin lispro,DB00024
DB00047,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin glargine.,Insulin glargine,DB00024
DB00071,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin pork.,Insulin pork,DB00024
DB00197,Thyrotropin alfa may decrease the hypoglycemic activities of Troglitazone.,Troglitazone,DB00024
DB00263,Thyrotropin alfa may decrease the hypoglycemic activities of Sulfisoxazole.,Sulfisoxazole,DB00024
DB00280,Thyrotropin alfa may decrease the hypoglycemic activities of Disopyramide.,Disopyramide,DB00024
DB00284,Thyrotropin alfa may decrease the hypoglycemic activities of Acarbose.,Acarbose,DB00024
DB00359,Thyrotropin alfa may decrease the hypoglycemic activities of Sulfadiazine.,Sulfadiazine,DB00024
DB00412,Thyrotropin alfa may decrease the hypoglycemic activities of Rosiglitazone.,Rosiglitazone,DB00024
DB00468,Thyrotropin alfa may decrease the hypoglycemic activities of Quinine.,Quinine,DB00024
DB00491,Thyrotropin alfa may decrease the hypoglycemic activities of Miglitol.,Miglitol,DB00024
DB00731,Thyrotropin alfa may decrease the hypoglycemic activities of Nateglinide.,Nateglinide,DB00024
DB00738,Thyrotropin alfa may decrease the hypoglycemic activities of Pentamidine.,Pentamidine,DB00024
DB00834,Thyrotropin alfa may decrease the hypoglycemic activities of Mifepristone.,Mifepristone,DB00024
DB00912,Thyrotropin alfa may decrease the hypoglycemic activities of Repaglinide.,Repaglinide,DB00024
DB00914,Thyrotropin alfa may decrease the hypoglycemic activities of Phenformin.,Phenformin,DB00024
DB01015,Thyrotropin alfa may decrease the hypoglycemic activities of Sulfamethoxazole.,Sulfamethoxazole,DB00024
DB01132,Thyrotropin alfa may decrease the hypoglycemic activities of Pioglitazone.,Pioglitazone,DB00024
DB01200,Thyrotropin alfa may decrease the hypoglycemic activities of Bromocriptine.,Bromocriptine,DB00024
DB01252,Thyrotropin alfa may decrease the hypoglycemic activities of Mitiglinide.,Mitiglinide,DB00024
DB01261,Thyrotropin alfa may decrease the hypoglycemic activities of Sitagliptin.,Sitagliptin,DB00024
DB01276,Thyrotropin alfa may decrease the hypoglycemic activities of Exenatide.,Exenatide,DB00024
DB01277,Thyrotropin alfa may decrease the hypoglycemic activities of Mecasermin.,Mecasermin,DB00024
DB01278,Thyrotropin alfa may decrease the hypoglycemic activities of Pramlintide.,Pramlintide,DB00024
DB01306,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin aspart.,Insulin aspart,DB00024
DB01307,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin detemir.,Insulin detemir,DB00024
DB01309,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin glulisine.,Insulin glulisine,DB00024
DB01382,Thyrotropin alfa may decrease the hypoglycemic activities of Glymidine.,Glymidine,DB00024
DB01700,Thyrotropin alfa may decrease the hypoglycemic activities of AICA ribonucleotide.,AICA ribonucleotide,DB00024
DB04830,Thyrotropin alfa may decrease the hypoglycemic activities of Buformin.,Buformin,DB00024
DB04876,Thyrotropin alfa may decrease the hypoglycemic activities of Vildagliptin.,Vildagliptin,DB00024
DB04878,Thyrotropin alfa may decrease the hypoglycemic activities of Voglibose.,Voglibose,DB00024
DB05115,Thyrotropin alfa may decrease the hypoglycemic activities of NN344.,NN344,DB00024
DB05819,Thyrotropin alfa may decrease the hypoglycemic activities of NBI-6024.,NBI-6024,DB00024
DB06011,Thyrotropin alfa may decrease the hypoglycemic activities of AMG-222.,AMG-222,DB00024
DB06127,Thyrotropin alfa may decrease the hypoglycemic activities of Bisegliptin.,Bisegliptin,DB00024
DB06203,Thyrotropin alfa may decrease the hypoglycemic activities of Alogliptin.,Alogliptin,DB00024
DB06292,Thyrotropin alfa may decrease the hypoglycemic activities of Dapagliflozin.,Dapagliflozin,DB00024
DB06335,Thyrotropin alfa may decrease the hypoglycemic activities of Saxagliptin.,Saxagliptin,DB00024
DB06655,Thyrotropin alfa may decrease the hypoglycemic activities of Liraglutide.,Liraglutide,DB00024
DB08382,Thyrotropin alfa may decrease the hypoglycemic activities of Gosogliptin.,Gosogliptin,DB00024
DB08882,Thyrotropin alfa may decrease the hypoglycemic activities of Linagliptin.,Linagliptin,DB00024
DB08907,Thyrotropin alfa may decrease the hypoglycemic activities of Canagliflozin.,Canagliflozin,DB00024
DB09022,Thyrotropin alfa may decrease the hypoglycemic activities of Benfluorex.,Benfluorex,DB00024
DB09038,Thyrotropin alfa may decrease the hypoglycemic activities of Empagliflozin.,Empagliflozin,DB00024
DB09043,Thyrotropin alfa may decrease the hypoglycemic activities of Albiglutide.,Albiglutide,DB00024
DB09045,Thyrotropin alfa may decrease the hypoglycemic activities of Dulaglutide.,Dulaglutide,DB00024
DB09198,Thyrotropin alfa may decrease the hypoglycemic activities of Lobeglitazone.,Lobeglitazone,DB00024
DB09199,Thyrotropin alfa may decrease the hypoglycemic activities of Netoglitazone.,Netoglitazone,DB00024
DB09200,Thyrotropin alfa may decrease the hypoglycemic activities of Rivoglitazone.,Rivoglitazone,DB00024
DB09201,Thyrotropin alfa may decrease the hypoglycemic activities of Ciglitazone.,Ciglitazone,DB00024
DB09265,Thyrotropin alfa may decrease the hypoglycemic activities of Lixisenatide.,Lixisenatide,DB00024
DB09456,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin beef.,Insulin beef,DB00024
DB09564,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin degludec.,Insulin degludec,DB00024
DB11567,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin peglispro.,Insulin peglispro,DB00024
DB11568,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin tregopil.,Insulin tregopil,DB00024
DB11698,Thyrotropin alfa may decrease the hypoglycemic activities of Ipragliflozin.,Ipragliflozin,DB00024
DB11723,Thyrotropin alfa may decrease the hypoglycemic activities of Dutogliptin.,Dutogliptin,DB00024
DB11780,Thyrotropin alfa may decrease the hypoglycemic activities of Allicin.,Allicin,DB00024
DB11824,Thyrotropin alfa may decrease the hypoglycemic activities of Tofogliflozin.,Tofogliflozin,DB00024
DB11827,Thyrotropin alfa may decrease the hypoglycemic activities of Ertugliflozin.,Ertugliflozin,DB00024
DB11898,"Thyrotropin alfa may decrease the hypoglycemic activities of 2,4-thiazolidinedione.","2,4-thiazolidinedione",DB00024
DB11950,Thyrotropin alfa may decrease the hypoglycemic activities of Teneligliptin.,Teneligliptin,DB00024
DB11992,Thyrotropin alfa may decrease the hypoglycemic activities of Omarigliptin.,Omarigliptin,DB00024
DB12268,Thyrotropin alfa may decrease the hypoglycemic activities of Carmegliptin.,Carmegliptin,DB00024
DB12412,Thyrotropin alfa may decrease the hypoglycemic activities of Gemigliptin.,Gemigliptin,DB00024
DB12417,Thyrotropin alfa may decrease the hypoglycemic activities of Anagliptin.,Anagliptin,DB00024
DB12625,Thyrotropin alfa may decrease the hypoglycemic activities of Evogliptin.,Evogliptin,DB00024
DB12713,Thyrotropin alfa may decrease the hypoglycemic activities of Sotagliflozin.,Sotagliflozin,DB00024
DB12781,Thyrotropin alfa may decrease the hypoglycemic activities of Balaglitazone.,Balaglitazone,DB00024
DB12935,Thyrotropin alfa may decrease the hypoglycemic activities of Remogliflozin etabonate.,Remogliflozin etabonate,DB00024
DB13446,Thyrotropin alfa may decrease the hypoglycemic activities of Guar gum.,Guar gum,DB00024
DB13928,Thyrotropin alfa may decrease the hypoglycemic activities of Semaglutide.,Semaglutide,DB00024
DB14027,Thyrotropin alfa may decrease the hypoglycemic activities of Taspoglutide.,Taspoglutide,DB00024
DB14035,Thyrotropin alfa may decrease the hypoglycemic activities of Englitazone.,Englitazone,DB00024
DB15171,Thyrotropin alfa may decrease the hypoglycemic activities of Tirzepatide.,Tirzepatide,DB00024
DB15217,Thyrotropin alfa may decrease the hypoglycemic activities of Gastric inhibitory polypeptide.,Gastric inhibitory polypeptide,DB00024
DB00540,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Nortriptyline.,Nortriptyline,DB00024
DB00321,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Amitriptyline.,Amitriptyline,DB00024
DB00344,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Protriptyline.,Protriptyline,DB00024
DB00458,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Imipramine.,Imipramine,DB00024
DB00543,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Amoxapine.,Amoxapine,DB00024
DB00726,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Trimipramine.,Trimipramine,DB00024
DB01142,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Doxepin.,Doxepin,DB00024
DB01151,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Desipramine.,Desipramine,DB00024
DB01242,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Clomipramine.,Clomipramine,DB00024
DB04836,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Amineptine.,Amineptine,DB00024
DB08996,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Dimetacrine.,Dimetacrine,DB00024
DB09016,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Butriptyline.,Butriptyline,DB00024
DB09167,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Dosulepin.,Dosulepin,DB00024
DB09289,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Tianeptine.,Tianeptine,DB00024
DB09307,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Oxaprotiline.,Oxaprotiline,DB00024
DB12930,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Opipramol.,Opipramol,DB00024
DB13114,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Amitriptylinoxide.,Amitriptylinoxide,DB00024
DB13225,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Dibenzepin.,Dibenzepin,DB00024
DB13246,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Quinupramine.,Quinupramine,DB00024
DB13384,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Melitracen.,Melitracen,DB00024
DB13411,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Lofepramine.,Lofepramine,DB00024
DB13496,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Iprindole.,Iprindole,DB00024
DB13782,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Imipramine oxide.,Imipramine oxide,DB00024
DB00513,"The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Antihemophilic factor, human recombinant.",Aminocaproic acid,DB00025
DB00058,"Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Alpha-1-proteinase inhibitor,DB00025
DB00170,"Menadione may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Menadione,DB00025
DB00302,"Tranexamic acid may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Tranexamic acid,DB00025
DB06692,"Aprotinin may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Aprotinin,DB00025
DB11091,"Hydrogen peroxide may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Hydrogen peroxide,DB00025
DB13244,"Aminomethylbenzoic acid may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Aminomethylbenzoic acid,DB00025
DB13729,"Camostat may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Camostat,DB00025
DB12726,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Monteplase.",Monteplase,DB00025
DB00001,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Lepirudin.",Lepirudin,DB00025
DB00006,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Bivalirudin.",Bivalirudin,DB00025
DB00009,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Alteplase.",Alteplase,DB00025
DB00013,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Urokinase.",Urokinase,DB00025
DB00015,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Reteplase.",Reteplase,DB00025
DB00029,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Anistreplase.",Anistreplase,DB00025
DB00031,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tenecteplase.",Tenecteplase,DB00025
DB00054,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Abciximab.",Abciximab,DB00025
DB00055,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Drotrecogin alfa.",Drotrecogin alfa,DB00025
DB00086,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Streptokinase.",Streptokinase,DB00025
DB00266,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dicoumarol.",Dicoumarol,DB00025
DB00278,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Argatroban.",Argatroban,DB00025
DB00407,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ardeparin.",Ardeparin,DB00025
DB00498,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Phenindione.",Phenindione,DB00025
DB00569,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Fondaparinux.",Fondaparinux,DB00025
DB00682,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Warfarin.",Warfarin,DB00025
DB00686,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Pentosan polysulfate.",Pentosan polysulfate,DB00025
DB00945,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Acetylsalicylic acid.",Acetylsalicylic acid,DB00025
DB00946,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Phenprocoumon.",Phenprocoumon,DB00025
DB00975,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dipyridamole.",Dipyridamole,DB00025
DB01088,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Iloprost.",Iloprost,DB00025
DB01109,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Heparin.",Heparin,DB00025
DB01225,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Enoxaparin.",Enoxaparin,DB00025
DB01240,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Epoprostenol.",Epoprostenol,DB00025
DB01418,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Acenocoumarol.",Acenocoumarol,DB00025
DB03410,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with 4-hydroxycoumarin.",4-hydroxycoumarin,DB00025
DB04665,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Coumarin.",Coumarin,DB00025
DB04898,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ximelagatran.",Ximelagatran,DB00025
DB04925,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Desmoteplase.",Desmoteplase,DB00025
DB04932,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Defibrotide.",Defibrotide,DB00025
DB05099,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ancrod.",Ancrod,DB00025
DB05229,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Beraprost.",Beraprost,DB00025
DB05254,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Fibrinolysin.",Fibrinolysin,DB00025
DB06209,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Prasugrel.",Prasugrel,DB00025
DB06228,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Rivaroxaban.",Rivaroxaban,DB00025
DB06271,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Sulodexide.",Sulodexide,DB00025
DB06406,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Idraparinux.",Idraparinux,DB00025
DB06441,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Cangrelor.",Cangrelor,DB00025
DB06543,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Astaxanthin.",Astaxanthin,DB00025
DB06605,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Apixaban.",Apixaban,DB00025
DB06635,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Otamixaban.",Otamixaban,DB00025
DB06679,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Amediplase.",Amediplase,DB00025
DB06695,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dabigatran etexilate.",Dabigatran etexilate,DB00025
DB06754,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Danaparoid.",Danaparoid,DB00025
DB06779,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dalteparin.",Dalteparin,DB00025
DB06822,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tinzaparin.",Tinzaparin,DB00025
DB07767,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ferulic acid.",Ferulic acid,DB00025
DB08496,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with (R)-warfarin.",(R)-warfarin,DB00025
DB08794,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ethyl biscoumacetate.",Ethyl biscoumacetate,DB00025
DB08813,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Nadroparin.",Nadroparin,DB00025
DB08814,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Triflusal.",Triflusal,DB00025
DB08816,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ticagrelor.",Ticagrelor,DB00025
DB08994,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ditazole.",Ditazole,DB00025
DB09030,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Vorapaxar.",Vorapaxar,DB00025
DB09075,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Edoxaban.",Edoxaban,DB00025
DB09125,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Potassium citrate.",Potassium citrate,DB00025
DB09154,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Sodium citrate.",Sodium citrate,DB00025
DB09255,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dextran.",Dextran,DB00025
DB09258,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Bemiparin.",Bemiparin,DB00025
DB09259,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Reviparin.",Reviparin,DB00025
DB09260,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Parnaparin.",Parnaparin,DB00025
DB09261,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Certoparin.",Certoparin,DB00025
DB11095,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Desirudin.",Desirudin,DB00025
DB11154,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Zinc citrate.",Zinc citrate,DB00025
DB11166,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Antithrombin Alfa.",Antithrombin Alfa,DB00025
DB11312,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Protein C.",Protein C,DB00025
DB11598,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Antithrombin III human.",Antithrombin III human,DB00025
DB11984,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Letaxaban.",Letaxaban,DB00025
DB12289,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Darexaban.",Darexaban,DB00025
DB12364,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Betrixaban.",Betrixaban,DB00025
DB12598,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Nafamostat.",Nafamostat,DB00025
DB12831,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Gabexate.",Gabexate,DB00025
DB13136,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Fluindione.",Fluindione,DB00025
DB13149,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Protein S human.",Protein S human,DB00025
DB13199,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Brinase.",Brinase,DB00025
DB13275,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Clorindione.",Clorindione,DB00025
DB13347,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Diphenadione.",Diphenadione,DB00025
DB13451,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tioclomarol.",Tioclomarol,DB00025
DB13616,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Melagatran.",Melagatran,DB00025
DB13646,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Saruplase.",Saruplase,DB00025
DB14055,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with (S)-Warfarin.",(S)-Warfarin,DB00025
DB14094,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tocopherylquinone.",Tocopherylquinone,DB00025
DB14598,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Edetate calcium disodium anhydrous.",Edetate calcium disodium anhydrous,DB00025
DB14726,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dabigatran.",Dabigatran,DB00025
DB06294,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Semuloparin.",Semuloparin,DB00025
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Anakinra.,Etanercept,DB00026
DB00051,The risk or severity of adverse effects can be increased when Adalimumab is combined with Anakinra.,Adalimumab,DB00026
DB00065,The risk or severity of adverse effects can be increased when Infliximab is combined with Anakinra.,Infliximab,DB00026
DB04956,The risk or severity of adverse effects can be increased when Afelimomab is combined with Anakinra.,Afelimomab,DB00026
DB06674,The risk or severity of adverse effects can be increased when Golimumab is combined with Anakinra.,Golimumab,DB00026
DB08904,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Anakinra.,Certolizumab pegol,DB00026
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Anakinra.,Denosumab,DB00026
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Anakinra.,Peginterferon alfa-2a,DB00026
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Anakinra.,Interferon alfa-n1,DB00026
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Anakinra.,Interferon alfa-n3,DB00026
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Anakinra.,Peginterferon alfa-2b,DB00026
DB00033,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00026
DB00034,"The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00026
DB00041,The risk or severity of adverse effects can be increased when Anakinra is combined with Aldesleukin.,Aldesleukin,DB00026
DB00056,The risk or severity of adverse effects can be increased when Anakinra is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00026
DB00059,The risk or severity of adverse effects can be increased when Anakinra is combined with Pegaspargase.,Pegaspargase,DB00026
DB00068,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon beta-1b.,Interferon beta-1b,DB00026
DB00069,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00026
DB00073,The risk or severity of adverse effects can be increased when Anakinra is combined with Rituximab.,Rituximab,DB00026
DB00074,The risk or severity of adverse effects can be increased when Anakinra is combined with Basiliximab.,Basiliximab,DB00026
DB00075,The risk or severity of adverse effects can be increased when Anakinra is combined with Muromonab.,Muromonab,DB00026
DB00078,The risk or severity of adverse effects can be increased when Anakinra is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00026
DB00081,The risk or severity of adverse effects can be increased when Anakinra is combined with Tositumomab.,Tositumomab,DB00026
DB00087,The risk or severity of adverse effects can be increased when Anakinra is combined with Alemtuzumab.,Alemtuzumab,DB00026
DB00092,The risk or severity of adverse effects can be increased when Anakinra is combined with Alefacept.,Alefacept,DB00026
DB00095,The risk or severity of adverse effects can be increased when Anakinra is combined with Efalizumab.,Efalizumab,DB00026
DB00098,The risk or severity of adverse effects can be increased when Anakinra is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit),DB00026
DB00105,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00026
DB00111,The risk or severity of adverse effects can be increased when Anakinra is combined with Daclizumab.,Daclizumab,DB00026
DB00112,The risk or severity of adverse effects can be increased when Anakinra is combined with Bevacizumab.,Bevacizumab,DB00026
DB00120,The risk or severity of adverse effects can be increased when Anakinra is combined with Phenylalanine.,Phenylalanine,DB00026
DB00242,The risk or severity of adverse effects can be increased when Anakinra is combined with Cladribine.,Cladribine,DB00026
DB00276,The risk or severity of adverse effects can be increased when Anakinra is combined with Amsacrine.,Amsacrine,DB00026
DB00290,The risk or severity of adverse effects can be increased when Anakinra is combined with Bleomycin.,Bleomycin,DB00026
DB00291,The risk or severity of adverse effects can be increased when Anakinra is combined with Chlorambucil.,Chlorambucil,DB00026
DB00293,The risk or severity of adverse effects can be increased when Anakinra is combined with Raltitrexed.,Raltitrexed,DB00026
DB00305,The risk or severity of adverse effects can be increased when Anakinra is combined with Mitomycin.,Mitomycin,DB00026
DB00322,The risk or severity of adverse effects can be increased when Anakinra is combined with Floxuridine.,Floxuridine,DB00026
DB00352,The risk or severity of adverse effects can be increased when Anakinra is combined with Tioguanine.,Tioguanine,DB00026
DB00380,The risk or severity of adverse effects can be increased when Anakinra is combined with Dexrazoxane.,Dexrazoxane,DB00026
DB00428,The risk or severity of adverse effects can be increased when Anakinra is combined with Streptozocin.,Streptozocin,DB00026
DB00432,The risk or severity of adverse effects can be increased when Anakinra is combined with Trifluridine.,Trifluridine,DB00026
DB00441,The risk or severity of adverse effects can be increased when Anakinra is combined with Gemcitabine.,Gemcitabine,DB00026
DB00445,The risk or severity of adverse effects can be increased when Anakinra is combined with Epirubicin.,Epirubicin,DB00026
DB00446,The risk or severity of adverse effects can be increased when Anakinra is combined with Chloramphenicol.,Chloramphenicol,DB00026
DB00480,The risk or severity of adverse effects can be increased when Anakinra is combined with Lenalidomide.,Lenalidomide,DB00026
DB00488,The risk or severity of adverse effects can be increased when Anakinra is combined with Altretamine.,Altretamine,DB00026
DB00515,The risk or severity of adverse effects can be increased when Anakinra is combined with Cisplatin.,Cisplatin,DB00026
DB00526,The risk or severity of adverse effects can be increased when Anakinra is combined with Oxaliplatin.,Oxaliplatin,DB00026
DB00550,The risk or severity of adverse effects can be increased when Anakinra is combined with Propylthiouracil.,Propylthiouracil,DB00026
DB00552,The risk or severity of adverse effects can be increased when Anakinra is combined with Pentostatin.,Pentostatin,DB00026
DB00601,The risk or severity of adverse effects can be increased when Anakinra is combined with Linezolid.,Linezolid,DB00026
DB00631,The risk or severity of adverse effects can be increased when Anakinra is combined with Clofarabine.,Clofarabine,DB00026
DB00763,The risk or severity of adverse effects can be increased when Anakinra is combined with Methimazole.,Methimazole,DB00026
DB00795,The risk or severity of adverse effects can be increased when Anakinra is combined with Sulfasalazine.,Sulfasalazine,DB00026
DB00853,The risk or severity of adverse effects can be increased when Anakinra is combined with Temozolomide.,Temozolomide,DB00026
DB00859,The risk or severity of adverse effects can be increased when Anakinra is combined with Penicillamine.,Penicillamine,DB00026
DB00888,The risk or severity of adverse effects can be increased when Anakinra is combined with Mechlorethamine.,Mechlorethamine,DB00026
DB00928,The risk or severity of adverse effects can be increased when Anakinra is combined with Azacitidine.,Azacitidine,DB00026
DB00958,The risk or severity of adverse effects can be increased when Anakinra is combined with Carboplatin.,Carboplatin,DB00026
DB00970,The risk or severity of adverse effects can be increased when Anakinra is combined with Dactinomycin.,Dactinomycin,DB00026
DB01005,The risk or severity of adverse effects can be increased when Anakinra is combined with Hydroxyurea.,Hydroxyurea,DB00026
DB01024,The risk or severity of adverse effects can be increased when Anakinra is combined with Mycophenolic acid.,Mycophenolic acid,DB00026
DB01030,The risk or severity of adverse effects can be increased when Anakinra is combined with Topotecan.,Topotecan,DB00026
DB01033,The risk or severity of adverse effects can be increased when Anakinra is combined with Mercaptopurine.,Mercaptopurine,DB00026
DB01042,The risk or severity of adverse effects can be increased when Anakinra is combined with Melphalan.,Melphalan,DB00026
DB01073,The risk or severity of adverse effects can be increased when Anakinra is combined with Fludarabine.,Fludarabine,DB00026
DB01099,The risk or severity of adverse effects can be increased when Anakinra is combined with Flucytosine.,Flucytosine,DB00026
DB01168,The risk or severity of adverse effects can be increased when Anakinra is combined with Procarbazine.,Procarbazine,DB00026
DB01169,The risk or severity of adverse effects can be increased when Anakinra is combined with Arsenic trioxide.,Arsenic trioxide,DB00026
DB01204,The risk or severity of adverse effects can be increased when Anakinra is combined with Mitoxantrone.,Mitoxantrone,DB00026
DB01206,The risk or severity of adverse effects can be increased when Anakinra is combined with Lomustine.,Lomustine,DB00026
DB01257,The risk or severity of adverse effects can be increased when Anakinra is combined with Eculizumab.,Eculizumab,DB00026
DB01262,The risk or severity of adverse effects can be increased when Anakinra is combined with Decitabine.,Decitabine,DB00026
DB01280,The risk or severity of adverse effects can be increased when Anakinra is combined with Nelarabine.,Nelarabine,DB00026
DB01423,The risk or severity of adverse effects can be increased when Anakinra is combined with Stepronin.,Stepronin,DB00026
DB01816,The risk or severity of adverse effects can be increased when Anakinra is combined with Castanospermine.,Castanospermine,DB00026
DB02546,The risk or severity of adverse effects can be increased when Anakinra is combined with Vorinostat.,Vorinostat,DB00026
DB02806,The risk or severity of adverse effects can be increased when Anakinra is combined with 2-Methoxyethanol.,2-Methoxyethanol,DB00026
DB03523,The risk or severity of adverse effects can be increased when Anakinra is combined with Brequinar.,Brequinar,DB00026
DB05258,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfa.,Interferon alfa,DB00026
DB05259,The risk or severity of adverse effects can be increased when Anakinra is combined with Glatiramer.,Glatiramer,DB00026
DB05260,The risk or severity of adverse effects can be increased when Anakinra is combined with Gallium nitrate.,Gallium nitrate,DB00026
DB05459,The risk or severity of adverse effects can be increased when Anakinra is combined with Briakinumab.,Briakinumab,DB00026
DB05472,The risk or severity of adverse effects can be increased when Anakinra is combined with omega interferon.,omega interferon,DB00026
DB06273,The risk or severity of adverse effects can be increased when Anakinra is combined with Tocilizumab.,Tocilizumab,DB00026
DB06372,The risk or severity of adverse effects can be increased when Anakinra is combined with Rilonacept.,Rilonacept,DB00026
DB06612,The risk or severity of adverse effects can be increased when Anakinra is combined with Mepolizumab.,Mepolizumab,DB00026
DB06662,The risk or severity of adverse effects can be increased when Anakinra is combined with Abetimus.,Abetimus,DB00026
DB06681,The risk or severity of adverse effects can be increased when Anakinra is combined with Belatacept.,Belatacept,DB00026
DB06813,The risk or severity of adverse effects can be increased when Anakinra is combined with Pralatrexate.,Pralatrexate,DB00026
DB08059,The risk or severity of adverse effects can be increased when Anakinra is combined with Wortmannin.,Wortmannin,DB00026
DB08871,The risk or severity of adverse effects can be increased when Anakinra is combined with Eribulin.,Eribulin,DB00026
DB08879,The risk or severity of adverse effects can be increased when Anakinra is combined with Belimumab.,Belimumab,DB00026
DB08880,The risk or severity of adverse effects can be increased when Anakinra is combined with Teriflunomide.,Teriflunomide,DB00026
DB08889,The risk or severity of adverse effects can be increased when Anakinra is combined with Carfilzomib.,Carfilzomib,DB00026
DB08908,The risk or severity of adverse effects can be increased when Anakinra is combined with Dimethyl fumarate.,Dimethyl fumarate,DB00026
DB08935,The risk or severity of adverse effects can be increased when Anakinra is combined with Obinutuzumab.,Obinutuzumab,DB00026
DB09029,The risk or severity of adverse effects can be increased when Anakinra is combined with Secukinumab.,Secukinumab,DB00026
DB09033,The risk or severity of adverse effects can be increased when Anakinra is combined with Vedolizumab.,Vedolizumab,DB00026
DB09036,The risk or severity of adverse effects can be increased when Anakinra is combined with Siltuximab.,Siltuximab,DB00026
DB09052,The risk or severity of adverse effects can be increased when Anakinra is combined with Blinatumomab.,Blinatumomab,DB00026
DB09077,The risk or severity of adverse effects can be increased when Anakinra is combined with Dinutuximab.,Dinutuximab,DB00026
DB09091,The risk or severity of adverse effects can be increased when Anakinra is combined with Tixocortol.,Tixocortol,DB00026
DB09122,The risk or severity of adverse effects can be increased when Anakinra is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00026
DB09312,The risk or severity of adverse effects can be increased when Anakinra is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse),DB00026
DB11466,The risk or severity of adverse effects can be increased when Anakinra is combined with Tepoxalin.,Tepoxalin,DB00026
DB11569,The risk or severity of adverse effects can be increased when Anakinra is combined with Ixekizumab.,Ixekizumab,DB00026
DB11580,The risk or severity of adverse effects can be increased when Anakinra is combined with Ravulizumab.,Ravulizumab,DB00026
DB11616,The risk or severity of adverse effects can be increased when Anakinra is combined with Pirarubicin.,Pirarubicin,DB00026
DB11693,The risk or severity of adverse effects can be increased when Anakinra is combined with Voclosporin.,Voclosporin,DB00026
DB11708,The risk or severity of adverse effects can be increased when Anakinra is combined with Peficitinib.,Peficitinib,DB00026
DB11767,The risk or severity of adverse effects can be increased when Anakinra is combined with Sarilumab.,Sarilumab,DB00026
DB11776,The risk or severity of adverse effects can be increased when Anakinra is combined with Brodalumab.,Brodalumab,DB00026
DB11803,The risk or severity of adverse effects can be increased when Anakinra is combined with Sirukumab.,Sirukumab,DB00026
DB11834,The risk or severity of adverse effects can be increased when Anakinra is combined with Guselkumab.,Guselkumab,DB00026
DB11988,The risk or severity of adverse effects can be increased when Anakinra is combined with Ocrelizumab.,Ocrelizumab,DB00026
DB12025,The risk or severity of adverse effects can be increased when Anakinra is combined with Triptolide.,Triptolide,DB00026
DB12612,The risk or severity of adverse effects can be increased when Anakinra is combined with Ozanimod.,Ozanimod,DB00026
DB12617,The risk or severity of adverse effects can be increased when Anakinra is combined with Mizoribine.,Mizoribine,DB00026
DB12692,The risk or severity of adverse effects can be increased when Anakinra is combined with Gusperimus.,Gusperimus,DB00026
DB12814,The risk or severity of adverse effects can be increased when Anakinra is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00026
DB12902,The risk or severity of adverse effects can be increased when Anakinra is combined with Trofosfamide.,Trofosfamide,DB00026
DB12947,The risk or severity of adverse effects can be increased when Anakinra is combined with Doxifluridine.,Doxifluridine,DB00026
DB12991,The risk or severity of adverse effects can be increased when Anakinra is combined with Deoxyspergualin.,Deoxyspergualin,DB00026
DB12996,The risk or severity of adverse effects can be increased when Anakinra is combined with Acteoside.,Acteoside,DB00026
DB13003,The risk or severity of adverse effects can be increased when Anakinra is combined with Cortivazol.,Cortivazol,DB00026
DB13014,The risk or severity of adverse effects can be increased when Anakinra is combined with Hypericin.,Hypericin,DB00026
DB13068,The risk or severity of adverse effects can be increased when Anakinra is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A,DB00026
DB13223,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluocortin.,Fluocortin,DB00026
DB13241,The risk or severity of adverse effects can be increased when Anakinra is combined with Begelomab.,Begelomab,DB00026
DB13491,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluperolone.,Fluperolone,DB00026
DB13664,The risk or severity of adverse effects can be increased when Anakinra is combined with Formocortal.,Formocortal,DB00026
DB13728,The risk or severity of adverse effects can be increased when Anakinra is combined with Halometasone.,Halometasone,DB00026
DB13843,The risk or severity of adverse effects can be increased when Anakinra is combined with Cloprednol.,Cloprednol,DB00026
DB13856,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluclorolone.,Fluclorolone,DB00026
DB14219,The risk or severity of adverse effects can be increased when Anakinra is combined with Monomethyl fumarate.,Monomethyl fumarate,DB00026
DB14724,The risk or severity of adverse effects can be increased when Anakinra is combined with Emapalumab.,Emapalumab,DB00026
DB14762,The risk or severity of adverse effects can be increased when Anakinra is combined with Risankizumab.,Risankizumab,DB00026
DB14919,The risk or severity of adverse effects can be increased when Anakinra is combined with Rozanolixizumab.,Rozanolixizumab,DB00026
DB15253,The risk or severity of adverse effects can be increased when Anakinra is combined with Bleselumab.,Bleselumab,DB00026
DB00180,The risk or severity of adverse effects can be increased when Anakinra is combined with Flunisolide.,Flunisolide,DB00026
DB00394,The risk or severity of adverse effects can be increased when Anakinra is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate,DB00026
DB00443,The risk or severity of adverse effects can be increased when Anakinra is combined with Betamethasone.,Betamethasone,DB00026
DB00591,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluocinolone acetonide.,Fluocinolone acetonide,DB00026
DB00635,The risk or severity of adverse effects can be increased when Anakinra is combined with Prednisone.,Prednisone,DB00026
DB00687,The risk or severity of adverse effects can be increased when Anakinra is combined with Fludrocortisone.,Fludrocortisone,DB00026
DB00764,The risk or severity of adverse effects can be increased when Anakinra is combined with Mometasone.,Mometasone,DB00026
DB00860,The risk or severity of adverse effects can be increased when Anakinra is combined with Prednisolone.,Prednisolone,DB00026
DB00959,The risk or severity of adverse effects can be increased when Anakinra is combined with Methylprednisolone.,Methylprednisolone,DB00026
DB01196,The risk or severity of adverse effects can be increased when Anakinra is combined with Estramustine.,Estramustine,DB00026
DB01285,The risk or severity of adverse effects can be increased when Anakinra is combined with Corticotropin.,Corticotropin,DB00026
DB01380,The risk or severity of adverse effects can be increased when Anakinra is combined with Cortisone acetate.,Cortisone acetate,DB00026
DB01384,The risk or severity of adverse effects can be increased when Anakinra is combined with Paramethasone.,Paramethasone,DB00026
DB01611,The risk or severity of adverse effects can be increased when Anakinra is combined with Hydroxychloroquine.,Hydroxychloroquine,DB00026
DB04630,The risk or severity of adverse effects can be increased when Anakinra is combined with Aldosterone.,Aldosterone,DB00026
DB08970,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluprednidene.,Fluprednidene,DB00026
DB08971,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluocortolone.,Fluocortolone,DB00026
DB09082,The risk or severity of adverse effects can be increased when Anakinra is combined with Vilanterol.,Vilanterol,DB00026
DB09378,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluprednisolone.,Fluprednisolone,DB00026
DB09383,The risk or severity of adverse effects can be increased when Anakinra is combined with Meprednisone.,Meprednisone,DB00026
DB11487,The risk or severity of adverse effects can be increased when Anakinra is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate,DB00026
DB11529,The risk or severity of adverse effects can be increased when Anakinra is combined with Melengestrol.,Melengestrol,DB00026
DB11750,The risk or severity of adverse effects can be increased when Anakinra is combined with Clobetasol.,Clobetasol,DB00026
DB11817,The risk or severity of adverse effects can be increased when Anakinra is combined with Baricitinib.,Baricitinib,DB00026
DB11921,The risk or severity of adverse effects can be increased when Anakinra is combined with Deflazacort.,Deflazacort,DB00026
DB13208,The risk or severity of adverse effects can be increased when Anakinra is combined with Prednylidene.,Prednylidene,DB00026
DB14066,The risk or severity of adverse effects can be increased when Anakinra is combined with Tetrandrine.,Tetrandrine,DB00026
DB14512,The risk or severity of adverse effects can be increased when Anakinra is combined with Mometasone furoate.,Mometasone furoate,DB00026
DB14545,The risk or severity of adverse effects can be increased when Anakinra is combined with Hydrocortisone succinate.,Hydrocortisone succinate,DB00026
DB01222,The risk or severity of adverse effects can be increased when Anakinra is combined with Budesonide.,Budesonide,DB00026
DB01394,The risk or severity of adverse effects can be increased when Anakinra is combined with Colchicine.,Colchicine,DB00026
DB00108,The risk or severity of adverse effects can be increased when Anakinra is combined with Natalizumab.,Natalizumab,DB00026
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Anakinra.,Pimecrolimus,DB00026
DB01656,Anakinra may increase the immunosuppressive activities of Roflumilast.,Roflumilast,DB00026
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Anakinra.,Sipuleucel-T,DB00026
DB01281,The risk or severity of adverse effects can be increased when Anakinra is combined with Abatacept.,Abatacept,DB00026
DB06168,Anakinra may increase the immunosuppressive activities of Canakinumab.,Canakinumab,DB00026
DB08895,The risk or severity of adverse effects can be increased when Anakinra is combined with Tofacitinib.,Tofacitinib,DB00026
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Anakinra.,Sulfamethoxazole,DB00026
DB01097,The risk or severity of adverse effects can be increased when Anakinra is combined with Leflunomide.,Leflunomide,DB00026
DB00072,Trastuzumab may increase the neutropenic activities of Anakinra.,Trastuzumab,DB00026
DB08868,Anakinra may increase the immunosuppressive activities of Fingolimod.,Fingolimod,DB00026
DB00864,Tacrolimus may increase the immunosuppressive activities of Anakinra.,Tacrolimus,DB00026
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Anakinra.,G17DT,DB00026
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Anakinra.,PEV3A,DB00026
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Anakinra.,INGN 225,DB00026
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Anakinra.,Rindopepimut,DB00026
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Anakinra.,SRP 299,DB00026
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Anakinra.,GI-5005,DB00026
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Anakinra.,Vitespen,DB00026
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Anakinra.,TG4010,DB00026
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Anakinra.,Anthrax immune globulin human,DB00026
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Anakinra.","Rabies virus inactivated antigen, B",DB00026
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Anakinra.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen,DB00026
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Anakinra.,Rotavirus vaccine,DB00026
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Anakinra.","Rabies virus inactivated antigen, A",DB00026
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Anakinra.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen,DB00026
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Clostridium tetani toxoid antigen (formaldehyde inactivated),DB00026
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated),DB00026
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated),DB00026
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),DB00026
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated),DB00026
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Anakinra.,Typhoid Vi polysaccharide vaccine,DB00026
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Anakinra.,Hepatitis A Vaccine,DB00026
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Anakinra.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,DB00026
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated),DB00026
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated),DB00026
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated),DB00026
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated),DB00026
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Anakinra.,Human rabies virus immune globulin,DB00026
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Anakinra.,Hepatitis B Vaccine (Recombinant),DB00026
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Anakinra.,Tecemotide,DB00026
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Anakinra.,Typhoid vaccine,DB00026
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated),DB00026
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated),DB00026
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Anakinra.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen,DB00026
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated),DB00026
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Anakinra.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen,DB00026
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated),DB00026
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated),DB00026
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Anakinra.,Vaccinia virus strain new york city board of health live antigen,DB00026
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Anakinra.,Pertussis vaccine,DB00026
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Yersinia pestis 195/p antigen (formaldehyde inactivated),DB00026
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Anakinra.,Varicella Zoster Vaccine (Recombinant),DB00026
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Anakinra.,Modified vaccinia ankara,DB00026
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Anakinra.","Ebola Zaire vaccine (live, attenuated)",DB00026
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Anakinra.,Rubella virus vaccine,DB00026
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Anakinra.,Varicella Zoster Vaccine (Live/attenuated),DB00026
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Anakinra.,Bacillus calmette-guerin substrain tice live antigen,DB00026
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Anakinra.,Bacillus calmette-guerin substrain connaught live antigen,DB00026
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Anakinra.,Yellow Fever Vaccine,DB00026
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Anakinra.,Anthrax vaccine,DB00026
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Anakinra.,Typhoid Vaccine Live,DB00026
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Anakinra.,Bacillus calmette-guerin substrain danish 1331 live antigen,DB00026
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Anakinra.,BCG vaccine,DB00026
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Anakinra.,Human adenovirus e serotype 4 strain cl-68578 antigen,DB00026
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Anakinra.,Vibrio cholerae CVD 103-HgR strain live antigen,DB00026
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Anakinra.,Adenovirus type 7 vaccine live,DB00026
DB00201,The metabolism of Caffeine can be increased when combined with Anakinra.,Caffeine,DB00026
DB00176,The metabolism of Fluvoxamine can be increased when combined with Anakinra.,Fluvoxamine,DB00026
DB00195,The metabolism of Betaxolol can be increased when combined with Anakinra.,Betaxolol,DB00026
DB00261,The metabolism of Anagrelide can be increased when combined with Anakinra.,Anagrelide,DB00026
DB00262,The metabolism of Carmustine can be increased when combined with Anakinra.,Carmustine,DB00026
DB00268,The metabolism of Ropinirole can be increased when combined with Anakinra.,Ropinirole,DB00026
DB00280,The metabolism of Disopyramide can be increased when combined with Anakinra.,Disopyramide,DB00026
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Anakinra.,Conjugated estrogens,DB00026
DB00296,The metabolism of Ropivacaine can be increased when combined with Anakinra.,Ropivacaine,DB00026
DB00315,The metabolism of Zolmitriptan can be increased when combined with Anakinra.,Zolmitriptan,DB00026
DB00316,The metabolism of Acetaminophen can be increased when combined with Anakinra.,Acetaminophen,DB00026
DB00334,The metabolism of Olanzapine can be increased when combined with Anakinra.,Olanzapine,DB00026
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Anakinra.,Chlorzoxazone,DB00026
DB00365,The metabolism of Grepafloxacin can be increased when combined with Anakinra.,Grepafloxacin,DB00026
DB00370,The metabolism of Mirtazapine can be increased when combined with Anakinra.,Mirtazapine,DB00026
DB00379,The metabolism of Mexiletine can be increased when combined with Anakinra.,Mexiletine,DB00026
DB00382,The metabolism of Tacrine can be increased when combined with Anakinra.,Tacrine,DB00026
DB00384,The metabolism of Triamterene can be increased when combined with Anakinra.,Triamterene,DB00026
DB00442,The metabolism of Entecavir can be increased when combined with Anakinra.,Entecavir,DB00026
DB00477,The metabolism of Chlorpromazine can be increased when combined with Anakinra.,Chlorpromazine,DB00026
DB00518,The metabolism of Albendazole can be increased when combined with Anakinra.,Albendazole,DB00026
DB00544,The metabolism of Fluorouracil can be increased when combined with Anakinra.,Fluorouracil,DB00026
DB00629,The metabolism of Guanabenz can be increased when combined with Anakinra.,Guanabenz,DB00026
DB00642,The metabolism of Pemetrexed can be increased when combined with Anakinra.,Pemetrexed,DB00026
DB00730,The metabolism of Thiabendazole can be increased when combined with Anakinra.,Thiabendazole,DB00026
DB00740,The metabolism of Riluzole can be increased when combined with Anakinra.,Riluzole,DB00026
DB00787,The metabolism of Acyclovir can be increased when combined with Anakinra.,Acyclovir,DB00026
DB00806,The metabolism of Pentoxifylline can be increased when combined with Anakinra.,Pentoxifylline,DB00026
DB00831,The metabolism of Trifluoperazine can be increased when combined with Anakinra.,Trifluoperazine,DB00026
DB00863,The metabolism of Ranitidine can be increased when combined with Anakinra.,Ranitidine,DB00026
DB00898,The metabolism of Ethanol can be increased when combined with Anakinra.,Ethanol,DB00026
DB00934,The metabolism of Maprotiline can be increased when combined with Anakinra.,Maprotiline,DB00026
DB00978,The metabolism of Lomefloxacin can be increased when combined with Anakinra.,Lomefloxacin,DB00026
DB00993,The metabolism of Azathioprine can be increased when combined with Anakinra.,Azathioprine,DB00026
DB00998,The metabolism of Frovatriptan can be increased when combined with Anakinra.,Frovatriptan,DB00026
DB01002,The metabolism of Levobupivacaine can be increased when combined with Anakinra.,Levobupivacaine,DB00026
DB01012,The metabolism of Cinacalcet can be increased when combined with Anakinra.,Cinacalcet,DB00026
DB01056,The metabolism of Tocainide can be increased when combined with Anakinra.,Tocainide,DB00026
DB01087,The metabolism of Primaquine can be increased when combined with Anakinra.,Primaquine,DB00026
DB01094,The metabolism of Hesperetin can be increased when combined with Anakinra.,Hesperetin,DB00026
DB01182,The metabolism of Propafenone can be increased when combined with Anakinra.,Propafenone,DB00026
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Anakinra.,Dexfenfluramine,DB00026
DB01303,The metabolism of Oxtriphylline can be increased when combined with Anakinra.,Oxtriphylline,DB00026
DB01367,The metabolism of Rasagiline can be increased when combined with Anakinra.,Rasagiline,DB00026
DB01405,The metabolism of Temafloxacin can be increased when combined with Anakinra.,Temafloxacin,DB00026
DB01412,The metabolism of Theobromine can be increased when combined with Anakinra.,Theobromine,DB00026
DB01482,The metabolism of Fenethylline can be increased when combined with Anakinra.,Fenethylline,DB00026
DB01558,The metabolism of Bromazepam can be increased when combined with Anakinra.,Bromazepam,DB00026
DB01623,The metabolism of Thiothixene can be increased when combined with Anakinra.,Thiothixene,DB00026
DB01645,The metabolism of Genistein can be increased when combined with Anakinra.,Genistein,DB00026
DB01667,The metabolism of 8-azaguanine can be increased when combined with Anakinra.,8-azaguanine,DB00026
DB02134,The metabolism of Xanthine can be increased when combined with Anakinra.,Xanthine,DB00026
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Anakinra.,9-Methylguanine,DB00026
DB02568,The metabolism of Peldesine can be increased when combined with Anakinra.,Peldesine,DB00026
DB02709,The metabolism of Resveratrol can be increased when combined with Anakinra.,Resveratrol,DB00026
DB04076,The metabolism of Hypoxanthine can be increased when combined with Anakinra.,Hypoxanthine,DB00026
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Anakinra.,9-Deazaguanine,DB00026
DB04871,The metabolism of Lorcaserin can be increased when combined with Anakinra.,Lorcaserin,DB00026
DB04948,The metabolism of Lofexidine can be increased when combined with Anakinra.,Lofexidine,DB00026
DB04951,The metabolism of Pirfenidone can be increased when combined with Anakinra.,Pirfenidone,DB00026
DB06148,The metabolism of Mianserin can be increased when combined with Anakinra.,Mianserin,DB00026
DB06210,The metabolism of Eltrombopag can be increased when combined with Anakinra.,Eltrombopag,DB00026
DB06216,The metabolism of Asenapine can be increased when combined with Anakinra.,Asenapine,DB00026
DB06235,The metabolism of Vadimezan can be increased when combined with Anakinra.,Vadimezan,DB00026
DB06479,The metabolism of Propentofylline can be increased when combined with Anakinra.,Propentofylline,DB00026
DB06594,The metabolism of Agomelatine can be increased when combined with Anakinra.,Agomelatine,DB00026
DB06769,The metabolism of Bendamustine can be increased when combined with Anakinra.,Bendamustine,DB00026
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Anakinra.,Benzyl alcohol,DB00026
DB06774,The metabolism of Capsaicin can be increased when combined with Anakinra.,Capsaicin,DB00026
DB08496,The metabolism of (R)-warfarin can be increased when combined with Anakinra.,(R)-warfarin,DB00026
DB09071,The metabolism of Tasimelteon can be increased when combined with Anakinra.,Tasimelteon,DB00026
DB09118,The metabolism of Stiripentol can be increased when combined with Anakinra.,Stiripentol,DB00026
DB09225,The metabolism of Zotepine can be increased when combined with Anakinra.,Zotepine,DB00026
DB09273,The metabolism of Doxofylline can be increased when combined with Anakinra.,Doxofylline,DB00026
DB09290,The metabolism of Ramosetron can be increased when combined with Anakinra.,Ramosetron,DB00026
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Anakinra.,6-O-benzylguanine,DB00026
DB11967,The metabolism of Binimetinib can be increased when combined with Anakinra.,Binimetinib,DB00026
DB12026,The metabolism of Voxilaprevir can be increased when combined with Anakinra.,Voxilaprevir,DB00026
DB12245,The metabolism of Triclabendazole can be increased when combined with Anakinra.,Triclabendazole,DB00026
DB12332,The metabolism of Rucaparib can be increased when combined with Anakinra.,Rucaparib,DB00026
DB12406,The metabolism of Lisofylline can be increased when combined with Anakinra.,Lisofylline,DB00026
DB12531,The metabolism of Lobucavir can be increased when combined with Anakinra.,Lobucavir,DB00026
DB12926,The metabolism of Cafedrine can be increased when combined with Anakinra.,Cafedrine,DB00026
DB12927,The metabolism of Theodrenaline can be increased when combined with Anakinra.,Theodrenaline,DB00026
DB12945,The metabolism of Dihydralazine can be increased when combined with Anakinra.,Dihydralazine,DB00026
DB13203,The metabolism of Bamifylline can be increased when combined with Anakinra.,Bamifylline,DB00026
DB13449,The metabolism of Proxyphylline can be increased when combined with Anakinra.,Proxyphylline,DB00026
DB13573,The metabolism of Acefylline can be increased when combined with Anakinra.,Acefylline,DB00026
DB13592,The metabolism of Etamiphylline can be increased when combined with Anakinra.,Etamiphylline,DB00026
DB13634,The metabolism of Pentifylline can be increased when combined with Anakinra.,Pentifylline,DB00026
DB13812,The metabolism of Bufylline can be increased when combined with Anakinra.,Bufylline,DB00026
DB14018,The metabolism of Bromotheophylline can be increased when combined with Anakinra.,Bromotheophylline,DB00026
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Anakinra.,8-chlorotheophylline,DB00026
DB11757,The metabolism of Istradefylline can be increased when combined with Anakinra.,Istradefylline,DB00026
DB04889,The metabolism of Bicifadine can be increased when combined with Anakinra.,Bicifadine,DB00026
DB05708,The metabolism of GTS-21 can be increased when combined with Anakinra.,GTS-21,DB00026
DB00977,The metabolism of Ethinylestradiol can be increased when combined with Anakinra.,Ethinylestradiol,DB00026
DB00425,The metabolism of Zolpidem can be increased when combined with Anakinra.,Zolpidem,DB00026
DB00458,The metabolism of Imipramine can be increased when combined with Anakinra.,Imipramine,DB00026
DB00532,The metabolism of Mephenytoin can be increased when combined with Anakinra.,Mephenytoin,DB00026
DB00540,The metabolism of Nortriptyline can be increased when combined with Anakinra.,Nortriptyline,DB00026
DB00575,The metabolism of Clonidine can be increased when combined with Anakinra.,Clonidine,DB00026
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Anakinra.,Cyclobenzaprine,DB00026
DB01242,The metabolism of Clomipramine can be increased when combined with Anakinra.,Clomipramine,DB00026
DB11689,The metabolism of Selumetinib can be increased when combined with Anakinra.,Selumetinib,DB00026
DB00277,The metabolism of Theophylline can be increased when combined with Anakinra.,Theophylline,DB00026
DB00564,The metabolism of Carbamazepine can be increased when combined with Anakinra.,Carbamazepine,DB00026
DB00682,The metabolism of Warfarin can be increased when combined with Anakinra.,Warfarin,DB00026
DB00697,The metabolism of Tizanidine can be increased when combined with Anakinra.,Tizanidine,DB00026
DB01100,The metabolism of Pimozide can be increased when combined with Anakinra.,Pimozide,DB00026
DB01223,The metabolism of Aminophylline can be increased when combined with Anakinra.,Aminophylline,DB00026
DB01418,The metabolism of Acenocoumarol can be increased when combined with Anakinra.,Acenocoumarol,DB00026
DB09256,The metabolism of Tegafur can be increased when combined with Anakinra.,Tegafur,DB00026
DB00851,The metabolism of Dacarbazine can be increased when combined with Anakinra.,Dacarbazine,DB00026
DB08910,The metabolism of Pomalidomide can be increased when combined with Anakinra.,Pomalidomide,DB00026
DB00238,The metabolism of Nevirapine can be increased when combined with Anakinra.,Nevirapine,DB00026
DB00471,The metabolism of Montelukast can be increased when combined with Anakinra.,Montelukast,DB00026
DB00690,The metabolism of Flurazepam can be increased when combined with Anakinra.,Flurazepam,DB00026
DB00916,The metabolism of Metronidazole can be increased when combined with Anakinra.,Metronidazole,DB00026
DB00983,The metabolism of Formoterol can be increased when combined with Anakinra.,Formoterol,DB00026
DB01006,The metabolism of Letrozole can be increased when combined with Anakinra.,Letrozole,DB00026
DB01028,The metabolism of Methoxyflurane can be increased when combined with Anakinra.,Methoxyflurane,DB00026
DB01159,The metabolism of Halothane can be increased when combined with Anakinra.,Halothane,DB00026
DB01236,The metabolism of Sevoflurane can be increased when combined with Anakinra.,Sevoflurane,DB00026
DB01274,The metabolism of Arformoterol can be increased when combined with Anakinra.,Arformoterol,DB00026
DB01544,The metabolism of Flunitrazepam can be increased when combined with Anakinra.,Flunitrazepam,DB00026
DB06292,The metabolism of Dapagliflozin can be increased when combined with Anakinra.,Dapagliflozin,DB00026
DB06470,The metabolism of Clomethiazole can be increased when combined with Anakinra.,Clomethiazole,DB00026
DB09068,The metabolism of Vortioxetine can be increased when combined with Anakinra.,Vortioxetine,DB00026
DB09327,The metabolism of Tegafur-uracil can be increased when combined with Anakinra.,Tegafur-uracil,DB00026
DB11586,The metabolism of Asunaprevir can be increased when combined with Anakinra.,Asunaprevir,DB00026
DB04977,The metabolism of Plitidepsin can be increased when combined with Anakinra.,Plitidepsin,DB00026
DB06119,The metabolism of Cenobamate can be increased when combined with Anakinra.,Cenobamate,DB00026
DB00193,The metabolism of Tramadol can be increased when combined with Anakinra.,Tramadol,DB00026
DB00333,The metabolism of Methadone can be increased when combined with Anakinra.,Methadone,DB00026
DB00349,The metabolism of Clobazam can be increased when combined with Anakinra.,Clobazam,DB00026
DB00625,The metabolism of Efavirenz can be increased when combined with Anakinra.,Efavirenz,DB00026
DB00753,The metabolism of Isoflurane can be increased when combined with Anakinra.,Isoflurane,DB00026
DB00818,The metabolism of Propofol can be increased when combined with Anakinra.,Propofol,DB00026
DB00835,The metabolism of Brompheniramine can be increased when combined with Anakinra.,Brompheniramine,DB00026
DB00836,The metabolism of Loperamide can be increased when combined with Anakinra.,Loperamide,DB00026
DB00849,The metabolism of Methylphenobarbital can be increased when combined with Anakinra.,Methylphenobarbital,DB00026
DB00865,The metabolism of Benzphetamine can be increased when combined with Anakinra.,Benzphetamine,DB00026
DB01069,The metabolism of Promethazine can be increased when combined with Anakinra.,Promethazine,DB00026
DB01074,The metabolism of Perhexiline can be increased when combined with Anakinra.,Perhexiline,DB00026
DB01221,The metabolism of Ketamine can be increased when combined with Anakinra.,Ketamine,DB00026
DB01466,The metabolism of Ethylmorphine can be increased when combined with Anakinra.,Ethylmorphine,DB00026
DB01559,The metabolism of Clotiazepam can be increased when combined with Anakinra.,Clotiazepam,DB00026
DB04938,The metabolism of Ospemifene can be increased when combined with Anakinra.,Ospemifene,DB00026
DB04975,The metabolism of Banoxantrone can be increased when combined with Anakinra.,Banoxantrone,DB00026
DB05541,The metabolism of Brivaracetam can be increased when combined with Anakinra.,Brivaracetam,DB00026
DB06176,The metabolism of Romidepsin can be increased when combined with Anakinra.,Romidepsin,DB00026
DB06209,The metabolism of Prasugrel can be increased when combined with Anakinra.,Prasugrel,DB00026
DB06697,The metabolism of Artemether can be increased when combined with Anakinra.,Artemether,DB00026
DB06710,The metabolism of Methyltestosterone can be increased when combined with Anakinra.,Methyltestosterone,DB00026
DB06738,The metabolism of Ketobemidone can be increased when combined with Anakinra.,Ketobemidone,DB00026
DB06739,The metabolism of Seratrodast can be increased when combined with Anakinra.,Seratrodast,DB00026
DB11613,The metabolism of Velpatasvir can be increased when combined with Anakinra.,Velpatasvir,DB00026
DB13132,The metabolism of Artemisinin can be increased when combined with Anakinra.,Artemisinin,DB00026
DB13943,The metabolism of Testosterone cypionate can be increased when combined with Anakinra.,Testosterone cypionate,DB00026
DB13944,The metabolism of Testosterone enanthate can be increased when combined with Anakinra.,Testosterone enanthate,DB00026
DB13946,The metabolism of Testosterone undecanoate can be increased when combined with Anakinra.,Testosterone undecanoate,DB00026
DB01156,The metabolism of Bupropion can be increased when combined with Anakinra.,Bupropion,DB00026
DB00956,The metabolism of Hydrocodone can be increased when combined with Anakinra.,Hydrocodone,DB00026
DB14975,The metabolism of Voxelotor can be increased when combined with Anakinra.,Voxelotor,DB00026
DB11837,The metabolism of Osilodrostat can be increased when combined with Anakinra.,Osilodrostat,DB00026
DB13384,The metabolism of Melitracen can be increased when combined with Anakinra.,Melitracen,DB00026
DB13411,The metabolism of Lofepramine can be increased when combined with Anakinra.,Lofepramine,DB00026
DB00714,The metabolism of Apomorphine can be increased when combined with Anakinra.,Apomorphine,DB00026
DB09167,The metabolism of Dosulepin can be increased when combined with Anakinra.,Dosulepin,DB00026
DB00213,The metabolism of Pantoprazole can be increased when combined with Anakinra.,Pantoprazole,DB00026
DB00215,The metabolism of Citalopram can be increased when combined with Anakinra.,Citalopram,DB00026
DB00312,The metabolism of Pentobarbital can be increased when combined with Anakinra.,Pentobarbital,DB00026
DB00338,The metabolism of Omeprazole can be increased when combined with Anakinra.,Omeprazole,DB00026
DB00347,The metabolism of Trimethadione can be increased when combined with Anakinra.,Trimethadione,DB00026
DB00395,The metabolism of Carisoprodol can be increased when combined with Anakinra.,Carisoprodol,DB00026
DB00448,The metabolism of Lansoprazole can be increased when combined with Anakinra.,Lansoprazole,DB00026
DB00474,The metabolism of Methohexital can be increased when combined with Anakinra.,Methohexital,DB00026
DB00582,The metabolism of Voriconazole can be increased when combined with Anakinra.,Voriconazole,DB00026
DB00679,The metabolism of Thioridazine can be increased when combined with Anakinra.,Thioridazine,DB00026
DB00736,The metabolism of Esomeprazole can be increased when combined with Anakinra.,Esomeprazole,DB00026
DB00794,The metabolism of Primidone can be increased when combined with Anakinra.,Primidone,DB00026
DB00909,The metabolism of Zonisamide can be increased when combined with Anakinra.,Zonisamide,DB00026
DB01129,The metabolism of Rabeprazole can be increased when combined with Anakinra.,Rabeprazole,DB00026
DB01131,The metabolism of Proguanil can be increased when combined with Anakinra.,Proguanil,DB00026
DB01175,The metabolism of Escitalopram can be increased when combined with Anakinra.,Escitalopram,DB00026
DB01259,The metabolism of Lapatinib can be increased when combined with Anakinra.,Lapatinib,DB00026
DB01323,The metabolism of St. John's Wort can be increased when combined with Anakinra.,St. John's Wort,DB00026
DB01355,The metabolism of Hexobarbital can be increased when combined with Anakinra.,Hexobarbital,DB00026
DB01483,The metabolism of Barbital can be increased when combined with Anakinra.,Barbital,DB00026
DB05246,The metabolism of Methsuximide can be increased when combined with Anakinra.,Methsuximide,DB00026
DB05351,The metabolism of Dexlansoprazole can be increased when combined with Anakinra.,Dexlansoprazole,DB00026
DB06218,The metabolism of Lacosamide can be increased when combined with Anakinra.,Lacosamide,DB00026
DB06414,The metabolism of Etravirine can be increased when combined with Anakinra.,Etravirine,DB00026
DB06605,The metabolism of Apixaban can be increased when combined with Anakinra.,Apixaban,DB00026
DB09166,The metabolism of Etizolam can be increased when combined with Anakinra.,Etizolam,DB00026
DB12130,The metabolism of Lorlatinib can be increased when combined with Anakinra.,Lorlatinib,DB00026
DB12474,The metabolism of Lynestrenol can be increased when combined with Anakinra.,Lynestrenol,DB00026
DB13762,The metabolism of Dexrabeprazole can be increased when combined with Anakinra.,Dexrabeprazole,DB00026
DB14055,The metabolism of (S)-Warfarin can be increased when combined with Anakinra.,(S)-Warfarin,DB00026
DB00715,The metabolism of Paroxetine can be increased when combined with Anakinra.,Paroxetine,DB00026
DB12500,The metabolism of Fedratinib can be increased when combined with Anakinra.,Fedratinib,DB00026
DB04861,The metabolism of Nebivolol can be increased when combined with Anakinra.,Nebivolol,DB00026
DB06684,The metabolism of Vilazodone can be increased when combined with Anakinra.,Vilazodone,DB00026
DB01104,The metabolism of Sertraline can be increased when combined with Anakinra.,Sertraline,DB00026
DB11823,The metabolism of Esketamine can be increased when combined with Anakinra.,Esketamine,DB00026
DB00252,The metabolism of Phenytoin can be increased when combined with Anakinra.,Phenytoin,DB00026
DB00599,The metabolism of Thiopental can be increased when combined with Anakinra.,Thiopental,DB00026
DB01174,The metabolism of Phenobarbital can be increased when combined with Anakinra.,Phenobarbital,DB00026
DB01320,The metabolism of Fosphenytoin can be increased when combined with Anakinra.,Fosphenytoin,DB00026
DB00613,The metabolism of Amodiaquine can be increased when combined with Anakinra.,Amodiaquine,DB00026
DB00799,The metabolism of Tazarotene can be increased when combined with Anakinra.,Tazarotene,DB00026
DB05229,The metabolism of Beraprost can be increased when combined with Anakinra.,Beraprost,DB00026
DB06510,The metabolism of Muraglitazar can be increased when combined with Anakinra.,Muraglitazar,DB00026
DB09296,The metabolism of Ombitasvir can be increased when combined with Anakinra.,Ombitasvir,DB00026
DB01217,The metabolism of Anastrozole can be increased when combined with Anakinra.,Anastrozole,DB00026
DB00255,The metabolism of Diethylstilbestrol can be increased when combined with Anakinra.,Diethylstilbestrol,DB00026
DB00295,The metabolism of Morphine can be increased when combined with Anakinra.,Morphine,DB00026
DB00359,The metabolism of Sulfadiazine can be increased when combined with Anakinra.,Sulfadiazine,DB00026
DB00402,The metabolism of Eszopiclone can be increased when combined with Anakinra.,Eszopiclone,DB00026
DB00622,The metabolism of Nicardipine can be increased when combined with Anakinra.,Nicardipine,DB00026
DB00912,The metabolism of Repaglinide can be increased when combined with Anakinra.,Repaglinide,DB00026
DB01261,The metabolism of Sitagliptin can be increased when combined with Anakinra.,Sitagliptin,DB00026
DB06670,The metabolism of Odanacatib can be increased when combined with Anakinra.,Odanacatib,DB00026
DB08502,The metabolism of Capravirine can be increased when combined with Anakinra.,Capravirine,DB00026
DB08931,The metabolism of Riociguat can be increased when combined with Anakinra.,Riociguat,DB00026
DB09198,The metabolism of Lobeglitazone can be increased when combined with Anakinra.,Lobeglitazone,DB00026
DB09199,The metabolism of Netoglitazone can be increased when combined with Anakinra.,Netoglitazone,DB00026
DB09200,The metabolism of Rivoglitazone can be increased when combined with Anakinra.,Rivoglitazone,DB00026
DB09201,The metabolism of Ciglitazone can be increased when combined with Anakinra.,Ciglitazone,DB00026
DB11362,The metabolism of Selexipag can be increased when combined with Anakinra.,Selexipag,DB00026
DB11901,The metabolism of Apalutamide can be increased when combined with Anakinra.,Apalutamide,DB00026
DB11978,The metabolism of Glasdegib can be increased when combined with Anakinra.,Glasdegib,DB00026
DB12781,The metabolism of Balaglitazone can be increased when combined with Anakinra.,Balaglitazone,DB00026
DB01132,The metabolism of Pioglitazone can be increased when combined with Anakinra.,Pioglitazone,DB00026
DB11652,The metabolism of Tucatinib can be increased when combined with Anakinra.,Tucatinib,DB00026
DB00946,The metabolism of Phenprocoumon can be increased when combined with Anakinra.,Phenprocoumon,DB00026
DB01229,The metabolism of Paclitaxel can be increased when combined with Anakinra.,Paclitaxel,DB00026
DB00177,The metabolism of Valsartan can be increased when combined with Anakinra.,Valsartan,DB00026
DB00184,The metabolism of Nicotine can be increased when combined with Anakinra.,Nicotine,DB00026
DB00197,The metabolism of Troglitazone can be increased when combined with Anakinra.,Troglitazone,DB00026
DB00214,The metabolism of Torasemide can be increased when combined with Anakinra.,Torasemide,DB00026
DB00222,The metabolism of Glimepiride can be increased when combined with Anakinra.,Glimepiride,DB00026
DB00285,The metabolism of Venlafaxine can be increased when combined with Anakinra.,Venlafaxine,DB00026
DB00304,The metabolism of Desogestrel can be increased when combined with Anakinra.,Desogestrel,DB00026
DB00307,The metabolism of Bexarotene can be increased when combined with Anakinra.,Bexarotene,DB00026
DB00327,The metabolism of Hydromorphone can be increased when combined with Anakinra.,Hydromorphone,DB00026
DB00328,The metabolism of Indomethacin can be increased when combined with Anakinra.,Indomethacin,DB00026
DB00343,The metabolism of Diltiazem can be increased when combined with Anakinra.,Diltiazem,DB00026
DB00374,The metabolism of Treprostinil can be increased when combined with Anakinra.,Treprostinil,DB00026
DB00412,The metabolism of Rosiglitazone can be increased when combined with Anakinra.,Rosiglitazone,DB00026
DB00414,The metabolism of Acetohexamide can be increased when combined with Anakinra.,Acetohexamide,DB00026
DB00420,The metabolism of Promazine can be increased when combined with Anakinra.,Promazine,DB00026
DB00440,The metabolism of Trimethoprim can be increased when combined with Anakinra.,Trimethoprim,DB00026
DB00461,The metabolism of Nabumetone can be increased when combined with Anakinra.,Nabumetone,DB00026
DB00468,The metabolism of Quinine can be increased when combined with Anakinra.,Quinine,DB00026
DB00469,The metabolism of Tenoxicam can be increased when combined with Anakinra.,Tenoxicam,DB00026
DB00472,The metabolism of Fluoxetine can be increased when combined with Anakinra.,Fluoxetine,DB00026
DB00476,The metabolism of Duloxetine can be increased when combined with Anakinra.,Duloxetine,DB00026
DB00482,The metabolism of Celecoxib can be increased when combined with Anakinra.,Celecoxib,DB00026
DB00495,The metabolism of Zidovudine can be increased when combined with Anakinra.,Zidovudine,DB00026
DB00502,The metabolism of Haloperidol can be increased when combined with Anakinra.,Haloperidol,DB00026
DB00531,The metabolism of Cyclophosphamide can be increased when combined with Anakinra.,Cyclophosphamide,DB00026
DB00533,The metabolism of Rofecoxib can be increased when combined with Anakinra.,Rofecoxib,DB00026
DB00549,The metabolism of Zafirlukast can be increased when combined with Anakinra.,Zafirlukast,DB00026
DB00554,The metabolism of Piroxicam can be increased when combined with Anakinra.,Piroxicam,DB00026
DB00559,The metabolism of Bosentan can be increased when combined with Anakinra.,Bosentan,DB00026
DB00568,The metabolism of Cinnarizine can be increased when combined with Anakinra.,Cinnarizine,DB00026
DB00580,The metabolism of Valdecoxib can be increased when combined with Anakinra.,Valdecoxib,DB00026
DB00586,The metabolism of Diclofenac can be increased when combined with Anakinra.,Diclofenac,DB00026
DB00617,The metabolism of Paramethadione can be increased when combined with Anakinra.,Paramethadione,DB00026
DB00661,The metabolism of Verapamil can be increased when combined with Anakinra.,Verapamil,DB00026
DB00672,The metabolism of Chlorpropamide can be increased when combined with Anakinra.,Chlorpropamide,DB00026
DB00678,The metabolism of Losartan can be increased when combined with Anakinra.,Losartan,DB00026
DB00701,The metabolism of Amprenavir can be increased when combined with Anakinra.,Amprenavir,DB00026
DB00712,The metabolism of Flurbiprofen can be increased when combined with Anakinra.,Flurbiprofen,DB00026
DB00731,The metabolism of Nateglinide can be increased when combined with Anakinra.,Nateglinide,DB00026
DB00744,The metabolism of Zileuton can be increased when combined with Anakinra.,Zileuton,DB00026
DB00749,The metabolism of Etodolac can be increased when combined with Anakinra.,Etodolac,DB00026
DB00755,The metabolism of Tretinoin can be increased when combined with Anakinra.,Tretinoin,DB00026
DB00758,The metabolism of Clopidogrel can be increased when combined with Anakinra.,Clopidogrel,DB00026
DB00783,The metabolism of Estradiol can be increased when combined with Anakinra.,Estradiol,DB00026
DB00784,The metabolism of Mefenamic acid can be increased when combined with Anakinra.,Mefenamic acid,DB00026
DB00788,The metabolism of Naproxen can be increased when combined with Anakinra.,Naproxen,DB00026
DB00796,The metabolism of Candesartan cilexetil can be increased when combined with Anakinra.,Candesartan cilexetil,DB00026
DB00812,The metabolism of Phenylbutazone can be increased when combined with Anakinra.,Phenylbutazone,DB00026
DB00814,The metabolism of Meloxicam can be increased when combined with Anakinra.,Meloxicam,DB00026
DB00839,The metabolism of Tolazamide can be increased when combined with Anakinra.,Tolazamide,DB00026
DB00843,The metabolism of Donepezil can be increased when combined with Anakinra.,Donepezil,DB00026
DB00857,The metabolism of Terbinafine can be increased when combined with Anakinra.,Terbinafine,DB00026
DB00904,The metabolism of Ondansetron can be increased when combined with Anakinra.,Ondansetron,DB00026
DB00921,The metabolism of Buprenorphine can be increased when combined with Anakinra.,Buprenorphine,DB00026
DB00936,The metabolism of Salicylic acid can be increased when combined with Anakinra.,Salicylic acid,DB00026
DB00945,The metabolism of Acetylsalicylic acid can be increased when combined with Anakinra.,Acetylsalicylic acid,DB00026
DB00969,The metabolism of Alosetron can be increased when combined with Anakinra.,Alosetron,DB00026
DB00972,The metabolism of Azelastine can be increased when combined with Anakinra.,Azelastine,DB00026
DB00980,The metabolism of Ramelteon can be increased when combined with Anakinra.,Ramelteon,DB00026
DB01016,The metabolism of Glyburide can be increased when combined with Anakinra.,Glyburide,DB00026
DB01029,The metabolism of Irbesartan can be increased when combined with Anakinra.,Irbesartan,DB00026
DB01036,The metabolism of Tolterodine can be increased when combined with Anakinra.,Tolterodine,DB00026
DB01037,The metabolism of Selegiline can be increased when combined with Anakinra.,Selegiline,DB00026
DB01041,The metabolism of Thalidomide can be increased when combined with Anakinra.,Thalidomide,DB00026
DB01050,The metabolism of Ibuprofen can be increased when combined with Anakinra.,Ibuprofen,DB00026
DB01065,The metabolism of Melatonin can be increased when combined with Anakinra.,Melatonin,DB00026
DB01067,The metabolism of Glipizide can be increased when combined with Anakinra.,Glipizide,DB00026
DB01072,The metabolism of Atazanavir can be increased when combined with Anakinra.,Atazanavir,DB00026
DB01075,The metabolism of Diphenhydramine can be increased when combined with Anakinra.,Diphenhydramine,DB00026
DB01095,The metabolism of Fluvastatin can be increased when combined with Anakinra.,Fluvastatin,DB00026
DB01098,The metabolism of Rosuvastatin can be increased when combined with Anakinra.,Rosuvastatin,DB00026
DB01120,The metabolism of Gliclazide can be increased when combined with Anakinra.,Gliclazide,DB00026
DB01124,The metabolism of Tolbutamide can be increased when combined with Anakinra.,Tolbutamide,DB00026
DB01136,The metabolism of Carvedilol can be increased when combined with Anakinra.,Carvedilol,DB00026
DB01154,The metabolism of Thiamylal can be increased when combined with Anakinra.,Thiamylal,DB00026
DB01171,The metabolism of Moclobemide can be increased when combined with Anakinra.,Moclobemide,DB00026
DB01177,The metabolism of Idarubicin can be increased when combined with Anakinra.,Idarubicin,DB00026
DB01198,The metabolism of Zopiclone can be increased when combined with Anakinra.,Zopiclone,DB00026
DB01251,The metabolism of Gliquidone can be increased when combined with Anakinra.,Gliquidone,DB00026
DB01283,The metabolism of Lumiracoxib can be increased when combined with Anakinra.,Lumiracoxib,DB00026
DB01289,The metabolism of Glisoxepide can be increased when combined with Anakinra.,Glisoxepide,DB00026
DB01357,The metabolism of Mestranol can be increased when combined with Anakinra.,Mestranol,DB00026
DB01424,The metabolism of Aminophenazone can be increased when combined with Anakinra.,Aminophenazone,DB00026
DB01435,The metabolism of Antipyrine can be increased when combined with Anakinra.,Antipyrine,DB00026
DB01589,The metabolism of Quazepam can be increased when combined with Anakinra.,Quazepam,DB00026
DB01628,The metabolism of Etoricoxib can be increased when combined with Anakinra.,Etoricoxib,DB00026
DB03756,The metabolism of Doconexent can be increased when combined with Anakinra.,Doconexent,DB00026
DB03783,The metabolism of Phenacetin can be increased when combined with Anakinra.,Phenacetin,DB00026
DB04557,The metabolism of Arachidonic Acid can be increased when combined with Anakinra.,Arachidonic Acid,DB00026
DB04574,The metabolism of Estrone sulfate can be increased when combined with Anakinra.,Estrone sulfate,DB00026
DB04665,The metabolism of Coumarin can be increased when combined with Anakinra.,Coumarin,DB00026
DB04725,The metabolism of Licofelone can be increased when combined with Anakinra.,Licofelone,DB00026
DB04841,The metabolism of Flunarizine can be increased when combined with Anakinra.,Flunarizine,DB00026
DB04898,The metabolism of Ximelagatran can be increased when combined with Anakinra.,Ximelagatran,DB00026
DB06204,The metabolism of Tapentadol can be increased when combined with Anakinra.,Tapentadol,DB00026
DB06268,The metabolism of Sitaxentan can be increased when combined with Anakinra.,Sitaxentan,DB00026
DB06370,The metabolism of Indisulam can be increased when combined with Anakinra.,Indisulam,DB00026
DB06652,The metabolism of Vicriviroc can be increased when combined with Anakinra.,Vicriviroc,DB00026
DB06725,The metabolism of Lornoxicam can be increased when combined with Anakinra.,Lornoxicam,DB00026
DB06737,The metabolism of Zaltoprofen can be increased when combined with Anakinra.,Zaltoprofen,DB00026
DB06803,The metabolism of Niclosamide can be increased when combined with Anakinra.,Niclosamide,DB00026
DB07615,The metabolism of Tranilast can be increased when combined with Anakinra.,Tranilast,DB00026
DB08439,The metabolism of Parecoxib can be increased when combined with Anakinra.,Parecoxib,DB00026
DB08828,The metabolism of Vismodegib can be increased when combined with Anakinra.,Vismodegib,DB00026
DB08860,The metabolism of Pitavastatin can be increased when combined with Anakinra.,Pitavastatin,DB00026
DB08875,The metabolism of Cabozantinib can be increased when combined with Anakinra.,Cabozantinib,DB00026
DB08899,The metabolism of Enzalutamide can be increased when combined with Anakinra.,Enzalutamide,DB00026
DB08962,The metabolism of Glibornuride can be increased when combined with Anakinra.,Glibornuride,DB00026
DB09048,The metabolism of Netupitant can be increased when combined with Anakinra.,Netupitant,DB00026
DB09061,The metabolism of Cannabidiol can be increased when combined with Anakinra.,Cannabidiol,DB00026
DB09080,The metabolism of Olodaterol can be increased when combined with Anakinra.,Olodaterol,DB00026
DB09288,The metabolism of Propacetamol can be increased when combined with Anakinra.,Propacetamol,DB00026
DB11560,The metabolism of Lesinurad can be increased when combined with Anakinra.,Lesinurad,DB00026
DB11614,The metabolism of Rupatadine can be increased when combined with Anakinra.,Rupatadine,DB00026
DB13406,The metabolism of Carbutamide can be increased when combined with Anakinra.,Carbutamide,DB00026
DB13675,The metabolism of Metahexamide can be increased when combined with Anakinra.,Metahexamide,DB00026
DB13919,The metabolism of Candesartan can be increased when combined with Anakinra.,Candesartan,DB00026
DB13941,The metabolism of Piperaquine can be increased when combined with Anakinra.,Piperaquine,DB00026
DB13952,The metabolism of Estradiol acetate can be increased when combined with Anakinra.,Estradiol acetate,DB00026
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Anakinra.,Estradiol benzoate,DB00026
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Anakinra.,Estradiol cypionate,DB00026
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Anakinra.,Estradiol dienanthate,DB00026
DB13956,The metabolism of Estradiol valerate can be increased when combined with Anakinra.,Estradiol valerate,DB00026
DB14009,The metabolism of Medical Cannabis can be increased when combined with Anakinra.,Medical Cannabis,DB00026
DB14011,The metabolism of Nabiximols can be increased when combined with Anakinra.,Nabiximols,DB00026
DB00829,The metabolism of Diazepam can be increased when combined with Anakinra.,Diazepam,DB00026
DB00514,The metabolism of Dextromethorphan can be increased when combined with Anakinra.,Dextromethorphan,DB00026
DB00470,The metabolism of Dronabinol can be increased when combined with Anakinra.,Dronabinol,DB00026
DB09213,The metabolism of Dexibuprofen can be increased when combined with Anakinra.,Dexibuprofen,DB00026
DB00465,The metabolism of Ketorolac can be increased when combined with Anakinra.,Ketorolac,DB00026
DB15233,The metabolism of Avapritinib can be increased when combined with Anakinra.,Avapritinib,DB00026
DB00321,The metabolism of Amitriptyline can be increased when combined with Anakinra.,Amitriptyline,DB00026
DB01142,The metabolism of Doxepin can be increased when combined with Anakinra.,Doxepin,DB00026
DB00216,The metabolism of Eletriptan can be increased when combined with Anakinra.,Eletriptan,DB00026
DB00404,The metabolism of Alprazolam can be increased when combined with Anakinra.,Alprazolam,DB00026
DB00726,The metabolism of Trimipramine can be increased when combined with Anakinra.,Trimipramine,DB00026
DB01101,The metabolism of Capecitabine can be increased when combined with Anakinra.,Capecitabine,DB00026
DB00266,The metabolism of Dicoumarol can be increased when combined with Anakinra.,Dicoumarol,DB00026
DB00313,The metabolism of Valproic acid can be increased when combined with Anakinra.,Valproic acid,DB00026
DB00908,The metabolism of Quinidine can be increased when combined with Anakinra.,Quinidine,DB00026
DB13136,The metabolism of Fluindione can be increased when combined with Anakinra.,Fluindione,DB00026
DB01224,The metabolism of Quetiapine can be increased when combined with Anakinra.,Quetiapine,DB00026
DB00182,The metabolism of Amphetamine can be increased when combined with Anakinra.,Amphetamine,DB00026
DB00187,The metabolism of Esmolol can be increased when combined with Anakinra.,Esmolol,DB00026
DB00245,The metabolism of Benzatropine can be increased when combined with Anakinra.,Benzatropine,DB00026
DB00289,The metabolism of Atomoxetine can be increased when combined with Anakinra.,Atomoxetine,DB00026
DB00335,The metabolism of Atenolol can be increased when combined with Anakinra.,Atenolol,DB00026
DB00373,The metabolism of Timolol can be increased when combined with Anakinra.,Timolol,DB00026
DB00409,The metabolism of Remoxipride can be increased when combined with Anakinra.,Remoxipride,DB00026
DB00592,The metabolism of Piperazine can be increased when combined with Anakinra.,Piperazine,DB00026
DB00699,The metabolism of Nicergoline can be increased when combined with Anakinra.,Nicergoline,DB00026
DB00737,The metabolism of Meclizine can be increased when combined with Anakinra.,Meclizine,DB00026
DB00805,The metabolism of Minaprine can be increased when combined with Anakinra.,Minaprine,DB00026
DB00866,The metabolism of Alprenolol can be increased when combined with Anakinra.,Alprenolol,DB00026
DB00914,The metabolism of Phenformin can be increased when combined with Anakinra.,Phenformin,DB00026
DB00933,The metabolism of Mesoridazine can be increased when combined with Anakinra.,Mesoridazine,DB00026
DB00960,The metabolism of Pindolol can be increased when combined with Anakinra.,Pindolol,DB00026
DB01071,The metabolism of Mequitazine can be increased when combined with Anakinra.,Mequitazine,DB00026
DB01079,The metabolism of Tegaserod can be increased when combined with Anakinra.,Tegaserod,DB00026
DB01193,The metabolism of Acebutolol can be increased when combined with Anakinra.,Acebutolol,DB00026
DB01203,The metabolism of Nadolol can be increased when combined with Anakinra.,Nadolol,DB00026
DB01228,The metabolism of Encainide can be increased when combined with Anakinra.,Encainide,DB00026
DB01233,The metabolism of Metoclopramide can be increased when combined with Anakinra.,Metoclopramide,DB00026
DB01255,The metabolism of Lisdexamfetamine can be increased when combined with Anakinra.,Lisdexamfetamine,DB00026
DB01295,The metabolism of Bevantolol can be increased when combined with Anakinra.,Bevantolol,DB00026
DB01297,The metabolism of Practolol can be increased when combined with Anakinra.,Practolol,DB00026
DB01359,The metabolism of Penbutolol can be increased when combined with Anakinra.,Penbutolol,DB00026
DB01403,The metabolism of Methotrimeprazine can be increased when combined with Anakinra.,Methotrimeprazine,DB00026
DB01429,The metabolism of Aprindine can be increased when combined with Anakinra.,Aprindine,DB00026
DB01454,The metabolism of Midomafetamine can be increased when combined with Anakinra.,Midomafetamine,DB00026
DB01472,The metabolism of 4-Methoxyamphetamine can be increased when combined with Anakinra.,4-Methoxyamphetamine,DB00026
DB01576,The metabolism of Dextroamphetamine can be increased when combined with Anakinra.,Dextroamphetamine,DB00026
DB01577,The metabolism of Metamfetamine can be increased when combined with Anakinra.,Metamfetamine,DB00026
DB01580,The metabolism of Oxprenolol can be increased when combined with Anakinra.,Oxprenolol,DB00026
DB04840,The metabolism of Debrisoquine can be increased when combined with Anakinra.,Debrisoquine,DB00026
DB04844,The metabolism of Tetrabenazine can be increased when combined with Anakinra.,Tetrabenazine,DB00026
DB04846,The metabolism of Celiprolol can be increased when combined with Anakinra.,Celiprolol,DB00026
DB06217,The metabolism of Vernakalant can be increased when combined with Anakinra.,Vernakalant,DB00026
DB06506,The metabolism of Repinotan can be increased when combined with Anakinra.,Repinotan,DB00026
DB06608,The metabolism of Tafenoquine can be increased when combined with Anakinra.,Tafenoquine,DB00026
DB06678,The metabolism of Esmirtazapine can be increased when combined with Anakinra.,Esmirtazapine,DB00026
DB06726,The metabolism of Bufuralol can be increased when combined with Anakinra.,Bufuralol,DB00026
DB06727,The metabolism of Sparteine can be increased when combined with Anakinra.,Sparteine,DB00026
DB06735,The metabolism of Enclomiphene can be increased when combined with Anakinra.,Enclomiphene,DB00026
DB08807,The metabolism of Bopindolol can be increased when combined with Anakinra.,Bopindolol,DB00026
DB08808,The metabolism of Bupranolol can be increased when combined with Anakinra.,Bupranolol,DB00026
DB08952,The metabolism of Indenolol can be increased when combined with Anakinra.,Indenolol,DB00026
DB09013,The metabolism of Befunolol can be increased when combined with Anakinra.,Befunolol,DB00026
DB09076,The metabolism of Umeclidinium can be increased when combined with Anakinra.,Umeclidinium,DB00026
DB09204,The metabolism of Arotinolol can be increased when combined with Anakinra.,Arotinolol,DB00026
DB09351,The metabolism of Levobetaxolol can be increased when combined with Anakinra.,Levobetaxolol,DB00026
DB11770,The metabolism of Talinolol can be increased when combined with Anakinra.,Talinolol,DB00026
DB11785,The metabolism of Anisodamine can be increased when combined with Anakinra.,Anisodamine,DB00026
DB11855,The metabolism of Revefenacin can be increased when combined with Anakinra.,Revefenacin,DB00026
DB11979,The metabolism of Elagolix can be increased when combined with Anakinra.,Elagolix,DB00026
DB12070,The metabolism of Letermovir can be increased when combined with Anakinra.,Letermovir,DB00026
DB12212,The metabolism of Landiolol can be increased when combined with Anakinra.,Landiolol,DB00026
DB12752,The metabolism of Bucindolol can be increased when combined with Anakinra.,Bucindolol,DB00026
DB13443,The metabolism of Esatenolol can be increased when combined with Anakinra.,Esatenolol,DB00026
DB13508,The metabolism of Cloranolol can be increased when combined with Anakinra.,Cloranolol,DB00026
DB13530,The metabolism of Mepindolol can be increased when combined with Anakinra.,Mepindolol,DB00026
DB13679,The metabolism of Dexchlorpheniramine can be increased when combined with Anakinra.,Dexchlorpheniramine,DB00026
DB13757,The metabolism of Epanolol can be increased when combined with Anakinra.,Epanolol,DB00026
DB13775,The metabolism of Tertatolol can be increased when combined with Anakinra.,Tertatolol,DB00026
DB00850,The metabolism of Perphenazine can be increased when combined with Anakinra.,Perphenazine,DB00026
DB09173,The metabolism of Butyrfentanyl can be increased when combined with Anakinra.,Butyrfentanyl,DB00026
DB00281,The metabolism of Lidocaine can be increased when combined with Anakinra.,Lidocaine,DB00026
DB00598,The metabolism of Labetalol can be increased when combined with Anakinra.,Labetalol,DB00026
DB14010,"The metabolism of 5-methoxy-N,N-dimethyltryptamine can be increased when combined with Anakinra.","5-methoxy-N,N-dimethyltryptamine",DB00026
DB01410,The metabolism of Ciclesonide can be increased when combined with Anakinra.,Ciclesonide,DB00026
DB00918,The metabolism of Almotriptan can be increased when combined with Anakinra.,Almotriptan,DB00026
DB08918,The metabolism of Levomilnacipran can be increased when combined with Anakinra.,Levomilnacipran,DB00026
DB08922,The metabolism of Perospirone can be increased when combined with Anakinra.,Perospirone,DB00026
DB09183,The metabolism of Dasabuvir can be increased when combined with Anakinra.,Dasabuvir,DB00026
DB00185,The metabolism of Cevimeline can be increased when combined with Anakinra.,Cevimeline,DB00026
DB00243,The metabolism of Ranolazine can be increased when combined with Anakinra.,Ranolazine,DB00026
DB00297,The metabolism of Bupivacaine can be increased when combined with Anakinra.,Bupivacaine,DB00026
DB00318,The metabolism of Codeine can be increased when combined with Anakinra.,Codeine,DB00026
DB00377,The metabolism of Palonosetron can be increased when combined with Anakinra.,Palonosetron,DB00026
DB00589,The metabolism of Lisuride can be increased when combined with Anakinra.,Lisuride,DB00026
DB00647,The metabolism of Dextropropoxyphene can be increased when combined with Anakinra.,Dextropropoxyphene,DB00026
DB00674,The metabolism of Galantamine can be increased when combined with Anakinra.,Galantamine,DB00026
DB00705,The metabolism of Delavirdine can be increased when combined with Anakinra.,Delavirdine,DB00026
DB00706,The metabolism of Tamsulosin can be increased when combined with Anakinra.,Tamsulosin,DB00026
DB00757,The metabolism of Dolasetron can be increased when combined with Anakinra.,Dolasetron,DB00026
DB01149,The metabolism of Nefazodone can be increased when combined with Anakinra.,Nefazodone,DB00026
DB01192,The metabolism of Oxymorphone can be increased when combined with Anakinra.,Oxymorphone,DB00026
DB01244,The metabolism of Bepridil can be increased when combined with Anakinra.,Bepridil,DB00026
DB01392,The metabolism of Yohimbine can be increased when combined with Anakinra.,Yohimbine,DB00026
DB01409,The metabolism of Tiotropium can be increased when combined with Anakinra.,Tiotropium,DB00026
DB01551,The metabolism of Dihydrocodeine can be increased when combined with Anakinra.,Dihydrocodeine,DB00026
DB01591,The metabolism of Solifenacin can be increased when combined with Anakinra.,Solifenacin,DB00026
DB01621,The metabolism of Pipotiazine can be increased when combined with Anakinra.,Pipotiazine,DB00026
DB02703,The metabolism of Fusidic acid can be increased when combined with Anakinra.,Fusidic acid,DB00026
DB04829,The metabolism of Lysergic acid diethylamide can be increased when combined with Anakinra.,Lysergic acid diethylamide,DB00026
DB04884,The metabolism of Dapoxetine can be increased when combined with Anakinra.,Dapoxetine,DB00026
DB04905,The metabolism of Tesmilifene can be increased when combined with Anakinra.,Tesmilifene,DB00026
DB04920,The metabolism of Clevidipine can be increased when combined with Anakinra.,Clevidipine,DB00026
DB05271,The metabolism of Rotigotine can be increased when combined with Anakinra.,Rotigotine,DB00026
DB06016,The metabolism of Cariprazine can be increased when combined with Anakinra.,Cariprazine,DB00026
DB06144,The metabolism of Sertindole can be increased when combined with Anakinra.,Sertindole,DB00026
DB06203,The metabolism of Alogliptin can be increased when combined with Anakinra.,Alogliptin,DB00026
DB06702,The metabolism of Fesoterodine can be increased when combined with Anakinra.,Fesoterodine,DB00026
DB08893,The metabolism of Mirabegron can be increased when combined with Anakinra.,Mirabegron,DB00026
DB09128,The metabolism of Brexpiprazole can be increased when combined with Anakinra.,Brexpiprazole,DB00026
DB09195,The metabolism of Lorpiprazole can be increased when combined with Anakinra.,Lorpiprazole,DB00026
DB09555,The metabolism of Dexchlorpheniramine maleate can be increased when combined with Anakinra.,Dexchlorpheniramine maleate,DB00026
DB11130,The metabolism of Opium can be increased when combined with Anakinra.,Opium,DB00026
DB11642,The metabolism of Pitolisant can be increased when combined with Anakinra.,Pitolisant,DB00026
DB13293,The metabolism of Ipecac can be increased when combined with Anakinra.,Ipecac,DB00026
DB00344,The metabolism of Protriptyline can be increased when combined with Anakinra.,Protriptyline,DB00026
DB00496,The metabolism of Darifenacin can be increased when combined with Anakinra.,Darifenacin,DB00026
DB00543,The metabolism of Amoxapine can be increased when combined with Anakinra.,Amoxapine,DB00026
DB00932,The metabolism of Tipranavir can be increased when combined with Anakinra.,Tipranavir,DB00026
DB09039,The metabolism of Eliglustat can be increased when combined with Anakinra.,Eliglustat,DB00026
DB12930,The metabolism of Opipramol can be increased when combined with Anakinra.,Opipramol,DB00026
DB00489,The metabolism of Sotalol can be increased when combined with Anakinra.,Sotalol,DB00026
DB01035,The metabolism of Procainamide can be increased when combined with Anakinra.,Procainamide,DB00026
DB01195,The metabolism of Flecainide can be increased when combined with Anakinra.,Flecainide,DB00026
DB00228,The metabolism of Enflurane can be increased when combined with Anakinra.,Enflurane,DB00026
DB06712,The metabolism of Nilvadipine can be increased when combined with Anakinra.,Nilvadipine,DB00026
DB06728,The metabolism of Aniline can be increased when combined with Anakinra.,Aniline,DB00026
DB00949,The metabolism of Felbamate can be increased when combined with Anakinra.,Felbamate,DB00026
DB00593,The metabolism of Ethosuximide can be increased when combined with Anakinra.,Ethosuximide,DB00026
DB00186,The metabolism of Lorazepam can be increased when combined with Anakinra.,Lorazepam,DB00026
DB00191,The metabolism of Phentermine can be increased when combined with Anakinra.,Phentermine,DB00026
DB00207,The metabolism of Azithromycin can be increased when combined with Anakinra.,Azithromycin,DB00026
DB00208,The metabolism of Ticlopidine can be increased when combined with Anakinra.,Ticlopidine,DB00026
DB00264,The metabolism of Metoprolol can be increased when combined with Anakinra.,Metoprolol,DB00026
DB00426,The metabolism of Famciclovir can be increased when combined with Anakinra.,Famciclovir,DB00026
DB00433,The metabolism of Prochlorperazine can be increased when combined with Anakinra.,Prochlorperazine,DB00026
DB00567,The metabolism of Cephalexin can be increased when combined with Anakinra.,Cephalexin,DB00026
DB00590,The metabolism of Doxazosin can be increased when combined with Anakinra.,Doxazosin,DB00026
DB01039,The metabolism of Fenofibrate can be increased when combined with Anakinra.,Fenofibrate,DB00026
DB01395,The metabolism of Drospirenone can be increased when combined with Anakinra.,Drospirenone,DB00026
DB01411,The metabolism of Pranlukast can be increased when combined with Anakinra.,Pranlukast,DB00026
DB01431,The metabolism of Allylestrenol can be increased when combined with Anakinra.,Allylestrenol,DB00026
DB01624,The metabolism of Zuclopenthixol can be increased when combined with Anakinra.,Zuclopenthixol,DB00026
DB06201,The metabolism of Rufinamide can be increased when combined with Anakinra.,Rufinamide,DB00026
DB06480,The metabolism of Prucalopride can be increased when combined with Anakinra.,Prucalopride,DB00026
DB08882,The metabolism of Linagliptin can be increased when combined with Anakinra.,Linagliptin,DB00026
DB09030,The metabolism of Vorapaxar can be increased when combined with Anakinra.,Vorapaxar,DB00026
DB09034,The metabolism of Suvorexant can be increased when combined with Anakinra.,Suvorexant,DB00026
DB09079,The metabolism of Nintedanib can be increased when combined with Anakinra.,Nintedanib,DB00026
DB09299,The metabolism of Tenofovir alafenamide can be increased when combined with Anakinra.,Tenofovir alafenamide,DB00026
DB09330,The metabolism of Osimertinib can be increased when combined with Anakinra.,Osimertinib,DB00026
DB11094,The metabolism of Vitamin D can be increased when combined with Anakinra.,Vitamin D,DB00026
DB11273,The metabolism of Dihydroergocornine can be increased when combined with Anakinra.,Dihydroergocornine,DB00026
DB11730,The metabolism of Ribociclib can be increased when combined with Anakinra.,Ribociclib,DB00026
DB11952,The metabolism of Duvelisib can be increased when combined with Anakinra.,Duvelisib,DB00026
DB12141,The metabolism of Gilteritinib can be increased when combined with Anakinra.,Gilteritinib,DB00026
DB12515,The metabolism of 9-aminocamptothecin can be increased when combined with Anakinra.,9-aminocamptothecin,DB00026
DB12952,The metabolism of Methylprednisone can be increased when combined with Anakinra.,Methylprednisone,DB00026
DB13345,The metabolism of Dihydroergocristine can be increased when combined with Anakinra.,Dihydroergocristine,DB00026
DB13385,The metabolism of Dihydroergocryptine can be increased when combined with Anakinra.,Dihydroergocryptine,DB00026
DB14126,The metabolism of Tenofovir can be increased when combined with Anakinra.,Tenofovir,DB00026
DB15444,The metabolism of Elexacaftor can be increased when combined with Anakinra.,Elexacaftor,DB00026
DB06717,The metabolism of Fosaprepitant can be increased when combined with Anakinra.,Fosaprepitant,DB00026
DB12825,The metabolism of Lefamulin can be increased when combined with Anakinra.,Lefamulin,DB00026
DB12887,The metabolism of Tazemetostat can be increased when combined with Anakinra.,Tazemetostat,DB00026
DB00454,The metabolism of Meperidine can be increased when combined with Anakinra.,Meperidine,DB00026
DB01151,The metabolism of Desipramine can be increased when combined with Anakinra.,Desipramine,DB00026
DB12371,The metabolism of Siponimod can be increased when combined with Anakinra.,Siponimod,DB00026
DB00247,The metabolism of Methysergide can be increased when combined with Anakinra.,Methysergide,DB00026
DB08827,The metabolism of Lomitapide can be increased when combined with Anakinra.,Lomitapide,DB00026
DB11742,The metabolism of Ebastine can be increased when combined with Anakinra.,Ebastine,DB00026
DB05015,The metabolism of Belinostat can be increased when combined with Anakinra.,Belinostat,DB00026
DB01118,The metabolism of Amiodarone can be increased when combined with Anakinra.,Amiodarone,DB00026
DB00675,The metabolism of Tamoxifen can be increased when combined with Anakinra.,Tamoxifen,DB00026
DB00204,The metabolism of Dofetilide can be increased when combined with Anakinra.,Dofetilide,DB00026
DB00342,The metabolism of Terfenadine can be increased when combined with Anakinra.,Terfenadine,DB00026
DB00451,The metabolism of Levothyroxine can be increased when combined with Anakinra.,Levothyroxine,DB00026
DB00604,The metabolism of Cisapride can be increased when combined with Anakinra.,Cisapride,DB00026
DB00877,The metabolism of Sirolimus can be increased when combined with Anakinra.,Sirolimus,DB00026
DB01008,The metabolism of Busulfan can be increased when combined with Anakinra.,Busulfan,DB00026
DB01254,The metabolism of Dasatinib can be increased when combined with Anakinra.,Dasatinib,DB00026
DB01396,The metabolism of Digitoxin can be increased when combined with Anakinra.,Digitoxin,DB00026
DB01590,The metabolism of Everolimus can be increased when combined with Anakinra.,Everolimus,DB00026
DB03410,The metabolism of 4-hydroxycoumarin can be increased when combined with Anakinra.,4-hydroxycoumarin,DB00026
DB04855,The metabolism of Dronedarone can be increased when combined with Anakinra.,Dronedarone,DB00026
DB06287,The metabolism of Temsirolimus can be increased when combined with Anakinra.,Temsirolimus,DB00026
DB09053,The metabolism of Ibrutinib can be increased when combined with Anakinra.,Ibrutinib,DB00026
DB09289,The metabolism of Tianeptine can be increased when combined with Anakinra.,Tianeptine,DB00026
DB11633,The metabolism of Isavuconazole can be increased when combined with Anakinra.,Isavuconazole,DB00026
DB13275,The metabolism of Clorindione can be increased when combined with Anakinra.,Clorindione,DB00026
DB00398,The metabolism of Sorafenib can be increased when combined with Anakinra.,Sorafenib,DB00026
DB00444,The metabolism of Teniposide can be increased when combined with Anakinra.,Teniposide,DB00026
DB00530,The metabolism of Erlotinib can be increased when combined with Anakinra.,Erlotinib,DB00026
DB00541,The metabolism of Vincristine can be increased when combined with Anakinra.,Vincristine,DB00026
DB00619,The metabolism of Imatinib can be increased when combined with Anakinra.,Imatinib,DB00026
DB00773,The metabolism of Etoposide can be increased when combined with Anakinra.,Etoposide,DB00026
DB01248,The metabolism of Docetaxel can be increased when combined with Anakinra.,Docetaxel,DB00026
DB01268,The metabolism of Sunitinib can be increased when combined with Anakinra.,Sunitinib,DB00026
DB06626,The metabolism of Axitinib can be increased when combined with Anakinra.,Axitinib,DB00026
DB08865,The metabolism of Crizotinib can be increased when combined with Anakinra.,Crizotinib,DB00026
DB08901,The metabolism of Ponatinib can be increased when combined with Anakinra.,Ponatinib,DB00026
DB12483,The metabolism of Copanlisib can be increased when combined with Anakinra.,Copanlisib,DB00026
DB00188,The metabolism of Bortezomib can be increased when combined with Anakinra.,Bortezomib,DB00026
DB00363,The metabolism of Clozapine can be increased when combined with Anakinra.,Clozapine,DB00026
DB01181,The metabolism of Ifosfamide can be increased when combined with Anakinra.,Ifosfamide,DB00026
DB05109,The metabolism of Trabectedin can be increased when combined with Anakinra.,Trabectedin,DB00026
DB12147,The metabolism of Erdafitinib can be increased when combined with Anakinra.,Erdafitinib,DB00026
DB13874,The metabolism of Enasidenib can be increased when combined with Anakinra.,Enasidenib,DB00026
DB06589,The metabolism of Pazopanib can be increased when combined with Anakinra.,Pazopanib,DB00026
DB05239,The metabolism of Cobimetinib can be increased when combined with Anakinra.,Cobimetinib,DB00026
DB09063,The metabolism of Ceritinib can be increased when combined with Anakinra.,Ceritinib,DB00026
DB11963,The metabolism of Dacomitinib can be increased when combined with Anakinra.,Dacomitinib,DB00026
DB12015,The metabolism of Alpelisib can be increased when combined with Anakinra.,Alpelisib,DB00026
DB00309,The metabolism of Vindesine can be increased when combined with Anakinra.,Vindesine,DB00026
DB00361,The metabolism of Vinorelbine can be increased when combined with Anakinra.,Vinorelbine,DB00026
DB00570,The metabolism of Vinblastine can be increased when combined with Anakinra.,Vinblastine,DB00026
DB00694,The metabolism of Daunorubicin can be increased when combined with Anakinra.,Daunorubicin,DB00026
DB00987,The metabolism of Cytarabine can be increased when combined with Anakinra.,Cytarabine,DB00026
DB00997,The metabolism of Doxorubicin can be increased when combined with Anakinra.,Doxorubicin,DB00026
DB01108,The metabolism of Trilostane can be increased when combined with Anakinra.,Trilostane,DB00026
DB04572,The metabolism of Thiotepa can be increased when combined with Anakinra.,Thiotepa,DB00026
DB04845,The metabolism of Ixabepilone can be increased when combined with Anakinra.,Ixabepilone,DB00026
DB04868,The metabolism of Nilotinib can be increased when combined with Anakinra.,Nilotinib,DB00026
DB06603,The metabolism of Panobinostat can be increased when combined with Anakinra.,Panobinostat,DB00026
DB06616,The metabolism of Bosutinib can be increased when combined with Anakinra.,Bosutinib,DB00026
DB08870,The metabolism of Brentuximab vedotin can be increased when combined with Anakinra.,Brentuximab vedotin,DB00026
DB08877,The metabolism of Ruxolitinib can be increased when combined with Anakinra.,Ruxolitinib,DB00026
DB09073,The metabolism of Palbociclib can be increased when combined with Anakinra.,Palbociclib,DB00026
DB08912,The metabolism of Dabrafenib can be increased when combined with Anakinra.,Dabrafenib,DB00026
DB12267,The metabolism of Brigatinib can be increased when combined with Anakinra.,Brigatinib,DB00026
DB11718,The metabolism of Encorafenib can be increased when combined with Anakinra.,Encorafenib,DB00026
DB00563,The metabolism of Methotrexate can be increased when combined with Anakinra.,Methotrexate,DB00026
DB05294,The metabolism of Vandetanib can be increased when combined with Anakinra.,Vandetanib,DB00026
DB05812,The metabolism of Abiraterone can be increased when combined with Anakinra.,Abiraterone,DB00026
DB08881,The metabolism of Vemurafenib can be increased when combined with Anakinra.,Vemurafenib,DB00026
DB11363,The metabolism of Alectinib can be increased when combined with Anakinra.,Alectinib,DB00026
DB11581,The metabolism of Venetoclax can be increased when combined with Anakinra.,Venetoclax,DB00026
DB11641,The metabolism of Vinflunine can be increased when combined with Anakinra.,Vinflunine,DB00026
DB11703,The metabolism of Acalabrutinib can be increased when combined with Anakinra.,Acalabrutinib,DB00026
DB15035,The metabolism of Zanubrutinib can be increased when combined with Anakinra.,Zanubrutinib,DB00026
DB00248,The metabolism of Cabergoline can be increased when combined with Anakinra.,Cabergoline,DB00026
DB06595,The metabolism of Midostaurin can be increased when combined with Anakinra.,Midostaurin,DB00026
DB09143,The metabolism of Sonidegib can be increased when combined with Anakinra.,Sonidegib,DB00026
DB11828,The metabolism of Neratinib can be increased when combined with Anakinra.,Neratinib,DB00026
DB11986,The metabolism of Entrectinib can be increased when combined with Anakinra.,Entrectinib,DB00026
DB12978,The metabolism of Pexidartinib can be increased when combined with Anakinra.,Pexidartinib,DB00026
DB14568,The metabolism of Ivosidenib can be increased when combined with Anakinra.,Ivosidenib,DB00026
DB09054,The metabolism of Idelalisib can be increased when combined with Anakinra.,Idelalisib,DB00026
DB09570,The metabolism of Ixazomib can be increased when combined with Anakinra.,Ixazomib,DB00026
DB00199,The metabolism of Erythromycin can be increased when combined with Anakinra.,Erythromycin,DB00026
DB00246,The metabolism of Ziprasidone can be increased when combined with Anakinra.,Ziprasidone,DB00026
DB00439,The metabolism of Cerivastatin can be increased when combined with Anakinra.,Cerivastatin,DB00026
DB00499,The metabolism of Flutamide can be increased when combined with Anakinra.,Flutamide,DB00026
DB00528,The metabolism of Lercanidipine can be increased when combined with Anakinra.,Lercanidipine,DB00026
DB00571,The metabolism of Propranolol can be increased when combined with Anakinra.,Propranolol,DB00026
DB00588,The metabolism of Fluticasone propionate can be increased when combined with Anakinra.,Fluticasone propionate,DB00026
DB00608,The metabolism of Chloroquine can be increased when combined with Anakinra.,Chloroquine,DB00026
DB00688,The metabolism of Mycophenolate mofetil can be increased when combined with Anakinra.,Mycophenolate mofetil,DB00026
DB00717,The metabolism of Norethisterone can be increased when combined with Anakinra.,Norethisterone,DB00026
DB00738,The metabolism of Pentamidine can be increased when combined with Anakinra.,Pentamidine,DB00026
DB00741,The metabolism of Hydrocortisone can be increased when combined with Anakinra.,Hydrocortisone,DB00026
DB00762,The metabolism of Irinotecan can be increased when combined with Anakinra.,Irinotecan,DB00026
DB00822,The metabolism of Disulfiram can be increased when combined with Anakinra.,Disulfiram,DB00026
DB00834,The metabolism of Mifepristone can be increased when combined with Anakinra.,Mifepristone,DB00026
DB00938,The metabolism of Salmeterol can be increased when combined with Anakinra.,Salmeterol,DB00026
DB00962,The metabolism of Zaleplon can be increased when combined with Anakinra.,Zaleplon,DB00026
DB00976,The metabolism of Telithromycin can be increased when combined with Anakinra.,Telithromycin,DB00026
DB01054,The metabolism of Nitrendipine can be increased when combined with Anakinra.,Nitrendipine,DB00026
DB01058,The metabolism of Praziquantel can be increased when combined with Anakinra.,Praziquantel,DB00026
DB01062,The metabolism of Oxybutynin can be increased when combined with Anakinra.,Oxybutynin,DB00026
DB01076,The metabolism of Atorvastatin can be increased when combined with Anakinra.,Atorvastatin,DB00026
DB01103,The metabolism of Quinacrine can be increased when combined with Anakinra.,Quinacrine,DB00026
DB01115,The metabolism of Nifedipine can be increased when combined with Anakinra.,Nifedipine,DB00026
DB01126,The metabolism of Dutasteride can be increased when combined with Anakinra.,Dutasteride,DB00026
DB01166,The metabolism of Cilostazol can be increased when combined with Anakinra.,Cilostazol,DB00026
DB01184,The metabolism of Domperidone can be increased when combined with Anakinra.,Domperidone,DB00026
DB01211,The metabolism of Clarithromycin can be increased when combined with Anakinra.,Clarithromycin,DB00026
DB01216,The metabolism of Finasteride can be increased when combined with Anakinra.,Finasteride,DB00026
DB01218,The metabolism of Halofantrine can be increased when combined with Anakinra.,Halofantrine,DB00026
DB05521,The metabolism of Telaprevir can be increased when combined with Anakinra.,Telaprevir,DB00026
DB05773,The metabolism of Trastuzumab emtansine can be increased when combined with Anakinra.,Trastuzumab emtansine,DB00026
DB06267,The metabolism of Udenafil can be increased when combined with Anakinra.,Udenafil,DB00026
DB06335,The metabolism of Saxagliptin can be increased when combined with Anakinra.,Saxagliptin,DB00026
DB06403,The metabolism of Ambrisentan can be increased when combined with Anakinra.,Ambrisentan,DB00026
DB06419,The metabolism of Cethromycin can be increased when combined with Anakinra.,Cethromycin,DB00026
DB06772,The metabolism of Cabazitaxel can be increased when combined with Anakinra.,Cabazitaxel,DB00026
DB06789,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Anakinra.,Hydroxyprogesterone caproate,DB00026
DB08820,The metabolism of Ivacaftor can be increased when combined with Anakinra.,Ivacaftor,DB00026
DB08873,The metabolism of Boceprevir can be increased when combined with Anakinra.,Boceprevir,DB00026
DB08883,The metabolism of Perampanel can be increased when combined with Anakinra.,Perampanel,DB00026
DB08906,The metabolism of Fluticasone furoate can be increased when combined with Anakinra.,Fluticasone furoate,DB00026
DB09065,The metabolism of Cobicistat can be increased when combined with Anakinra.,Cobicistat,DB00026
DB09074,The metabolism of Olaparib can be increased when combined with Anakinra.,Olaparib,DB00026
DB09102,The metabolism of Daclatasvir can be increased when combined with Anakinra.,Daclatasvir,DB00026
DB09231,The metabolism of Benidipine can be increased when combined with Anakinra.,Benidipine,DB00026
DB09297,The metabolism of Paritaprevir can be increased when combined with Anakinra.,Paritaprevir,DB00026
DB11574,The metabolism of Elbasvir can be increased when combined with Anakinra.,Elbasvir,DB00026
DB11712,The metabolism of Tezacaftor can be increased when combined with Anakinra.,Tezacaftor,DB00026
DB11737,The metabolism of Icotinib can be increased when combined with Anakinra.,Icotinib,DB00026
DB12301,The metabolism of Doravirine can be increased when combined with Anakinra.,Doravirine,DB00026
DB13867,The metabolism of Fluticasone can be increased when combined with Anakinra.,Fluticasone,DB00026
DB14538,The metabolism of Hydrocortisone aceponate can be increased when combined with Anakinra.,Hydrocortisone aceponate,DB00026
DB14539,The metabolism of Hydrocortisone acetate can be increased when combined with Anakinra.,Hydrocortisone acetate,DB00026
DB14541,The metabolism of Hydrocortisone cypionate can be increased when combined with Anakinra.,Hydrocortisone cypionate,DB00026
DB14542,The metabolism of Hydrocortisone phosphate can be increased when combined with Anakinra.,Hydrocortisone phosphate,DB00026
DB00396,The metabolism of Progesterone can be increased when combined with Anakinra.,Progesterone,DB00026
DB04856,The metabolism of Dexloxiglumide can be increased when combined with Anakinra.,Dexloxiglumide,DB00026
DB04957,The metabolism of Azimilide can be increased when combined with Anakinra.,Azimilide,DB00026
DB00250,The metabolism of Dapsone can be increased when combined with Anakinra.,Dapsone,DB00026
DB00317,The metabolism of Gefitinib can be increased when combined with Anakinra.,Gefitinib,DB00026
DB00367,The metabolism of Levonorgestrel can be increased when combined with Anakinra.,Levonorgestrel,DB00026
DB00497,The metabolism of Oxycodone can be increased when combined with Anakinra.,Oxycodone,DB00026
DB00620,The metabolism of Triamcinolone can be increased when combined with Anakinra.,Triamcinolone,DB00026
DB00624,The metabolism of Testosterone can be increased when combined with Anakinra.,Testosterone,DB00026
DB00656,The metabolism of Trazodone can be increased when combined with Anakinra.,Trazodone,DB00026
DB00734,The metabolism of Risperidone can be increased when combined with Anakinra.,Risperidone,DB00026
DB01114,The metabolism of Chlorpheniramine can be increased when combined with Anakinra.,Chlorpheniramine,DB00026
DB01238,The metabolism of Aripiprazole can be increased when combined with Anakinra.,Aripiprazole,DB00026
DB01267,The metabolism of Paliperidone can be increased when combined with Anakinra.,Paliperidone,DB00026
DB04946,The metabolism of Iloperidone can be increased when combined with Anakinra.,Iloperidone,DB00026
DB11915,The metabolism of Valbenazine can be increased when combined with Anakinra.,Valbenazine,DB00026
DB12161,The metabolism of Deutetrabenazine can be increased when combined with Anakinra.,Deutetrabenazine,DB00026
DB14185,The metabolism of Aripiprazole lauroxil can be increased when combined with Anakinra.,Aripiprazole lauroxil,DB00026
DB01234,The metabolism of Dexamethasone can be increased when combined with Anakinra.,Dexamethasone,DB00026
DB09237,The metabolism of Levamlodipine can be increased when combined with Anakinra.,Levamlodipine,DB00026
DB11951,The metabolism of Lemborexant can be increased when combined with Anakinra.,Lemborexant,DB00026
DB00557,The metabolism of Hydroxyzine can be increased when combined with Anakinra.,Hydroxyzine,DB00026
DB00203,The metabolism of Sildenafil can be increased when combined with Anakinra.,Sildenafil,DB00026
DB00227,The metabolism of Lovastatin can be increased when combined with Anakinra.,Lovastatin,DB00026
DB00490,The metabolism of Buspirone can be increased when combined with Anakinra.,Buspirone,DB00026
DB00641,The metabolism of Simvastatin can be increased when combined with Anakinra.,Simvastatin,DB00026
DB00673,The metabolism of Aprepitant can be increased when combined with Anakinra.,Aprepitant,DB00026
DB00820,The metabolism of Tadalafil can be increased when combined with Anakinra.,Tadalafil,DB00026
DB00862,The metabolism of Vardenafil can be increased when combined with Anakinra.,Vardenafil,DB00026
DB01190,The metabolism of Clindamycin can be increased when combined with Anakinra.,Clindamycin,DB00026
DB00503,The metabolism of Ritonavir can be increased when combined with Anakinra.,Ritonavir,DB00026
DB00224,The metabolism of Indinavir can be increased when combined with Anakinra.,Indinavir,DB00026
DB00401,The metabolism of Nisoldipine can be increased when combined with Anakinra.,Nisoldipine,DB00026
DB00637,The metabolism of Astemizole can be increased when combined with Anakinra.,Astemizole,DB00026
DB00683,The metabolism of Midazolam can be increased when combined with Anakinra.,Midazolam,DB00026
DB00700,The metabolism of Eplerenone can be increased when combined with Anakinra.,Eplerenone,DB00026
DB00802,The metabolism of Alfentanil can be increased when combined with Anakinra.,Alfentanil,DB00026
DB00813,The metabolism of Fentanyl can be increased when combined with Anakinra.,Fentanyl,DB00026
DB00897,The metabolism of Triazolam can be increased when combined with Anakinra.,Triazolam,DB00026
DB01023,The metabolism of Felodipine can be increased when combined with Anakinra.,Felodipine,DB00026
DB01227,The metabolism of Levacetylmethadol can be increased when combined with Anakinra.,Levacetylmethadol,DB00026
DB01232,The metabolism of Saquinavir can be increased when combined with Anakinra.,Saquinavir,DB00026
DB06228,The metabolism of Rivaroxaban can be increased when combined with Anakinra.,Rivaroxaban,DB00026
DB05804,The metabolism of Prasterone sulfate can be increased when combined with Anakinra.,Prasterone sulfate,DB00026
DB00091,Anakinra may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine,DB00026
DB05676,The therapeutic efficacy of Apremilast can be decreased when used in combination with Anakinra.,Apremilast,DB00026
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Anakinra.,Magnesium,DB00026
DB01601,The serum concentration of Anakinra can be increased when it is combined with Lopinavir.,Lopinavir,DB00026
DB12530,The risk or severity of infection can be increased when Anakinra is combined with Inebilizumab.,Inebilizumab,DB00026
DB12768,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Gramicidin D.,BCG vaccine,DB00027
DB00266,The risk or severity of bleeding can be increased when Gramicidin D is combined with Dicoumarol.,Dicoumarol,DB00027
DB00498,The risk or severity of bleeding can be increased when Gramicidin D is combined with Phenindione.,Phenindione,DB00027
DB00682,The risk or severity of bleeding can be increased when Gramicidin D is combined with Warfarin.,Warfarin,DB00027
DB00946,The risk or severity of bleeding can be increased when Gramicidin D is combined with Phenprocoumon.,Phenprocoumon,DB00027
DB01418,The risk or severity of bleeding can be increased when Gramicidin D is combined with Acenocoumarol.,Acenocoumarol,DB00027
DB03410,The risk or severity of bleeding can be increased when Gramicidin D is combined with 4-hydroxycoumarin.,4-hydroxycoumarin,DB00027
DB04665,The risk or severity of bleeding can be increased when Gramicidin D is combined with Coumarin.,Coumarin,DB00027
DB08496,The risk or severity of bleeding can be increased when Gramicidin D is combined with (R)-warfarin.,(R)-warfarin,DB00027
DB08794,The risk or severity of bleeding can be increased when Gramicidin D is combined with Ethyl biscoumacetate.,Ethyl biscoumacetate,DB00027
DB13136,The risk or severity of bleeding can be increased when Gramicidin D is combined with Fluindione.,Fluindione,DB00027
DB13275,The risk or severity of bleeding can be increased when Gramicidin D is combined with Clorindione.,Clorindione,DB00027
DB13347,The risk or severity of bleeding can be increased when Gramicidin D is combined with Diphenadione.,Diphenadione,DB00027
DB13451,The risk or severity of bleeding can be increased when Gramicidin D is combined with Tioclomarol.,Tioclomarol,DB00027
DB14055,The risk or severity of bleeding can be increased when Gramicidin D is combined with (S)-Warfarin.,(S)-Warfarin,DB00027
DB14443,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Gramicidin D.,Vibrio cholerae CVD 103-HgR strain live antigen,DB00027
DB00255,Diethylstilbestrol may increase the thrombogenic activities of Human immunoglobulin G.,Diethylstilbestrol,DB00028
DB00269,Chlorotrianisene may increase the thrombogenic activities of Human immunoglobulin G.,Chlorotrianisene,DB00028
DB00286,Conjugated estrogens may increase the thrombogenic activities of Human immunoglobulin G.,Conjugated estrogens,DB00028
DB00655,Estrone may increase the thrombogenic activities of Human immunoglobulin G.,Estrone,DB00028
DB00783,Estradiol may increase the thrombogenic activities of Human immunoglobulin G.,Estradiol,DB00028
DB00890,Dienestrol may increase the thrombogenic activities of Human immunoglobulin G.,Dienestrol,DB00028
DB00977,Ethinylestradiol may increase the thrombogenic activities of Human immunoglobulin G.,Ethinylestradiol,DB00028
DB01357,Mestranol may increase the thrombogenic activities of Human immunoglobulin G.,Mestranol,DB00028
DB04573,Estriol may increase the thrombogenic activities of Human immunoglobulin G.,Estriol,DB00028
DB04574,Estrone sulfate may increase the thrombogenic activities of Human immunoglobulin G.,Estrone sulfate,DB00028
DB04575,Quinestrol may increase the thrombogenic activities of Human immunoglobulin G.,Quinestrol,DB00028
DB07931,Hexestrol may increase the thrombogenic activities of Human immunoglobulin G.,Hexestrol,DB00028
DB09070,Tibolone may increase the thrombogenic activities of Human immunoglobulin G.,Tibolone,DB00028
DB09317,"Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Human immunoglobulin G.","Synthetic Conjugated Estrogens, A",DB00028
DB09318,"Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Human immunoglobulin G.","Synthetic Conjugated Estrogens, B",DB00028
DB09369,Polyestradiol phosphate may increase the thrombogenic activities of Human immunoglobulin G.,Polyestradiol phosphate,DB00028
DB09381,Esterified estrogens may increase the thrombogenic activities of Human immunoglobulin G.,Esterified estrogens,DB00028
DB11478,Zeranol may increase the thrombogenic activities of Human immunoglobulin G.,Zeranol,DB00028
DB11674,Equol may increase the thrombogenic activities of Human immunoglobulin G.,Equol,DB00028
DB12487,Promestriene may increase the thrombogenic activities of Human immunoglobulin G.,Promestriene,DB00028
DB13143,Methallenestril may increase the thrombogenic activities of Human immunoglobulin G.,Methallenestril,DB00028
DB13386,Epimestrol may increase the thrombogenic activities of Human immunoglobulin G.,Epimestrol,DB00028
DB13418,Moxestrol may increase the thrombogenic activities of Human immunoglobulin G.,Moxestrol,DB00028
DB13952,Estradiol acetate may increase the thrombogenic activities of Human immunoglobulin G.,Estradiol acetate,DB00028
DB13953,Estradiol benzoate may increase the thrombogenic activities of Human immunoglobulin G.,Estradiol benzoate,DB00028
DB13954,Estradiol cypionate may increase the thrombogenic activities of Human immunoglobulin G.,Estradiol cypionate,DB00028
DB13956,Estradiol valerate may increase the thrombogenic activities of Human immunoglobulin G.,Estradiol valerate,DB00028
DB15334,Biochanin A may increase the thrombogenic activities of Human immunoglobulin G.,Biochanin A,DB00028
DB15335,Formononetin may increase the thrombogenic activities of Human immunoglobulin G.,Formononetin,DB00028
DB00002,The risk or severity of adverse effects can be increased when Cetuximab is combined with Human immunoglobulin G.,Cetuximab,DB00028
DB00043,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Omalizumab.,Omalizumab,DB00028
DB00051,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Adalimumab.,Adalimumab,DB00028
DB00054,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abciximab.,Abciximab,DB00028
DB00056,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00028
DB00057,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Indium In-111 satumomab pendetide.,Indium In-111 satumomab pendetide,DB00028
DB00065,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Infliximab.,Infliximab,DB00028
DB00072,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Trastuzumab.,Trastuzumab,DB00028
DB00073,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rituximab.,Rituximab,DB00028
DB00074,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Basiliximab.,Basiliximab,DB00028
DB00075,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Muromonab.,Muromonab,DB00028
DB00076,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Digoxin Immune Fab (Ovine).,Digoxin Immune Fab (Ovine),DB00028
DB00078,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00028
DB00081,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tositumomab.,Tositumomab,DB00028
DB00087,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Alemtuzumab.,Alemtuzumab,DB00028
DB00089,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Capromab pendetide.,Capromab pendetide,DB00028
DB00095,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Efalizumab.,Efalizumab,DB00028
DB00098,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit),DB00028
DB00108,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Natalizumab.,Natalizumab,DB00028
DB00110,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Palivizumab.,Palivizumab,DB00028
DB00111,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Daclizumab.,Daclizumab,DB00028
DB00112,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bevacizumab.,Bevacizumab,DB00028
DB00113,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Technetium Tc-99m arcitumomab.,Technetium Tc-99m arcitumomab,DB00028
DB01257,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eculizumab.,Eculizumab,DB00028
DB01269,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Panitumumab.,Panitumumab,DB00028
DB01270,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ranibizumab.,Ranibizumab,DB00028
DB04901,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Galiximab.,Galiximab,DB00028
DB04949,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pexelizumab.,Pexelizumab,DB00028
DB04956,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Afelimomab.,Afelimomab,DB00028
DB04958,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Epratuzumab.,Epratuzumab,DB00028
DB04962,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bectumomab.,Bectumomab,DB00028
DB04964,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Oregovomab.,Oregovomab,DB00028
DB04988,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with IGN311.,IGN311,DB00028
DB05006,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Adecatumumab.,Adecatumumab,DB00028
DB05097,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Labetuzumab.,Labetuzumab,DB00028
DB05101,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Matuzumab.,Matuzumab,DB00028
DB05111,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fontolizumab.,Fontolizumab,DB00028
DB05136,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bavituximab.,Bavituximab,DB00028
DB05139,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with CR002.,CR002,DB00028
DB05209,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rozrolimupab.,Rozrolimupab,DB00028
DB05304,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Girentuximab.,Girentuximab,DB00028
DB05336,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Obiltoxaximab.,Obiltoxaximab,DB00028
DB05405,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with XTL-001.,XTL-001,DB00028
DB05437,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with NAV 1800.,NAV 1800,DB00028
DB05459,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Briakinumab.,Briakinumab,DB00028
DB05496,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Otelixizumab.,Otelixizumab,DB00028
DB05545,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with AMG 108.,AMG 108,DB00028
DB05550,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Iratumumab.,Iratumumab,DB00028
DB05555,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Enokizumab.,Enokizumab,DB00028
DB05578,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ramucirumab.,Ramucirumab,DB00028
DB05595,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Farletuzumab.,Farletuzumab,DB00028
DB05656,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Veltuzumab.,Veltuzumab,DB00028
DB05679,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ustekinumab.,Ustekinumab,DB00028
DB05773,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00028
DB05793,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with PRO-542.,PRO-542,DB00028
DB05797,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with TNX-901.,TNX-901,DB00028
DB05889,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin,DB00028
DB05892,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with RI 624.,RI 624,DB00028
DB05915,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with MYO-029.,MYO-029,DB00028
DB05916,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with CT-011.,CT-011,DB00028
DB05941,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Leronlimab.,Leronlimab,DB00028
DB05996,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Glembatumumab vedotin.,Glembatumumab vedotin,DB00028
DB06043,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Olaratumab.,Olaratumab,DB00028
DB06049,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with IPH 2101.,IPH 2101,DB00028
DB06050,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with TB-402.,TB-402,DB00028
DB06081,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Caplacizumab.,Caplacizumab,DB00028
DB06101,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with IMC-1C11.,IMC-1C11,DB00028
DB06116,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eldelumab.,Eldelumab,DB00028
DB06162,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lumiliximab.,Lumiliximab,DB00028
DB06168,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Canakinumab.,Canakinumab,DB00028
DB06186,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ipilimumab.,Ipilimumab,DB00028
DB06192,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Nimotuzumab.,Nimotuzumab,DB00028
DB06241,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Clenoliximab.,Clenoliximab,DB00028
DB06273,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tocilizumab.,Tocilizumab,DB00028
DB06304,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with BIIB015.,BIIB015,DB00028
DB06305,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sonepcizumab.,Sonepcizumab,DB00028
DB06310,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Motavizumab.,Motavizumab,DB00028
DB06317,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Elotuzumab.,Elotuzumab,DB00028
DB06318,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with AVE9633.,AVE9633,DB00028
DB06322,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Carotuximab.,Carotuximab,DB00028
DB06324,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with XmAb 2513.,XmAb 2513,DB00028
DB06342,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Coltuximab ravtansine.,Coltuximab ravtansine,DB00028
DB06343,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Teprotumumab.,Teprotumumab,DB00028
DB06360,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lucatumumab.,Lucatumumab,DB00028
DB06366,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pertuzumab.,Pertuzumab,DB00028
DB06371,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Siplizumab.,Siplizumab,DB00028
DB06467,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Apolizumab.,Apolizumab,DB00028
DB06474,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sibrotuzumab.,Sibrotuzumab,DB00028
DB06550,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bivatuzumab.,Bivatuzumab,DB00028
DB06557,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lerdelimumab.,Lerdelimumab,DB00028
DB06599,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lexatumumab.,Lexatumumab,DB00028
DB06602,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Reslizumab.,Reslizumab,DB00028
DB06606,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Teplizumab.,Teplizumab,DB00028
DB06607,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Catumaxomab.,Catumaxomab,DB00028
DB06612,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mepolizumab.,Mepolizumab,DB00028
DB06643,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Denosumab.,Denosumab,DB00028
DB06647,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Volociximab.,Volociximab,DB00028
DB06650,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ofatumumab.,Ofatumumab,DB00028
DB06674,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Golimumab.,Golimumab,DB00028
DB08870,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Brentuximab vedotin.,Brentuximab vedotin,DB00028
DB08879,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Belimumab.,Belimumab,DB00028
DB08902,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Raxibacumab.,Raxibacumab,DB00028
DB08904,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Certolizumab pegol.,Certolizumab pegol,DB00028
DB08935,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Obinutuzumab.,Obinutuzumab,DB00028
DB09029,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Secukinumab.,Secukinumab,DB00028
DB09033,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vedolizumab.,Vedolizumab,DB00028
DB09035,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Nivolumab.,Nivolumab,DB00028
DB09036,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Siltuximab.,Siltuximab,DB00028
DB09037,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pembrolizumab.,Pembrolizumab,DB00028
DB09045,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dulaglutide.,Dulaglutide,DB00028
DB09052,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Blinatumomab.,Blinatumomab,DB00028
DB09057,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Anthrax immune globulin human.,Anthrax immune globulin human,DB00028
DB09077,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dinutuximab.,Dinutuximab,DB00028
DB09105,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Asfotase alfa.,Asfotase alfa,DB00028
DB09264,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Idarucizumab.,Idarucizumab,DB00028
DB09302,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Alirocumab.,Alirocumab,DB00028
DB09303,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Evolocumab.,Evolocumab,DB00028
DB09312,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse),DB00028
DB09331,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Daratumumab.,Daratumumab,DB00028
DB09559,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Necitumumab.,Necitumumab,DB00028
DB11569,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ixekizumab.,Ixekizumab,DB00028
DB11580,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ravulizumab.,Ravulizumab,DB00028
DB11595,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Atezolizumab.,Atezolizumab,DB00028
DB11604,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tetanus Immune Globulin.,Tetanus Immune Globulin,DB00028
DB11608,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eftrenonacog alfa.,Eftrenonacog alfa,DB00028
DB11621,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Human Varicella-Zoster Immune Globulin.,Human Varicella-Zoster Immune Globulin,DB00028
DB11646,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Conatumumab.,Conatumumab,DB00028
DB11657,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tabalumab.,Tabalumab,DB00028
DB11680,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ficlatuzumab.,Ficlatuzumab,DB00028
DB11685,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Figitumumab.,Figitumumab,DB00028
DB11714,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Durvalumab.,Durvalumab,DB00028
DB11715,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bapineuzumab.,Bapineuzumab,DB00028
DB11731,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Depatuxizumab mafodotin.,Depatuxizumab mafodotin,DB00028
DB11746,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Onartuzumab.,Onartuzumab,DB00028
DB11756,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Solanezumab.,Solanezumab,DB00028
DB11767,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sarilumab.,Sarilumab,DB00028
DB11771,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tremelimumab.,Tremelimumab,DB00028
DB11776,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Brodalumab.,Brodalumab,DB00028
DB11803,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sirukumab.,Sirukumab,DB00028
DB11826,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lampalizumab.,Lampalizumab,DB00028
DB11834,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Guselkumab.,Guselkumab,DB00028
DB11840,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dalotuzumab.,Dalotuzumab,DB00028
DB11849,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Emibetuzumab.,Emibetuzumab,DB00028
DB11850,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ublituximab.,Ublituximab,DB00028
DB11856,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ligelizumab.,Ligelizumab,DB00028
DB11857,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Seribantumab.,Seribantumab,DB00028
DB11862,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Landogrozumab.,Landogrozumab,DB00028
DB11866,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Romosozumab.,Romosozumab,DB00028
DB11884,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vadastuximab Talirine.,Vadastuximab Talirine,DB00028
DB11914,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lebrikizumab.,Lebrikizumab,DB00028
DB11930,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Varlilumab.,Varlilumab,DB00028
DB11945,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Avelumab.,Avelumab,DB00028
DB11959,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Crenezumab.,Crenezumab,DB00028
DB11972,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rilotumumab.,Rilotumumab,DB00028
DB11976,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Anifrolumab.,Anifrolumab,DB00028
DB11988,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ocrelizumab.,Ocrelizumab,DB00028
DB12023,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Benralizumab.,Benralizumab,DB00028
DB12034,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gantenerumab.,Gantenerumab,DB00028
DB12053,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Visilizumab.,Visilizumab,DB00028
DB12077,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Urelumab.,Urelumab,DB00028
DB12089,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine,DB00028
DB12090,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Patritumab.,Patritumab,DB00028
DB12102,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fulranumab.,Fulranumab,DB00028
DB12104,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tarextumab.,Tarextumab,DB00028
DB12118,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sotatercept.,Sotatercept,DB00028
DB12119,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gevokizumab.,Gevokizumab,DB00028
DB12142,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Duligotuzumab.,Duligotuzumab,DB00028
DB12152,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Simtuzumab.,Simtuzumab,DB00028
DB12157,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fasinumab.,Fasinumab,DB00028
DB12159,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dupilumab.,Dupilumab,DB00028
DB12169,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tralokinumab.,Tralokinumab,DB00028
DB12189,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Etrolizumab.,Etrolizumab,DB00028
DB12202,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Zalutumumab.,Zalutumumab,DB00028
DB12205,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ganitumab.,Ganitumab,DB00028
DB12213,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Etaracizumab.,Etaracizumab,DB00028
DB12240,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Polatuzumab vedotin.,Polatuzumab vedotin,DB00028
DB12246,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Inclacumab.,Inclacumab,DB00028
DB12250,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Cixutumumab.,Cixutumumab,DB00028
DB12261,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ascrinvacumab.,Ascrinvacumab,DB00028
DB12274,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Aducanumab.,Aducanumab,DB00028
DB12281,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Luspatercept.,Luspatercept,DB00028
DB12296,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with GS-5745.,GS-5745,DB00028
DB12317,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vanucizumab.,Vanucizumab,DB00028
DB12331,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Labetuzumab govitecan.,Labetuzumab govitecan,DB00028
DB12335,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tanezumab.,Tanezumab,DB00028
DB12342,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ensituximab.,Ensituximab,DB00028
DB12344,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fezakinumab.,Fezakinumab,DB00028
DB12363,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dusigitumab.,Dusigitumab,DB00028
DB12396,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fresolimumab.,Fresolimumab,DB00028
DB12413,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Indusatumab vedotin.,Indusatumab vedotin,DB00028
DB12456,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bococizumab.,Bococizumab,DB00028
DB12489,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mirvetuximab Soravtansine.,Mirvetuximab Soravtansine,DB00028
DB12498,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mogamulizumab.,Mogamulizumab,DB00028
DB12520,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Plozalizumab.,Plozalizumab,DB00028
DB12530,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Inebilizumab.,Inebilizumab,DB00028
DB12534,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mavrilimumab.,Mavrilimumab,DB00028
DB12560,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Blosozumab.,Blosozumab,DB00028
DB12584,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bimagrumab.,Bimagrumab,DB00028
DB12589,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dacetuzumab.,Dacetuzumab,DB00028
DB12609,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tovetumab.,Tovetumab,DB00028
DB12683,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lumretuzumab.,Lumretuzumab,DB00028
DB12698,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ibalizumab.,Ibalizumab,DB00028
DB12701,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Intetumumab.,Intetumumab,DB00028
DB12718,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Carlumab.,Carlumab,DB00028
DB12734,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Demcizumab.,Demcizumab,DB00028
DB12773,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sifalimumab.,Sifalimumab,DB00028
DB12775,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abituzumab.,Abituzumab,DB00028
DB12797,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ecromeximab.,Ecromeximab,DB00028
DB12807,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Naptumomab Estafenatox.,Naptumomab Estafenatox,DB00028
DB12815,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Crotedumab.,Crotedumab,DB00028
DB12820,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Concizumab.,Concizumab,DB00028
DB12826,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Depatuxizumab.,Depatuxizumab,DB00028
DB12844,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rontalizumab.,Rontalizumab,DB00028
DB12845,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Amatuximab.,Amatuximab,DB00028
DB12849,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Clazakizumab.,Clazakizumab,DB00028
DB12891,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ozanezumab.,Ozanezumab,DB00028
DB12893,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sacituzumab govitecan.,Sacituzumab govitecan,DB00028
DB12917,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bimekizumab.,Bimekizumab,DB00028
DB12943,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Milatuzumab.,Milatuzumab,DB00028
DB12976,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Robatumumab.,Robatumumab,DB00028
DB13017,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rovalpituzumab Tesirine.,Rovalpituzumab Tesirine,DB00028
DB13037,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Namilumab.,Namilumab,DB00028
DB13045,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Racotumomab.,Racotumomab,DB00028
DB13073,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tregalizumab.,Tregalizumab,DB00028
DB13127,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Olokizumab.,Olokizumab,DB00028
DB13140,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bezlotoxumab.,Bezlotoxumab,DB00028
DB13375,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Edrecolomab.,Edrecolomab,DB00028
DB13535,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Nebacumab.,Nebacumab,DB00028
DB13886,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Human cytomegalovirus immune globulin.,Human cytomegalovirus immune globulin,DB00028
DB13923,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Emicizumab.,Emicizumab,DB00028
DB13976,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sulesomab.,Sulesomab,DB00028
DB13979,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Besilesomab.,Besilesomab,DB00028
DB14004,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tildrakizumab.,Tildrakizumab,DB00028
DB14012,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Burosumab.,Burosumab,DB00028
DB14039,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Erenumab.,Erenumab,DB00028
DB14040,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eptinezumab.,Eptinezumab,DB00028
DB14041,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fremanezumab.,Fremanezumab,DB00028
DB14042,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Galcanezumab.,Galcanezumab,DB00028
DB14211,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fanolesomab.,Fanolesomab,DB00028
DB14580,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lecanemab.,Lecanemab,DB00028
DB14597,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lanadelumab.,Lanadelumab,DB00028
DB14707,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Cemiplimab.,Cemiplimab,DB00028
DB14724,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Emapalumab.,Emapalumab,DB00028
DB14762,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Risankizumab.,Risankizumab,DB00028
DB14776,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Camrelizumab.,Camrelizumab,DB00028
DB14778,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Setrusumab.,Setrusumab,DB00028
DB14784,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gancotamab.,Gancotamab,DB00028
DB14809,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Anetumab ravtansine.,Anetumab ravtansine,DB00028
DB14811,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Isatuximab.,Isatuximab,DB00028
DB14824,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Icrucumab.,Icrucumab,DB00028
DB14843,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Codrituzumab.,Codrituzumab,DB00028
DB14864,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Brolucizumab.,Brolucizumab,DB00028
DB14871,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Xentuzumab.,Xentuzumab,DB00028
DB14877,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lintuzumab.,Lintuzumab,DB00028
DB14891,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vobarilizumab.,Vobarilizumab,DB00028
DB14897,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Parsatuzumab.,Parsatuzumab,DB00028
DB14905,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Emactuzumab.,Emactuzumab,DB00028
DB14907,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bevacizumab zirconium Zr-89.,Bevacizumab zirconium Zr-89,DB00028
DB14908,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Refanezumab.,Refanezumab,DB00028
DB14919,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rozanolixizumab.,Rozanolixizumab,DB00028
DB14947,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bermekimab.,Bermekimab,DB00028
DB14952,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pamrevlumab.,Pamrevlumab,DB00028
DB14959,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Opicinumab.,Opicinumab,DB00028
DB14962,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Trastuzumab deruxtecan.,Trastuzumab deruxtecan,DB00028
DB14967,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Margetuximab.,Margetuximab,DB00028
DB14988,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dalantercept.,Dalantercept,DB00028
DB14997,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pateclizumab.,Pateclizumab,DB00028
DB15014,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gremubamab.,Gremubamab,DB00028
DB15022,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Apomab.,Apomab,DB00028
DB15044,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tafasitamab.,Tafasitamab,DB00028
DB15045,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ipafricept.,Ipafricept,DB00028
DB15076,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abrilumab.,Abrilumab,DB00028
DB15089,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Frovocimab.,Frovocimab,DB00028
DB15090,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tezepelumab.,Tezepelumab,DB00028
DB15101,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tigatuzumab.,Tigatuzumab,DB00028
DB15104,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Telisotuzumab vedotin.,Telisotuzumab vedotin,DB00028
DB15113,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Utomilumab.,Utomilumab,DB00028
DB15118,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Zolbetuximab.,Zolbetuximab,DB00028
DB15135,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ponezumab.,Ponezumab,DB00028
DB15160,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Asunercept.,Asunercept,DB00028
DB15172,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Suvratoxumab.,Suvratoxumab,DB00028
DB15225,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mitazalimab.,Mitazalimab,DB00028
DB15252,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Nemolizumab.,Nemolizumab,DB00028
DB15253,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bleselumab.,Bleselumab,DB00028
DB15277,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gedivumab.,Gedivumab,DB00028
DB15336,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Valanafusp alfa.,Valanafusp alfa,DB00028
DB15349,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sofituzumab vedotin.,Sofituzumab vedotin,DB00028
DB15354,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Evinacumab.,Evinacumab,DB00028
DB15363,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Istiratumab.,Istiratumab,DB00028
DB15383,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pidilizumab.,Pidilizumab,DB00028
DB15397,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with GMA-161.,GMA-161,DB00028
DB15409,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ladiratuzumab vedotin.,Ladiratuzumab vedotin,DB00028
DB15415,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tomaralimab.,Tomaralimab,DB00028
DB15428,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vesencumab.,Vesencumab,DB00028
DB15432,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pinatuzumab vedotin.,Pinatuzumab vedotin,DB00028
DB15441,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lulizumab pegol.,Lulizumab pegol,DB00028
DB15443,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lorukafusp alfa.,Lorukafusp alfa,DB00028
DB15453,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Naratuximab emtansine.,Naratuximab emtansine,DB00028
DB15559,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Zenocutuzumab.,Zenocutuzumab,DB00028
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Human immunoglobulin G.","Ebola Zaire vaccine (live, attenuated)",DB00028
DB06605,Apixaban may increase the anticoagulant activities of Anistreplase.,Apixaban,DB00029
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Anistreplase.,Dabigatran etexilate,DB00029
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Anistreplase.,Dasatinib,DB00029
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Anistreplase is combined with Deferasirox.,Deferasirox,DB00029
DB01586,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid,DB00029
DB02123,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid,DB00029
DB02659,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Cholic Acid.,Cholic Acid,DB00029
DB02691,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Glycocholic acid.,Glycocholic acid,DB00029
DB03619,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Deoxycholic acid.,Deoxycholic acid,DB00029
DB04348,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Taurocholic acid.,Taurocholic acid,DB00029
DB05990,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Obeticholic acid.,Obeticholic acid,DB00029
DB06777,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid,DB00029
DB08833,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid,DB00029
DB08834,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid,DB00029
DB08857,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Bamet-UD2.,Bamet-UD2,DB00029
DB11622,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Dehydrocholic acid.,Dehydrocholic acid,DB00029
DB11789,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid,DB00029
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Anistreplase.,Edoxaban,DB00029
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Anistreplase.,Ibrutinib,DB00029
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Anistreplase is combined with Obinutuzumab.,Obinutuzumab,DB00029
DB06228,Anistreplase may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban,DB00029
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Anistreplase is combined with Sugammadex.,Sugammadex,DB00029
DB09070,Tibolone may increase the anticoagulant activities of Anistreplase.,Tibolone,DB00029
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Anistreplase.,Tipranavir,DB00029
DB00013,Urokinase may increase the anticoagulant activities of Anistreplase.,Urokinase,DB00029
DB00163,Vitamin E may increase the anticoagulant activities of Anistreplase.,Vitamin E,DB00029
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Anistreplase.,Vorapaxar,DB00029
DB06692,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Aprotinin.,Aprotinin,DB00029
DB01381,The therapeutic efficacy of Anistreplase can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba,DB00029
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Anistreplase.,Ifosfamide,DB00029
DB00468,The therapeutic efficacy of Anistreplase can be increased when used in combination with Quinine.,Quinine,DB00029
DB00908,The therapeutic efficacy of Anistreplase can be increased when used in combination with Quinidine.,Quinidine,DB00029
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Anistreplase.,Tamoxifen,DB00029
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Anistreplase.,Toremifene,DB00029
DB00806,The therapeutic efficacy of Anistreplase can be increased when used in combination with Pentoxifylline.,Pentoxifylline,DB00029
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Anistreplase.,Pentosan polysulfate,DB00029
DB00583,The therapeutic efficacy of Anistreplase can be increased when used in combination with Levocarnitine.,Levocarnitine,DB00029
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Anistreplase.,Diethylstilbestrol,DB00029
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Anistreplase.,Chlorotrianisene,DB00029
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Anistreplase.,Conjugated estrogens,DB00029
DB00783,Estradiol may decrease the anticoagulant activities of Anistreplase.,Estradiol,DB00029
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Anistreplase.,Ethinylestradiol,DB00029
DB01357,Mestranol may decrease the anticoagulant activities of Anistreplase.,Mestranol,DB00029
DB04573,Estriol may decrease the anticoagulant activities of Anistreplase.,Estriol,DB00029
DB04574,Estrone sulfate may decrease the anticoagulant activities of Anistreplase.,Estrone sulfate,DB00029
DB04575,Quinestrol may decrease the anticoagulant activities of Anistreplase.,Quinestrol,DB00029
DB07931,Hexestrol may decrease the anticoagulant activities of Anistreplase.,Hexestrol,DB00029
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Anistreplase.","Synthetic Conjugated Estrogens, A",DB00029
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Anistreplase.","Synthetic Conjugated Estrogens, B",DB00029
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Anistreplase.,Polyestradiol phosphate,DB00029
DB09381,Esterified estrogens may decrease the anticoagulant activities of Anistreplase.,Esterified estrogens,DB00029
DB11478,Zeranol may decrease the anticoagulant activities of Anistreplase.,Zeranol,DB00029
DB11674,Equol may decrease the anticoagulant activities of Anistreplase.,Equol,DB00029
DB12487,Promestriene may decrease the anticoagulant activities of Anistreplase.,Promestriene,DB00029
DB13143,Methallenestril may decrease the anticoagulant activities of Anistreplase.,Methallenestril,DB00029
DB13386,Epimestrol may decrease the anticoagulant activities of Anistreplase.,Epimestrol,DB00029
DB13418,Moxestrol may decrease the anticoagulant activities of Anistreplase.,Moxestrol,DB00029
DB13952,Estradiol acetate may decrease the anticoagulant activities of Anistreplase.,Estradiol acetate,DB00029
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Anistreplase.,Estradiol benzoate,DB00029
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Anistreplase.,Estradiol cypionate,DB00029
DB13956,Estradiol valerate may decrease the anticoagulant activities of Anistreplase.,Estradiol valerate,DB00029
DB15334,Biochanin A may decrease the anticoagulant activities of Anistreplase.,Biochanin A,DB00029
DB15335,Formononetin may decrease the anticoagulant activities of Anistreplase.,Formononetin,DB00029
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Anistreplase.,Icosapent,DB00029
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Anistreplase.,Mesalazine,DB00029
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Anistreplase.,Indomethacin,DB00029
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Anistreplase.,Nabumetone,DB00029
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Anistreplase.,Ketorolac,DB00029
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Anistreplase.,Tenoxicam,DB00029
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Anistreplase.,Celecoxib,DB00029
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Anistreplase.,Tolmetin,DB00029
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Anistreplase.,Rofecoxib,DB00029
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Anistreplase.,Piroxicam,DB00029
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Anistreplase.,Fenoprofen,DB00029
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Anistreplase.,Valdecoxib,DB00029
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Anistreplase.,Diclofenac,DB00029
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Anistreplase.,Sulindac,DB00029
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Anistreplase.,Flurbiprofen,DB00029
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Anistreplase.,Etodolac,DB00029
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Anistreplase.,Mefenamic acid,DB00029
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Anistreplase.,Naproxen,DB00029
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Anistreplase.,Sulfasalazine,DB00029
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Anistreplase.,Phenylbutazone,DB00029
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Anistreplase.,Meloxicam,DB00029
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Anistreplase.,Carprofen,DB00029
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Anistreplase.,Diflunisal,DB00029
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Anistreplase.,Salicylic acid,DB00029
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Anistreplase.,Meclofenamic acid,DB00029
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Anistreplase.,Oxaprozin,DB00029
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Anistreplase.,Ketoprofen,DB00029
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Anistreplase.,Balsalazide,DB00029
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Anistreplase.,Olsalazine,DB00029
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Anistreplase.,Lumiracoxib,DB00029
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Anistreplase.,Magnesium salicylate,DB00029
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Anistreplase.,Salsalate,DB00029
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Anistreplase.,Choline magnesium trisalicylate,DB00029
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Anistreplase.,Antrafenine,DB00029
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Anistreplase.,Aminophenazone,DB00029
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Anistreplase.,Antipyrine,DB00029
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Anistreplase.,Tiaprofenic acid,DB00029
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Anistreplase.,Etoricoxib,DB00029
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Anistreplase.,Taxifolin,DB00029
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Anistreplase.,Oxyphenbutazone,DB00029
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Anistreplase.,Niflumic acid,DB00029
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Anistreplase.,Licofelone,DB00029
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Anistreplase.,Benoxaprofen,DB00029
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Anistreplase.,Metamizole,DB00029
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Anistreplase.,Zomepirac,DB00029
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Anistreplase.,Cimicoxib,DB00029
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Anistreplase.,Lornoxicam,DB00029
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Anistreplase.,Aceclofenac,DB00029
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Anistreplase.,Zaltoprofen,DB00029
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Anistreplase.,Azapropazone,DB00029
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Anistreplase.,Felbinac,DB00029
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Anistreplase.,Parecoxib,DB00029
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Anistreplase.,Salicylamide,DB00029
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Anistreplase.,Kebuzone,DB00029
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Anistreplase.,Isoxicam,DB00029
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Anistreplase.,Indoprofen,DB00029
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Anistreplase.,Ibuproxam,DB00029
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Anistreplase.,Floctafenine,DB00029
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Anistreplase.,Fenbufen,DB00029
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Anistreplase.,Etofenamate,DB00029
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Anistreplase.,Epirizole,DB00029
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Anistreplase.,Benzydamine,DB00029
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Anistreplase.,Loxoprofen,DB00029
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Anistreplase.,Dexketoprofen,DB00029
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Anistreplase.,Droxicam,DB00029
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Anistreplase.,Tolfenamic acid,DB00029
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Anistreplase.,Firocoxib,DB00029
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Anistreplase.,Clonixin,DB00029
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Anistreplase.,Morniflumate,DB00029
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Anistreplase.,Propacetamol,DB00029
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Anistreplase.,Talniflumate,DB00029
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Anistreplase.,Robenacoxib,DB00029
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Anistreplase.,Tepoxalin,DB00029
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Anistreplase.,Flunixin,DB00029
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Anistreplase.,Polmacoxib,DB00029
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Anistreplase.,Betulinic Acid,DB00029
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Anistreplase.,Ebselen,DB00029
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Anistreplase.,Tinoridine,DB00029
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Anistreplase.,Alclofenac,DB00029
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Anistreplase.,Fentiazac,DB00029
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Anistreplase.,Suxibuzone,DB00029
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Anistreplase.,Bumadizone,DB00029
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Anistreplase.,Alminoprofen,DB00029
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Anistreplase.,Flunoxaprofen,DB00029
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Anistreplase.,Feprazone,DB00029
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Anistreplase.,Difenpiramide,DB00029
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Anistreplase.,Nifenazone,DB00029
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Anistreplase.,Lonazolac,DB00029
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Anistreplase.,Tenidap,DB00029
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Anistreplase.,Bendazac,DB00029
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Anistreplase.,Pranoprofen,DB00029
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Anistreplase.,Propyphenazone,DB00029
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Anistreplase.,Proglumetacin,DB00029
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Anistreplase.,Guacetisal,DB00029
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Anistreplase.,Ethenzamide,DB00029
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Anistreplase.,Carbaspirin calcium,DB00029
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Anistreplase.,Mofebutazone,DB00029
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Anistreplase.,Proquazone,DB00029
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Anistreplase.,Benorilate,DB00029
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Anistreplase.,Pirprofen,DB00029
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Anistreplase.,Imidazole salicylate,DB00029
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Anistreplase.,SC-236,DB00029
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Anistreplase.,NS-398,DB00029
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Anistreplase.,Flurbiprofen axetil,DB00029
DB04865,The risk or severity of bleeding can be increased when Anistreplase is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate,DB00029
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Anistreplase.,Omega-3 fatty acids,DB00029
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Anistreplase is combined with Tositumomab.,Tositumomab,DB00029
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Anistreplase.,Limaprost,DB00029
DB00048,The risk or severity of adverse effects can be increased when Anistreplase is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum,DB00029
DB00389,Carbimazole may increase the anticoagulant activities of Anistreplase.,Carbimazole,DB00029
DB00550,Propylthiouracil may increase the anticoagulant activities of Anistreplase.,Propylthiouracil,DB00029
DB00763,Methimazole may increase the anticoagulant activities of Anistreplase.,Methimazole,DB00029
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Anistreplase.","3,5-Diiodotyrosine",DB00029
DB06715,Potassium Iodide may increase the anticoagulant activities of Anistreplase.,Potassium Iodide,DB00029
DB07637,Dibromotyrosine may increase the anticoagulant activities of Anistreplase.,Dibromotyrosine,DB00029
DB09418,Potassium perchlorate may increase the anticoagulant activities of Anistreplase.,Potassium perchlorate,DB00029
DB13644,Methylthiouracil may increase the anticoagulant activities of Anistreplase.,Methylthiouracil,DB00029
DB13804,Benzylthiouracil may increase the anticoagulant activities of Anistreplase.,Benzylthiouracil,DB00029
DB00834,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Mifepristone.,Mifepristone,DB00029
DB04066,The therapeutic efficacy of Anistreplase can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid,DB00029
DB04682,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol,DB00029
DB05830,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Trestolone.,Trestolone,DB00029
DB06266,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Lonidamine.,Lonidamine,DB00029
DB08867,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ulipristal.,Ulipristal,DB00029
DB09401,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Isosorbide.,Isosorbide,DB00029
DB11507,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cloprostenol.,Cloprostenol,DB00029
DB12025,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Triptolide.,Triptolide,DB00029
DB13044,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Gossypol.,Gossypol,DB00029
DB13310,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ormeloxifene.,Ormeloxifene,DB00029
DB00294,Etonogestrel may decrease the anticoagulant activities of Anistreplase.,Etonogestrel,DB00029
DB00304,Desogestrel may decrease the anticoagulant activities of Anistreplase.,Desogestrel,DB00029
DB00351,Megestrol acetate may decrease the anticoagulant activities of Anistreplase.,Megestrol acetate,DB00029
DB00367,Levonorgestrel may decrease the anticoagulant activities of Anistreplase.,Levonorgestrel,DB00029
DB00378,Dydrogesterone may decrease the anticoagulant activities of Anistreplase.,Dydrogesterone,DB00029
DB00396,Progesterone may decrease the anticoagulant activities of Anistreplase.,Progesterone,DB00029
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Anistreplase.,Medroxyprogesterone acetate,DB00029
DB00717,Norethisterone may decrease the anticoagulant activities of Anistreplase.,Norethisterone,DB00029
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Anistreplase.,Ethynodiol diacetate,DB00029
DB00957,Norgestimate may decrease the anticoagulant activities of Anistreplase.,Norgestimate,DB00029
DB01395,Drospirenone may decrease the anticoagulant activities of Anistreplase.,Drospirenone,DB00029
DB01431,Allylestrenol may decrease the anticoagulant activities of Anistreplase.,Allylestrenol,DB00029
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Anistreplase.,Cyproterone acetate,DB00029
DB06713,Norelgestromin may decrease the anticoagulant activities of Anistreplase.,Norelgestromin,DB00029
DB06730,Gestodene may decrease the anticoagulant activities of Anistreplase.,Gestodene,DB00029
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Anistreplase.,Hydroxyprogesterone caproate,DB00029
DB09123,Dienogest may decrease the anticoagulant activities of Anistreplase.,Dienogest,DB00029
DB09124,Medrogestone may decrease the anticoagulant activities of Anistreplase.,Medrogestone,DB00029
DB09371,Norethynodrel may decrease the anticoagulant activities of Anistreplase.,Norethynodrel,DB00029
DB09389,Norgestrel may decrease the anticoagulant activities of Anistreplase.,Norgestrel,DB00029
DB11372,Altrenogest may decrease the anticoagulant activities of Anistreplase.,Altrenogest,DB00029
DB11619,Gestrinone may decrease the anticoagulant activities of Anistreplase.,Gestrinone,DB00029
DB11636,Nomegestrol may decrease the anticoagulant activities of Anistreplase.,Nomegestrol,DB00029
DB12474,Lynestrenol may decrease the anticoagulant activities of Anistreplase.,Lynestrenol,DB00029
DB13230,Gestonorone may decrease the anticoagulant activities of Anistreplase.,Gestonorone,DB00029
DB13528,Chlormadinone may decrease the anticoagulant activities of Anistreplase.,Chlormadinone,DB00029
DB13533,Methylestrenolone may decrease the anticoagulant activities of Anistreplase.,Methylestrenolone,DB00029
DB13563,Norgestrienone may decrease the anticoagulant activities of Anistreplase.,Norgestrienone,DB00029
DB13602,Promegestone may decrease the anticoagulant activities of Anistreplase.,Promegestone,DB00029
DB13685,Quingestanol may decrease the anticoagulant activities of Anistreplase.,Quingestanol,DB00029
DB13857,Demegestone may decrease the anticoagulant activities of Anistreplase.,Demegestone,DB00029
DB13866,Etynodiol may decrease the anticoagulant activities of Anistreplase.,Etynodiol,DB00029
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Anistreplase.,Nomegestrol acetate,DB00029
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Anistreplase.,Hydroxyprogesterone,DB00029
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Anistreplase.,Norethindrone enanthate,DB00029
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Anistreplase.,Quingestanol acetate,DB00029
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Anistreplase.,Aminosalicylic acid,DB00029
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Anistreplase.,Bismuth subsalicylate,DB00029
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Anistreplase.,Dersalazine,DB00029
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Anistreplase.,Phenyl aminosalicylate,DB00029
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Anistreplase.,Methyl salicylate,DB00029
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Anistreplase.,Trolamine salicylate,DB00029
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Anistreplase.,Aloxiprin,DB00029
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Anistreplase.,Choline salicylate,DB00029
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Anistreplase.,Thiosalicylic acid,DB00029
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Anistreplase.,Abciximab,DB00029
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Anistreplase.,Eptifibatide,DB00029
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Anistreplase.,Ticlopidine,DB00029
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Anistreplase.,Anagrelide,DB00029
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Anistreplase.,Clopidogrel,DB00029
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Anistreplase.,Tirofiban,DB00029
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Anistreplase.,Dipyridamole,DB00029
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Anistreplase.,Iloprost,DB00029
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Anistreplase.,Sulfinpyrazone,DB00029
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Anistreplase.,Cilostazol,DB00029
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Anistreplase.,Ridogrel,DB00029
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Anistreplase.,Sevoflurane,DB00029
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Anistreplase.,Epoprostenol,DB00029
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Anistreplase.,Resveratrol,DB00029
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Anistreplase.,Nimesulide,DB00029
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Anistreplase.,Tesmilifene,DB00029
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Anistreplase.,Defibrotide,DB00029
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Anistreplase.,Beraprost,DB00029
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Anistreplase.,Ibudilast,DB00029
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Anistreplase.,Andrographolide,DB00029
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Anistreplase.,Caplacizumab,DB00029
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Anistreplase.,Prasugrel,DB00029
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Anistreplase.,Cangrelor,DB00029
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Anistreplase.,Tranilast,DB00029
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Anistreplase.,Triflusal,DB00029
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Anistreplase.,Ticagrelor,DB00029
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Anistreplase.,Icosapent ethyl,DB00029
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Anistreplase.,Trapidil,DB00029
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Anistreplase.,Naftopidil,DB00029
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Anistreplase.,Sarpogrelate,DB00029
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Anistreplase.,Ifetroban,DB00029
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Anistreplase.,Nitroaspirin,DB00029
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Anistreplase.,Ketanserin,DB00029
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Anistreplase.,Indobufen,DB00029
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Anistreplase.,Butylphthalide,DB00029
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Anistreplase.,Hydroxytyrosol,DB00029
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Anistreplase.,Ramatroban,DB00029
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Anistreplase.,Picotamide,DB00029
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Anistreplase.,Cloricromen,DB00029
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Anistreplase.,Linsidomine,DB00029
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Anistreplase.,Buflomedil,DB00029
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Anistreplase.,Relcovaptan,DB00029
DB00374,The risk or severity of adverse effects can be increased when Anistreplase is combined with Treprostinil.,Treprostinil,DB00029
DB03404,Hemin may increase the anticoagulant activities of Anistreplase.,Hemin,DB00029
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Anistreplase.,Acemetacin,DB00029
DB00624,Testosterone may increase the anticoagulant activities of Anistreplase.,Testosterone,DB00029
DB01420,Testosterone propionate may increase the anticoagulant activities of Anistreplase.,Testosterone propionate,DB00029
DB01481,1-Testosterone may increase the anticoagulant activities of Anistreplase.,1-Testosterone,DB00029
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Anistreplase.,4-Hydroxytestosterone,DB00029
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Anistreplase.,Dehydrochloromethyltestosterone,DB00029
DB01541,Boldenone may increase the anticoagulant activities of Anistreplase.,Boldenone,DB00029
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Anistreplase.,18-methyl-19-nortestosterone,DB00029
DB01564,Calusterone may increase the anticoagulant activities of Anistreplase.,Calusterone,DB00029
DB01569,Formebolone may increase the anticoagulant activities of Anistreplase.,Formebolone,DB00029
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Anistreplase.,Methyl-1-testosterone,DB00029
DB02901,Stanolone may increase the anticoagulant activities of Anistreplase.,Stanolone,DB00029
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Anistreplase.,5beta-dihydrotestosterone,DB00029
DB08619,Testosterone succinate may increase the anticoagulant activities of Anistreplase.,Testosterone succinate,DB00029
DB11429,Mibolerone may increase the anticoagulant activities of Anistreplase.,Mibolerone,DB00029
DB13943,Testosterone cypionate may increase the anticoagulant activities of Anistreplase.,Testosterone cypionate,DB00029
DB13944,Testosterone enanthate may increase the anticoagulant activities of Anistreplase.,Testosterone enanthate,DB00029
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Anistreplase.,Testosterone undecanoate,DB00029
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Anistreplase.,Testosterone enantate benzilic acid hydrazone,DB00029
DB13951,Stanolone acetate may increase the anticoagulant activities of Anistreplase.,Stanolone acetate,DB00029
DB13958,Trestolone acetate may increase the anticoagulant activities of Anistreplase.,Trestolone acetate,DB00029
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Anistreplase.","(1,2,6,7-3H)Testosterone",DB00029
DB14655,Drostanolone propionate may increase the anticoagulant activities of Anistreplase.,Drostanolone propionate,DB00029
DB11051,The risk or severity of adverse effects can be increased when Anistreplase is combined with Azficel-T.,Azficel-T,DB00029
DB09568,The therapeutic efficacy of Anistreplase can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids,DB00029
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Anistreplase.,Calcium acetate,DB00029
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Anistreplase.,Calcium chloride,DB00029
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Anistreplase.,Calcium,DB00029
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Anistreplase.,Calcium gluconate,DB00029
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Anistreplase.,Eftrenonacog alfa,DB00029
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Anistreplase.,Albutrepenonacog alfa,DB00029
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Anistreplase.,Emicizumab,DB00029
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Anistreplase.,Turoctocog alfa pegol,DB00029
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Anistreplase.","Antihemophilic factor, human recombinant",DB00029
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Anistreplase.,Coagulation factor VIIa Recombinant Human,DB00029
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Anistreplase.,Coagulation Factor IX (Recombinant),DB00029
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Anistreplase.,Pantothenic acid,DB00029
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Anistreplase.,Formic acid,DB00029
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Anistreplase.,Platelet Activating Factor,DB00029
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Anistreplase.,Calcium carbonate,DB00029
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Anistreplase.,Turoctocog alfa,DB00029
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Anistreplase.,Fibrinogen human,DB00029
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Anistreplase.,Catridecacog,DB00029
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Anistreplase.","Antihemophilic Factor (Recombinant), PEGylated",DB00029
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Anistreplase.,Calcium citrate,DB00029
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Anistreplase.,Calcium threonate,DB00029
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Anistreplase.,Prothrombin,DB00029
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Anistreplase.,Factor IX Complex (Human),DB00029
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Anistreplase.,Calcium Phosphate,DB00029
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Anistreplase.,Susoctocog alfa,DB00029
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Anistreplase.,Rusalatide acetate,DB00029
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Anistreplase.,Vatreptacog alfa,DB00029
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Anistreplase.,Factor XIII (human),DB00029
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Anistreplase.,Von Willebrand Factor Human,DB00029
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Anistreplase.,Coagulation factor X human,DB00029
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Anistreplase.,Coagulation factor VII human,DB00029
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Anistreplase.,Anti-inhibitor coagulant complex,DB00029
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Anistreplase.,Coagulation Factor IX Human,DB00029
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Anistreplase.,Antihemophilic factor human,DB00029
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Anistreplase.,Kallidinogenase,DB00029
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Anistreplase.,Trenonacog alfa,DB00029
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Anistreplase.,Nonacog beta pegol,DB00029
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Anistreplase.,Moroctocog alfa,DB00029
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Anistreplase.,Beroctocog alfa,DB00029
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Anistreplase.,Andexanet alfa,DB00029
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Anistreplase.,Calcium cation,DB00029
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Anistreplase.,Damoctocog alfa pegol,DB00029
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Anistreplase.,Fluvoxamine,DB00029
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Anistreplase.,Citalopram,DB00029
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Anistreplase.,Fluoxetine,DB00029
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Anistreplase.,Paroxetine,DB00029
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Anistreplase.,Nefazodone,DB00029
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Anistreplase.,Zimelidine,DB00029
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Anistreplase.,Dapoxetine,DB00029
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Anistreplase.,Seproxetine,DB00029
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Anistreplase.,Indalpine,DB00029
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Anistreplase.,Ritanserin,DB00029
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Anistreplase.,Alaproclate,DB00029
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Anistreplase.,Duloxetine,DB00029
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Anistreplase.,Sibutramine,DB00029
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Anistreplase.,Milnacipran,DB00029
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Anistreplase.,Desvenlafaxine,DB00029
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Anistreplase.,Levomilnacipran,DB00029
DB00285,Venlafaxine may increase the antiplatelet activities of Anistreplase.,Venlafaxine,DB00029
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Anistreplase.,Amphetamine,DB00029
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Anistreplase.,Linezolid,DB00029
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Anistreplase.,Furazolidone,DB00029
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Anistreplase.,Procaine,DB00029
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Anistreplase.,Tranylcypromine,DB00029
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Anistreplase.,Phenelzine,DB00029
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Anistreplase.,Minaprine,DB00029
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Anistreplase.,Selegiline,DB00029
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Anistreplase.,Procarbazine,DB00029
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Anistreplase.,Moclobemide,DB00029
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Anistreplase.,Isocarboxazid,DB00029
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Anistreplase.,Rasagiline,DB00029
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Anistreplase.,Pargyline,DB00029
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Anistreplase.,Clorgiline,DB00029
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Anistreplase.,Iproniazid,DB00029
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Anistreplase.,Nialamide,DB00029
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Anistreplase.,Safinamide,DB00029
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Anistreplase.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",DB00029
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Anistreplase.,Methylene blue,DB00029
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Anistreplase.,Hydracarbazine,DB00029
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Anistreplase.,Pirlindole,DB00029
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Anistreplase.,Toloxatone,DB00029
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Anistreplase.,Benmoxin,DB00029
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Anistreplase.,Mebanazine,DB00029
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Anistreplase.,Octamoxin,DB00029
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Anistreplase.,Pheniprazine,DB00029
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Anistreplase.,Phenoxypropazine,DB00029
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Anistreplase.,Pivhydrazine,DB00029
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Anistreplase.,Safrazine,DB00029
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Anistreplase.,Caroxazone,DB00029
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Anistreplase.,Harmaline,DB00029
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Anistreplase.,Brofaromine,DB00029
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Anistreplase.,Bivalirudin,DB00029
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Anistreplase.,Dicoumarol,DB00029
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Anistreplase.,Argatroban,DB00029
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Anistreplase.,Ardeparin,DB00029
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Anistreplase.,Phenindione,DB00029
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Anistreplase.,Fondaparinux,DB00029
DB00682,The risk or severity of bleeding can be increased when Warfarin is combined with Anistreplase.,Warfarin,DB00029
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Anistreplase.,Phenprocoumon,DB00029
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Anistreplase.,Edetic acid,DB00029
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Anistreplase.,Heparin,DB00029
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Anistreplase.,Enoxaparin,DB00029
DB01418,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Anistreplase.,Acenocoumarol,DB00029
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Anistreplase.,Ximelagatran,DB00029
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Anistreplase.,Ancrod,DB00029
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Anistreplase.,Sulodexide,DB00029
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Anistreplase.,Idraparinux,DB00029
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Anistreplase.,Otamixaban,DB00029
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Anistreplase.,Danaparoid,DB00029
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Anistreplase.,Dalteparin,DB00029
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Anistreplase.,Ferulic acid,DB00029
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Anistreplase.,Ethyl biscoumacetate,DB00029
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Anistreplase.,Nadroparin,DB00029
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Anistreplase.,Dextran,DB00029
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Anistreplase.,Reviparin,DB00029
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Anistreplase.,Certoparin,DB00029
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Anistreplase.,Desirudin,DB00029
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Anistreplase.,Protocatechualdehyde,DB00029
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Anistreplase.,Protein C,DB00029
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Anistreplase.,Antithrombin III human,DB00029
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Anistreplase.,Letaxaban,DB00029
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Anistreplase.,Darexaban,DB00029
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Anistreplase.,Nafamostat,DB00029
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Anistreplase.,Gabexate,DB00029
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Anistreplase.,Troxerutin,DB00029
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Anistreplase.,Fluindione,DB00029
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Anistreplase.,Protein S human,DB00029
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Anistreplase.,Melagatran,DB00029
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Anistreplase.,Potassium citrate,DB00029
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Anistreplase.,Sodium citrate,DB00029
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Anistreplase.,Tenecteplase,DB00029
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Anistreplase.,Drotrecogin alfa,DB00029
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Anistreplase.,Tinzaparin,DB00029
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Anistreplase.,Brinase,DB00029
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Anistreplase.,Saruplase,DB00029
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Anistreplase.,Streptokinase,DB00029
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Anistreplase.,Desmoteplase,DB00029
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Anistreplase.,Fibrinolysin,DB00029
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Anistreplase.,Astaxanthin,DB00029
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Anistreplase.,Ditazole,DB00029
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Anistreplase.,Bemiparin,DB00029
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Anistreplase.,Parnaparin,DB00029
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Anistreplase.,Clorindione,DB00029
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Anistreplase.,Diphenadione,DB00029
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Anistreplase.,Tioclomarol,DB00029
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Anistreplase.,Lepirudin,DB00029
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Anistreplase.,Alteplase,DB00029
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Anistreplase.,Reteplase,DB00029
DB14094,The risk or severity of bleeding can be increased when Anistreplase is combined with Tocopherylquinone.,Tocopherylquinone,DB00029
DB06679,The risk or severity of bleeding can be increased when Anistreplase is combined with Amediplase.,Amediplase,DB00029
DB03410,The risk or severity of bleeding can be increased when Anistreplase is combined with 4-hydroxycoumarin.,4-hydroxycoumarin,DB00029
DB08496,The risk or severity of bleeding can be increased when Anistreplase is combined with (R)-warfarin.,(R)-warfarin,DB00029
DB14055,The risk or severity of bleeding can be increased when Anistreplase is combined with (S)-Warfarin.,(S)-Warfarin,DB00029
DB12364,The risk or severity of bleeding can be increased when Anistreplase is combined with Betrixaban.,Betrixaban,DB00029
DB14598,The risk or severity of bleeding can be increased when Anistreplase is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous,DB00029
DB11154,The risk or severity of bleeding can be increased when Anistreplase is combined with Zinc citrate.,Zinc citrate,DB00029
DB11166,The risk or severity of bleeding can be increased when Anistreplase is combined with Antithrombin Alfa.,Antithrombin Alfa,DB00029
DB04665,The risk or severity of bleeding can be increased when Anistreplase is combined with Coumarin.,Coumarin,DB00029
DB14726,The risk or severity of bleeding can be increased when Anistreplase is combined with Dabigatran.,Dabigatran,DB00029
DB06294,The risk or severity of bleeding can be increased when Anistreplase is combined with Semuloparin.,Semuloparin,DB00029
DB12726,The risk or severity of bleeding can be increased when Anistreplase is combined with Monteplase.,Monteplase,DB00029
DB00177,The risk or severity of angioedema can be increased when Anistreplase is combined with Valsartan.,Valsartan,DB00029
DB00178,The risk or severity of angioedema can be increased when Anistreplase is combined with Ramipril.,Ramipril,DB00029
DB00230,The risk or severity of angioedema can be increased when Anistreplase is combined with Pregabalin.,Pregabalin,DB00029
DB00492,The risk or severity of angioedema can be increased when Anistreplase is combined with Fosinopril.,Fosinopril,DB00029
DB00519,The risk or severity of angioedema can be increased when Anistreplase is combined with Trandolapril.,Trandolapril,DB00029
DB00542,The risk or severity of angioedema can be increased when Anistreplase is combined with Benazepril.,Benazepril,DB00029
DB00584,The risk or severity of angioedema can be increased when Anistreplase is combined with Enalapril.,Enalapril,DB00029
DB00678,The risk or severity of angioedema can be increased when Anistreplase is combined with Losartan.,Losartan,DB00029
DB00691,The risk or severity of angioedema can be increased when Anistreplase is combined with Moexipril.,Moexipril,DB00029
DB00722,The risk or severity of angioedema can be increased when Anistreplase is combined with Lisinopril.,Lisinopril,DB00029
DB00790,The risk or severity of angioedema can be increased when Anistreplase is combined with Perindopril.,Perindopril,DB00029
DB00876,The risk or severity of angioedema can be increased when Anistreplase is combined with Eprosartan.,Eprosartan,DB00029
DB00877,The risk or severity of angioedema can be increased when Anistreplase is combined with Sirolimus.,Sirolimus,DB00029
DB00881,The risk or severity of angioedema can be increased when Anistreplase is combined with Quinapril.,Quinapril,DB00029
DB00886,The risk or severity of angioedema can be increased when Anistreplase is combined with Omapatrilat.,Omapatrilat,DB00029
DB00966,The risk or severity of angioedema can be increased when Anistreplase is combined with Telmisartan.,Telmisartan,DB00029
DB01050,The risk or severity of angioedema can be increased when Anistreplase is combined with Ibuprofen.,Ibuprofen,DB00029
DB01180,The risk or severity of angioedema can be increased when Anistreplase is combined with Rescinnamine.,Rescinnamine,DB00029
DB01197,The risk or severity of angioedema can be increased when Anistreplase is combined with Captopril.,Captopril,DB00029
DB01261,The risk or severity of angioedema can be increased when Anistreplase is combined with Sitagliptin.,Sitagliptin,DB00029
DB01340,The risk or severity of angioedema can be increased when Anistreplase is combined with Cilazapril.,Cilazapril,DB00029
DB01342,The risk or severity of angioedema can be increased when Anistreplase is combined with Forasartan.,Forasartan,DB00029
DB01347,The risk or severity of angioedema can be increased when Anistreplase is combined with Saprisartan.,Saprisartan,DB00029
DB01348,The risk or severity of angioedema can be increased when Anistreplase is combined with Spirapril.,Spirapril,DB00029
DB04876,The risk or severity of angioedema can be increased when Anistreplase is combined with Vildagliptin.,Vildagliptin,DB00029
DB06011,The risk or severity of angioedema can be increased when Anistreplase is combined with AMG-222.,AMG-222,DB00029
DB06127,The risk or severity of angioedema can be increased when Anistreplase is combined with Bisegliptin.,Bisegliptin,DB00029
DB06196,The risk or severity of angioedema can be increased when Anistreplase is combined with Icatibant.,Icatibant,DB00029
DB06203,The risk or severity of angioedema can be increased when Anistreplase is combined with Alogliptin.,Alogliptin,DB00029
DB06245,The risk or severity of angioedema can be increased when Anistreplase is combined with Lanoteplase.,Lanoteplase,DB00029
DB06287,The risk or severity of angioedema can be increased when Anistreplase is combined with Temsirolimus.,Temsirolimus,DB00029
DB06335,The risk or severity of angioedema can be increased when Anistreplase is combined with Saxagliptin.,Saxagliptin,DB00029
DB08382,The risk or severity of angioedema can be increased when Anistreplase is combined with Gosogliptin.,Gosogliptin,DB00029
DB08822,The risk or severity of angioedema can be increased when Anistreplase is combined with Azilsartan medoxomil.,Azilsartan medoxomil,DB00029
DB08836,The risk or severity of angioedema can be increased when Anistreplase is combined with Temocapril.,Temocapril,DB00029
DB08882,The risk or severity of angioedema can be increased when Anistreplase is combined with Linagliptin.,Linagliptin,DB00029
DB09292,The risk or severity of angioedema can be increased when Anistreplase is combined with Sacubitril.,Sacubitril,DB00029
DB09477,The risk or severity of angioedema can be increased when Anistreplase is combined with Enalaprilat.,Enalaprilat,DB00029
DB11723,The risk or severity of angioedema can be increased when Anistreplase is combined with Dutogliptin.,Dutogliptin,DB00029
DB11783,The risk or severity of angioedema can be increased when Anistreplase is combined with Imidapril.,Imidapril,DB00029
DB11950,The risk or severity of angioedema can be increased when Anistreplase is combined with Teneligliptin.,Teneligliptin,DB00029
DB11992,The risk or severity of angioedema can be increased when Anistreplase is combined with Omarigliptin.,Omarigliptin,DB00029
DB12268,The risk or severity of angioedema can be increased when Anistreplase is combined with Carmegliptin.,Carmegliptin,DB00029
DB12412,The risk or severity of angioedema can be increased when Anistreplase is combined with Gemigliptin.,Gemigliptin,DB00029
DB12417,The risk or severity of angioedema can be increased when Anistreplase is combined with Anagliptin.,Anagliptin,DB00029
DB12625,The risk or severity of angioedema can be increased when Anistreplase is combined with Evogliptin.,Evogliptin,DB00029
DB13166,The risk or severity of angioedema can be increased when Anistreplase is combined with Zofenopril.,Zofenopril,DB00029
DB13312,The risk or severity of angioedema can be increased when Anistreplase is combined with Delapril.,Delapril,DB00029
DB14125,The risk or severity of angioedema can be increased when Anistreplase is combined with Benazeprilat.,Benazeprilat,DB00029
DB14207,The risk or severity of angioedema can be increased when Anistreplase is combined with Fosinoprilat.,Fosinoprilat,DB00029
DB14208,The risk or severity of angioedema can be increased when Anistreplase is combined with Ramiprilat.,Ramiprilat,DB00029
DB14209,The risk or severity of angioedema can be increased when Anistreplase is combined with Trandolaprilat.,Trandolaprilat,DB00029
DB14210,The risk or severity of angioedema can be increased when Anistreplase is combined with Moexiprilat.,Moexiprilat,DB00029
DB14213,The risk or severity of angioedema can be increased when Anistreplase is combined with Perindoprilat.,Perindoprilat,DB00029
DB14217,The risk or severity of angioedema can be increased when Anistreplase is combined with Quinaprilat.,Quinaprilat,DB00029
DB14231,The risk or severity of angioedema can be increased when Anistreplase is combined with Quinoline Yellow WS.,Quinoline Yellow WS,DB00029
DB00203,The risk or severity of hemorrhage can be increased when Anistreplase is combined with Sildenafil.,Sildenafil,DB00029
DB00008,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a,DB00029
DB00011,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-n1.,Interferon alfa-n1,DB00029
DB00018,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-n3.,Interferon alfa-n3,DB00029
DB00022,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b,DB00029
DB00033,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00029
DB00034,"The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00029
DB00041,The risk or severity of bleeding can be increased when Anistreplase is combined with Aldesleukin.,Aldesleukin,DB00029
DB00056,The risk or severity of bleeding can be increased when Anistreplase is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00029
DB00068,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon beta-1b.,Interferon beta-1b,DB00029
DB00069,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00029
DB00073,The risk or severity of bleeding can be increased when Anistreplase is combined with Rituximab.,Rituximab,DB00029
DB00078,The risk or severity of bleeding can be increased when Anistreplase is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00029
DB00087,The risk or severity of bleeding can be increased when Anistreplase is combined with Alemtuzumab.,Alemtuzumab,DB00029
DB00105,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00029
DB00120,The risk or severity of bleeding can be increased when Anistreplase is combined with Phenylalanine.,Phenylalanine,DB00029
DB00188,The risk or severity of bleeding can be increased when Anistreplase is combined with Bortezomib.,Bortezomib,DB00029
DB00242,The risk or severity of bleeding can be increased when Anistreplase is combined with Cladribine.,Cladribine,DB00029
DB00262,The risk or severity of bleeding can be increased when Anistreplase is combined with Carmustine.,Carmustine,DB00029
DB00276,The risk or severity of bleeding can be increased when Anistreplase is combined with Amsacrine.,Amsacrine,DB00029
DB00291,The risk or severity of bleeding can be increased when Anistreplase is combined with Chlorambucil.,Chlorambucil,DB00029
DB00293,The risk or severity of bleeding can be increased when Anistreplase is combined with Raltitrexed.,Raltitrexed,DB00029
DB00305,The risk or severity of bleeding can be increased when Anistreplase is combined with Mitomycin.,Mitomycin,DB00029
DB00307,The risk or severity of bleeding can be increased when Anistreplase is combined with Bexarotene.,Bexarotene,DB00029
DB00309,The risk or severity of bleeding can be increased when Anistreplase is combined with Vindesine.,Vindesine,DB00029
DB00322,The risk or severity of bleeding can be increased when Anistreplase is combined with Floxuridine.,Floxuridine,DB00029
DB00352,The risk or severity of bleeding can be increased when Anistreplase is combined with Tioguanine.,Tioguanine,DB00029
DB00361,The risk or severity of bleeding can be increased when Anistreplase is combined with Vinorelbine.,Vinorelbine,DB00029
DB00380,The risk or severity of bleeding can be increased when Anistreplase is combined with Dexrazoxane.,Dexrazoxane,DB00029
DB00398,The risk or severity of bleeding can be increased when Anistreplase is combined with Sorafenib.,Sorafenib,DB00029
DB00428,The risk or severity of bleeding can be increased when Anistreplase is combined with Streptozocin.,Streptozocin,DB00029
DB00441,The risk or severity of bleeding can be increased when Anistreplase is combined with Gemcitabine.,Gemcitabine,DB00029
DB00444,The risk or severity of bleeding can be increased when Anistreplase is combined with Teniposide.,Teniposide,DB00029
DB00445,The risk or severity of bleeding can be increased when Anistreplase is combined with Epirubicin.,Epirubicin,DB00029
DB00446,The risk or severity of bleeding can be increased when Anistreplase is combined with Chloramphenicol.,Chloramphenicol,DB00029
DB00480,The risk or severity of bleeding can be increased when Anistreplase is combined with Lenalidomide.,Lenalidomide,DB00029
DB00488,The risk or severity of bleeding can be increased when Anistreplase is combined with Altretamine.,Altretamine,DB00029
DB00495,The risk or severity of bleeding can be increased when Anistreplase is combined with Zidovudine.,Zidovudine,DB00029
DB00515,The risk or severity of bleeding can be increased when Anistreplase is combined with Cisplatin.,Cisplatin,DB00029
DB00526,The risk or severity of bleeding can be increased when Anistreplase is combined with Oxaliplatin.,Oxaliplatin,DB00029
DB00531,The risk or severity of bleeding can be increased when Anistreplase is combined with Cyclophosphamide.,Cyclophosphamide,DB00029
DB00544,The risk or severity of bleeding can be increased when Anistreplase is combined with Fluorouracil.,Fluorouracil,DB00029
DB00552,The risk or severity of bleeding can be increased when Anistreplase is combined with Pentostatin.,Pentostatin,DB00029
DB00563,The risk or severity of bleeding can be increased when Anistreplase is combined with Methotrexate.,Methotrexate,DB00029
DB00564,The risk or severity of bleeding can be increased when Anistreplase is combined with Carbamazepine.,Carbamazepine,DB00029
DB00570,The risk or severity of bleeding can be increased when Anistreplase is combined with Vinblastine.,Vinblastine,DB00029
DB00619,The risk or severity of bleeding can be increased when Anistreplase is combined with Imatinib.,Imatinib,DB00029
DB00631,The risk or severity of bleeding can be increased when Anistreplase is combined with Clofarabine.,Clofarabine,DB00029
DB00642,The risk or severity of bleeding can be increased when Anistreplase is combined with Pemetrexed.,Pemetrexed,DB00029
DB00694,The risk or severity of bleeding can be increased when Anistreplase is combined with Daunorubicin.,Daunorubicin,DB00029
DB00762,The risk or severity of bleeding can be increased when Anistreplase is combined with Irinotecan.,Irinotecan,DB00029
DB00773,The risk or severity of bleeding can be increased when Anistreplase is combined with Etoposide.,Etoposide,DB00029
DB00851,The risk or severity of bleeding can be increased when Anistreplase is combined with Dacarbazine.,Dacarbazine,DB00029
DB00853,The risk or severity of bleeding can be increased when Anistreplase is combined with Temozolomide.,Temozolomide,DB00029
DB00859,The risk or severity of bleeding can be increased when Anistreplase is combined with Penicillamine.,Penicillamine,DB00029
DB00864,The risk or severity of bleeding can be increased when Anistreplase is combined with Tacrolimus.,Tacrolimus,DB00029
DB00888,The risk or severity of bleeding can be increased when Anistreplase is combined with Mechlorethamine.,Mechlorethamine,DB00029
DB00928,The risk or severity of bleeding can be increased when Anistreplase is combined with Azacitidine.,Azacitidine,DB00029
DB00958,The risk or severity of bleeding can be increased when Anistreplase is combined with Carboplatin.,Carboplatin,DB00029
DB00970,The risk or severity of bleeding can be increased when Anistreplase is combined with Dactinomycin.,Dactinomycin,DB00029
DB00987,The risk or severity of bleeding can be increased when Anistreplase is combined with Cytarabine.,Cytarabine,DB00029
DB00997,The risk or severity of bleeding can be increased when Anistreplase is combined with Doxorubicin.,Doxorubicin,DB00029
DB01005,The risk or severity of bleeding can be increased when Anistreplase is combined with Hydroxyurea.,Hydroxyurea,DB00029
DB01008,The risk or severity of bleeding can be increased when Anistreplase is combined with Busulfan.,Busulfan,DB00029
DB01030,The risk or severity of bleeding can be increased when Anistreplase is combined with Topotecan.,Topotecan,DB00029
DB01033,The risk or severity of bleeding can be increased when Anistreplase is combined with Mercaptopurine.,Mercaptopurine,DB00029
DB01041,The risk or severity of bleeding can be increased when Anistreplase is combined with Thalidomide.,Thalidomide,DB00029
DB01042,The risk or severity of bleeding can be increased when Anistreplase is combined with Melphalan.,Melphalan,DB00029
DB01073,The risk or severity of bleeding can be increased when Anistreplase is combined with Fludarabine.,Fludarabine,DB00029
DB01099,The risk or severity of bleeding can be increased when Anistreplase is combined with Flucytosine.,Flucytosine,DB00029
DB01101,The risk or severity of bleeding can be increased when Anistreplase is combined with Capecitabine.,Capecitabine,DB00029
DB01169,The risk or severity of bleeding can be increased when Anistreplase is combined with Arsenic trioxide.,Arsenic trioxide,DB00029
DB01177,The risk or severity of bleeding can be increased when Anistreplase is combined with Idarubicin.,Idarubicin,DB00029
DB01204,The risk or severity of bleeding can be increased when Anistreplase is combined with Mitoxantrone.,Mitoxantrone,DB00029
DB01206,The risk or severity of bleeding can be increased when Anistreplase is combined with Lomustine.,Lomustine,DB00029
DB01229,The risk or severity of bleeding can be increased when Anistreplase is combined with Paclitaxel.,Paclitaxel,DB00029
DB01248,The risk or severity of bleeding can be increased when Anistreplase is combined with Docetaxel.,Docetaxel,DB00029
DB01262,The risk or severity of bleeding can be increased when Anistreplase is combined with Decitabine.,Decitabine,DB00029
DB01280,The risk or severity of bleeding can be increased when Anistreplase is combined with Nelarabine.,Nelarabine,DB00029
DB01590,The risk or severity of bleeding can be increased when Anistreplase is combined with Everolimus.,Everolimus,DB00029
DB02546,The risk or severity of bleeding can be increased when Anistreplase is combined with Vorinostat.,Vorinostat,DB00029
DB04572,The risk or severity of bleeding can be increased when Anistreplase is combined with Thiotepa.,Thiotepa,DB00029
DB04845,The risk or severity of bleeding can be increased when Anistreplase is combined with Ixabepilone.,Ixabepilone,DB00029
DB04868,The risk or severity of bleeding can be increased when Anistreplase is combined with Nilotinib.,Nilotinib,DB00029
DB05015,The risk or severity of bleeding can be increased when Anistreplase is combined with Belinostat.,Belinostat,DB00029
DB05109,The risk or severity of bleeding can be increased when Anistreplase is combined with Trabectedin.,Trabectedin,DB00029
DB05258,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa.,Interferon alfa,DB00029
DB05472,The risk or severity of bleeding can be increased when Anistreplase is combined with omega interferon.,omega interferon,DB00029
DB05773,The risk or severity of bleeding can be increased when Anistreplase is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00029
DB06616,The risk or severity of bleeding can be increased when Anistreplase is combined with Bosutinib.,Bosutinib,DB00029
DB06769,The risk or severity of bleeding can be increased when Anistreplase is combined with Bendamustine.,Bendamustine,DB00029
DB06772,The risk or severity of bleeding can be increased when Anistreplase is combined with Cabazitaxel.,Cabazitaxel,DB00029
DB08871,The risk or severity of bleeding can be increased when Anistreplase is combined with Eribulin.,Eribulin,DB00029
DB08877,The risk or severity of bleeding can be increased when Anistreplase is combined with Ruxolitinib.,Ruxolitinib,DB00029
DB08889,The risk or severity of bleeding can be increased when Anistreplase is combined with Carfilzomib.,Carfilzomib,DB00029
DB08895,The risk or severity of bleeding can be increased when Anistreplase is combined with Tofacitinib.,Tofacitinib,DB00029
DB08901,The risk or severity of bleeding can be increased when Anistreplase is combined with Ponatinib.,Ponatinib,DB00029
DB08910,The risk or severity of bleeding can be increased when Anistreplase is combined with Pomalidomide.,Pomalidomide,DB00029
DB09042,The risk or severity of bleeding can be increased when Anistreplase is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00029
DB09052,The risk or severity of bleeding can be increased when Anistreplase is combined with Blinatumomab.,Blinatumomab,DB00029
DB09073,The risk or severity of bleeding can be increased when Anistreplase is combined with Palbociclib.,Palbociclib,DB00029
DB09074,The risk or severity of bleeding can be increased when Anistreplase is combined with Olaparib.,Olaparib,DB00029
DB09077,The risk or severity of bleeding can be increased when Anistreplase is combined with Dinutuximab.,Dinutuximab,DB00029
DB09122,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00029
DB12814,The risk or severity of bleeding can be increased when Anistreplase is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00029
DB00229,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefotiam.,Cefotiam,DB00029
DB00267,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefmenoxime.,Cefmenoxime,DB00029
DB00274,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefmetazole.,Cefmetazole,DB00029
DB00430,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefpiramide.,Cefpiramide,DB00029
DB00438,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftazidime.,Ceftazidime,DB00029
DB00447,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Loracarbef.,Loracarbef,DB00029
DB00456,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefalotin.,Cefalotin,DB00029
DB00493,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefotaxime.,Cefotaxime,DB00029
DB00535,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefdinir.,Cefdinir,DB00029
DB00567,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cephalexin.,Cephalexin,DB00029
DB00671,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefixime.,Cefixime,DB00029
DB00689,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cephaloglycin.,Cephaloglycin,DB00029
DB00833,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefaclor.,Cefaclor,DB00029
DB00923,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceforanide.,Ceforanide,DB00029
DB01066,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefditoren.,Cefditoren,DB00029
DB01112,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefuroxime.,Cefuroxime,DB00029
DB01139,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefapirin.,Cefapirin,DB00029
DB01140,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefadroxil.,Cefadroxil,DB00029
DB01150,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefprozil.,Cefprozil,DB00029
DB01212,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftriaxone.,Ceftriaxone,DB00029
DB01326,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefamandole.,Cefamandole,DB00029
DB01327,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefazolin.,Cefazolin,DB00029
DB01328,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefonicid.,Cefonicid,DB00029
DB01329,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefoperazone.,Cefoperazone,DB00029
DB01330,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefotetan.,Cefotetan,DB00029
DB01331,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefoxitin.,Cefoxitin,DB00029
DB01332,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftizoxime.,Ceftizoxime,DB00029
DB01333,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefradine.,Cefradine,DB00029
DB01413,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefepime.,Cefepime,DB00029
DB01414,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefacetrile.,Cefacetrile,DB00029
DB01415,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftibuten.,Ceftibuten,DB00029
DB01416,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefpodoxime.,Cefpodoxime,DB00029
DB04570,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Latamoxef.,Latamoxef,DB00029
DB04918,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftobiprole.,Ceftobiprole,DB00029
DB06590,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil,DB00029
DB09008,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefaloridine.,Cefaloridine,DB00029
DB09050,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftolozane.,Ceftolozane,DB00029
DB09062,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefminox.,Cefminox,DB00029
DB11367,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefroxadine.,Cefroxadine,DB00029
DB11935,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Flomoxef.,Flomoxef,DB00029
DB13266,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefatrizine.,Cefatrizine,DB00029
DB13461,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefcapene.,Cefcapene,DB00029
DB13470,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefodizime.,Cefodizime,DB00029
DB13499,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefsulodin.,Cefsulodin,DB00029
DB13504,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefetamet.,Cefetamet,DB00029
DB13638,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefbuperazone.,Cefbuperazone,DB00029
DB13667,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefozopran.,Cefozopran,DB00029
DB13682,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefpirome.,Cefpirome,DB00029
DB13778,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefazedone.,Cefazedone,DB00029
DB13821,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftezole.,Ceftezole,DB00029
DB14725,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate,DB00029
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Anistreplase.,Doxycycline,DB00029
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Anistreplase.,Azithromycin,DB00029
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Anistreplase.,Omega-3-acid ethyl esters,DB00029
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Anistreplase.,Acetylsalicylic acid,DB00029
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Anistreplase.,Tazobactam,DB00029
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Anistreplase.,Erythromycin,DB00029
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Anistreplase.,Trazodone,DB00029
DB00620,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Triamcinolone.,Triamcinolone,DB00029
DB09079,The risk or severity of bleeding can be increased when Anistreplase is combined with Nintedanib.,Nintedanib,DB00029
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Anistreplase.,Escitalopram,DB00029
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Anistreplase.,Sertraline,DB00029
DB00232,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Methyclothiazide.,Methyclothiazide,DB00029
DB00436,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide,DB00029
DB00562,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Benzthiazide.,Benzthiazide,DB00029
DB00606,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cyclothiazide.,Cyclothiazide,DB00029
DB00774,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide,DB00029
DB00880,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Chlorothiazide.,Chlorothiazide,DB00029
DB00999,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide,DB00029
DB01021,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide,DB00029
DB01324,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Polythiazide.,Polythiazide,DB00029
DB13430,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Mebutizide.,Mebutizide,DB00029
DB13532,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide,DB00029
DB06655,Liraglutide may increase the hypoglycemic activities of Insulin human.,Liraglutide,DB00030
DB09046,Metreleptin may increase the hypoglycemic activities of Insulin human.,Metreleptin,DB00030
DB00082,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Insulin human.,Pegvisomant,DB00030
DB01132,The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin human.,Pioglitazone,DB00030
DB01278,Pramlintide may increase the hypoglycemic activities of Insulin human.,Pramlintide,DB00030
DB00412,The risk or severity of congestive heart failure can be increased when Insulin human is combined with Rosiglitazone.,Rosiglitazone,DB00030
DB00166,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Insulin human.,Lipoic acid,DB00030
DB00974,Edetic acid may increase the hypoglycemic activities of Insulin human.,Edetic acid,DB00030
DB00187,Esmolol may increase the hypoglycemic activities of Insulin human.,Esmolol,DB00030
DB00218,The therapeutic efficacy of Insulin human can be increased when used in combination with Moxifloxacin.,Moxifloxacin,DB00030
DB00365,The therapeutic efficacy of Insulin human can be increased when used in combination with Grepafloxacin.,Grepafloxacin,DB00030
DB00467,The therapeutic efficacy of Insulin human can be increased when used in combination with Enoxacin.,Enoxacin,DB00030
DB00487,The therapeutic efficacy of Insulin human can be increased when used in combination with Pefloxacin.,Pefloxacin,DB00030
DB00537,The therapeutic efficacy of Insulin human can be increased when used in combination with Ciprofloxacin.,Ciprofloxacin,DB00030
DB00685,The therapeutic efficacy of Insulin human can be increased when used in combination with Trovafloxacin.,Trovafloxacin,DB00030
DB00779,The therapeutic efficacy of Insulin human can be increased when used in combination with Nalidixic acid.,Nalidixic acid,DB00030
DB00817,The therapeutic efficacy of Insulin human can be increased when used in combination with Rosoxacin.,Rosoxacin,DB00030
DB00827,The therapeutic efficacy of Insulin human can be increased when used in combination with Cinoxacin.,Cinoxacin,DB00030
DB00978,The therapeutic efficacy of Insulin human can be increased when used in combination with Lomefloxacin.,Lomefloxacin,DB00030
DB01044,The therapeutic efficacy of Insulin human can be increased when used in combination with Gatifloxacin.,Gatifloxacin,DB00030
DB01059,The therapeutic efficacy of Insulin human can be increased when used in combination with Norfloxacin.,Norfloxacin,DB00030
DB01137,The therapeutic efficacy of Insulin human can be increased when used in combination with Levofloxacin.,Levofloxacin,DB00030
DB01155,The therapeutic efficacy of Insulin human can be increased when used in combination with Gemifloxacin.,Gemifloxacin,DB00030
DB01165,The therapeutic efficacy of Insulin human can be increased when used in combination with Ofloxacin.,Ofloxacin,DB00030
DB01208,The therapeutic efficacy of Insulin human can be increased when used in combination with Sparfloxacin.,Sparfloxacin,DB00030
DB01405,The therapeutic efficacy of Insulin human can be increased when used in combination with Temafloxacin.,Temafloxacin,DB00030
DB04576,The therapeutic efficacy of Insulin human can be increased when used in combination with Fleroxacin.,Fleroxacin,DB00030
DB05488,The therapeutic efficacy of Insulin human can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,Technetium Tc-99m ciprofloxacin,DB00030
DB06160,The therapeutic efficacy of Insulin human can be increased when used in combination with Garenoxacin.,Garenoxacin,DB00030
DB06600,The therapeutic efficacy of Insulin human can be increased when used in combination with Nemonoxacin.,Nemonoxacin,DB00030
DB08972,The therapeutic efficacy of Insulin human can be increased when used in combination with Flumequine.,Flumequine,DB00030
DB11404,The therapeutic efficacy of Insulin human can be increased when used in combination with Enrofloxacin.,Enrofloxacin,DB00030
DB11443,The therapeutic efficacy of Insulin human can be increased when used in combination with Orbifloxacin.,Orbifloxacin,DB00030
DB11491,The therapeutic efficacy of Insulin human can be increased when used in combination with Sarafloxacin.,Sarafloxacin,DB00030
DB11511,The therapeutic efficacy of Insulin human can be increased when used in combination with Difloxacin.,Difloxacin,DB00030
DB11774,The therapeutic efficacy of Insulin human can be increased when used in combination with Pazufloxacin.,Pazufloxacin,DB00030
DB11892,The therapeutic efficacy of Insulin human can be increased when used in combination with Prulifloxacin.,Prulifloxacin,DB00030
DB11943,The therapeutic efficacy of Insulin human can be increased when used in combination with Delafloxacin.,Delafloxacin,DB00030
DB13261,The therapeutic efficacy of Insulin human can be increased when used in combination with Sitafloxacin.,Sitafloxacin,DB00030
DB13627,The therapeutic efficacy of Insulin human can be increased when used in combination with Oxolinic acid.,Oxolinic acid,DB00030
DB13772,The therapeutic efficacy of Insulin human can be increased when used in combination with Rufloxacin.,Rufloxacin,DB00030
DB13823,The therapeutic efficacy of Insulin human can be increased when used in combination with Pipemidic acid.,Pipemidic acid,DB00030
DB00232,The therapeutic efficacy of Insulin human can be decreased when used in combination with Methyclothiazide.,Methyclothiazide,DB00030
DB00310,The therapeutic efficacy of Insulin human can be decreased when used in combination with Chlorthalidone.,Chlorthalidone,DB00030
DB00436,The therapeutic efficacy of Insulin human can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide,DB00030
DB00524,The therapeutic efficacy of Insulin human can be decreased when used in combination with Metolazone.,Metolazone,DB00030
DB00562,The therapeutic efficacy of Insulin human can be decreased when used in combination with Benzthiazide.,Benzthiazide,DB00030
DB00774,The therapeutic efficacy of Insulin human can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide,DB00030
DB00808,The therapeutic efficacy of Insulin human can be decreased when used in combination with Indapamide.,Indapamide,DB00030
DB00880,The therapeutic efficacy of Insulin human can be decreased when used in combination with Chlorothiazide.,Chlorothiazide,DB00030
DB00999,The therapeutic efficacy of Insulin human can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide,DB00030
DB01021,The therapeutic efficacy of Insulin human can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide,DB00030
DB01324,The therapeutic efficacy of Insulin human can be decreased when used in combination with Polythiazide.,Polythiazide,DB00030
DB01325,The therapeutic efficacy of Insulin human can be decreased when used in combination with Quinethazone.,Quinethazone,DB00030
DB13532,The therapeutic efficacy of Insulin human can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide,DB00030
DB13989,The therapeutic efficacy of Insulin human can be decreased when used in combination with Epitizide.,Epitizide,DB00030
DB00344,Protriptyline may decrease the hypoglycemic activities of Insulin human.,Protriptyline,DB00030
DB00543,Amoxapine may decrease the hypoglycemic activities of Insulin human.,Amoxapine,DB00030
DB00726,Trimipramine may decrease the hypoglycemic activities of Insulin human.,Trimipramine,DB00030
DB04836,Amineptine may decrease the hypoglycemic activities of Insulin human.,Amineptine,DB00030
DB08996,Dimetacrine may decrease the hypoglycemic activities of Insulin human.,Dimetacrine,DB00030
DB09016,Butriptyline may decrease the hypoglycemic activities of Insulin human.,Butriptyline,DB00030
DB09167,Dosulepin may decrease the hypoglycemic activities of Insulin human.,Dosulepin,DB00030
DB09289,Tianeptine may decrease the hypoglycemic activities of Insulin human.,Tianeptine,DB00030
DB09307,Oxaprotiline may decrease the hypoglycemic activities of Insulin human.,Oxaprotiline,DB00030
DB12930,Opipramol may decrease the hypoglycemic activities of Insulin human.,Opipramol,DB00030
DB13114,Amitriptylinoxide may decrease the hypoglycemic activities of Insulin human.,Amitriptylinoxide,DB00030
DB13225,Dibenzepin may decrease the hypoglycemic activities of Insulin human.,Dibenzepin,DB00030
DB13246,Quinupramine may decrease the hypoglycemic activities of Insulin human.,Quinupramine,DB00030
DB13384,Melitracen may decrease the hypoglycemic activities of Insulin human.,Melitracen,DB00030
DB13411,Lofepramine may decrease the hypoglycemic activities of Insulin human.,Lofepramine,DB00030
DB13496,Iprindole may decrease the hypoglycemic activities of Insulin human.,Iprindole,DB00030
DB13782,Imipramine oxide may decrease the hypoglycemic activities of Insulin human.,Imipramine oxide,DB00030
DB06292,Dapagliflozin may increase the hypoglycemic activities of Insulin human.,Dapagliflozin,DB00030
DB08907,Canagliflozin may increase the hypoglycemic activities of Insulin human.,Canagliflozin,DB00030
DB00007,The therapeutic efficacy of Insulin human can be decreased when used in combination with Leuprolide.,Leuprolide,DB00030
DB00014,The therapeutic efficacy of Insulin human can be decreased when used in combination with Goserelin.,Goserelin,DB00030
DB00104,The therapeutic efficacy of Insulin human can be decreased when used in combination with Octreotide.,Octreotide,DB00030
DB00220,The therapeutic efficacy of Insulin human can be decreased when used in combination with Nelfinavir.,Nelfinavir,DB00030
DB00224,The therapeutic efficacy of Insulin human can be decreased when used in combination with Indinavir.,Indinavir,DB00030
DB00246,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ziprasidone.,Ziprasidone,DB00030
DB00294,The therapeutic efficacy of Insulin human can be decreased when used in combination with Etonogestrel.,Etonogestrel,DB00030
DB00304,The therapeutic efficacy of Insulin human can be decreased when used in combination with Desogestrel.,Desogestrel,DB00030
DB00334,The therapeutic efficacy of Insulin human can be decreased when used in combination with Olanzapine.,Olanzapine,DB00030
DB00351,The therapeutic efficacy of Insulin human can be decreased when used in combination with Megestrol acetate.,Megestrol acetate,DB00030
DB00363,The therapeutic efficacy of Insulin human can be decreased when used in combination with Clozapine.,Clozapine,DB00030
DB00367,The therapeutic efficacy of Insulin human can be decreased when used in combination with Levonorgestrel.,Levonorgestrel,DB00030
DB00396,The therapeutic efficacy of Insulin human can be decreased when used in combination with Progesterone.,Progesterone,DB00030
DB00477,The therapeutic efficacy of Insulin human can be decreased when used in combination with Chlorpromazine.,Chlorpromazine,DB00030
DB00502,The therapeutic efficacy of Insulin human can be decreased when used in combination with Haloperidol.,Haloperidol,DB00030
DB00503,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ritonavir.,Ritonavir,DB00030
DB00592,The therapeutic efficacy of Insulin human can be decreased when used in combination with Piperazine.,Piperazine,DB00030
DB00603,The therapeutic efficacy of Insulin human can be decreased when used in combination with Medroxyprogesterone acetate.,Medroxyprogesterone acetate,DB00030
DB00627,The therapeutic efficacy of Insulin human can be decreased when used in combination with Niacin.,Niacin,DB00030
DB00668,The therapeutic efficacy of Insulin human can be decreased when used in combination with Epinephrine.,Epinephrine,DB00030
DB00717,The therapeutic efficacy of Insulin human can be decreased when used in combination with Norethisterone.,Norethisterone,DB00030
DB00734,The therapeutic efficacy of Insulin human can be decreased when used in combination with Risperidone.,Risperidone,DB00030
DB00738,The therapeutic efficacy of Insulin human can be decreased when used in combination with Pentamidine.,Pentamidine,DB00030
DB00823,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ethynodiol diacetate.,Ethynodiol diacetate,DB00030
DB00852,The therapeutic efficacy of Insulin human can be decreased when used in combination with Pseudoephedrine.,Pseudoephedrine,DB00030
DB00864,The therapeutic efficacy of Insulin human can be decreased when used in combination with Tacrolimus.,Tacrolimus,DB00030
DB00877,The therapeutic efficacy of Insulin human can be decreased when used in combination with Sirolimus.,Sirolimus,DB00030
DB00903,The therapeutic efficacy of Insulin human can be decreased when used in combination with Etacrynic acid.,Etacrynic acid,DB00030
DB00932,The therapeutic efficacy of Insulin human can be decreased when used in combination with Tipranavir.,Tipranavir,DB00030
DB00957,The therapeutic efficacy of Insulin human can be decreased when used in combination with Norgestimate.,Norgestimate,DB00030
DB00977,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ethinylestradiol.,Ethinylestradiol,DB00030
DB01072,The therapeutic efficacy of Insulin human can be decreased when used in combination with Atazanavir.,Atazanavir,DB00030
DB01169,The therapeutic efficacy of Insulin human can be decreased when used in combination with Arsenic trioxide.,Arsenic trioxide,DB00030
DB01224,The therapeutic efficacy of Insulin human can be decreased when used in combination with Quetiapine.,Quetiapine,DB00030
DB01232,The therapeutic efficacy of Insulin human can be decreased when used in combination with Saquinavir.,Saquinavir,DB00030
DB01238,The therapeutic efficacy of Insulin human can be decreased when used in combination with Aripiprazole.,Aripiprazole,DB00030
DB01267,The therapeutic efficacy of Insulin human can be decreased when used in combination with Paliperidone.,Paliperidone,DB00030
DB01319,The therapeutic efficacy of Insulin human can be decreased when used in combination with Fosamprenavir.,Fosamprenavir,DB00030
DB01323,The therapeutic efficacy of Insulin human can be decreased when used in combination with St. John's Wort.,St. John's Wort,DB00030
DB01357,The therapeutic efficacy of Insulin human can be decreased when used in combination with Mestranol.,Mestranol,DB00030
DB01363,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ephedra sinica root.,Ephedra sinica root,DB00030
DB01395,The therapeutic efficacy of Insulin human can be decreased when used in combination with Drospirenone.,Drospirenone,DB00030
DB01403,The therapeutic efficacy of Insulin human can be decreased when used in combination with Methotrimeprazine.,Methotrimeprazine,DB00030
DB01406,The therapeutic efficacy of Insulin human can be decreased when used in combination with Danazol.,Danazol,DB00030
DB01590,The therapeutic efficacy of Insulin human can be decreased when used in combination with Everolimus.,Everolimus,DB00030
DB01601,The therapeutic efficacy of Insulin human can be decreased when used in combination with Lopinavir.,Lopinavir,DB00030
DB01621,The therapeutic efficacy of Insulin human can be decreased when used in combination with Pipotiazine.,Pipotiazine,DB00030
DB02546,The therapeutic efficacy of Insulin human can be decreased when used in combination with Vorinostat.,Vorinostat,DB00030
DB04574,The therapeutic efficacy of Insulin human can be decreased when used in combination with Estrone sulfate.,Estrone sulfate,DB00030
DB04839,The therapeutic efficacy of Insulin human can be decreased when used in combination with Cyproterone acetate.,Cyproterone acetate,DB00030
DB04868,The therapeutic efficacy of Insulin human can be decreased when used in combination with Nilotinib.,Nilotinib,DB00030
DB04946,The therapeutic efficacy of Insulin human can be decreased when used in combination with Iloperidone.,Iloperidone,DB00030
DB06216,The therapeutic efficacy of Insulin human can be decreased when used in combination with Asenapine.,Asenapine,DB00030
DB06287,The therapeutic efficacy of Insulin human can be decreased when used in combination with Temsirolimus.,Temsirolimus,DB00030
DB06663,The therapeutic efficacy of Insulin human can be decreased when used in combination with Pasireotide.,Pasireotide,DB00030
DB06719,The therapeutic efficacy of Insulin human can be decreased when used in combination with Buserelin.,Buserelin,DB00030
DB06788,The therapeutic efficacy of Insulin human can be decreased when used in combination with Histrelin.,Histrelin,DB00030
DB06789,The therapeutic efficacy of Insulin human can be decreased when used in combination with Hydroxyprogesterone caproate.,Hydroxyprogesterone caproate,DB00030
DB06791,The therapeutic efficacy of Insulin human can be decreased when used in combination with Lanreotide.,Lanreotide,DB00030
DB06825,The therapeutic efficacy of Insulin human can be decreased when used in combination with Triptorelin.,Triptorelin,DB00030
DB08815,The therapeutic efficacy of Insulin human can be decreased when used in combination with Lurasidone.,Lurasidone,DB00030
DB08912,The therapeutic efficacy of Insulin human can be decreased when used in combination with Dabrafenib.,Dabrafenib,DB00030
DB09009,The therapeutic efficacy of Insulin human can be decreased when used in combination with Articaine.,Articaine,DB00030
DB09063,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ceritinib.,Ceritinib,DB00030
DB09123,The therapeutic efficacy of Insulin human can be decreased when used in combination with Dienogest.,Dienogest,DB00030
DB09128,The therapeutic efficacy of Insulin human can be decreased when used in combination with Brexpiprazole.,Brexpiprazole,DB00030
DB06343,The therapeutic efficacy of Insulin human can be decreased when used in combination with Teprotumumab.,Teprotumumab,DB00030
DB00621,Oxandrolone may increase the hypoglycemic activities of Insulin human.,Oxandrolone,DB00030
DB00624,Testosterone may increase the hypoglycemic activities of Insulin human.,Testosterone,DB00030
DB00984,Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin human.,Nandrolone phenpropionate,DB00030
DB01185,Fluoxymesterone may increase the hypoglycemic activities of Insulin human.,Fluoxymesterone,DB00030
DB01420,Testosterone propionate may increase the hypoglycemic activities of Insulin human.,Testosterone propionate,DB00030
DB02901,Stanolone may increase the hypoglycemic activities of Insulin human.,Stanolone,DB00030
DB06412,Oxymetholone may increase the hypoglycemic activities of Insulin human.,Oxymetholone,DB00030
DB06710,Methyltestosterone may increase the hypoglycemic activities of Insulin human.,Methyltestosterone,DB00030
DB06718,Stanozolol may increase the hypoglycemic activities of Insulin human.,Stanozolol,DB00030
DB08804,Nandrolone decanoate may increase the hypoglycemic activities of Insulin human.,Nandrolone decanoate,DB00030
DB12461,GLPG-0492 may increase the hypoglycemic activities of Insulin human.,GLPG-0492,DB00030
DB13169,Nandrolone may increase the hypoglycemic activities of Insulin human.,Nandrolone,DB00030
DB13587,Mesterolone may increase the hypoglycemic activities of Insulin human.,Mesterolone,DB00030
DB13943,Testosterone cypionate may increase the hypoglycemic activities of Insulin human.,Testosterone cypionate,DB00030
DB13944,Testosterone enanthate may increase the hypoglycemic activities of Insulin human.,Testosterone enanthate,DB00030
DB00215,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Citalopram.,Citalopram,DB00030
DB00230,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Pregabalin.,Pregabalin,DB00030
DB00285,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Venlafaxine.,Venlafaxine,DB00030
DB00328,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Indomethacin.,Indomethacin,DB00030
DB01104,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Sertraline.,Sertraline,DB00030
DB01149,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Nefazodone.,Nefazodone,DB00030
DB01175,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Escitalopram.,Escitalopram,DB00030
DB04832,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Zimelidine.,Zimelidine,DB00030
DB04884,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Dapoxetine.,Dapoxetine,DB00030
DB04896,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Milnacipran.,Milnacipran,DB00030
DB06700,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Desvenlafaxine.,Desvenlafaxine,DB00030
DB08918,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Levomilnacipran.,Levomilnacipran,DB00030
DB08953,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Indalpine.,Indalpine,DB00030
DB09270,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Ubidecarenone.,Ubidecarenone,DB00030
DB12693,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Ritanserin.,Ritanserin,DB00030
DB13233,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Alaproclate.,Alaproclate,DB00030
DB13358,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Cibenzoline.,Cibenzoline,DB00030
DB14025,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Clinafloxacin.,Clinafloxacin,DB00030
DB09038,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Empagliflozin.,Empagliflozin,DB00030
DB00233,Aminosalicylic acid may increase the hypoglycemic activities of Insulin human.,Aminosalicylic acid,DB00030
DB00244,Mesalazine may increase the hypoglycemic activities of Insulin human.,Mesalazine,DB00030
DB00795,Sulfasalazine may increase the hypoglycemic activities of Insulin human.,Sulfasalazine,DB00030
DB00861,Diflunisal may increase the hypoglycemic activities of Insulin human.,Diflunisal,DB00030
DB00936,Salicylic acid may increase the hypoglycemic activities of Insulin human.,Salicylic acid,DB00030
DB01014,Balsalazide may increase the hypoglycemic activities of Insulin human.,Balsalazide,DB00030
DB01250,Olsalazine may increase the hypoglycemic activities of Insulin human.,Olsalazine,DB00030
DB01294,Bismuth subsalicylate may increase the hypoglycemic activities of Insulin human.,Bismuth subsalicylate,DB00030
DB06251,Dersalazine may increase the hypoglycemic activities of Insulin human.,Dersalazine,DB00030
DB06807,Phenyl aminosalicylate may increase the hypoglycemic activities of Insulin human.,Phenyl aminosalicylate,DB00030
DB09543,Methyl salicylate may increase the hypoglycemic activities of Insulin human.,Methyl salicylate,DB00030
DB11079,Trolamine salicylate may increase the hypoglycemic activities of Insulin human.,Trolamine salicylate,DB00030
DB12445,Nitroaspirin may increase the hypoglycemic activities of Insulin human.,Nitroaspirin,DB00030
DB13509,Aloxiprin may increase the hypoglycemic activities of Insulin human.,Aloxiprin,DB00030
DB13538,Guacetisal may increase the hypoglycemic activities of Insulin human.,Guacetisal,DB00030
DB13612,Carbaspirin calcium may increase the hypoglycemic activities of Insulin human.,Carbaspirin calcium,DB00030
DB14006,Choline salicylate may increase the hypoglycemic activities of Insulin human.,Choline salicylate,DB00030
DB14026,Thiosalicylic acid may increase the hypoglycemic activities of Insulin human.,Thiosalicylic acid,DB00030
DB01261,Sitagliptin may increase the hypoglycemic activities of Insulin human.,Sitagliptin,DB00030
DB04876,Vildagliptin may increase the hypoglycemic activities of Insulin human.,Vildagliptin,DB00030
DB06011,AMG-222 may increase the hypoglycemic activities of Insulin human.,AMG-222,DB00030
DB06127,Bisegliptin may increase the hypoglycemic activities of Insulin human.,Bisegliptin,DB00030
DB06203,Alogliptin may increase the hypoglycemic activities of Insulin human.,Alogliptin,DB00030
DB06335,Saxagliptin may increase the hypoglycemic activities of Insulin human.,Saxagliptin,DB00030
DB08382,Gosogliptin may increase the hypoglycemic activities of Insulin human.,Gosogliptin,DB00030
DB08882,Linagliptin may increase the hypoglycemic activities of Insulin human.,Linagliptin,DB00030
DB11723,Dutogliptin may increase the hypoglycemic activities of Insulin human.,Dutogliptin,DB00030
DB11950,Teneligliptin may increase the hypoglycemic activities of Insulin human.,Teneligliptin,DB00030
DB11992,Omarigliptin may increase the hypoglycemic activities of Insulin human.,Omarigliptin,DB00030
DB12268,Carmegliptin may increase the hypoglycemic activities of Insulin human.,Carmegliptin,DB00030
DB12412,Gemigliptin may increase the hypoglycemic activities of Insulin human.,Gemigliptin,DB00030
DB12417,Anagliptin may increase the hypoglycemic activities of Insulin human.,Anagliptin,DB00030
DB12625,Evogliptin may increase the hypoglycemic activities of Insulin human.,Evogliptin,DB00030
DB01276,Exenatide may increase the hypoglycemic activities of Insulin human.,Exenatide,DB00030
DB09043,Albiglutide may increase the hypoglycemic activities of Insulin human.,Albiglutide,DB00030
DB09045,Dulaglutide may increase the hypoglycemic activities of Insulin human.,Dulaglutide,DB00030
DB09265,Lixisenatide may increase the hypoglycemic activities of Insulin human.,Lixisenatide,DB00030
DB13928,Semaglutide may increase the hypoglycemic activities of Insulin human.,Semaglutide,DB00030
DB14027,Taspoglutide may increase the hypoglycemic activities of Insulin human.,Taspoglutide,DB00030
DB00752,Tranylcypromine may increase the hypoglycemic activities of Insulin human.,Tranylcypromine,DB00030
DB00780,Phenelzine may increase the hypoglycemic activities of Insulin human.,Phenelzine,DB00030
DB01171,Moclobemide may increase the hypoglycemic activities of Insulin human.,Moclobemide,DB00030
DB01247,Isocarboxazid may increase the hypoglycemic activities of Insulin human.,Isocarboxazid,DB00030
DB01626,Pargyline may increase the hypoglycemic activities of Insulin human.,Pargyline,DB00030
DB00805,Minaprine may increase the hypoglycemic activities of Insulin human.,Minaprine,DB00030
DB04818,Iproniazid may increase the hypoglycemic activities of Insulin human.,Iproniazid,DB00030
DB04820,Nialamide may increase the hypoglycemic activities of Insulin human.,Nialamide,DB00030
DB09244,Pirlindole may increase the hypoglycemic activities of Insulin human.,Pirlindole,DB00030
DB09245,Toloxatone may increase the hypoglycemic activities of Insulin human.,Toloxatone,DB00030
DB09243,Hydracarbazine may increase the hypoglycemic activities of Insulin human.,Hydracarbazine,DB00030
DB09241,Methylene blue may increase the hypoglycemic activities of Insulin human.,Methylene blue,DB00030
DB09246,Benmoxin may increase the hypoglycemic activities of Insulin human.,Benmoxin,DB00030
DB09248,Mebanazine may increase the hypoglycemic activities of Insulin human.,Mebanazine,DB00030
DB09249,Octamoxin may increase the hypoglycemic activities of Insulin human.,Octamoxin,DB00030
DB09250,Pheniprazine may increase the hypoglycemic activities of Insulin human.,Pheniprazine,DB00030
DB09251,Phenoxypropazine may increase the hypoglycemic activities of Insulin human.,Phenoxypropazine,DB00030
DB09252,Pivhydrazine may increase the hypoglycemic activities of Insulin human.,Pivhydrazine,DB00030
DB09253,Safrazine may increase the hypoglycemic activities of Insulin human.,Safrazine,DB00030
DB09254,Caroxazone may increase the hypoglycemic activities of Insulin human.,Caroxazone,DB00030
DB00614,Furazolidone may increase the hypoglycemic activities of Insulin human.,Furazolidone,DB00030
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Insulin human.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",DB00030
DB13875,Harmaline may increase the hypoglycemic activities of Insulin human.,Harmaline,DB00030
DB13876,Brofaromine may increase the hypoglycemic activities of Insulin human.,Brofaromine,DB00030
DB00721,Procaine may increase the hypoglycemic activities of Insulin human.,Procaine,DB00030
DB00182,Amphetamine may increase the hypoglycemic activities of Insulin human.,Amphetamine,DB00030
DB01168,Procarbazine may increase the hypoglycemic activities of Insulin human.,Procarbazine,DB00030
DB00601,Linezolid may increase the hypoglycemic activities of Insulin human.,Linezolid,DB00030
DB06654,Safinamide may increase the hypoglycemic activities of Insulin human.,Safinamide,DB00030
DB04017,Clorgiline may increase the hypoglycemic activities of Insulin human.,Clorgiline,DB00030
DB11827,The therapeutic efficacy of Insulin human can be increased when used in combination with Ertugliflozin.,Ertugliflozin,DB00030
DB00203,The therapeutic efficacy of Insulin human can be increased when used in combination with Sildenafil.,Sildenafil,DB00030
DB00214,The therapeutic efficacy of Insulin human can be increased when used in combination with Torasemide.,Torasemide,DB00030
DB00263,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfisoxazole.,Sulfisoxazole,DB00030
DB00311,The therapeutic efficacy of Insulin human can be increased when used in combination with Ethoxzolamide.,Ethoxzolamide,DB00030
DB00359,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfadiazine.,Sulfadiazine,DB00030
DB00482,The therapeutic efficacy of Insulin human can be increased when used in combination with Celecoxib.,Celecoxib,DB00030
DB00559,The therapeutic efficacy of Insulin human can be increased when used in combination with Bosentan.,Bosentan,DB00030
DB00576,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamethizole.,Sulfamethizole,DB00030
DB00606,The therapeutic efficacy of Insulin human can be increased when used in combination with Cyclothiazide.,Cyclothiazide,DB00030
DB00664,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfametopyrazine.,Sulfametopyrazine,DB00030
DB00669,The therapeutic efficacy of Insulin human can be increased when used in combination with Sumatriptan.,Sumatriptan,DB00030
DB00695,The therapeutic efficacy of Insulin human can be increased when used in combination with Furosemide.,Furosemide,DB00030
DB00706,The therapeutic efficacy of Insulin human can be increased when used in combination with Tamsulosin.,Tamsulosin,DB00030
DB00819,The therapeutic efficacy of Insulin human can be increased when used in combination with Acetazolamide.,Acetazolamide,DB00030
DB00887,The therapeutic efficacy of Insulin human can be increased when used in combination with Bumetanide.,Bumetanide,DB00030
DB00891,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfapyridine.,Sulfapyridine,DB00030
DB00909,The therapeutic efficacy of Insulin human can be increased when used in combination with Zonisamide.,Zonisamide,DB00030
DB01015,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamethoxazole.,Sulfamethoxazole,DB00030
DB01032,The therapeutic efficacy of Insulin human can be increased when used in combination with Probenecid.,Probenecid,DB00030
DB01098,The therapeutic efficacy of Insulin human can be increased when used in combination with Rosuvastatin.,Rosuvastatin,DB00030
DB01119,The therapeutic efficacy of Insulin human can be increased when used in combination with Diazoxide.,Diazoxide,DB00030
DB01144,The therapeutic efficacy of Insulin human can be increased when used in combination with Diclofenamide.,Diclofenamide,DB00030
DB01264,The therapeutic efficacy of Insulin human can be increased when used in combination with Darunavir.,Darunavir,DB00030
DB01298,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfacytine.,Sulfacytine,DB00030
DB01299,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfadoxine.,Sulfadoxine,DB00030
DB01382,The therapeutic efficacy of Insulin human can be increased when used in combination with Glymidine.,Glymidine,DB00030
DB01581,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamerazine.,Sulfamerazine,DB00030
DB01582,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamethazine.,Sulfamethazine,DB00030
DB02925,The therapeutic efficacy of Insulin human can be increased when used in combination with Piretanide.,Piretanide,DB00030
DB04707,The therapeutic efficacy of Insulin human can be increased when used in combination with Hydroxyfasudil.,Hydroxyfasudil,DB00030
DB06150,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfadimethoxine.,Sulfadimethoxine,DB00030
DB06290,The therapeutic efficacy of Insulin human can be increased when used in combination with Simeprevir.,Simeprevir,DB00030
DB06729,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaphenazole.,Sulfaphenazole,DB00030
DB06821,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfameter.,Sulfameter,DB00030
DB07996,The therapeutic efficacy of Insulin human can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,DB00030
DB08162,The therapeutic efficacy of Insulin human can be increased when used in combination with Fasudil.,Fasudil,DB00030
DB08798,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamoxole.,Sulfamoxole,DB00030
DB08881,The therapeutic efficacy of Insulin human can be increased when used in combination with Vemurafenib.,Vemurafenib,DB00030
DB08961,The therapeutic efficacy of Insulin human can be increased when used in combination with Azosemide.,Azosemide,DB00030
DB11389,The therapeutic efficacy of Insulin human can be increased when used in combination with Clorsulon.,Clorsulon,DB00030
DB11461,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfachlorpyridazine.,Sulfachlorpyridazine,DB00030
DB11462,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaethoxypyridazine.,Sulfaethoxypyridazine,DB00030
DB11463,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfanitran.,Sulfanitran,DB00030
DB11464,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaquinoxaline.,Sulfaquinoxaline,DB00030
DB12051,The therapeutic efficacy of Insulin human can be increased when used in combination with Setrobuvir.,Setrobuvir,DB00030
DB12921,The therapeutic efficacy of Insulin human can be increased when used in combination with Chlorsulfaquinoxaline.,Chlorsulfaquinoxaline,DB00030
DB13214,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfadicramide.,Sulfadicramide,DB00030
DB13248,The therapeutic efficacy of Insulin human can be increased when used in combination with Phthalylsulfathiazole.,Phthalylsulfathiazole,DB00030
DB13283,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaisodimidine.,Sulfaisodimidine,DB00030
DB13284,The therapeutic efficacy of Insulin human can be increased when used in combination with Meticrane.,Meticrane,DB00030
DB13320,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaperin.,Sulfaperin,DB00030
DB13405,The therapeutic efficacy of Insulin human can be increased when used in combination with Mefruside.,Mefruside,DB00030
DB13430,The therapeutic efficacy of Insulin human can be increased when used in combination with Mebutizide.,Mebutizide,DB00030
DB13485,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfametomidine.,Sulfametomidine,DB00030
DB13547,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfatolamide.,Sulfatolamide,DB00030
DB13556,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamazone.,Sulfamazone,DB00030
DB13580,The therapeutic efficacy of Insulin human can be increased when used in combination with Succinylsulfathiazole.,Succinylsulfathiazole,DB00030
DB13617,The therapeutic efficacy of Insulin human can be increased when used in combination with Clorexolone.,Clorexolone,DB00030
DB13663,The therapeutic efficacy of Insulin human can be increased when used in combination with Clofenamide.,Clofenamide,DB00030
DB13699,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfathiourea.,Sulfathiourea,DB00030
DB13708,The therapeutic efficacy of Insulin human can be increased when used in combination with Fenquizone.,Fenquizone,DB00030
DB13726,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaguanidine.,Sulfaguanidine,DB00030
DB13773,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamethoxypyridazine.,Sulfamethoxypyridazine,DB00030
DB13792,The therapeutic efficacy of Insulin human can be increased when used in combination with Clopamide.,Clopamide,DB00030
DB13803,The therapeutic efficacy of Insulin human can be increased when used in combination with Xipamide.,Xipamide,DB00030
DB14033,The therapeutic efficacy of Insulin human can be increased when used in combination with Acetyl sulfisoxazole.,Acetyl sulfisoxazole,DB00030
DB14708,The therapeutic efficacy of Insulin human can be increased when used in combination with Tosylchloramide.,Tosylchloramide,DB00030
DB00703,The therapeutic efficacy of Insulin human can be increased when used in combination with Methazolamide.,Methazolamide,DB00030
DB06370,The therapeutic efficacy of Insulin human can be increased when used in combination with Indisulam.,Indisulam,DB00030
DB00176,The metabolism of Fluvoxamine can be increased when combined with Insulin human.,Fluvoxamine,DB00030
DB00184,The metabolism of Nicotine can be increased when combined with Insulin human.,Nicotine,DB00030
DB00188,The metabolism of Bortezomib can be increased when combined with Insulin human.,Bortezomib,DB00030
DB00201,The metabolism of Caffeine can be increased when combined with Insulin human.,Caffeine,DB00030
DB00261,The metabolism of Anagrelide can be increased when combined with Insulin human.,Anagrelide,DB00030
DB00262,The metabolism of Carmustine can be increased when combined with Insulin human.,Carmustine,DB00030
DB00281,The metabolism of Lidocaine can be increased when combined with Insulin human.,Lidocaine,DB00030
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Insulin human.,Conjugated estrogens,DB00030
DB00296,The metabolism of Ropivacaine can be increased when combined with Insulin human.,Ropivacaine,DB00030
DB00315,The metabolism of Zolmitriptan can be increased when combined with Insulin human.,Zolmitriptan,DB00030
DB00316,The metabolism of Acetaminophen can be increased when combined with Insulin human.,Acetaminophen,DB00030
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Insulin human.,Chlorzoxazone,DB00030
DB00370,The metabolism of Mirtazapine can be increased when combined with Insulin human.,Mirtazapine,DB00030
DB00379,The metabolism of Mexiletine can be increased when combined with Insulin human.,Mexiletine,DB00030
DB00382,The metabolism of Tacrine can be increased when combined with Insulin human.,Tacrine,DB00030
DB00384,The metabolism of Triamterene can be increased when combined with Insulin human.,Triamterene,DB00030
DB00420,The metabolism of Promazine can be increased when combined with Insulin human.,Promazine,DB00030
DB00425,The metabolism of Zolpidem can be increased when combined with Insulin human.,Zolpidem,DB00030
DB00442,The metabolism of Entecavir can be increased when combined with Insulin human.,Entecavir,DB00030
DB00461,The metabolism of Nabumetone can be increased when combined with Insulin human.,Nabumetone,DB00030
DB00472,The metabolism of Fluoxetine can be increased when combined with Insulin human.,Fluoxetine,DB00030
DB00476,The metabolism of Duloxetine can be increased when combined with Insulin human.,Duloxetine,DB00030
DB00499,The metabolism of Flutamide can be increased when combined with Insulin human.,Flutamide,DB00030
DB00518,The metabolism of Albendazole can be increased when combined with Insulin human.,Albendazole,DB00030
DB00533,The metabolism of Rofecoxib can be increased when combined with Insulin human.,Rofecoxib,DB00030
DB00544,The metabolism of Fluorouracil can be increased when combined with Insulin human.,Fluorouracil,DB00030
DB00568,The metabolism of Cinnarizine can be increased when combined with Insulin human.,Cinnarizine,DB00030
DB00586,The metabolism of Diclofenac can be increased when combined with Insulin human.,Diclofenac,DB00030
DB00619,The metabolism of Imatinib can be increased when combined with Insulin human.,Imatinib,DB00030
DB00629,The metabolism of Guanabenz can be increased when combined with Insulin human.,Guanabenz,DB00030
DB00642,The metabolism of Pemetrexed can be increased when combined with Insulin human.,Pemetrexed,DB00030
DB00661,The metabolism of Verapamil can be increased when combined with Insulin human.,Verapamil,DB00030
DB00715,The metabolism of Paroxetine can be increased when combined with Insulin human.,Paroxetine,DB00030
DB00730,The metabolism of Thiabendazole can be increased when combined with Insulin human.,Thiabendazole,DB00030
DB00740,The metabolism of Riluzole can be increased when combined with Insulin human.,Riluzole,DB00030
DB00744,The metabolism of Zileuton can be increased when combined with Insulin human.,Zileuton,DB00030
DB00758,The metabolism of Clopidogrel can be increased when combined with Insulin human.,Clopidogrel,DB00030
DB00787,The metabolism of Acyclovir can be increased when combined with Insulin human.,Acyclovir,DB00030
DB00788,The metabolism of Naproxen can be increased when combined with Insulin human.,Naproxen,DB00030
DB00806,The metabolism of Pentoxifylline can be increased when combined with Insulin human.,Pentoxifylline,DB00030
DB00831,The metabolism of Trifluoperazine can be increased when combined with Insulin human.,Trifluoperazine,DB00030
DB00850,The metabolism of Perphenazine can be increased when combined with Insulin human.,Perphenazine,DB00030
DB00857,The metabolism of Terbinafine can be increased when combined with Insulin human.,Terbinafine,DB00030
DB00863,The metabolism of Ranitidine can be increased when combined with Insulin human.,Ranitidine,DB00030
DB00898,The metabolism of Ethanol can be increased when combined with Insulin human.,Ethanol,DB00030
DB00934,The metabolism of Maprotiline can be increased when combined with Insulin human.,Maprotiline,DB00030
DB00969,The metabolism of Alosetron can be increased when combined with Insulin human.,Alosetron,DB00030
DB00980,The metabolism of Ramelteon can be increased when combined with Insulin human.,Ramelteon,DB00030
DB00993,The metabolism of Azathioprine can be increased when combined with Insulin human.,Azathioprine,DB00030
DB00998,The metabolism of Frovatriptan can be increased when combined with Insulin human.,Frovatriptan,DB00030
DB01002,The metabolism of Levobupivacaine can be increased when combined with Insulin human.,Levobupivacaine,DB00030
DB01012,The metabolism of Cinacalcet can be increased when combined with Insulin human.,Cinacalcet,DB00030
DB01037,The metabolism of Selegiline can be increased when combined with Insulin human.,Selegiline,DB00030
DB01056,The metabolism of Tocainide can be increased when combined with Insulin human.,Tocainide,DB00030
DB01058,The metabolism of Praziquantel can be increased when combined with Insulin human.,Praziquantel,DB00030
DB01065,The metabolism of Melatonin can be increased when combined with Insulin human.,Melatonin,DB00030
DB01087,The metabolism of Primaquine can be increased when combined with Insulin human.,Primaquine,DB00030
DB01094,The metabolism of Hesperetin can be increased when combined with Insulin human.,Hesperetin,DB00030
DB01097,The metabolism of Leflunomide can be increased when combined with Insulin human.,Leflunomide,DB00030
DB01166,The metabolism of Cilostazol can be increased when combined with Insulin human.,Cilostazol,DB00030
DB01184,The metabolism of Domperidone can be increased when combined with Insulin human.,Domperidone,DB00030
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Insulin human.,Dexfenfluramine,DB00030
DB01303,The metabolism of Oxtriphylline can be increased when combined with Insulin human.,Oxtriphylline,DB00030
DB01367,The metabolism of Rasagiline can be increased when combined with Insulin human.,Rasagiline,DB00030
DB01412,The metabolism of Theobromine can be increased when combined with Insulin human.,Theobromine,DB00030
DB01424,The metabolism of Aminophenazone can be increased when combined with Insulin human.,Aminophenazone,DB00030
DB01435,The metabolism of Antipyrine can be increased when combined with Insulin human.,Antipyrine,DB00030
DB01482,The metabolism of Fenethylline can be increased when combined with Insulin human.,Fenethylline,DB00030
DB01558,The metabolism of Bromazepam can be increased when combined with Insulin human.,Bromazepam,DB00030
DB01623,The metabolism of Thiothixene can be increased when combined with Insulin human.,Thiothixene,DB00030
DB01628,The metabolism of Etoricoxib can be increased when combined with Insulin human.,Etoricoxib,DB00030
DB01645,The metabolism of Genistein can be increased when combined with Insulin human.,Genistein,DB00030
DB01667,The metabolism of 8-azaguanine can be increased when combined with Insulin human.,8-azaguanine,DB00030
DB02134,The metabolism of Xanthine can be increased when combined with Insulin human.,Xanthine,DB00030
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Insulin human.,9-Methylguanine,DB00030
DB02568,The metabolism of Peldesine can be increased when combined with Insulin human.,Peldesine,DB00030
DB02709,The metabolism of Resveratrol can be increased when combined with Insulin human.,Resveratrol,DB00030
DB03783,The metabolism of Phenacetin can be increased when combined with Insulin human.,Phenacetin,DB00030
DB04076,The metabolism of Hypoxanthine can be increased when combined with Insulin human.,Hypoxanthine,DB00030
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Insulin human.,9-Deazaguanine,DB00030
DB04841,The metabolism of Flunarizine can be increased when combined with Insulin human.,Flunarizine,DB00030
DB04871,The metabolism of Lorcaserin can be increased when combined with Insulin human.,Lorcaserin,DB00030
DB04948,The metabolism of Lofexidine can be increased when combined with Insulin human.,Lofexidine,DB00030
DB04951,The metabolism of Pirfenidone can be increased when combined with Insulin human.,Pirfenidone,DB00030
DB05676,The metabolism of Apremilast can be increased when combined with Insulin human.,Apremilast,DB00030
DB06148,The metabolism of Mianserin can be increased when combined with Insulin human.,Mianserin,DB00030
DB06210,The metabolism of Eltrombopag can be increased when combined with Insulin human.,Eltrombopag,DB00030
DB06235,The metabolism of Vadimezan can be increased when combined with Insulin human.,Vadimezan,DB00030
DB06479,The metabolism of Propentofylline can be increased when combined with Insulin human.,Propentofylline,DB00030
DB06589,The metabolism of Pazopanib can be increased when combined with Insulin human.,Pazopanib,DB00030
DB06594,The metabolism of Agomelatine can be increased when combined with Insulin human.,Agomelatine,DB00030
DB06626,The metabolism of Axitinib can be increased when combined with Insulin human.,Axitinib,DB00030
DB06769,The metabolism of Bendamustine can be increased when combined with Insulin human.,Bendamustine,DB00030
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Insulin human.,Benzyl alcohol,DB00030
DB06774,The metabolism of Capsaicin can be increased when combined with Insulin human.,Capsaicin,DB00030
DB08496,The metabolism of (R)-warfarin can be increased when combined with Insulin human.,(R)-warfarin,DB00030
DB08883,The metabolism of Perampanel can be increased when combined with Insulin human.,Perampanel,DB00030
DB09071,The metabolism of Tasimelteon can be increased when combined with Insulin human.,Tasimelteon,DB00030
DB09118,The metabolism of Stiripentol can be increased when combined with Insulin human.,Stiripentol,DB00030
DB09225,The metabolism of Zotepine can be increased when combined with Insulin human.,Zotepine,DB00030
DB09273,The metabolism of Doxofylline can be increased when combined with Insulin human.,Doxofylline,DB00030
DB09288,The metabolism of Propacetamol can be increased when combined with Insulin human.,Propacetamol,DB00030
DB09290,The metabolism of Ramosetron can be increased when combined with Insulin human.,Ramosetron,DB00030
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Insulin human.,6-O-benzylguanine,DB00030
DB11967,The metabolism of Binimetinib can be increased when combined with Insulin human.,Binimetinib,DB00030
DB12026,The metabolism of Voxilaprevir can be increased when combined with Insulin human.,Voxilaprevir,DB00030
DB12245,The metabolism of Triclabendazole can be increased when combined with Insulin human.,Triclabendazole,DB00030
DB12332,The metabolism of Rucaparib can be increased when combined with Insulin human.,Rucaparib,DB00030
DB12406,The metabolism of Lisofylline can be increased when combined with Insulin human.,Lisofylline,DB00030
DB12531,The metabolism of Lobucavir can be increased when combined with Insulin human.,Lobucavir,DB00030
DB12926,The metabolism of Cafedrine can be increased when combined with Insulin human.,Cafedrine,DB00030
DB12927,The metabolism of Theodrenaline can be increased when combined with Insulin human.,Theodrenaline,DB00030
DB12945,The metabolism of Dihydralazine can be increased when combined with Insulin human.,Dihydralazine,DB00030
DB13203,The metabolism of Bamifylline can be increased when combined with Insulin human.,Bamifylline,DB00030
DB13449,The metabolism of Proxyphylline can be increased when combined with Insulin human.,Proxyphylline,DB00030
DB13573,The metabolism of Acefylline can be increased when combined with Insulin human.,Acefylline,DB00030
DB13592,The metabolism of Etamiphylline can be increased when combined with Insulin human.,Etamiphylline,DB00030
DB13634,The metabolism of Pentifylline can be increased when combined with Insulin human.,Pentifylline,DB00030
DB13812,The metabolism of Bufylline can be increased when combined with Insulin human.,Bufylline,DB00030
DB13952,The metabolism of Estradiol acetate can be increased when combined with Insulin human.,Estradiol acetate,DB00030
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Insulin human.,Estradiol benzoate,DB00030
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Insulin human.,Estradiol cypionate,DB00030
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Insulin human.,Estradiol dienanthate,DB00030
DB13956,The metabolism of Estradiol valerate can be increased when combined with Insulin human.,Estradiol valerate,DB00030
DB14018,The metabolism of Bromotheophylline can be increased when combined with Insulin human.,Bromotheophylline,DB00030
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Insulin human.,8-chlorotheophylline,DB00030
DB01115,The metabolism of Nifedipine can be increased when combined with Insulin human.,Nifedipine,DB00030
DB11757,The metabolism of Istradefylline can be increased when combined with Insulin human.,Istradefylline,DB00030
DB00972,The metabolism of Azelastine can be increased when combined with Insulin human.,Azelastine,DB00030
DB00625,The metabolism of Efavirenz can be increased when combined with Insulin human.,Efavirenz,DB00030
DB04889,The metabolism of Bicifadine can be increased when combined with Insulin human.,Bicifadine,DB00030
DB05708,The metabolism of GTS-21 can be increased when combined with Insulin human.,GTS-21,DB00030
DB01195,The metabolism of Flecainide can be increased when combined with Insulin human.,Flecainide,DB00030
DB00783,The metabolism of Estradiol can be increased when combined with Insulin human.,Estradiol,DB00030
DB00321,The metabolism of Amitriptyline can be increased when combined with Insulin human.,Amitriptyline,DB00030
DB00458,The metabolism of Imipramine can be increased when combined with Insulin human.,Imipramine,DB00030
DB01142,The metabolism of Doxepin can be increased when combined with Insulin human.,Doxepin,DB00030
DB00532,The metabolism of Mephenytoin can be increased when combined with Insulin human.,Mephenytoin,DB00030
DB00540,The metabolism of Nortriptyline can be increased when combined with Insulin human.,Nortriptyline,DB00030
DB00575,The metabolism of Clonidine can be increased when combined with Insulin human.,Clonidine,DB00030
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Insulin human.,Cyclobenzaprine,DB00030
DB01151,The metabolism of Desipramine can be increased when combined with Insulin human.,Desipramine,DB00030
DB01242,The metabolism of Clomipramine can be increased when combined with Insulin human.,Clomipramine,DB00030
DB11689,The metabolism of Selumetinib can be increased when combined with Insulin human.,Selumetinib,DB00030
DB00277,The metabolism of Theophylline can be increased when combined with Insulin human.,Theophylline,DB00030
DB00398,The metabolism of Sorafenib can be increased when combined with Insulin human.,Sorafenib,DB00030
DB00530,The metabolism of Erlotinib can be increased when combined with Insulin human.,Erlotinib,DB00030
DB00564,The metabolism of Carbamazepine can be increased when combined with Insulin human.,Carbamazepine,DB00030
DB00682,The metabolism of Warfarin can be increased when combined with Insulin human.,Warfarin,DB00030
DB00697,The metabolism of Tizanidine can be increased when combined with Insulin human.,Tizanidine,DB00030
DB00773,The metabolism of Etoposide can be increased when combined with Insulin human.,Etoposide,DB00030
DB00851,The metabolism of Dacarbazine can be increased when combined with Insulin human.,Dacarbazine,DB00030
DB01100,The metabolism of Pimozide can be increased when combined with Insulin human.,Pimozide,DB00030
DB01223,The metabolism of Aminophylline can be increased when combined with Insulin human.,Aminophylline,DB00030
DB01254,The metabolism of Dasatinib can be increased when combined with Insulin human.,Dasatinib,DB00030
DB01418,The metabolism of Acenocoumarol can be increased when combined with Insulin human.,Acenocoumarol,DB00030
DB08910,The metabolism of Pomalidomide can be increased when combined with Insulin human.,Pomalidomide,DB00030
DB09256,The metabolism of Tegafur can be increased when combined with Insulin human.,Tegafur,DB00030
DB13874,The metabolism of Enasidenib can be increased when combined with Insulin human.,Enasidenib,DB00030
DB00675,The metabolism of Tamoxifen can be increased when combined with Insulin human.,Tamoxifen,DB00030
DB00046,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin lispro.,Insulin lispro,DB00030
DB00047,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin glargine.,Insulin glargine,DB00030
DB00071,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin pork.,Insulin pork,DB00030
DB00197,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Troglitazone.,Troglitazone,DB00030
DB00222,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glimepiride.,Glimepiride,DB00030
DB00280,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Disopyramide.,Disopyramide,DB00030
DB00284,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Acarbose.,Acarbose,DB00030
DB00414,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Acetohexamide.,Acetohexamide,DB00030
DB00468,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Quinine.,Quinine,DB00030
DB00491,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Miglitol.,Miglitol,DB00030
DB00672,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Chlorpropamide.,Chlorpropamide,DB00030
DB00731,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Nateglinide.,Nateglinide,DB00030
DB00834,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Mifepristone.,Mifepristone,DB00030
DB00839,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Tolazamide.,Tolazamide,DB00030
DB00912,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Repaglinide.,Repaglinide,DB00030
DB00914,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Phenformin.,Phenformin,DB00030
DB01016,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glyburide.,Glyburide,DB00030
DB01067,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glipizide.,Glipizide,DB00030
DB01120,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Gliclazide.,Gliclazide,DB00030
DB01124,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Tolbutamide.,Tolbutamide,DB00030
DB01200,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Bromocriptine.,Bromocriptine,DB00030
DB01251,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Gliquidone.,Gliquidone,DB00030
DB01252,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Mitiglinide.,Mitiglinide,DB00030
DB01268,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Sunitinib.,Sunitinib,DB00030
DB01277,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Mecasermin.,Mecasermin,DB00030
DB01289,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glisoxepide.,Glisoxepide,DB00030
DB01306,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin aspart.,Insulin aspart,DB00030
DB01307,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin detemir.,Insulin detemir,DB00030
DB01309,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin glulisine.,Insulin glulisine,DB00030
DB01700,The risk or severity of hypoglycemia can be increased when Insulin human is combined with AICA ribonucleotide.,AICA ribonucleotide,DB00030
DB04830,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Buformin.,Buformin,DB00030
DB04878,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Voglibose.,Voglibose,DB00030
DB05115,The risk or severity of hypoglycemia can be increased when Insulin human is combined with NN344.,NN344,DB00030
DB05819,The risk or severity of hypoglycemia can be increased when Insulin human is combined with NBI-6024.,NBI-6024,DB00030
DB08962,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glibornuride.,Glibornuride,DB00030
DB09022,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Benfluorex.,Benfluorex,DB00030
DB09198,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Lobeglitazone.,Lobeglitazone,DB00030
DB09199,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Netoglitazone.,Netoglitazone,DB00030
DB09200,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Rivoglitazone.,Rivoglitazone,DB00030
DB09201,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Ciglitazone.,Ciglitazone,DB00030
DB09456,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin beef.,Insulin beef,DB00030
DB09564,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin degludec.,Insulin degludec,DB00030
DB11567,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin peglispro.,Insulin peglispro,DB00030
DB11568,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin tregopil.,Insulin tregopil,DB00030
DB11698,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Ipragliflozin.,Ipragliflozin,DB00030
DB11780,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Allicin.,Allicin,DB00030
DB11824,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Tofogliflozin.,Tofogliflozin,DB00030
DB11898,"The risk or severity of hypoglycemia can be increased when Insulin human is combined with 2,4-thiazolidinedione.","2,4-thiazolidinedione",DB00030
DB12713,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Sotagliflozin.,Sotagliflozin,DB00030
DB12781,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Balaglitazone.,Balaglitazone,DB00030
DB12935,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Remogliflozin etabonate.,Remogliflozin etabonate,DB00030
DB13406,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Carbutamide.,Carbutamide,DB00030
DB13446,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Guar gum.,Guar gum,DB00030
DB13675,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Metahexamide.,Metahexamide,DB00030
DB14035,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Englitazone.,Englitazone,DB00030
DB15171,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Tirzepatide.,Tirzepatide,DB00030
DB15217,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Gastric inhibitory polypeptide.,Gastric inhibitory polypeptide,DB00030
DB00270,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin human.,Isradipine,DB00030
DB00343,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Insulin human.,Diltiazem,DB00030
DB00347,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Insulin human.,Trimethadione,DB00030
DB00381,The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin human.,Amlodipine,DB00030
DB00393,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Insulin human.,Nimodipine,DB00030
DB00401,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Insulin human.,Nisoldipine,DB00030
DB00528,The risk or severity of hypoglycemia can be increased when Lercanidipine is combined with Insulin human.,Lercanidipine,DB00030
DB00555,The risk or severity of hypoglycemia can be increased when Lamotrigine is combined with Insulin human.,Lamotrigine,DB00030
DB00593,The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Insulin human.,Ethosuximide,DB00030
DB00622,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Insulin human.,Nicardipine,DB00030
DB00653,The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin human.,Magnesium sulfate,DB00030
DB00836,The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin human.,Loperamide,DB00030
DB01054,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Insulin human.,Nitrendipine,DB00030
DB01074,The risk or severity of hypoglycemia can be increased when Perhexiline is combined with Insulin human.,Perhexiline,DB00030
DB01244,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Insulin human.,Bepridil,DB00030
DB01388,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Insulin human.,Mibefradil,DB00030
DB04743,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Insulin human.,Nimesulide,DB00030
DB04825,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Insulin human.,Prenylamine,DB00030
DB04838,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Insulin human.,Cyclandelate,DB00030
DB04842,The risk or severity of hypoglycemia can be increased when Fluspirilene is combined with Insulin human.,Fluspirilene,DB00030
DB04920,The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Insulin human.,Clevidipine,DB00030
DB05246,The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Insulin human.,Methsuximide,DB00030
DB05885,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Insulin human.,Seletracetam,DB00030
DB06152,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Insulin human.,Nylidrin,DB00030
DB06283,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Insulin human.,Ziconotide,DB00030
DB06446,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Insulin human.,Dotarizine,DB00030
DB06694,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Insulin human.,Xylometazoline,DB00030
DB06712,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Insulin human.,Nilvadipine,DB00030
DB07615,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Insulin human.,Tranilast,DB00030
DB08838,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Insulin human.,Agmatine,DB00030
DB08980,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Insulin human.,Fendiline,DB00030
DB08992,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Insulin human.,Eperisone,DB00030
DB09089,The risk or severity of hypoglycemia can be increased when Trimebutine is combined with Insulin human.,Trimebutine,DB00030
DB09090,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Insulin human.,Pinaverium,DB00030
DB09216,The risk or severity of hypoglycemia can be increased when Tolfenamic acid is combined with Insulin human.,Tolfenamic acid,DB00030
DB09227,The risk or severity of hypoglycemia can be increased when Barnidipine is combined with Insulin human.,Barnidipine,DB00030
DB09229,The risk or severity of hypoglycemia can be increased when Aranidipine is combined with Insulin human.,Aranidipine,DB00030
DB09230,The risk or severity of hypoglycemia can be increased when Azelnidipine is combined with Insulin human.,Azelnidipine,DB00030
DB09231,The risk or severity of hypoglycemia can be increased when Benidipine is combined with Insulin human.,Benidipine,DB00030
DB09232,The risk or severity of hypoglycemia can be increased when Cilnidipine is combined with Insulin human.,Cilnidipine,DB00030
DB09234,The risk or severity of hypoglycemia can be increased when Darodipine is combined with Insulin human.,Darodipine,DB00030
DB09235,The risk or severity of hypoglycemia can be increased when Efonidipine is combined with Insulin human.,Efonidipine,DB00030
DB09236,The risk or severity of hypoglycemia can be increased when Lacidipine is combined with Insulin human.,Lacidipine,DB00030
DB09238,The risk or severity of hypoglycemia can be increased when Manidipine is combined with Insulin human.,Manidipine,DB00030
DB09239,The risk or severity of hypoglycemia can be increased when Niguldipine is combined with Insulin human.,Niguldipine,DB00030
DB09240,The risk or severity of hypoglycemia can be increased when Niludipine is combined with Insulin human.,Niludipine,DB00030
DB11960,The risk or severity of hypoglycemia can be increased when Carboxyamidotriazole is combined with Insulin human.,Carboxyamidotriazole,DB00030
DB12092,The risk or severity of hypoglycemia can be increased when Naftopidil is combined with Insulin human.,Naftopidil,DB00030
DB12093,The risk or severity of hypoglycemia can be increased when Tetrahydropalmatine is combined with Insulin human.,Tetrahydropalmatine,DB00030
DB12131,The risk or severity of hypoglycemia can be increased when Vinpocetine is combined with Insulin human.,Vinpocetine,DB00030
DB12923,The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Insulin human.,Gallopamil,DB00030
DB13488,The risk or severity of hypoglycemia can be increased when Bencyclane is combined with Insulin human.,Bencyclane,DB00030
DB13500,The risk or severity of hypoglycemia can be increased when Otilonium is combined with Insulin human.,Otilonium,DB00030
DB13725,The risk or severity of hypoglycemia can be increased when Terodiline is combined with Insulin human.,Terodiline,DB00030
DB13766,The risk or severity of hypoglycemia can be increased when Lidoflazine is combined with Insulin human.,Lidoflazine,DB00030
DB13791,The risk or severity of hypoglycemia can be increased when Penfluridol is combined with Insulin human.,Penfluridol,DB00030
DB13835,The risk or severity of hypoglycemia can be increased when Caroverine is combined with Insulin human.,Caroverine,DB00030
DB13950,The risk or severity of hypoglycemia can be increased when WIN 55212-2 is combined with Insulin human.,WIN 55212-2,DB00030
DB13961,The risk or severity of hypoglycemia can be increased when Fish oil is combined with Insulin human.,Fish oil,DB00030
DB14063,The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Insulin human.,Dexverapamil,DB00030
DB14064,The risk or severity of hypoglycemia can be increased when Emopamil is combined with Insulin human.,Emopamil,DB00030
DB14065,The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Insulin human.,Lomerizine,DB00030
DB14066,The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Insulin human.,Tetrandrine,DB00030
DB14068,The risk or severity of hypoglycemia can be increased when Dexniguldipine is combined with Insulin human.,Dexniguldipine,DB00030
DB01023,The risk or severity of hypoglycemia can be increased when Felodipine is combined with Insulin human.,Felodipine,DB00030
DB01118,The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin human.,Amiodarone,DB00030
DB00191,The therapeutic efficacy of Insulin human can be increased when used in combination with Phentermine.,Phentermine,DB00030
DB00268,The metabolism of Ropinirole can be increased when combined with Insulin human.,Ropinirole,DB00030
DB13074,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Insulin human.,Macimorelin,DB00030
DB00279,The therapeutic efficacy of Insulin human can be decreased when used in combination with Liothyronine.,Liothyronine,DB00030
DB00331,The risk or severity of adverse effects can be increased when Insulin human is combined with Metformin.,Metformin,DB00030
DB00542,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Insulin human.,Benazepril,DB00030
DB13946,The risk or severity of adverse effects can be increased when Testosterone undecanoate is combined with Insulin human.,Testosterone undecanoate,DB00030
DB00945,The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin human.,Acetylsalicylic acid,DB00030
DB00181,The therapeutic efficacy of Insulin human can be decreased when used in combination with Baclofen.,Baclofen,DB00030
DB00489,The risk or severity of hypoglycemia can be increased when Sotalol is combined with Insulin human.,Sotalol,DB00030
DB00196,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Fluconazole.,Fluconazole,DB00030
DB00040,The therapeutic efficacy of Insulin human can be decreased when used in combination with Glucagon.,Glucagon,DB00030
DB00264,The therapeutic efficacy of Insulin human can be increased when used in combination with Metoprolol.,Metoprolol,DB00030
DB00335,The therapeutic efficacy of Insulin human can be increased when used in combination with Atenolol.,Atenolol,DB00030
DB00373,The therapeutic efficacy of Insulin human can be increased when used in combination with Timolol.,Timolol,DB00030
DB00598,The therapeutic efficacy of Insulin human can be increased when used in combination with Labetalol.,Labetalol,DB00030
DB00612,The therapeutic efficacy of Insulin human can be increased when used in combination with Bisoprolol.,Bisoprolol,DB00030
DB00866,The therapeutic efficacy of Insulin human can be increased when used in combination with Alprenolol.,Alprenolol,DB00030
DB00960,The therapeutic efficacy of Insulin human can be increased when used in combination with Pindolol.,Pindolol,DB00030
DB01193,The therapeutic efficacy of Insulin human can be increased when used in combination with Acebutolol.,Acebutolol,DB00030
DB01203,The therapeutic efficacy of Insulin human can be increased when used in combination with Nadolol.,Nadolol,DB00030
DB01295,The therapeutic efficacy of Insulin human can be increased when used in combination with Bevantolol.,Bevantolol,DB00030
DB01297,The therapeutic efficacy of Insulin human can be increased when used in combination with Practolol.,Practolol,DB00030
DB01359,The therapeutic efficacy of Insulin human can be increased when used in combination with Penbutolol.,Penbutolol,DB00030
DB01580,The therapeutic efficacy of Insulin human can be increased when used in combination with Oxprenolol.,Oxprenolol,DB00030
DB03322,The therapeutic efficacy of Insulin human can be increased when used in combination with Dexpropranolol.,Dexpropranolol,DB00030
DB04846,The therapeutic efficacy of Insulin human can be increased when used in combination with Celiprolol.,Celiprolol,DB00030
DB04861,The therapeutic efficacy of Insulin human can be increased when used in combination with Nebivolol.,Nebivolol,DB00030
DB06726,The therapeutic efficacy of Insulin human can be increased when used in combination with Bufuralol.,Bufuralol,DB00030
DB08807,The therapeutic efficacy of Insulin human can be increased when used in combination with Bopindolol.,Bopindolol,DB00030
DB08808,The therapeutic efficacy of Insulin human can be increased when used in combination with Bupranolol.,Bupranolol,DB00030
DB08952,The therapeutic efficacy of Insulin human can be increased when used in combination with Indenolol.,Indenolol,DB00030
DB09013,The therapeutic efficacy of Insulin human can be increased when used in combination with Befunolol.,Befunolol,DB00030
DB09204,The therapeutic efficacy of Insulin human can be increased when used in combination with Arotinolol.,Arotinolol,DB00030
DB09351,The therapeutic efficacy of Insulin human can be increased when used in combination with Levobetaxolol.,Levobetaxolol,DB00030
DB11770,The therapeutic efficacy of Insulin human can be increased when used in combination with Talinolol.,Talinolol,DB00030
DB11785,The therapeutic efficacy of Insulin human can be increased when used in combination with Anisodamine.,Anisodamine,DB00030
DB12212,The therapeutic efficacy of Insulin human can be increased when used in combination with Landiolol.,Landiolol,DB00030
DB12752,The therapeutic efficacy of Insulin human can be increased when used in combination with Bucindolol.,Bucindolol,DB00030
DB13443,The therapeutic efficacy of Insulin human can be increased when used in combination with Esatenolol.,Esatenolol,DB00030
DB13508,The therapeutic efficacy of Insulin human can be increased when used in combination with Cloranolol.,Cloranolol,DB00030
DB13530,The therapeutic efficacy of Insulin human can be increased when used in combination with Mepindolol.,Mepindolol,DB00030
DB13757,The therapeutic efficacy of Insulin human can be increased when used in combination with Epanolol.,Epanolol,DB00030
DB13775,The therapeutic efficacy of Insulin human can be increased when used in combination with Tertatolol.,Tertatolol,DB00030
DB00195,The therapeutic efficacy of Betaxolol can be increased when used in combination with Insulin human.,Betaxolol,DB00030
DB00571,The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin human.,Propranolol,DB00030
DB01136,The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin human.,Carvedilol,DB00030
DB01182,The therapeutic efficacy of Propafenone can be increased when used in combination with Insulin human.,Propafenone,DB00030
DB01611,The therapeutic efficacy of Insulin human can be increased when used in combination with Hydroxychloroquine.,Hydroxychloroquine,DB00030
DB01233,The therapeutic efficacy of Metoclopramide can be increased when used in combination with Insulin human.,Metoclopramide,DB00030
DB00394,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Insulin human.,Beclomethasone dipropionate,DB00030
DB00443,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Insulin human.,Betamethasone,DB00030
DB00620,The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Insulin human.,Triamcinolone,DB00030
DB00635,The risk or severity of hyperglycemia can be increased when Prednisone is combined with Insulin human.,Prednisone,DB00030
DB00687,The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Insulin human.,Fludrocortisone,DB00030
DB00741,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin human.,Hydrocortisone,DB00030
DB00764,The risk or severity of hyperglycemia can be increased when Mometasone is combined with Insulin human.,Mometasone,DB00030
DB00860,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Insulin human.,Prednisolone,DB00030
DB00959,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Insulin human.,Methylprednisolone,DB00030
DB01234,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin human.,Dexamethasone,DB00030
DB01285,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Insulin human.,Corticotropin,DB00030
DB01380,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Insulin human.,Cortisone acetate,DB00030
DB01384,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Insulin human.,Paramethasone,DB00030
DB01410,The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Insulin human.,Ciclesonide,DB00030
DB08906,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin human.,Fluticasone furoate,DB00030
DB08970,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin human.,Fluprednidene,DB00030
DB08971,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin human.,Fluocortolone,DB00030
DB09383,The risk or severity of hyperglycemia can be increased when Meprednisone is combined with Insulin human.,Meprednisone,DB00030
DB11487,The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin human.,Dexamethasone isonicotinate,DB00030
DB11750,The risk or severity of hyperglycemia can be increased when Clobetasol is combined with Insulin human.,Clobetasol,DB00030
DB11921,The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Insulin human.,Deflazacort,DB00030
DB13003,The risk or severity of hyperglycemia can be increased when Cortivazol is combined with Insulin human.,Cortivazol,DB00030
DB13208,The risk or severity of hyperglycemia can be increased when Prednylidene is combined with Insulin human.,Prednylidene,DB00030
DB13843,The risk or severity of hyperglycemia can be increased when Cloprednol is combined with Insulin human.,Cloprednol,DB00030
DB13867,The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin human.,Fluticasone,DB00030
DB14512,The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Insulin human.,Mometasone furoate,DB00030
DB00180,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Insulin human.,Flunisolide,DB00030
DB01108,The risk or severity of hyperglycemia can be increased when Trilostane is combined with Insulin human.,Trilostane,DB00030
DB01222,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin human.,Budesonide,DB00030
DB04630,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Insulin human.,Aldosterone,DB00030
DB09378,The risk or severity of hyperglycemia can be increased when Fluprednisolone is combined with Insulin human.,Fluprednisolone,DB00030
DB11529,The risk or severity of hyperglycemia can be increased when Melengestrol is combined with Insulin human.,Melengestrol,DB00030
DB14681,The risk or severity of hyperglycemia can be increased when Cortisone is combined with Insulin human.,Cortisone,DB00030
DB00223,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Insulin human.,Diflorasone,DB00030
DB00240,The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Insulin human.,Alclometasone,DB00030
DB00253,The risk or severity of hyperglycemia can be increased when Medrysone is combined with Insulin human.,Medrysone,DB00030
DB00288,The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Insulin human.,Amcinonide,DB00030
DB00324,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Insulin human.,Fluorometholone,DB00030
DB00547,The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Insulin human.,Desoximetasone,DB00030
DB00588,The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin human.,Fluticasone propionate,DB00030
DB00591,The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Insulin human.,Fluocinolone acetonide,DB00030
DB00596,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin human.,Ulobetasol,DB00030
DB00663,The risk or severity of hyperglycemia can be increased when Flumethasone is combined with Insulin human.,Flumethasone,DB00030
DB00838,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Insulin human.,Clocortolone,DB00030
DB00846,The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Insulin human.,Flurandrenolide,DB00030
DB14596,The risk or severity of hyperglycemia can be increased when Loteprednol etabonate is combined with Insulin human.,Loteprednol etabonate,DB00030
DB00896,The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Insulin human.,Rimexolone,DB00030
DB01013,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Insulin human.,Clobetasol propionate,DB00030
DB01047,The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Insulin human.,Fluocinonide,DB00030
DB01130,The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Insulin human.,Prednicarbate,DB00030
DB01260,The risk or severity of hyperglycemia can be increased when Desonide is combined with Insulin human.,Desonide,DB00030
DB06781,The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Insulin human.,Difluprednate,DB00030
DB06786,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin human.,Halcinonide,DB00030
DB09091,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Insulin human.,Tixocortol,DB00030
DB09095,The risk or severity of hyperglycemia can be increased when Difluocortolone is combined with Insulin human.,Difluocortolone,DB00030
DB13158,The risk or severity of hyperglycemia can be increased when Clobetasone is combined with Insulin human.,Clobetasone,DB00030
DB13223,The risk or severity of hyperglycemia can be increased when Fluocortin is combined with Insulin human.,Fluocortin,DB00030
DB13491,The risk or severity of hyperglycemia can be increased when Fluperolone is combined with Insulin human.,Fluperolone,DB00030
DB13664,The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin human.,Formocortal,DB00030
DB13728,The risk or severity of hyperglycemia can be increased when Halometasone is combined with Insulin human.,Halometasone,DB00030
DB13856,The risk or severity of hyperglycemia can be increased when Fluclorolone is combined with Insulin human.,Fluclorolone,DB00030
DB14538,The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Insulin human.,Hydrocortisone aceponate,DB00030
DB14539,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin human.,Hydrocortisone acetate,DB00030
DB14540,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin human.,Hydrocortisone butyrate,DB00030
DB14541,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin human.,Hydrocortisone cypionate,DB00030
DB14543,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin human.,Hydrocortisone probutate,DB00030
DB14544,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin human.,Hydrocortisone valerate,DB00030
DB14545,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin human.,Hydrocortisone succinate,DB00030
DB00873,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Insulin human.,Loteprednol,DB00030
DB14631,The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Insulin human.,Prednisolone phosphate,DB00030
DB14633,The risk or severity of hyperglycemia can be increased when Prednisolone hemisuccinate is combined with Insulin human.,Prednisolone hemisuccinate,DB00030
DB14634,The risk or severity of hyperglycemia can be increased when Fluprednidene acetate is combined with Insulin human.,Fluprednidene acetate,DB00030
DB14643,The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Insulin human.,Methylprednisolone aceponate,DB00030
DB14644,The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Insulin human.,Methylprednisolone hemisuccinate,DB00030
DB14646,The risk or severity of hyperglycemia can be increased when Prednisone acetate is combined with Insulin human.,Prednisone acetate,DB00030
DB14652,The risk or severity of hyperglycemia can be increased when Clocortolone acetate is combined with Insulin human.,Clocortolone acetate,DB00030
DB14659,The risk or severity of hyperglycemia can be increased when Melengestrol acetate is combined with Insulin human.,Melengestrol acetate,DB00030
DB14669,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Insulin human.,Betamethasone phosphate,DB00030
DB15566,The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Insulin human.,Prednisolone acetate,DB00030
DB00451,The therapeutic efficacy of Insulin human can be decreased when used in combination with Levothyroxine.,Levothyroxine,DB00030
DB00024,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin human.,Thyrotropin alfa,DB00030
DB01583,Liotrix may decrease the hypoglycemic activities of Insulin human.,Liotrix,DB00030
DB03604,Tiratricol may decrease the hypoglycemic activities of Insulin human.,Tiratricol,DB00030
DB09100,"Thyroid, porcine may decrease the hypoglycemic activities of Insulin human.","Thyroid, porcine",DB00030
DB06605,Apixaban may increase the anticoagulant activities of Tenecteplase.,Apixaban,DB00031
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Tenecteplase.,Dabigatran etexilate,DB00031
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Tenecteplase.,Dasatinib,DB00031
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Tenecteplase is combined with Deferasirox.,Deferasirox,DB00031
DB01586,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid,DB00031
DB02123,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid,DB00031
DB02659,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Cholic Acid.,Cholic Acid,DB00031
DB02691,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Glycocholic acid.,Glycocholic acid,DB00031
DB03619,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Deoxycholic acid.,Deoxycholic acid,DB00031
DB04348,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Taurocholic acid.,Taurocholic acid,DB00031
DB05990,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Obeticholic acid.,Obeticholic acid,DB00031
DB06777,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid,DB00031
DB08833,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid,DB00031
DB08834,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid,DB00031
DB08857,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Bamet-UD2.,Bamet-UD2,DB00031
DB11622,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Dehydrocholic acid.,Dehydrocholic acid,DB00031
DB11789,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid,DB00031
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Tenecteplase.,Edoxaban,DB00031
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Tenecteplase.,Ibrutinib,DB00031
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Tenecteplase is combined with Obinutuzumab.,Obinutuzumab,DB00031
DB06228,Tenecteplase may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban,DB00031
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Tenecteplase is combined with Sugammadex.,Sugammadex,DB00031
DB09070,Tibolone may increase the anticoagulant activities of Tenecteplase.,Tibolone,DB00031
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Tenecteplase.,Tipranavir,DB00031
DB00013,Urokinase may increase the anticoagulant activities of Tenecteplase.,Urokinase,DB00031
DB00163,Vitamin E may increase the anticoagulant activities of Tenecteplase.,Vitamin E,DB00031
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Tenecteplase.,Vorapaxar,DB00031
DB06692,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Aprotinin.,Aprotinin,DB00031
DB01381,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba,DB00031
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Tenecteplase.,Ifosfamide,DB00031
DB00468,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Quinine.,Quinine,DB00031
DB00908,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Quinidine.,Quinidine,DB00031
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Tenecteplase.,Tamoxifen,DB00031
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Tenecteplase.,Toremifene,DB00031
DB00806,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Pentoxifylline.,Pentoxifylline,DB00031
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Tenecteplase.,Pentosan polysulfate,DB00031
DB00583,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Levocarnitine.,Levocarnitine,DB00031
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Tenecteplase.,Diethylstilbestrol,DB00031
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Tenecteplase.,Chlorotrianisene,DB00031
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Tenecteplase.,Conjugated estrogens,DB00031
DB00783,Estradiol may decrease the anticoagulant activities of Tenecteplase.,Estradiol,DB00031
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Tenecteplase.,Ethinylestradiol,DB00031
DB01357,Mestranol may decrease the anticoagulant activities of Tenecteplase.,Mestranol,DB00031
DB04573,Estriol may decrease the anticoagulant activities of Tenecteplase.,Estriol,DB00031
DB04574,Estrone sulfate may decrease the anticoagulant activities of Tenecteplase.,Estrone sulfate,DB00031
DB04575,Quinestrol may decrease the anticoagulant activities of Tenecteplase.,Quinestrol,DB00031
DB07931,Hexestrol may decrease the anticoagulant activities of Tenecteplase.,Hexestrol,DB00031
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Tenecteplase.","Synthetic Conjugated Estrogens, A",DB00031
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Tenecteplase.","Synthetic Conjugated Estrogens, B",DB00031
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Tenecteplase.,Polyestradiol phosphate,DB00031
DB09381,Esterified estrogens may decrease the anticoagulant activities of Tenecteplase.,Esterified estrogens,DB00031
DB11478,Zeranol may decrease the anticoagulant activities of Tenecteplase.,Zeranol,DB00031
DB11674,Equol may decrease the anticoagulant activities of Tenecteplase.,Equol,DB00031
DB12487,Promestriene may decrease the anticoagulant activities of Tenecteplase.,Promestriene,DB00031
DB13143,Methallenestril may decrease the anticoagulant activities of Tenecteplase.,Methallenestril,DB00031
DB13386,Epimestrol may decrease the anticoagulant activities of Tenecteplase.,Epimestrol,DB00031
DB13418,Moxestrol may decrease the anticoagulant activities of Tenecteplase.,Moxestrol,DB00031
DB13952,Estradiol acetate may decrease the anticoagulant activities of Tenecteplase.,Estradiol acetate,DB00031
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Tenecteplase.,Estradiol benzoate,DB00031
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Tenecteplase.,Estradiol cypionate,DB00031
DB13956,Estradiol valerate may decrease the anticoagulant activities of Tenecteplase.,Estradiol valerate,DB00031
DB15334,Biochanin A may decrease the anticoagulant activities of Tenecteplase.,Biochanin A,DB00031
DB15335,Formononetin may decrease the anticoagulant activities of Tenecteplase.,Formononetin,DB00031
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Tenecteplase.,Icosapent,DB00031
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Tenecteplase.,Mesalazine,DB00031
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Tenecteplase.,Indomethacin,DB00031
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Tenecteplase.,Nabumetone,DB00031
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Tenecteplase.,Ketorolac,DB00031
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Tenecteplase.,Tenoxicam,DB00031
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Tenecteplase.,Celecoxib,DB00031
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Tenecteplase.,Tolmetin,DB00031
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Tenecteplase.,Rofecoxib,DB00031
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Tenecteplase.,Piroxicam,DB00031
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Tenecteplase.,Fenoprofen,DB00031
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Tenecteplase.,Valdecoxib,DB00031
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Tenecteplase.,Diclofenac,DB00031
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Tenecteplase.,Sulindac,DB00031
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Tenecteplase.,Flurbiprofen,DB00031
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Tenecteplase.,Etodolac,DB00031
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Tenecteplase.,Mefenamic acid,DB00031
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Tenecteplase.,Naproxen,DB00031
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Tenecteplase.,Sulfasalazine,DB00031
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Tenecteplase.,Phenylbutazone,DB00031
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Tenecteplase.,Meloxicam,DB00031
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Tenecteplase.,Carprofen,DB00031
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Tenecteplase.,Diflunisal,DB00031
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Tenecteplase.,Salicylic acid,DB00031
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Tenecteplase.,Meclofenamic acid,DB00031
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Tenecteplase.,Oxaprozin,DB00031
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Tenecteplase.,Ketoprofen,DB00031
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Tenecteplase.,Balsalazide,DB00031
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Tenecteplase.,Olsalazine,DB00031
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Tenecteplase.,Lumiracoxib,DB00031
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Tenecteplase.,Magnesium salicylate,DB00031
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Tenecteplase.,Salsalate,DB00031
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Tenecteplase.,Choline magnesium trisalicylate,DB00031
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Tenecteplase.,Antrafenine,DB00031
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Tenecteplase.,Aminophenazone,DB00031
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Tenecteplase.,Antipyrine,DB00031
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Tenecteplase.,Tiaprofenic acid,DB00031
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Tenecteplase.,Etoricoxib,DB00031
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Tenecteplase.,Taxifolin,DB00031
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Tenecteplase.,Oxyphenbutazone,DB00031
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Tenecteplase.,Niflumic acid,DB00031
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Tenecteplase.,Licofelone,DB00031
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Tenecteplase.,Benoxaprofen,DB00031
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Tenecteplase.,Metamizole,DB00031
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Tenecteplase.,Zomepirac,DB00031
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Tenecteplase.,Cimicoxib,DB00031
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Tenecteplase.,Lornoxicam,DB00031
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Tenecteplase.,Aceclofenac,DB00031
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Tenecteplase.,Zaltoprofen,DB00031
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Tenecteplase.,Azapropazone,DB00031
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Tenecteplase.,Felbinac,DB00031
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Tenecteplase.,Parecoxib,DB00031
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Tenecteplase.,Salicylamide,DB00031
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Tenecteplase.,Kebuzone,DB00031
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Tenecteplase.,Isoxicam,DB00031
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Tenecteplase.,Indoprofen,DB00031
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Tenecteplase.,Ibuproxam,DB00031
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Tenecteplase.,Floctafenine,DB00031
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Tenecteplase.,Fenbufen,DB00031
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Tenecteplase.,Etofenamate,DB00031
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Tenecteplase.,Epirizole,DB00031
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Tenecteplase.,Benzydamine,DB00031
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Tenecteplase.,Loxoprofen,DB00031
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Tenecteplase.,Dexketoprofen,DB00031
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Tenecteplase.,Droxicam,DB00031
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Tenecteplase.,Tolfenamic acid,DB00031
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Tenecteplase.,Firocoxib,DB00031
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Tenecteplase.,Clonixin,DB00031
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Tenecteplase.,Morniflumate,DB00031
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Tenecteplase.,Propacetamol,DB00031
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Tenecteplase.,Talniflumate,DB00031
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Tenecteplase.,Robenacoxib,DB00031
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Tenecteplase.,Tepoxalin,DB00031
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Tenecteplase.,Flunixin,DB00031
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Tenecteplase.,Polmacoxib,DB00031
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Tenecteplase.,Betulinic Acid,DB00031
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Tenecteplase.,Ebselen,DB00031
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Tenecteplase.,Tinoridine,DB00031
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Tenecteplase.,Alclofenac,DB00031
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Tenecteplase.,Fentiazac,DB00031
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Tenecteplase.,Suxibuzone,DB00031
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Tenecteplase.,Bumadizone,DB00031
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Tenecteplase.,Alminoprofen,DB00031
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Tenecteplase.,Flunoxaprofen,DB00031
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Tenecteplase.,Feprazone,DB00031
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Tenecteplase.,Difenpiramide,DB00031
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Tenecteplase.,Nifenazone,DB00031
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Tenecteplase.,Lonazolac,DB00031
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Tenecteplase.,Tenidap,DB00031
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Tenecteplase.,Bendazac,DB00031
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Tenecteplase.,Pranoprofen,DB00031
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Tenecteplase.,Propyphenazone,DB00031
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Tenecteplase.,Proglumetacin,DB00031
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Tenecteplase.,Guacetisal,DB00031
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Tenecteplase.,Ethenzamide,DB00031
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Tenecteplase.,Carbaspirin calcium,DB00031
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Tenecteplase.,Mofebutazone,DB00031
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Tenecteplase.,Proquazone,DB00031
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Tenecteplase.,Benorilate,DB00031
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Tenecteplase.,Pirprofen,DB00031
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Tenecteplase.,Imidazole salicylate,DB00031
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Tenecteplase.,SC-236,DB00031
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Tenecteplase.,NS-398,DB00031
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Tenecteplase.,Flurbiprofen axetil,DB00031
DB04865,The risk or severity of bleeding can be increased when Tenecteplase is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate,DB00031
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Tenecteplase.,Omega-3 fatty acids,DB00031
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Tenecteplase is combined with Tositumomab.,Tositumomab,DB00031
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Tenecteplase.,Limaprost,DB00031
DB00048,The risk or severity of adverse effects can be increased when Tenecteplase is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum,DB00031
DB00389,Carbimazole may increase the anticoagulant activities of Tenecteplase.,Carbimazole,DB00031
DB00550,Propylthiouracil may increase the anticoagulant activities of Tenecteplase.,Propylthiouracil,DB00031
DB00763,Methimazole may increase the anticoagulant activities of Tenecteplase.,Methimazole,DB00031
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Tenecteplase.","3,5-Diiodotyrosine",DB00031
DB06715,Potassium Iodide may increase the anticoagulant activities of Tenecteplase.,Potassium Iodide,DB00031
DB07637,Dibromotyrosine may increase the anticoagulant activities of Tenecteplase.,Dibromotyrosine,DB00031
DB09418,Potassium perchlorate may increase the anticoagulant activities of Tenecteplase.,Potassium perchlorate,DB00031
DB13644,Methylthiouracil may increase the anticoagulant activities of Tenecteplase.,Methylthiouracil,DB00031
DB13804,Benzylthiouracil may increase the anticoagulant activities of Tenecteplase.,Benzylthiouracil,DB00031
DB00834,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Mifepristone.,Mifepristone,DB00031
DB04066,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid,DB00031
DB04682,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol,DB00031
DB05830,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Trestolone.,Trestolone,DB00031
DB06266,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Lonidamine.,Lonidamine,DB00031
DB08867,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ulipristal.,Ulipristal,DB00031
DB09401,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Isosorbide.,Isosorbide,DB00031
DB11507,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cloprostenol.,Cloprostenol,DB00031
DB12025,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Triptolide.,Triptolide,DB00031
DB13044,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Gossypol.,Gossypol,DB00031
DB13310,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ormeloxifene.,Ormeloxifene,DB00031
DB00294,Etonogestrel may decrease the anticoagulant activities of Tenecteplase.,Etonogestrel,DB00031
DB00304,Desogestrel may decrease the anticoagulant activities of Tenecteplase.,Desogestrel,DB00031
DB00351,Megestrol acetate may decrease the anticoagulant activities of Tenecteplase.,Megestrol acetate,DB00031
DB00367,Levonorgestrel may decrease the anticoagulant activities of Tenecteplase.,Levonorgestrel,DB00031
DB00378,Dydrogesterone may decrease the anticoagulant activities of Tenecteplase.,Dydrogesterone,DB00031
DB00396,Progesterone may decrease the anticoagulant activities of Tenecteplase.,Progesterone,DB00031
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Tenecteplase.,Medroxyprogesterone acetate,DB00031
DB00717,Norethisterone may decrease the anticoagulant activities of Tenecteplase.,Norethisterone,DB00031
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Tenecteplase.,Ethynodiol diacetate,DB00031
DB00957,Norgestimate may decrease the anticoagulant activities of Tenecteplase.,Norgestimate,DB00031
DB01395,Drospirenone may decrease the anticoagulant activities of Tenecteplase.,Drospirenone,DB00031
DB01431,Allylestrenol may decrease the anticoagulant activities of Tenecteplase.,Allylestrenol,DB00031
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Tenecteplase.,Cyproterone acetate,DB00031
DB06713,Norelgestromin may decrease the anticoagulant activities of Tenecteplase.,Norelgestromin,DB00031
DB06730,Gestodene may decrease the anticoagulant activities of Tenecteplase.,Gestodene,DB00031
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Tenecteplase.,Hydroxyprogesterone caproate,DB00031
DB09123,Dienogest may decrease the anticoagulant activities of Tenecteplase.,Dienogest,DB00031
DB09124,Medrogestone may decrease the anticoagulant activities of Tenecteplase.,Medrogestone,DB00031
DB09371,Norethynodrel may decrease the anticoagulant activities of Tenecteplase.,Norethynodrel,DB00031
DB09389,Norgestrel may decrease the anticoagulant activities of Tenecteplase.,Norgestrel,DB00031
DB11372,Altrenogest may decrease the anticoagulant activities of Tenecteplase.,Altrenogest,DB00031
DB11619,Gestrinone may decrease the anticoagulant activities of Tenecteplase.,Gestrinone,DB00031
DB11636,Nomegestrol may decrease the anticoagulant activities of Tenecteplase.,Nomegestrol,DB00031
DB12474,Lynestrenol may decrease the anticoagulant activities of Tenecteplase.,Lynestrenol,DB00031
DB13230,Gestonorone may decrease the anticoagulant activities of Tenecteplase.,Gestonorone,DB00031
DB13528,Chlormadinone may decrease the anticoagulant activities of Tenecteplase.,Chlormadinone,DB00031
DB13533,Methylestrenolone may decrease the anticoagulant activities of Tenecteplase.,Methylestrenolone,DB00031
DB13563,Norgestrienone may decrease the anticoagulant activities of Tenecteplase.,Norgestrienone,DB00031
DB13602,Promegestone may decrease the anticoagulant activities of Tenecteplase.,Promegestone,DB00031
DB13685,Quingestanol may decrease the anticoagulant activities of Tenecteplase.,Quingestanol,DB00031
DB13857,Demegestone may decrease the anticoagulant activities of Tenecteplase.,Demegestone,DB00031
DB13866,Etynodiol may decrease the anticoagulant activities of Tenecteplase.,Etynodiol,DB00031
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Tenecteplase.,Nomegestrol acetate,DB00031
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Tenecteplase.,Hydroxyprogesterone,DB00031
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Tenecteplase.,Norethindrone enanthate,DB00031
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Tenecteplase.,Quingestanol acetate,DB00031
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Tenecteplase.,Aminosalicylic acid,DB00031
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Tenecteplase.,Bismuth subsalicylate,DB00031
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Tenecteplase.,Dersalazine,DB00031
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Tenecteplase.,Phenyl aminosalicylate,DB00031
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Tenecteplase.,Methyl salicylate,DB00031
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Tenecteplase.,Trolamine salicylate,DB00031
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Tenecteplase.,Aloxiprin,DB00031
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Tenecteplase.,Choline salicylate,DB00031
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Tenecteplase.,Thiosalicylic acid,DB00031
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Tenecteplase.,Abciximab,DB00031
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Tenecteplase.,Eptifibatide,DB00031
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Tenecteplase.,Ticlopidine,DB00031
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Tenecteplase.,Anagrelide,DB00031
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Tenecteplase.,Clopidogrel,DB00031
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Tenecteplase.,Tirofiban,DB00031
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Tenecteplase.,Dipyridamole,DB00031
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Tenecteplase.,Iloprost,DB00031
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Tenecteplase.,Sulfinpyrazone,DB00031
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Tenecteplase.,Cilostazol,DB00031
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Tenecteplase.,Ridogrel,DB00031
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Tenecteplase.,Sevoflurane,DB00031
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Tenecteplase.,Epoprostenol,DB00031
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Tenecteplase.,Resveratrol,DB00031
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Tenecteplase.,Nimesulide,DB00031
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Tenecteplase.,Tesmilifene,DB00031
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Tenecteplase.,Defibrotide,DB00031
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Tenecteplase.,Beraprost,DB00031
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Tenecteplase.,Ibudilast,DB00031
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Tenecteplase.,Andrographolide,DB00031
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Tenecteplase.,Caplacizumab,DB00031
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Tenecteplase.,Prasugrel,DB00031
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Tenecteplase.,Cangrelor,DB00031
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Tenecteplase.,Tranilast,DB00031
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Tenecteplase.,Triflusal,DB00031
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Tenecteplase.,Ticagrelor,DB00031
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Tenecteplase.,Icosapent ethyl,DB00031
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Tenecteplase.,Trapidil,DB00031
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Tenecteplase.,Naftopidil,DB00031
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Tenecteplase.,Sarpogrelate,DB00031
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Tenecteplase.,Ifetroban,DB00031
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Tenecteplase.,Nitroaspirin,DB00031
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Tenecteplase.,Ketanserin,DB00031
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Tenecteplase.,Indobufen,DB00031
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Tenecteplase.,Butylphthalide,DB00031
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Tenecteplase.,Hydroxytyrosol,DB00031
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Tenecteplase.,Ramatroban,DB00031
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Tenecteplase.,Picotamide,DB00031
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Tenecteplase.,Cloricromen,DB00031
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Tenecteplase.,Linsidomine,DB00031
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Tenecteplase.,Buflomedil,DB00031
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Tenecteplase.,Relcovaptan,DB00031
DB00374,The risk or severity of adverse effects can be increased when Tenecteplase is combined with Treprostinil.,Treprostinil,DB00031
DB03404,Hemin may increase the anticoagulant activities of Tenecteplase.,Hemin,DB00031
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Tenecteplase.,Acemetacin,DB00031
DB00624,Testosterone may increase the anticoagulant activities of Tenecteplase.,Testosterone,DB00031
DB01420,Testosterone propionate may increase the anticoagulant activities of Tenecteplase.,Testosterone propionate,DB00031
DB01481,1-Testosterone may increase the anticoagulant activities of Tenecteplase.,1-Testosterone,DB00031
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Tenecteplase.,4-Hydroxytestosterone,DB00031
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Tenecteplase.,Dehydrochloromethyltestosterone,DB00031
DB01541,Boldenone may increase the anticoagulant activities of Tenecteplase.,Boldenone,DB00031
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Tenecteplase.,18-methyl-19-nortestosterone,DB00031
DB01564,Calusterone may increase the anticoagulant activities of Tenecteplase.,Calusterone,DB00031
DB01569,Formebolone may increase the anticoagulant activities of Tenecteplase.,Formebolone,DB00031
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Tenecteplase.,Methyl-1-testosterone,DB00031
DB02901,Stanolone may increase the anticoagulant activities of Tenecteplase.,Stanolone,DB00031
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Tenecteplase.,5beta-dihydrotestosterone,DB00031
DB08619,Testosterone succinate may increase the anticoagulant activities of Tenecteplase.,Testosterone succinate,DB00031
DB11429,Mibolerone may increase the anticoagulant activities of Tenecteplase.,Mibolerone,DB00031
DB13943,Testosterone cypionate may increase the anticoagulant activities of Tenecteplase.,Testosterone cypionate,DB00031
DB13944,Testosterone enanthate may increase the anticoagulant activities of Tenecteplase.,Testosterone enanthate,DB00031
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Tenecteplase.,Testosterone undecanoate,DB00031
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Tenecteplase.,Testosterone enantate benzilic acid hydrazone,DB00031
DB13951,Stanolone acetate may increase the anticoagulant activities of Tenecteplase.,Stanolone acetate,DB00031
DB13958,Trestolone acetate may increase the anticoagulant activities of Tenecteplase.,Trestolone acetate,DB00031
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Tenecteplase.","(1,2,6,7-3H)Testosterone",DB00031
DB14655,Drostanolone propionate may increase the anticoagulant activities of Tenecteplase.,Drostanolone propionate,DB00031
DB11051,The risk or severity of adverse effects can be increased when Tenecteplase is combined with Azficel-T.,Azficel-T,DB00031
DB09568,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids,DB00031
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Tenecteplase.,Calcium acetate,DB00031
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Tenecteplase.,Calcium chloride,DB00031
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Tenecteplase.,Calcium,DB00031
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Tenecteplase.,Calcium gluconate,DB00031
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Tenecteplase.,Eftrenonacog alfa,DB00031
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Tenecteplase.,Albutrepenonacog alfa,DB00031
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Tenecteplase.,Emicizumab,DB00031
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Tenecteplase.,Turoctocog alfa pegol,DB00031
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tenecteplase.","Antihemophilic factor, human recombinant",DB00031
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tenecteplase.,Coagulation factor VIIa Recombinant Human,DB00031
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Tenecteplase.,Coagulation Factor IX (Recombinant),DB00031
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Tenecteplase.,Pantothenic acid,DB00031
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Tenecteplase.,Formic acid,DB00031
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Tenecteplase.,Platelet Activating Factor,DB00031
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Tenecteplase.,Calcium carbonate,DB00031
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Tenecteplase.,Turoctocog alfa,DB00031
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Tenecteplase.,Fibrinogen human,DB00031
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Tenecteplase.,Catridecacog,DB00031
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Tenecteplase.","Antihemophilic Factor (Recombinant), PEGylated",DB00031
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Tenecteplase.,Calcium citrate,DB00031
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Tenecteplase.,Calcium threonate,DB00031
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Tenecteplase.,Prothrombin,DB00031
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Tenecteplase.,Factor IX Complex (Human),DB00031
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Tenecteplase.,Calcium Phosphate,DB00031
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Tenecteplase.,Susoctocog alfa,DB00031
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Tenecteplase.,Rusalatide acetate,DB00031
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Tenecteplase.,Vatreptacog alfa,DB00031
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Tenecteplase.,Factor XIII (human),DB00031
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Tenecteplase.,Von Willebrand Factor Human,DB00031
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Tenecteplase.,Coagulation factor X human,DB00031
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Tenecteplase.,Coagulation factor VII human,DB00031
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Tenecteplase.,Anti-inhibitor coagulant complex,DB00031
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Tenecteplase.,Coagulation Factor IX Human,DB00031
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Tenecteplase.,Antihemophilic factor human,DB00031
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Tenecteplase.,Kallidinogenase,DB00031
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Tenecteplase.,Trenonacog alfa,DB00031
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Tenecteplase.,Nonacog beta pegol,DB00031
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Tenecteplase.,Moroctocog alfa,DB00031
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Tenecteplase.,Beroctocog alfa,DB00031
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Tenecteplase.,Andexanet alfa,DB00031
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Tenecteplase.,Calcium cation,DB00031
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Tenecteplase.,Damoctocog alfa pegol,DB00031
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Tenecteplase.,Fluvoxamine,DB00031
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Tenecteplase.,Citalopram,DB00031
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Tenecteplase.,Fluoxetine,DB00031
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Tenecteplase.,Paroxetine,DB00031
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Tenecteplase.,Nefazodone,DB00031
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Tenecteplase.,Zimelidine,DB00031
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Tenecteplase.,Dapoxetine,DB00031
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Tenecteplase.,Seproxetine,DB00031
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Tenecteplase.,Indalpine,DB00031
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Tenecteplase.,Ritanserin,DB00031
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Tenecteplase.,Alaproclate,DB00031
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Tenecteplase.,Duloxetine,DB00031
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Tenecteplase.,Sibutramine,DB00031
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Tenecteplase.,Milnacipran,DB00031
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Tenecteplase.,Desvenlafaxine,DB00031
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Tenecteplase.,Levomilnacipran,DB00031
DB00285,Venlafaxine may increase the antiplatelet activities of Tenecteplase.,Venlafaxine,DB00031
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Tenecteplase.,Amphetamine,DB00031
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Tenecteplase.,Linezolid,DB00031
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Tenecteplase.,Furazolidone,DB00031
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Tenecteplase.,Procaine,DB00031
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Tenecteplase.,Tranylcypromine,DB00031
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Tenecteplase.,Phenelzine,DB00031
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Tenecteplase.,Minaprine,DB00031
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Tenecteplase.,Selegiline,DB00031
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Tenecteplase.,Procarbazine,DB00031
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Tenecteplase.,Moclobemide,DB00031
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Tenecteplase.,Isocarboxazid,DB00031
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Tenecteplase.,Rasagiline,DB00031
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Tenecteplase.,Pargyline,DB00031
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Tenecteplase.,Clorgiline,DB00031
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Tenecteplase.,Iproniazid,DB00031
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Tenecteplase.,Nialamide,DB00031
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Tenecteplase.,Safinamide,DB00031
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Tenecteplase.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",DB00031
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Tenecteplase.,Methylene blue,DB00031
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Tenecteplase.,Hydracarbazine,DB00031
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Tenecteplase.,Pirlindole,DB00031
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Tenecteplase.,Toloxatone,DB00031
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Tenecteplase.,Benmoxin,DB00031
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Tenecteplase.,Mebanazine,DB00031
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Tenecteplase.,Octamoxin,DB00031
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Tenecteplase.,Pheniprazine,DB00031
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Tenecteplase.,Phenoxypropazine,DB00031
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Tenecteplase.,Pivhydrazine,DB00031
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Tenecteplase.,Safrazine,DB00031
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Tenecteplase.,Caroxazone,DB00031
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Tenecteplase.,Harmaline,DB00031
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Tenecteplase.,Brofaromine,DB00031
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tenecteplase.,Bivalirudin,DB00031
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Tenecteplase.,Dicoumarol,DB00031
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Tenecteplase.,Argatroban,DB00031
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Tenecteplase.,Ardeparin,DB00031
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Tenecteplase.,Phenindione,DB00031
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Tenecteplase.,Fondaparinux,DB00031
DB00682,The risk or severity of bleeding can be increased when Warfarin is combined with Tenecteplase.,Warfarin,DB00031
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Tenecteplase.,Phenprocoumon,DB00031
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Tenecteplase.,Edetic acid,DB00031
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Tenecteplase.,Heparin,DB00031
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Tenecteplase.,Enoxaparin,DB00031
DB01418,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Tenecteplase.,Acenocoumarol,DB00031
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Tenecteplase.,Ximelagatran,DB00031
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Tenecteplase.,Ancrod,DB00031
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Tenecteplase.,Sulodexide,DB00031
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Tenecteplase.,Idraparinux,DB00031
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Tenecteplase.,Otamixaban,DB00031
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Tenecteplase.,Danaparoid,DB00031
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Tenecteplase.,Dalteparin,DB00031
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Tenecteplase.,Ferulic acid,DB00031
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Tenecteplase.,Ethyl biscoumacetate,DB00031
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Tenecteplase.,Nadroparin,DB00031
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Tenecteplase.,Dextran,DB00031
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Tenecteplase.,Reviparin,DB00031
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Tenecteplase.,Certoparin,DB00031
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Tenecteplase.,Desirudin,DB00031
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Tenecteplase.,Protocatechualdehyde,DB00031
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Tenecteplase.,Protein C,DB00031
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Tenecteplase.,Antithrombin III human,DB00031
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Tenecteplase.,Letaxaban,DB00031
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Tenecteplase.,Darexaban,DB00031
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Tenecteplase.,Nafamostat,DB00031
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Tenecteplase.,Gabexate,DB00031
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Tenecteplase.,Troxerutin,DB00031
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Tenecteplase.,Fluindione,DB00031
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Tenecteplase.,Protein S human,DB00031
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Tenecteplase.,Melagatran,DB00031
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Tenecteplase.,Potassium citrate,DB00031
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Tenecteplase.,Sodium citrate,DB00031
DB00055,The risk or severity of bleeding can be increased when Tenecteplase is combined with Drotrecogin alfa.,Drotrecogin alfa,DB00031
DB06822,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tinzaparin.,Tinzaparin,DB00031
DB13199,The risk or severity of bleeding can be increased when Tenecteplase is combined with Brinase.,Brinase,DB00031
DB13646,The risk or severity of bleeding can be increased when Tenecteplase is combined with Saruplase.,Saruplase,DB00031
DB00086,The risk or severity of bleeding can be increased when Tenecteplase is combined with Streptokinase.,Streptokinase,DB00031
DB04925,The risk or severity of bleeding can be increased when Tenecteplase is combined with Desmoteplase.,Desmoteplase,DB00031
DB05254,The risk or severity of bleeding can be increased when Tenecteplase is combined with Fibrinolysin.,Fibrinolysin,DB00031
DB06543,The risk or severity of bleeding can be increased when Tenecteplase is combined with Astaxanthin.,Astaxanthin,DB00031
DB08994,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ditazole.,Ditazole,DB00031
DB09258,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bemiparin.,Bemiparin,DB00031
DB09260,The risk or severity of bleeding can be increased when Tenecteplase is combined with Parnaparin.,Parnaparin,DB00031
DB13275,The risk or severity of bleeding can be increased when Tenecteplase is combined with Clorindione.,Clorindione,DB00031
DB13347,The risk or severity of bleeding can be increased when Tenecteplase is combined with Diphenadione.,Diphenadione,DB00031
DB13451,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tioclomarol.,Tioclomarol,DB00031
DB00001,The risk or severity of bleeding can be increased when Tenecteplase is combined with Lepirudin.,Lepirudin,DB00031
DB00009,The risk or severity of bleeding can be increased when Tenecteplase is combined with Alteplase.,Alteplase,DB00031
DB00015,The risk or severity of bleeding can be increased when Tenecteplase is combined with Reteplase.,Reteplase,DB00031
DB00029,The risk or severity of bleeding can be increased when Tenecteplase is combined with Anistreplase.,Anistreplase,DB00031
DB14094,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tocopherylquinone.,Tocopherylquinone,DB00031
DB06679,The risk or severity of bleeding can be increased when Tenecteplase is combined with Amediplase.,Amediplase,DB00031
DB03410,The risk or severity of bleeding can be increased when Tenecteplase is combined with 4-hydroxycoumarin.,4-hydroxycoumarin,DB00031
DB08496,The risk or severity of bleeding can be increased when Tenecteplase is combined with (R)-warfarin.,(R)-warfarin,DB00031
DB14055,The risk or severity of bleeding can be increased when Tenecteplase is combined with (S)-Warfarin.,(S)-Warfarin,DB00031
DB12364,The risk or severity of bleeding can be increased when Tenecteplase is combined with Betrixaban.,Betrixaban,DB00031
DB14598,The risk or severity of bleeding can be increased when Tenecteplase is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous,DB00031
DB11154,The risk or severity of bleeding can be increased when Tenecteplase is combined with Zinc citrate.,Zinc citrate,DB00031
DB11166,The risk or severity of bleeding can be increased when Tenecteplase is combined with Antithrombin Alfa.,Antithrombin Alfa,DB00031
DB04665,The risk or severity of bleeding can be increased when Tenecteplase is combined with Coumarin.,Coumarin,DB00031
DB14726,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dabigatran.,Dabigatran,DB00031
DB06294,The risk or severity of bleeding can be increased when Tenecteplase is combined with Semuloparin.,Semuloparin,DB00031
DB12726,The risk or severity of bleeding can be increased when Tenecteplase is combined with Monteplase.,Monteplase,DB00031
DB00177,The risk or severity of angioedema can be increased when Tenecteplase is combined with Valsartan.,Valsartan,DB00031
DB00178,The risk or severity of angioedema can be increased when Tenecteplase is combined with Ramipril.,Ramipril,DB00031
DB00230,The risk or severity of angioedema can be increased when Tenecteplase is combined with Pregabalin.,Pregabalin,DB00031
DB00492,The risk or severity of angioedema can be increased when Tenecteplase is combined with Fosinopril.,Fosinopril,DB00031
DB00519,The risk or severity of angioedema can be increased when Tenecteplase is combined with Trandolapril.,Trandolapril,DB00031
DB00542,The risk or severity of angioedema can be increased when Tenecteplase is combined with Benazepril.,Benazepril,DB00031
DB00584,The risk or severity of angioedema can be increased when Tenecteplase is combined with Enalapril.,Enalapril,DB00031
DB00678,The risk or severity of angioedema can be increased when Tenecteplase is combined with Losartan.,Losartan,DB00031
DB00691,The risk or severity of angioedema can be increased when Tenecteplase is combined with Moexipril.,Moexipril,DB00031
DB00722,The risk or severity of angioedema can be increased when Tenecteplase is combined with Lisinopril.,Lisinopril,DB00031
DB00790,The risk or severity of angioedema can be increased when Tenecteplase is combined with Perindopril.,Perindopril,DB00031
DB00876,The risk or severity of angioedema can be increased when Tenecteplase is combined with Eprosartan.,Eprosartan,DB00031
DB00877,The risk or severity of angioedema can be increased when Tenecteplase is combined with Sirolimus.,Sirolimus,DB00031
DB00881,The risk or severity of angioedema can be increased when Tenecteplase is combined with Quinapril.,Quinapril,DB00031
DB00886,The risk or severity of angioedema can be increased when Tenecteplase is combined with Omapatrilat.,Omapatrilat,DB00031
DB00966,The risk or severity of angioedema can be increased when Tenecteplase is combined with Telmisartan.,Telmisartan,DB00031
DB01050,The risk or severity of angioedema can be increased when Tenecteplase is combined with Ibuprofen.,Ibuprofen,DB00031
DB01180,The risk or severity of angioedema can be increased when Tenecteplase is combined with Rescinnamine.,Rescinnamine,DB00031
DB01197,The risk or severity of angioedema can be increased when Tenecteplase is combined with Captopril.,Captopril,DB00031
DB01261,The risk or severity of angioedema can be increased when Tenecteplase is combined with Sitagliptin.,Sitagliptin,DB00031
DB01340,The risk or severity of angioedema can be increased when Tenecteplase is combined with Cilazapril.,Cilazapril,DB00031
DB01342,The risk or severity of angioedema can be increased when Tenecteplase is combined with Forasartan.,Forasartan,DB00031
DB01347,The risk or severity of angioedema can be increased when Tenecteplase is combined with Saprisartan.,Saprisartan,DB00031
DB01348,The risk or severity of angioedema can be increased when Tenecteplase is combined with Spirapril.,Spirapril,DB00031
DB04876,The risk or severity of angioedema can be increased when Tenecteplase is combined with Vildagliptin.,Vildagliptin,DB00031
DB06011,The risk or severity of angioedema can be increased when Tenecteplase is combined with AMG-222.,AMG-222,DB00031
DB06127,The risk or severity of angioedema can be increased when Tenecteplase is combined with Bisegliptin.,Bisegliptin,DB00031
DB06196,The risk or severity of angioedema can be increased when Tenecteplase is combined with Icatibant.,Icatibant,DB00031
DB06203,The risk or severity of angioedema can be increased when Tenecteplase is combined with Alogliptin.,Alogliptin,DB00031
DB06245,The risk or severity of angioedema can be increased when Tenecteplase is combined with Lanoteplase.,Lanoteplase,DB00031
DB06287,The risk or severity of angioedema can be increased when Tenecteplase is combined with Temsirolimus.,Temsirolimus,DB00031
DB06335,The risk or severity of angioedema can be increased when Tenecteplase is combined with Saxagliptin.,Saxagliptin,DB00031
DB08382,The risk or severity of angioedema can be increased when Tenecteplase is combined with Gosogliptin.,Gosogliptin,DB00031
DB08822,The risk or severity of angioedema can be increased when Tenecteplase is combined with Azilsartan medoxomil.,Azilsartan medoxomil,DB00031
DB08836,The risk or severity of angioedema can be increased when Tenecteplase is combined with Temocapril.,Temocapril,DB00031
DB08882,The risk or severity of angioedema can be increased when Tenecteplase is combined with Linagliptin.,Linagliptin,DB00031
DB09292,The risk or severity of angioedema can be increased when Tenecteplase is combined with Sacubitril.,Sacubitril,DB00031
DB09477,The risk or severity of angioedema can be increased when Tenecteplase is combined with Enalaprilat.,Enalaprilat,DB00031
DB11723,The risk or severity of angioedema can be increased when Tenecteplase is combined with Dutogliptin.,Dutogliptin,DB00031
DB11783,The risk or severity of angioedema can be increased when Tenecteplase is combined with Imidapril.,Imidapril,DB00031
DB11950,The risk or severity of angioedema can be increased when Tenecteplase is combined with Teneligliptin.,Teneligliptin,DB00031
DB11992,The risk or severity of angioedema can be increased when Tenecteplase is combined with Omarigliptin.,Omarigliptin,DB00031
DB12268,The risk or severity of angioedema can be increased when Tenecteplase is combined with Carmegliptin.,Carmegliptin,DB00031
DB12412,The risk or severity of angioedema can be increased when Tenecteplase is combined with Gemigliptin.,Gemigliptin,DB00031
DB12417,The risk or severity of angioedema can be increased when Tenecteplase is combined with Anagliptin.,Anagliptin,DB00031
DB12625,The risk or severity of angioedema can be increased when Tenecteplase is combined with Evogliptin.,Evogliptin,DB00031
DB13166,The risk or severity of angioedema can be increased when Tenecteplase is combined with Zofenopril.,Zofenopril,DB00031
DB13312,The risk or severity of angioedema can be increased when Tenecteplase is combined with Delapril.,Delapril,DB00031
DB14125,The risk or severity of angioedema can be increased when Tenecteplase is combined with Benazeprilat.,Benazeprilat,DB00031
DB14207,The risk or severity of angioedema can be increased when Tenecteplase is combined with Fosinoprilat.,Fosinoprilat,DB00031
DB14208,The risk or severity of angioedema can be increased when Tenecteplase is combined with Ramiprilat.,Ramiprilat,DB00031
DB14209,The risk or severity of angioedema can be increased when Tenecteplase is combined with Trandolaprilat.,Trandolaprilat,DB00031
DB14210,The risk or severity of angioedema can be increased when Tenecteplase is combined with Moexiprilat.,Moexiprilat,DB00031
DB14213,The risk or severity of angioedema can be increased when Tenecteplase is combined with Perindoprilat.,Perindoprilat,DB00031
DB14217,The risk or severity of angioedema can be increased when Tenecteplase is combined with Quinaprilat.,Quinaprilat,DB00031
DB14231,The risk or severity of angioedema can be increased when Tenecteplase is combined with Quinoline Yellow WS.,Quinoline Yellow WS,DB00031
DB00203,The risk or severity of hemorrhage can be increased when Tenecteplase is combined with Sildenafil.,Sildenafil,DB00031
DB00008,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a,DB00031
DB00011,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-n1.,Interferon alfa-n1,DB00031
DB00018,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-n3.,Interferon alfa-n3,DB00031
DB00022,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b,DB00031
DB00033,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00031
DB00034,"The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00031
DB00041,The risk or severity of bleeding can be increased when Tenecteplase is combined with Aldesleukin.,Aldesleukin,DB00031
DB00056,The risk or severity of bleeding can be increased when Tenecteplase is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00031
DB00068,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon beta-1b.,Interferon beta-1b,DB00031
DB00069,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00031
DB00073,The risk or severity of bleeding can be increased when Tenecteplase is combined with Rituximab.,Rituximab,DB00031
DB00078,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00031
DB00087,The risk or severity of bleeding can be increased when Tenecteplase is combined with Alemtuzumab.,Alemtuzumab,DB00031
DB00105,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00031
DB00120,The risk or severity of bleeding can be increased when Tenecteplase is combined with Phenylalanine.,Phenylalanine,DB00031
DB00188,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bortezomib.,Bortezomib,DB00031
DB00242,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cladribine.,Cladribine,DB00031
DB00262,The risk or severity of bleeding can be increased when Tenecteplase is combined with Carmustine.,Carmustine,DB00031
DB00276,The risk or severity of bleeding can be increased when Tenecteplase is combined with Amsacrine.,Amsacrine,DB00031
DB00291,The risk or severity of bleeding can be increased when Tenecteplase is combined with Chlorambucil.,Chlorambucil,DB00031
DB00293,The risk or severity of bleeding can be increased when Tenecteplase is combined with Raltitrexed.,Raltitrexed,DB00031
DB00305,The risk or severity of bleeding can be increased when Tenecteplase is combined with Mitomycin.,Mitomycin,DB00031
DB00307,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bexarotene.,Bexarotene,DB00031
DB00309,The risk or severity of bleeding can be increased when Tenecteplase is combined with Vindesine.,Vindesine,DB00031
DB00322,The risk or severity of bleeding can be increased when Tenecteplase is combined with Floxuridine.,Floxuridine,DB00031
DB00352,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tioguanine.,Tioguanine,DB00031
DB00361,The risk or severity of bleeding can be increased when Tenecteplase is combined with Vinorelbine.,Vinorelbine,DB00031
DB00380,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dexrazoxane.,Dexrazoxane,DB00031
DB00398,The risk or severity of bleeding can be increased when Tenecteplase is combined with Sorafenib.,Sorafenib,DB00031
DB00428,The risk or severity of bleeding can be increased when Tenecteplase is combined with Streptozocin.,Streptozocin,DB00031
DB00441,The risk or severity of bleeding can be increased when Tenecteplase is combined with Gemcitabine.,Gemcitabine,DB00031
DB00444,The risk or severity of bleeding can be increased when Tenecteplase is combined with Teniposide.,Teniposide,DB00031
DB00445,The risk or severity of bleeding can be increased when Tenecteplase is combined with Epirubicin.,Epirubicin,DB00031
DB00446,The risk or severity of bleeding can be increased when Tenecteplase is combined with Chloramphenicol.,Chloramphenicol,DB00031
DB00480,The risk or severity of bleeding can be increased when Tenecteplase is combined with Lenalidomide.,Lenalidomide,DB00031
DB00488,The risk or severity of bleeding can be increased when Tenecteplase is combined with Altretamine.,Altretamine,DB00031
DB00495,The risk or severity of bleeding can be increased when Tenecteplase is combined with Zidovudine.,Zidovudine,DB00031
DB00515,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cisplatin.,Cisplatin,DB00031
DB00526,The risk or severity of bleeding can be increased when Tenecteplase is combined with Oxaliplatin.,Oxaliplatin,DB00031
DB00531,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cyclophosphamide.,Cyclophosphamide,DB00031
DB00544,The risk or severity of bleeding can be increased when Tenecteplase is combined with Fluorouracil.,Fluorouracil,DB00031
DB00552,The risk or severity of bleeding can be increased when Tenecteplase is combined with Pentostatin.,Pentostatin,DB00031
DB00563,The risk or severity of bleeding can be increased when Tenecteplase is combined with Methotrexate.,Methotrexate,DB00031
DB00564,The risk or severity of bleeding can be increased when Tenecteplase is combined with Carbamazepine.,Carbamazepine,DB00031
DB00570,The risk or severity of bleeding can be increased when Tenecteplase is combined with Vinblastine.,Vinblastine,DB00031
DB00619,The risk or severity of bleeding can be increased when Tenecteplase is combined with Imatinib.,Imatinib,DB00031
DB00631,The risk or severity of bleeding can be increased when Tenecteplase is combined with Clofarabine.,Clofarabine,DB00031
DB00642,The risk or severity of bleeding can be increased when Tenecteplase is combined with Pemetrexed.,Pemetrexed,DB00031
DB00694,The risk or severity of bleeding can be increased when Tenecteplase is combined with Daunorubicin.,Daunorubicin,DB00031
DB00762,The risk or severity of bleeding can be increased when Tenecteplase is combined with Irinotecan.,Irinotecan,DB00031
DB00773,The risk or severity of bleeding can be increased when Tenecteplase is combined with Etoposide.,Etoposide,DB00031
DB00851,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dacarbazine.,Dacarbazine,DB00031
DB00853,The risk or severity of bleeding can be increased when Tenecteplase is combined with Temozolomide.,Temozolomide,DB00031
DB00859,The risk or severity of bleeding can be increased when Tenecteplase is combined with Penicillamine.,Penicillamine,DB00031
DB00864,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tacrolimus.,Tacrolimus,DB00031
DB00888,The risk or severity of bleeding can be increased when Tenecteplase is combined with Mechlorethamine.,Mechlorethamine,DB00031
DB00928,The risk or severity of bleeding can be increased when Tenecteplase is combined with Azacitidine.,Azacitidine,DB00031
DB00958,The risk or severity of bleeding can be increased when Tenecteplase is combined with Carboplatin.,Carboplatin,DB00031
DB00970,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dactinomycin.,Dactinomycin,DB00031
DB00987,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cytarabine.,Cytarabine,DB00031
DB00997,The risk or severity of bleeding can be increased when Tenecteplase is combined with Doxorubicin.,Doxorubicin,DB00031
DB01005,The risk or severity of bleeding can be increased when Tenecteplase is combined with Hydroxyurea.,Hydroxyurea,DB00031
DB01008,The risk or severity of bleeding can be increased when Tenecteplase is combined with Busulfan.,Busulfan,DB00031
DB01030,The risk or severity of bleeding can be increased when Tenecteplase is combined with Topotecan.,Topotecan,DB00031
DB01033,The risk or severity of bleeding can be increased when Tenecteplase is combined with Mercaptopurine.,Mercaptopurine,DB00031
DB01041,The risk or severity of bleeding can be increased when Tenecteplase is combined with Thalidomide.,Thalidomide,DB00031
DB01042,The risk or severity of bleeding can be increased when Tenecteplase is combined with Melphalan.,Melphalan,DB00031
DB01073,The risk or severity of bleeding can be increased when Tenecteplase is combined with Fludarabine.,Fludarabine,DB00031
DB01099,The risk or severity of bleeding can be increased when Tenecteplase is combined with Flucytosine.,Flucytosine,DB00031
DB01101,The risk or severity of bleeding can be increased when Tenecteplase is combined with Capecitabine.,Capecitabine,DB00031
DB01169,The risk or severity of bleeding can be increased when Tenecteplase is combined with Arsenic trioxide.,Arsenic trioxide,DB00031
DB01177,The risk or severity of bleeding can be increased when Tenecteplase is combined with Idarubicin.,Idarubicin,DB00031
DB01204,The risk or severity of bleeding can be increased when Tenecteplase is combined with Mitoxantrone.,Mitoxantrone,DB00031
DB01206,The risk or severity of bleeding can be increased when Tenecteplase is combined with Lomustine.,Lomustine,DB00031
DB01229,The risk or severity of bleeding can be increased when Tenecteplase is combined with Paclitaxel.,Paclitaxel,DB00031
DB01248,The risk or severity of bleeding can be increased when Tenecteplase is combined with Docetaxel.,Docetaxel,DB00031
DB01262,The risk or severity of bleeding can be increased when Tenecteplase is combined with Decitabine.,Decitabine,DB00031
DB01280,The risk or severity of bleeding can be increased when Tenecteplase is combined with Nelarabine.,Nelarabine,DB00031
DB01590,The risk or severity of bleeding can be increased when Tenecteplase is combined with Everolimus.,Everolimus,DB00031
DB02546,The risk or severity of bleeding can be increased when Tenecteplase is combined with Vorinostat.,Vorinostat,DB00031
DB04572,The risk or severity of bleeding can be increased when Tenecteplase is combined with Thiotepa.,Thiotepa,DB00031
DB04845,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ixabepilone.,Ixabepilone,DB00031
DB04868,The risk or severity of bleeding can be increased when Tenecteplase is combined with Nilotinib.,Nilotinib,DB00031
DB05015,The risk or severity of bleeding can be increased when Tenecteplase is combined with Belinostat.,Belinostat,DB00031
DB05109,The risk or severity of bleeding can be increased when Tenecteplase is combined with Trabectedin.,Trabectedin,DB00031
DB05258,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa.,Interferon alfa,DB00031
DB05472,The risk or severity of bleeding can be increased when Tenecteplase is combined with omega interferon.,omega interferon,DB00031
DB05773,The risk or severity of bleeding can be increased when Tenecteplase is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00031
DB06616,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bosutinib.,Bosutinib,DB00031
DB06769,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bendamustine.,Bendamustine,DB00031
DB06772,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cabazitaxel.,Cabazitaxel,DB00031
DB08871,The risk or severity of bleeding can be increased when Tenecteplase is combined with Eribulin.,Eribulin,DB00031
DB08877,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ruxolitinib.,Ruxolitinib,DB00031
DB08889,The risk or severity of bleeding can be increased when Tenecteplase is combined with Carfilzomib.,Carfilzomib,DB00031
DB08895,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tofacitinib.,Tofacitinib,DB00031
DB08901,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ponatinib.,Ponatinib,DB00031
DB08910,The risk or severity of bleeding can be increased when Tenecteplase is combined with Pomalidomide.,Pomalidomide,DB00031
DB09042,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00031
DB09052,The risk or severity of bleeding can be increased when Tenecteplase is combined with Blinatumomab.,Blinatumomab,DB00031
DB09073,The risk or severity of bleeding can be increased when Tenecteplase is combined with Palbociclib.,Palbociclib,DB00031
DB09074,The risk or severity of bleeding can be increased when Tenecteplase is combined with Olaparib.,Olaparib,DB00031
DB09077,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dinutuximab.,Dinutuximab,DB00031
DB09122,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00031
DB12814,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00031
DB00229,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefotiam.,Cefotiam,DB00031
DB00267,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefmenoxime.,Cefmenoxime,DB00031
DB00274,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefmetazole.,Cefmetazole,DB00031
DB00430,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefpiramide.,Cefpiramide,DB00031
DB00438,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftazidime.,Ceftazidime,DB00031
DB00447,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Loracarbef.,Loracarbef,DB00031
DB00456,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefalotin.,Cefalotin,DB00031
DB00493,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefotaxime.,Cefotaxime,DB00031
DB00535,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefdinir.,Cefdinir,DB00031
DB00567,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cephalexin.,Cephalexin,DB00031
DB00671,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefixime.,Cefixime,DB00031
DB00689,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cephaloglycin.,Cephaloglycin,DB00031
DB00833,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefaclor.,Cefaclor,DB00031
DB00923,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceforanide.,Ceforanide,DB00031
DB01066,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefditoren.,Cefditoren,DB00031
DB01112,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefuroxime.,Cefuroxime,DB00031
DB01139,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefapirin.,Cefapirin,DB00031
DB01140,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefadroxil.,Cefadroxil,DB00031
DB01150,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefprozil.,Cefprozil,DB00031
DB01212,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftriaxone.,Ceftriaxone,DB00031
DB01326,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefamandole.,Cefamandole,DB00031
DB01327,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefazolin.,Cefazolin,DB00031
DB01328,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefonicid.,Cefonicid,DB00031
DB01329,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefoperazone.,Cefoperazone,DB00031
DB01330,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefotetan.,Cefotetan,DB00031
DB01331,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefoxitin.,Cefoxitin,DB00031
DB01332,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftizoxime.,Ceftizoxime,DB00031
DB01333,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefradine.,Cefradine,DB00031
DB01413,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefepime.,Cefepime,DB00031
DB01414,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefacetrile.,Cefacetrile,DB00031
DB01415,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftibuten.,Ceftibuten,DB00031
DB01416,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefpodoxime.,Cefpodoxime,DB00031
DB04570,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Latamoxef.,Latamoxef,DB00031
DB04918,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftobiprole.,Ceftobiprole,DB00031
DB06590,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil,DB00031
DB09008,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefaloridine.,Cefaloridine,DB00031
DB09050,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftolozane.,Ceftolozane,DB00031
DB09062,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefminox.,Cefminox,DB00031
DB11367,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefroxadine.,Cefroxadine,DB00031
DB11935,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Flomoxef.,Flomoxef,DB00031
DB13266,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefatrizine.,Cefatrizine,DB00031
DB13461,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefcapene.,Cefcapene,DB00031
DB13470,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefodizime.,Cefodizime,DB00031
DB13499,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefsulodin.,Cefsulodin,DB00031
DB13504,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefetamet.,Cefetamet,DB00031
DB13638,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefbuperazone.,Cefbuperazone,DB00031
DB13667,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefozopran.,Cefozopran,DB00031
DB13682,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefpirome.,Cefpirome,DB00031
DB13778,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefazedone.,Cefazedone,DB00031
DB13821,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftezole.,Ceftezole,DB00031
DB14725,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate,DB00031
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Tenecteplase.,Doxycycline,DB00031
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Tenecteplase.,Azithromycin,DB00031
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Tenecteplase.,Omega-3-acid ethyl esters,DB00031
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Tenecteplase.,Acetylsalicylic acid,DB00031
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Tenecteplase.,Tazobactam,DB00031
DB00727,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Nitroglycerin.,Nitroglycerin,DB00031
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Tenecteplase.,Erythromycin,DB00031
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Tenecteplase.,Trazodone,DB00031
DB00620,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Triamcinolone.,Triamcinolone,DB00031
DB09079,The risk or severity of bleeding can be increased when Tenecteplase is combined with Nintedanib.,Nintedanib,DB00031
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Tenecteplase.,Escitalopram,DB00031
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Tenecteplase.,Sertraline,DB00031
DB00232,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Methyclothiazide.,Methyclothiazide,DB00031
DB00436,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide,DB00031
DB00562,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Benzthiazide.,Benzthiazide,DB00031
DB00606,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cyclothiazide.,Cyclothiazide,DB00031
DB00774,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide,DB00031
DB00880,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Chlorothiazide.,Chlorothiazide,DB00031
DB00999,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide,DB00031
DB01021,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide,DB00031
DB01324,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Polythiazide.,Polythiazide,DB00031
DB13430,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Mebutizide.,Mebutizide,DB00031
DB13532,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide,DB00031
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Interferon gamma-1b.,Denosumab,DB00033
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon gamma-1b.,Etanercept,DB00033
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon gamma-1b.,Peginterferon alfa-2a,DB00033
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon gamma-1b.,Interferon alfa-n1,DB00033
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon gamma-1b.,Interferon alfa-n3,DB00033
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon gamma-1b.,Peginterferon alfa-2b,DB00033
DB00026,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon gamma-1b.,Anakinra,DB00033
DB00034,"The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00033
DB00041,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Aldesleukin.,Aldesleukin,DB00033
DB00051,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Adalimumab.,Adalimumab,DB00033
DB00056,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00033
DB00059,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pegaspargase.,Pegaspargase,DB00033
DB00065,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Infliximab.,Infliximab,DB00033
DB00068,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon beta-1b.,Interferon beta-1b,DB00033
DB00069,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00033
DB00073,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Rituximab.,Rituximab,DB00033
DB00074,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Basiliximab.,Basiliximab,DB00033
DB00075,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Muromonab.,Muromonab,DB00033
DB00078,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00033
DB00081,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tositumomab.,Tositumomab,DB00033
DB00087,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Alemtuzumab.,Alemtuzumab,DB00033
DB00092,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Alefacept.,Alefacept,DB00033
DB00095,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Efalizumab.,Efalizumab,DB00033
DB00098,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit),DB00033
DB00105,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00033
DB00111,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Daclizumab.,Daclizumab,DB00033
DB00112,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bevacizumab.,Bevacizumab,DB00033
DB00120,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Phenylalanine.,Phenylalanine,DB00033
DB00180,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Flunisolide.,Flunisolide,DB00033
DB00188,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bortezomib.,Bortezomib,DB00033
DB00242,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cladribine.,Cladribine,DB00033
DB00262,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Carmustine.,Carmustine,DB00033
DB00276,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Amsacrine.,Amsacrine,DB00033
DB00290,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bleomycin.,Bleomycin,DB00033
DB00291,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Chlorambucil.,Chlorambucil,DB00033
DB00293,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Raltitrexed.,Raltitrexed,DB00033
DB00305,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mitomycin.,Mitomycin,DB00033
DB00307,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bexarotene.,Bexarotene,DB00033
DB00309,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vindesine.,Vindesine,DB00033
DB00322,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Floxuridine.,Floxuridine,DB00033
DB00328,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Indomethacin.,Indomethacin,DB00033
DB00352,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tioguanine.,Tioguanine,DB00033
DB00361,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vinorelbine.,Vinorelbine,DB00033
DB00380,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dexrazoxane.,Dexrazoxane,DB00033
DB00394,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate,DB00033
DB00398,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sorafenib.,Sorafenib,DB00033
DB00428,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Streptozocin.,Streptozocin,DB00033
DB00432,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trifluridine.,Trifluridine,DB00033
DB00441,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gemcitabine.,Gemcitabine,DB00033
DB00443,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Betamethasone.,Betamethasone,DB00033
DB00444,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Teniposide.,Teniposide,DB00033
DB00445,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Epirubicin.,Epirubicin,DB00033
DB00446,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Chloramphenicol.,Chloramphenicol,DB00033
DB00480,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Lenalidomide.,Lenalidomide,DB00033
DB00488,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Altretamine.,Altretamine,DB00033
DB00495,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Zidovudine.,Zidovudine,DB00033
DB00515,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cisplatin.,Cisplatin,DB00033
DB00526,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Oxaliplatin.,Oxaliplatin,DB00033
DB00531,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cyclophosphamide.,Cyclophosphamide,DB00033
DB00541,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vincristine.,Vincristine,DB00033
DB00544,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluorouracil.,Fluorouracil,DB00033
DB00550,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Propylthiouracil.,Propylthiouracil,DB00033
DB00552,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pentostatin.,Pentostatin,DB00033
DB00563,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Methotrexate.,Methotrexate,DB00033
DB00564,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Carbamazepine.,Carbamazepine,DB00033
DB00570,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vinblastine.,Vinblastine,DB00033
DB00588,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluticasone propionate.,Fluticasone propionate,DB00033
DB00591,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluocinolone acetonide.,Fluocinolone acetonide,DB00033
DB00601,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Linezolid.,Linezolid,DB00033
DB00619,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Imatinib.,Imatinib,DB00033
DB00620,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Triamcinolone.,Triamcinolone,DB00033
DB00631,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Clofarabine.,Clofarabine,DB00033
DB00635,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Prednisone.,Prednisone,DB00033
DB00642,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pemetrexed.,Pemetrexed,DB00033
DB00687,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fludrocortisone.,Fludrocortisone,DB00033
DB00688,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mycophenolate mofetil.,Mycophenolate mofetil,DB00033
DB00694,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Daunorubicin.,Daunorubicin,DB00033
DB00755,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tretinoin.,Tretinoin,DB00033
DB00762,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Irinotecan.,Irinotecan,DB00033
DB00763,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Methimazole.,Methimazole,DB00033
DB00764,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mometasone.,Mometasone,DB00033
DB00773,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Etoposide.,Etoposide,DB00033
DB00795,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sulfasalazine.,Sulfasalazine,DB00033
DB00851,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dacarbazine.,Dacarbazine,DB00033
DB00853,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Temozolomide.,Temozolomide,DB00033
DB00859,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Penicillamine.,Penicillamine,DB00033
DB00860,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Prednisolone.,Prednisolone,DB00033
DB00877,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sirolimus.,Sirolimus,DB00033
DB00888,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mechlorethamine.,Mechlorethamine,DB00033
DB00928,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Azacitidine.,Azacitidine,DB00033
DB00958,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Carboplatin.,Carboplatin,DB00033
DB00959,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Methylprednisolone.,Methylprednisolone,DB00033
DB00970,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dactinomycin.,Dactinomycin,DB00033
DB00987,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cytarabine.,Cytarabine,DB00033
DB00993,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Azathioprine.,Azathioprine,DB00033
DB00997,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Doxorubicin.,Doxorubicin,DB00033
DB01005,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydroxyurea.,Hydroxyurea,DB00033
DB01008,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Busulfan.,Busulfan,DB00033
DB01024,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mycophenolic acid.,Mycophenolic acid,DB00033
DB01030,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Topotecan.,Topotecan,DB00033
DB01033,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mercaptopurine.,Mercaptopurine,DB00033
DB01041,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Thalidomide.,Thalidomide,DB00033
DB01042,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Melphalan.,Melphalan,DB00033
DB01073,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fludarabine.,Fludarabine,DB00033
DB01099,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Flucytosine.,Flucytosine,DB00033
DB01101,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Capecitabine.,Capecitabine,DB00033
DB01108,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trilostane.,Trilostane,DB00033
DB01168,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Procarbazine.,Procarbazine,DB00033
DB01169,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Arsenic trioxide.,Arsenic trioxide,DB00033
DB01177,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Idarubicin.,Idarubicin,DB00033
DB01181,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ifosfamide.,Ifosfamide,DB00033
DB01196,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Estramustine.,Estramustine,DB00033
DB01204,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mitoxantrone.,Mitoxantrone,DB00033
DB01206,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Lomustine.,Lomustine,DB00033
DB01222,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Budesonide.,Budesonide,DB00033
DB01229,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Paclitaxel.,Paclitaxel,DB00033
DB01234,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dexamethasone.,Dexamethasone,DB00033
DB01248,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Docetaxel.,Docetaxel,DB00033
DB01254,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dasatinib.,Dasatinib,DB00033
DB01257,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Eculizumab.,Eculizumab,DB00033
DB01262,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Decitabine.,Decitabine,DB00033
DB01268,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sunitinib.,Sunitinib,DB00033
DB01280,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Nelarabine.,Nelarabine,DB00033
DB01281,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Abatacept.,Abatacept,DB00033
DB01285,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Corticotropin.,Corticotropin,DB00033
DB01380,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cortisone acetate.,Cortisone acetate,DB00033
DB01384,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Paramethasone.,Paramethasone,DB00033
DB01394,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Colchicine.,Colchicine,DB00033
DB01410,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ciclesonide.,Ciclesonide,DB00033
DB01423,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Stepronin.,Stepronin,DB00033
DB01590,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Everolimus.,Everolimus,DB00033
DB01611,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydroxychloroquine.,Hydroxychloroquine,DB00033
DB01816,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Castanospermine.,Castanospermine,DB00033
DB02546,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vorinostat.,Vorinostat,DB00033
DB02806,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with 2-Methoxyethanol.,2-Methoxyethanol,DB00033
DB03523,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Brequinar.,Brequinar,DB00033
DB04572,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Thiotepa.,Thiotepa,DB00033
DB04630,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Aldosterone.,Aldosterone,DB00033
DB04845,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ixabepilone.,Ixabepilone,DB00033
DB04868,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Nilotinib.,Nilotinib,DB00033
DB04951,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pirfenidone.,Pirfenidone,DB00033
DB04956,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Afelimomab.,Afelimomab,DB00033
DB05015,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Belinostat.,Belinostat,DB00033
DB05109,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trabectedin.,Trabectedin,DB00033
DB05258,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfa.,Interferon alfa,DB00033
DB05259,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Glatiramer.,Glatiramer,DB00033
DB05260,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gallium nitrate.,Gallium nitrate,DB00033
DB05459,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Briakinumab.,Briakinumab,DB00033
DB05472,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with omega interferon.,omega interferon,DB00033
DB05676,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Apremilast.,Apremilast,DB00033
DB05773,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00033
DB06168,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Canakinumab.,Canakinumab,DB00033
DB06273,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tocilizumab.,Tocilizumab,DB00033
DB06287,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Temsirolimus.,Temsirolimus,DB00033
DB06372,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Rilonacept.,Rilonacept,DB00033
DB06589,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pazopanib.,Pazopanib,DB00033
DB06603,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Panobinostat.,Panobinostat,DB00033
DB06612,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mepolizumab.,Mepolizumab,DB00033
DB06616,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bosutinib.,Bosutinib,DB00033
DB06662,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Abetimus.,Abetimus,DB00033
DB06674,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Golimumab.,Golimumab,DB00033
DB06681,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Belatacept.,Belatacept,DB00033
DB06769,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bendamustine.,Bendamustine,DB00033
DB06772,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cabazitaxel.,Cabazitaxel,DB00033
DB06813,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pralatrexate.,Pralatrexate,DB00033
DB08059,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Wortmannin.,Wortmannin,DB00033
DB08870,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Brentuximab vedotin.,Brentuximab vedotin,DB00033
DB08871,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Eribulin.,Eribulin,DB00033
DB08877,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ruxolitinib.,Ruxolitinib,DB00033
DB08879,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Belimumab.,Belimumab,DB00033
DB08880,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Teriflunomide.,Teriflunomide,DB00033
DB08889,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Carfilzomib.,Carfilzomib,DB00033
DB08901,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ponatinib.,Ponatinib,DB00033
DB08904,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Certolizumab pegol.,Certolizumab pegol,DB00033
DB08906,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluticasone furoate.,Fluticasone furoate,DB00033
DB08908,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dimethyl fumarate.,Dimethyl fumarate,DB00033
DB08910,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pomalidomide.,Pomalidomide,DB00033
DB08935,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Obinutuzumab.,Obinutuzumab,DB00033
DB08970,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluprednidene.,Fluprednidene,DB00033
DB08971,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluocortolone.,Fluocortolone,DB00033
DB09029,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Secukinumab.,Secukinumab,DB00033
DB09033,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vedolizumab.,Vedolizumab,DB00033
DB09036,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Siltuximab.,Siltuximab,DB00033
DB09052,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Blinatumomab.,Blinatumomab,DB00033
DB09053,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ibrutinib.,Ibrutinib,DB00033
DB09054,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Idelalisib.,Idelalisib,DB00033
DB09073,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Palbociclib.,Palbociclib,DB00033
DB09074,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Olaparib.,Olaparib,DB00033
DB09077,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dinutuximab.,Dinutuximab,DB00033
DB09082,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vilanterol.,Vilanterol,DB00033
DB09091,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tixocortol.,Tixocortol,DB00033
DB09122,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00033
DB09312,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse),DB00033
DB09378,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluprednisolone.,Fluprednisolone,DB00033
DB09383,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Meprednisone.,Meprednisone,DB00033
DB11466,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tepoxalin.,Tepoxalin,DB00033
DB11487,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate,DB00033
DB11529,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Melengestrol.,Melengestrol,DB00033
DB11569,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ixekizumab.,Ixekizumab,DB00033
DB11580,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ravulizumab.,Ravulizumab,DB00033
DB11616,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pirarubicin.,Pirarubicin,DB00033
DB11693,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Voclosporin.,Voclosporin,DB00033
DB11708,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Peficitinib.,Peficitinib,DB00033
DB11750,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Clobetasol.,Clobetasol,DB00033
DB11767,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sarilumab.,Sarilumab,DB00033
DB11776,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Brodalumab.,Brodalumab,DB00033
DB11803,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sirukumab.,Sirukumab,DB00033
DB11817,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Baricitinib.,Baricitinib,DB00033
DB11834,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Guselkumab.,Guselkumab,DB00033
DB11921,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Deflazacort.,Deflazacort,DB00033
DB11988,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ocrelizumab.,Ocrelizumab,DB00033
DB12025,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Triptolide.,Triptolide,DB00033
DB12371,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Siponimod.,Siponimod,DB00033
DB12612,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ozanimod.,Ozanimod,DB00033
DB12617,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mizoribine.,Mizoribine,DB00033
DB12692,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gusperimus.,Gusperimus,DB00033
DB12814,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00033
DB12902,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trofosfamide.,Trofosfamide,DB00033
DB12947,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Doxifluridine.,Doxifluridine,DB00033
DB12991,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Deoxyspergualin.,Deoxyspergualin,DB00033
DB12996,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Acteoside.,Acteoside,DB00033
DB13003,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cortivazol.,Cortivazol,DB00033
DB13014,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hypericin.,Hypericin,DB00033
DB13068,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A,DB00033
DB13208,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Prednylidene.,Prednylidene,DB00033
DB13223,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluocortin.,Fluocortin,DB00033
DB13241,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Begelomab.,Begelomab,DB00033
DB13491,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluperolone.,Fluperolone,DB00033
DB13664,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Formocortal.,Formocortal,DB00033
DB13728,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Halometasone.,Halometasone,DB00033
DB13843,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cloprednol.,Cloprednol,DB00033
DB13856,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluclorolone.,Fluclorolone,DB00033
DB13867,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluticasone.,Fluticasone,DB00033
DB14066,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tetrandrine.,Tetrandrine,DB00033
DB14219,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Monomethyl fumarate.,Monomethyl fumarate,DB00033
DB14512,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mometasone furoate.,Mometasone furoate,DB00033
DB14538,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydrocortisone aceponate.,Hydrocortisone aceponate,DB00033
DB14539,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydrocortisone acetate.,Hydrocortisone acetate,DB00033
DB14545,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydrocortisone succinate.,Hydrocortisone succinate,DB00033
DB14724,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Emapalumab.,Emapalumab,DB00033
DB14762,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Risankizumab.,Risankizumab,DB00033
DB14919,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Rozanolixizumab.,Rozanolixizumab,DB00033
DB15253,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bleselumab.,Bleselumab,DB00033
DB00108,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Natalizumab.,Natalizumab,DB00033
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon gamma-1b.,Pimecrolimus,DB00033
DB01656,Roflumilast may increase the immunosuppressive activities of Interferon gamma-1b.,Roflumilast,DB00033
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Interferon gamma-1b.,Sipuleucel-T,DB00033
DB00363,The risk or severity of neutropenia can be increased when Interferon gamma-1b is combined with Clozapine.,Clozapine,DB00033
DB00315,The metabolism of Zolmitriptan can be decreased when combined with Interferon gamma-1b.,Zolmitriptan,DB00033
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Interferon gamma-1b.,Sulfamethoxazole,DB00033
DB01097,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Leflunomide.,Leflunomide,DB00033
DB08895,Interferon gamma-1b may increase the immunosuppressive activities of Tofacitinib.,Tofacitinib,DB00033
DB00072,Trastuzumab may increase the neutropenic activities of Interferon gamma-1b.,Trastuzumab,DB00033
DB08868,Interferon gamma-1b may increase the immunosuppressive activities of Fingolimod.,Fingolimod,DB00033
DB00864,Tacrolimus may increase the immunosuppressive activities of Interferon gamma-1b.,Tacrolimus,DB00033
DB00201,The metabolism of Caffeine can be decreased when combined with Interferon gamma-1b.,Caffeine,DB00033
DB00651,The metabolism of Dyphylline can be decreased when combined with Interferon gamma-1b.,Dyphylline,DB00033
DB00806,The metabolism of Pentoxifylline can be decreased when combined with Interferon gamma-1b.,Pentoxifylline,DB00033
DB01303,The metabolism of Oxtriphylline can be decreased when combined with Interferon gamma-1b.,Oxtriphylline,DB00033
DB01412,The metabolism of Theobromine can be decreased when combined with Interferon gamma-1b.,Theobromine,DB00033
DB01482,The metabolism of Fenethylline can be decreased when combined with Interferon gamma-1b.,Fenethylline,DB00033
DB01667,The metabolism of 8-azaguanine can be decreased when combined with Interferon gamma-1b.,8-azaguanine,DB00033
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Interferon gamma-1b.","7,9-Dimethylguanine",DB00033
DB02134,The metabolism of Xanthine can be decreased when combined with Interferon gamma-1b.,Xanthine,DB00033
DB02245,The metabolism of 7-Deazaguanine can be decreased when combined with Interferon gamma-1b.,7-Deazaguanine,DB00033
DB02377,The metabolism of Guanine can be decreased when combined with Interferon gamma-1b.,Guanine,DB00033
DB02489,The metabolism of 9-Methylguanine can be decreased when combined with Interferon gamma-1b.,9-Methylguanine,DB00033
DB02568,The metabolism of Peldesine can be decreased when combined with Interferon gamma-1b.,Peldesine,DB00033
DB04076,The metabolism of Hypoxanthine can be decreased when combined with Interferon gamma-1b.,Hypoxanthine,DB00033
DB04356,The metabolism of 9-Deazaguanine can be decreased when combined with Interferon gamma-1b.,9-Deazaguanine,DB00033
DB06479,The metabolism of Propentofylline can be decreased when combined with Interferon gamma-1b.,Propentofylline,DB00033
DB06575,The metabolism of Valomaciclovir can be decreased when combined with Interferon gamma-1b.,Valomaciclovir,DB00033
DB07954,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Interferon gamma-1b.,3-isobutyl-1-methyl-7H-xanthine,DB00033
DB08844,The metabolism of Uric acid can be decreased when combined with Interferon gamma-1b.,Uric acid,DB00033
DB09273,The metabolism of Doxofylline can be decreased when combined with Interferon gamma-1b.,Doxofylline,DB00033
DB11919,The metabolism of 6-O-benzylguanine can be decreased when combined with Interferon gamma-1b.,6-O-benzylguanine,DB00033
DB12406,The metabolism of Lisofylline can be decreased when combined with Interferon gamma-1b.,Lisofylline,DB00033
DB12531,The metabolism of Lobucavir can be decreased when combined with Interferon gamma-1b.,Lobucavir,DB00033
DB12926,The metabolism of Cafedrine can be decreased when combined with Interferon gamma-1b.,Cafedrine,DB00033
DB12927,The metabolism of Theodrenaline can be decreased when combined with Interferon gamma-1b.,Theodrenaline,DB00033
DB13203,The metabolism of Bamifylline can be decreased when combined with Interferon gamma-1b.,Bamifylline,DB00033
DB13449,The metabolism of Proxyphylline can be decreased when combined with Interferon gamma-1b.,Proxyphylline,DB00033
DB13573,The metabolism of Acefylline can be decreased when combined with Interferon gamma-1b.,Acefylline,DB00033
DB13592,The metabolism of Etamiphylline can be decreased when combined with Interferon gamma-1b.,Etamiphylline,DB00033
DB13634,The metabolism of Pentifylline can be decreased when combined with Interferon gamma-1b.,Pentifylline,DB00033
DB13812,The metabolism of Bufylline can be decreased when combined with Interferon gamma-1b.,Bufylline,DB00033
DB14018,The metabolism of Bromotheophylline can be decreased when combined with Interferon gamma-1b.,Bromotheophylline,DB00033
DB14029,The metabolism of Furafylline can be decreased when combined with Interferon gamma-1b.,Furafylline,DB00033
DB14132,The metabolism of 8-chlorotheophylline can be decreased when combined with Interferon gamma-1b.,8-chlorotheophylline,DB00033
DB15122,The metabolism of PCS-499 can be decreased when combined with Interferon gamma-1b.,PCS-499,DB00033
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Interferon gamma-1b.,G17DT,DB00033
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Interferon gamma-1b.,PEV3A,DB00033
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Interferon gamma-1b.,INGN 225,DB00033
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Interferon gamma-1b.,Rindopepimut,DB00033
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Interferon gamma-1b.,SRP 299,DB00033
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Interferon gamma-1b.,GI-5005,DB00033
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Interferon gamma-1b.,Vitespen,DB00033
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Interferon gamma-1b.,TG4010,DB00033
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Interferon gamma-1b.,Anthrax immune globulin human,DB00033
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Interferon gamma-1b.","Rabies virus inactivated antigen, B",DB00033
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon gamma-1b.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen,DB00033
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Interferon gamma-1b.,Rotavirus vaccine,DB00033
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Interferon gamma-1b.","Rabies virus inactivated antigen, A",DB00033
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Interferon gamma-1b.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen,DB00033
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Clostridium tetani toxoid antigen (formaldehyde inactivated),DB00033
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated),DB00033
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated),DB00033
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),DB00033
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated),DB00033
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Interferon gamma-1b.,Typhoid Vi polysaccharide vaccine,DB00033
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon gamma-1b.,Hepatitis A Vaccine,DB00033
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon gamma-1b.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,DB00033
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated),DB00033
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated),DB00033
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated),DB00033
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated),DB00033
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Interferon gamma-1b.,Human rabies virus immune globulin,DB00033
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon gamma-1b.,Hepatitis B Vaccine (Recombinant),DB00033
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Interferon gamma-1b.,Tecemotide,DB00033
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Interferon gamma-1b.,Typhoid vaccine,DB00033
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated),DB00033
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated),DB00033
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen,DB00033
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated),DB00033
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen,DB00033
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated),DB00033
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated),DB00033
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Interferon gamma-1b.,Vaccinia virus strain new york city board of health live antigen,DB00033
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Interferon gamma-1b.,Pertussis vaccine,DB00033
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Yersinia pestis 195/p antigen (formaldehyde inactivated),DB00033
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Interferon gamma-1b.,Varicella Zoster Vaccine (Recombinant),DB00033
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Interferon gamma-1b.,Modified vaccinia ankara,DB00033
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Interferon gamma-1b.","Ebola Zaire vaccine (live, attenuated)",DB00033
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon gamma-1b.,Abciximab,DB00033
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Interferon gamma-1b.,Eptifibatide,DB00033
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Interferon gamma-1b.,Ticlopidine,DB00033
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Interferon gamma-1b.,Tirofiban,DB00033
DB00945,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon gamma-1b.,Acetylsalicylic acid,DB00033
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Interferon gamma-1b.,Dipyridamole,DB00033
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Interferon gamma-1b.,Iloprost,DB00033
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon gamma-1b.,Sulfinpyrazone,DB00033
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Interferon gamma-1b.,Ridogrel,DB00033
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Interferon gamma-1b.,Sevoflurane,DB00033
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon gamma-1b.,Epoprostenol,DB00033
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Interferon gamma-1b.,Nimesulide,DB00033
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Interferon gamma-1b.,Tesmilifene,DB00033
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Interferon gamma-1b.,Defibrotide,DB00033
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Interferon gamma-1b.,Beraprost,DB00033
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Interferon gamma-1b.,Ibudilast,DB00033
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Interferon gamma-1b.,Andrographolide,DB00033
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Interferon gamma-1b.,Caplacizumab,DB00033
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Interferon gamma-1b.,Prasugrel,DB00033
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Interferon gamma-1b.,Cangrelor,DB00033
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Interferon gamma-1b.,Tranilast,DB00033
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Interferon gamma-1b.,Triflusal,DB00033
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Interferon gamma-1b.,Ticagrelor,DB00033
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Interferon gamma-1b.,Icosapent ethyl,DB00033
DB09030,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon gamma-1b.,Vorapaxar,DB00033
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Interferon gamma-1b.,Trapidil,DB00033
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Interferon gamma-1b.,Naftopidil,DB00033
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Interferon gamma-1b.,Sarpogrelate,DB00033
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Interferon gamma-1b.,Ifetroban,DB00033
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Interferon gamma-1b.,Nitroaspirin,DB00033
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Interferon gamma-1b.,Ketanserin,DB00033
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Interferon gamma-1b.,Indobufen,DB00033
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Interferon gamma-1b.,Butylphthalide,DB00033
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Interferon gamma-1b.,Hydroxytyrosol,DB00033
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Interferon gamma-1b.,Ramatroban,DB00033
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Interferon gamma-1b.,Picotamide,DB00033
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Interferon gamma-1b.,Cloricromen,DB00033
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Interferon gamma-1b.,Linsidomine,DB00033
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Interferon gamma-1b.,Buflomedil,DB00033
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Interferon gamma-1b.,Relcovaptan,DB00033
DB13200,Interferon gamma-1b may increase the myelosuppressive activities of Lipegfilgrastim.,Lipegfilgrastim,DB00033
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Interferon gamma-1b.,Rubella virus vaccine,DB00033
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Interferon gamma-1b.,Varicella Zoster Vaccine (Live/attenuated),DB00033
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Interferon gamma-1b.,Bacillus calmette-guerin substrain tice live antigen,DB00033
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Interferon gamma-1b.,Bacillus calmette-guerin substrain connaught live antigen,DB00033
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Interferon gamma-1b.,Yellow Fever Vaccine,DB00033
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Interferon gamma-1b.,Anthrax vaccine,DB00033
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Interferon gamma-1b.,Typhoid Vaccine Live,DB00033
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Interferon gamma-1b.,Bacillus calmette-guerin substrain danish 1331 live antigen,DB00033
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Interferon gamma-1b.,BCG vaccine,DB00033
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon gamma-1b.,Human adenovirus e serotype 4 strain cl-68578 antigen,DB00033
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Interferon gamma-1b.,Vibrio cholerae CVD 103-HgR strain live antigen,DB00033
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Interferon gamma-1b.,Adenovirus type 7 vaccine live,DB00033
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon gamma-1b.,Palifermin,DB00033
DB00176,The metabolism of Fluvoxamine can be decreased when combined with Interferon gamma-1b.,Fluvoxamine,DB00033
DB00184,The metabolism of Nicotine can be decreased when combined with Interferon gamma-1b.,Nicotine,DB00033
DB00195,The metabolism of Betaxolol can be decreased when combined with Interferon gamma-1b.,Betaxolol,DB00033
DB00261,The metabolism of Anagrelide can be decreased when combined with Interferon gamma-1b.,Anagrelide,DB00033
DB00280,The metabolism of Disopyramide can be decreased when combined with Interferon gamma-1b.,Disopyramide,DB00033
DB00281,The metabolism of Lidocaine can be decreased when combined with Interferon gamma-1b.,Lidocaine,DB00033
DB00286,The metabolism of Conjugated estrogens can be decreased when combined with Interferon gamma-1b.,Conjugated estrogens,DB00033
DB00296,The metabolism of Ropivacaine can be decreased when combined with Interferon gamma-1b.,Ropivacaine,DB00033
DB00316,The metabolism of Acetaminophen can be decreased when combined with Interferon gamma-1b.,Acetaminophen,DB00033
DB00334,The metabolism of Olanzapine can be decreased when combined with Interferon gamma-1b.,Olanzapine,DB00033
DB00356,The metabolism of Chlorzoxazone can be decreased when combined with Interferon gamma-1b.,Chlorzoxazone,DB00033
DB00365,The metabolism of Grepafloxacin can be decreased when combined with Interferon gamma-1b.,Grepafloxacin,DB00033
DB00370,The metabolism of Mirtazapine can be decreased when combined with Interferon gamma-1b.,Mirtazapine,DB00033
DB00379,The metabolism of Mexiletine can be decreased when combined with Interferon gamma-1b.,Mexiletine,DB00033
DB00382,The metabolism of Tacrine can be decreased when combined with Interferon gamma-1b.,Tacrine,DB00033
DB00384,The metabolism of Triamterene can be decreased when combined with Interferon gamma-1b.,Triamterene,DB00033
DB00420,The metabolism of Promazine can be decreased when combined with Interferon gamma-1b.,Promazine,DB00033
DB00425,The metabolism of Zolpidem can be decreased when combined with Interferon gamma-1b.,Zolpidem,DB00033
DB00442,The metabolism of Entecavir can be decreased when combined with Interferon gamma-1b.,Entecavir,DB00033
DB00461,The metabolism of Nabumetone can be decreased when combined with Interferon gamma-1b.,Nabumetone,DB00033
DB00468,The metabolism of Quinine can be decreased when combined with Interferon gamma-1b.,Quinine,DB00033
DB00472,The metabolism of Fluoxetine can be decreased when combined with Interferon gamma-1b.,Fluoxetine,DB00033
DB00476,The metabolism of Duloxetine can be decreased when combined with Interferon gamma-1b.,Duloxetine,DB00033
DB00477,The metabolism of Chlorpromazine can be decreased when combined with Interferon gamma-1b.,Chlorpromazine,DB00033
DB00499,The metabolism of Flutamide can be decreased when combined with Interferon gamma-1b.,Flutamide,DB00033
DB00502,The metabolism of Haloperidol can be decreased when combined with Interferon gamma-1b.,Haloperidol,DB00033
DB00518,The metabolism of Albendazole can be decreased when combined with Interferon gamma-1b.,Albendazole,DB00033
DB00533,The metabolism of Rofecoxib can be decreased when combined with Interferon gamma-1b.,Rofecoxib,DB00033
DB00568,The metabolism of Cinnarizine can be decreased when combined with Interferon gamma-1b.,Cinnarizine,DB00033
DB00571,The metabolism of Propranolol can be decreased when combined with Interferon gamma-1b.,Propranolol,DB00033
DB00586,The metabolism of Diclofenac can be decreased when combined with Interferon gamma-1b.,Diclofenac,DB00033
DB00629,The metabolism of Guanabenz can be decreased when combined with Interferon gamma-1b.,Guanabenz,DB00033
DB00661,The metabolism of Verapamil can be decreased when combined with Interferon gamma-1b.,Verapamil,DB00033
DB00715,The metabolism of Paroxetine can be decreased when combined with Interferon gamma-1b.,Paroxetine,DB00033
DB00730,The metabolism of Thiabendazole can be decreased when combined with Interferon gamma-1b.,Thiabendazole,DB00033
DB00740,The metabolism of Riluzole can be decreased when combined with Interferon gamma-1b.,Riluzole,DB00033
DB00744,The metabolism of Zileuton can be decreased when combined with Interferon gamma-1b.,Zileuton,DB00033
DB00758,The metabolism of Clopidogrel can be decreased when combined with Interferon gamma-1b.,Clopidogrel,DB00033
DB00783,The metabolism of Estradiol can be decreased when combined with Interferon gamma-1b.,Estradiol,DB00033
DB00787,The metabolism of Acyclovir can be decreased when combined with Interferon gamma-1b.,Acyclovir,DB00033
DB00788,The metabolism of Naproxen can be decreased when combined with Interferon gamma-1b.,Naproxen,DB00033
DB00831,The metabolism of Trifluoperazine can be decreased when combined with Interferon gamma-1b.,Trifluoperazine,DB00033
DB00850,The metabolism of Perphenazine can be decreased when combined with Interferon gamma-1b.,Perphenazine,DB00033
DB00857,The metabolism of Terbinafine can be decreased when combined with Interferon gamma-1b.,Terbinafine,DB00033
DB00863,The metabolism of Ranitidine can be decreased when combined with Interferon gamma-1b.,Ranitidine,DB00033
DB00898,The metabolism of Ethanol can be decreased when combined with Interferon gamma-1b.,Ethanol,DB00033
DB00934,The metabolism of Maprotiline can be decreased when combined with Interferon gamma-1b.,Maprotiline,DB00033
DB00969,The metabolism of Alosetron can be decreased when combined with Interferon gamma-1b.,Alosetron,DB00033
DB00978,The metabolism of Lomefloxacin can be decreased when combined with Interferon gamma-1b.,Lomefloxacin,DB00033
DB00980,The metabolism of Ramelteon can be decreased when combined with Interferon gamma-1b.,Ramelteon,DB00033
DB00998,The metabolism of Frovatriptan can be decreased when combined with Interferon gamma-1b.,Frovatriptan,DB00033
DB01002,The metabolism of Levobupivacaine can be decreased when combined with Interferon gamma-1b.,Levobupivacaine,DB00033
DB01012,The metabolism of Cinacalcet can be decreased when combined with Interferon gamma-1b.,Cinacalcet,DB00033
DB01037,The metabolism of Selegiline can be decreased when combined with Interferon gamma-1b.,Selegiline,DB00033
DB01056,The metabolism of Tocainide can be decreased when combined with Interferon gamma-1b.,Tocainide,DB00033
DB01058,The metabolism of Praziquantel can be decreased when combined with Interferon gamma-1b.,Praziquantel,DB00033
DB01065,The metabolism of Melatonin can be decreased when combined with Interferon gamma-1b.,Melatonin,DB00033
DB01087,The metabolism of Primaquine can be decreased when combined with Interferon gamma-1b.,Primaquine,DB00033
DB01094,The metabolism of Hesperetin can be decreased when combined with Interferon gamma-1b.,Hesperetin,DB00033
DB01115,The metabolism of Nifedipine can be decreased when combined with Interferon gamma-1b.,Nifedipine,DB00033
DB01136,The metabolism of Carvedilol can be decreased when combined with Interferon gamma-1b.,Carvedilol,DB00033
DB01166,The metabolism of Cilostazol can be decreased when combined with Interferon gamma-1b.,Cilostazol,DB00033
DB01182,The metabolism of Propafenone can be decreased when combined with Interferon gamma-1b.,Propafenone,DB00033
DB01184,The metabolism of Domperidone can be decreased when combined with Interferon gamma-1b.,Domperidone,DB00033
DB01191,The metabolism of Dexfenfluramine can be decreased when combined with Interferon gamma-1b.,Dexfenfluramine,DB00033
DB01367,The metabolism of Rasagiline can be decreased when combined with Interferon gamma-1b.,Rasagiline,DB00033
DB01405,The metabolism of Temafloxacin can be decreased when combined with Interferon gamma-1b.,Temafloxacin,DB00033
DB01424,The metabolism of Aminophenazone can be decreased when combined with Interferon gamma-1b.,Aminophenazone,DB00033
DB01435,The metabolism of Antipyrine can be decreased when combined with Interferon gamma-1b.,Antipyrine,DB00033
DB01558,The metabolism of Bromazepam can be decreased when combined with Interferon gamma-1b.,Bromazepam,DB00033
DB01623,The metabolism of Thiothixene can be decreased when combined with Interferon gamma-1b.,Thiothixene,DB00033
DB01628,The metabolism of Etoricoxib can be decreased when combined with Interferon gamma-1b.,Etoricoxib,DB00033
DB01645,The metabolism of Genistein can be decreased when combined with Interferon gamma-1b.,Genistein,DB00033
DB02709,The metabolism of Resveratrol can be decreased when combined with Interferon gamma-1b.,Resveratrol,DB00033
DB03783,The metabolism of Phenacetin can be decreased when combined with Interferon gamma-1b.,Phenacetin,DB00033
DB04574,The metabolism of Estrone sulfate can be decreased when combined with Interferon gamma-1b.,Estrone sulfate,DB00033
DB04841,The metabolism of Flunarizine can be decreased when combined with Interferon gamma-1b.,Flunarizine,DB00033
DB04871,The metabolism of Lorcaserin can be decreased when combined with Interferon gamma-1b.,Lorcaserin,DB00033
DB04948,The metabolism of Lofexidine can be decreased when combined with Interferon gamma-1b.,Lofexidine,DB00033
DB06148,The metabolism of Mianserin can be decreased when combined with Interferon gamma-1b.,Mianserin,DB00033
DB06210,The metabolism of Eltrombopag can be decreased when combined with Interferon gamma-1b.,Eltrombopag,DB00033
DB06216,The metabolism of Asenapine can be decreased when combined with Interferon gamma-1b.,Asenapine,DB00033
DB06235,The metabolism of Vadimezan can be decreased when combined with Interferon gamma-1b.,Vadimezan,DB00033
DB06292,The metabolism of Dapagliflozin can be decreased when combined with Interferon gamma-1b.,Dapagliflozin,DB00033
DB06594,The metabolism of Agomelatine can be decreased when combined with Interferon gamma-1b.,Agomelatine,DB00033
DB06626,The metabolism of Axitinib can be decreased when combined with Interferon gamma-1b.,Axitinib,DB00033
DB06770,The metabolism of Benzyl alcohol can be decreased when combined with Interferon gamma-1b.,Benzyl alcohol,DB00033
DB06774,The metabolism of Capsaicin can be decreased when combined with Interferon gamma-1b.,Capsaicin,DB00033
DB08496,The metabolism of (R)-warfarin can be decreased when combined with Interferon gamma-1b.,(R)-warfarin,DB00033
DB08883,The metabolism of Perampanel can be decreased when combined with Interferon gamma-1b.,Perampanel,DB00033
DB09071,The metabolism of Tasimelteon can be decreased when combined with Interferon gamma-1b.,Tasimelteon,DB00033
DB09118,The metabolism of Stiripentol can be decreased when combined with Interferon gamma-1b.,Stiripentol,DB00033
DB09225,The metabolism of Zotepine can be decreased when combined with Interferon gamma-1b.,Zotepine,DB00033
DB09288,The metabolism of Propacetamol can be decreased when combined with Interferon gamma-1b.,Propacetamol,DB00033
DB09290,The metabolism of Ramosetron can be decreased when combined with Interferon gamma-1b.,Ramosetron,DB00033
DB11967,The metabolism of Binimetinib can be decreased when combined with Interferon gamma-1b.,Binimetinib,DB00033
DB12026,The metabolism of Voxilaprevir can be decreased when combined with Interferon gamma-1b.,Voxilaprevir,DB00033
DB12245,The metabolism of Triclabendazole can be decreased when combined with Interferon gamma-1b.,Triclabendazole,DB00033
DB12332,The metabolism of Rucaparib can be decreased when combined with Interferon gamma-1b.,Rucaparib,DB00033
DB12945,The metabolism of Dihydralazine can be decreased when combined with Interferon gamma-1b.,Dihydralazine,DB00033
DB13952,The metabolism of Estradiol acetate can be decreased when combined with Interferon gamma-1b.,Estradiol acetate,DB00033
DB13953,The metabolism of Estradiol benzoate can be decreased when combined with Interferon gamma-1b.,Estradiol benzoate,DB00033
DB13954,The metabolism of Estradiol cypionate can be decreased when combined with Interferon gamma-1b.,Estradiol cypionate,DB00033
DB13955,The metabolism of Estradiol dienanthate can be decreased when combined with Interferon gamma-1b.,Estradiol dienanthate,DB00033
DB13956,The metabolism of Estradiol valerate can be decreased when combined with Interferon gamma-1b.,Estradiol valerate,DB00033
DB11757,The metabolism of Istradefylline can be decreased when combined with Interferon gamma-1b.,Istradefylline,DB00033
DB00972,The metabolism of Azelastine can be decreased when combined with Interferon gamma-1b.,Azelastine,DB00033
DB00625,The metabolism of Efavirenz can be decreased when combined with Interferon gamma-1b.,Efavirenz,DB00033
DB01233,The metabolism of Metoclopramide can be decreased when combined with Interferon gamma-1b.,Metoclopramide,DB00033
DB04889,The metabolism of Bicifadine can be decreased when combined with Interferon gamma-1b.,Bicifadine,DB00033
DB05708,The metabolism of GTS-21 can be decreased when combined with Interferon gamma-1b.,GTS-21,DB00033
DB01195,The metabolism of Flecainide can be decreased when combined with Interferon gamma-1b.,Flecainide,DB00033
DB00977,The metabolism of Ethinylestradiol can be decreased when combined with Interferon gamma-1b.,Ethinylestradiol,DB00033
DB00321,The metabolism of Amitriptyline can be decreased when combined with Interferon gamma-1b.,Amitriptyline,DB00033
DB00458,The metabolism of Imipramine can be decreased when combined with Interferon gamma-1b.,Imipramine,DB00033
DB01142,The metabolism of Doxepin can be decreased when combined with Interferon gamma-1b.,Doxepin,DB00033
DB00532,The metabolism of Mephenytoin can be decreased when combined with Interferon gamma-1b.,Mephenytoin,DB00033
DB00540,The metabolism of Nortriptyline can be decreased when combined with Interferon gamma-1b.,Nortriptyline,DB00033
DB00575,The metabolism of Clonidine can be decreased when combined with Interferon gamma-1b.,Clonidine,DB00033
DB00924,The metabolism of Cyclobenzaprine can be decreased when combined with Interferon gamma-1b.,Cyclobenzaprine,DB00033
DB01151,The metabolism of Desipramine can be decreased when combined with Interferon gamma-1b.,Desipramine,DB00033
DB01242,The metabolism of Clomipramine can be decreased when combined with Interferon gamma-1b.,Clomipramine,DB00033
DB11689,The metabolism of Selumetinib can be decreased when combined with Interferon gamma-1b.,Selumetinib,DB00033
DB00277,The metabolism of Theophylline can be decreased when combined with Interferon gamma-1b.,Theophylline,DB00033
DB00682,The metabolism of Warfarin can be decreased when combined with Interferon gamma-1b.,Warfarin,DB00033
DB00697,The metabolism of Tizanidine can be decreased when combined with Interferon gamma-1b.,Tizanidine,DB00033
DB01100,The metabolism of Pimozide can be decreased when combined with Interferon gamma-1b.,Pimozide,DB00033
DB01223,The metabolism of Aminophylline can be decreased when combined with Interferon gamma-1b.,Aminophylline,DB00033
DB01418,The metabolism of Acenocoumarol can be decreased when combined with Interferon gamma-1b.,Acenocoumarol,DB00033
DB00530,The metabolism of Erlotinib can be decreased when combined with Interferon gamma-1b.,Erlotinib,DB00033
DB09256,The metabolism of Tegafur can be decreased when combined with Interferon gamma-1b.,Tegafur,DB00033
DB13874,The metabolism of Enasidenib can be decreased when combined with Interferon gamma-1b.,Enasidenib,DB00033
DB00675,The metabolism of Tamoxifen can be decreased when combined with Interferon gamma-1b.,Tamoxifen,DB00033
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon gamma-1b.,Lepirudin,DB00033
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon gamma-1b.,Bivalirudin,DB00033
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon gamma-1b.,Alteplase,DB00033
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon gamma-1b.,Urokinase,DB00033
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon gamma-1b.,Reteplase,DB00033
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon gamma-1b.,Anistreplase,DB00033
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon gamma-1b.,Tenecteplase,DB00033
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Interferon gamma-1b.,Drotrecogin alfa,DB00033
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Interferon gamma-1b.,Streptokinase,DB00033
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Interferon gamma-1b.,Dicoumarol,DB00033
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Interferon gamma-1b.,Argatroban,DB00033
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Interferon gamma-1b.,Ardeparin,DB00033
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Interferon gamma-1b.,Phenindione,DB00033
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Interferon gamma-1b.,Fondaparinux,DB00033
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Interferon gamma-1b.,Pentosan polysulfate,DB00033
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Interferon gamma-1b.,Phenprocoumon,DB00033
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Interferon gamma-1b.,Heparin,DB00033
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Interferon gamma-1b.,Enoxaparin,DB00033
DB03410,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Interferon gamma-1b.,4-hydroxycoumarin,DB00033
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Interferon gamma-1b.,Coumarin,DB00033
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon gamma-1b.,Ximelagatran,DB00033
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Interferon gamma-1b.,Desmoteplase,DB00033
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Interferon gamma-1b.,Ancrod,DB00033
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Interferon gamma-1b.,Fibrinolysin,DB00033
DB06228,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon gamma-1b.,Rivaroxaban,DB00033
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Interferon gamma-1b.,Sulodexide,DB00033
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Interferon gamma-1b.,Semuloparin,DB00033
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Interferon gamma-1b.,Idraparinux,DB00033
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Interferon gamma-1b.,Astaxanthin,DB00033
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Interferon gamma-1b.,Apixaban,DB00033
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Interferon gamma-1b.,Otamixaban,DB00033
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Interferon gamma-1b.,Amediplase,DB00033
DB06695,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Interferon gamma-1b.,Dabigatran etexilate,DB00033
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Interferon gamma-1b.,Danaparoid,DB00033
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Interferon gamma-1b.,Dalteparin,DB00033
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Interferon gamma-1b.,Tinzaparin,DB00033
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Interferon gamma-1b.,Ferulic acid,DB00033
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Interferon gamma-1b.,Ethyl biscoumacetate,DB00033
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Interferon gamma-1b.,Nadroparin,DB00033
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Interferon gamma-1b.,Ditazole,DB00033
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Interferon gamma-1b.,Edoxaban,DB00033
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Interferon gamma-1b.,Potassium citrate,DB00033
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Interferon gamma-1b.,Sodium citrate,DB00033
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Interferon gamma-1b.,Dextran,DB00033
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Interferon gamma-1b.,Bemiparin,DB00033
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Interferon gamma-1b.,Reviparin,DB00033
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Interferon gamma-1b.,Parnaparin,DB00033
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Interferon gamma-1b.,Certoparin,DB00033
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Interferon gamma-1b.,Desirudin,DB00033
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Interferon gamma-1b.,Zinc citrate,DB00033
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Interferon gamma-1b.,Antithrombin Alfa,DB00033
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Interferon gamma-1b.,Protein C,DB00033
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Interferon gamma-1b.,Antithrombin III human,DB00033
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Interferon gamma-1b.,Letaxaban,DB00033
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Interferon gamma-1b.,Darexaban,DB00033
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Interferon gamma-1b.,Betrixaban,DB00033
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon gamma-1b.,Nafamostat,DB00033
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Interferon gamma-1b.,Monteplase,DB00033
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Interferon gamma-1b.,Gabexate,DB00033
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Interferon gamma-1b.,Fluindione,DB00033
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Interferon gamma-1b.,Protein S human,DB00033
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Interferon gamma-1b.,Brinase,DB00033
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Interferon gamma-1b.,Clorindione,DB00033
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Interferon gamma-1b.,Diphenadione,DB00033
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Interferon gamma-1b.,Tioclomarol,DB00033
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Interferon gamma-1b.,Melagatran,DB00033
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Interferon gamma-1b.,Saruplase,DB00033
DB14055,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Interferon gamma-1b.,(S)-Warfarin,DB00033
DB14094,The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Interferon gamma-1b.,Tocopherylquinone,DB00033
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Interferon gamma-1b.,Edetate calcium disodium anhydrous,DB00033
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Interferon gamma-1b.,Dabigatran,DB00033
DB00232,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Interferon gamma-1b.,Methyclothiazide,DB00033
DB00436,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Interferon gamma-1b.,Bendroflumethiazide,DB00033
DB00562,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Interferon gamma-1b.,Benzthiazide,DB00033
DB00606,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Interferon gamma-1b.,Cyclothiazide,DB00033
DB00774,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon gamma-1b.,Hydroflumethiazide,DB00033
DB00880,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Interferon gamma-1b.,Chlorothiazide,DB00033
DB00999,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon gamma-1b.,Hydrochlorothiazide,DB00033
DB01021,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Interferon gamma-1b.,Trichlormethiazide,DB00033
DB01324,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Interferon gamma-1b.,Polythiazide,DB00033
DB13430,The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Interferon gamma-1b.,Mebutizide,DB00033
DB13532,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Interferon gamma-1b.,Cyclopenthiazide,DB00033
DB09042,The risk or severity of myelosuppression can be increased when Interferon gamma-1b is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00033
DB00091,Interferon gamma-1b may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine,DB00033
DB00268,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ropinirole.,Ropinirole,DB00033
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Interferon gamma-1b.,Cyanocobalamin,DB00033
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon gamma-1b.,Allopurinol,DB00033
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Interferon gamma-1b.,Magnesium,DB00033
DB01601,The serum concentration of Interferon gamma-1b can be increased when it is combined with Lopinavir.,Lopinavir,DB00033
DB12530,The risk or severity of infection can be increased when Interferon gamma-1b is combined with Inebilizumab.,Inebilizumab,DB00033
DB06643,"The risk or severity of adverse effects can be increased when Denosumab is combined with Interferon alfa-2a, Recombinant.",Denosumab,DB00034
DB00005,"The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-2a, Recombinant.",Etanercept,DB00034
DB00008,"The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-2a, Recombinant.",Peginterferon alfa-2a,DB00034
DB00011,"The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa-2a, Recombinant.",Interferon alfa-n1,DB00034
DB00018,"The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfa-2a, Recombinant.",Interferon alfa-n3,DB00034
DB00022,"The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfa-2a, Recombinant.",Peginterferon alfa-2b,DB00034
DB00026,"The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfa-2a, Recombinant.",Anakinra,DB00034
DB00033,"The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfa-2a, Recombinant.",Interferon gamma-1b,DB00034
DB00051,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Adalimumab.",Adalimumab,DB00034
DB00056,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Gemtuzumab ozogamicin.",Gemtuzumab ozogamicin,DB00034
DB00059,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pegaspargase.",Pegaspargase,DB00034
DB00065,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Infliximab.",Infliximab,DB00034
DB00068,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Interferon beta-1b.",Interferon beta-1b,DB00034
DB00069,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Interferon alfacon-1.",Interferon alfacon-1,DB00034
DB00073,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Rituximab.",Rituximab,DB00034
DB00074,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Basiliximab.",Basiliximab,DB00034
DB00075,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Muromonab.",Muromonab,DB00034
DB00078,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ibritumomab tiuxetan.",Ibritumomab tiuxetan,DB00034
DB00081,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tositumomab.",Tositumomab,DB00034
DB00087,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Alemtuzumab.",Alemtuzumab,DB00034
DB00092,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Alefacept.",Alefacept,DB00034
DB00095,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Efalizumab.",Efalizumab,DB00034
DB00098,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Antithymocyte immunoglobulin (rabbit).",Antithymocyte immunoglobulin (rabbit),DB00034
DB00105,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Interferon alfa-2b.",Interferon alfa-2b,DB00034
DB00111,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Daclizumab.",Daclizumab,DB00034
DB00112,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bevacizumab.",Bevacizumab,DB00034
DB00120,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Phenylalanine.",Phenylalanine,DB00034
DB00180,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Flunisolide.",Flunisolide,DB00034
DB00188,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bortezomib.",Bortezomib,DB00034
DB00242,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cladribine.",Cladribine,DB00034
DB00262,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Carmustine.",Carmustine,DB00034
DB00276,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Amsacrine.",Amsacrine,DB00034
DB00290,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bleomycin.",Bleomycin,DB00034
DB00291,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Chlorambucil.",Chlorambucil,DB00034
DB00293,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Raltitrexed.",Raltitrexed,DB00034
DB00305,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mitomycin.",Mitomycin,DB00034
DB00307,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bexarotene.",Bexarotene,DB00034
DB00309,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vindesine.",Vindesine,DB00034
DB00322,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Floxuridine.",Floxuridine,DB00034
DB00328,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Indomethacin.",Indomethacin,DB00034
DB00352,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tioguanine.",Tioguanine,DB00034
DB00361,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vinorelbine.",Vinorelbine,DB00034
DB00380,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dexrazoxane.",Dexrazoxane,DB00034
DB00394,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Beclomethasone dipropionate.",Beclomethasone dipropionate,DB00034
DB00398,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sorafenib.",Sorafenib,DB00034
DB00428,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Streptozocin.",Streptozocin,DB00034
DB00432,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trifluridine.",Trifluridine,DB00034
DB00441,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Gemcitabine.",Gemcitabine,DB00034
DB00443,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Betamethasone.",Betamethasone,DB00034
DB00444,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Teniposide.",Teniposide,DB00034
DB00445,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Epirubicin.",Epirubicin,DB00034
DB00446,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Chloramphenicol.",Chloramphenicol,DB00034
DB00480,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Lenalidomide.",Lenalidomide,DB00034
DB00488,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Altretamine.",Altretamine,DB00034
DB00495,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Zidovudine.",Zidovudine,DB00034
DB00515,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cisplatin.",Cisplatin,DB00034
DB00526,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Oxaliplatin.",Oxaliplatin,DB00034
DB00531,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cyclophosphamide.",Cyclophosphamide,DB00034
DB00541,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vincristine.",Vincristine,DB00034
DB00544,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluorouracil.",Fluorouracil,DB00034
DB00550,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Propylthiouracil.",Propylthiouracil,DB00034
DB00552,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pentostatin.",Pentostatin,DB00034
DB00563,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Methotrexate.",Methotrexate,DB00034
DB00564,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Carbamazepine.",Carbamazepine,DB00034
DB00570,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vinblastine.",Vinblastine,DB00034
DB00588,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluticasone propionate.",Fluticasone propionate,DB00034
DB00591,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluocinolone acetonide.",Fluocinolone acetonide,DB00034
DB00601,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Linezolid.",Linezolid,DB00034
DB00619,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Imatinib.",Imatinib,DB00034
DB00620,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Triamcinolone.",Triamcinolone,DB00034
DB00631,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Clofarabine.",Clofarabine,DB00034
DB00635,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Prednisone.",Prednisone,DB00034
DB00642,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pemetrexed.",Pemetrexed,DB00034
DB00687,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fludrocortisone.",Fludrocortisone,DB00034
DB00688,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mycophenolate mofetil.",Mycophenolate mofetil,DB00034
DB00694,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Daunorubicin.",Daunorubicin,DB00034
DB00755,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tretinoin.",Tretinoin,DB00034
DB00762,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Irinotecan.",Irinotecan,DB00034
DB00763,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Methimazole.",Methimazole,DB00034
DB00764,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mometasone.",Mometasone,DB00034
DB00773,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Etoposide.",Etoposide,DB00034
DB00795,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sulfasalazine.",Sulfasalazine,DB00034
DB00851,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dacarbazine.",Dacarbazine,DB00034
DB00853,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Temozolomide.",Temozolomide,DB00034
DB00859,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Penicillamine.",Penicillamine,DB00034
DB00860,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Prednisolone.",Prednisolone,DB00034
DB00877,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sirolimus.",Sirolimus,DB00034
DB00888,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mechlorethamine.",Mechlorethamine,DB00034
DB00928,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Azacitidine.",Azacitidine,DB00034
DB00958,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Carboplatin.",Carboplatin,DB00034
DB00959,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Methylprednisolone.",Methylprednisolone,DB00034
DB00970,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dactinomycin.",Dactinomycin,DB00034
DB00987,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cytarabine.",Cytarabine,DB00034
DB00993,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Azathioprine.",Azathioprine,DB00034
DB00997,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Doxorubicin.",Doxorubicin,DB00034
DB01005,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydroxyurea.",Hydroxyurea,DB00034
DB01008,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Busulfan.",Busulfan,DB00034
DB01024,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mycophenolic acid.",Mycophenolic acid,DB00034
DB01030,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Topotecan.",Topotecan,DB00034
DB01033,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mercaptopurine.",Mercaptopurine,DB00034
DB01041,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Thalidomide.",Thalidomide,DB00034
DB01042,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Melphalan.",Melphalan,DB00034
DB01073,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fludarabine.",Fludarabine,DB00034
DB01099,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Flucytosine.",Flucytosine,DB00034
DB01101,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Capecitabine.",Capecitabine,DB00034
DB01108,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trilostane.",Trilostane,DB00034
DB01168,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Procarbazine.",Procarbazine,DB00034
DB01169,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Arsenic trioxide.",Arsenic trioxide,DB00034
DB01177,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Idarubicin.",Idarubicin,DB00034
DB01181,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ifosfamide.",Ifosfamide,DB00034
DB01196,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Estramustine.",Estramustine,DB00034
DB01204,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mitoxantrone.",Mitoxantrone,DB00034
DB01206,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Lomustine.",Lomustine,DB00034
DB01222,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Budesonide.",Budesonide,DB00034
DB01229,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Paclitaxel.",Paclitaxel,DB00034
DB01234,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dexamethasone.",Dexamethasone,DB00034
DB01248,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Docetaxel.",Docetaxel,DB00034
DB01254,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dasatinib.",Dasatinib,DB00034
DB01257,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Eculizumab.",Eculizumab,DB00034
DB01262,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Decitabine.",Decitabine,DB00034
DB01268,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sunitinib.",Sunitinib,DB00034
DB01280,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Nelarabine.",Nelarabine,DB00034
DB01281,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Abatacept.",Abatacept,DB00034
DB01285,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Corticotropin.",Corticotropin,DB00034
DB01380,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cortisone acetate.",Cortisone acetate,DB00034
DB01384,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Paramethasone.",Paramethasone,DB00034
DB01394,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Colchicine.",Colchicine,DB00034
DB01410,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ciclesonide.",Ciclesonide,DB00034
DB01423,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Stepronin.",Stepronin,DB00034
DB01590,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Everolimus.",Everolimus,DB00034
DB01611,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydroxychloroquine.",Hydroxychloroquine,DB00034
DB01816,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Castanospermine.",Castanospermine,DB00034
DB02546,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vorinostat.",Vorinostat,DB00034
DB02806,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with 2-Methoxyethanol.",2-Methoxyethanol,DB00034
DB03523,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Brequinar.",Brequinar,DB00034
DB04572,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Thiotepa.",Thiotepa,DB00034
DB04630,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Aldosterone.",Aldosterone,DB00034
DB04845,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ixabepilone.",Ixabepilone,DB00034
DB04868,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Nilotinib.",Nilotinib,DB00034
DB04951,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pirfenidone.",Pirfenidone,DB00034
DB04956,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Afelimomab.",Afelimomab,DB00034
DB05015,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Belinostat.",Belinostat,DB00034
DB05109,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trabectedin.",Trabectedin,DB00034
DB05258,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Interferon alfa.",Interferon alfa,DB00034
DB05259,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Glatiramer.",Glatiramer,DB00034
DB05260,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Gallium nitrate.",Gallium nitrate,DB00034
DB05459,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Briakinumab.",Briakinumab,DB00034
DB05472,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with omega interferon.",omega interferon,DB00034
DB05676,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Apremilast.",Apremilast,DB00034
DB05773,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trastuzumab emtansine.",Trastuzumab emtansine,DB00034
DB06168,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Canakinumab.",Canakinumab,DB00034
DB06273,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tocilizumab.",Tocilizumab,DB00034
DB06287,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Temsirolimus.",Temsirolimus,DB00034
DB06372,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Rilonacept.",Rilonacept,DB00034
DB06589,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pazopanib.",Pazopanib,DB00034
DB06603,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Panobinostat.",Panobinostat,DB00034
DB06612,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mepolizumab.",Mepolizumab,DB00034
DB06616,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bosutinib.",Bosutinib,DB00034
DB06662,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Abetimus.",Abetimus,DB00034
DB06674,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Golimumab.",Golimumab,DB00034
DB06681,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Belatacept.",Belatacept,DB00034
DB06769,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bendamustine.",Bendamustine,DB00034
DB06772,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cabazitaxel.",Cabazitaxel,DB00034
DB06813,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pralatrexate.",Pralatrexate,DB00034
DB08059,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Wortmannin.",Wortmannin,DB00034
DB08870,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Brentuximab vedotin.",Brentuximab vedotin,DB00034
DB08871,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Eribulin.",Eribulin,DB00034
DB08877,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ruxolitinib.",Ruxolitinib,DB00034
DB08879,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Belimumab.",Belimumab,DB00034
DB08880,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Teriflunomide.",Teriflunomide,DB00034
DB08889,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Carfilzomib.",Carfilzomib,DB00034
DB08901,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ponatinib.",Ponatinib,DB00034
DB08904,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Certolizumab pegol.",Certolizumab pegol,DB00034
DB08906,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluticasone furoate.",Fluticasone furoate,DB00034
DB08908,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dimethyl fumarate.",Dimethyl fumarate,DB00034
DB08910,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pomalidomide.",Pomalidomide,DB00034
DB08935,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Obinutuzumab.",Obinutuzumab,DB00034
DB08970,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluprednidene.",Fluprednidene,DB00034
DB08971,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluocortolone.",Fluocortolone,DB00034
DB09029,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Secukinumab.",Secukinumab,DB00034
DB09033,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vedolizumab.",Vedolizumab,DB00034
DB09036,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Siltuximab.",Siltuximab,DB00034
DB09052,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Blinatumomab.",Blinatumomab,DB00034
DB09053,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ibrutinib.",Ibrutinib,DB00034
DB09054,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Idelalisib.",Idelalisib,DB00034
DB09073,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Palbociclib.",Palbociclib,DB00034
DB09074,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Olaparib.",Olaparib,DB00034
DB09077,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dinutuximab.",Dinutuximab,DB00034
DB09082,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vilanterol.",Vilanterol,DB00034
DB09091,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tixocortol.",Tixocortol,DB00034
DB09122,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Peginterferon beta-1a.",Peginterferon beta-1a,DB00034
DB09312,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Antilymphocyte immunoglobulin (horse).",Antilymphocyte immunoglobulin (horse),DB00034
DB09378,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluprednisolone.",Fluprednisolone,DB00034
DB09383,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Meprednisone.",Meprednisone,DB00034
DB11466,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tepoxalin.",Tepoxalin,DB00034
DB11487,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dexamethasone isonicotinate.",Dexamethasone isonicotinate,DB00034
DB11529,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Melengestrol.",Melengestrol,DB00034
DB11569,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ixekizumab.",Ixekizumab,DB00034
DB11580,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ravulizumab.",Ravulizumab,DB00034
DB11616,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pirarubicin.",Pirarubicin,DB00034
DB11693,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Voclosporin.",Voclosporin,DB00034
DB11708,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Peficitinib.",Peficitinib,DB00034
DB11750,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Clobetasol.",Clobetasol,DB00034
DB11767,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sarilumab.",Sarilumab,DB00034
DB11776,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Brodalumab.",Brodalumab,DB00034
DB11803,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sirukumab.",Sirukumab,DB00034
DB11817,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Baricitinib.",Baricitinib,DB00034
DB11834,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Guselkumab.",Guselkumab,DB00034
DB11921,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Deflazacort.",Deflazacort,DB00034
DB11988,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ocrelizumab.",Ocrelizumab,DB00034
DB12025,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Triptolide.",Triptolide,DB00034
DB12371,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Siponimod.",Siponimod,DB00034
DB12612,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ozanimod.",Ozanimod,DB00034
DB12617,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mizoribine.",Mizoribine,DB00034
DB12692,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Gusperimus.",Gusperimus,DB00034
DB12814,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cepeginterferon alfa-2B.",Cepeginterferon alfa-2B,DB00034
DB12902,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trofosfamide.",Trofosfamide,DB00034
DB12947,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Doxifluridine.",Doxifluridine,DB00034
DB12991,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Deoxyspergualin.",Deoxyspergualin,DB00034
DB12996,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Acteoside.",Acteoside,DB00034
DB13003,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cortivazol.",Cortivazol,DB00034
DB13014,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hypericin.",Hypericin,DB00034
DB13068,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.",9-(N-methyl-L-isoleucine)-cyclosporin A,DB00034
DB13208,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Prednylidene.",Prednylidene,DB00034
DB13223,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluocortin.",Fluocortin,DB00034
DB13241,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Begelomab.",Begelomab,DB00034
DB13491,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluperolone.",Fluperolone,DB00034
DB13664,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Formocortal.",Formocortal,DB00034
DB13728,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Halometasone.",Halometasone,DB00034
DB13843,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cloprednol.",Cloprednol,DB00034
DB13856,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluclorolone.",Fluclorolone,DB00034
DB13867,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluticasone.",Fluticasone,DB00034
DB14066,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tetrandrine.",Tetrandrine,DB00034
DB14219,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Monomethyl fumarate.",Monomethyl fumarate,DB00034
DB14512,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mometasone furoate.",Mometasone furoate,DB00034
DB14538,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydrocortisone aceponate.",Hydrocortisone aceponate,DB00034
DB14539,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydrocortisone acetate.",Hydrocortisone acetate,DB00034
DB14545,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydrocortisone succinate.",Hydrocortisone succinate,DB00034
DB14724,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Emapalumab.",Emapalumab,DB00034
DB14762,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Risankizumab.",Risankizumab,DB00034
DB14919,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Rozanolixizumab.",Rozanolixizumab,DB00034
DB15253,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bleselumab.",Bleselumab,DB00034
DB00108,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Natalizumab.",Natalizumab,DB00034
DB00337,"The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfa-2a, Recombinant.",Pimecrolimus,DB00034
DB01656,"Roflumilast may increase the immunosuppressive activities of Interferon alfa-2a, Recombinant.",Roflumilast,DB00034
DB06688,"The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Sipuleucel-T,DB00034
DB00041,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Aldesleukin.",Aldesleukin,DB00034
DB00363,"The risk or severity of neutropenia can be increased when Interferon alfa-2a, Recombinant is combined with Clozapine.",Clozapine,DB00034
DB00333,"The serum concentration of Methadone can be increased when it is combined with Interferon alfa-2a, Recombinant.",Methadone,DB00034
DB00811,"The risk or severity of anemia can be increased when Interferon alfa-2a, Recombinant is combined with Ribavirin.",Ribavirin,DB00034
DB00315,"The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-2a, Recombinant.",Zolmitriptan,DB00034
DB01015,"The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Interferon alfa-2a, Recombinant.",Sulfamethoxazole,DB00034
DB01265,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Telbivudine.",Telbivudine,DB00034
DB01097,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Leflunomide.",Leflunomide,DB00034
DB08895,"Interferon alfa-2a, Recombinant may increase the immunosuppressive activities of Tofacitinib.",Tofacitinib,DB00034
DB00072,"Trastuzumab may increase the neutropenic activities of Interferon alfa-2a, Recombinant.",Trastuzumab,DB00034
DB08868,"Interferon alfa-2a, Recombinant may increase the immunosuppressive activities of Fingolimod.",Fingolimod,DB00034
DB00864,"Tacrolimus may increase the immunosuppressive activities of Interferon alfa-2a, Recombinant.",Tacrolimus,DB00034
DB00201,"The metabolism of Caffeine can be decreased when combined with Interferon alfa-2a, Recombinant.",Caffeine,DB00034
DB00651,"The metabolism of Dyphylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Dyphylline,DB00034
DB00806,"The metabolism of Pentoxifylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Pentoxifylline,DB00034
DB01303,"The metabolism of Oxtriphylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Oxtriphylline,DB00034
DB01412,"The metabolism of Theobromine can be decreased when combined with Interferon alfa-2a, Recombinant.",Theobromine,DB00034
DB01482,"The metabolism of Fenethylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Fenethylline,DB00034
DB01667,"The metabolism of 8-azaguanine can be decreased when combined with Interferon alfa-2a, Recombinant.",8-azaguanine,DB00034
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Interferon alfa-2a, Recombinant.","7,9-Dimethylguanine",DB00034
DB02134,"The metabolism of Xanthine can be decreased when combined with Interferon alfa-2a, Recombinant.",Xanthine,DB00034
DB02245,"The metabolism of 7-Deazaguanine can be decreased when combined with Interferon alfa-2a, Recombinant.",7-Deazaguanine,DB00034
DB02377,"The metabolism of Guanine can be decreased when combined with Interferon alfa-2a, Recombinant.",Guanine,DB00034
DB02489,"The metabolism of 9-Methylguanine can be decreased when combined with Interferon alfa-2a, Recombinant.",9-Methylguanine,DB00034
DB02568,"The metabolism of Peldesine can be decreased when combined with Interferon alfa-2a, Recombinant.",Peldesine,DB00034
DB04076,"The metabolism of Hypoxanthine can be decreased when combined with Interferon alfa-2a, Recombinant.",Hypoxanthine,DB00034
DB04356,"The metabolism of 9-Deazaguanine can be decreased when combined with Interferon alfa-2a, Recombinant.",9-Deazaguanine,DB00034
DB06479,"The metabolism of Propentofylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Propentofylline,DB00034
DB06575,"The metabolism of Valomaciclovir can be decreased when combined with Interferon alfa-2a, Recombinant.",Valomaciclovir,DB00034
DB07954,"The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Interferon alfa-2a, Recombinant.",3-isobutyl-1-methyl-7H-xanthine,DB00034
DB08844,"The metabolism of Uric acid can be decreased when combined with Interferon alfa-2a, Recombinant.",Uric acid,DB00034
DB09273,"The metabolism of Doxofylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Doxofylline,DB00034
DB11919,"The metabolism of 6-O-benzylguanine can be decreased when combined with Interferon alfa-2a, Recombinant.",6-O-benzylguanine,DB00034
DB12406,"The metabolism of Lisofylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Lisofylline,DB00034
DB12531,"The metabolism of Lobucavir can be decreased when combined with Interferon alfa-2a, Recombinant.",Lobucavir,DB00034
DB12926,"The metabolism of Cafedrine can be decreased when combined with Interferon alfa-2a, Recombinant.",Cafedrine,DB00034
DB12927,"The metabolism of Theodrenaline can be decreased when combined with Interferon alfa-2a, Recombinant.",Theodrenaline,DB00034
DB13203,"The metabolism of Bamifylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Bamifylline,DB00034
DB13449,"The metabolism of Proxyphylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Proxyphylline,DB00034
DB13573,"The metabolism of Acefylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Acefylline,DB00034
DB13592,"The metabolism of Etamiphylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Etamiphylline,DB00034
DB13634,"The metabolism of Pentifylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Pentifylline,DB00034
DB13812,"The metabolism of Bufylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Bufylline,DB00034
DB14018,"The metabolism of Bromotheophylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Bromotheophylline,DB00034
DB14029,"The metabolism of Furafylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Furafylline,DB00034
DB14132,"The metabolism of 8-chlorotheophylline can be decreased when combined with Interferon alfa-2a, Recombinant.",8-chlorotheophylline,DB00034
DB15122,"The metabolism of PCS-499 can be decreased when combined with Interferon alfa-2a, Recombinant.",PCS-499,DB00034
DB04914,"The therapeutic efficacy of G17DT can be decreased when used in combination with Interferon alfa-2a, Recombinant.",G17DT,DB00034
DB05144,"The therapeutic efficacy of PEV3A can be decreased when used in combination with Interferon alfa-2a, Recombinant.",PEV3A,DB00034
DB05325,"The therapeutic efficacy of INGN 225 can be decreased when used in combination with Interferon alfa-2a, Recombinant.",INGN 225,DB00034
DB05374,"The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Rindopepimut,DB00034
DB05440,"The therapeutic efficacy of SRP 299 can be decreased when used in combination with Interferon alfa-2a, Recombinant.",SRP 299,DB00034
DB05942,"The therapeutic efficacy of GI-5005 can be decreased when used in combination with Interferon alfa-2a, Recombinant.",GI-5005,DB00034
DB06400,"The therapeutic efficacy of Vitespen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Vitespen,DB00034
DB06584,"The therapeutic efficacy of TG4010 can be decreased when used in combination with Interferon alfa-2a, Recombinant.",TG4010,DB00034
DB09057,"The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Anthrax immune globulin human,DB00034
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Interferon alfa-2a, Recombinant.","Rabies virus inactivated antigen, B",DB00034
DB10076,"The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen,DB00034
DB10276,"The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Rotavirus vaccine,DB00034
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Interferon alfa-2a, Recombinant.","Rabies virus inactivated antigen, A",DB00034
DB10342,"The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen,DB00034
DB10583,"The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Clostridium tetani toxoid antigen (formaldehyde inactivated),DB00034
DB10584,"The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated),DB00034
DB10600,"The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated),DB00034
DB10769,"The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),DB00034
DB10794,"The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated),DB00034
DB10803,"The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Typhoid Vi polysaccharide vaccine,DB00034
DB10989,"The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Hepatitis A Vaccine,DB00034
DB10990,"The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,DB00034
DB11038,"The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated),DB00034
DB11040,"The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated),DB00034
DB11041,"The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated),DB00034
DB11044,"The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated),DB00034
DB11603,"The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Human rabies virus immune globulin,DB00034
DB11627,"The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Hepatitis B Vaccine (Recombinant),DB00034
DB12568,"The therapeutic efficacy of Tecemotide can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Tecemotide,DB00034
DB14022,"The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Typhoid vaccine,DB00034
DB14384,"The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated),DB00034
DB14385,"The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated),DB00034
DB14394,"The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen,DB00034
DB14445,"The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated),DB00034
DB14449,"The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen,DB00034
DB14619,"The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated),DB00034
DB14620,"The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated),DB00034
DB14711,"The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Vaccinia virus strain new york city board of health live antigen,DB00034
DB15274,"The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Pertussis vaccine,DB00034
DB15461,"The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Yersinia pestis 195/p antigen (formaldehyde inactivated),DB00034
DB13924,"The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Varicella Zoster Vaccine (Recombinant),DB00034
DB15483,"The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Modified vaccinia ankara,DB00034
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.","Ebola Zaire vaccine (live, attenuated)",DB00034
DB00054,"The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-2a, Recombinant.",Abciximab,DB00034
DB00063,"The risk or severity of bleeding can be increased when Eptifibatide is combined with Interferon alfa-2a, Recombinant.",Eptifibatide,DB00034
DB00208,"The risk or severity of bleeding can be increased when Ticlopidine is combined with Interferon alfa-2a, Recombinant.",Ticlopidine,DB00034
DB00775,"The risk or severity of bleeding can be increased when Tirofiban is combined with Interferon alfa-2a, Recombinant.",Tirofiban,DB00034
DB00945,"The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon alfa-2a, Recombinant.",Acetylsalicylic acid,DB00034
DB00975,"The risk or severity of bleeding can be increased when Dipyridamole is combined with Interferon alfa-2a, Recombinant.",Dipyridamole,DB00034
DB01088,"The risk or severity of bleeding can be increased when Iloprost is combined with Interferon alfa-2a, Recombinant.",Iloprost,DB00034
DB01138,"The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon alfa-2a, Recombinant.",Sulfinpyrazone,DB00034
DB01207,"The risk or severity of bleeding can be increased when Ridogrel is combined with Interferon alfa-2a, Recombinant.",Ridogrel,DB00034
DB01236,"The risk or severity of bleeding can be increased when Sevoflurane is combined with Interferon alfa-2a, Recombinant.",Sevoflurane,DB00034
DB01240,"The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfa-2a, Recombinant.",Epoprostenol,DB00034
DB04743,"The risk or severity of bleeding can be increased when Nimesulide is combined with Interferon alfa-2a, Recombinant.",Nimesulide,DB00034
DB04905,"The risk or severity of bleeding can be increased when Tesmilifene is combined with Interferon alfa-2a, Recombinant.",Tesmilifene,DB00034
DB04932,"The risk or severity of bleeding can be increased when Defibrotide is combined with Interferon alfa-2a, Recombinant.",Defibrotide,DB00034
DB05229,"The risk or severity of bleeding can be increased when Beraprost is combined with Interferon alfa-2a, Recombinant.",Beraprost,DB00034
DB05266,"The risk or severity of bleeding can be increased when Ibudilast is combined with Interferon alfa-2a, Recombinant.",Ibudilast,DB00034
DB05767,"The risk or severity of bleeding can be increased when Andrographolide is combined with Interferon alfa-2a, Recombinant.",Andrographolide,DB00034
DB06081,"The risk or severity of bleeding can be increased when Caplacizumab is combined with Interferon alfa-2a, Recombinant.",Caplacizumab,DB00034
DB06209,"The risk or severity of bleeding can be increased when Prasugrel is combined with Interferon alfa-2a, Recombinant.",Prasugrel,DB00034
DB06441,"The risk or severity of bleeding can be increased when Cangrelor is combined with Interferon alfa-2a, Recombinant.",Cangrelor,DB00034
DB07615,"The risk or severity of bleeding can be increased when Tranilast is combined with Interferon alfa-2a, Recombinant.",Tranilast,DB00034
DB08814,"The risk or severity of bleeding can be increased when Triflusal is combined with Interferon alfa-2a, Recombinant.",Triflusal,DB00034
DB08816,"The risk or severity of bleeding can be increased when Ticagrelor is combined with Interferon alfa-2a, Recombinant.",Ticagrelor,DB00034
DB08887,"The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Interferon alfa-2a, Recombinant.",Icosapent ethyl,DB00034
DB09030,"The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfa-2a, Recombinant.",Vorapaxar,DB00034
DB09283,"The risk or severity of bleeding can be increased when Trapidil is combined with Interferon alfa-2a, Recombinant.",Trapidil,DB00034
DB12092,"The risk or severity of bleeding can be increased when Naftopidil is combined with Interferon alfa-2a, Recombinant.",Naftopidil,DB00034
DB12163,"The risk or severity of bleeding can be increased when Sarpogrelate is combined with Interferon alfa-2a, Recombinant.",Sarpogrelate,DB00034
DB12321,"The risk or severity of bleeding can be increased when Ifetroban is combined with Interferon alfa-2a, Recombinant.",Ifetroban,DB00034
DB12445,"The risk or severity of bleeding can be increased when Nitroaspirin is combined with Interferon alfa-2a, Recombinant.",Nitroaspirin,DB00034
DB12465,"The risk or severity of bleeding can be increased when Ketanserin is combined with Interferon alfa-2a, Recombinant.",Ketanserin,DB00034
DB12545,"The risk or severity of bleeding can be increased when Indobufen is combined with Interferon alfa-2a, Recombinant.",Indobufen,DB00034
DB12749,"The risk or severity of bleeding can be increased when Butylphthalide is combined with Interferon alfa-2a, Recombinant.",Butylphthalide,DB00034
DB12771,"The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Interferon alfa-2a, Recombinant.",Hydroxytyrosol,DB00034
DB13036,"The risk or severity of bleeding can be increased when Ramatroban is combined with Interferon alfa-2a, Recombinant.",Ramatroban,DB00034
DB13327,"The risk or severity of bleeding can be increased when Picotamide is combined with Interferon alfa-2a, Recombinant.",Picotamide,DB00034
DB13367,"The risk or severity of bleeding can be increased when Cloricromen is combined with Interferon alfa-2a, Recombinant.",Cloricromen,DB00034
DB13400,"The risk or severity of bleeding can be increased when Linsidomine is combined with Interferon alfa-2a, Recombinant.",Linsidomine,DB00034
DB13510,"The risk or severity of bleeding can be increased when Buflomedil is combined with Interferon alfa-2a, Recombinant.",Buflomedil,DB00034
DB13929,"The risk or severity of bleeding can be increased when Relcovaptan is combined with Interferon alfa-2a, Recombinant.",Relcovaptan,DB00034
DB13200,"Interferon alfa-2a, Recombinant may increase the myelosuppressive activities of Lipegfilgrastim.",Lipegfilgrastim,DB00034
DB10317,"The risk or severity of infection can be increased when Rubella virus vaccine is combined with Interferon alfa-2a, Recombinant.",Rubella virus vaccine,DB00034
DB10318,"The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Interferon alfa-2a, Recombinant.",Varicella Zoster Vaccine (Live/attenuated),DB00034
DB10343,"The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Interferon alfa-2a, Recombinant.",Bacillus calmette-guerin substrain tice live antigen,DB00034
DB10804,"The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Interferon alfa-2a, Recombinant.",Bacillus calmette-guerin substrain connaught live antigen,DB00034
DB10805,"The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Interferon alfa-2a, Recombinant.",Yellow Fever Vaccine,DB00034
DB11003,"The risk or severity of infection can be increased when Anthrax vaccine is combined with Interferon alfa-2a, Recombinant.",Anthrax vaccine,DB00034
DB11050,"The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Interferon alfa-2a, Recombinant.",Typhoid Vaccine Live,DB00034
DB12386,"The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Interferon alfa-2a, Recombinant.",Bacillus calmette-guerin substrain danish 1331 live antigen,DB00034
DB12768,"The risk or severity of infection can be increased when BCG vaccine is combined with Interferon alfa-2a, Recombinant.",BCG vaccine,DB00034
DB14409,"The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfa-2a, Recombinant.",Human adenovirus e serotype 4 strain cl-68578 antigen,DB00034
DB14443,"The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Interferon alfa-2a, Recombinant.",Vibrio cholerae CVD 103-HgR strain live antigen,DB00034
DB14685,"The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Interferon alfa-2a, Recombinant.",Adenovirus type 7 vaccine live,DB00034
DB00039,"The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Palifermin,DB00034
DB00176,"The metabolism of Fluvoxamine can be decreased when combined with Interferon alfa-2a, Recombinant.",Fluvoxamine,DB00034
DB00184,"The metabolism of Nicotine can be decreased when combined with Interferon alfa-2a, Recombinant.",Nicotine,DB00034
DB00195,"The metabolism of Betaxolol can be decreased when combined with Interferon alfa-2a, Recombinant.",Betaxolol,DB00034
DB00261,"The metabolism of Anagrelide can be decreased when combined with Interferon alfa-2a, Recombinant.",Anagrelide,DB00034
DB00280,"The metabolism of Disopyramide can be decreased when combined with Interferon alfa-2a, Recombinant.",Disopyramide,DB00034
DB00281,"The metabolism of Lidocaine can be decreased when combined with Interferon alfa-2a, Recombinant.",Lidocaine,DB00034
DB00286,"The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-2a, Recombinant.",Conjugated estrogens,DB00034
DB00296,"The metabolism of Ropivacaine can be decreased when combined with Interferon alfa-2a, Recombinant.",Ropivacaine,DB00034
DB00316,"The metabolism of Acetaminophen can be decreased when combined with Interferon alfa-2a, Recombinant.",Acetaminophen,DB00034
DB00334,"The metabolism of Olanzapine can be decreased when combined with Interferon alfa-2a, Recombinant.",Olanzapine,DB00034
DB00356,"The metabolism of Chlorzoxazone can be decreased when combined with Interferon alfa-2a, Recombinant.",Chlorzoxazone,DB00034
DB00365,"The metabolism of Grepafloxacin can be decreased when combined with Interferon alfa-2a, Recombinant.",Grepafloxacin,DB00034
DB00370,"The metabolism of Mirtazapine can be decreased when combined with Interferon alfa-2a, Recombinant.",Mirtazapine,DB00034
DB00379,"The metabolism of Mexiletine can be decreased when combined with Interferon alfa-2a, Recombinant.",Mexiletine,DB00034
DB00382,"The metabolism of Tacrine can be decreased when combined with Interferon alfa-2a, Recombinant.",Tacrine,DB00034
DB00384,"The metabolism of Triamterene can be decreased when combined with Interferon alfa-2a, Recombinant.",Triamterene,DB00034
DB00420,"The metabolism of Promazine can be decreased when combined with Interferon alfa-2a, Recombinant.",Promazine,DB00034
DB00425,"The metabolism of Zolpidem can be decreased when combined with Interferon alfa-2a, Recombinant.",Zolpidem,DB00034
DB00442,"The metabolism of Entecavir can be decreased when combined with Interferon alfa-2a, Recombinant.",Entecavir,DB00034
DB00461,"The metabolism of Nabumetone can be decreased when combined with Interferon alfa-2a, Recombinant.",Nabumetone,DB00034
DB00468,"The metabolism of Quinine can be decreased when combined with Interferon alfa-2a, Recombinant.",Quinine,DB00034
DB00472,"The metabolism of Fluoxetine can be decreased when combined with Interferon alfa-2a, Recombinant.",Fluoxetine,DB00034
DB00476,"The metabolism of Duloxetine can be decreased when combined with Interferon alfa-2a, Recombinant.",Duloxetine,DB00034
DB00477,"The metabolism of Chlorpromazine can be decreased when combined with Interferon alfa-2a, Recombinant.",Chlorpromazine,DB00034
DB00499,"The metabolism of Flutamide can be decreased when combined with Interferon alfa-2a, Recombinant.",Flutamide,DB00034
DB00502,"The metabolism of Haloperidol can be decreased when combined with Interferon alfa-2a, Recombinant.",Haloperidol,DB00034
DB00518,"The metabolism of Albendazole can be decreased when combined with Interferon alfa-2a, Recombinant.",Albendazole,DB00034
DB00533,"The metabolism of Rofecoxib can be decreased when combined with Interferon alfa-2a, Recombinant.",Rofecoxib,DB00034
DB00568,"The metabolism of Cinnarizine can be decreased when combined with Interferon alfa-2a, Recombinant.",Cinnarizine,DB00034
DB00571,"The metabolism of Propranolol can be decreased when combined with Interferon alfa-2a, Recombinant.",Propranolol,DB00034
DB00586,"The metabolism of Diclofenac can be decreased when combined with Interferon alfa-2a, Recombinant.",Diclofenac,DB00034
DB00629,"The metabolism of Guanabenz can be decreased when combined with Interferon alfa-2a, Recombinant.",Guanabenz,DB00034
DB00661,"The metabolism of Verapamil can be decreased when combined with Interferon alfa-2a, Recombinant.",Verapamil,DB00034
DB00715,"The metabolism of Paroxetine can be decreased when combined with Interferon alfa-2a, Recombinant.",Paroxetine,DB00034
DB00730,"The metabolism of Thiabendazole can be decreased when combined with Interferon alfa-2a, Recombinant.",Thiabendazole,DB00034
DB00740,"The metabolism of Riluzole can be decreased when combined with Interferon alfa-2a, Recombinant.",Riluzole,DB00034
DB00744,"The metabolism of Zileuton can be decreased when combined with Interferon alfa-2a, Recombinant.",Zileuton,DB00034
DB00758,"The metabolism of Clopidogrel can be decreased when combined with Interferon alfa-2a, Recombinant.",Clopidogrel,DB00034
DB00783,"The metabolism of Estradiol can be decreased when combined with Interferon alfa-2a, Recombinant.",Estradiol,DB00034
DB00787,"The metabolism of Acyclovir can be decreased when combined with Interferon alfa-2a, Recombinant.",Acyclovir,DB00034
DB00788,"The metabolism of Naproxen can be decreased when combined with Interferon alfa-2a, Recombinant.",Naproxen,DB00034
DB00831,"The metabolism of Trifluoperazine can be decreased when combined with Interferon alfa-2a, Recombinant.",Trifluoperazine,DB00034
DB00850,"The metabolism of Perphenazine can be decreased when combined with Interferon alfa-2a, Recombinant.",Perphenazine,DB00034
DB00857,"The metabolism of Terbinafine can be decreased when combined with Interferon alfa-2a, Recombinant.",Terbinafine,DB00034
DB00863,"The metabolism of Ranitidine can be decreased when combined with Interferon alfa-2a, Recombinant.",Ranitidine,DB00034
DB00898,"The metabolism of Ethanol can be decreased when combined with Interferon alfa-2a, Recombinant.",Ethanol,DB00034
DB00934,"The metabolism of Maprotiline can be decreased when combined with Interferon alfa-2a, Recombinant.",Maprotiline,DB00034
DB00969,"The metabolism of Alosetron can be decreased when combined with Interferon alfa-2a, Recombinant.",Alosetron,DB00034
DB00978,"The metabolism of Lomefloxacin can be decreased when combined with Interferon alfa-2a, Recombinant.",Lomefloxacin,DB00034
DB00980,"The metabolism of Ramelteon can be decreased when combined with Interferon alfa-2a, Recombinant.",Ramelteon,DB00034
DB00998,"The metabolism of Frovatriptan can be decreased when combined with Interferon alfa-2a, Recombinant.",Frovatriptan,DB00034
DB01002,"The metabolism of Levobupivacaine can be decreased when combined with Interferon alfa-2a, Recombinant.",Levobupivacaine,DB00034
DB01012,"The metabolism of Cinacalcet can be decreased when combined with Interferon alfa-2a, Recombinant.",Cinacalcet,DB00034
DB01037,"The metabolism of Selegiline can be decreased when combined with Interferon alfa-2a, Recombinant.",Selegiline,DB00034
DB01056,"The metabolism of Tocainide can be decreased when combined with Interferon alfa-2a, Recombinant.",Tocainide,DB00034
DB01058,"The metabolism of Praziquantel can be decreased when combined with Interferon alfa-2a, Recombinant.",Praziquantel,DB00034
DB01065,"The metabolism of Melatonin can be decreased when combined with Interferon alfa-2a, Recombinant.",Melatonin,DB00034
DB01087,"The metabolism of Primaquine can be decreased when combined with Interferon alfa-2a, Recombinant.",Primaquine,DB00034
DB01094,"The metabolism of Hesperetin can be decreased when combined with Interferon alfa-2a, Recombinant.",Hesperetin,DB00034
DB01115,"The metabolism of Nifedipine can be decreased when combined with Interferon alfa-2a, Recombinant.",Nifedipine,DB00034
DB01136,"The metabolism of Carvedilol can be decreased when combined with Interferon alfa-2a, Recombinant.",Carvedilol,DB00034
DB01166,"The metabolism of Cilostazol can be decreased when combined with Interferon alfa-2a, Recombinant.",Cilostazol,DB00034
DB01182,"The metabolism of Propafenone can be decreased when combined with Interferon alfa-2a, Recombinant.",Propafenone,DB00034
DB01184,"The metabolism of Domperidone can be decreased when combined with Interferon alfa-2a, Recombinant.",Domperidone,DB00034
DB01191,"The metabolism of Dexfenfluramine can be decreased when combined with Interferon alfa-2a, Recombinant.",Dexfenfluramine,DB00034
DB01367,"The metabolism of Rasagiline can be decreased when combined with Interferon alfa-2a, Recombinant.",Rasagiline,DB00034
DB01405,"The metabolism of Temafloxacin can be decreased when combined with Interferon alfa-2a, Recombinant.",Temafloxacin,DB00034
DB01424,"The metabolism of Aminophenazone can be decreased when combined with Interferon alfa-2a, Recombinant.",Aminophenazone,DB00034
DB01435,"The metabolism of Antipyrine can be decreased when combined with Interferon alfa-2a, Recombinant.",Antipyrine,DB00034
DB01558,"The metabolism of Bromazepam can be decreased when combined with Interferon alfa-2a, Recombinant.",Bromazepam,DB00034
DB01623,"The metabolism of Thiothixene can be decreased when combined with Interferon alfa-2a, Recombinant.",Thiothixene,DB00034
DB01628,"The metabolism of Etoricoxib can be decreased when combined with Interferon alfa-2a, Recombinant.",Etoricoxib,DB00034
DB01645,"The metabolism of Genistein can be decreased when combined with Interferon alfa-2a, Recombinant.",Genistein,DB00034
DB02709,"The metabolism of Resveratrol can be decreased when combined with Interferon alfa-2a, Recombinant.",Resveratrol,DB00034
DB03783,"The metabolism of Phenacetin can be decreased when combined with Interferon alfa-2a, Recombinant.",Phenacetin,DB00034
DB04574,"The metabolism of Estrone sulfate can be decreased when combined with Interferon alfa-2a, Recombinant.",Estrone sulfate,DB00034
DB04841,"The metabolism of Flunarizine can be decreased when combined with Interferon alfa-2a, Recombinant.",Flunarizine,DB00034
DB04871,"The metabolism of Lorcaserin can be decreased when combined with Interferon alfa-2a, Recombinant.",Lorcaserin,DB00034
DB04948,"The metabolism of Lofexidine can be decreased when combined with Interferon alfa-2a, Recombinant.",Lofexidine,DB00034
DB06148,"The metabolism of Mianserin can be decreased when combined with Interferon alfa-2a, Recombinant.",Mianserin,DB00034
DB06210,"The metabolism of Eltrombopag can be decreased when combined with Interferon alfa-2a, Recombinant.",Eltrombopag,DB00034
DB06216,"The metabolism of Asenapine can be decreased when combined with Interferon alfa-2a, Recombinant.",Asenapine,DB00034
DB06235,"The metabolism of Vadimezan can be decreased when combined with Interferon alfa-2a, Recombinant.",Vadimezan,DB00034
DB06292,"The metabolism of Dapagliflozin can be decreased when combined with Interferon alfa-2a, Recombinant.",Dapagliflozin,DB00034
DB06594,"The metabolism of Agomelatine can be decreased when combined with Interferon alfa-2a, Recombinant.",Agomelatine,DB00034
DB06626,"The metabolism of Axitinib can be decreased when combined with Interferon alfa-2a, Recombinant.",Axitinib,DB00034
DB06770,"The metabolism of Benzyl alcohol can be decreased when combined with Interferon alfa-2a, Recombinant.",Benzyl alcohol,DB00034
DB06774,"The metabolism of Capsaicin can be decreased when combined with Interferon alfa-2a, Recombinant.",Capsaicin,DB00034
DB08496,"The metabolism of (R)-warfarin can be decreased when combined with Interferon alfa-2a, Recombinant.",(R)-warfarin,DB00034
DB08883,"The metabolism of Perampanel can be decreased when combined with Interferon alfa-2a, Recombinant.",Perampanel,DB00034
DB09071,"The metabolism of Tasimelteon can be decreased when combined with Interferon alfa-2a, Recombinant.",Tasimelteon,DB00034
DB09118,"The metabolism of Stiripentol can be decreased when combined with Interferon alfa-2a, Recombinant.",Stiripentol,DB00034
DB09225,"The metabolism of Zotepine can be decreased when combined with Interferon alfa-2a, Recombinant.",Zotepine,DB00034
DB09288,"The metabolism of Propacetamol can be decreased when combined with Interferon alfa-2a, Recombinant.",Propacetamol,DB00034
DB09290,"The metabolism of Ramosetron can be decreased when combined with Interferon alfa-2a, Recombinant.",Ramosetron,DB00034
DB11967,"The metabolism of Binimetinib can be decreased when combined with Interferon alfa-2a, Recombinant.",Binimetinib,DB00034
DB12026,"The metabolism of Voxilaprevir can be decreased when combined with Interferon alfa-2a, Recombinant.",Voxilaprevir,DB00034
DB12245,"The metabolism of Triclabendazole can be decreased when combined with Interferon alfa-2a, Recombinant.",Triclabendazole,DB00034
DB12332,"The metabolism of Rucaparib can be decreased when combined with Interferon alfa-2a, Recombinant.",Rucaparib,DB00034
DB12945,"The metabolism of Dihydralazine can be decreased when combined with Interferon alfa-2a, Recombinant.",Dihydralazine,DB00034
DB13952,"The metabolism of Estradiol acetate can be decreased when combined with Interferon alfa-2a, Recombinant.",Estradiol acetate,DB00034
DB13953,"The metabolism of Estradiol benzoate can be decreased when combined with Interferon alfa-2a, Recombinant.",Estradiol benzoate,DB00034
DB13954,"The metabolism of Estradiol cypionate can be decreased when combined with Interferon alfa-2a, Recombinant.",Estradiol cypionate,DB00034
DB13955,"The metabolism of Estradiol dienanthate can be decreased when combined with Interferon alfa-2a, Recombinant.",Estradiol dienanthate,DB00034
DB13956,"The metabolism of Estradiol valerate can be decreased when combined with Interferon alfa-2a, Recombinant.",Estradiol valerate,DB00034
DB11757,"The metabolism of Istradefylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Istradefylline,DB00034
DB00972,"The metabolism of Azelastine can be decreased when combined with Interferon alfa-2a, Recombinant.",Azelastine,DB00034
DB00625,"The metabolism of Efavirenz can be decreased when combined with Interferon alfa-2a, Recombinant.",Efavirenz,DB00034
DB01233,"The metabolism of Metoclopramide can be decreased when combined with Interferon alfa-2a, Recombinant.",Metoclopramide,DB00034
DB04889,"The metabolism of Bicifadine can be decreased when combined with Interferon alfa-2a, Recombinant.",Bicifadine,DB00034
DB05708,"The metabolism of GTS-21 can be decreased when combined with Interferon alfa-2a, Recombinant.",GTS-21,DB00034
DB01195,"The metabolism of Flecainide can be decreased when combined with Interferon alfa-2a, Recombinant.",Flecainide,DB00034
DB00977,"The metabolism of Ethinylestradiol can be decreased when combined with Interferon alfa-2a, Recombinant.",Ethinylestradiol,DB00034
DB00321,"The metabolism of Amitriptyline can be decreased when combined with Interferon alfa-2a, Recombinant.",Amitriptyline,DB00034
DB00458,"The metabolism of Imipramine can be decreased when combined with Interferon alfa-2a, Recombinant.",Imipramine,DB00034
DB01142,"The metabolism of Doxepin can be decreased when combined with Interferon alfa-2a, Recombinant.",Doxepin,DB00034
DB00532,"The metabolism of Mephenytoin can be decreased when combined with Interferon alfa-2a, Recombinant.",Mephenytoin,DB00034
DB00540,"The metabolism of Nortriptyline can be decreased when combined with Interferon alfa-2a, Recombinant.",Nortriptyline,DB00034
DB00575,"The metabolism of Clonidine can be decreased when combined with Interferon alfa-2a, Recombinant.",Clonidine,DB00034
DB00924,"The metabolism of Cyclobenzaprine can be decreased when combined with Interferon alfa-2a, Recombinant.",Cyclobenzaprine,DB00034
DB01151,"The metabolism of Desipramine can be decreased when combined with Interferon alfa-2a, Recombinant.",Desipramine,DB00034
DB01242,"The metabolism of Clomipramine can be decreased when combined with Interferon alfa-2a, Recombinant.",Clomipramine,DB00034
DB11689,"The metabolism of Selumetinib can be decreased when combined with Interferon alfa-2a, Recombinant.",Selumetinib,DB00034
DB00277,"The metabolism of Theophylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Theophylline,DB00034
DB00682,"The metabolism of Warfarin can be decreased when combined with Interferon alfa-2a, Recombinant.",Warfarin,DB00034
DB00697,"The metabolism of Tizanidine can be decreased when combined with Interferon alfa-2a, Recombinant.",Tizanidine,DB00034
DB01100,"The metabolism of Pimozide can be decreased when combined with Interferon alfa-2a, Recombinant.",Pimozide,DB00034
DB01223,"The metabolism of Aminophylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Aminophylline,DB00034
DB01418,"The metabolism of Acenocoumarol can be decreased when combined with Interferon alfa-2a, Recombinant.",Acenocoumarol,DB00034
DB00530,"The metabolism of Erlotinib can be decreased when combined with Interferon alfa-2a, Recombinant.",Erlotinib,DB00034
DB09256,"The metabolism of Tegafur can be decreased when combined with Interferon alfa-2a, Recombinant.",Tegafur,DB00034
DB13874,"The metabolism of Enasidenib can be decreased when combined with Interferon alfa-2a, Recombinant.",Enasidenib,DB00034
DB00675,"The metabolism of Tamoxifen can be decreased when combined with Interferon alfa-2a, Recombinant.",Tamoxifen,DB00034
DB00001,"The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-2a, Recombinant.",Lepirudin,DB00034
DB00006,"The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-2a, Recombinant.",Bivalirudin,DB00034
DB00009,"The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-2a, Recombinant.",Alteplase,DB00034
DB00013,"The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-2a, Recombinant.",Urokinase,DB00034
DB00015,"The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-2a, Recombinant.",Reteplase,DB00034
DB00029,"The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-2a, Recombinant.",Anistreplase,DB00034
DB00031,"The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-2a, Recombinant.",Tenecteplase,DB00034
DB00055,"The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Interferon alfa-2a, Recombinant.",Drotrecogin alfa,DB00034
DB00086,"The risk or severity of bleeding can be increased when Streptokinase is combined with Interferon alfa-2a, Recombinant.",Streptokinase,DB00034
DB00266,"The risk or severity of bleeding can be increased when Dicoumarol is combined with Interferon alfa-2a, Recombinant.",Dicoumarol,DB00034
DB00278,"The risk or severity of bleeding can be increased when Argatroban is combined with Interferon alfa-2a, Recombinant.",Argatroban,DB00034
DB00407,"The risk or severity of bleeding can be increased when Ardeparin is combined with Interferon alfa-2a, Recombinant.",Ardeparin,DB00034
DB00498,"The risk or severity of bleeding can be increased when Phenindione is combined with Interferon alfa-2a, Recombinant.",Phenindione,DB00034
DB00569,"The risk or severity of bleeding can be increased when Fondaparinux is combined with Interferon alfa-2a, Recombinant.",Fondaparinux,DB00034
DB00686,"The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Interferon alfa-2a, Recombinant.",Pentosan polysulfate,DB00034
DB00946,"The risk or severity of bleeding can be increased when Phenprocoumon is combined with Interferon alfa-2a, Recombinant.",Phenprocoumon,DB00034
DB01109,"The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfa-2a, Recombinant.",Heparin,DB00034
DB01225,"The risk or severity of bleeding can be increased when Enoxaparin is combined with Interferon alfa-2a, Recombinant.",Enoxaparin,DB00034
DB03410,"The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Interferon alfa-2a, Recombinant.",4-hydroxycoumarin,DB00034
DB04665,"The risk or severity of bleeding can be increased when Coumarin is combined with Interferon alfa-2a, Recombinant.",Coumarin,DB00034
DB04898,"The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfa-2a, Recombinant.",Ximelagatran,DB00034
DB04925,"The risk or severity of bleeding can be increased when Desmoteplase is combined with Interferon alfa-2a, Recombinant.",Desmoteplase,DB00034
DB05099,"The risk or severity of bleeding can be increased when Ancrod is combined with Interferon alfa-2a, Recombinant.",Ancrod,DB00034
DB05254,"The risk or severity of bleeding can be increased when Fibrinolysin is combined with Interferon alfa-2a, Recombinant.",Fibrinolysin,DB00034
DB06228,"The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon alfa-2a, Recombinant.",Rivaroxaban,DB00034
DB06271,"The risk or severity of bleeding can be increased when Sulodexide is combined with Interferon alfa-2a, Recombinant.",Sulodexide,DB00034
DB06294,"The risk or severity of bleeding can be increased when Semuloparin is combined with Interferon alfa-2a, Recombinant.",Semuloparin,DB00034
DB06406,"The risk or severity of bleeding can be increased when Idraparinux is combined with Interferon alfa-2a, Recombinant.",Idraparinux,DB00034
DB06543,"The risk or severity of bleeding can be increased when Astaxanthin is combined with Interferon alfa-2a, Recombinant.",Astaxanthin,DB00034
DB06605,"The risk or severity of bleeding can be increased when Apixaban is combined with Interferon alfa-2a, Recombinant.",Apixaban,DB00034
DB06635,"The risk or severity of bleeding can be increased when Otamixaban is combined with Interferon alfa-2a, Recombinant.",Otamixaban,DB00034
DB06679,"The risk or severity of bleeding can be increased when Amediplase is combined with Interferon alfa-2a, Recombinant.",Amediplase,DB00034
DB06695,"The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Interferon alfa-2a, Recombinant.",Dabigatran etexilate,DB00034
DB06754,"The risk or severity of bleeding can be increased when Danaparoid is combined with Interferon alfa-2a, Recombinant.",Danaparoid,DB00034
DB06779,"The risk or severity of bleeding can be increased when Dalteparin is combined with Interferon alfa-2a, Recombinant.",Dalteparin,DB00034
DB06822,"The risk or severity of bleeding can be increased when Tinzaparin is combined with Interferon alfa-2a, Recombinant.",Tinzaparin,DB00034
DB07767,"The risk or severity of bleeding can be increased when Ferulic acid is combined with Interferon alfa-2a, Recombinant.",Ferulic acid,DB00034
DB08794,"The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Interferon alfa-2a, Recombinant.",Ethyl biscoumacetate,DB00034
DB08813,"The risk or severity of bleeding can be increased when Nadroparin is combined with Interferon alfa-2a, Recombinant.",Nadroparin,DB00034
DB08994,"The risk or severity of bleeding can be increased when Ditazole is combined with Interferon alfa-2a, Recombinant.",Ditazole,DB00034
DB09075,"The risk or severity of bleeding can be increased when Edoxaban is combined with Interferon alfa-2a, Recombinant.",Edoxaban,DB00034
DB09125,"The risk or severity of bleeding can be increased when Potassium citrate is combined with Interferon alfa-2a, Recombinant.",Potassium citrate,DB00034
DB09154,"The risk or severity of bleeding can be increased when Sodium citrate is combined with Interferon alfa-2a, Recombinant.",Sodium citrate,DB00034
DB09255,"The risk or severity of bleeding can be increased when Dextran is combined with Interferon alfa-2a, Recombinant.",Dextran,DB00034
DB09258,"The risk or severity of bleeding can be increased when Bemiparin is combined with Interferon alfa-2a, Recombinant.",Bemiparin,DB00034
DB09259,"The risk or severity of bleeding can be increased when Reviparin is combined with Interferon alfa-2a, Recombinant.",Reviparin,DB00034
DB09260,"The risk or severity of bleeding can be increased when Parnaparin is combined with Interferon alfa-2a, Recombinant.",Parnaparin,DB00034
DB09261,"The risk or severity of bleeding can be increased when Certoparin is combined with Interferon alfa-2a, Recombinant.",Certoparin,DB00034
DB11095,"The risk or severity of bleeding can be increased when Desirudin is combined with Interferon alfa-2a, Recombinant.",Desirudin,DB00034
DB11154,"The risk or severity of bleeding can be increased when Zinc citrate is combined with Interferon alfa-2a, Recombinant.",Zinc citrate,DB00034
DB11166,"The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Interferon alfa-2a, Recombinant.",Antithrombin Alfa,DB00034
DB11312,"The risk or severity of bleeding can be increased when Protein C is combined with Interferon alfa-2a, Recombinant.",Protein C,DB00034
DB11598,"The risk or severity of bleeding can be increased when Antithrombin III human is combined with Interferon alfa-2a, Recombinant.",Antithrombin III human,DB00034
DB11984,"The risk or severity of bleeding can be increased when Letaxaban is combined with Interferon alfa-2a, Recombinant.",Letaxaban,DB00034
DB12289,"The risk or severity of bleeding can be increased when Darexaban is combined with Interferon alfa-2a, Recombinant.",Darexaban,DB00034
DB12364,"The risk or severity of bleeding can be increased when Betrixaban is combined with Interferon alfa-2a, Recombinant.",Betrixaban,DB00034
DB12598,"The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfa-2a, Recombinant.",Nafamostat,DB00034
DB12726,"The risk or severity of bleeding can be increased when Monteplase is combined with Interferon alfa-2a, Recombinant.",Monteplase,DB00034
DB12831,"The risk or severity of bleeding can be increased when Gabexate is combined with Interferon alfa-2a, Recombinant.",Gabexate,DB00034
DB13136,"The risk or severity of bleeding can be increased when Fluindione is combined with Interferon alfa-2a, Recombinant.",Fluindione,DB00034
DB13149,"The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfa-2a, Recombinant.",Protein S human,DB00034
DB13199,"The risk or severity of bleeding can be increased when Brinase is combined with Interferon alfa-2a, Recombinant.",Brinase,DB00034
DB13275,"The risk or severity of bleeding can be increased when Clorindione is combined with Interferon alfa-2a, Recombinant.",Clorindione,DB00034
DB13347,"The risk or severity of bleeding can be increased when Diphenadione is combined with Interferon alfa-2a, Recombinant.",Diphenadione,DB00034
DB13451,"The risk or severity of bleeding can be increased when Tioclomarol is combined with Interferon alfa-2a, Recombinant.",Tioclomarol,DB00034
DB13616,"The risk or severity of bleeding can be increased when Melagatran is combined with Interferon alfa-2a, Recombinant.",Melagatran,DB00034
DB13646,"The risk or severity of bleeding can be increased when Saruplase is combined with Interferon alfa-2a, Recombinant.",Saruplase,DB00034
DB14055,"The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Interferon alfa-2a, Recombinant.",(S)-Warfarin,DB00034
DB14094,"The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Interferon alfa-2a, Recombinant.",Tocopherylquinone,DB00034
DB14598,"The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Interferon alfa-2a, Recombinant.",Edetate calcium disodium anhydrous,DB00034
DB14726,"The risk or severity of bleeding can be increased when Dabigatran is combined with Interferon alfa-2a, Recombinant.",Dabigatran,DB00034
DB00232,"The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Interferon alfa-2a, Recombinant.",Methyclothiazide,DB00034
DB00436,"The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Interferon alfa-2a, Recombinant.",Bendroflumethiazide,DB00034
DB00562,"The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Interferon alfa-2a, Recombinant.",Benzthiazide,DB00034
DB00606,"The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Interferon alfa-2a, Recombinant.",Cyclothiazide,DB00034
DB00774,"The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfa-2a, Recombinant.",Hydroflumethiazide,DB00034
DB00880,"The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Interferon alfa-2a, Recombinant.",Chlorothiazide,DB00034
DB00999,"The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfa-2a, Recombinant.",Hydrochlorothiazide,DB00034
DB01021,"The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Interferon alfa-2a, Recombinant.",Trichlormethiazide,DB00034
DB01324,"The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Interferon alfa-2a, Recombinant.",Polythiazide,DB00034
DB13430,"The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Interferon alfa-2a, Recombinant.",Mebutizide,DB00034
DB13532,"The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Interferon alfa-2a, Recombinant.",Cyclopenthiazide,DB00034
DB09042,"The risk or severity of myelosuppression can be increased when Interferon alfa-2a, Recombinant is combined with Tedizolid phosphate.",Tedizolid phosphate,DB00034
DB00091,"Interferon alfa-2a, Recombinant may increase the immunosuppressive activities of Cyclosporine.",Cyclosporine,DB00034
DB00268,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ropinirole.",Ropinirole,DB00034
DB00115,"The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Cyanocobalamin,DB00034
DB00437,"The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon alfa-2a, Recombinant.",Allopurinol,DB00034
DB14513,"The serum concentration of Magnesium can be decreased when it is combined with Interferon alfa-2a, Recombinant.",Magnesium,DB00034
DB01601,"The serum concentration of Interferon alfa-2a, Recombinant can be increased when it is combined with Lopinavir.",Lopinavir,DB00034
DB12530,"The risk or severity of infection can be increased when Interferon alfa-2a, Recombinant is combined with Inebilizumab.",Inebilizumab,DB00034
DB00564,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Desmopressin.,Carbamazepine,DB00035
DB00477,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Desmopressin.,Chlorpromazine,DB00035
DB00618,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Demeclocycline.,Demeclocycline,DB00035
DB00555,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Desmopressin.,Lamotrigine,DB00035
DB01356,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Lithium cation.,Lithium cation,DB00035
DB14507,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Lithium citrate.,Lithium citrate,DB00035
DB14509,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Lithium carbonate.,Lithium carbonate,DB00035
DB14506,The therapeutic efficacy of Lithium hydroxide can be decreased when used in combination with Desmopressin.,Lithium hydroxide,DB00035
DB06212,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Tolvaptan.,Tolvaptan,DB00035
DB00176,The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Desmopressin.,Fluvoxamine,DB00035
DB00215,The risk or severity of hyponatremia can be increased when Citalopram is combined with Desmopressin.,Citalopram,DB00035
DB00472,The risk or severity of hyponatremia can be increased when Fluoxetine is combined with Desmopressin.,Fluoxetine,DB00035
DB00476,The risk or severity of hyponatremia can be increased when Duloxetine is combined with Desmopressin.,Duloxetine,DB00035
DB00656,The risk or severity of hyponatremia can be increased when Trazodone is combined with Desmopressin.,Trazodone,DB00035
DB00715,The risk or severity of hyponatremia can be increased when Paroxetine is combined with Desmopressin.,Paroxetine,DB00035
DB01104,The risk or severity of hyponatremia can be increased when Sertraline is combined with Desmopressin.,Sertraline,DB00035
DB01105,The risk or severity of hyponatremia can be increased when Sibutramine is combined with Desmopressin.,Sibutramine,DB00035
DB01149,The risk or severity of hyponatremia can be increased when Nefazodone is combined with Desmopressin.,Nefazodone,DB00035
DB01175,The risk or severity of hyponatremia can be increased when Escitalopram is combined with Desmopressin.,Escitalopram,DB00035
DB04832,The risk or severity of hyponatremia can be increased when Zimelidine is combined with Desmopressin.,Zimelidine,DB00035
DB04884,The risk or severity of hyponatremia can be increased when Dapoxetine is combined with Desmopressin.,Dapoxetine,DB00035
DB04896,The risk or severity of hyponatremia can be increased when Milnacipran is combined with Desmopressin.,Milnacipran,DB00035
DB06700,The risk or severity of hyponatremia can be increased when Desvenlafaxine is combined with Desmopressin.,Desvenlafaxine,DB00035
DB06731,The risk or severity of hyponatremia can be increased when Seproxetine is combined with Desmopressin.,Seproxetine,DB00035
DB08918,The risk or severity of hyponatremia can be increased when Levomilnacipran is combined with Desmopressin.,Levomilnacipran,DB00035
DB08953,The risk or severity of hyponatremia can be increased when Indalpine is combined with Desmopressin.,Indalpine,DB00035
DB12693,The risk or severity of hyponatremia can be increased when Ritanserin is combined with Desmopressin.,Ritanserin,DB00035
DB13233,The risk or severity of hyponatremia can be increased when Alaproclate is combined with Desmopressin.,Alaproclate,DB00035
DB00177,Desmopressin may decrease the antihypertensive activities of Valsartan.,Valsartan,DB00035
DB00178,Desmopressin may decrease the antihypertensive activities of Ramipril.,Ramipril,DB00035
DB00187,Desmopressin may decrease the antihypertensive activities of Esmolol.,Esmolol,DB00035
DB00195,Desmopressin may decrease the antihypertensive activities of Betaxolol.,Betaxolol,DB00035
DB00212,Desmopressin may decrease the antihypertensive activities of Remikiren.,Remikiren,DB00035
DB00226,Desmopressin may decrease the antihypertensive activities of Guanadrel.,Guanadrel,DB00035
DB00275,Desmopressin may decrease the antihypertensive activities of Olmesartan.,Olmesartan,DB00035
DB00335,Desmopressin may decrease the antihypertensive activities of Atenolol.,Atenolol,DB00035
DB00343,Desmopressin may decrease the antihypertensive activities of Diltiazem.,Diltiazem,DB00035
DB00350,Desmopressin may decrease the antihypertensive activities of Minoxidil.,Minoxidil,DB00035
DB00374,Desmopressin may decrease the antihypertensive activities of Treprostinil.,Treprostinil,DB00035
DB00381,Desmopressin may decrease the antihypertensive activities of Amlodipine.,Amlodipine,DB00035
DB00393,Desmopressin may decrease the antihypertensive activities of Nimodipine.,Nimodipine,DB00035
DB00457,Desmopressin may decrease the antihypertensive activities of Prazosin.,Prazosin,DB00035
DB00519,Desmopressin may decrease the antihypertensive activities of Trandolapril.,Trandolapril,DB00035
DB00528,Desmopressin may decrease the antihypertensive activities of Lercanidipine.,Lercanidipine,DB00035
DB00542,Desmopressin may decrease the antihypertensive activities of Benazepril.,Benazepril,DB00035
DB00559,Desmopressin may decrease the antihypertensive activities of Bosentan.,Bosentan,DB00035
DB00584,Desmopressin may decrease the antihypertensive activities of Enalapril.,Enalapril,DB00035
DB00590,Desmopressin may decrease the antihypertensive activities of Doxazosin.,Doxazosin,DB00035
DB00616,Desmopressin may decrease the antihypertensive activities of Candoxatril.,Candoxatril,DB00035
DB00622,Desmopressin may decrease the antihypertensive activities of Nicardipine.,Nicardipine,DB00035
DB00678,Desmopressin may decrease the antihypertensive activities of Losartan.,Losartan,DB00035
DB00691,Desmopressin may decrease the antihypertensive activities of Moexipril.,Moexipril,DB00035
DB00727,Desmopressin may decrease the antihypertensive activities of Nitroglycerin.,Nitroglycerin,DB00035
DB00765,Desmopressin may decrease the antihypertensive activities of Metyrosine.,Metyrosine,DB00035
DB00785,Desmopressin may decrease the antihypertensive activities of Cryptenamine.,Cryptenamine,DB00035
DB00796,Desmopressin may decrease the antihypertensive activities of Candesartan cilexetil.,Candesartan cilexetil,DB00035
DB00866,Desmopressin may decrease the antihypertensive activities of Alprenolol.,Alprenolol,DB00035
DB00876,Desmopressin may decrease the antihypertensive activities of Eprosartan.,Eprosartan,DB00035
DB00881,Desmopressin may decrease the antihypertensive activities of Quinapril.,Quinapril,DB00035
DB00966,Desmopressin may decrease the antihypertensive activities of Telmisartan.,Telmisartan,DB00035
DB01023,Desmopressin may decrease the antihypertensive activities of Felodipine.,Felodipine,DB00035
DB01029,Desmopressin may decrease the antihypertensive activities of Irbesartan.,Irbesartan,DB00035
DB01054,Desmopressin may decrease the antihypertensive activities of Nitrendipine.,Nitrendipine,DB00035
DB01089,Desmopressin may decrease the antihypertensive activities of Deserpidine.,Deserpidine,DB00035
DB01090,Desmopressin may decrease the antihypertensive activities of Pentolinium.,Pentolinium,DB00035
DB01116,Desmopressin may decrease the antihypertensive activities of Trimethaphan.,Trimethaphan,DB00035
DB01136,Desmopressin may decrease the antihypertensive activities of Carvedilol.,Carvedilol,DB00035
DB01158,Desmopressin may decrease the antihypertensive activities of Bretylium.,Bretylium,DB00035
DB01162,Desmopressin may decrease the antihypertensive activities of Terazosin.,Terazosin,DB00035
DB01193,Desmopressin may decrease the antihypertensive activities of Acebutolol.,Acebutolol,DB00035
DB01197,Desmopressin may decrease the antihypertensive activities of Captopril.,Captopril,DB00035
DB01244,Desmopressin may decrease the antihypertensive activities of Bepridil.,Bepridil,DB00035
DB01295,Desmopressin may decrease the antihypertensive activities of Bevantolol.,Bevantolol,DB00035
DB01297,Desmopressin may decrease the antihypertensive activities of Practolol.,Practolol,DB00035
DB01340,Desmopressin may decrease the antihypertensive activities of Cilazapril.,Cilazapril,DB00035
DB01347,Desmopressin may decrease the antihypertensive activities of Saprisartan.,Saprisartan,DB00035
DB01348,Desmopressin may decrease the antihypertensive activities of Spirapril.,Spirapril,DB00035
DB01388,Desmopressin may decrease the antihypertensive activities of Mibefradil.,Mibefradil,DB00035
DB01580,Desmopressin may decrease the antihypertensive activities of Oxprenolol.,Oxprenolol,DB00035
DB03322,Desmopressin may decrease the antihypertensive activities of Dexpropranolol.,Dexpropranolol,DB00035
DB04840,Desmopressin may decrease the antihypertensive activities of Debrisoquine.,Debrisoquine,DB00035
DB04846,Desmopressin may decrease the antihypertensive activities of Celiprolol.,Celiprolol,DB00035
DB04861,Desmopressin may decrease the antihypertensive activities of Nebivolol.,Nebivolol,DB00035
DB06268,Desmopressin may decrease the antihypertensive activities of Sitaxentan.,Sitaxentan,DB00035
DB06403,Desmopressin may decrease the antihypertensive activities of Ambrisentan.,Ambrisentan,DB00035
DB06445,Desmopressin may decrease the antihypertensive activities of Diethylnorspermine.,Diethylnorspermine,DB00035
DB06712,Desmopressin may decrease the antihypertensive activities of Nilvadipine.,Nilvadipine,DB00035
DB06762,Desmopressin may decrease the antihypertensive activities of Pinacidil.,Pinacidil,DB00035
DB07767,Desmopressin may decrease the antihypertensive activities of Ferulic acid.,Ferulic acid,DB00035
DB08808,Desmopressin may decrease the antihypertensive activities of Bupranolol.,Bupranolol,DB00035
DB08836,Desmopressin may decrease the antihypertensive activities of Temocapril.,Temocapril,DB00035
DB08931,Desmopressin may decrease the antihypertensive activities of Riociguat.,Riociguat,DB00035
DB08952,Desmopressin may decrease the antihypertensive activities of Indenolol.,Indenolol,DB00035
DB08960,Desmopressin may decrease the antihypertensive activities of Hexamethonium.,Hexamethonium,DB00035
DB09026,Desmopressin may decrease the antihypertensive activities of Aliskiren.,Aliskiren,DB00035
DB09206,Desmopressin may decrease the antihypertensive activities of Trimazosin.,Trimazosin,DB00035
DB09236,Desmopressin may decrease the antihypertensive activities of Lacidipine.,Lacidipine,DB00035
DB09238,Desmopressin may decrease the antihypertensive activities of Manidipine.,Manidipine,DB00035
DB09239,Desmopressin may decrease the antihypertensive activities of Niguldipine.,Niguldipine,DB00035
DB09363,Desmopressin may decrease the antihypertensive activities of Rauwolfia serpentina root.,Rauwolfia serpentina root,DB00035
DB11362,Desmopressin may decrease the antihypertensive activities of Selexipag.,Selexipag,DB00035
DB11720,Desmopressin may decrease the antihypertensive activities of Angiotensin 1-7.,Angiotensin 1-7,DB00035
DB11770,Desmopressin may decrease the antihypertensive activities of Talinolol.,Talinolol,DB00035
DB11783,Desmopressin may decrease the antihypertensive activities of Imidapril.,Imidapril,DB00035
DB12054,Desmopressin may decrease the antihypertensive activities of BQ-123.,BQ-123,DB00035
DB12093,Desmopressin may decrease the antihypertensive activities of Tetrahydropalmatine.,Tetrahydropalmatine,DB00035
DB12212,Desmopressin may decrease the antihypertensive activities of Landiolol.,Landiolol,DB00035
DB12465,Desmopressin may decrease the antihypertensive activities of Ketanserin.,Ketanserin,DB00035
DB12945,Desmopressin may decrease the antihypertensive activities of Dihydralazine.,Dihydralazine,DB00035
DB13166,Desmopressin may decrease the antihypertensive activities of Zofenopril.,Zofenopril,DB00035
DB13211,Desmopressin may decrease the antihypertensive activities of Guanoxan.,Guanoxan,DB00035
DB13312,Desmopressin may decrease the antihypertensive activities of Delapril.,Delapril,DB00035
DB13374,Desmopressin may decrease the antihypertensive activities of Vincamine.,Vincamine,DB00035
DB13400,Desmopressin may decrease the antihypertensive activities of Linsidomine.,Linsidomine,DB00035
DB13410,Desmopressin may decrease the antihypertensive activities of Guanoxabenz.,Guanoxabenz,DB00035
DB13429,Desmopressin may decrease the antihypertensive activities of Tolonidine.,Tolonidine,DB00035
DB13435,Desmopressin may decrease the antihypertensive activities of Endralazine.,Endralazine,DB00035
DB13443,Desmopressin may decrease the antihypertensive activities of Esatenolol.,Esatenolol,DB00035
DB13452,Desmopressin may decrease the antihypertensive activities of Cadralazine.,Cadralazine,DB00035
DB13508,Desmopressin may decrease the antihypertensive activities of Cloranolol.,Cloranolol,DB00035
DB13575,Desmopressin may decrease the antihypertensive activities of Bietaserpine.,Bietaserpine,DB00035
DB13604,Desmopressin may decrease the antihypertensive activities of Guanazodine.,Guanazodine,DB00035
DB13631,Desmopressin may decrease the antihypertensive activities of Methoserpidine.,Methoserpidine,DB00035
DB13757,Desmopressin may decrease the antihypertensive activities of Epanolol.,Epanolol,DB00035
DB13779,Desmopressin may decrease the antihypertensive activities of Guanoclor.,Guanoclor,DB00035
DB13919,Desmopressin may decrease the antihypertensive activities of Candesartan.,Candesartan,DB00035
DB14068,Desmopressin may decrease the antihypertensive activities of Dexniguldipine.,Dexniguldipine,DB00035
DB14094,Desmopressin may decrease the antihypertensive activities of Tocopherylquinone.,Tocopherylquinone,DB00035
DB14125,Desmopressin may decrease the antihypertensive activities of Benazeprilat.,Benazeprilat,DB00035
DB14207,Desmopressin may decrease the antihypertensive activities of Fosinoprilat.,Fosinoprilat,DB00035
DB14208,Desmopressin may decrease the antihypertensive activities of Ramiprilat.,Ramiprilat,DB00035
DB14213,Desmopressin may decrease the antihypertensive activities of Perindoprilat.,Perindoprilat,DB00035
DB14217,Desmopressin may decrease the antihypertensive activities of Quinaprilat.,Quinaprilat,DB00035
DB00193,The risk or severity of hyponatremia can be increased when Tramadol is combined with Desmopressin.,Tramadol,DB00035
DB00295,The risk or severity of hyponatremia can be increased when Morphine is combined with Desmopressin.,Morphine,DB00035
DB00318,The risk or severity of hyponatremia can be increased when Codeine is combined with Desmopressin.,Codeine,DB00035
DB00327,The risk or severity of hyponatremia can be increased when Hydromorphone is combined with Desmopressin.,Hydromorphone,DB00035
DB00333,The risk or severity of hyponatremia can be increased when Methadone is combined with Desmopressin.,Methadone,DB00035
DB00454,The risk or severity of hyponatremia can be increased when Meperidine is combined with Desmopressin.,Meperidine,DB00035
DB00497,The risk or severity of hyponatremia can be increased when Oxycodone is combined with Desmopressin.,Oxycodone,DB00035
DB00611,The risk or severity of hyponatremia can be increased when Butorphanol is combined with Desmopressin.,Butorphanol,DB00035
DB00647,The risk or severity of hyponatremia can be increased when Dextropropoxyphene is combined with Desmopressin.,Dextropropoxyphene,DB00035
DB00652,The risk or severity of hyponatremia can be increased when Pentazocine is combined with Desmopressin.,Pentazocine,DB00035
DB00704,The risk or severity of hyponatremia can be increased when Naltrexone is combined with Desmopressin.,Naltrexone,DB00035
DB00708,The risk or severity of hyponatremia can be increased when Sufentanil is combined with Desmopressin.,Sufentanil,DB00035
DB00802,The risk or severity of hyponatremia can be increased when Alfentanil is combined with Desmopressin.,Alfentanil,DB00035
DB00813,The risk or severity of hyponatremia can be increased when Fentanyl is combined with Desmopressin.,Fentanyl,DB00035
DB00844,The risk or severity of hyponatremia can be increased when Nalbuphine is combined with Desmopressin.,Nalbuphine,DB00035
DB00854,The risk or severity of hyponatremia can be increased when Levorphanol is combined with Desmopressin.,Levorphanol,DB00035
DB00899,The risk or severity of hyponatremia can be increased when Remifentanil is combined with Desmopressin.,Remifentanil,DB00035
DB00921,The risk or severity of hyponatremia can be increased when Buprenorphine is combined with Desmopressin.,Buprenorphine,DB00035
DB00956,The risk or severity of hyponatremia can be increased when Hydrocodone is combined with Desmopressin.,Hydrocodone,DB00035
DB01081,The risk or severity of hyponatremia can be increased when Diphenoxylate is combined with Desmopressin.,Diphenoxylate,DB00035
DB01192,The risk or severity of hyponatremia can be increased when Oxymorphone is combined with Desmopressin.,Oxymorphone,DB00035
DB01209,The risk or severity of hyponatremia can be increased when Dezocine is combined with Desmopressin.,Dezocine,DB00035
DB01227,The risk or severity of hyponatremia can be increased when Levacetylmethadol is combined with Desmopressin.,Levacetylmethadol,DB00035
DB01433,The risk or severity of hyponatremia can be increased when Methadyl acetate is combined with Desmopressin.,Methadyl acetate,DB00035
DB01450,The risk or severity of hyponatremia can be increased when Dihydroetorphine is combined with Desmopressin.,Dihydroetorphine,DB00035
DB01452,The risk or severity of hyponatremia can be increased when Diamorphine is combined with Desmopressin.,Diamorphine,DB00035
DB01459,The risk or severity of hyponatremia can be increased when Bezitramide is combined with Desmopressin.,Bezitramide,DB00035
DB01466,The risk or severity of hyponatremia can be increased when Ethylmorphine is combined with Desmopressin.,Ethylmorphine,DB00035
DB01497,The risk or severity of hyponatremia can be increased when Etorphine is combined with Desmopressin.,Etorphine,DB00035
DB01529,The risk or severity of hyponatremia can be increased when Dextromoramide is combined with Desmopressin.,Dextromoramide,DB00035
DB01531,The risk or severity of hyponatremia can be increased when Desomorphine is combined with Desmopressin.,Desomorphine,DB00035
DB01535,The risk or severity of hyponatremia can be increased when Carfentanil is combined with Desmopressin.,Carfentanil,DB00035
DB01551,The risk or severity of hyponatremia can be increased when Dihydrocodeine is combined with Desmopressin.,Dihydrocodeine,DB00035
DB01555,The risk or severity of hyponatremia can be increased when Alphacetylmethadol is combined with Desmopressin.,Alphacetylmethadol,DB00035
DB01565,The risk or severity of hyponatremia can be increased when Dihydromorphine is combined with Desmopressin.,Dihydromorphine,DB00035
DB06204,The risk or severity of hyponatremia can be increased when Tapentadol is combined with Desmopressin.,Tapentadol,DB00035
DB06738,The risk or severity of hyponatremia can be increased when Ketobemidone is combined with Desmopressin.,Ketobemidone,DB00035
DB08861,The risk or severity of hyponatremia can be increased when DPDPE is combined with Desmopressin.,DPDPE,DB00035
DB09174,The risk or severity of hyponatremia can be increased when Lofentanil is combined with Desmopressin.,Lofentanil,DB00035
DB09272,The risk or severity of hyponatremia can be increased when Eluxadoline is combined with Desmopressin.,Eluxadoline,DB00035
DB11130,The risk or severity of hyponatremia can be increased when Opium is combined with Desmopressin.,Opium,DB00035
DB11609,The risk or severity of hyponatremia can be increased when Normethadone is combined with Desmopressin.,Normethadone,DB00035
DB12492,The risk or severity of hyponatremia can be increased when Piritramide is combined with Desmopressin.,Piritramide,DB00035
DB13160,The risk or severity of hyponatremia can be increased when Alphaprodine is combined with Desmopressin.,Alphaprodine,DB00035
DB13454,The risk or severity of hyponatremia can be increased when Nicomorphine is combined with Desmopressin.,Nicomorphine,DB00035
DB13478,The risk or severity of hyponatremia can be increased when Meptazinol is combined with Desmopressin.,Meptazinol,DB00035
DB13605,The risk or severity of hyponatremia can be increased when Phenoperidine is combined with Desmopressin.,Phenoperidine,DB00035
DB13606,The risk or severity of hyponatremia can be increased when Phenazocine is combined with Desmopressin.,Phenazocine,DB00035
DB13787,The risk or severity of hyponatremia can be increased when Tilidine is combined with Desmopressin.,Tilidine,DB00035
DB15360,"The risk or severity of hyponatremia can be increased when Carfentanil, C-11 is combined with Desmopressin.","Carfentanil, C-11",DB00035
DB15465,The risk or severity of hyponatremia can be increased when Benzhydrocodone is combined with Desmopressin.,Benzhydrocodone,DB00035
DB00191,The risk or severity of hypertension can be increased when Desmopressin is combined with Phentermine.,Phentermine,DB00035
DB00211,The risk or severity of hypertension can be increased when Desmopressin is combined with Midodrine.,Midodrine,DB00035
DB00216,The risk or severity of hypertension can be increased when Desmopressin is combined with Eletriptan.,Eletriptan,DB00035
DB00217,The risk or severity of hypertension can be increased when Desmopressin is combined with Bethanidine.,Bethanidine,DB00035
DB00221,The risk or severity of hypertension can be increased when Desmopressin is combined with Isoetharine.,Isoetharine,DB00035
DB00246,The risk or severity of hypertension can be increased when Desmopressin is combined with Ziprasidone.,Ziprasidone,DB00035
DB00247,The risk or severity of hypertension can be increased when Desmopressin is combined with Methysergide.,Methysergide,DB00035
DB00248,The risk or severity of hypertension can be increased when Desmopressin is combined with Cabergoline.,Cabergoline,DB00035
DB00315,The risk or severity of hypertension can be increased when Desmopressin is combined with Zolmitriptan.,Zolmitriptan,DB00035
DB00320,The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergotamine.,Dihydroergotamine,DB00035
DB00353,The risk or severity of hypertension can be increased when Desmopressin is combined with Methylergometrine.,Methylergometrine,DB00035
DB00368,The risk or severity of hypertension can be increased when Desmopressin is combined with Norepinephrine.,Norepinephrine,DB00035
DB00370,The risk or severity of hypertension can be increased when Desmopressin is combined with Mirtazapine.,Mirtazapine,DB00035
DB00388,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenylephrine.,Phenylephrine,DB00035
DB00397,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenylpropanolamine.,Phenylpropanolamine,DB00035
DB00420,The risk or severity of hypertension can be increased when Desmopressin is combined with Promazine.,Promazine,DB00035
DB00450,The risk or severity of hypertension can be increased when Desmopressin is combined with Droperidol.,Droperidol,DB00035
DB00561,The risk or severity of hypertension can be increased when Desmopressin is combined with Doxapram.,Doxapram,DB00035
DB00572,The risk or severity of hypertension can be increased when Desmopressin is combined with Atropine.,Atropine,DB00035
DB00575,The risk or severity of hypertension can be increased when Desmopressin is combined with Clonidine.,Clonidine,DB00035
DB00589,The risk or severity of hypertension can be increased when Desmopressin is combined with Lisuride.,Lisuride,DB00035
DB00601,The risk or severity of hypertension can be increased when Desmopressin is combined with Linezolid.,Linezolid,DB00035
DB00610,The risk or severity of hypertension can be increased when Desmopressin is combined with Metaraminol.,Metaraminol,DB00035
DB00614,The risk or severity of hypertension can be increased when Desmopressin is combined with Furazolidone.,Furazolidone,DB00035
DB00629,The risk or severity of hypertension can be increased when Desmopressin is combined with Guanabenz.,Guanabenz,DB00035
DB00668,The risk or severity of hypertension can be increased when Desmopressin is combined with Epinephrine.,Epinephrine,DB00035
DB00679,The risk or severity of hypertension can be increased when Desmopressin is combined with Thioridazine.,Thioridazine,DB00035
DB00696,The risk or severity of hypertension can be increased when Desmopressin is combined with Ergotamine.,Ergotamine,DB00035
DB00699,The risk or severity of hypertension can be increased when Desmopressin is combined with Nicergoline.,Nicergoline,DB00035
DB00723,The risk or severity of hypertension can be increased when Desmopressin is combined with Methoxamine.,Methoxamine,DB00035
DB00734,The risk or severity of hypertension can be increased when Desmopressin is combined with Risperidone.,Risperidone,DB00035
DB00752,The risk or severity of hypertension can be increased when Desmopressin is combined with Tranylcypromine.,Tranylcypromine,DB00035
DB00753,The risk or severity of hypertension can be increased when Desmopressin is combined with Isoflurane.,Isoflurane,DB00035
DB00777,The risk or severity of hypertension can be increased when Desmopressin is combined with Propiomazine.,Propiomazine,DB00035
DB00797,The risk or severity of hypertension can be increased when Desmopressin is combined with Tolazoline.,Tolazoline,DB00035
DB00805,The risk or severity of hypertension can be increased when Desmopressin is combined with Minaprine.,Minaprine,DB00035
DB00816,The risk or severity of hypertension can be increased when Desmopressin is combined with Orciprenaline.,Orciprenaline,DB00035
DB00818,The risk or severity of hypertension can be increased when Desmopressin is combined with Propofol.,Propofol,DB00035
DB00830,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenmetrazine.,Phenmetrazine,DB00035
DB00831,The risk or severity of hypertension can be increased when Desmopressin is combined with Trifluoperazine.,Trifluoperazine,DB00035
DB00852,The risk or severity of hypertension can be increased when Desmopressin is combined with Pseudoephedrine.,Pseudoephedrine,DB00035
DB00865,The risk or severity of hypertension can be increased when Desmopressin is combined with Benzphetamine.,Benzphetamine,DB00035
DB00867,The risk or severity of hypertension can be increased when Desmopressin is combined with Ritodrine.,Ritodrine,DB00035
DB00875,The risk or severity of hypertension can be increased when Desmopressin is combined with Flupentixol.,Flupentixol,DB00035
DB00886,The risk or severity of hypertension can be increased when Desmopressin is combined with Omapatrilat.,Omapatrilat,DB00035
DB00901,The risk or severity of hypertension can be increased when Desmopressin is combined with Bitolterol.,Bitolterol,DB00035
DB00925,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenoxybenzamine.,Phenoxybenzamine,DB00035
DB00935,The risk or severity of hypertension can be increased when Desmopressin is combined with Oxymetazoline.,Oxymetazoline,DB00035
DB00937,The risk or severity of hypertension can be increased when Desmopressin is combined with Diethylpropion.,Diethylpropion,DB00035
DB00938,The risk or severity of hypertension can be increased when Desmopressin is combined with Salmeterol.,Salmeterol,DB00035
DB00952,The risk or severity of hypertension can be increased when Desmopressin is combined with Naratriptan.,Naratriptan,DB00035
DB00983,The risk or severity of hypertension can be increased when Desmopressin is combined with Formoterol.,Formoterol,DB00035
DB00998,The risk or severity of hypertension can be increased when Desmopressin is combined with Frovatriptan.,Frovatriptan,DB00035
DB01028,The risk or severity of hypertension can be increased when Desmopressin is combined with Methoxyflurane.,Methoxyflurane,DB00035
DB01037,The risk or severity of hypertension can be increased when Desmopressin is combined with Selegiline.,Selegiline,DB00035
DB01049,The risk or severity of hypertension can be increased when Desmopressin is combined with Ergoloid mesylate.,Ergoloid mesylate,DB00035
DB01064,The risk or severity of hypertension can be increased when Desmopressin is combined with Isoprenaline.,Isoprenaline,DB00035
DB01102,The risk or severity of hypertension can be increased when Desmopressin is combined with Arbutamine.,Arbutamine,DB00035
DB01126,The risk or severity of hypertension can be increased when Desmopressin is combined with Dutasteride.,Dutasteride,DB00035
DB01159,The risk or severity of hypertension can be increased when Desmopressin is combined with Halothane.,Halothane,DB00035
DB01171,The risk or severity of hypertension can be increased when Desmopressin is combined with Moclobemide.,Moclobemide,DB00035
DB01180,The risk or severity of hypertension can be increased when Desmopressin is combined with Rescinnamine.,Rescinnamine,DB00035
DB01182,The risk or severity of hypertension can be increased when Desmopressin is combined with Propafenone.,Propafenone,DB00035
DB01186,The risk or severity of hypertension can be increased when Desmopressin is combined with Pergolide.,Pergolide,DB00035
DB01189,The risk or severity of hypertension can be increased when Desmopressin is combined with Desflurane.,Desflurane,DB00035
DB01200,The risk or severity of hypertension can be increased when Desmopressin is combined with Bromocriptine.,Bromocriptine,DB00035
DB01216,The risk or severity of hypertension can be increased when Desmopressin is combined with Finasteride.,Finasteride,DB00035
DB01236,The risk or severity of hypertension can be increased when Desmopressin is combined with Sevoflurane.,Sevoflurane,DB00035
DB01238,The risk or severity of hypertension can be increased when Desmopressin is combined with Aripiprazole.,Aripiprazole,DB00035
DB01247,The risk or severity of hypertension can be increased when Desmopressin is combined with Isocarboxazid.,Isocarboxazid,DB00035
DB01253,The risk or severity of hypertension can be increased when Desmopressin is combined with Ergometrine.,Ergometrine,DB00035
DB01255,The risk or severity of hypertension can be increased when Desmopressin is combined with Lisdexamfetamine.,Lisdexamfetamine,DB00035
DB01288,The risk or severity of hypertension can be increased when Desmopressin is combined with Fenoterol.,Fenoterol,DB00035
DB01291,The risk or severity of hypertension can be increased when Desmopressin is combined with Pirbuterol.,Pirbuterol,DB00035
DB01363,The risk or severity of hypertension can be increased when Desmopressin is combined with Ephedra sinica root.,Ephedra sinica root,DB00035
DB01364,The risk or severity of hypertension can be increased when Desmopressin is combined with Ephedrine.,Ephedrine,DB00035
DB01365,The risk or severity of hypertension can be increased when Desmopressin is combined with Mephentermine.,Mephentermine,DB00035
DB01366,The risk or severity of hypertension can be increased when Desmopressin is combined with Procaterol.,Procaterol,DB00035
DB01392,The risk or severity of hypertension can be increased when Desmopressin is combined with Yohimbine.,Yohimbine,DB00035
DB01403,The risk or severity of hypertension can be increased when Desmopressin is combined with Methotrimeprazine.,Methotrimeprazine,DB00035
DB01407,The risk or severity of hypertension can be increased when Desmopressin is combined with Clenbuterol.,Clenbuterol,DB00035
DB01408,The risk or severity of hypertension can be increased when Desmopressin is combined with Bambuterol.,Bambuterol,DB00035
DB01442,The risk or severity of hypertension can be increased when Desmopressin is combined with MMDA.,MMDA,DB00035
DB01454,The risk or severity of hypertension can be increased when Desmopressin is combined with Midomafetamine.,Midomafetamine,DB00035
DB01467,"The risk or severity of hypertension can be increased when Desmopressin is combined with 2,5-Dimethoxy-4-ethylamphetamine.","2,5-Dimethoxy-4-ethylamphetamine",DB00035
DB01472,The risk or severity of hypertension can be increased when Desmopressin is combined with 4-Methoxyamphetamine.,4-Methoxyamphetamine,DB00035
DB01484,"The risk or severity of hypertension can be increased when Desmopressin is combined with 4-Bromo-2,5-dimethoxyamphetamine.","4-Bromo-2,5-dimethoxyamphetamine",DB00035
DB01509,The risk or severity of hypertension can be increased when Desmopressin is combined with Tenamfetamine.,Tenamfetamine,DB00035
DB01556,The risk or severity of hypertension can be increased when Desmopressin is combined with Chlorphentermine.,Chlorphentermine,DB00035
DB01576,The risk or severity of hypertension can be increased when Desmopressin is combined with Dextroamphetamine.,Dextroamphetamine,DB00035
DB01579,The risk or severity of hypertension can be increased when Desmopressin is combined with Phendimetrazine.,Phendimetrazine,DB00035
DB01591,The risk or severity of hypertension can be increased when Desmopressin is combined with Solifenacin.,Solifenacin,DB00035
DB01608,The risk or severity of hypertension can be increased when Desmopressin is combined with Periciazine.,Periciazine,DB00035
DB01614,The risk or severity of hypertension can be increased when Desmopressin is combined with Acepromazine.,Acepromazine,DB00035
DB01622,The risk or severity of hypertension can be increased when Desmopressin is combined with Thioproperazine.,Thioproperazine,DB00035
DB01624,The risk or severity of hypertension can be increased when Desmopressin is combined with Zuclopenthixol.,Zuclopenthixol,DB00035
DB01626,The risk or severity of hypertension can be increased when Desmopressin is combined with Pargyline.,Pargyline,DB00035
DB02032,The risk or severity of hypertension can be increased when Desmopressin is combined with Epicaptopril.,Epicaptopril,DB00035
DB04017,The risk or severity of hypertension can be increased when Desmopressin is combined with Clorgiline.,Clorgiline,DB00035
DB04581,The risk or severity of hypertension can be increased when Desmopressin is combined with 1-benzylimidazole.,1-benzylimidazole,DB00035
DB04818,The risk or severity of hypertension can be increased when Desmopressin is combined with Iproniazid.,Iproniazid,DB00035
DB04820,The risk or severity of hypertension can be increased when Desmopressin is combined with Nialamide.,Nialamide,DB00035
DB04829,The risk or severity of hypertension can be increased when Desmopressin is combined with Lysergic acid diethylamide.,Lysergic acid diethylamide,DB00035
DB04855,The risk or severity of hypertension can be increased when Desmopressin is combined with Dronedarone.,Dronedarone,DB00035
DB04908,The risk or severity of hypertension can be increased when Desmopressin is combined with Flibanserin.,Flibanserin,DB00035
DB04946,The risk or severity of hypertension can be increased when Desmopressin is combined with Iloperidone.,Iloperidone,DB00035
DB05039,The risk or severity of hypertension can be increased when Desmopressin is combined with Indacaterol.,Indacaterol,DB00035
DB05271,The risk or severity of hypertension can be increased when Desmopressin is combined with Rotigotine.,Rotigotine,DB00035
DB05395,The risk or severity of hypertension can be increased when Desmopressin is combined with Amibegron.,Amibegron,DB00035
DB05562,The risk or severity of hypertension can be increased when Desmopressin is combined with Naluzotan.,Naluzotan,DB00035
DB06016,The risk or severity of hypertension can be increased when Desmopressin is combined with Cariprazine.,Cariprazine,DB00035
DB06148,The risk or severity of hypertension can be increased when Desmopressin is combined with Mianserin.,Mianserin,DB00035
DB06152,The risk or severity of hypertension can be increased when Desmopressin is combined with Nylidrin.,Nylidrin,DB00035
DB06153,The risk or severity of hypertension can be increased when Desmopressin is combined with Pizotifen.,Pizotifen,DB00035
DB06190,The risk or severity of hypertension can be increased when Desmopressin is combined with Solabegron.,Solabegron,DB00035
DB06216,The risk or severity of hypertension can be increased when Desmopressin is combined with Asenapine.,Asenapine,DB00035
DB06654,The risk or severity of hypertension can be increased when Desmopressin is combined with Safinamide.,Safinamide,DB00035
DB06678,The risk or severity of hypertension can be increased when Desmopressin is combined with Esmirtazapine.,Esmirtazapine,DB00035
DB06684,The risk or severity of hypertension can be increased when Desmopressin is combined with Vilazodone.,Vilazodone,DB00035
DB06690,The risk or severity of hypertension can be increased when Desmopressin is combined with Nitrous oxide.,Nitrous oxide,DB00035
DB06694,The risk or severity of hypertension can be increased when Desmopressin is combined with Xylometazoline.,Xylometazoline,DB00035
DB06701,The risk or severity of hypertension can be increased when Desmopressin is combined with Dexmethylphenidate.,Dexmethylphenidate,DB00035
DB06706,The risk or severity of hypertension can be increased when Desmopressin is combined with Isometheptene.,Isometheptene,DB00035
DB06707,The risk or severity of hypertension can be increased when Desmopressin is combined with Levonordefrin.,Levonordefrin,DB00035
DB06711,The risk or severity of hypertension can be increased when Desmopressin is combined with Naphazoline.,Naphazoline,DB00035
DB06763,The risk or severity of hypertension can be increased when Desmopressin is combined with Saralasin.,Saralasin,DB00035
DB06764,The risk or severity of hypertension can be increased when Desmopressin is combined with Tetryzoline.,Tetryzoline,DB00035
DB08810,The risk or severity of hypertension can be increased when Desmopressin is combined with Cinitapride.,Cinitapride,DB00035
DB08815,The risk or severity of hypertension can be increased when Desmopressin is combined with Lurasidone.,Lurasidone,DB00035
DB08841,The risk or severity of hypertension can be increased when Desmopressin is combined with Tyramine.,Tyramine,DB00035
DB08925,The risk or severity of hypertension can be increased when Desmopressin is combined with Adrafinil.,Adrafinil,DB00035
DB08941,The risk or severity of hypertension can be increased when Desmopressin is combined with Isoxsuprine.,Isoxsuprine,DB00035
DB08950,The risk or severity of hypertension can be increased when Desmopressin is combined with Indoramin.,Indoramin,DB00035
DB08954,The risk or severity of hypertension can be increased when Desmopressin is combined with Ifenprodil.,Ifenprodil,DB00035
DB08957,The risk or severity of hypertension can be increased when Desmopressin is combined with Hexoprenaline.,Hexoprenaline,DB00035
DB08985,The risk or severity of hypertension can be increased when Desmopressin is combined with Etilefrine.,Etilefrine,DB00035
DB09061,The risk or severity of hypertension can be increased when Desmopressin is combined with Cannabidiol.,Cannabidiol,DB00035
DB09080,The risk or severity of hypertension can be increased when Desmopressin is combined with Olodaterol.,Olodaterol,DB00035
DB09128,The risk or severity of hypertension can be increased when Desmopressin is combined with Brexpiprazole.,Brexpiprazole,DB00035
DB09202,The risk or severity of hypertension can be increased when Desmopressin is combined with Cirazoline.,Cirazoline,DB00035
DB09203,The risk or severity of hypertension can be increased when Desmopressin is combined with Synephrine.,Synephrine,DB00035
DB09242,The risk or severity of hypertension can be increased when Desmopressin is combined with Moxonidine.,Moxonidine,DB00035
DB09243,The risk or severity of hypertension can be increased when Desmopressin is combined with Hydracarbazine.,Hydracarbazine,DB00035
DB09246,The risk or severity of hypertension can be increased when Desmopressin is combined with Benmoxin.,Benmoxin,DB00035
DB09248,The risk or severity of hypertension can be increased when Desmopressin is combined with Mebanazine.,Mebanazine,DB00035
DB09249,The risk or severity of hypertension can be increased when Desmopressin is combined with Octamoxin.,Octamoxin,DB00035
DB09250,The risk or severity of hypertension can be increased when Desmopressin is combined with Pheniprazine.,Pheniprazine,DB00035
DB09251,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenoxypropazine.,Phenoxypropazine,DB00035
DB09252,The risk or severity of hypertension can be increased when Desmopressin is combined with Pivhydrazine.,Pivhydrazine,DB00035
DB09253,The risk or severity of hypertension can be increased when Desmopressin is combined with Safrazine.,Safrazine,DB00035
DB09254,The risk or severity of hypertension can be increased when Desmopressin is combined with Caroxazone.,Caroxazone,DB00035
DB09273,The risk or severity of hypertension can be increased when Desmopressin is combined with Doxofylline.,Doxofylline,DB00035
DB09480,The risk or severity of hypertension can be increased when Desmopressin is combined with Iofetamine I-123.,Iofetamine I-123,DB00035
DB11124,The risk or severity of hypertension can be increased when Desmopressin is combined with Racepinephrine.,Racepinephrine,DB00035
DB11273,The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergocornine.,Dihydroergocornine,DB00035
DB11373,The risk or severity of hypertension can be increased when Desmopressin is combined with Amitraz.,Amitraz,DB00035
DB11428,The risk or severity of hypertension can be increased when Desmopressin is combined with Medetomidine.,Medetomidine,DB00035
DB11477,The risk or severity of hypertension can be increased when Desmopressin is combined with Xylazine.,Xylazine,DB00035
DB11481,The risk or severity of hypertension can be increased when Desmopressin is combined with Atipamezole.,Atipamezole,DB00035
DB11541,The risk or severity of hypertension can be increased when Desmopressin is combined with Ractopamine.,Ractopamine,DB00035
DB11543,The risk or severity of hypertension can be increased when Desmopressin is combined with Romifidine.,Romifidine,DB00035
DB11556,The risk or severity of hypertension can be increased when Desmopressin is combined with Detomidine.,Detomidine,DB00035
DB11738,The risk or severity of hypertension can be increased when Desmopressin is combined with Rilmenidine.,Rilmenidine,DB00035
DB11755,The risk or severity of hypertension can be increased when Desmopressin is combined with Tetrahydrocannabivarin.,Tetrahydrocannabivarin,DB00035
DB11785,The risk or severity of hypertension can be increased when Desmopressin is combined with Anisodamine.,Anisodamine,DB00035
DB11871,The risk or severity of hypertension can be increased when Desmopressin is combined with PF-00610355.,PF-00610355,DB00035
DB12080,The risk or severity of hypertension can be increased when Desmopressin is combined with Ritobegron.,Ritobegron,DB00035
DB12092,The risk or severity of hypertension can be increased when Desmopressin is combined with Naftopidil.,Naftopidil,DB00035
DB12100,The risk or severity of hypertension can be increased when Desmopressin is combined with Abediterol.,Abediterol,DB00035
DB12248,The risk or severity of hypertension can be increased when Desmopressin is combined with Tulobuterol.,Tulobuterol,DB00035
DB12313,The risk or severity of hypertension can be increased when Desmopressin is combined with Dopexamine.,Dopexamine,DB00035
DB12361,The risk or severity of hypertension can be increased when Desmopressin is combined with Piclozotan.,Piclozotan,DB00035
DB12371,The risk or severity of hypertension can be increased when Desmopressin is combined with Siponimod.,Siponimod,DB00035
DB12551,The risk or severity of hypertension can be increased when Desmopressin is combined with Idazoxan.,Idazoxan,DB00035
DB12661,The risk or severity of hypertension can be increased when Desmopressin is combined with Urapidil.,Urapidil,DB00035
DB12779,The risk or severity of hypertension can be increased when Desmopressin is combined with Higenamine.,Higenamine,DB00035
DB12846,The risk or severity of hypertension can be increased when Desmopressin is combined with Reproterol.,Reproterol,DB00035
DB12927,The risk or severity of hypertension can be increased when Desmopressin is combined with Theodrenaline.,Theodrenaline,DB00035
DB13064,The risk or severity of hypertension can be increased when Desmopressin is combined with Tramazoline.,Tramazoline,DB00035
DB13108,The risk or severity of hypertension can be increased when Desmopressin is combined with Mephedrone.,Mephedrone,DB00035
DB13251,The risk or severity of hypertension can be increased when Desmopressin is combined with Octopamine.,Octopamine,DB00035
DB13323,The risk or severity of hypertension can be increased when Desmopressin is combined with Trichloroethylene.,Trichloroethylene,DB00035
DB13341,The risk or severity of hypertension can be increased when Desmopressin is combined with Fenozolone.,Fenozolone,DB00035
DB13345,The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergocristine.,Dihydroergocristine,DB00035
DB13378,The risk or severity of hypertension can be increased when Desmopressin is combined with Norfenefrine.,Norfenefrine,DB00035
DB13385,The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergocryptine.,Dihydroergocryptine,DB00035
DB13398,The risk or severity of hypertension can be increased when Desmopressin is combined with Oxyfedrine.,Oxyfedrine,DB00035
DB13399,The risk or severity of hypertension can be increased when Desmopressin is combined with Terguride.,Terguride,DB00035
DB13453,The risk or severity of hypertension can be increased when Desmopressin is combined with Xenon.,Xenon,DB00035
DB13510,The risk or severity of hypertension can be increased when Desmopressin is combined with Buflomedil.,Buflomedil,DB00035
DB13520,The risk or severity of hypertension can be increased when Desmopressin is combined with Metergoline.,Metergoline,DB00035
DB13559,The risk or severity of hypertension can be increased when Desmopressin is combined with Rimiterol.,Rimiterol,DB00035
DB13598,The risk or severity of hypertension can be increased when Desmopressin is combined with Diethyl ether.,Diethyl ether,DB00035
DB13624,The risk or severity of hypertension can be increased when Desmopressin is combined with Methoxyphenamine.,Methoxyphenamine,DB00035
DB13692,The risk or severity of hypertension can be increased when Desmopressin is combined with Tretoquinol.,Tretoquinol,DB00035
DB13703,The risk or severity of hypertension can be increased when Desmopressin is combined with Gepefrine.,Gepefrine,DB00035
DB13777,The risk or severity of hypertension can be increased when Desmopressin is combined with Prenalterol.,Prenalterol,DB00035
DB13781,The risk or severity of hypertension can be increased when Desmopressin is combined with Xamoterol.,Xamoterol,DB00035
DB13852,The risk or severity of hypertension can be increased when Desmopressin is combined with Mefenorex.,Mefenorex,DB00035
DB13875,The risk or severity of hypertension can be increased when Desmopressin is combined with Harmaline.,Harmaline,DB00035
DB13917,The risk or severity of hypertension can be increased when Desmopressin is combined with Deoxyepinephrine.,Deoxyepinephrine,DB00035
DB13940,"The risk or severity of hypertension can be increased when Desmopressin is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.","2,5-Dimethoxy-4-ethylthioamphetamine",DB00035
DB14010,"The risk or severity of hypertension can be increased when Desmopressin is combined with 5-methoxy-N,N-dimethyltryptamine.","5-methoxy-N,N-dimethyltryptamine",DB00035
DB14185,The risk or severity of hypertension can be increased when Desmopressin is combined with Aripiprazole lauroxil.,Aripiprazole lauroxil,DB00035
DB14231,The risk or severity of hypertension can be increased when Desmopressin is combined with Quinoline Yellow WS.,Quinoline Yellow WS,DB00035
DB15685,The risk or severity of hypertension can be increased when Desmopressin is combined with Selpercatinib.,Selpercatinib,DB00035
DB00321,The risk or severity of hyponatremia and water intoxication can be increased when Amitriptyline is combined with Desmopressin.,Amitriptyline,DB00035
DB00344,The risk or severity of hyponatremia and water intoxication can be increased when Protriptyline is combined with Desmopressin.,Protriptyline,DB00035
DB00458,The risk or severity of hyponatremia and water intoxication can be increased when Imipramine is combined with Desmopressin.,Imipramine,DB00035
DB00540,The risk or severity of hyponatremia and water intoxication can be increased when Nortriptyline is combined with Desmopressin.,Nortriptyline,DB00035
DB00543,The risk or severity of hyponatremia and water intoxication can be increased when Amoxapine is combined with Desmopressin.,Amoxapine,DB00035
DB00726,The risk or severity of hyponatremia and water intoxication can be increased when Trimipramine is combined with Desmopressin.,Trimipramine,DB00035
DB01142,The risk or severity of hyponatremia and water intoxication can be increased when Doxepin is combined with Desmopressin.,Doxepin,DB00035
DB01151,The risk or severity of hyponatremia and water intoxication can be increased when Desipramine is combined with Desmopressin.,Desipramine,DB00035
DB01242,The risk or severity of hyponatremia and water intoxication can be increased when Clomipramine is combined with Desmopressin.,Clomipramine,DB00035
DB04836,The risk or severity of hyponatremia and water intoxication can be increased when Amineptine is combined with Desmopressin.,Amineptine,DB00035
DB08996,The risk or severity of hyponatremia and water intoxication can be increased when Dimetacrine is combined with Desmopressin.,Dimetacrine,DB00035
DB09016,The risk or severity of hyponatremia and water intoxication can be increased when Butriptyline is combined with Desmopressin.,Butriptyline,DB00035
DB09167,The risk or severity of hyponatremia and water intoxication can be increased when Dosulepin is combined with Desmopressin.,Dosulepin,DB00035
DB09289,The risk or severity of hyponatremia and water intoxication can be increased when Tianeptine is combined with Desmopressin.,Tianeptine,DB00035
DB09307,The risk or severity of hyponatremia and water intoxication can be increased when Oxaprotiline is combined with Desmopressin.,Oxaprotiline,DB00035
DB12930,The risk or severity of hyponatremia and water intoxication can be increased when Opipramol is combined with Desmopressin.,Opipramol,DB00035
DB13114,The risk or severity of hyponatremia and water intoxication can be increased when Amitriptylinoxide is combined with Desmopressin.,Amitriptylinoxide,DB00035
DB13225,The risk or severity of hyponatremia and water intoxication can be increased when Dibenzepin is combined with Desmopressin.,Dibenzepin,DB00035
DB13246,The risk or severity of hyponatremia and water intoxication can be increased when Quinupramine is combined with Desmopressin.,Quinupramine,DB00035
DB13384,The risk or severity of hyponatremia and water intoxication can be increased when Melitracen is combined with Desmopressin.,Melitracen,DB00035
DB13411,The risk or severity of hyponatremia and water intoxication can be increased when Lofepramine is combined with Desmopressin.,Lofepramine,DB00035
DB13496,The risk or severity of hyponatremia and water intoxication can be increased when Iprindole is combined with Desmopressin.,Iprindole,DB00035
DB13782,The risk or severity of hyponatremia and water intoxication can be increased when Imipramine oxide is combined with Desmopressin.,Imipramine oxide,DB00035
DB00159,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Icosapent is combined with Desmopressin.",Icosapent,DB00035
DB00244,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Mesalazine is combined with Desmopressin.",Mesalazine,DB00035
DB00328,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Indomethacin is combined with Desmopressin.",Indomethacin,DB00035
DB00461,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Nabumetone is combined with Desmopressin.",Nabumetone,DB00035
DB00465,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ketorolac is combined with Desmopressin.",Ketorolac,DB00035
DB00469,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tenoxicam is combined with Desmopressin.",Tenoxicam,DB00035
DB00482,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Celecoxib is combined with Desmopressin.",Celecoxib,DB00035
DB00500,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tolmetin is combined with Desmopressin.",Tolmetin,DB00035
DB00533,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Rofecoxib is combined with Desmopressin.",Rofecoxib,DB00035
DB00554,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Piroxicam is combined with Desmopressin.",Piroxicam,DB00035
DB00573,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Fenoprofen is combined with Desmopressin.",Fenoprofen,DB00035
DB00580,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Valdecoxib is combined with Desmopressin.",Valdecoxib,DB00035
DB00586,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Diclofenac is combined with Desmopressin.",Diclofenac,DB00035
DB00605,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Sulindac is combined with Desmopressin.",Sulindac,DB00035
DB00712,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Flurbiprofen is combined with Desmopressin.",Flurbiprofen,DB00035
DB00749,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Etodolac is combined with Desmopressin.",Etodolac,DB00035
DB00784,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Mefenamic acid is combined with Desmopressin.",Mefenamic acid,DB00035
DB00788,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Naproxen is combined with Desmopressin.",Naproxen,DB00035
DB00795,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Sulfasalazine is combined with Desmopressin.",Sulfasalazine,DB00035
DB00812,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Phenylbutazone is combined with Desmopressin.",Phenylbutazone,DB00035
DB00814,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Meloxicam is combined with Desmopressin.",Meloxicam,DB00035
DB00821,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Carprofen is combined with Desmopressin.",Carprofen,DB00035
DB00861,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Diflunisal is combined with Desmopressin.",Diflunisal,DB00035
DB00936,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Salicylic acid is combined with Desmopressin.",Salicylic acid,DB00035
DB00939,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Meclofenamic acid is combined with Desmopressin.",Meclofenamic acid,DB00035
DB00945,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Acetylsalicylic acid is combined with Desmopressin.",Acetylsalicylic acid,DB00035
DB00991,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Oxaprozin is combined with Desmopressin.",Oxaprozin,DB00035
DB01009,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ketoprofen is combined with Desmopressin.",Ketoprofen,DB00035
DB01014,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Balsalazide is combined with Desmopressin.",Balsalazide,DB00035
DB01050,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ibuprofen is combined with Desmopressin.",Ibuprofen,DB00035
DB01250,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Olsalazine is combined with Desmopressin.",Olsalazine,DB00035
DB01283,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Lumiracoxib is combined with Desmopressin.",Lumiracoxib,DB00035
DB01397,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Magnesium salicylate is combined with Desmopressin.",Magnesium salicylate,DB00035
DB01399,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Salsalate is combined with Desmopressin.",Salsalate,DB00035
DB01401,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Choline magnesium trisalicylate is combined with Desmopressin.",Choline magnesium trisalicylate,DB00035
DB01419,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Antrafenine is combined with Desmopressin.",Antrafenine,DB00035
DB01424,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Aminophenazone is combined with Desmopressin.",Aminophenazone,DB00035
DB01435,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Antipyrine is combined with Desmopressin.",Antipyrine,DB00035
DB01600,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tiaprofenic acid is combined with Desmopressin.",Tiaprofenic acid,DB00035
DB01628,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Etoricoxib is combined with Desmopressin.",Etoricoxib,DB00035
DB02224,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Taxifolin is combined with Desmopressin.",Taxifolin,DB00035
DB03585,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Oxyphenbutazone is combined with Desmopressin.",Oxyphenbutazone,DB00035
DB04552,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Niflumic acid is combined with Desmopressin.",Niflumic acid,DB00035
DB04725,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Licofelone is combined with Desmopressin.",Licofelone,DB00035
DB04743,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Nimesulide is combined with Desmopressin.",Nimesulide,DB00035
DB04812,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Benoxaprofen is combined with Desmopressin.",Benoxaprofen,DB00035
DB04817,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Metamizole is combined with Desmopressin.",Metamizole,DB00035
DB04828,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Zomepirac is combined with Desmopressin.",Zomepirac,DB00035
DB05095,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Cimicoxib is combined with Desmopressin.",Cimicoxib,DB00035
DB06725,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Lornoxicam is combined with Desmopressin.",Lornoxicam,DB00035
DB06736,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Aceclofenac is combined with Desmopressin.",Aceclofenac,DB00035
DB06737,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Zaltoprofen is combined with Desmopressin.",Zaltoprofen,DB00035
DB07402,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Azapropazone is combined with Desmopressin.",Azapropazone,DB00035
DB07477,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Felbinac is combined with Desmopressin.",Felbinac,DB00035
DB08439,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Parecoxib is combined with Desmopressin.",Parecoxib,DB00035
DB08797,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Salicylamide is combined with Desmopressin.",Salicylamide,DB00035
DB08940,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Kebuzone is combined with Desmopressin.",Kebuzone,DB00035
DB08942,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Isoxicam is combined with Desmopressin.",Isoxicam,DB00035
DB08951,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Indoprofen is combined with Desmopressin.",Indoprofen,DB00035
DB08955,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ibuproxam is combined with Desmopressin.",Ibuproxam,DB00035
DB08976,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Floctafenine is combined with Desmopressin.",Floctafenine,DB00035
DB08981,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Fenbufen is combined with Desmopressin.",Fenbufen,DB00035
DB08984,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Etofenamate is combined with Desmopressin.",Etofenamate,DB00035
DB08991,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Epirizole is combined with Desmopressin.",Epirizole,DB00035
DB09084,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Benzydamine is combined with Desmopressin.",Benzydamine,DB00035
DB09212,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Loxoprofen is combined with Desmopressin.",Loxoprofen,DB00035
DB09213,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Dexibuprofen is combined with Desmopressin.",Dexibuprofen,DB00035
DB09214,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Dexketoprofen is combined with Desmopressin.",Dexketoprofen,DB00035
DB09215,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Droxicam is combined with Desmopressin.",Droxicam,DB00035
DB09216,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tolfenamic acid is combined with Desmopressin.",Tolfenamic acid,DB00035
DB09217,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Firocoxib is combined with Desmopressin.",Firocoxib,DB00035
DB09218,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Clonixin is combined with Desmopressin.",Clonixin,DB00035
DB09285,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Morniflumate is combined with Desmopressin.",Morniflumate,DB00035
DB09288,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Propacetamol is combined with Desmopressin.",Propacetamol,DB00035
DB09295,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Talniflumate is combined with Desmopressin.",Talniflumate,DB00035
DB11455,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Robenacoxib is combined with Desmopressin.",Robenacoxib,DB00035
DB11466,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tepoxalin is combined with Desmopressin.",Tepoxalin,DB00035
DB11518,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Flunixin is combined with Desmopressin.",Flunixin,DB00035
DB12399,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Polmacoxib is combined with Desmopressin.",Polmacoxib,DB00035
DB12445,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Nitroaspirin is combined with Desmopressin.",Nitroaspirin,DB00035
DB12480,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Betulinic Acid is combined with Desmopressin.",Betulinic Acid,DB00035
DB12545,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Indobufen is combined with Desmopressin.",Indobufen,DB00035
DB12610,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ebselen is combined with Desmopressin.",Ebselen,DB00035
DB13001,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tinoridine is combined with Desmopressin.",Tinoridine,DB00035
DB13167,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Alclofenac is combined with Desmopressin.",Alclofenac,DB00035
DB13217,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Fentiazac is combined with Desmopressin.",Fentiazac,DB00035
DB13232,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Suxibuzone is combined with Desmopressin.",Suxibuzone,DB00035
DB13286,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Bumadizone is combined with Desmopressin.",Bumadizone,DB00035
DB13314,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Alminoprofen is combined with Desmopressin.",Alminoprofen,DB00035
DB13317,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Flunoxaprofen is combined with Desmopressin.",Flunoxaprofen,DB00035
DB13364,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Feprazone is combined with Desmopressin.",Feprazone,DB00035
DB13371,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Difenpiramide is combined with Desmopressin.",Difenpiramide,DB00035
DB13407,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Nifenazone is combined with Desmopressin.",Nifenazone,DB00035
DB13432,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Lonazolac is combined with Desmopressin.",Lonazolac,DB00035
DB13481,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tenidap is combined with Desmopressin.",Tenidap,DB00035
DB13501,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Bendazac is combined with Desmopressin.",Bendazac,DB00035
DB13514,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Pranoprofen is combined with Desmopressin.",Pranoprofen,DB00035
DB13524,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Propyphenazone is combined with Desmopressin.",Propyphenazone,DB00035
DB13527,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Proglumetacin is combined with Desmopressin.",Proglumetacin,DB00035
DB13538,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Guacetisal is combined with Desmopressin.",Guacetisal,DB00035
DB13544,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ethenzamide is combined with Desmopressin.",Ethenzamide,DB00035
DB13612,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Carbaspirin calcium is combined with Desmopressin.",Carbaspirin calcium,DB00035
DB13629,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Mofebutazone is combined with Desmopressin.",Mofebutazone,DB00035
DB13649,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Proquazone is combined with Desmopressin.",Proquazone,DB00035
DB13657,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Benorilate is combined with Desmopressin.",Benorilate,DB00035
DB13722,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Pirprofen is combined with Desmopressin.",Pirprofen,DB00035
DB13783,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Acemetacin is combined with Desmopressin.",Acemetacin,DB00035
DB13860,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Imidazole salicylate is combined with Desmopressin.",Imidazole salicylate,DB00035
DB14059,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when SC-236 is combined with Desmopressin.",SC-236,DB00035
DB14060,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when NS-398 is combined with Desmopressin.",NS-398,DB00035
DB14938,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Flurbiprofen axetil is combined with Desmopressin.",Flurbiprofen axetil,DB00035
DB00091,Cyclosporine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cyclosporine,DB00035
DB00229,Cefotiam may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefotiam,DB00035
DB00267,Cefmenoxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefmenoxime,DB00035
DB00274,Cefmetazole may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefmetazole,DB00035
DB00282,Pamidronic acid may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Pamidronic acid,DB00035
DB00300,Tenofovir disoproxil may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Tenofovir disoproxil,DB00035
DB00369,Cidofovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cidofovir,DB00035
DB00384,Triamterene may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Triamterene,DB00035
DB00430,Cefpiramide may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefpiramide,DB00035
DB00438,Ceftazidime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftazidime,DB00035
DB00447,Loracarbef may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Loracarbef,DB00035
DB00456,Cefalotin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefalotin,DB00035
DB00493,Cefotaxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefotaxime,DB00035
DB00529,Foscarnet may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Foscarnet,DB00035
DB00563,Methotrexate may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Methotrexate,DB00035
DB00567,Cephalexin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cephalexin,DB00035
DB00577,Valaciclovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Valaciclovir,DB00035
DB00626,Bacitracin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Bacitracin,DB00035
DB00681,Amphotericin B may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Amphotericin B,DB00035
DB00689,Cephaloglycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cephaloglycin,DB00035
DB00718,Adefovir dipivoxil may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Adefovir dipivoxil,DB00035
DB00738,Pentamidine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Pentamidine,DB00035
DB00742,Mannitol may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Mannitol,DB00035
DB00787,Acyclovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Acyclovir,DB00035
DB00833,Cefaclor may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefaclor,DB00035
DB00864,Tacrolimus may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Tacrolimus,DB00035
DB00903,Etacrynic acid may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Etacrynic acid,DB00035
DB00923,Ceforanide may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceforanide,DB00035
DB00958,Carboplatin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Carboplatin,DB00035
DB00999,Hydrochlorothiazide may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Hydrochlorothiazide,DB00035
DB01066,Cefditoren may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefditoren,DB00035
DB01072,Atazanavir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Atazanavir,DB00035
DB01111,Colistimethate may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Colistimethate,DB00035
DB01112,Cefuroxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefuroxime,DB00035
DB01139,Cefapirin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefapirin,DB00035
DB01140,Cefadroxil may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefadroxil,DB00035
DB01150,Cefprozil may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefprozil,DB00035
DB01212,Ceftriaxone may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftriaxone,DB00035
DB01326,Cefamandole may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefamandole,DB00035
DB01327,Cefazolin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefazolin,DB00035
DB01328,Cefonicid may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefonicid,DB00035
DB01329,Cefoperazone may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefoperazone,DB00035
DB01330,Cefotetan may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefotetan,DB00035
DB01331,Cefoxitin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefoxitin,DB00035
DB01332,Ceftizoxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftizoxime,DB00035
DB01333,Cefradine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefradine,DB00035
DB01413,Cefepime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefepime,DB00035
DB01414,Cefacetrile may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefacetrile,DB00035
DB01415,Ceftibuten may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftibuten,DB00035
DB01416,Cefpodoxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefpodoxime,DB00035
DB01601,Lopinavir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Lopinavir,DB00035
DB02247,Hydrolyzed Cephalothin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Hydrolyzed Cephalothin,DB00035
DB03450,Cephalothin Group may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cephalothin Group,DB00035
DB04570,Latamoxef may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Latamoxef,DB00035
DB04918,Ceftobiprole may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftobiprole,DB00035
DB06590,Ceftaroline fosamil may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftaroline fosamil,DB00035
DB09008,Cefaloridine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefaloridine,DB00035
DB09062,Cefminox may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefminox,DB00035
DB09299,Tenofovir alafenamide may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Tenofovir alafenamide,DB00035
DB11367,Cefroxadine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefroxadine,DB00035
DB11935,Flomoxef may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Flomoxef,DB00035
DB12151,Brincidofovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Brincidofovir,DB00035
DB13266,Cefatrizine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefatrizine,DB00035
DB13461,Cefcapene may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefcapene,DB00035
DB13470,Cefodizime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefodizime,DB00035
DB13499,Cefsulodin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefsulodin,DB00035
DB13504,Cefetamet may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefetamet,DB00035
DB13638,Cefbuperazone may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefbuperazone,DB00035
DB13667,Cefozopran may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefozopran,DB00035
DB13682,Cefpirome may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefpirome,DB00035
DB13778,Cefazedone may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefazedone,DB00035
DB13821,Ceftezole may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftezole,DB00035
DB13868,Adefovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Adefovir,DB00035
DB14126,Tenofovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Tenofovir,DB00035
DB14713,Inotersen may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Inotersen,DB00035
DB01438,Phenazopyridine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Phenazopyridine,DB00035
DB15066,Givosiran may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Givosiran,DB00035
DB00007,Leuprolide may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Leuprolide,DB00035
DB00014,Goserelin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Goserelin,DB00035
DB00017,Salmon calcitonin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Salmon calcitonin,DB00035
DB00041,Desmopressin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Aldesleukin,DB00035
DB00080,Desmopressin may decrease the excretion rate of Daptomycin which could result in a higher serum level.,Daptomycin,DB00035
DB00081,Desmopressin may decrease the excretion rate of Tositumomab which could result in a higher serum level.,Tositumomab,DB00035
DB00115,Desmopressin may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.,Cyanocobalamin,DB00035
DB00158,Desmopressin may decrease the excretion rate of Folic acid which could result in a higher serum level.,Folic acid,DB00035
DB00165,Desmopressin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,Pyridoxine,DB00035
DB00181,Desmopressin may decrease the excretion rate of Baclofen which could result in a higher serum level.,Baclofen,DB00035
DB00182,Desmopressin may decrease the excretion rate of Amphetamine which could result in a higher serum level.,Amphetamine,DB00035
DB00185,Desmopressin may decrease the excretion rate of Cevimeline which could result in a higher serum level.,Cevimeline,DB00035
DB00186,Desmopressin may decrease the excretion rate of Lorazepam which could result in a higher serum level.,Lorazepam,DB00035
DB00190,Desmopressin may decrease the excretion rate of Carbidopa which could result in a higher serum level.,Carbidopa,DB00035
DB00196,Desmopressin may decrease the excretion rate of Fluconazole which could result in a higher serum level.,Fluconazole,DB00035
DB00198,Desmopressin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,Oseltamivir,DB00035
DB00200,Desmopressin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,Hydroxocobalamin,DB00035
DB00206,Desmopressin may decrease the excretion rate of Reserpine which could result in a higher serum level.,Reserpine,DB00035
DB00208,Desmopressin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,Ticlopidine,DB00035
DB00213,Desmopressin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.,Pantoprazole,DB00035
DB00225,Desmopressin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,Gadodiamide,DB00035
DB00230,Desmopressin may decrease the excretion rate of Pregabalin which could result in a higher serum level.,Pregabalin,DB00035
DB00231,Desmopressin may decrease the excretion rate of Temazepam which could result in a higher serum level.,Temazepam,DB00035
DB00235,Desmopressin may decrease the excretion rate of Milrinone which could result in a higher serum level.,Milrinone,DB00035
DB00237,Desmopressin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,Butabarbital,DB00035
DB00243,Desmopressin may decrease the excretion rate of Ranolazine which could result in a higher serum level.,Ranolazine,DB00035
DB00245,Desmopressin may decrease the excretion rate of Benzatropine which could result in a higher serum level.,Benzatropine,DB00035
DB00254,Desmopressin may decrease the excretion rate of Doxycycline which could result in a higher serum level.,Doxycycline,DB00035
DB00262,Desmopressin may decrease the excretion rate of Carmustine which could result in a higher serum level.,Carmustine,DB00035
DB00264,Desmopressin may decrease the excretion rate of Metoprolol which could result in a higher serum level.,Metoprolol,DB00035
DB00270,Desmopressin may decrease the excretion rate of Isradipine which could result in a higher serum level.,Isradipine,DB00035
DB00271,Desmopressin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,Diatrizoate,DB00035
DB00273,Desmopressin may decrease the excretion rate of Topiramate which could result in a higher serum level.,Topiramate,DB00035
DB00279,Desmopressin may decrease the excretion rate of Liothyronine which could result in a higher serum level.,Liothyronine,DB00035
DB00280,Desmopressin may decrease the excretion rate of Disopyramide which could result in a higher serum level.,Disopyramide,DB00035
DB00284,Desmopressin may decrease the excretion rate of Acarbose which could result in a higher serum level.,Acarbose,DB00035
DB00285,Desmopressin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,Venlafaxine,DB00035
DB00286,Desmopressin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,Conjugated estrogens,DB00035
DB00289,Desmopressin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.,Atomoxetine,DB00035
DB00290,Desmopressin may decrease the excretion rate of Bleomycin which could result in a higher serum level.,Bleomycin,DB00035
DB00292,Desmopressin may decrease the excretion rate of Etomidate which could result in a higher serum level.,Etomidate,DB00035
DB00294,Desmopressin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,Etonogestrel,DB00035
DB00296,Desmopressin may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,Ropivacaine,DB00035
DB00303,Desmopressin may decrease the excretion rate of Ertapenem which could result in a higher serum level.,Ertapenem,DB00035
DB00308,Desmopressin may decrease the excretion rate of Ibutilide which could result in a higher serum level.,Ibutilide,DB00035
DB00312,Desmopressin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,Pentobarbital,DB00035
DB00316,Desmopressin may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,Acetaminophen,DB00035
DB00319,Desmopressin may decrease the excretion rate of Piperacillin which could result in a higher serum level.,Piperacillin,DB00035
DB00322,Desmopressin may decrease the excretion rate of Floxuridine which could result in a higher serum level.,Floxuridine,DB00035
DB00323,Desmopressin may decrease the excretion rate of Tolcapone which could result in a higher serum level.,Tolcapone,DB00035
DB00325,Desmopressin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,Nitroprusside,DB00035
DB00330,Desmopressin may decrease the excretion rate of Ethambutol which could result in a higher serum level.,Ethambutol,DB00035
DB00331,Desmopressin may decrease the excretion rate of Metformin which could result in a higher serum level.,Metformin,DB00035
DB00339,Desmopressin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,Pyrazinamide,DB00035
DB00341,Desmopressin may decrease the excretion rate of Cetirizine which could result in a higher serum level.,Cetirizine,DB00035
DB00349,Desmopressin may decrease the excretion rate of Clobazam which could result in a higher serum level.,Clobazam,DB00035
DB00351,Desmopressin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,Megestrol acetate,DB00035
DB00355,Desmopressin may decrease the excretion rate of Aztreonam which could result in a higher serum level.,Aztreonam,DB00035
DB00356,Desmopressin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,Chlorzoxazone,DB00035
DB00359,Desmopressin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,Sulfadiazine,DB00035
DB00363,Desmopressin may decrease the excretion rate of Clozapine which could result in a higher serum level.,Clozapine,DB00035
DB00364,Desmopressin may decrease the excretion rate of Sucralfate which could result in a higher serum level.,Sucralfate,DB00035
DB00372,Desmopressin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,Thiethylperazine,DB00035
DB00373,Desmopressin may decrease the excretion rate of Timolol which could result in a higher serum level.,Timolol,DB00035
DB00377,Desmopressin may decrease the excretion rate of Palonosetron which could result in a higher serum level.,Palonosetron,DB00035
DB00380,Desmopressin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,Dexrazoxane,DB00035
DB00398,Desmopressin may decrease the excretion rate of Sorafenib which could result in a higher serum level.,Sorafenib,DB00035
DB00401,Desmopressin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,Nisoldipine,DB00035
DB00402,Desmopressin may decrease the excretion rate of Eszopiclone which could result in a higher serum level.,Eszopiclone,DB00035
DB00404,Desmopressin may decrease the excretion rate of Alprazolam which could result in a higher serum level.,Alprazolam,DB00035
DB00412,Desmopressin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,Rosiglitazone,DB00035
DB00413,Desmopressin may decrease the excretion rate of Pramipexole which could result in a higher serum level.,Pramipexole,DB00035
DB00415,Desmopressin may decrease the excretion rate of Ampicillin which could result in a higher serum level.,Ampicillin,DB00035
DB00418,Desmopressin may decrease the excretion rate of Secobarbital which could result in a higher serum level.,Secobarbital,DB00035
DB00422,Desmopressin may decrease the excretion rate of Methylphenidate which could result in a higher serum level.,Methylphenidate,DB00035
DB00432,Desmopressin may decrease the excretion rate of Trifluridine which could result in a higher serum level.,Trifluridine,DB00035
DB00435,Desmopressin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,Nitric Oxide,DB00035
DB00437,Desmopressin may decrease the excretion rate of Allopurinol which could result in a higher serum level.,Allopurinol,DB00035
DB00440,Desmopressin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.,Trimethoprim,DB00035
DB00441,Desmopressin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,Gemcitabine,DB00035
DB00480,Desmopressin may decrease the excretion rate of Lenalidomide which could result in a higher serum level.,Lenalidomide,DB00035
DB00490,Desmopressin may decrease the excretion rate of Buspirone which could result in a higher serum level.,Buspirone,DB00035
DB00492,Desmopressin may decrease the excretion rate of Fosinopril which could result in a higher serum level.,Fosinopril,DB00035
DB00499,Desmopressin may decrease the excretion rate of Flutamide which could result in a higher serum level.,Flutamide,DB00035
DB00501,Desmopressin may decrease the excretion rate of Cimetidine which could result in a higher serum level.,Cimetidine,DB00035
DB00502,Desmopressin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,Haloperidol,DB00035
DB00535,Desmopressin may decrease the excretion rate of Cefdinir which could result in a higher serum level.,Cefdinir,DB00035
DB00537,Desmopressin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.,Ciprofloxacin,DB00035
DB00548,Desmopressin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.,Azelaic acid,DB00035
DB00553,Desmopressin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.,Methoxsalen,DB00035
DB00558,Desmopressin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,Zanamivir,DB00035
DB00569,Desmopressin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.,Fondaparinux,DB00035
DB00571,Desmopressin may decrease the excretion rate of Propranolol which could result in a higher serum level.,Propranolol,DB00035
DB00583,Desmopressin may decrease the excretion rate of Levocarnitine which could result in a higher serum level.,Levocarnitine,DB00035
DB00591,Desmopressin may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.,Fluocinolone acetonide,DB00035
DB00597,Desmopressin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,Gadoteridol,DB00035
DB00598,Desmopressin may decrease the excretion rate of Labetalol which could result in a higher serum level.,Labetalol,DB00035
DB00603,Desmopressin may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.,Medroxyprogesterone acetate,DB00035
DB00608,Desmopressin may decrease the excretion rate of Chloroquine which could result in a higher serum level.,Chloroquine,DB00035
DB00612,Desmopressin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,Bisoprolol,DB00035
DB00624,Desmopressin may decrease the excretion rate of Testosterone which could result in a higher serum level.,Testosterone,DB00035
DB00628,Desmopressin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.,Clorazepic acid,DB00035
DB00631,Desmopressin may decrease the excretion rate of Clofarabine which could result in a higher serum level.,Clofarabine,DB00035
DB00633,Desmopressin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.,Dexmedetomidine,DB00035
DB00635,Desmopressin may decrease the excretion rate of Prednisone which could result in a higher serum level.,Prednisone,DB00035
DB00651,Desmopressin may decrease the excretion rate of Dyphylline which could result in a higher serum level.,Dyphylline,DB00035
DB00657,Desmopressin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.,Mecamylamine,DB00035
DB00660,Desmopressin may decrease the excretion rate of Metaxalone which could result in a higher serum level.,Metaxalone,DB00035
DB00661,Desmopressin may decrease the excretion rate of Verapamil which could result in a higher serum level.,Verapamil,DB00035
DB00665,Desmopressin may decrease the excretion rate of Nilutamide which could result in a higher serum level.,Nilutamide,DB00035
DB00669,Desmopressin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.,Sumatriptan,DB00035
DB00672,Desmopressin may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.,Chlorpropamide,DB00035
DB00683,Desmopressin may decrease the excretion rate of Midazolam which could result in a higher serum level.,Midazolam,DB00035
DB00688,Desmopressin may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.,Mycophenolate mofetil,DB00035
DB00690,Desmopressin may decrease the excretion rate of Flurazepam which could result in a higher serum level.,Flurazepam,DB00035
DB00692,Desmopressin may decrease the excretion rate of Phentolamine which could result in a higher serum level.,Phentolamine,DB00035
DB00698,Desmopressin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,Nitrofurantoin,DB00035
DB00706,Desmopressin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.,Tamsulosin,DB00035
DB00709,Desmopressin may decrease the excretion rate of Lamivudine which could result in a higher serum level.,Lamivudine,DB00035
DB00713,Desmopressin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,Oxacillin,DB00035
DB00716,Desmopressin may decrease the excretion rate of Nedocromil which could result in a higher serum level.,Nedocromil,DB00035
DB00722,Desmopressin may decrease the excretion rate of Lisinopril which could result in a higher serum level.,Lisinopril,DB00035
DB00730,Desmopressin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.,Thiabendazole,DB00035
DB00731,Desmopressin may decrease the excretion rate of Nateglinide which could result in a higher serum level.,Nateglinide,DB00035
DB00733,Desmopressin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.,Pralidoxime,DB00035
DB00743,Desmopressin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,Gadobenic acid,DB00035
DB00759,Desmopressin may decrease the excretion rate of Tetracycline which could result in a higher serum level.,Tetracycline,DB00035
DB00760,Desmopressin may decrease the excretion rate of Meropenem which could result in a higher serum level.,Meropenem,DB00035
DB00761,Desmopressin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.,Potassium chloride,DB00035
DB00763,Desmopressin may decrease the excretion rate of Methimazole which could result in a higher serum level.,Methimazole,DB00035
DB00775,Desmopressin may decrease the excretion rate of Tirofiban which could result in a higher serum level.,Tirofiban,DB00035
DB00780,Desmopressin may decrease the excretion rate of Phenelzine which could result in a higher serum level.,Phenelzine,DB00035
DB00782,Desmopressin may decrease the excretion rate of Propantheline which could result in a higher serum level.,Propantheline,DB00035
DB00783,Desmopressin may decrease the excretion rate of Estradiol which could result in a higher serum level.,Estradiol,DB00035
DB00789,Desmopressin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,Gadopentetic acid,DB00035
DB00790,Desmopressin may decrease the excretion rate of Perindopril which could result in a higher serum level.,Perindopril,DB00035
DB00800,Desmopressin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.,Fenoldopam,DB00035
DB00804,Desmopressin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.,Dicyclomine,DB00035
DB00806,Desmopressin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.,Pentoxifylline,DB00035
DB00811,Desmopressin may decrease the excretion rate of Ribavirin which could result in a higher serum level.,Ribavirin,DB00035
DB00820,Desmopressin may decrease the excretion rate of Tadalafil which could result in a higher serum level.,Tadalafil,DB00035
DB00828,Desmopressin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.,Fosfomycin,DB00035
DB00829,Desmopressin may decrease the excretion rate of Diazepam which could result in a higher serum level.,Diazepam,DB00035
DB00839,Desmopressin may decrease the excretion rate of Tolazamide which could result in a higher serum level.,Tolazamide,DB00035
DB00841,Desmopressin may decrease the excretion rate of Dobutamine which could result in a higher serum level.,Dobutamine,DB00035
DB00842,Desmopressin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,Oxazepam,DB00035
DB00851,Desmopressin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,Dacarbazine,DB00035
DB00853,Desmopressin may decrease the excretion rate of Temozolomide which could result in a higher serum level.,Temozolomide,DB00035
DB00863,Desmopressin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,Ranitidine,DB00035
DB00871,Desmopressin may decrease the excretion rate of Terbutaline which could result in a higher serum level.,Terbutaline,DB00035
DB00894,Desmopressin may decrease the excretion rate of Testolactone which could result in a higher serum level.,Testolactone,DB00035
DB00897,Desmopressin may decrease the excretion rate of Triazolam which could result in a higher serum level.,Triazolam,DB00035
DB00900,Desmopressin may decrease the excretion rate of Didanosine which could result in a higher serum level.,Didanosine,DB00035
DB00911,Desmopressin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,Tinidazole,DB00035
DB00915,Desmopressin may decrease the excretion rate of Amantadine which could result in a higher serum level.,Amantadine,DB00035
DB00918,Desmopressin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,Almotriptan,DB00035
DB00928,Desmopressin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,Azacitidine,DB00035
DB00934,Desmopressin may decrease the excretion rate of Maprotiline which could result in a higher serum level.,Maprotiline,DB00035
DB00951,Desmopressin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,Isoniazid,DB00035
DB00953,Desmopressin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,Rizatriptan,DB00035
DB00960,Desmopressin may decrease the excretion rate of Pindolol which could result in a higher serum level.,Pindolol,DB00035
DB00961,Desmopressin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,Mepivacaine,DB00035
DB00962,Desmopressin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,Zaleplon,DB00035
DB00968,Desmopressin may decrease the excretion rate of Methyldopa which could result in a higher serum level.,Methyldopa,DB00035
DB00980,Desmopressin may decrease the excretion rate of Ramelteon which could result in a higher serum level.,Ramelteon,DB00035
DB00988,Desmopressin may decrease the excretion rate of Dopamine which could result in a higher serum level.,Dopamine,DB00035
DB00993,Desmopressin may decrease the excretion rate of Azathioprine which could result in a higher serum level.,Azathioprine,DB00035
DB00995,Desmopressin may decrease the excretion rate of Auranofin which could result in a higher serum level.,Auranofin,DB00035
DB01001,Desmopressin may decrease the excretion rate of Salbutamol which could result in a higher serum level.,Salbutamol,DB00035
DB01002,Desmopressin may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,Levobupivacaine,DB00035
DB01004,Desmopressin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,Ganciclovir,DB00035
DB01010,Desmopressin may decrease the excretion rate of Edrophonium which could result in a higher serum level.,Edrophonium,DB00035
DB01011,Desmopressin may decrease the excretion rate of Metyrapone which could result in a higher serum level.,Metyrapone,DB00035
DB01015,Desmopressin may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,Sulfamethoxazole,DB00035
DB01018,Desmopressin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,Guanfacine,DB00035
DB01020,Desmopressin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,Isosorbide mononitrate,DB00035
DB01022,Desmopressin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,Phylloquinone,DB00035
DB01024,Desmopressin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,Mycophenolic acid,DB00035
DB01030,Desmopressin may decrease the excretion rate of Topotecan which could result in a higher serum level.,Topotecan,DB00035
DB01032,Desmopressin may decrease the excretion rate of Probenecid which could result in a higher serum level.,Probenecid,DB00035
DB01036,Desmopressin may decrease the excretion rate of Tolterodine which could result in a higher serum level.,Tolterodine,DB00035
DB01039,Desmopressin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.,Fenofibrate,DB00035
DB01043,Desmopressin may decrease the excretion rate of Memantine which could result in a higher serum level.,Memantine,DB00035
DB01046,Desmopressin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.,Lubiprostone,DB00035
DB01048,Desmopressin may decrease the excretion rate of Abacavir which could result in a higher serum level.,Abacavir,DB00035
DB01060,Desmopressin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.,Amoxicillin,DB00035
DB01067,Desmopressin may decrease the excretion rate of Glipizide which could result in a higher serum level.,Glipizide,DB00035
DB01068,Desmopressin may decrease the excretion rate of Clonazepam which could result in a higher serum level.,Clonazepam,DB00035
DB01069,Desmopressin may decrease the excretion rate of Promethazine which could result in a higher serum level.,Promethazine,DB00035
DB01093,Desmopressin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.,Dimethyl sulfoxide,DB00035
DB01099,Desmopressin may decrease the excretion rate of Flucytosine which could result in a higher serum level.,Flucytosine,DB00035
DB01101,Desmopressin may decrease the excretion rate of Capecitabine which could result in a higher serum level.,Capecitabine,DB00035
DB01115,Desmopressin may decrease the excretion rate of Nifedipine which could result in a higher serum level.,Nifedipine,DB00035
DB01124,Desmopressin may decrease the excretion rate of Tolbutamide which could result in a higher serum level.,Tolbutamide,DB00035
DB01129,Desmopressin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.,Rabeprazole,DB00035
DB01133,Desmopressin may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.,Tiludronic acid,DB00035
DB01135,Desmopressin may decrease the excretion rate of Doxacurium which could result in a higher serum level.,Doxacurium,DB00035
DB01137,Desmopressin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.,Levofloxacin,DB00035
DB01148,Desmopressin may decrease the excretion rate of Flavoxate which could result in a higher serum level.,Flavoxate,DB00035
DB01156,Desmopressin may decrease the excretion rate of Bupropion which could result in a higher serum level.,Bupropion,DB00035
DB01157,Desmopressin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.,Trimetrexate,DB00035
DB01166,Desmopressin may decrease the excretion rate of Cilostazol which could result in a higher serum level.,Cilostazol,DB00035
DB01169,Desmopressin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,Arsenic trioxide,DB00035
DB01170,Desmopressin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,Guanethidine,DB00035
DB01181,Desmopressin may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,Ifosfamide,DB00035
DB01203,Desmopressin may decrease the excretion rate of Nadolol which could result in a higher serum level.,Nadolol,DB00035
DB01205,Desmopressin may decrease the excretion rate of Flumazenil which could result in a higher serum level.,Flumazenil,DB00035
DB01213,Desmopressin may decrease the excretion rate of Fomepizole which could result in a higher serum level.,Fomepizole,DB00035
DB01215,Desmopressin may decrease the excretion rate of Estazolam which could result in a higher serum level.,Estazolam,DB00035
DB01221,Desmopressin may decrease the excretion rate of Ketamine which could result in a higher serum level.,Ketamine,DB00035
DB01222,Desmopressin may decrease the excretion rate of Budesonide which could result in a higher serum level.,Budesonide,DB00035
DB01224,Desmopressin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,Quetiapine,DB00035
DB01233,Desmopressin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,Metoclopramide,DB00035
DB01240,Desmopressin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,Epoprostenol,DB00035
DB01241,Desmopressin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,Gemfibrozil,DB00035
DB01249,Desmopressin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,Iodixanol,DB00035
DB01261,Desmopressin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,Sitagliptin,DB00035
DB01267,Desmopressin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,Paliperidone,DB00035
DB01273,Desmopressin may decrease the excretion rate of Varenicline which could result in a higher serum level.,Varenicline,DB00035
DB01274,Desmopressin may decrease the excretion rate of Arformoterol which could result in a higher serum level.,Arformoterol,DB00035
DB01275,Desmopressin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,Hydralazine,DB00035
DB01359,Desmopressin may decrease the excretion rate of Penbutolol which could result in a higher serum level.,Penbutolol,DB00035
DB01367,Desmopressin may decrease the excretion rate of Rasagiline which could result in a higher serum level.,Rasagiline,DB00035
DB01394,Desmopressin may decrease the excretion rate of Colchicine which could result in a higher serum level.,Colchicine,DB00035
DB01409,Desmopressin may decrease the excretion rate of Tiotropium which could result in a higher serum level.,Tiotropium,DB00035
DB01420,Desmopressin may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.,Testosterone propionate,DB00035
DB01427,Desmopressin may decrease the excretion rate of Amrinone which could result in a higher serum level.,Amrinone,DB00035
DB01428,Desmopressin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,Oxybenzone,DB00035
DB01431,Desmopressin may decrease the excretion rate of Allylestrenol which could result in a higher serum level.,Allylestrenol,DB00035
DB01550,Desmopressin may decrease the excretion rate of Fenproporex which could result in a higher serum level.,Fenproporex,DB00035
DB01558,Desmopressin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,Bromazepam,DB00035
DB01563,Desmopressin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.,Chloral hydrate,DB00035
DB01577,Desmopressin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.,Metamfetamine,DB00035
DB01587,Desmopressin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,Ketazolam,DB00035
DB01610,Desmopressin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,Valganciclovir,DB00035
DB01638,Desmopressin may decrease the excretion rate of Sorbitol which could result in a higher serum level.,Sorbitol,DB00035
DB01656,Desmopressin may decrease the excretion rate of Roflumilast which could result in a higher serum level.,Roflumilast,DB00035
DB01685,Desmopressin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,Topiroxostat,DB00035
DB04574,Desmopressin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,Estrone sulfate,DB00035
DB04871,Desmopressin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,Lorcaserin,DB00035
DB04895,Desmopressin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,Pegaptanib,DB00035
DB04920,Desmopressin may decrease the excretion rate of Clevidipine which could result in a higher serum level.,Clevidipine,DB00035
DB04948,Desmopressin may decrease the excretion rate of Lofexidine which could result in a higher serum level.,Lofexidine,DB00035
DB04953,Desmopressin may decrease the excretion rate of Ezogabine which could result in a higher serum level.,Ezogabine,DB00035
DB05018,Desmopressin may decrease the excretion rate of Migalastat which could result in a higher serum level.,Migalastat,DB00035
DB05541,Desmopressin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,Brivaracetam,DB00035
DB05676,Desmopressin may decrease the excretion rate of Apremilast which could result in a higher serum level.,Apremilast,DB00035
DB06154,Desmopressin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,Pentaerythritol tetranitrate,DB00035
DB06186,Desmopressin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,Ipilimumab,DB00035
DB06196,Desmopressin may decrease the excretion rate of Icatibant which could result in a higher serum level.,Icatibant,DB00035
DB06203,Desmopressin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,Alogliptin,DB00035
DB06209,Desmopressin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,Prasugrel,DB00035
DB06211,Desmopressin may decrease the excretion rate of Doripenem which could result in a higher serum level.,Doripenem,DB00035
DB06228,Desmopressin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,Rivaroxaban,DB00035
DB06230,Desmopressin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,Nalmefene,DB00035
DB06262,Desmopressin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,Droxidopa,DB00035
DB06282,Desmopressin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,Levocetirizine,DB00035
DB06335,Desmopressin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,Saxagliptin,DB00035
DB06402,Desmopressin may decrease the excretion rate of Telavancin which could result in a higher serum level.,Telavancin,DB00035
DB06480,Desmopressin may decrease the excretion rate of Prucalopride which could result in a higher serum level.,Prucalopride,DB00035
DB06623,Desmopressin may decrease the excretion rate of Flupirtine which could result in a higher serum level.,Flupirtine,DB00035
DB06637,Desmopressin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,Dalfampridine,DB00035
DB06695,Desmopressin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,Dabigatran etexilate,DB00035
DB06702,Desmopressin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,Fesoterodine,DB00035
DB06705,Desmopressin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,Gadofosveset trisodium,DB00035
DB06710,Desmopressin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,Methyltestosterone,DB00035
DB06767,Desmopressin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,Ammonium chloride,DB00035
DB06782,Desmopressin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,Dimercaprol,DB00035
DB06796,Desmopressin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,Mangafodipir,DB00035
DB06800,Desmopressin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,Methylnaltrexone,DB00035
DB06809,Desmopressin may decrease the excretion rate of Plerixafor which could result in a higher serum level.,Plerixafor,DB00035
DB06813,Desmopressin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,Pralatrexate,DB00035
DB06823,Desmopressin may decrease the excretion rate of Tiopronin which could result in a higher serum level.,Tiopronin,DB00035
DB06824,Desmopressin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,Triethylenetetramine,DB00035
DB08824,Desmopressin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,Ioflupane I-123,DB00035
DB08826,Desmopressin may decrease the excretion rate of Deferiprone which could result in a higher serum level.,Deferiprone,DB00035
DB08840,Desmopressin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,N-methylnicotinamide,DB00035
DB08872,Desmopressin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,Gabapentin enacarbil,DB00035
DB08877,Desmopressin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,Ruxolitinib,DB00035
DB08893,Desmopressin may decrease the excretion rate of Mirabegron which could result in a higher serum level.,Mirabegron,DB00035
DB08894,Desmopressin may decrease the excretion rate of Peginesatide which could result in a higher serum level.,Peginesatide,DB00035
DB08897,Desmopressin may decrease the excretion rate of Aclidinium which could result in a higher serum level.,Aclidinium,DB00035
DB08899,Desmopressin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,Enzalutamide,DB00035
DB08900,Desmopressin may decrease the excretion rate of Teduglutide which could result in a higher serum level.,Teduglutide,DB00035
DB08904,Desmopressin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,Certolizumab pegol,DB00035
DB08905,Desmopressin may decrease the excretion rate of Formestane which could result in a higher serum level.,Formestane,DB00035
DB08909,Desmopressin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,Glycerol phenylbutyrate,DB00035
DB08910,Desmopressin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,Pomalidomide,DB00035
DB08911,Desmopressin may decrease the excretion rate of Trametinib which could result in a higher serum level.,Trametinib,DB00035
DB08932,Desmopressin may decrease the excretion rate of Macitentan which could result in a higher serum level.,Macitentan,DB00035
DB08934,Desmopressin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,Sofosbuvir,DB00035
DB08964,Desmopressin may decrease the excretion rate of Gemeprost which could result in a higher serum level.,Gemeprost,DB00035
DB09027,Desmopressin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,Ledipasvir,DB00035
DB09050,Desmopressin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,Ceftolozane,DB00035
DB09066,Desmopressin may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,Corifollitropin alfa,DB00035
DB09068,Desmopressin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,Vortioxetine,DB00035
DB09071,Desmopressin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,Tasimelteon,DB00035
DB09075,Desmopressin may decrease the excretion rate of Edoxaban which could result in a higher serum level.,Edoxaban,DB00035
DB09081,Desmopressin may decrease the excretion rate of Idebenone which could result in a higher serum level.,Idebenone,DB00035
DB09082,Desmopressin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,Vilanterol,DB00035
DB09089,Desmopressin may decrease the excretion rate of Trimebutine which could result in a higher serum level.,Trimebutine,DB00035
DB09091,Desmopressin may decrease the excretion rate of Tixocortol which could result in a higher serum level.,Tixocortol,DB00035
DB09103,Desmopressin may decrease the excretion rate of Ancestim which could result in a higher serum level.,Ancestim,DB00035
DB09104,Desmopressin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.,Magnesium hydroxide,DB00035
DB09106,Desmopressin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,Hydroxyethyl Starch,DB00035
DB09111,Desmopressin may decrease the excretion rate of Pentastarch which could result in a higher serum level.,Pentastarch,DB00035
DB09118,Desmopressin may decrease the excretion rate of Stiripentol which could result in a higher serum level.,Stiripentol,DB00035
DB09121,Desmopressin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.,Aurothioglucose,DB00035
DB09123,Desmopressin may decrease the excretion rate of Dienogest which could result in a higher serum level.,Dienogest,DB00035
DB09129,Desmopressin may decrease the excretion rate of Chromic chloride which could result in a higher serum level.,Chromic chloride,DB00035
DB09132,Desmopressin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,Gadoteric acid,DB00035
DB09133,Desmopressin may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.,Iothalamic acid,DB00035
DB09134,Desmopressin may decrease the excretion rate of Ioversol which could result in a higher serum level.,Ioversol,DB00035
DB09135,Desmopressin may decrease the excretion rate of Ioxilan which could result in a higher serum level.,Ioxilan,DB00035
DB09136,Desmopressin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.,Isosulfan blue,DB00035
DB09137,Desmopressin may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.,Technetium Tc-99m mebrofenin,DB00035
DB09139,Desmopressin may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.,Technetium Tc-99m oxidronate,DB00035
DB09148,Desmopressin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.,Florbetaben (18F),DB00035
DB09149,Desmopressin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.,Florbetapir (18F),DB00035
DB09156,Desmopressin may decrease the excretion rate of Iopromide which could result in a higher serum level.,Iopromide,DB00035
DB09163,Desmopressin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.,Technetium Tc-99m exametazime,DB00035
DB09165,Desmopressin may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.,Technetium Tc-99m pyrophosphate,DB00035
DB09185,Desmopressin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,Viloxazine,DB00035
DB09194,Desmopressin may decrease the excretion rate of Etoperidone which could result in a higher serum level.,Etoperidone,DB00035
DB09195,Desmopressin may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.,Lorpiprazole,DB00035
DB09204,Desmopressin may decrease the excretion rate of Arotinolol which could result in a higher serum level.,Arotinolol,DB00035
DB09205,Desmopressin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.,Moxisylyte,DB00035
DB09209,Desmopressin may decrease the excretion rate of Pholcodine which could result in a higher serum level.,Pholcodine,DB00035
DB09210,Desmopressin may decrease the excretion rate of Piracetam which could result in a higher serum level.,Piracetam,DB00035
DB09219,Desmopressin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,Bisoxatin,DB00035
DB09220,Desmopressin may decrease the excretion rate of Nicorandil which could result in a higher serum level.,Nicorandil,DB00035
DB09223,Desmopressin may decrease the excretion rate of Blonanserin which could result in a higher serum level.,Blonanserin,DB00035
DB09224,Desmopressin may decrease the excretion rate of Melperone which could result in a higher serum level.,Melperone,DB00035
DB09241,Desmopressin may decrease the excretion rate of Methylene blue which could result in a higher serum level.,Methylene blue,DB00035
DB09244,Desmopressin may decrease the excretion rate of Pirlindole which could result in a higher serum level.,Pirlindole,DB00035
DB09245,Desmopressin may decrease the excretion rate of Toloxatone which could result in a higher serum level.,Toloxatone,DB00035
DB09255,Desmopressin may decrease the excretion rate of Dextran which could result in a higher serum level.,Dextran,DB00035
DB09256,Desmopressin may decrease the excretion rate of Tegafur which could result in a higher serum level.,Tegafur,DB00035
DB09257,Desmopressin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,Gimeracil,DB00035
DB09262,Desmopressin may decrease the excretion rate of Imidafenacin which could result in a higher serum level.,Imidafenacin,DB00035
DB09264,Desmopressin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.,Idarucizumab,DB00035
DB09265,Desmopressin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.,Lixisenatide,DB00035
DB09268,Desmopressin may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.,Picosulfuric acid,DB00035
DB09276,Desmopressin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.,Sodium aurothiomalate,DB00035
DB09277,Desmopressin may decrease the excretion rate of Choline C 11 which could result in a higher serum level.,Choline C 11,DB00035
DB09281,Desmopressin may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.,Magnesium trisilicate,DB00035
DB09292,Desmopressin may decrease the excretion rate of Sacubitril which could result in a higher serum level.,Sacubitril,DB00035
DB09301,Desmopressin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.,Chondroitin sulfate,DB00035
DB09317,"Desmopressin may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.","Synthetic Conjugated Estrogens, A",DB00035
DB09318,"Desmopressin may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.","Synthetic Conjugated Estrogens, B",DB00035
DB09320,Desmopressin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.,Procaine benzylpenicillin,DB00035
DB09324,Desmopressin may decrease the excretion rate of Sulbactam which could result in a higher serum level.,Sulbactam,DB00035
DB09325,Desmopressin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.,Sodium fluoride,DB00035
DB09329,"Desmopressin may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.","Antihemophilic Factor (Recombinant), PEGylated",DB00035
DB09344,Desmopressin may decrease the excretion rate of Invert sugar which could result in a higher serum level.,Invert sugar,DB00035
DB09357,Desmopressin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.,Dexpanthenol,DB00035
DB09394,Desmopressin may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.,Phosphoric acid,DB00035
DB09395,Desmopressin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.,Sodium acetate,DB00035
DB09407,Desmopressin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.,Magnesium chloride,DB00035
DB09418,Desmopressin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.,Potassium perchlorate,DB00035
DB09472,Desmopressin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.,Sodium sulfate,DB00035
DB09477,Desmopressin may decrease the excretion rate of Enalaprilat which could result in a higher serum level.,Enalaprilat,DB00035
DB09481,Desmopressin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.,Magnesium carbonate,DB00035
DB09488,Desmopressin may decrease the excretion rate of Acrivastine which could result in a higher serum level.,Acrivastine,DB00035
DB09496,Desmopressin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,Octinoxate,DB00035
DB09502,Desmopressin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.,Fludeoxyglucose (18F),DB00035
DB09546,Desmopressin may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.,Iobenguane sulfate I-123,DB00035
DB09570,Desmopressin may decrease the excretion rate of Ixazomib which could result in a higher serum level.,Ixazomib,DB00035
DB11077,Desmopressin may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.,Polyethylene glycol 400,DB00035
DB11090,Desmopressin may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.,Potassium nitrate,DB00035
DB11098,Desmopressin may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.,Potassium bicarbonate,DB00035
DB11102,Desmopressin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,N-acetyltyrosine,DB00035
DB11114,Desmopressin may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.,Eucalyptus oil,DB00035
DB11127,Desmopressin may decrease the excretion rate of Selenious acid which could result in a higher serum level.,Selenious acid,DB00035
DB11135,Desmopressin may decrease the excretion rate of Selenium which could result in a higher serum level.,Selenium,DB00035
DB11136,Desmopressin may decrease the excretion rate of Chromium which could result in a higher serum level.,Chromium,DB00035
DB11145,Desmopressin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,Oxyquinoline,DB00035
DB11156,Desmopressin may decrease the excretion rate of Pyrantel which could result in a higher serum level.,Pyrantel,DB00035
DB11164,Desmopressin may decrease the excretion rate of Bicisate which could result in a higher serum level.,Bicisate,DB00035
DB11251,Desmopressin may decrease the excretion rate of Tocopherol which could result in a higher serum level.,Tocopherol,DB00035
DB11278,Desmopressin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.,DL-Methylephedrine,DB00035
DB11328,Desmopressin may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.,Tetradecyl hydrogen sulfate (ester),DB00035
DB11338,Desmopressin may decrease the excretion rate of Clove oil which could result in a higher serum level.,Clove oil,DB00035
DB11358,Desmopressin may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.,Evening primrose oil,DB00035
DB11364,Desmopressin may decrease the excretion rate of Pidotimod which could result in a higher serum level.,Pidotimod,DB00035
DB11560,Desmopressin may decrease the excretion rate of Lesinurad which could result in a higher serum level.,Lesinurad,DB00035
DB11577,Desmopressin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.,Indigotindisulfonic acid,DB00035
DB11587,Desmopressin may decrease the excretion rate of Etafedrine which could result in a higher serum level.,Etafedrine,DB00035
DB11598,Desmopressin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.,Antithrombin III human,DB00035
DB11642,Desmopressin may decrease the excretion rate of Pitolisant which could result in a higher serum level.,Pitolisant,DB00035
DB11691,Desmopressin may decrease the excretion rate of Naldemedine which could result in a higher serum level.,Naldemedine,DB00035
DB11699,Desmopressin may decrease the excretion rate of Tropisetron which could result in a higher serum level.,Tropisetron,DB00035
DB11817,Desmopressin may decrease the excretion rate of Baricitinib which could result in a higher serum level.,Baricitinib,DB00035
DB11901,Desmopressin may decrease the excretion rate of Apalutamide which could result in a higher serum level.,Apalutamide,DB00035
DB11915,Desmopressin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,Valbenazine,DB00035
DB11943,Desmopressin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.,Delafloxacin,DB00035
DB11989,Desmopressin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,Benznidazole,DB00035
DB12007,Desmopressin may decrease the excretion rate of Isoflavone which could result in a higher serum level.,Isoflavone,DB00035
DB12107,Desmopressin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,Vaborbactam,DB00035
DB12161,Desmopressin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.,Deutetrabenazine,DB00035
DB12278,Desmopressin may decrease the excretion rate of Propiverine which could result in a higher serum level.,Propiverine,DB00035
DB12783,Desmopressin may decrease the excretion rate of Benserazide which could result in a higher serum level.,Benserazide,DB00035
DB13025,Desmopressin may decrease the excretion rate of Tiapride which could result in a higher serum level.,Tiapride,DB00035
DB13139,Desmopressin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,Levosalbutamol,DB00035
DB13156,Desmopressin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.,Inosine pranobex,DB00035
DB13178,Desmopressin may decrease the excretion rate of Inositol which could result in a higher serum level.,Inositol,DB00035
DB13185,Desmopressin may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.,Oxabolone cipionate,DB00035
DB13191,Desmopressin may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.,Phosphocreatine,DB00035
DB13269,Desmopressin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.,Dichlorobenzyl alcohol,DB00035
DB13293,Desmopressin may decrease the excretion rate of Ipecac which could result in a higher serum level.,Ipecac,DB00035
DB13595,Desmopressin may decrease the excretion rate of Almasilate which could result in a higher serum level.,Almasilate,DB00035
DB13873,Desmopressin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.,Fenofibric acid,DB00035
DB13884,Desmopressin may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.,Albutrepenonacog alfa,DB00035
DB13909,Desmopressin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,Bismuth subgallate,DB00035
DB13943,Desmopressin may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.,Testosterone cypionate,DB00035
DB13944,Desmopressin may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.,Testosterone enanthate,DB00035
DB13952,Desmopressin may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.,Estradiol acetate,DB00035
DB13954,Desmopressin may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.,Estradiol cypionate,DB00035
DB13955,Desmopressin may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.,Estradiol dienanthate,DB00035
DB13956,Desmopressin may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.,Estradiol valerate,DB00035
DB13967,Desmopressin may decrease the excretion rate of Patent Blue which could result in a higher serum level.,Patent Blue,DB00035
DB14006,Desmopressin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.,Choline salicylate,DB00035
DB14007,Desmopressin may decrease the excretion rate of Pentetic acid which could result in a higher serum level.,Pentetic acid,DB00035
DB14498,Desmopressin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.,Potassium acetate,DB00035
DB14499,Desmopressin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.,Potassium sulfate,DB00035
DB14526,Desmopressin may decrease the excretion rate of Chromic citrate which could result in a higher serum level.,Chromic citrate,DB00035
DB14527,Desmopressin may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.,Chromic nitrate,DB00035
DB14528,Desmopressin may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.,Chromium gluconate,DB00035
DB14529,Desmopressin may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.,Chromium nicotinate,DB00035
DB14530,Desmopressin may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.,Chromous sulfate,DB00035
DB06815,Desmopressin may decrease the excretion rate of Pyrithione which could result in a higher serum level.,Pyrithione,DB00035
DB11121,Desmopressin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.,Chloroxylenol,DB00035
DB01183,Desmopressin may decrease the excretion rate of Naloxone which could result in a higher serum level.,Naloxone,DB00035
DB11085,Desmopressin may decrease the excretion rate of Resorcinol which could result in a higher serum level.,Resorcinol,DB00035
DB15593,Desmopressin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,Golodirsen,DB00035
DB00879,Desmopressin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.,Emtricitabine,DB00035
DB00452,Framycetin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Framycetin,DB00035
DB00479,Amikacin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Amikacin,DB00035
DB00684,Tobramycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Tobramycin,DB00035
DB00798,Gentamicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Gentamicin,DB00035
DB00955,Netilmicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Netilmicin,DB00035
DB00994,Neomycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Neomycin,DB00035
DB01082,Streptomycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Streptomycin,DB00035
DB01172,Kanamycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Kanamycin,DB00035
DB01421,Paromomycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Paromomycin,DB00035
DB03615,Ribostamycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ribostamycin,DB00035
DB04263,Geneticin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Geneticin,DB00035
DB04626,Apramycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Apramycin,DB00035
DB04729,Gentamicin C1a may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Gentamicin C1a,DB00035
DB04808,Neamine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Neamine,DB00035
DB06696,Arbekacin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Arbekacin,DB00035
DB08437,Puromycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Puromycin,DB00035
DB11512,Dihydrostreptomycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Dihydrostreptomycin,DB00035
DB11520,Hygromycin B may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Hygromycin B,DB00035
DB12604,Sisomicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Sisomicin,DB00035
DB13270,Dibekacin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Dibekacin,DB00035
DB13274,Micronomicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Micronomicin,DB00035
DB13540,Isepamicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Isepamicin,DB00035
DB13673,Bekanamycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Bekanamycin,DB00035
DB00552,Desmopressin may decrease the excretion rate of Pentostatin which could result in a higher serum level.,Pentostatin,DB00035
DB13145,Desmopressin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,Nedaplatin,DB00035
DB00314,Desmopressin may decrease the excretion rate of Capreomycin which could result in a higher serum level.,Capreomycin,DB00035
DB00390,Desmopressin may decrease the excretion rate of Digoxin which could result in a higher serum level.,Digoxin,DB00035
DB00512,Desmopressin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,Vancomycin,DB00035
DB00515,Desmopressin may decrease the excretion rate of Cisplatin which could result in a higher serum level.,Cisplatin,DB00035
DB00642,Desmopressin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.,Pemetrexed,DB00035
DB00682,Desmopressin may decrease the excretion rate of Warfarin which could result in a higher serum level.,Warfarin,DB00035
DB00908,Desmopressin may decrease the excretion rate of Quinidine which could result in a higher serum level.,Quinidine,DB00035
DB00982,Desmopressin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,Isotretinoin,DB00035
DB01035,Desmopressin may decrease the excretion rate of Procainamide which could result in a higher serum level.,Procainamide,DB00035
DB12615,Desmopressin may decrease the excretion rate of Plazomicin which could result in a higher serum level.,Plazomicin,DB00035
DB13316,Desmopressin may increase the excretion rate of Ibopamine which could result in a lower serum level and potentially a reduction in efficacy.,Ibopamine,DB00035
DB00524,Desmopressin may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.,Metolazone,DB00035
DB00695,Desmopressin may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.,Furosemide,DB00035
DB00808,Desmopressin may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.,Indapamide,DB00035
DB00887,Desmopressin may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,Bumetanide,DB00035
DB00909,Desmopressin may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,Zonisamide,DB00035
DB08907,Desmopressin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.,Canagliflozin,DB00035
DB09338,Desmopressin may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.,Mersalyl,DB00035
DB00214,Torasemide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Torasemide,DB00035
DB00232,Methyclothiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Methyclothiazide,DB00035
DB00310,Chlorthalidone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Chlorthalidone,DB00035
DB00311,Ethoxzolamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Ethoxzolamide,DB00035
DB00421,Spironolactone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Spironolactone,DB00035
DB00436,Bendroflumethiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Bendroflumethiazide,DB00035
DB00562,Benzthiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Benzthiazide,DB00035
DB00594,Amiloride may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Amiloride,DB00035
DB00606,Cyclothiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Cyclothiazide,DB00035
DB00700,Eplerenone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Eplerenone,DB00035
DB00703,Methazolamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Methazolamide,DB00035
DB00774,Hydroflumethiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Hydroflumethiazide,DB00035
DB00819,Acetazolamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Acetazolamide,DB00035
DB00872,Conivaptan may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Conivaptan,DB00035
DB00880,Chlorothiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Chlorothiazide,DB00035
DB01021,Trichlormethiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Trichlormethiazide,DB00035
DB01119,Diazoxide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Diazoxide,DB00035
DB01144,Diclofenamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Diclofenamide,DB00035
DB01324,Polythiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Polythiazide,DB00035
DB01325,Quinethazone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Quinethazone,DB00035
DB01395,Drospirenone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Drospirenone,DB00035
DB01412,Theobromine may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Theobromine,DB00035
DB02925,Piretanide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Piretanide,DB00035
DB04831,Tienilic acid may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Tienilic acid,DB00035
DB05034,Ularitide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Ularitide,DB00035
DB06292,Dapagliflozin may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Dapagliflozin,DB00035
DB06370,Indisulam may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Indisulam,DB00035
DB08961,Azosemide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Azosemide,DB00035
DB09015,Canrenoic acid may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenoic acid,DB00035
DB09125,Potassium citrate may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium citrate,DB00035
DB09235,Efonidipine may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Efonidipine,DB00035
DB09401,Isosorbide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Isosorbide,DB00035
DB11827,Ertugliflozin may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Ertugliflozin,DB00035
DB12221,Canrenone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenone,DB00035
DB12670,Rolofylline may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Rolofylline,DB00035
DB12704,Spiradoline may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Spiradoline,DB00035
DB12766,Cicletanine may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Cicletanine,DB00035
DB13284,Meticrane may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Meticrane,DB00035
DB13405,Mefruside may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Mefruside,DB00035
DB13430,Mebutizide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Mebutizide,DB00035
DB13532,Cyclopenthiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Cyclopenthiazide,DB00035
DB13617,Clorexolone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Clorexolone,DB00035
DB13663,Clofenamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Clofenamide,DB00035
DB13708,Fenquizone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Fenquizone,DB00035
DB13792,Clopamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Clopamide,DB00035
DB13801,Muzolimine may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Muzolimine,DB00035
DB13803,Xipamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Xipamide,DB00035
DB13989,Epitizide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Epitizide,DB00035
DB14018,Bromotheophylline may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Bromotheophylline,DB00035
DB14500,Potassium may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium,DB00035
DB11823,The risk or severity of hypertension can be increased when Esketamine is combined with Desmopressin.,Esketamine,DB00035
DB14754,The risk or severity of hypertension can be increased when Solriamfetol is combined with Desmopressin.,Solriamfetol,DB00035
DB13946,Testosterone undecanoate may increase the hypertensive activities of Desmopressin.,Testosterone undecanoate,DB00035
DB09310,Catridecacog may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Catridecacog,DB00036
DB00513,The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Coagulation factor VIIa Recombinant Human.,Aminocaproic acid,DB00036
DB00058,Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Alpha-1-proteinase inhibitor,DB00036
DB00170,Menadione may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Menadione,DB00036
DB00302,Tranexamic acid may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Tranexamic acid,DB00036
DB06692,Aprotinin may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Aprotinin,DB00036
DB11091,Hydrogen peroxide may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Hydrogen peroxide,DB00036
DB13244,Aminomethylbenzoic acid may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Aminomethylbenzoic acid,DB00036
DB13729,Camostat may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Camostat,DB00036
DB12726,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Monteplase.,Monteplase,DB00036
DB00001,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Lepirudin.,Lepirudin,DB00036
DB00006,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Bivalirudin.,Bivalirudin,DB00036
DB00009,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Alteplase.,Alteplase,DB00036
DB00013,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Urokinase.,Urokinase,DB00036
DB00015,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Reteplase.,Reteplase,DB00036
DB00029,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Anistreplase.,Anistreplase,DB00036
DB00031,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tenecteplase.,Tenecteplase,DB00036
DB00054,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Abciximab.,Abciximab,DB00036
DB00055,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Drotrecogin alfa.,Drotrecogin alfa,DB00036
DB00086,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Streptokinase.,Streptokinase,DB00036
DB00266,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dicoumarol.,Dicoumarol,DB00036
DB00278,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Argatroban.,Argatroban,DB00036
DB00407,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ardeparin.,Ardeparin,DB00036
DB00498,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Phenindione.,Phenindione,DB00036
DB00569,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Fondaparinux.,Fondaparinux,DB00036
DB00682,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Warfarin.,Warfarin,DB00036
DB00686,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Pentosan polysulfate.,Pentosan polysulfate,DB00036
DB00945,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Acetylsalicylic acid.,Acetylsalicylic acid,DB00036
DB00946,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Phenprocoumon.,Phenprocoumon,DB00036
DB00975,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dipyridamole.,Dipyridamole,DB00036
DB01088,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Iloprost.,Iloprost,DB00036
DB01109,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Heparin.,Heparin,DB00036
DB01225,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Enoxaparin.,Enoxaparin,DB00036
DB01240,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Epoprostenol.,Epoprostenol,DB00036
DB01418,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Acenocoumarol.,Acenocoumarol,DB00036
DB03410,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with 4-hydroxycoumarin.,4-hydroxycoumarin,DB00036
DB04665,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Coumarin.,Coumarin,DB00036
DB04898,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ximelagatran.,Ximelagatran,DB00036
DB04925,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Desmoteplase.,Desmoteplase,DB00036
DB04932,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Defibrotide.,Defibrotide,DB00036
DB05099,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ancrod.,Ancrod,DB00036
DB05229,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Beraprost.,Beraprost,DB00036
DB05254,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Fibrinolysin.,Fibrinolysin,DB00036
DB06209,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Prasugrel.,Prasugrel,DB00036
DB06228,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Rivaroxaban.,Rivaroxaban,DB00036
DB06271,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Sulodexide.,Sulodexide,DB00036
DB06406,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Idraparinux.,Idraparinux,DB00036
DB06441,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Cangrelor.,Cangrelor,DB00036
DB06543,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Astaxanthin.,Astaxanthin,DB00036
DB06605,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Apixaban.,Apixaban,DB00036
DB06635,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Otamixaban.,Otamixaban,DB00036
DB06679,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Amediplase.,Amediplase,DB00036
DB06695,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dabigatran etexilate.,Dabigatran etexilate,DB00036
DB06754,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Danaparoid.,Danaparoid,DB00036
DB06779,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dalteparin.,Dalteparin,DB00036
DB06822,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tinzaparin.,Tinzaparin,DB00036
DB07767,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ferulic acid.,Ferulic acid,DB00036
DB08496,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with (R)-warfarin.,(R)-warfarin,DB00036
DB08794,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ethyl biscoumacetate.,Ethyl biscoumacetate,DB00036
DB08813,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Nadroparin.,Nadroparin,DB00036
DB08814,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Triflusal.,Triflusal,DB00036
DB08816,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ticagrelor.,Ticagrelor,DB00036
DB08994,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ditazole.,Ditazole,DB00036
DB09030,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Vorapaxar.,Vorapaxar,DB00036
DB09075,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Edoxaban.,Edoxaban,DB00036
DB09125,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Potassium citrate.,Potassium citrate,DB00036
DB09154,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Sodium citrate.,Sodium citrate,DB00036
DB09255,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dextran.,Dextran,DB00036
DB09258,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Bemiparin.,Bemiparin,DB00036
DB09259,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Reviparin.,Reviparin,DB00036
DB09260,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Parnaparin.,Parnaparin,DB00036
DB09261,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Certoparin.,Certoparin,DB00036
DB11095,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Desirudin.,Desirudin,DB00036
DB11154,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Zinc citrate.,Zinc citrate,DB00036
DB11166,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Antithrombin Alfa.,Antithrombin Alfa,DB00036
DB11312,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Protein C.,Protein C,DB00036
DB11598,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Antithrombin III human.,Antithrombin III human,DB00036
DB11984,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Letaxaban.,Letaxaban,DB00036
DB12289,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Darexaban.,Darexaban,DB00036
DB12364,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Betrixaban.,Betrixaban,DB00036
DB12598,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Nafamostat.,Nafamostat,DB00036
DB12831,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Gabexate.,Gabexate,DB00036
DB13136,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Fluindione.,Fluindione,DB00036
DB13149,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Protein S human.,Protein S human,DB00036
DB13199,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Brinase.,Brinase,DB00036
DB13275,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Clorindione.,Clorindione,DB00036
DB13347,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Diphenadione.,Diphenadione,DB00036
DB13451,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tioclomarol.,Tioclomarol,DB00036
DB13616,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Melagatran.,Melagatran,DB00036
DB13646,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Saruplase.,Saruplase,DB00036
DB14055,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with (S)-Warfarin.,(S)-Warfarin,DB00036
DB14094,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tocopherylquinone.,Tocopherylquinone,DB00036
DB14598,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous,DB00036
DB14726,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dabigatran.,Dabigatran,DB00036
DB06294,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Semuloparin.,Semuloparin,DB00036
DB00407,The serum concentration of Palifermin can be increased when it is combined with Ardeparin.,Ardeparin,DB00039
DB01109,The serum concentration of Palifermin can be increased when it is combined with Heparin.,Heparin,DB00039
DB01225,The serum concentration of Palifermin can be increased when it is combined with Enoxaparin.,Enoxaparin,DB00039
DB06271,The serum concentration of Palifermin can be increased when it is combined with Sulodexide.,Sulodexide,DB00039
DB06294,The serum concentration of Palifermin can be increased when it is combined with Semuloparin.,Semuloparin,DB00039
DB06754,The serum concentration of Palifermin can be increased when it is combined with Danaparoid.,Danaparoid,DB00039
DB06779,The serum concentration of Palifermin can be increased when it is combined with Dalteparin.,Dalteparin,DB00039
DB06822,The serum concentration of Palifermin can be increased when it is combined with Tinzaparin.,Tinzaparin,DB00039
DB08813,The serum concentration of Palifermin can be increased when it is combined with Nadroparin.,Nadroparin,DB00039
DB09258,The serum concentration of Palifermin can be increased when it is combined with Bemiparin.,Bemiparin,DB00039
DB09259,The serum concentration of Palifermin can be increased when it is combined with Reviparin.,Reviparin,DB00039
DB09260,The serum concentration of Palifermin can be increased when it is combined with Parnaparin.,Parnaparin,DB00039
DB09261,The serum concentration of Palifermin can be increased when it is combined with Certoparin.,Certoparin,DB00039
DB00008,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2a.,Peginterferon alfa-2a,DB00039
DB00011,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-n1.,Interferon alfa-n1,DB00039
DB00018,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-n3.,Interferon alfa-n3,DB00039
DB00022,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2b.,Peginterferon alfa-2b,DB00039
DB00033,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon gamma-1b.,Interferon gamma-1b,DB00039
DB00034,"The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00039
DB00041,The therapeutic efficacy of Palifermin can be decreased when used in combination with Aldesleukin.,Aldesleukin,DB00039
DB00056,The therapeutic efficacy of Palifermin can be decreased when used in combination with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00039
DB00068,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon beta-1b.,Interferon beta-1b,DB00039
DB00069,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfacon-1.,Interferon alfacon-1,DB00039
DB00073,The therapeutic efficacy of Palifermin can be decreased when used in combination with Rituximab.,Rituximab,DB00039
DB00078,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00039
DB00081,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tositumomab.,Tositumomab,DB00039
DB00087,The therapeutic efficacy of Palifermin can be decreased when used in combination with Alemtuzumab.,Alemtuzumab,DB00039
DB00105,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-2b.,Interferon alfa-2b,DB00039
DB00120,The therapeutic efficacy of Palifermin can be decreased when used in combination with Phenylalanine.,Phenylalanine,DB00039
DB00188,The therapeutic efficacy of Palifermin can be decreased when used in combination with Bortezomib.,Bortezomib,DB00039
DB00242,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cladribine.,Cladribine,DB00039
DB00262,The therapeutic efficacy of Palifermin can be decreased when used in combination with Carmustine.,Carmustine,DB00039
DB00276,The therapeutic efficacy of Palifermin can be decreased when used in combination with Amsacrine.,Amsacrine,DB00039
DB00291,The therapeutic efficacy of Palifermin can be decreased when used in combination with Chlorambucil.,Chlorambucil,DB00039
DB00293,The therapeutic efficacy of Palifermin can be decreased when used in combination with Raltitrexed.,Raltitrexed,DB00039
DB00305,The therapeutic efficacy of Palifermin can be decreased when used in combination with Mitomycin.,Mitomycin,DB00039
DB00307,The therapeutic efficacy of Palifermin can be decreased when used in combination with Bexarotene.,Bexarotene,DB00039
DB00309,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vindesine.,Vindesine,DB00039
DB00322,The therapeutic efficacy of Palifermin can be decreased when used in combination with Floxuridine.,Floxuridine,DB00039
DB00328,The therapeutic efficacy of Palifermin can be decreased when used in combination with Indomethacin.,Indomethacin,DB00039
DB00352,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tioguanine.,Tioguanine,DB00039
DB00361,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vinorelbine.,Vinorelbine,DB00039
DB00380,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dexrazoxane.,Dexrazoxane,DB00039
DB00398,The therapeutic efficacy of Palifermin can be decreased when used in combination with Sorafenib.,Sorafenib,DB00039
DB00428,The therapeutic efficacy of Palifermin can be decreased when used in combination with Streptozocin.,Streptozocin,DB00039
DB00441,The therapeutic efficacy of Palifermin can be decreased when used in combination with Gemcitabine.,Gemcitabine,DB00039
DB00444,The therapeutic efficacy of Palifermin can be decreased when used in combination with Teniposide.,Teniposide,DB00039
DB00445,The therapeutic efficacy of Palifermin can be decreased when used in combination with Epirubicin.,Epirubicin,DB00039
DB00446,The therapeutic efficacy of Palifermin can be decreased when used in combination with Chloramphenicol.,Chloramphenicol,DB00039
DB00480,The therapeutic efficacy of Palifermin can be decreased when used in combination with Lenalidomide.,Lenalidomide,DB00039
DB00488,The therapeutic efficacy of Palifermin can be decreased when used in combination with Altretamine.,Altretamine,DB00039
DB00495,The therapeutic efficacy of Palifermin can be decreased when used in combination with Zidovudine.,Zidovudine,DB00039
DB00515,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cisplatin.,Cisplatin,DB00039
DB00526,The therapeutic efficacy of Palifermin can be decreased when used in combination with Oxaliplatin.,Oxaliplatin,DB00039
DB00531,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cyclophosphamide.,Cyclophosphamide,DB00039
DB00544,The therapeutic efficacy of Palifermin can be decreased when used in combination with Fluorouracil.,Fluorouracil,DB00039
DB00550,The therapeutic efficacy of Palifermin can be decreased when used in combination with Propylthiouracil.,Propylthiouracil,DB00039
DB00552,The therapeutic efficacy of Palifermin can be decreased when used in combination with Pentostatin.,Pentostatin,DB00039
DB00563,The therapeutic efficacy of Palifermin can be decreased when used in combination with Methotrexate.,Methotrexate,DB00039
DB00564,The therapeutic efficacy of Palifermin can be decreased when used in combination with Carbamazepine.,Carbamazepine,DB00039
DB00570,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vinblastine.,Vinblastine,DB00039
DB00601,The therapeutic efficacy of Palifermin can be decreased when used in combination with Linezolid.,Linezolid,DB00039
DB00619,The therapeutic efficacy of Palifermin can be decreased when used in combination with Imatinib.,Imatinib,DB00039
DB00631,The therapeutic efficacy of Palifermin can be decreased when used in combination with Clofarabine.,Clofarabine,DB00039
DB00642,The therapeutic efficacy of Palifermin can be decreased when used in combination with Pemetrexed.,Pemetrexed,DB00039
DB00694,The therapeutic efficacy of Palifermin can be decreased when used in combination with Daunorubicin.,Daunorubicin,DB00039
DB00762,The therapeutic efficacy of Palifermin can be decreased when used in combination with Irinotecan.,Irinotecan,DB00039
DB00763,The therapeutic efficacy of Palifermin can be decreased when used in combination with Methimazole.,Methimazole,DB00039
DB00773,The therapeutic efficacy of Palifermin can be decreased when used in combination with Etoposide.,Etoposide,DB00039
DB00851,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dacarbazine.,Dacarbazine,DB00039
DB00853,The therapeutic efficacy of Palifermin can be decreased when used in combination with Temozolomide.,Temozolomide,DB00039
DB00859,The therapeutic efficacy of Palifermin can be decreased when used in combination with Penicillamine.,Penicillamine,DB00039
DB00864,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tacrolimus.,Tacrolimus,DB00039
DB00877,The therapeutic efficacy of Palifermin can be decreased when used in combination with Sirolimus.,Sirolimus,DB00039
DB00888,The therapeutic efficacy of Palifermin can be decreased when used in combination with Mechlorethamine.,Mechlorethamine,DB00039
DB00928,The therapeutic efficacy of Palifermin can be decreased when used in combination with Azacitidine.,Azacitidine,DB00039
DB00958,The therapeutic efficacy of Palifermin can be decreased when used in combination with Carboplatin.,Carboplatin,DB00039
DB00970,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dactinomycin.,Dactinomycin,DB00039
DB00987,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cytarabine.,Cytarabine,DB00039
DB00997,The therapeutic efficacy of Palifermin can be decreased when used in combination with Doxorubicin.,Doxorubicin,DB00039
DB01005,The therapeutic efficacy of Palifermin can be decreased when used in combination with Hydroxyurea.,Hydroxyurea,DB00039
DB01008,The therapeutic efficacy of Palifermin can be decreased when used in combination with Busulfan.,Busulfan,DB00039
DB01030,The therapeutic efficacy of Palifermin can be decreased when used in combination with Topotecan.,Topotecan,DB00039
DB01033,The therapeutic efficacy of Palifermin can be decreased when used in combination with Mercaptopurine.,Mercaptopurine,DB00039
DB01041,The therapeutic efficacy of Palifermin can be decreased when used in combination with Thalidomide.,Thalidomide,DB00039
DB01042,The therapeutic efficacy of Palifermin can be decreased when used in combination with Melphalan.,Melphalan,DB00039
DB01073,The therapeutic efficacy of Palifermin can be decreased when used in combination with Fludarabine.,Fludarabine,DB00039
DB01099,The therapeutic efficacy of Palifermin can be decreased when used in combination with Flucytosine.,Flucytosine,DB00039
DB01101,The therapeutic efficacy of Palifermin can be decreased when used in combination with Capecitabine.,Capecitabine,DB00039
DB01168,The therapeutic efficacy of Palifermin can be decreased when used in combination with Procarbazine.,Procarbazine,DB00039
DB01169,The therapeutic efficacy of Palifermin can be decreased when used in combination with Arsenic trioxide.,Arsenic trioxide,DB00039
DB01177,The therapeutic efficacy of Palifermin can be decreased when used in combination with Idarubicin.,Idarubicin,DB00039
DB01181,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ifosfamide.,Ifosfamide,DB00039
DB01204,The therapeutic efficacy of Palifermin can be decreased when used in combination with Mitoxantrone.,Mitoxantrone,DB00039
DB01206,The therapeutic efficacy of Palifermin can be decreased when used in combination with Lomustine.,Lomustine,DB00039
DB01229,The therapeutic efficacy of Palifermin can be decreased when used in combination with Paclitaxel.,Paclitaxel,DB00039
DB01248,The therapeutic efficacy of Palifermin can be decreased when used in combination with Docetaxel.,Docetaxel,DB00039
DB01254,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dasatinib.,Dasatinib,DB00039
DB01262,The therapeutic efficacy of Palifermin can be decreased when used in combination with Decitabine.,Decitabine,DB00039
DB01280,The therapeutic efficacy of Palifermin can be decreased when used in combination with Nelarabine.,Nelarabine,DB00039
DB01590,The therapeutic efficacy of Palifermin can be decreased when used in combination with Everolimus.,Everolimus,DB00039
DB02546,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vorinostat.,Vorinostat,DB00039
DB04572,The therapeutic efficacy of Palifermin can be decreased when used in combination with Thiotepa.,Thiotepa,DB00039
DB04845,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ixabepilone.,Ixabepilone,DB00039
DB04868,The therapeutic efficacy of Palifermin can be decreased when used in combination with Nilotinib.,Nilotinib,DB00039
DB05015,The therapeutic efficacy of Palifermin can be decreased when used in combination with Belinostat.,Belinostat,DB00039
DB05109,The therapeutic efficacy of Palifermin can be decreased when used in combination with Trabectedin.,Trabectedin,DB00039
DB05258,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa.,Interferon alfa,DB00039
DB05472,The therapeutic efficacy of Palifermin can be decreased when used in combination with omega interferon.,omega interferon,DB00039
DB05773,The therapeutic efficacy of Palifermin can be decreased when used in combination with Trastuzumab emtansine.,Trastuzumab emtansine,DB00039
DB06287,The therapeutic efficacy of Palifermin can be decreased when used in combination with Temsirolimus.,Temsirolimus,DB00039
DB06616,The therapeutic efficacy of Palifermin can be decreased when used in combination with Bosutinib.,Bosutinib,DB00039
DB06769,The therapeutic efficacy of Palifermin can be decreased when used in combination with Bendamustine.,Bendamustine,DB00039
DB06772,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cabazitaxel.,Cabazitaxel,DB00039
DB08871,The therapeutic efficacy of Palifermin can be decreased when used in combination with Eribulin.,Eribulin,DB00039
DB08877,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ruxolitinib.,Ruxolitinib,DB00039
DB08889,The therapeutic efficacy of Palifermin can be decreased when used in combination with Carfilzomib.,Carfilzomib,DB00039
DB08895,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tofacitinib.,Tofacitinib,DB00039
DB08901,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ponatinib.,Ponatinib,DB00039
DB08910,The therapeutic efficacy of Palifermin can be decreased when used in combination with Pomalidomide.,Pomalidomide,DB00039
DB08935,The therapeutic efficacy of Palifermin can be decreased when used in combination with Obinutuzumab.,Obinutuzumab,DB00039
DB09042,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tedizolid phosphate.,Tedizolid phosphate,DB00039
DB09052,The therapeutic efficacy of Palifermin can be decreased when used in combination with Blinatumomab.,Blinatumomab,DB00039
DB09053,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ibrutinib.,Ibrutinib,DB00039
DB09073,The therapeutic efficacy of Palifermin can be decreased when used in combination with Palbociclib.,Palbociclib,DB00039
DB09074,The therapeutic efficacy of Palifermin can be decreased when used in combination with Olaparib.,Olaparib,DB00039
DB09077,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dinutuximab.,Dinutuximab,DB00039
DB09122,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon beta-1a.,Peginterferon beta-1a,DB00039
DB12814,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00039
DB00193,Tramadol may increase the gastrointestinal motility reducing activities of Glucagon.,Tramadol,DB00040
DB00209,Trospium may increase the gastrointestinal motility reducing activities of Glucagon.,Trospium,DB00040
DB00219,Oxyphenonium may increase the gastrointestinal motility reducing activities of Glucagon.,Oxyphenonium,DB00040
DB00245,Benzatropine may increase the gastrointestinal motility reducing activities of Glucagon.,Benzatropine,DB00040
DB00246,Ziprasidone may increase the gastrointestinal motility reducing activities of Glucagon.,Ziprasidone,DB00040
DB00280,Disopyramide may increase the gastrointestinal motility reducing activities of Glucagon.,Disopyramide,DB00040
DB00321,Amitriptyline may increase the gastrointestinal motility reducing activities of Glucagon.,Amitriptyline,DB00040
DB00332,Ipratropium may increase the gastrointestinal motility reducing activities of Glucagon.,Ipratropium,DB00040
DB00334,Olanzapine may increase the gastrointestinal motility reducing activities of Glucagon.,Olanzapine,DB00040
DB00340,Metixene may increase the gastrointestinal motility reducing activities of Glucagon.,Metixene,DB00040
DB00342,Terfenadine may increase the gastrointestinal motility reducing activities of Glucagon.,Terfenadine,DB00040
DB00354,Buclizine may increase the gastrointestinal motility reducing activities of Glucagon.,Buclizine,DB00040
DB00363,Clozapine may increase the gastrointestinal motility reducing activities of Glucagon.,Clozapine,DB00040
DB00366,Doxylamine may increase the gastrointestinal motility reducing activities of Glucagon.,Doxylamine,DB00040
DB00376,Trihexyphenidyl may increase the gastrointestinal motility reducing activities of Glucagon.,Trihexyphenidyl,DB00040
DB00383,Oxyphencyclimine may increase the gastrointestinal motility reducing activities of Glucagon.,Oxyphencyclimine,DB00040
DB00387,Procyclidine may increase the gastrointestinal motility reducing activities of Glucagon.,Procyclidine,DB00040
DB00392,Profenamine may increase the gastrointestinal motility reducing activities of Glucagon.,Profenamine,DB00040
DB00420,Promazine may increase the gastrointestinal motility reducing activities of Glucagon.,Promazine,DB00040
DB00424,Hyoscyamine may increase the gastrointestinal motility reducing activities of Glucagon.,Hyoscyamine,DB00040
DB00434,Cyproheptadine may increase the gastrointestinal motility reducing activities of Glucagon.,Cyproheptadine,DB00040
DB00458,Imipramine may increase the gastrointestinal motility reducing activities of Glucagon.,Imipramine,DB00040
DB00462,Methscopolamine bromide may increase the gastrointestinal motility reducing activities of Glucagon.,Methscopolamine bromide,DB00040
DB00477,Chlorpromazine may increase the gastrointestinal motility reducing activities of Glucagon.,Chlorpromazine,DB00040
DB00483,Gallamine triethiodide may increase the gastrointestinal motility reducing activities of Glucagon.,Gallamine triethiodide,DB00040
DB00496,Darifenacin may increase the gastrointestinal motility reducing activities of Glucagon.,Darifenacin,DB00040
DB00505,Tridihexethyl may increase the gastrointestinal motility reducing activities of Glucagon.,Tridihexethyl,DB00040
DB00508,Triflupromazine may increase the gastrointestinal motility reducing activities of Glucagon.,Triflupromazine,DB00040
DB00517,Anisotropine methylbromide may increase the gastrointestinal motility reducing activities of Glucagon.,Anisotropine methylbromide,DB00040
DB00540,Nortriptyline may increase the gastrointestinal motility reducing activities of Glucagon.,Nortriptyline,DB00040
DB00543,Amoxapine may increase the gastrointestinal motility reducing activities of Glucagon.,Amoxapine,DB00040
DB00555,Lamotrigine may increase the gastrointestinal motility reducing activities of Glucagon.,Lamotrigine,DB00040
DB00572,Atropine may increase the gastrointestinal motility reducing activities of Glucagon.,Atropine,DB00040
DB00622,Nicardipine may increase the gastrointestinal motility reducing activities of Glucagon.,Nicardipine,DB00040
DB00670,Pirenzepine may increase the gastrointestinal motility reducing activities of Glucagon.,Pirenzepine,DB00040
DB00715,Paroxetine may increase the gastrointestinal motility reducing activities of Glucagon.,Paroxetine,DB00040
DB00725,Homatropine methylbromide may increase the gastrointestinal motility reducing activities of Glucagon.,Homatropine methylbromide,DB00040
DB00728,Rocuronium may increase the gastrointestinal motility reducing activities of Glucagon.,Rocuronium,DB00040
DB00747,Scopolamine may increase the gastrointestinal motility reducing activities of Glucagon.,Scopolamine,DB00040
DB00767,Benzquinamide may increase the gastrointestinal motility reducing activities of Glucagon.,Benzquinamide,DB00040
DB00771,Clidinium may increase the gastrointestinal motility reducing activities of Glucagon.,Clidinium,DB00040
DB00777,Propiomazine may increase the gastrointestinal motility reducing activities of Glucagon.,Propiomazine,DB00040
DB00782,Propantheline may increase the gastrointestinal motility reducing activities of Glucagon.,Propantheline,DB00040
DB00804,Dicyclomine may increase the gastrointestinal motility reducing activities of Glucagon.,Dicyclomine,DB00040
DB00810,Biperiden may increase the gastrointestinal motility reducing activities of Glucagon.,Biperiden,DB00040
DB00835,Brompheniramine may increase the gastrointestinal motility reducing activities of Glucagon.,Brompheniramine,DB00040
DB00875,Flupentixol may increase the gastrointestinal motility reducing activities of Glucagon.,Flupentixol,DB00040
DB00907,Cocaine may increase the gastrointestinal motility reducing activities of Glucagon.,Cocaine,DB00040
DB00908,Quinidine may increase the gastrointestinal motility reducing activities of Glucagon.,Quinidine,DB00040
DB00934,Maprotiline may increase the gastrointestinal motility reducing activities of Glucagon.,Maprotiline,DB00040
DB00940,Methantheline may increase the gastrointestinal motility reducing activities of Glucagon.,Methantheline,DB00040
DB00942,Cycrimine may increase the gastrointestinal motility reducing activities of Glucagon.,Cycrimine,DB00040
DB00986,Glycopyrronium may increase the gastrointestinal motility reducing activities of Glucagon.,Glycopyrronium,DB00040
DB01036,Tolterodine may increase the gastrointestinal motility reducing activities of Glucagon.,Tolterodine,DB00040
DB01062,Oxybutynin may increase the gastrointestinal motility reducing activities of Glucagon.,Oxybutynin,DB00040
DB01069,Promethazine may increase the gastrointestinal motility reducing activities of Glucagon.,Promethazine,DB00040
DB01075,Diphenhydramine may increase the gastrointestinal motility reducing activities of Glucagon.,Diphenhydramine,DB00040
DB01135,Doxacurium may increase the gastrointestinal motility reducing activities of Glucagon.,Doxacurium,DB00040
DB01142,Doxepin may increase the gastrointestinal motility reducing activities of Glucagon.,Doxepin,DB00040
DB01148,Flavoxate may increase the gastrointestinal motility reducing activities of Glucagon.,Flavoxate,DB00040
DB01151,Desipramine may increase the gastrointestinal motility reducing activities of Glucagon.,Desipramine,DB00040
DB01173,Orphenadrine may increase the gastrointestinal motility reducing activities of Glucagon.,Orphenadrine,DB00040
DB01175,Escitalopram may increase the gastrointestinal motility reducing activities of Glucagon.,Escitalopram,DB00040
DB01224,Quetiapine may increase the gastrointestinal motility reducing activities of Glucagon.,Quetiapine,DB00040
DB01226,Mivacurium may increase the gastrointestinal motility reducing activities of Glucagon.,Mivacurium,DB00040
DB01231,Diphenidol may increase the gastrointestinal motility reducing activities of Glucagon.,Diphenidol,DB00040
DB01238,Aripiprazole may increase the gastrointestinal motility reducing activities of Glucagon.,Aripiprazole,DB00040
DB01239,Chlorprothixene may increase the gastrointestinal motility reducing activities of Glucagon.,Chlorprothixene,DB00040
DB01336,Metocurine may increase the gastrointestinal motility reducing activities of Glucagon.,Metocurine,DB00040
DB01337,Pancuronium may increase the gastrointestinal motility reducing activities of Glucagon.,Pancuronium,DB00040
DB01338,Pipecuronium may increase the gastrointestinal motility reducing activities of Glucagon.,Pipecuronium,DB00040
DB01403,Methotrimeprazine may increase the gastrointestinal motility reducing activities of Glucagon.,Methotrimeprazine,DB00040
DB01409,Tiotropium may increase the gastrointestinal motility reducing activities of Glucagon.,Tiotropium,DB00040
DB01591,Solifenacin may increase the gastrointestinal motility reducing activities of Glucagon.,Solifenacin,DB00040
DB01625,Isopropamide may increase the gastrointestinal motility reducing activities of Glucagon.,Isopropamide,DB00040
DB04834,Rapacuronium may increase the gastrointestinal motility reducing activities of Glucagon.,Rapacuronium,DB00040
DB04843,Mepenzolate may increase the gastrointestinal motility reducing activities of Glucagon.,Mepenzolate,DB00040
DB06153,Pizotifen may increase the gastrointestinal motility reducing activities of Glucagon.,Pizotifen,DB00040
DB06702,Fesoterodine may increase the gastrointestinal motility reducing activities of Glucagon.,Fesoterodine,DB00040
DB06787,Hexocyclium may increase the gastrointestinal motility reducing activities of Glucagon.,Hexocyclium,DB00040
DB08801,Dimetindene may increase the gastrointestinal motility reducing activities of Glucagon.,Dimetindene,DB00040
DB08897,Aclidinium may increase the gastrointestinal motility reducing activities of Glucagon.,Aclidinium,DB00040
DB08997,Dexetimide may increase the gastrointestinal motility reducing activities of Glucagon.,Dexetimide,DB00040
DB09007,Chlorphenoxamine may increase the gastrointestinal motility reducing activities of Glucagon.,Chlorphenoxamine,DB00040
DB09023,Benactyzine may increase the gastrointestinal motility reducing activities of Glucagon.,Benactyzine,DB00040
DB09076,Umeclidinium may increase the gastrointestinal motility reducing activities of Glucagon.,Umeclidinium,DB00040
DB09089,Trimebutine may increase the gastrointestinal motility reducing activities of Glucagon.,Trimebutine,DB00040
DB09167,Dosulepin may increase the gastrointestinal motility reducing activities of Glucagon.,Dosulepin,DB00040
DB09262,Imidafenacin may increase the gastrointestinal motility reducing activities of Glucagon.,Imidafenacin,DB00040
DB09300,Butylscopolamine may increase the gastrointestinal motility reducing activities of Glucagon.,Butylscopolamine,DB00040
DB11235,Thonzylamine may increase the gastrointestinal motility reducing activities of Glucagon.,Thonzylamine,DB00040
DB11315,Methscopolamine may increase the gastrointestinal motility reducing activities of Glucagon.,Methscopolamine,DB00040
DB11855,Revefenacin may increase the gastrointestinal motility reducing activities of Glucagon.,Revefenacin,DB00040
DB12086,Oxitropium may increase the gastrointestinal motility reducing activities of Glucagon.,Oxitropium,DB00040
DB12278,Propiverine may increase the gastrointestinal motility reducing activities of Glucagon.,Propiverine,DB00040
DB12526,Batefenterol may increase the gastrointestinal motility reducing activities of Glucagon.,Batefenterol,DB00040
DB12554,Mebeverine may increase the gastrointestinal motility reducing activities of Glucagon.,Mebeverine,DB00040
DB13252,Tropatepine may increase the gastrointestinal motility reducing activities of Glucagon.,Tropatepine,DB00040
DB13254,Prifinium may increase the gastrointestinal motility reducing activities of Glucagon.,Prifinium,DB00040
DB13351,Piperidolate may increase the gastrointestinal motility reducing activities of Glucagon.,Piperidolate,DB00040
DB13369,Benzilone may increase the gastrointestinal motility reducing activities of Glucagon.,Benzilone,DB00040
DB13380,Difemerine may increase the gastrointestinal motility reducing activities of Glucagon.,Difemerine,DB00040
DB13413,Phenglutarimide may increase the gastrointestinal motility reducing activities of Glucagon.,Phenglutarimide,DB00040
DB13448,Mazaticol may increase the gastrointestinal motility reducing activities of Glucagon.,Mazaticol,DB00040
DB13468,Etybenzatropine may increase the gastrointestinal motility reducing activities of Glucagon.,Etybenzatropine,DB00040
DB13500,Otilonium may increase the gastrointestinal motility reducing activities of Glucagon.,Otilonium,DB00040
DB13505,Emepronium may increase the gastrointestinal motility reducing activities of Glucagon.,Emepronium,DB00040
DB13507,Poldine may increase the gastrointestinal motility reducing activities of Glucagon.,Poldine,DB00040
DB13542,Bevonium may increase the gastrointestinal motility reducing activities of Glucagon.,Bevonium,DB00040
DB13581,Rociverine may increase the gastrointestinal motility reducing activities of Glucagon.,Rociverine,DB00040
DB13619,Bornaprine may increase the gastrointestinal motility reducing activities of Glucagon.,Bornaprine,DB00040
DB13636,Etanautine may increase the gastrointestinal motility reducing activities of Glucagon.,Etanautine,DB00040
DB13666,Tiemonium iodide may increase the gastrointestinal motility reducing activities of Glucagon.,Tiemonium iodide,DB00040
DB13678,Dihexyverine may increase the gastrointestinal motility reducing activities of Glucagon.,Dihexyverine,DB00040
DB13695,Penthienate may increase the gastrointestinal motility reducing activities of Glucagon.,Penthienate,DB00040
DB13720,Diphemanil may increase the gastrointestinal motility reducing activities of Glucagon.,Diphemanil,DB00040
DB13738,Camylofin may increase the gastrointestinal motility reducing activities of Glucagon.,Camylofin,DB00040
DB13759,Fenpiverinium may increase the gastrointestinal motility reducing activities of Glucagon.,Fenpiverinium,DB00040
DB13769,Emetonium iodide may increase the gastrointestinal motility reducing activities of Glucagon.,Emetonium iodide,DB00040
DB13844,Pipenzolate may increase the gastrointestinal motility reducing activities of Glucagon.,Pipenzolate,DB00040
DB13850,Timepidium may increase the gastrointestinal motility reducing activities of Glucagon.,Timepidium,DB00040
DB00328,The therapeutic efficacy of Glucagon can be decreased when used in combination with Indomethacin.,Indomethacin,DB00040
DB00266,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Glucagon.,Dicoumarol,DB00040
DB00498,The therapeutic efficacy of Phenindione can be increased when used in combination with Glucagon.,Phenindione,DB00040
DB00682,The therapeutic efficacy of Warfarin can be increased when used in combination with Glucagon.,Warfarin,DB00040
DB00946,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Glucagon.,Phenprocoumon,DB00040
DB01418,The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Glucagon.,Acenocoumarol,DB00040
DB03410,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Glucagon.,4-hydroxycoumarin,DB00040
DB04665,The therapeutic efficacy of Coumarin can be increased when used in combination with Glucagon.,Coumarin,DB00040
DB08496,The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Glucagon.,(R)-warfarin,DB00040
DB08794,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Glucagon.,Ethyl biscoumacetate,DB00040
DB13136,The therapeutic efficacy of Fluindione can be increased when used in combination with Glucagon.,Fluindione,DB00040
DB13275,The therapeutic efficacy of Clorindione can be increased when used in combination with Glucagon.,Clorindione,DB00040
DB13347,The therapeutic efficacy of Diphenadione can be increased when used in combination with Glucagon.,Diphenadione,DB00040
DB13451,The therapeutic efficacy of Tioclomarol can be increased when used in combination with Glucagon.,Tioclomarol,DB00040
DB14055,The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Glucagon.,(S)-Warfarin,DB00040
DB00187,The therapeutic efficacy of Esmolol can be decreased when used in combination with Glucagon.,Esmolol,DB00040
DB00195,The therapeutic efficacy of Betaxolol can be decreased when used in combination with Glucagon.,Betaxolol,DB00040
DB00264,The therapeutic efficacy of Metoprolol can be decreased when used in combination with Glucagon.,Metoprolol,DB00040
DB00335,The therapeutic efficacy of Atenolol can be decreased when used in combination with Glucagon.,Atenolol,DB00040
DB00373,The therapeutic efficacy of Timolol can be decreased when used in combination with Glucagon.,Timolol,DB00040
DB00489,The therapeutic efficacy of Sotalol can be decreased when used in combination with Glucagon.,Sotalol,DB00040
DB00571,The therapeutic efficacy of Propranolol can be decreased when used in combination with Glucagon.,Propranolol,DB00040
DB00598,The therapeutic efficacy of Labetalol can be decreased when used in combination with Glucagon.,Labetalol,DB00040
DB00612,The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Glucagon.,Bisoprolol,DB00040
DB00866,The therapeutic efficacy of Alprenolol can be decreased when used in combination with Glucagon.,Alprenolol,DB00040
DB00960,The therapeutic efficacy of Pindolol can be decreased when used in combination with Glucagon.,Pindolol,DB00040
DB01136,The therapeutic efficacy of Carvedilol can be decreased when used in combination with Glucagon.,Carvedilol,DB00040
DB01182,The therapeutic efficacy of Propafenone can be decreased when used in combination with Glucagon.,Propafenone,DB00040
DB01193,The therapeutic efficacy of Acebutolol can be decreased when used in combination with Glucagon.,Acebutolol,DB00040
DB01203,The therapeutic efficacy of Nadolol can be decreased when used in combination with Glucagon.,Nadolol,DB00040
DB01295,The therapeutic efficacy of Bevantolol can be decreased when used in combination with Glucagon.,Bevantolol,DB00040
DB01297,The therapeutic efficacy of Practolol can be decreased when used in combination with Glucagon.,Practolol,DB00040
DB01359,The therapeutic efficacy of Penbutolol can be decreased when used in combination with Glucagon.,Penbutolol,DB00040
DB01580,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Glucagon.,Oxprenolol,DB00040
DB03322,The therapeutic efficacy of Dexpropranolol can be decreased when used in combination with Glucagon.,Dexpropranolol,DB00040
DB04846,The therapeutic efficacy of Celiprolol can be decreased when used in combination with Glucagon.,Celiprolol,DB00040
DB04861,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Glucagon.,Nebivolol,DB00040
DB06726,The therapeutic efficacy of Bufuralol can be decreased when used in combination with Glucagon.,Bufuralol,DB00040
DB08807,The therapeutic efficacy of Bopindolol can be decreased when used in combination with Glucagon.,Bopindolol,DB00040
DB08808,The therapeutic efficacy of Bupranolol can be decreased when used in combination with Glucagon.,Bupranolol,DB00040
DB08952,The therapeutic efficacy of Indenolol can be decreased when used in combination with Glucagon.,Indenolol,DB00040
DB09013,The therapeutic efficacy of Befunolol can be decreased when used in combination with Glucagon.,Befunolol,DB00040
DB09204,The therapeutic efficacy of Arotinolol can be decreased when used in combination with Glucagon.,Arotinolol,DB00040
DB09351,The therapeutic efficacy of Levobetaxolol can be decreased when used in combination with Glucagon.,Levobetaxolol,DB00040
DB11770,The therapeutic efficacy of Talinolol can be decreased when used in combination with Glucagon.,Talinolol,DB00040
DB11785,The therapeutic efficacy of Anisodamine can be decreased when used in combination with Glucagon.,Anisodamine,DB00040
DB12212,The therapeutic efficacy of Landiolol can be decreased when used in combination with Glucagon.,Landiolol,DB00040
DB12752,The therapeutic efficacy of Bucindolol can be decreased when used in combination with Glucagon.,Bucindolol,DB00040
DB13443,The therapeutic efficacy of Esatenolol can be decreased when used in combination with Glucagon.,Esatenolol,DB00040
DB13508,The therapeutic efficacy of Cloranolol can be decreased when used in combination with Glucagon.,Cloranolol,DB00040
DB13530,The therapeutic efficacy of Mepindolol can be decreased when used in combination with Glucagon.,Mepindolol,DB00040
DB13757,The therapeutic efficacy of Epanolol can be decreased when used in combination with Glucagon.,Epanolol,DB00040
DB13775,The therapeutic efficacy of Tertatolol can be decreased when used in combination with Glucagon.,Tertatolol,DB00040
DB00030,The therapeutic efficacy of Insulin human can be decreased when used in combination with Glucagon.,Insulin human,DB00040
DB00046,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Glucagon.,Insulin lispro,DB00040
DB00047,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Glucagon.,Insulin glargine,DB00040
DB00071,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Glucagon.,Insulin pork,DB00040
DB01306,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Glucagon.,Insulin aspart,DB00040
DB01307,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Glucagon.,Insulin detemir,DB00040
DB01309,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Glucagon.,Insulin glulisine,DB00040
DB05115,The therapeutic efficacy of NN344 can be decreased when used in combination with Glucagon.,NN344,DB00040
DB09456,The therapeutic efficacy of Insulin beef can be decreased when used in combination with Glucagon.,Insulin beef,DB00040
DB09564,The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Glucagon.,Insulin degludec,DB00040
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Glucagon.,Insulin peglispro,DB00040
DB11568,The therapeutic efficacy of Insulin tregopil can be decreased when used in combination with Glucagon.,Insulin tregopil,DB00040
DB11564,The therapeutic efficacy of Insulin argine can be decreased when used in combination with Glucagon.,Insulin argine,DB00040
DB14513,The serum concentration of Magnesium can be increased when it is combined with Glucagon.,Magnesium,DB00040
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Aldesleukin.,Denosumab,DB00041
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Aldesleukin.,Etanercept,DB00041
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Aldesleukin.,Interferon alfa-n1,DB00041
DB00026,The risk or severity of adverse effects can be increased when Anakinra is combined with Aldesleukin.,Anakinra,DB00041
DB00033,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Aldesleukin.,Interferon gamma-1b,DB00041
DB00051,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Adalimumab.,Adalimumab,DB00041
DB00056,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00041
DB00059,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pegaspargase.,Pegaspargase,DB00041
DB00065,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Infliximab.,Infliximab,DB00041
DB00068,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Interferon beta-1b.,Interferon beta-1b,DB00041
DB00073,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Rituximab.,Rituximab,DB00041
DB00074,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Basiliximab.,Basiliximab,DB00041
DB00075,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Muromonab.,Muromonab,DB00041
DB00078,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00041
DB00081,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tositumomab.,Tositumomab,DB00041
DB00087,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Alemtuzumab.,Alemtuzumab,DB00041
DB00092,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Alefacept.,Alefacept,DB00041
DB00095,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Efalizumab.,Efalizumab,DB00041
DB00098,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit),DB00041
DB00111,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Daclizumab.,Daclizumab,DB00041
DB00112,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bevacizumab.,Bevacizumab,DB00041
DB00120,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Phenylalanine.,Phenylalanine,DB00041
DB00180,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Flunisolide.,Flunisolide,DB00041
DB00242,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cladribine.,Cladribine,DB00041
DB00262,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carmustine.,Carmustine,DB00041
DB00276,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Amsacrine.,Amsacrine,DB00041
DB00290,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bleomycin.,Bleomycin,DB00041
DB00291,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Chlorambucil.,Chlorambucil,DB00041
DB00293,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Raltitrexed.,Raltitrexed,DB00041
DB00305,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mitomycin.,Mitomycin,DB00041
DB00307,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bexarotene.,Bexarotene,DB00041
DB00322,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Floxuridine.,Floxuridine,DB00041
DB00328,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Indomethacin.,Indomethacin,DB00041
DB00352,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tioguanine.,Tioguanine,DB00041
DB00380,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dexrazoxane.,Dexrazoxane,DB00041
DB00428,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Streptozocin.,Streptozocin,DB00041
DB00432,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Trifluridine.,Trifluridine,DB00041
DB00441,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gemcitabine.,Gemcitabine,DB00041
DB00445,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Epirubicin.,Epirubicin,DB00041
DB00446,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Chloramphenicol.,Chloramphenicol,DB00041
DB00480,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Lenalidomide.,Lenalidomide,DB00041
DB00488,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Altretamine.,Altretamine,DB00041
DB00495,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Zidovudine.,Zidovudine,DB00041
DB00515,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cisplatin.,Cisplatin,DB00041
DB00526,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Oxaliplatin.,Oxaliplatin,DB00041
DB00531,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cyclophosphamide.,Cyclophosphamide,DB00041
DB00544,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluorouracil.,Fluorouracil,DB00041
DB00552,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pentostatin.,Pentostatin,DB00041
DB00588,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluticasone propionate.,Fluticasone propionate,DB00041
DB00591,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluocinolone acetonide.,Fluocinolone acetonide,DB00041
DB00601,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Linezolid.,Linezolid,DB00041
DB00631,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Clofarabine.,Clofarabine,DB00041
DB00642,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pemetrexed.,Pemetrexed,DB00041
DB00687,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fludrocortisone.,Fludrocortisone,DB00041
DB00688,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mycophenolate mofetil.,Mycophenolate mofetil,DB00041
DB00755,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tretinoin.,Tretinoin,DB00041
DB00762,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Irinotecan.,Irinotecan,DB00041
DB00795,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sulfasalazine.,Sulfasalazine,DB00041
DB00851,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dacarbazine.,Dacarbazine,DB00041
DB00853,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Temozolomide.,Temozolomide,DB00041
DB00859,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Penicillamine.,Penicillamine,DB00041
DB00860,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Prednisolone.,Prednisolone,DB00041
DB00888,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mechlorethamine.,Mechlorethamine,DB00041
DB00928,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Azacitidine.,Azacitidine,DB00041
DB00958,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carboplatin.,Carboplatin,DB00041
DB00959,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Methylprednisolone.,Methylprednisolone,DB00041
DB00970,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dactinomycin.,Dactinomycin,DB00041
DB00993,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Azathioprine.,Azathioprine,DB00041
DB01005,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydroxyurea.,Hydroxyurea,DB00041
DB01024,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mycophenolic acid.,Mycophenolic acid,DB00041
DB01030,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Topotecan.,Topotecan,DB00041
DB01033,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mercaptopurine.,Mercaptopurine,DB00041
DB01041,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Thalidomide.,Thalidomide,DB00041
DB01042,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Melphalan.,Melphalan,DB00041
DB01073,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fludarabine.,Fludarabine,DB00041
DB01099,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Flucytosine.,Flucytosine,DB00041
DB01101,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Capecitabine.,Capecitabine,DB00041
DB01168,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Procarbazine.,Procarbazine,DB00041
DB01169,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Arsenic trioxide.,Arsenic trioxide,DB00041
DB01177,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Idarubicin.,Idarubicin,DB00041
DB01196,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Estramustine.,Estramustine,DB00041
DB01204,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mitoxantrone.,Mitoxantrone,DB00041
DB01206,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Lomustine.,Lomustine,DB00041
DB01234,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dexamethasone.,Dexamethasone,DB00041
DB01257,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Eculizumab.,Eculizumab,DB00041
DB01262,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Decitabine.,Decitabine,DB00041
DB01280,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nelarabine.,Nelarabine,DB00041
DB01281,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Abatacept.,Abatacept,DB00041
DB01285,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Corticotropin.,Corticotropin,DB00041
DB01423,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Stepronin.,Stepronin,DB00041
DB01611,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydroxychloroquine.,Hydroxychloroquine,DB00041
DB01816,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Castanospermine.,Castanospermine,DB00041
DB02546,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Vorinostat.,Vorinostat,DB00041
DB02806,The risk or severity of adverse effects can be increased when Aldesleukin is combined with 2-Methoxyethanol.,2-Methoxyethanol,DB00041
DB03523,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Brequinar.,Brequinar,DB00041
DB04630,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Aldosterone.,Aldosterone,DB00041
DB04951,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pirfenidone.,Pirfenidone,DB00041
DB04956,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Afelimomab.,Afelimomab,DB00041
DB05258,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Interferon alfa.,Interferon alfa,DB00041
DB05259,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Glatiramer.,Glatiramer,DB00041
DB05260,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gallium nitrate.,Gallium nitrate,DB00041
DB05459,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Briakinumab.,Briakinumab,DB00041
DB05472,The risk or severity of adverse effects can be increased when Aldesleukin is combined with omega interferon.,omega interferon,DB00041
DB05676,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Apremilast.,Apremilast,DB00041
DB05773,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00041
DB06168,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Canakinumab.,Canakinumab,DB00041
DB06273,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tocilizumab.,Tocilizumab,DB00041
DB06372,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Rilonacept.,Rilonacept,DB00041
DB06612,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mepolizumab.,Mepolizumab,DB00041
DB06662,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Abetimus.,Abetimus,DB00041
DB06674,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Golimumab.,Golimumab,DB00041
DB06681,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Belatacept.,Belatacept,DB00041
DB06769,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bendamustine.,Bendamustine,DB00041
DB06772,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cabazitaxel.,Cabazitaxel,DB00041
DB06813,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pralatrexate.,Pralatrexate,DB00041
DB08059,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Wortmannin.,Wortmannin,DB00041
DB08871,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Eribulin.,Eribulin,DB00041
DB08879,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Belimumab.,Belimumab,DB00041
DB08880,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Teriflunomide.,Teriflunomide,DB00041
DB08889,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carfilzomib.,Carfilzomib,DB00041
DB08904,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Certolizumab pegol.,Certolizumab pegol,DB00041
DB08908,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dimethyl fumarate.,Dimethyl fumarate,DB00041
DB08910,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pomalidomide.,Pomalidomide,DB00041
DB08935,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Obinutuzumab.,Obinutuzumab,DB00041
DB09029,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Secukinumab.,Secukinumab,DB00041
DB09033,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Vedolizumab.,Vedolizumab,DB00041
DB09036,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Siltuximab.,Siltuximab,DB00041
DB09052,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Blinatumomab.,Blinatumomab,DB00041
DB09074,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Olaparib.,Olaparib,DB00041
DB09077,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dinutuximab.,Dinutuximab,DB00041
DB09082,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Vilanterol.,Vilanterol,DB00041
DB09091,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tixocortol.,Tixocortol,DB00041
DB09122,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00041
DB09312,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse),DB00041
DB09378,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluprednisolone.,Fluprednisolone,DB00041
DB11466,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tepoxalin.,Tepoxalin,DB00041
DB11529,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Melengestrol.,Melengestrol,DB00041
DB11569,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ixekizumab.,Ixekizumab,DB00041
DB11580,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ravulizumab.,Ravulizumab,DB00041
DB11616,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pirarubicin.,Pirarubicin,DB00041
DB11693,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Voclosporin.,Voclosporin,DB00041
DB11708,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Peficitinib.,Peficitinib,DB00041
DB11767,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sarilumab.,Sarilumab,DB00041
DB11776,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Brodalumab.,Brodalumab,DB00041
DB11803,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sirukumab.,Sirukumab,DB00041
DB11817,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Baricitinib.,Baricitinib,DB00041
DB11834,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Guselkumab.,Guselkumab,DB00041
DB12025,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Triptolide.,Triptolide,DB00041
DB12612,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ozanimod.,Ozanimod,DB00041
DB12617,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mizoribine.,Mizoribine,DB00041
DB12692,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gusperimus.,Gusperimus,DB00041
DB12814,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00041
DB12902,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Trofosfamide.,Trofosfamide,DB00041
DB12947,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Doxifluridine.,Doxifluridine,DB00041
DB12991,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Deoxyspergualin.,Deoxyspergualin,DB00041
DB12996,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Acteoside.,Acteoside,DB00041
DB13014,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hypericin.,Hypericin,DB00041
DB13068,The risk or severity of adverse effects can be increased when Aldesleukin is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A,DB00041
DB13223,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluocortin.,Fluocortin,DB00041
DB13241,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Begelomab.,Begelomab,DB00041
DB13491,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluperolone.,Fluperolone,DB00041
DB13664,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Formocortal.,Formocortal,DB00041
DB13856,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluclorolone.,Fluclorolone,DB00041
DB14066,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tetrandrine.,Tetrandrine,DB00041
DB14219,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Monomethyl fumarate.,Monomethyl fumarate,DB00041
DB14538,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydrocortisone aceponate.,Hydrocortisone aceponate,DB00041
DB14539,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydrocortisone acetate.,Hydrocortisone acetate,DB00041
DB14545,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydrocortisone succinate.,Hydrocortisone succinate,DB00041
DB14724,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Emapalumab.,Emapalumab,DB00041
DB14762,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Risankizumab.,Risankizumab,DB00041
DB14919,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Rozanolixizumab.,Rozanolixizumab,DB00041
DB15253,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bleselumab.,Bleselumab,DB00041
DB01222,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Budesonide.,Budesonide,DB00041
DB12371,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Siponimod.,Siponimod,DB00041
DB00108,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Natalizumab.,Natalizumab,DB00041
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Aldesleukin.,Pimecrolimus,DB00041
DB01656,Roflumilast may increase the immunosuppressive activities of Aldesleukin.,Roflumilast,DB00041
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Aldesleukin.,Sipuleucel-T,DB00041
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Aldesleukin.,Peginterferon alfa-2a,DB00041
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Aldesleukin.,Interferon alfa-n3,DB00041
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Aldesleukin.,Peginterferon alfa-2b,DB00041
DB00034,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Aldesleukin.","Interferon alfa-2a, Recombinant",DB00041
DB00069,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Aldesleukin.,Interferon alfacon-1,DB00041
DB00105,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Aldesleukin.,Interferon alfa-2b,DB00041
DB00363,The risk or severity of neutropenia can be increased when Aldesleukin is combined with Clozapine.,Clozapine,DB00041
DB08894,The risk or severity of Thrombosis can be increased when Aldesleukin is combined with Peginesatide.,Peginesatide,DB00041
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aldesleukin.,Darbepoetin alfa,DB00041
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aldesleukin.,Erythropoietin,DB00041
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Aldesleukin.,Methoxy polyethylene glycol-epoetin beta,DB00041
DB00476,The risk or severity of orthostatic hypotension and syncope can be increased when Aldesleukin is combined with Duloxetine.,Duloxetine,DB00041
DB01235,The risk or severity of hypotension and orthostatic hypotension can be increased when Aldesleukin is combined with Levodopa.,Levodopa,DB00041
DB00734,Aldesleukin may increase the hypotensive activities of Risperidone.,Risperidone,DB00041
DB09039,The metabolism of Eliglustat can be decreased when combined with Aldesleukin.,Eliglustat,DB00041
DB09053,The metabolism of Ibrutinib can be decreased when combined with Aldesleukin.,Ibrutinib,DB00041
DB01166,The metabolism of Cilostazol can be decreased when combined with Aldesleukin.,Cilostazol,DB00041
DB01394,The metabolism of Colchicine can be decreased when combined with Aldesleukin.,Colchicine,DB00041
DB00813,The metabolism of Fentanyl can be decreased when combined with Aldesleukin.,Fentanyl,DB00041
DB04946,The metabolism of Iloperidone can be decreased when combined with Aldesleukin.,Iloperidone,DB00041
DB01256,The metabolism of Retapamulin can be decreased when combined with Aldesleukin.,Retapamulin,DB00041
DB08895,The metabolism of Tofacitinib can be decreased when combined with Aldesleukin.,Tofacitinib,DB00041
DB00862,The metabolism of Vardenafil can be decreased when combined with Aldesleukin.,Vardenafil,DB00041
DB00402,The metabolism of Eszopiclone can be decreased when combined with Aldesleukin.,Eszopiclone,DB00041
DB01198,The metabolism of Zopiclone can be decreased when combined with Aldesleukin.,Zopiclone,DB00041
DB00394,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Beclomethasone dipropionate.,Beclomethasone dipropionate,DB00041
DB00443,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Betamethasone.,Betamethasone,DB00041
DB00620,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Triamcinolone.,Triamcinolone,DB00041
DB00635,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisone.,Prednisone,DB00041
DB00764,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Mometasone.,Mometasone,DB00041
DB01380,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Cortisone acetate.,Cortisone acetate,DB00041
DB01384,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Paramethasone.,Paramethasone,DB00041
DB01410,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Ciclesonide.,Ciclesonide,DB00041
DB08906,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluticasone furoate.,Fluticasone furoate,DB00041
DB08970,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluprednidene.,Fluprednidene,DB00041
DB08971,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluocortolone.,Fluocortolone,DB00041
DB09383,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Meprednisone.,Meprednisone,DB00041
DB11487,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Dexamethasone isonicotinate.,Dexamethasone isonicotinate,DB00041
DB11750,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Clobetasol.,Clobetasol,DB00041
DB11921,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Deflazacort.,Deflazacort,DB00041
DB13003,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Cortivazol.,Cortivazol,DB00041
DB13208,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednylidene.,Prednylidene,DB00041
DB13728,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Halometasone.,Halometasone,DB00041
DB13843,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Cloprednol.,Cloprednol,DB00041
DB13867,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluticasone.,Fluticasone,DB00041
DB14512,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Mometasone furoate.,Mometasone furoate,DB00041
DB14631,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisolone phosphate.,Prednisolone phosphate,DB00041
DB14633,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisolone hemisuccinate.,Prednisolone hemisuccinate,DB00041
DB14634,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluprednidene acetate.,Fluprednidene acetate,DB00041
DB14644,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Methylprednisolone hemisuccinate.,Methylprednisolone hemisuccinate,DB00041
DB14646,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisone acetate.,Prednisone acetate,DB00041
DB14652,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Clocortolone acetate.,Clocortolone acetate,DB00041
DB14659,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Melengestrol acetate.,Melengestrol acetate,DB00041
DB14669,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Betamethasone phosphate.,Betamethasone phosphate,DB00041
DB14681,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Cortisone.,Cortisone,DB00041
DB00227,The metabolism of Lovastatin can be decreased when combined with Aldesleukin.,Lovastatin,DB00041
DB00271,The risk of a hypersensitivity reaction to Diatrizoate is increased when it is combined with Aldesleukin.,Diatrizoate,DB00041
DB00965,The risk of a hypersensitivity reaction to Ethiodized oil is increased when it is combined with Aldesleukin.,Ethiodized oil,DB00041
DB01249,The risk of a hypersensitivity reaction to Iodixanol is increased when it is combined with Aldesleukin.,Iodixanol,DB00041
DB01362,The risk of a hypersensitivity reaction to Iohexol is increased when it is combined with Aldesleukin.,Iohexol,DB00041
DB04711,The risk of a hypersensitivity reaction to Iodipamide is increased when it is combined with Aldesleukin.,Iodipamide,DB00041
DB08947,The risk of a hypersensitivity reaction to Iopamidol is increased when it is combined with Aldesleukin.,Iopamidol,DB00041
DB09134,The risk of a hypersensitivity reaction to Ioversol is increased when it is combined with Aldesleukin.,Ioversol,DB00041
DB09135,The risk of a hypersensitivity reaction to Ioxilan is increased when it is combined with Aldesleukin.,Ioxilan,DB00041
DB09156,The risk of a hypersensitivity reaction to Iopromide is increased when it is combined with Aldesleukin.,Iopromide,DB00041
DB00346,The metabolism of Alfuzosin can be decreased when combined with Aldesleukin.,Alfuzosin,DB00041
DB00404,The metabolism of Alprazolam can be decreased when combined with Aldesleukin.,Alprazolam,DB00041
DB00682,The serum concentration of Warfarin can be increased when it is combined with Aldesleukin.,Warfarin,DB00041
DB01418,The serum concentration of Acenocoumarol can be increased when it is combined with Aldesleukin.,Acenocoumarol,DB00041
DB08496,The serum concentration of (R)-warfarin can be increased when it is combined with Aldesleukin.,(R)-warfarin,DB00041
DB08735,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Aldesleukin.","R,S-Warfarin alcohol",DB00041
DB08736,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Aldesleukin.","S,R-Warfarin alcohol",DB00041
DB14055,The serum concentration of (S)-Warfarin can be increased when it is combined with Aldesleukin.,(S)-Warfarin,DB00041
DB00683,The serum concentration of Midazolam can be increased when it is combined with Aldesleukin.,Midazolam,DB00041
DB00864,The serum concentration of Tacrolimus can be increased when it is combined with Aldesleukin.,Tacrolimus,DB00041
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Aldesleukin.,Sulfamethoxazole,DB00041
DB01076,The metabolism of Atorvastatin can be decreased when combined with Aldesleukin.,Atorvastatin,DB00041
DB01097,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Leflunomide.,Leflunomide,DB00041
DB00072,Trastuzumab may increase the neutropenic activities of Aldesleukin.,Trastuzumab,DB00041
DB08868,Aldesleukin may increase the immunosuppressive activities of Fingolimod.,Fingolimod,DB00041
DB09220,Nicorandil may increase the hypotensive activities of Aldesleukin.,Nicorandil,DB00041
DB00614,Furazolidone may increase the orthostatic hypotensive activities of Aldesleukin.,Furazolidone,DB00041
DB00721,Procaine may increase the orthostatic hypotensive activities of Aldesleukin.,Procaine,DB00041
DB00752,Tranylcypromine may increase the orthostatic hypotensive activities of Aldesleukin.,Tranylcypromine,DB00041
DB00780,Phenelzine may increase the orthostatic hypotensive activities of Aldesleukin.,Phenelzine,DB00041
DB00805,Minaprine may increase the orthostatic hypotensive activities of Aldesleukin.,Minaprine,DB00041
DB01037,Selegiline may increase the orthostatic hypotensive activities of Aldesleukin.,Selegiline,DB00041
DB01171,Moclobemide may increase the orthostatic hypotensive activities of Aldesleukin.,Moclobemide,DB00041
DB01247,Isocarboxazid may increase the orthostatic hypotensive activities of Aldesleukin.,Isocarboxazid,DB00041
DB01367,Rasagiline may increase the orthostatic hypotensive activities of Aldesleukin.,Rasagiline,DB00041
DB01626,Pargyline may increase the orthostatic hypotensive activities of Aldesleukin.,Pargyline,DB00041
DB04017,Clorgiline may increase the orthostatic hypotensive activities of Aldesleukin.,Clorgiline,DB00041
DB04818,Iproniazid may increase the orthostatic hypotensive activities of Aldesleukin.,Iproniazid,DB00041
DB04820,Nialamide may increase the orthostatic hypotensive activities of Aldesleukin.,Nialamide,DB00041
DB06654,Safinamide may increase the orthostatic hypotensive activities of Aldesleukin.,Safinamide,DB00041
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Aldesleukin.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",DB00041
DB09241,Methylene blue may increase the orthostatic hypotensive activities of Aldesleukin.,Methylene blue,DB00041
DB09243,Hydracarbazine may increase the orthostatic hypotensive activities of Aldesleukin.,Hydracarbazine,DB00041
DB09244,Pirlindole may increase the orthostatic hypotensive activities of Aldesleukin.,Pirlindole,DB00041
DB09245,Toloxatone may increase the orthostatic hypotensive activities of Aldesleukin.,Toloxatone,DB00041
DB09246,Benmoxin may increase the orthostatic hypotensive activities of Aldesleukin.,Benmoxin,DB00041
DB09248,Mebanazine may increase the orthostatic hypotensive activities of Aldesleukin.,Mebanazine,DB00041
DB09249,Octamoxin may increase the orthostatic hypotensive activities of Aldesleukin.,Octamoxin,DB00041
DB09250,Pheniprazine may increase the orthostatic hypotensive activities of Aldesleukin.,Pheniprazine,DB00041
DB09251,Phenoxypropazine may increase the orthostatic hypotensive activities of Aldesleukin.,Phenoxypropazine,DB00041
DB09252,Pivhydrazine may increase the orthostatic hypotensive activities of Aldesleukin.,Pivhydrazine,DB00041
DB09253,Safrazine may increase the orthostatic hypotensive activities of Aldesleukin.,Safrazine,DB00041
DB09254,Caroxazone may increase the orthostatic hypotensive activities of Aldesleukin.,Caroxazone,DB00041
DB13875,Harmaline may increase the orthostatic hypotensive activities of Aldesleukin.,Harmaline,DB00041
DB13876,Brofaromine may increase the orthostatic hypotensive activities of Aldesleukin.,Brofaromine,DB00041
DB00182,Aldesleukin may increase the orthostatic hypotensive activities of Amphetamine.,Amphetamine,DB00041
DB00241,Butalbital may increase the hypotensive activities of Aldesleukin.,Butalbital,DB00041
DB00312,Pentobarbital may increase the hypotensive activities of Aldesleukin.,Pentobarbital,DB00041
DB00418,Secobarbital may increase the hypotensive activities of Aldesleukin.,Secobarbital,DB00041
DB00474,Methohexital may increase the hypotensive activities of Aldesleukin.,Methohexital,DB00041
DB00599,Thiopental may increase the hypotensive activities of Aldesleukin.,Thiopental,DB00041
DB00794,Primidone may increase the hypotensive activities of Aldesleukin.,Primidone,DB00041
DB00849,Methylphenobarbital may increase the hypotensive activities of Aldesleukin.,Methylphenobarbital,DB00041
DB01154,Thiamylal may increase the hypotensive activities of Aldesleukin.,Thiamylal,DB00041
DB01174,Phenobarbital may increase the hypotensive activities of Aldesleukin.,Phenobarbital,DB00041
DB01351,Amobarbital may increase the hypotensive activities of Aldesleukin.,Amobarbital,DB00041
DB01355,Hexobarbital may increase the hypotensive activities of Aldesleukin.,Hexobarbital,DB00041
DB01483,Barbital may increase the hypotensive activities of Aldesleukin.,Barbital,DB00041
DB09001,Barbexaclone may increase the hypotensive activities of Aldesleukin.,Barbexaclone,DB00041
DB00237,Aldesleukin may increase the hypotensive activities of Butabarbital.,Butabarbital,DB00041
DB00086,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Streptokinase.,Streptokinase,DB00041
DB00268,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ropinirole.,Ropinirole,DB00041
DB00334,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Olanzapine.,Olanzapine,DB00041
DB00486,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nabilone.,Nabilone,DB00041
DB00489,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sotalol.,Sotalol,DB00041
DB00679,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Thioridazine.,Thioridazine,DB00041
DB00697,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tizanidine.,Tizanidine,DB00041
DB00714,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Apomorphine.,Apomorphine,DB00041
DB00818,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Propofol.,Propofol,DB00041
DB00899,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Remifentanil.,Remifentanil,DB00041
DB00922,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Levosimendan.,Levosimendan,DB00041
DB01113,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Papaverine.,Papaverine,DB00041
DB01143,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Amifostine.,Amifostine,DB00041
DB01189,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Desflurane.,Desflurane,DB00041
DB01282,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carbetocin.,Carbetocin,DB00041
DB01612,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Amyl Nitrite.,Amyl Nitrite,DB00041
DB04899,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nesiritide.,Nesiritide,DB00041
DB08822,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Azilsartan medoxomil.,Azilsartan medoxomil,DB00041
DB08941,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Isoxsuprine.,Isoxsuprine,DB00041
DB09112,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nitrous acid.,Nitrous acid,DB00041
DB09279,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fimasartan.,Fimasartan,DB00041
DB09286,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pipamperone.,Pipamperone,DB00041
DB00177,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Valsartan.,Valsartan,DB00041
DB00178,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ramipril.,Ramipril,DB00041
DB00187,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Esmolol.,Esmolol,DB00041
DB00195,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Betaxolol.,Betaxolol,DB00041
DB00275,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Olmesartan.,Olmesartan,DB00041
DB00335,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Atenolol.,Atenolol,DB00041
DB00350,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Minoxidil.,Minoxidil,DB00041
DB00457,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Prazosin.,Prazosin,DB00041
DB00519,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Trandolapril.,Trandolapril,DB00041
DB00542,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Benazepril.,Benazepril,DB00041
DB00691,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Moexipril.,Moexipril,DB00041
DB00727,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nitroglycerin.,Nitroglycerin,DB00041
DB00796,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Candesartan cilexetil.,Candesartan cilexetil,DB00041
DB00797,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tolazoline.,Tolazoline,DB00041
DB00876,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Eprosartan.,Eprosartan,DB00041
DB00881,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Quinapril.,Quinapril,DB00041
DB00925,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Phenoxybenzamine.,Phenoxybenzamine,DB00041
DB00966,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Telmisartan.,Telmisartan,DB00041
DB01029,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Irbesartan.,Irbesartan,DB00041
DB01158,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bretylium.,Bretylium,DB00041
DB01162,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Terazosin.,Terazosin,DB00041
DB01193,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Acebutolol.,Acebutolol,DB00041
DB01197,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Captopril.,Captopril,DB00041
DB01340,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cilazapril.,Cilazapril,DB00041
DB01580,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Oxprenolol.,Oxprenolol,DB00041
DB08950,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Indoramin.,Indoramin,DB00041
DB09242,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Moxonidine.,Moxonidine,DB00041
DB11783,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Imidapril.,Imidapril,DB00041
DB00584,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Enalapril.,Enalapril,DB00041
DB00343,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Diltiazem.,Diltiazem,DB00041
DB00381,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Amlodipine.,Amlodipine,DB00041
DB00393,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nimodipine.,Nimodipine,DB00041
DB00528,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Lercanidipine.,Lercanidipine,DB00041
DB00622,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nicardipine.,Nicardipine,DB00041
DB00678,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Losartan.,Losartan,DB00041
DB01054,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nitrendipine.,Nitrendipine,DB00041
DB01244,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bepridil.,Bepridil,DB00041
DB04861,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nebivolol.,Nebivolol,DB00041
DB08931,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Riociguat.,Riociguat,DB00041
DB09026,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Aliskiren.,Aliskiren,DB00041
DB00295,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Morphine.,Morphine,DB00041
DB00297,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bupivacaine.,Bupivacaine,DB00041
DB00708,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sufentanil.,Sufentanil,DB00041
DB00883,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Isosorbide dinitrate.,Isosorbide dinitrate,DB00041
DB05271,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Rotigotine.,Rotigotine,DB00041
DB09227,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Barnidipine.,Barnidipine,DB00041
DB09232,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cilnidipine.,Cilnidipine,DB00041
DB00401,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nisoldipine.,Nisoldipine,DB00041
DB00575,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Clonidine.,Clonidine,DB00041
DB01023,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Felodipine.,Felodipine,DB00041
DB01200,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bromocriptine.,Bromocriptine,DB00041
DB01242,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Clomipramine.,Clomipramine,DB00041
DB09038,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Empagliflozin.,Empagliflozin,DB00041
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Aldesleukin.,G17DT,DB00041
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Aldesleukin.,PEV3A,DB00041
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Aldesleukin.,INGN 225,DB00041
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Aldesleukin.,Rindopepimut,DB00041
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Aldesleukin.,SRP 299,DB00041
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Aldesleukin.,GI-5005,DB00041
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Aldesleukin.,Vitespen,DB00041
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Aldesleukin.,TG4010,DB00041
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Aldesleukin.,Anthrax immune globulin human,DB00041
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Aldesleukin.","Rabies virus inactivated antigen, B",DB00041
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Aldesleukin.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen,DB00041
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Aldesleukin.,Rotavirus vaccine,DB00041
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Aldesleukin.","Rabies virus inactivated antigen, A",DB00041
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Aldesleukin.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen,DB00041
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Clostridium tetani toxoid antigen (formaldehyde inactivated),DB00041
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated),DB00041
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated),DB00041
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),DB00041
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated),DB00041
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Aldesleukin.,Typhoid Vi polysaccharide vaccine,DB00041
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Aldesleukin.,Hepatitis A Vaccine,DB00041
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Aldesleukin.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,DB00041
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated),DB00041
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated),DB00041
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated),DB00041
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated),DB00041
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Aldesleukin.,Human rabies virus immune globulin,DB00041
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Aldesleukin.,Hepatitis B Vaccine (Recombinant),DB00041
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Aldesleukin.,Tecemotide,DB00041
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Aldesleukin.,Typhoid vaccine,DB00041
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated),DB00041
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated),DB00041
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Aldesleukin.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen,DB00041
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated),DB00041
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Aldesleukin.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen,DB00041
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated),DB00041
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated),DB00041
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Aldesleukin.,Vaccinia virus strain new york city board of health live antigen,DB00041
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Aldesleukin.,Pertussis vaccine,DB00041
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Yersinia pestis 195/p antigen (formaldehyde inactivated),DB00041
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Aldesleukin.,Varicella Zoster Vaccine (Recombinant),DB00041
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Aldesleukin.,Modified vaccinia ankara,DB00041
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Aldesleukin.","Ebola Zaire vaccine (live, attenuated)",DB00041
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Aldesleukin.,Abciximab,DB00041
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Aldesleukin.,Eptifibatide,DB00041
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Aldesleukin.,Anagrelide,DB00041
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Aldesleukin.,Dipyridamole,DB00041
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Aldesleukin.,Iloprost,DB00041
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Aldesleukin.,Ridogrel,DB00041
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Aldesleukin.,Resveratrol,DB00041
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Aldesleukin.,Defibrotide,DB00041
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Aldesleukin.,Beraprost,DB00041
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Aldesleukin.,Ibudilast,DB00041
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Aldesleukin.,Andrographolide,DB00041
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Aldesleukin.,Caplacizumab,DB00041
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Aldesleukin.,Cangrelor,DB00041
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Aldesleukin.,Triflusal,DB00041
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Aldesleukin.,Icosapent ethyl,DB00041
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Aldesleukin.,Trapidil,DB00041
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Aldesleukin.,Sarpogrelate,DB00041
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Aldesleukin.,Ifetroban,DB00041
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Aldesleukin.,Butylphthalide,DB00041
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Aldesleukin.,Hydroxytyrosol,DB00041
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Aldesleukin.,Ramatroban,DB00041
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Aldesleukin.,Picotamide,DB00041
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Aldesleukin.,Cloricromen,DB00041
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Aldesleukin.,Buflomedil,DB00041
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Aldesleukin.,Relcovaptan,DB00041
DB12465,The risk or severity of bleeding can be increased when Aldesleukin is combined with Ketanserin.,Ketanserin,DB00041
DB13400,The risk or severity of bleeding can be increased when Aldesleukin is combined with Linsidomine.,Linsidomine,DB00041
DB12092,The risk or severity of bleeding can be increased when Aldesleukin is combined with Naftopidil.,Naftopidil,DB00041
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Aldesleukin.,Clopidogrel,DB00041
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Aldesleukin.,Sulfinpyrazone,DB00041
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Aldesleukin.,Tesmilifene,DB00041
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Aldesleukin.,Tranilast,DB00041
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Aldesleukin.,Ticagrelor,DB00041
DB09236,Aldesleukin may increase the hypotensive activities of Lacidipine.,Lacidipine,DB00041
DB00898,Ethanol may increase the hypotensive activities of Aldesleukin.,Ethanol,DB00041
DB11988,Ocrelizumab may increase the immunosuppressive activities of Aldesleukin.,Ocrelizumab,DB00041
DB13200,Aldesleukin may increase the myelosuppressive activities of Lipegfilgrastim.,Lipegfilgrastim,DB00041
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Aldesleukin.,Rubella virus vaccine,DB00041
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Aldesleukin.,Varicella Zoster Vaccine (Live/attenuated),DB00041
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Aldesleukin.,Bacillus calmette-guerin substrain tice live antigen,DB00041
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Aldesleukin.,Bacillus calmette-guerin substrain connaught live antigen,DB00041
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Aldesleukin.,Yellow Fever Vaccine,DB00041
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Aldesleukin.,Anthrax vaccine,DB00041
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Aldesleukin.,Typhoid Vaccine Live,DB00041
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Aldesleukin.,Bacillus calmette-guerin substrain danish 1331 live antigen,DB00041
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Aldesleukin.,BCG vaccine,DB00041
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Aldesleukin.,Human adenovirus e serotype 4 strain cl-68578 antigen,DB00041
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Aldesleukin.,Vibrio cholerae CVD 103-HgR strain live antigen,DB00041
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Aldesleukin.,Adenovirus type 7 vaccine live,DB00041
DB01238,The metabolism of Aripiprazole can be decreased when combined with Aldesleukin.,Aripiprazole,DB00041
DB14185,The metabolism of Aripiprazole lauroxil can be decreased when combined with Aldesleukin.,Aripiprazole lauroxil,DB00041
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Aldesleukin.,Palifermin,DB00041
DB00159,Icosapent may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Icosapent,DB00041
DB00229,Cefotiam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefotiam,DB00041
DB00244,Mesalazine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Mesalazine,DB00041
DB00267,Cefmenoxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefmenoxime,DB00041
DB00274,Cefmetazole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefmetazole,DB00041
DB00282,Pamidronic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Pamidronic acid,DB00041
DB00300,Tenofovir disoproxil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tenofovir disoproxil,DB00041
DB00369,Cidofovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cidofovir,DB00041
DB00384,Triamterene may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Triamterene,DB00041
DB00430,Cefpiramide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefpiramide,DB00041
DB00438,Ceftazidime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftazidime,DB00041
DB00447,Loracarbef may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Loracarbef,DB00041
DB00456,Cefalotin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefalotin,DB00041
DB00461,Nabumetone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Nabumetone,DB00041
DB00465,Ketorolac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ketorolac,DB00041
DB00469,Tenoxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tenoxicam,DB00041
DB00482,Celecoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Celecoxib,DB00041
DB00493,Cefotaxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefotaxime,DB00041
DB00500,Tolmetin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tolmetin,DB00041
DB00529,Foscarnet may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Foscarnet,DB00041
DB00533,Rofecoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Rofecoxib,DB00041
DB00554,Piroxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Piroxicam,DB00041
DB00567,Cephalexin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cephalexin,DB00041
DB00573,Fenoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Fenoprofen,DB00041
DB00577,Valaciclovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Valaciclovir,DB00041
DB00580,Valdecoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Valdecoxib,DB00041
DB00586,Diclofenac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Diclofenac,DB00041
DB00605,Sulindac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Sulindac,DB00041
DB00626,Bacitracin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Bacitracin,DB00041
DB00681,Amphotericin B may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Amphotericin B,DB00041
DB00689,Cephaloglycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cephaloglycin,DB00041
DB00712,Flurbiprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Flurbiprofen,DB00041
DB00718,Adefovir dipivoxil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Adefovir dipivoxil,DB00041
DB00738,Pentamidine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Pentamidine,DB00041
DB00742,Mannitol may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Mannitol,DB00041
DB00749,Etodolac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Etodolac,DB00041
DB00784,Mefenamic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Mefenamic acid,DB00041
DB00787,Acyclovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Acyclovir,DB00041
DB00788,Naproxen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Naproxen,DB00041
DB00812,Phenylbutazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Phenylbutazone,DB00041
DB00814,Meloxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Meloxicam,DB00041
DB00821,Carprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Carprofen,DB00041
DB00833,Cefaclor may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefaclor,DB00041
DB00861,Diflunisal may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Diflunisal,DB00041
DB00903,Etacrynic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Etacrynic acid,DB00041
DB00923,Ceforanide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceforanide,DB00041
DB00936,Salicylic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Salicylic acid,DB00041
DB00939,Meclofenamic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Meclofenamic acid,DB00041
DB00945,Acetylsalicylic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Acetylsalicylic acid,DB00041
DB00991,Oxaprozin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Oxaprozin,DB00041
DB00999,Hydrochlorothiazide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Hydrochlorothiazide,DB00041
DB01009,Ketoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ketoprofen,DB00041
DB01014,Balsalazide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Balsalazide,DB00041
DB01050,Ibuprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ibuprofen,DB00041
DB01066,Cefditoren may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefditoren,DB00041
DB01072,Atazanavir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Atazanavir,DB00041
DB01111,Colistimethate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Colistimethate,DB00041
DB01112,Cefuroxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefuroxime,DB00041
DB01139,Cefapirin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefapirin,DB00041
DB01140,Cefadroxil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefadroxil,DB00041
DB01150,Cefprozil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefprozil,DB00041
DB01212,Ceftriaxone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftriaxone,DB00041
DB01250,Olsalazine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Olsalazine,DB00041
DB01283,Lumiracoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Lumiracoxib,DB00041
DB01326,Cefamandole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefamandole,DB00041
DB01327,Cefazolin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefazolin,DB00041
DB01328,Cefonicid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefonicid,DB00041
DB01329,Cefoperazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefoperazone,DB00041
DB01330,Cefotetan may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefotetan,DB00041
DB01331,Cefoxitin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefoxitin,DB00041
DB01332,Ceftizoxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftizoxime,DB00041
DB01333,Cefradine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefradine,DB00041
DB01397,Magnesium salicylate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Magnesium salicylate,DB00041
DB01399,Salsalate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Salsalate,DB00041
DB01401,Choline magnesium trisalicylate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Choline magnesium trisalicylate,DB00041
DB01413,Cefepime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefepime,DB00041
DB01414,Cefacetrile may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefacetrile,DB00041
DB01415,Ceftibuten may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftibuten,DB00041
DB01416,Cefpodoxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefpodoxime,DB00041
DB01419,Antrafenine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Antrafenine,DB00041
DB01424,Aminophenazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Aminophenazone,DB00041
DB01435,Antipyrine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Antipyrine,DB00041
DB01600,Tiaprofenic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tiaprofenic acid,DB00041
DB01628,Etoricoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Etoricoxib,DB00041
DB02247,Hydrolyzed Cephalothin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Hydrolyzed Cephalothin,DB00041
DB03450,Cephalothin Group may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cephalothin Group,DB00041
DB03585,Oxyphenbutazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Oxyphenbutazone,DB00041
DB04552,Niflumic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Niflumic acid,DB00041
DB04570,Latamoxef may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Latamoxef,DB00041
DB04743,Nimesulide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Nimesulide,DB00041
DB04812,Benoxaprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Benoxaprofen,DB00041
DB04817,Metamizole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Metamizole,DB00041
DB04828,Zomepirac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Zomepirac,DB00041
DB04918,Ceftobiprole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftobiprole,DB00041
DB05095,Cimicoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cimicoxib,DB00041
DB06590,Ceftaroline fosamil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftaroline fosamil,DB00041
DB06725,Lornoxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Lornoxicam,DB00041
DB06736,Aceclofenac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Aceclofenac,DB00041
DB06737,Zaltoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Zaltoprofen,DB00041
DB07402,Azapropazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Azapropazone,DB00041
DB07477,Felbinac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Felbinac,DB00041
DB08439,Parecoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Parecoxib,DB00041
DB08797,Salicylamide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Salicylamide,DB00041
DB08940,Kebuzone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Kebuzone,DB00041
DB08942,Isoxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Isoxicam,DB00041
DB08951,Indoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Indoprofen,DB00041
DB08955,Ibuproxam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ibuproxam,DB00041
DB08976,Floctafenine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Floctafenine,DB00041
DB08981,Fenbufen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Fenbufen,DB00041
DB08984,Etofenamate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Etofenamate,DB00041
DB08991,Epirizole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Epirizole,DB00041
DB09008,Cefaloridine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefaloridine,DB00041
DB09062,Cefminox may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefminox,DB00041
DB09084,Benzydamine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Benzydamine,DB00041
DB09212,Loxoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Loxoprofen,DB00041
DB09213,Dexibuprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Dexibuprofen,DB00041
DB09214,Dexketoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Dexketoprofen,DB00041
DB09215,Droxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Droxicam,DB00041
DB09216,Tolfenamic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tolfenamic acid,DB00041
DB09217,Firocoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Firocoxib,DB00041
DB09218,Clonixin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Clonixin,DB00041
DB09285,Morniflumate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Morniflumate,DB00041
DB09295,Talniflumate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Talniflumate,DB00041
DB09299,Tenofovir alafenamide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tenofovir alafenamide,DB00041
DB11367,Cefroxadine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefroxadine,DB00041
DB11455,Robenacoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Robenacoxib,DB00041
DB11518,Flunixin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Flunixin,DB00041
DB11935,Flomoxef may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Flomoxef,DB00041
DB12151,Brincidofovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Brincidofovir,DB00041
DB12445,Nitroaspirin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Nitroaspirin,DB00041
DB12545,Indobufen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Indobufen,DB00041
DB13001,Tinoridine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tinoridine,DB00041
DB13167,Alclofenac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Alclofenac,DB00041
DB13217,Fentiazac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Fentiazac,DB00041
DB13232,Suxibuzone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Suxibuzone,DB00041
DB13266,Cefatrizine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefatrizine,DB00041
DB13286,Bumadizone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Bumadizone,DB00041
DB13314,Alminoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Alminoprofen,DB00041
DB13317,Flunoxaprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Flunoxaprofen,DB00041
DB13364,Feprazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Feprazone,DB00041
DB13371,Difenpiramide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Difenpiramide,DB00041
DB13407,Nifenazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Nifenazone,DB00041
DB13432,Lonazolac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Lonazolac,DB00041
DB13461,Cefcapene may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefcapene,DB00041
DB13470,Cefodizime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefodizime,DB00041
DB13481,Tenidap may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tenidap,DB00041
DB13499,Cefsulodin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefsulodin,DB00041
DB13501,Bendazac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Bendazac,DB00041
DB13504,Cefetamet may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefetamet,DB00041
DB13514,Pranoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Pranoprofen,DB00041
DB13524,Propyphenazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Propyphenazone,DB00041
DB13527,Proglumetacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Proglumetacin,DB00041
DB13538,Guacetisal may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Guacetisal,DB00041
DB13544,Ethenzamide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ethenzamide,DB00041
DB13612,Carbaspirin calcium may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Carbaspirin calcium,DB00041
DB13629,Mofebutazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Mofebutazone,DB00041
DB13638,Cefbuperazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefbuperazone,DB00041
DB13649,Proquazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Proquazone,DB00041
DB13657,Benorilate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Benorilate,DB00041
DB13667,Cefozopran may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefozopran,DB00041
DB13682,Cefpirome may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefpirome,DB00041
DB13722,Pirprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Pirprofen,DB00041
DB13778,Cefazedone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefazedone,DB00041
DB13783,Acemetacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Acemetacin,DB00041
DB13821,Ceftezole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftezole,DB00041
DB13860,Imidazole salicylate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Imidazole salicylate,DB00041
DB13868,Adefovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Adefovir,DB00041
DB14059,SC-236 may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,SC-236,DB00041
DB14060,NS-398 may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,NS-398,DB00041
DB14126,Tenofovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tenofovir,DB00041
DB14713,Inotersen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Inotersen,DB00041
DB01438,Phenazopyridine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Phenazopyridine,DB00041
DB15066,Givosiran may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Givosiran,DB00041
DB01356,Lithium cation may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Lithium cation,DB00041
DB14507,Lithium citrate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Lithium citrate,DB00041
DB00007,Leuprolide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Leuprolide,DB00041
DB00014,Goserelin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Goserelin,DB00041
DB00035,Desmopressin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Desmopressin,DB00041
DB00080,Aldesleukin may decrease the excretion rate of Daptomycin which could result in a higher serum level.,Daptomycin,DB00041
DB00158,Aldesleukin may decrease the excretion rate of Folic acid which could result in a higher serum level.,Folic acid,DB00041
DB00165,Aldesleukin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,Pyridoxine,DB00041
DB00176,Aldesleukin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,Fluvoxamine,DB00041
DB00181,Aldesleukin may decrease the excretion rate of Baclofen which could result in a higher serum level.,Baclofen,DB00041
DB00185,Aldesleukin may decrease the excretion rate of Cevimeline which could result in a higher serum level.,Cevimeline,DB00041
DB00190,Aldesleukin may decrease the excretion rate of Carbidopa which could result in a higher serum level.,Carbidopa,DB00041
DB00196,Aldesleukin may decrease the excretion rate of Fluconazole which could result in a higher serum level.,Fluconazole,DB00041
DB00198,Aldesleukin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,Oseltamivir,DB00041
DB00200,Aldesleukin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,Hydroxocobalamin,DB00041
DB00206,Aldesleukin may decrease the excretion rate of Reserpine which could result in a higher serum level.,Reserpine,DB00041
DB00213,Aldesleukin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.,Pantoprazole,DB00041
DB00225,Aldesleukin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,Gadodiamide,DB00041
DB00230,Aldesleukin may decrease the excretion rate of Pregabalin which could result in a higher serum level.,Pregabalin,DB00041
DB00231,Aldesleukin may decrease the excretion rate of Temazepam which could result in a higher serum level.,Temazepam,DB00041
DB00235,Aldesleukin may decrease the excretion rate of Milrinone which could result in a higher serum level.,Milrinone,DB00041
DB00243,Aldesleukin may decrease the excretion rate of Ranolazine which could result in a higher serum level.,Ranolazine,DB00041
DB00245,Aldesleukin may decrease the excretion rate of Benzatropine which could result in a higher serum level.,Benzatropine,DB00041
DB00254,Aldesleukin may decrease the excretion rate of Doxycycline which could result in a higher serum level.,Doxycycline,DB00041
DB00270,Aldesleukin may decrease the excretion rate of Isradipine which could result in a higher serum level.,Isradipine,DB00041
DB00273,Aldesleukin may decrease the excretion rate of Topiramate which could result in a higher serum level.,Topiramate,DB00041
DB00280,Aldesleukin may decrease the excretion rate of Disopyramide which could result in a higher serum level.,Disopyramide,DB00041
DB00284,Aldesleukin may decrease the excretion rate of Acarbose which could result in a higher serum level.,Acarbose,DB00041
DB00285,Aldesleukin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,Venlafaxine,DB00041
DB00286,Aldesleukin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,Conjugated estrogens,DB00041
DB00289,Aldesleukin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.,Atomoxetine,DB00041
DB00292,Aldesleukin may decrease the excretion rate of Etomidate which could result in a higher serum level.,Etomidate,DB00041
DB00294,Aldesleukin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,Etonogestrel,DB00041
DB00296,Aldesleukin may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,Ropivacaine,DB00041
DB00303,Aldesleukin may decrease the excretion rate of Ertapenem which could result in a higher serum level.,Ertapenem,DB00041
DB00308,Aldesleukin may decrease the excretion rate of Ibutilide which could result in a higher serum level.,Ibutilide,DB00041
DB00319,Aldesleukin may decrease the excretion rate of Piperacillin which could result in a higher serum level.,Piperacillin,DB00041
DB00323,Aldesleukin may decrease the excretion rate of Tolcapone which could result in a higher serum level.,Tolcapone,DB00041
DB00325,Aldesleukin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,Nitroprusside,DB00041
DB00327,Aldesleukin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,Hydromorphone,DB00041
DB00330,Aldesleukin may decrease the excretion rate of Ethambutol which could result in a higher serum level.,Ethambutol,DB00041
DB00331,Aldesleukin may decrease the excretion rate of Metformin which could result in a higher serum level.,Metformin,DB00041
DB00333,Aldesleukin may decrease the excretion rate of Methadone which could result in a higher serum level.,Methadone,DB00041
DB00339,Aldesleukin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,Pyrazinamide,DB00041
DB00341,Aldesleukin may decrease the excretion rate of Cetirizine which could result in a higher serum level.,Cetirizine,DB00041
DB00349,Aldesleukin may decrease the excretion rate of Clobazam which could result in a higher serum level.,Clobazam,DB00041
DB00351,Aldesleukin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,Megestrol acetate,DB00041
DB00355,Aldesleukin may decrease the excretion rate of Aztreonam which could result in a higher serum level.,Aztreonam,DB00041
DB00359,Aldesleukin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,Sulfadiazine,DB00041
DB00364,Aldesleukin may decrease the excretion rate of Sucralfate which could result in a higher serum level.,Sucralfate,DB00041
DB00372,Aldesleukin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,Thiethylperazine,DB00041
DB00373,Aldesleukin may decrease the excretion rate of Timolol which could result in a higher serum level.,Timolol,DB00041
DB00377,Aldesleukin may decrease the excretion rate of Palonosetron which could result in a higher serum level.,Palonosetron,DB00041
DB00412,Aldesleukin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,Rosiglitazone,DB00041
DB00413,Aldesleukin may decrease the excretion rate of Pramipexole which could result in a higher serum level.,Pramipexole,DB00041
DB00415,Aldesleukin may decrease the excretion rate of Ampicillin which could result in a higher serum level.,Ampicillin,DB00041
DB00422,Aldesleukin may decrease the excretion rate of Methylphenidate which could result in a higher serum level.,Methylphenidate,DB00041
DB00435,Aldesleukin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,Nitric Oxide,DB00041
DB00440,Aldesleukin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.,Trimethoprim,DB00041
DB00492,Aldesleukin may decrease the excretion rate of Fosinopril which could result in a higher serum level.,Fosinopril,DB00041
DB00499,Aldesleukin may decrease the excretion rate of Flutamide which could result in a higher serum level.,Flutamide,DB00041
DB00535,Aldesleukin may decrease the excretion rate of Cefdinir which could result in a higher serum level.,Cefdinir,DB00041
DB00537,Aldesleukin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.,Ciprofloxacin,DB00041
DB00548,Aldesleukin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.,Azelaic acid,DB00041
DB00553,Aldesleukin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.,Methoxsalen,DB00041
DB00555,Aldesleukin may decrease the excretion rate of Lamotrigine which could result in a higher serum level.,Lamotrigine,DB00041
DB00558,Aldesleukin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,Zanamivir,DB00041
DB00569,Aldesleukin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.,Fondaparinux,DB00041
DB00571,Aldesleukin may decrease the excretion rate of Propranolol which could result in a higher serum level.,Propranolol,DB00041
DB00583,Aldesleukin may decrease the excretion rate of Levocarnitine which could result in a higher serum level.,Levocarnitine,DB00041
DB00597,Aldesleukin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,Gadoteridol,DB00041
DB00598,Aldesleukin may decrease the excretion rate of Labetalol which could result in a higher serum level.,Labetalol,DB00041
DB00603,Aldesleukin may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.,Medroxyprogesterone acetate,DB00041
DB00608,Aldesleukin may decrease the excretion rate of Chloroquine which could result in a higher serum level.,Chloroquine,DB00041
DB00612,Aldesleukin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,Bisoprolol,DB00041
DB00624,Aldesleukin may decrease the excretion rate of Testosterone which could result in a higher serum level.,Testosterone,DB00041
DB00628,Aldesleukin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.,Clorazepic acid,DB00041
DB00633,Aldesleukin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.,Dexmedetomidine,DB00041
DB00651,Aldesleukin may decrease the excretion rate of Dyphylline which could result in a higher serum level.,Dyphylline,DB00041
DB00657,Aldesleukin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.,Mecamylamine,DB00041
DB00660,Aldesleukin may decrease the excretion rate of Metaxalone which could result in a higher serum level.,Metaxalone,DB00041
DB00661,Aldesleukin may decrease the excretion rate of Verapamil which could result in a higher serum level.,Verapamil,DB00041
DB00665,Aldesleukin may decrease the excretion rate of Nilutamide which could result in a higher serum level.,Nilutamide,DB00041
DB00669,Aldesleukin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.,Sumatriptan,DB00041
DB00672,Aldesleukin may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.,Chlorpropamide,DB00041
DB00690,Aldesleukin may decrease the excretion rate of Flurazepam which could result in a higher serum level.,Flurazepam,DB00041
DB00692,Aldesleukin may decrease the excretion rate of Phentolamine which could result in a higher serum level.,Phentolamine,DB00041
DB00698,Aldesleukin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,Nitrofurantoin,DB00041
DB00706,Aldesleukin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.,Tamsulosin,DB00041
DB00709,Aldesleukin may decrease the excretion rate of Lamivudine which could result in a higher serum level.,Lamivudine,DB00041
DB00713,Aldesleukin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,Oxacillin,DB00041
DB00716,Aldesleukin may decrease the excretion rate of Nedocromil which could result in a higher serum level.,Nedocromil,DB00041
DB00722,Aldesleukin may decrease the excretion rate of Lisinopril which could result in a higher serum level.,Lisinopril,DB00041
DB00730,Aldesleukin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.,Thiabendazole,DB00041
DB00731,Aldesleukin may decrease the excretion rate of Nateglinide which could result in a higher serum level.,Nateglinide,DB00041
DB00733,Aldesleukin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.,Pralidoxime,DB00041
DB00743,Aldesleukin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,Gadobenic acid,DB00041
DB00759,Aldesleukin may decrease the excretion rate of Tetracycline which could result in a higher serum level.,Tetracycline,DB00041
DB00760,Aldesleukin may decrease the excretion rate of Meropenem which could result in a higher serum level.,Meropenem,DB00041
DB00761,Aldesleukin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.,Potassium chloride,DB00041
DB00775,Aldesleukin may decrease the excretion rate of Tirofiban which could result in a higher serum level.,Tirofiban,DB00041
DB00782,Aldesleukin may decrease the excretion rate of Propantheline which could result in a higher serum level.,Propantheline,DB00041
DB00783,Aldesleukin may decrease the excretion rate of Estradiol which could result in a higher serum level.,Estradiol,DB00041
DB00789,Aldesleukin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,Gadopentetic acid,DB00041
DB00790,Aldesleukin may decrease the excretion rate of Perindopril which could result in a higher serum level.,Perindopril,DB00041
DB00800,Aldesleukin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.,Fenoldopam,DB00041
DB00804,Aldesleukin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.,Dicyclomine,DB00041
DB00806,Aldesleukin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.,Pentoxifylline,DB00041
DB00811,Aldesleukin may decrease the excretion rate of Ribavirin which could result in a higher serum level.,Ribavirin,DB00041
DB00828,Aldesleukin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.,Fosfomycin,DB00041
DB00829,Aldesleukin may decrease the excretion rate of Diazepam which could result in a higher serum level.,Diazepam,DB00041
DB00839,Aldesleukin may decrease the excretion rate of Tolazamide which could result in a higher serum level.,Tolazamide,DB00041
DB00841,Aldesleukin may decrease the excretion rate of Dobutamine which could result in a higher serum level.,Dobutamine,DB00041
DB00842,Aldesleukin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,Oxazepam,DB00041
DB00863,Aldesleukin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,Ranitidine,DB00041
DB00871,Aldesleukin may decrease the excretion rate of Terbutaline which could result in a higher serum level.,Terbutaline,DB00041
DB00894,Aldesleukin may decrease the excretion rate of Testolactone which could result in a higher serum level.,Testolactone,DB00041
DB00900,Aldesleukin may decrease the excretion rate of Didanosine which could result in a higher serum level.,Didanosine,DB00041
DB00911,Aldesleukin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,Tinidazole,DB00041
DB00915,Aldesleukin may decrease the excretion rate of Amantadine which could result in a higher serum level.,Amantadine,DB00041
DB00918,Aldesleukin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,Almotriptan,DB00041
DB00934,Aldesleukin may decrease the excretion rate of Maprotiline which could result in a higher serum level.,Maprotiline,DB00041
DB00951,Aldesleukin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,Isoniazid,DB00041
DB00953,Aldesleukin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,Rizatriptan,DB00041
DB00960,Aldesleukin may decrease the excretion rate of Pindolol which could result in a higher serum level.,Pindolol,DB00041
DB00961,Aldesleukin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,Mepivacaine,DB00041
DB00962,Aldesleukin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,Zaleplon,DB00041
DB00968,Aldesleukin may decrease the excretion rate of Methyldopa which could result in a higher serum level.,Methyldopa,DB00041
DB00980,Aldesleukin may decrease the excretion rate of Ramelteon which could result in a higher serum level.,Ramelteon,DB00041
DB00988,Aldesleukin may decrease the excretion rate of Dopamine which could result in a higher serum level.,Dopamine,DB00041
DB00995,Aldesleukin may decrease the excretion rate of Auranofin which could result in a higher serum level.,Auranofin,DB00041
DB01001,Aldesleukin may decrease the excretion rate of Salbutamol which could result in a higher serum level.,Salbutamol,DB00041
DB01002,Aldesleukin may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,Levobupivacaine,DB00041
DB01004,Aldesleukin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,Ganciclovir,DB00041
DB01010,Aldesleukin may decrease the excretion rate of Edrophonium which could result in a higher serum level.,Edrophonium,DB00041
DB01011,Aldesleukin may decrease the excretion rate of Metyrapone which could result in a higher serum level.,Metyrapone,DB00041
DB01018,Aldesleukin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,Guanfacine,DB00041
DB01020,Aldesleukin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,Isosorbide mononitrate,DB00041
DB01022,Aldesleukin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,Phylloquinone,DB00041
DB01032,Aldesleukin may decrease the excretion rate of Probenecid which could result in a higher serum level.,Probenecid,DB00041
DB01036,Aldesleukin may decrease the excretion rate of Tolterodine which could result in a higher serum level.,Tolterodine,DB00041
DB01043,Aldesleukin may decrease the excretion rate of Memantine which could result in a higher serum level.,Memantine,DB00041
DB01046,Aldesleukin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.,Lubiprostone,DB00041
DB01048,Aldesleukin may decrease the excretion rate of Abacavir which could result in a higher serum level.,Abacavir,DB00041
DB01060,Aldesleukin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.,Amoxicillin,DB00041
DB01067,Aldesleukin may decrease the excretion rate of Glipizide which could result in a higher serum level.,Glipizide,DB00041
DB01068,Aldesleukin may decrease the excretion rate of Clonazepam which could result in a higher serum level.,Clonazepam,DB00041
DB01069,Aldesleukin may decrease the excretion rate of Promethazine which could result in a higher serum level.,Promethazine,DB00041
DB01093,Aldesleukin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.,Dimethyl sulfoxide,DB00041
DB01105,Aldesleukin may decrease the excretion rate of Sibutramine which could result in a higher serum level.,Sibutramine,DB00041
DB01115,Aldesleukin may decrease the excretion rate of Nifedipine which could result in a higher serum level.,Nifedipine,DB00041
DB01124,Aldesleukin may decrease the excretion rate of Tolbutamide which could result in a higher serum level.,Tolbutamide,DB00041
DB01129,Aldesleukin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.,Rabeprazole,DB00041
DB01133,Aldesleukin may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.,Tiludronic acid,DB00041
DB01135,Aldesleukin may decrease the excretion rate of Doxacurium which could result in a higher serum level.,Doxacurium,DB00041
DB01137,Aldesleukin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.,Levofloxacin,DB00041
DB01148,Aldesleukin may decrease the excretion rate of Flavoxate which could result in a higher serum level.,Flavoxate,DB00041
DB01149,Aldesleukin may decrease the excretion rate of Nefazodone which could result in a higher serum level.,Nefazodone,DB00041
DB01156,Aldesleukin may decrease the excretion rate of Bupropion which could result in a higher serum level.,Bupropion,DB00041
DB01157,Aldesleukin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.,Trimetrexate,DB00041
DB01170,Aldesleukin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,Guanethidine,DB00041
DB01183,Aldesleukin may decrease the excretion rate of Naloxone which could result in a higher serum level.,Naloxone,DB00041
DB01203,Aldesleukin may decrease the excretion rate of Nadolol which could result in a higher serum level.,Nadolol,DB00041
DB01205,Aldesleukin may decrease the excretion rate of Flumazenil which could result in a higher serum level.,Flumazenil,DB00041
DB01213,Aldesleukin may decrease the excretion rate of Fomepizole which could result in a higher serum level.,Fomepizole,DB00041
DB01215,Aldesleukin may decrease the excretion rate of Estazolam which could result in a higher serum level.,Estazolam,DB00041
DB01221,Aldesleukin may decrease the excretion rate of Ketamine which could result in a higher serum level.,Ketamine,DB00041
DB01233,Aldesleukin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,Metoclopramide,DB00041
DB01240,Aldesleukin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,Epoprostenol,DB00041
DB01241,Aldesleukin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,Gemfibrozil,DB00041
DB01261,Aldesleukin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,Sitagliptin,DB00041
DB01267,Aldesleukin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,Paliperidone,DB00041
DB01273,Aldesleukin may decrease the excretion rate of Varenicline which could result in a higher serum level.,Varenicline,DB00041
DB01274,Aldesleukin may decrease the excretion rate of Arformoterol which could result in a higher serum level.,Arformoterol,DB00041
DB01275,Aldesleukin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,Hydralazine,DB00041
DB01359,Aldesleukin may decrease the excretion rate of Penbutolol which could result in a higher serum level.,Penbutolol,DB00041
DB01409,Aldesleukin may decrease the excretion rate of Tiotropium which could result in a higher serum level.,Tiotropium,DB00041
DB01420,Aldesleukin may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.,Testosterone propionate,DB00041
DB01427,Aldesleukin may decrease the excretion rate of Amrinone which could result in a higher serum level.,Amrinone,DB00041
DB01428,Aldesleukin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,Oxybenzone,DB00041
DB01550,Aldesleukin may decrease the excretion rate of Fenproporex which could result in a higher serum level.,Fenproporex,DB00041
DB01558,Aldesleukin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,Bromazepam,DB00041
DB01563,Aldesleukin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.,Chloral hydrate,DB00041
DB01577,Aldesleukin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.,Metamfetamine,DB00041
DB01587,Aldesleukin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,Ketazolam,DB00041
DB01610,Aldesleukin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,Valganciclovir,DB00041
DB01638,Aldesleukin may decrease the excretion rate of Sorbitol which could result in a higher serum level.,Sorbitol,DB00041
DB01685,Aldesleukin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,Topiroxostat,DB00041
DB04574,Aldesleukin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,Estrone sulfate,DB00041
DB04871,Aldesleukin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,Lorcaserin,DB00041
DB04895,Aldesleukin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,Pegaptanib,DB00041
DB04896,Aldesleukin may decrease the excretion rate of Milnacipran which could result in a higher serum level.,Milnacipran,DB00041
DB04920,Aldesleukin may decrease the excretion rate of Clevidipine which could result in a higher serum level.,Clevidipine,DB00041
DB04948,Aldesleukin may decrease the excretion rate of Lofexidine which could result in a higher serum level.,Lofexidine,DB00041
DB04953,Aldesleukin may decrease the excretion rate of Ezogabine which could result in a higher serum level.,Ezogabine,DB00041
DB05018,Aldesleukin may decrease the excretion rate of Migalastat which could result in a higher serum level.,Migalastat,DB00041
DB05541,Aldesleukin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,Brivaracetam,DB00041
DB06154,Aldesleukin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,Pentaerythritol tetranitrate,DB00041
DB06186,Aldesleukin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,Ipilimumab,DB00041
DB06196,Aldesleukin may decrease the excretion rate of Icatibant which could result in a higher serum level.,Icatibant,DB00041
DB06203,Aldesleukin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,Alogliptin,DB00041
DB06209,Aldesleukin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,Prasugrel,DB00041
DB06211,Aldesleukin may decrease the excretion rate of Doripenem which could result in a higher serum level.,Doripenem,DB00041
DB06230,Aldesleukin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,Nalmefene,DB00041
DB06262,Aldesleukin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,Droxidopa,DB00041
DB06282,Aldesleukin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,Levocetirizine,DB00041
DB06335,Aldesleukin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,Saxagliptin,DB00041
DB06402,Aldesleukin may decrease the excretion rate of Telavancin which could result in a higher serum level.,Telavancin,DB00041
DB06623,Aldesleukin may decrease the excretion rate of Flupirtine which could result in a higher serum level.,Flupirtine,DB00041
DB06637,Aldesleukin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,Dalfampridine,DB00041
DB06695,Aldesleukin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,Dabigatran etexilate,DB00041
DB06700,Aldesleukin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.,Desvenlafaxine,DB00041
DB06702,Aldesleukin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,Fesoterodine,DB00041
DB06705,Aldesleukin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,Gadofosveset trisodium,DB00041
DB06710,Aldesleukin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,Methyltestosterone,DB00041
DB06767,Aldesleukin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,Ammonium chloride,DB00041
DB06782,Aldesleukin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,Dimercaprol,DB00041
DB06796,Aldesleukin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,Mangafodipir,DB00041
DB06800,Aldesleukin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,Methylnaltrexone,DB00041
DB06809,Aldesleukin may decrease the excretion rate of Plerixafor which could result in a higher serum level.,Plerixafor,DB00041
DB06823,Aldesleukin may decrease the excretion rate of Tiopronin which could result in a higher serum level.,Tiopronin,DB00041
DB06824,Aldesleukin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,Triethylenetetramine,DB00041
DB08824,Aldesleukin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,Ioflupane I-123,DB00041
DB08826,Aldesleukin may decrease the excretion rate of Deferiprone which could result in a higher serum level.,Deferiprone,DB00041
DB08840,Aldesleukin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,N-methylnicotinamide,DB00041
DB08872,Aldesleukin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,Gabapentin enacarbil,DB00041
DB08893,Aldesleukin may decrease the excretion rate of Mirabegron which could result in a higher serum level.,Mirabegron,DB00041
DB08897,Aldesleukin may decrease the excretion rate of Aclidinium which could result in a higher serum level.,Aclidinium,DB00041
DB08899,Aldesleukin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,Enzalutamide,DB00041
DB08900,Aldesleukin may decrease the excretion rate of Teduglutide which could result in a higher serum level.,Teduglutide,DB00041
DB08905,Aldesleukin may decrease the excretion rate of Formestane which could result in a higher serum level.,Formestane,DB00041
DB08909,Aldesleukin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,Glycerol phenylbutyrate,DB00041
DB08911,Aldesleukin may decrease the excretion rate of Trametinib which could result in a higher serum level.,Trametinib,DB00041
DB08918,Aldesleukin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,Levomilnacipran,DB00041
DB08932,Aldesleukin may decrease the excretion rate of Macitentan which could result in a higher serum level.,Macitentan,DB00041
DB08934,Aldesleukin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,Sofosbuvir,DB00041
DB08964,Aldesleukin may decrease the excretion rate of Gemeprost which could result in a higher serum level.,Gemeprost,DB00041
DB09027,Aldesleukin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,Ledipasvir,DB00041
DB09050,Aldesleukin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,Ceftolozane,DB00041
DB09066,Aldesleukin may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,Corifollitropin alfa,DB00041
DB09068,Aldesleukin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,Vortioxetine,DB00041
DB09075,Aldesleukin may decrease the excretion rate of Edoxaban which could result in a higher serum level.,Edoxaban,DB00041
DB09081,Aldesleukin may decrease the excretion rate of Idebenone which could result in a higher serum level.,Idebenone,DB00041
DB09089,Aldesleukin may decrease the excretion rate of Trimebutine which could result in a higher serum level.,Trimebutine,DB00041
DB09103,Aldesleukin may decrease the excretion rate of Ancestim which could result in a higher serum level.,Ancestim,DB00041
DB09104,Aldesleukin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.,Magnesium hydroxide,DB00041
DB09106,Aldesleukin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,Hydroxyethyl Starch,DB00041
DB09111,Aldesleukin may decrease the excretion rate of Pentastarch which could result in a higher serum level.,Pentastarch,DB00041
DB09118,Aldesleukin may decrease the excretion rate of Stiripentol which could result in a higher serum level.,Stiripentol,DB00041
DB09121,Aldesleukin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.,Aurothioglucose,DB00041
DB09123,Aldesleukin may decrease the excretion rate of Dienogest which could result in a higher serum level.,Dienogest,DB00041
DB09129,Aldesleukin may decrease the excretion rate of Chromic chloride which could result in a higher serum level.,Chromic chloride,DB00041
DB09132,Aldesleukin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,Gadoteric acid,DB00041
DB09133,Aldesleukin may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.,Iothalamic acid,DB00041
DB09136,Aldesleukin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.,Isosulfan blue,DB00041
DB09137,Aldesleukin may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.,Technetium Tc-99m mebrofenin,DB00041
DB09139,Aldesleukin may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.,Technetium Tc-99m oxidronate,DB00041
DB09148,Aldesleukin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.,Florbetaben (18F),DB00041
DB09149,Aldesleukin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.,Florbetapir (18F),DB00041
DB09163,Aldesleukin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.,Technetium Tc-99m exametazime,DB00041
DB09165,Aldesleukin may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.,Technetium Tc-99m pyrophosphate,DB00041
DB09185,Aldesleukin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,Viloxazine,DB00041
DB09194,Aldesleukin may decrease the excretion rate of Etoperidone which could result in a higher serum level.,Etoperidone,DB00041
DB09195,Aldesleukin may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.,Lorpiprazole,DB00041
DB09204,Aldesleukin may decrease the excretion rate of Arotinolol which could result in a higher serum level.,Arotinolol,DB00041
DB09205,Aldesleukin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.,Moxisylyte,DB00041
DB09209,Aldesleukin may decrease the excretion rate of Pholcodine which could result in a higher serum level.,Pholcodine,DB00041
DB09210,Aldesleukin may decrease the excretion rate of Piracetam which could result in a higher serum level.,Piracetam,DB00041
DB09219,Aldesleukin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,Bisoxatin,DB00041
DB09223,Aldesleukin may decrease the excretion rate of Blonanserin which could result in a higher serum level.,Blonanserin,DB00041
DB09224,Aldesleukin may decrease the excretion rate of Melperone which could result in a higher serum level.,Melperone,DB00041
DB09255,Aldesleukin may decrease the excretion rate of Dextran which could result in a higher serum level.,Dextran,DB00041
DB09256,Aldesleukin may decrease the excretion rate of Tegafur which could result in a higher serum level.,Tegafur,DB00041
DB09257,Aldesleukin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,Gimeracil,DB00041
DB09262,Aldesleukin may decrease the excretion rate of Imidafenacin which could result in a higher serum level.,Imidafenacin,DB00041
DB09264,Aldesleukin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.,Idarucizumab,DB00041
DB09265,Aldesleukin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.,Lixisenatide,DB00041
DB09268,Aldesleukin may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.,Picosulfuric acid,DB00041
DB09276,Aldesleukin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.,Sodium aurothiomalate,DB00041
DB09277,Aldesleukin may decrease the excretion rate of Choline C 11 which could result in a higher serum level.,Choline C 11,DB00041
DB09281,Aldesleukin may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.,Magnesium trisilicate,DB00041
DB09292,Aldesleukin may decrease the excretion rate of Sacubitril which could result in a higher serum level.,Sacubitril,DB00041
DB09301,Aldesleukin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.,Chondroitin sulfate,DB00041
DB09317,"Aldesleukin may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.","Synthetic Conjugated Estrogens, A",DB00041
DB09318,"Aldesleukin may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.","Synthetic Conjugated Estrogens, B",DB00041
DB09320,Aldesleukin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.,Procaine benzylpenicillin,DB00041
DB09324,Aldesleukin may decrease the excretion rate of Sulbactam which could result in a higher serum level.,Sulbactam,DB00041
DB09325,Aldesleukin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.,Sodium fluoride,DB00041
DB09329,"Aldesleukin may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.","Antihemophilic Factor (Recombinant), PEGylated",DB00041
DB09344,Aldesleukin may decrease the excretion rate of Invert sugar which could result in a higher serum level.,Invert sugar,DB00041
DB09357,Aldesleukin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.,Dexpanthenol,DB00041
DB09394,Aldesleukin may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.,Phosphoric acid,DB00041
DB09395,Aldesleukin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.,Sodium acetate,DB00041
DB09407,Aldesleukin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.,Magnesium chloride,DB00041
DB09472,Aldesleukin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.,Sodium sulfate,DB00041
DB09477,Aldesleukin may decrease the excretion rate of Enalaprilat which could result in a higher serum level.,Enalaprilat,DB00041
DB09481,Aldesleukin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.,Magnesium carbonate,DB00041
DB09488,Aldesleukin may decrease the excretion rate of Acrivastine which could result in a higher serum level.,Acrivastine,DB00041
DB09496,Aldesleukin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,Octinoxate,DB00041
DB09502,Aldesleukin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.,Fludeoxyglucose (18F),DB00041
DB09546,Aldesleukin may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.,Iobenguane sulfate I-123,DB00041
DB11077,Aldesleukin may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.,Polyethylene glycol 400,DB00041
DB11090,Aldesleukin may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.,Potassium nitrate,DB00041
DB11098,Aldesleukin may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.,Potassium bicarbonate,DB00041
DB11102,Aldesleukin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,N-acetyltyrosine,DB00041
DB11114,Aldesleukin may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.,Eucalyptus oil,DB00041
DB11127,Aldesleukin may decrease the excretion rate of Selenious acid which could result in a higher serum level.,Selenious acid,DB00041
DB11130,Aldesleukin may decrease the excretion rate of Opium which could result in a higher serum level.,Opium,DB00041
DB11135,Aldesleukin may decrease the excretion rate of Selenium which could result in a higher serum level.,Selenium,DB00041
DB11136,Aldesleukin may decrease the excretion rate of Chromium which could result in a higher serum level.,Chromium,DB00041
DB11145,Aldesleukin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,Oxyquinoline,DB00041
DB11156,Aldesleukin may decrease the excretion rate of Pyrantel which could result in a higher serum level.,Pyrantel,DB00041
DB11164,Aldesleukin may decrease the excretion rate of Bicisate which could result in a higher serum level.,Bicisate,DB00041
DB11251,Aldesleukin may decrease the excretion rate of Tocopherol which could result in a higher serum level.,Tocopherol,DB00041
DB11278,Aldesleukin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.,DL-Methylephedrine,DB00041
DB11328,Aldesleukin may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.,Tetradecyl hydrogen sulfate (ester),DB00041
DB11338,Aldesleukin may decrease the excretion rate of Clove oil which could result in a higher serum level.,Clove oil,DB00041
DB11358,Aldesleukin may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.,Evening primrose oil,DB00041
DB11364,Aldesleukin may decrease the excretion rate of Pidotimod which could result in a higher serum level.,Pidotimod,DB00041
DB11560,Aldesleukin may decrease the excretion rate of Lesinurad which could result in a higher serum level.,Lesinurad,DB00041
DB11577,Aldesleukin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.,Indigotindisulfonic acid,DB00041
DB11587,Aldesleukin may decrease the excretion rate of Etafedrine which could result in a higher serum level.,Etafedrine,DB00041
DB11598,Aldesleukin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.,Antithrombin III human,DB00041
DB11642,Aldesleukin may decrease the excretion rate of Pitolisant which could result in a higher serum level.,Pitolisant,DB00041
DB11691,Aldesleukin may decrease the excretion rate of Naldemedine which could result in a higher serum level.,Naldemedine,DB00041
DB11699,Aldesleukin may decrease the excretion rate of Tropisetron which could result in a higher serum level.,Tropisetron,DB00041
DB11901,Aldesleukin may decrease the excretion rate of Apalutamide which could result in a higher serum level.,Apalutamide,DB00041
DB11915,Aldesleukin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,Valbenazine,DB00041
DB11943,Aldesleukin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.,Delafloxacin,DB00041
DB11989,Aldesleukin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,Benznidazole,DB00041
DB12007,Aldesleukin may decrease the excretion rate of Isoflavone which could result in a higher serum level.,Isoflavone,DB00041
DB12107,Aldesleukin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,Vaborbactam,DB00041
DB12161,Aldesleukin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.,Deutetrabenazine,DB00041
DB12278,Aldesleukin may decrease the excretion rate of Propiverine which could result in a higher serum level.,Propiverine,DB00041
DB12783,Aldesleukin may decrease the excretion rate of Benserazide which could result in a higher serum level.,Benserazide,DB00041
DB13025,Aldesleukin may decrease the excretion rate of Tiapride which could result in a higher serum level.,Tiapride,DB00041
DB13139,Aldesleukin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,Levosalbutamol,DB00041
DB13156,Aldesleukin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.,Inosine pranobex,DB00041
DB13178,Aldesleukin may decrease the excretion rate of Inositol which could result in a higher serum level.,Inositol,DB00041
DB13185,Aldesleukin may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.,Oxabolone cipionate,DB00041
DB13191,Aldesleukin may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.,Phosphocreatine,DB00041
DB13269,Aldesleukin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.,Dichlorobenzyl alcohol,DB00041
DB13293,Aldesleukin may decrease the excretion rate of Ipecac which could result in a higher serum level.,Ipecac,DB00041
DB13595,Aldesleukin may decrease the excretion rate of Almasilate which could result in a higher serum level.,Almasilate,DB00041
DB13873,Aldesleukin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.,Fenofibric acid,DB00041
DB13884,Aldesleukin may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.,Albutrepenonacog alfa,DB00041
DB13909,Aldesleukin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,Bismuth subgallate,DB00041
DB13943,Aldesleukin may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.,Testosterone cypionate,DB00041
DB13944,Aldesleukin may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.,Testosterone enanthate,DB00041
DB13946,Aldesleukin may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.,Testosterone undecanoate,DB00041
DB13952,Aldesleukin may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.,Estradiol acetate,DB00041
DB13954,Aldesleukin may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.,Estradiol cypionate,DB00041
DB13955,Aldesleukin may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.,Estradiol dienanthate,DB00041
DB13956,Aldesleukin may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.,Estradiol valerate,DB00041
DB13967,Aldesleukin may decrease the excretion rate of Patent Blue which could result in a higher serum level.,Patent Blue,DB00041
DB14006,Aldesleukin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.,Choline salicylate,DB00041
DB14007,Aldesleukin may decrease the excretion rate of Pentetic acid which could result in a higher serum level.,Pentetic acid,DB00041
DB14498,Aldesleukin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.,Potassium acetate,DB00041
DB14499,Aldesleukin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.,Potassium sulfate,DB00041
DB14526,Aldesleukin may decrease the excretion rate of Chromic citrate which could result in a higher serum level.,Chromic citrate,DB00041
DB14527,Aldesleukin may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.,Chromic nitrate,DB00041
DB14528,Aldesleukin may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.,Chromium gluconate,DB00041
DB14529,Aldesleukin may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.,Chromium nicotinate,DB00041
DB14530,Aldesleukin may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.,Chromous sulfate,DB00041
DB14754,Aldesleukin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,Solriamfetol,DB00041
DB06815,Aldesleukin may decrease the excretion rate of Pyrithione which could result in a higher serum level.,Pyrithione,DB00041
DB11121,Aldesleukin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.,Chloroxylenol,DB00041
DB11085,Aldesleukin may decrease the excretion rate of Resorcinol which could result in a higher serum level.,Resorcinol,DB00041
DB01224,Aldesleukin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,Quetiapine,DB00041
DB00501,Aldesleukin may decrease the excretion rate of Cimetidine which could result in a higher serum level.,Cimetidine,DB00041
DB15593,Aldesleukin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,Golodirsen,DB00041
DB00321,Aldesleukin may decrease the excretion rate of Amitriptyline which could result in a higher serum level.,Amitriptyline,DB00041
DB00458,Aldesleukin may decrease the excretion rate of Imipramine which could result in a higher serum level.,Imipramine,DB00041
DB00490,Aldesleukin may decrease the excretion rate of Buspirone which could result in a higher serum level.,Buspirone,DB00041
DB00820,Aldesleukin may decrease the excretion rate of Tadalafil which could result in a higher serum level.,Tadalafil,DB00041
DB01142,Aldesleukin may decrease the excretion rate of Doxepin which could result in a higher serum level.,Doxepin,DB00041
DB00318,Aldesleukin may decrease the excretion rate of Codeine which could result in a higher serum level.,Codeine,DB00041
DB00879,Aldesleukin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.,Emtricitabine,DB00041
DB00897,Aldesleukin may decrease the excretion rate of Triazolam which could result in a higher serum level.,Triazolam,DB00041
DB06228,Aldesleukin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,Rivaroxaban,DB00041
DB08996,Aldesleukin may decrease the excretion rate of Dimetacrine which could result in a higher serum level.,Dimetacrine,DB00041
DB14506,Aldesleukin may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.,Lithium hydroxide,DB00041
DB00452,Framycetin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Framycetin,DB00041
DB00479,Amikacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Amikacin,DB00041
DB00684,Tobramycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tobramycin,DB00041
DB00798,Gentamicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Gentamicin,DB00041
DB00955,Netilmicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Netilmicin,DB00041
DB00994,Neomycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Neomycin,DB00041
DB01082,Streptomycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Streptomycin,DB00041
DB01172,Kanamycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Kanamycin,DB00041
DB01421,Paromomycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Paromomycin,DB00041
DB03615,Ribostamycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ribostamycin,DB00041
DB04263,Geneticin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Geneticin,DB00041
DB04626,Apramycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Apramycin,DB00041
DB04729,Gentamicin C1a may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Gentamicin C1a,DB00041
DB04808,Neamine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Neamine,DB00041
DB06696,Arbekacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Arbekacin,DB00041
DB08437,Puromycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Puromycin,DB00041
DB11512,Dihydrostreptomycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Dihydrostreptomycin,DB00041
DB11520,Hygromycin B may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Hygromycin B,DB00041
DB12604,Sisomicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Sisomicin,DB00041
DB13270,Dibekacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Dibekacin,DB00041
DB13274,Micronomicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Micronomicin,DB00041
DB13540,Isepamicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Isepamicin,DB00041
DB13673,Bekanamycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Bekanamycin,DB00041
DB13145,Aldesleukin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,Nedaplatin,DB00041
DB00314,Aldesleukin may decrease the excretion rate of Capreomycin which could result in a higher serum level.,Capreomycin,DB00041
DB00390,Aldesleukin may decrease the excretion rate of Digoxin which could result in a higher serum level.,Digoxin,DB00041
DB00512,Aldesleukin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,Vancomycin,DB00041
DB00982,Aldesleukin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,Isotretinoin,DB00041
DB01035,Aldesleukin may decrease the excretion rate of Procainamide which could result in a higher serum level.,Procainamide,DB00041
DB12615,Aldesleukin may decrease the excretion rate of Plazomicin which could result in a higher serum level.,Plazomicin,DB00041
DB14509,Aldesleukin may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.,Lithium carbonate,DB00041
DB00232,Aldesleukin may increase the excretion rate of Methyclothiazide which could result in a lower serum level and potentially a reduction in efficacy.,Methyclothiazide,DB00041
DB00421,Aldesleukin may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy.,Spironolactone,DB00041
DB00594,Aldesleukin may increase the excretion rate of Amiloride which could result in a lower serum level and potentially a reduction in efficacy.,Amiloride,DB00041
DB00703,Aldesleukin may increase the excretion rate of Methazolamide which could result in a lower serum level and potentially a reduction in efficacy.,Methazolamide,DB00041
DB01144,Aldesleukin may increase the excretion rate of Diclofenamide which could result in a lower serum level and potentially a reduction in efficacy.,Diclofenamide,DB00041
DB09125,Potassium citrate may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium citrate,DB00041
DB00562,Benzthiazide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Benzthiazide,DB00041
DB13430,Mebutizide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Mebutizide,DB00041
DB00214,Aldesleukin may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.,Torasemide,DB00041
DB00310,Aldesleukin may increase the excretion rate of Chlorthalidone which could result in a lower serum level and potentially a reduction in efficacy.,Chlorthalidone,DB00041
DB00436,Aldesleukin may increase the excretion rate of Bendroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy.,Bendroflumethiazide,DB00041
DB00606,Aldesleukin may increase the excretion rate of Cyclothiazide which could result in a lower serum level and potentially a reduction in efficacy.,Cyclothiazide,DB00041
DB00774,Aldesleukin may increase the excretion rate of Hydroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy.,Hydroflumethiazide,DB00041
DB00880,Aldesleukin may increase the excretion rate of Chlorothiazide which could result in a lower serum level and potentially a reduction in efficacy.,Chlorothiazide,DB00041
DB01021,Aldesleukin may increase the excretion rate of Trichlormethiazide which could result in a lower serum level and potentially a reduction in efficacy.,Trichlormethiazide,DB00041
DB01119,Aldesleukin may increase the excretion rate of Diazoxide which could result in a lower serum level and potentially a reduction in efficacy.,Diazoxide,DB00041
DB01324,Aldesleukin may increase the excretion rate of Polythiazide which could result in a lower serum level and potentially a reduction in efficacy.,Polythiazide,DB00041
DB04831,Aldesleukin may increase the excretion rate of Tienilic acid which could result in a lower serum level and potentially a reduction in efficacy.,Tienilic acid,DB00041
DB12766,Aldesleukin may increase the excretion rate of Cicletanine which could result in a lower serum level and potentially a reduction in efficacy.,Cicletanine,DB00041
DB13532,Aldesleukin may increase the excretion rate of Cyclopenthiazide which could result in a lower serum level and potentially a reduction in efficacy.,Cyclopenthiazide,DB00041
DB13801,Aldesleukin may increase the excretion rate of Muzolimine which could result in a lower serum level and potentially a reduction in efficacy.,Muzolimine,DB00041
DB13803,Aldesleukin may increase the excretion rate of Xipamide which could result in a lower serum level and potentially a reduction in efficacy.,Xipamide,DB00041
DB00524,Aldesleukin may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.,Metolazone,DB00041
DB00695,Aldesleukin may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.,Furosemide,DB00041
DB00808,Aldesleukin may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.,Indapamide,DB00041
DB00887,Aldesleukin may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,Bumetanide,DB00041
DB00909,Aldesleukin may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,Zonisamide,DB00041
DB08907,Aldesleukin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.,Canagliflozin,DB00041
DB09338,Aldesleukin may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.,Mersalyl,DB00041
DB00311,Ethoxzolamide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Ethoxzolamide,DB00041
DB00819,Acetazolamide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Acetazolamide,DB00041
DB01325,Quinethazone may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Quinethazone,DB00041
DB01412,Theobromine may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Theobromine,DB00041
DB02925,Piretanide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Piretanide,DB00041
DB05034,Ularitide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Ularitide,DB00041
DB06370,Indisulam may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Indisulam,DB00041
DB08961,Azosemide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Azosemide,DB00041
DB09015,Canrenoic acid may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenoic acid,DB00041
DB09401,Isosorbide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Isosorbide,DB00041
DB11827,Ertugliflozin may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Ertugliflozin,DB00041
DB12221,Canrenone may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenone,DB00041
DB12670,Rolofylline may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Rolofylline,DB00041
DB12704,Spiradoline may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Spiradoline,DB00041
DB13284,Meticrane may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Meticrane,DB00041
DB13316,Ibopamine may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Ibopamine,DB00041
DB13405,Mefruside may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Mefruside,DB00041
DB13617,Clorexolone may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Clorexolone,DB00041
DB13663,Clofenamide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Clofenamide,DB00041
DB13708,Fenquizone may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Fenquizone,DB00041
DB13792,Clopamide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Clopamide,DB00041
DB13989,Epitizide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Epitizide,DB00041
DB14018,Bromotheophylline may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Bromotheophylline,DB00041
DB14500,Potassium may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium,DB00041
DB09235,Aldesleukin may increase the excretion rate of Efonidipine which could result in a lower serum level and potentially a reduction in efficacy.,Efonidipine,DB00041
DB06292,Dapagliflozin may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Dapagliflozin,DB00041
DB00700,Aldesleukin may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy.,Eplerenone,DB00041
DB00872,Aldesleukin may increase the excretion rate of Conivaptan which could result in a lower serum level and potentially a reduction in efficacy.,Conivaptan,DB00041
DB06212,Tolvaptan may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Tolvaptan,DB00041
DB00228,The metabolism of Enflurane can be decreased when combined with Aldesleukin.,Enflurane,DB00041
DB00347,The metabolism of Trimethadione can be decreased when combined with Aldesleukin.,Trimethadione,DB00041
DB00753,The metabolism of Isoflurane can be decreased when combined with Aldesleukin.,Isoflurane,DB00041
DB01028,The metabolism of Methoxyflurane can be decreased when combined with Aldesleukin.,Methoxyflurane,DB00041
DB01159,The metabolism of Halothane can be decreased when combined with Aldesleukin.,Halothane,DB00041
DB01236,The metabolism of Sevoflurane can be decreased when combined with Aldesleukin.,Sevoflurane,DB00041
DB06712,The metabolism of Nilvadipine can be decreased when combined with Aldesleukin.,Nilvadipine,DB00041
DB06728,The metabolism of Aniline can be decreased when combined with Aldesleukin.,Aniline,DB00041
DB06770,The metabolism of Benzyl alcohol can be decreased when combined with Aldesleukin.,Benzyl alcohol,DB00041
DB00356,The metabolism of Chlorzoxazone can be decreased when combined with Aldesleukin.,Chlorzoxazone,DB00041
DB00949,The metabolism of Felbamate can be decreased when combined with Aldesleukin.,Felbamate,DB00041
DB01136,The metabolism of Carvedilol can be decreased when combined with Aldesleukin.,Carvedilol,DB00041
DB06119,The metabolism of Cenobamate can be decreased when combined with Aldesleukin.,Cenobamate,DB00041
DB00252,The metabolism of Phenytoin can be decreased when combined with Aldesleukin.,Phenytoin,DB00041
DB00593,The metabolism of Ethosuximide can be decreased when combined with Aldesleukin.,Ethosuximide,DB00041
DB11689,The metabolism of Selumetinib can be decreased when combined with Aldesleukin.,Selumetinib,DB00041
DB00908,The metabolism of Quinidine can be decreased when combined with Aldesleukin.,Quinidine,DB00041
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Aldesleukin.,Lepirudin,DB00041
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Aldesleukin.,Bivalirudin,DB00041
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Aldesleukin.,Alteplase,DB00041
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Aldesleukin.,Urokinase,DB00041
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Aldesleukin.,Reteplase,DB00041
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Aldesleukin.,Anistreplase,DB00041
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Aldesleukin.,Tenecteplase,DB00041
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Aldesleukin.,Drotrecogin alfa,DB00041
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Aldesleukin.,Dicoumarol,DB00041
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Aldesleukin.,Ardeparin,DB00041
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Aldesleukin.,Phenindione,DB00041
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Aldesleukin.,Pentosan polysulfate,DB00041
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Aldesleukin.,Heparin,DB00041
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Aldesleukin.,Enoxaparin,DB00041
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Aldesleukin.,Coumarin,DB00041
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Aldesleukin.,Ximelagatran,DB00041
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Aldesleukin.,Desmoteplase,DB00041
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Aldesleukin.,Ancrod,DB00041
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Aldesleukin.,Fibrinolysin,DB00041
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Aldesleukin.,Sulodexide,DB00041
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Aldesleukin.,Semuloparin,DB00041
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Aldesleukin.,Idraparinux,DB00041
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Aldesleukin.,Astaxanthin,DB00041
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Aldesleukin.,Otamixaban,DB00041
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Aldesleukin.,Amediplase,DB00041
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Aldesleukin.,Danaparoid,DB00041
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Aldesleukin.,Dalteparin,DB00041
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Aldesleukin.,Tinzaparin,DB00041
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Aldesleukin.,Nadroparin,DB00041
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Aldesleukin.,Ditazole,DB00041
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Aldesleukin.,Sodium citrate,DB00041
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Aldesleukin.,Bemiparin,DB00041
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Aldesleukin.,Reviparin,DB00041
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Aldesleukin.,Parnaparin,DB00041
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Aldesleukin.,Certoparin,DB00041
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Aldesleukin.,Desirudin,DB00041
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Aldesleukin.,Zinc citrate,DB00041
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Aldesleukin.,Antithrombin Alfa,DB00041
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Aldesleukin.,Protein C,DB00041
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Aldesleukin.,Letaxaban,DB00041
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Aldesleukin.,Darexaban,DB00041
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Aldesleukin.,Betrixaban,DB00041
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Aldesleukin.,Nafamostat,DB00041
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Aldesleukin.,Monteplase,DB00041
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Aldesleukin.,Gabexate,DB00041
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Aldesleukin.,Protein S human,DB00041
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Aldesleukin.,Brinase,DB00041
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Aldesleukin.,Tioclomarol,DB00041
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Aldesleukin.,Melagatran,DB00041
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Aldesleukin.,Saruplase,DB00041
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Aldesleukin.,Edetate calcium disodium anhydrous,DB00041
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Aldesleukin.,Dabigatran,DB00041
DB07767,The risk or severity of bleeding can be increased when Aldesleukin is combined with Ferulic acid.,Ferulic acid,DB00041
DB14094,The risk or severity of bleeding can be increased when Aldesleukin is combined with Tocopherylquinone.,Tocopherylquinone,DB00041
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Aldesleukin.,Argatroban,DB00041
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Aldesleukin.,Apixaban,DB00041
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Aldesleukin.,Ethyl biscoumacetate,DB00041
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Aldesleukin.,Diphenadione,DB00041
DB09042,The risk or severity of myelosuppression can be increased when Aldesleukin is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00041
DB06480,The metabolism of Prucalopride can be decreased when combined with Aldesleukin.,Prucalopride,DB00041
DB00091,Aldesleukin may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine,DB00041
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Aldesleukin.,Cyanocobalamin,DB00041
DB00017,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Aldesleukin.,Salmon calcitonin,DB00041
DB00024,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Aldesleukin.,Thyrotropin alfa,DB00041
DB00066,The therapeutic efficacy of Follitropin can be decreased when used in combination with Aldesleukin.,Follitropin,DB00041
DB00279,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Aldesleukin.,Liothyronine,DB00041
DB00389,The therapeutic efficacy of Carbimazole can be decreased when used in combination with Aldesleukin.,Carbimazole,DB00041
DB00451,The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Aldesleukin.,Levothyroxine,DB00041
DB00550,The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Aldesleukin.,Propylthiouracil,DB00041
DB00763,The therapeutic efficacy of Methimazole can be decreased when used in combination with Aldesleukin.,Methimazole,DB00041
DB01583,The therapeutic efficacy of Liotrix can be decreased when used in combination with Aldesleukin.,Liotrix,DB00041
DB03374,"The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Aldesleukin.","3,5-Diiodotyrosine",DB00041
DB03604,The therapeutic efficacy of Tiratricol can be decreased when used in combination with Aldesleukin.,Tiratricol,DB00041
DB05084,The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Aldesleukin.,Abaloparatide,DB00041
DB05829,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Aldesleukin.,Parathyroid hormone,DB00041
DB06285,The therapeutic efficacy of Teriparatide can be decreased when used in combination with Aldesleukin.,Teriparatide,DB00041
DB06715,The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Aldesleukin.,Potassium Iodide,DB00041
DB07637,The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Aldesleukin.,Dibromotyrosine,DB00041
DB09100,"The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Aldesleukin.","Thyroid, porcine",DB00041
DB09418,The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Aldesleukin.,Potassium perchlorate,DB00041
DB09421,The therapeutic efficacy of Protirelin can be decreased when used in combination with Aldesleukin.,Protirelin,DB00041
DB12629,"The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with Aldesleukin.","3,5-diiodothyropropionic acid",DB00041
DB13644,The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Aldesleukin.,Methylthiouracil,DB00041
DB13742,The therapeutic efficacy of Elcatonin can be decreased when used in combination with Aldesleukin.,Elcatonin,DB00041
DB13804,The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Aldesleukin.,Benzylthiouracil,DB00041
DB15263,The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Aldesleukin.,Thyrotropin,DB00041
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Aldesleukin.,Allopurinol,DB00041
DB00316,Aldesleukin may increase the hepatotoxic activities of Acetaminophen.,Acetaminophen,DB00041
DB09288,Aldesleukin may increase the hepatotoxic activities of Propacetamol.,Propacetamol,DB00041
DB00212,Aldesleukin may increase the hypotensive activities of Remikiren.,Remikiren,DB00041
DB00217,Aldesleukin may increase the hypotensive activities of Bethanidine.,Bethanidine,DB00041
DB00226,Aldesleukin may increase the hypotensive activities of Guanadrel.,Guanadrel,DB00041
DB00374,Aldesleukin may increase the hypotensive activities of Treprostinil.,Treprostinil,DB00041
DB00616,Aldesleukin may increase the hypotensive activities of Candoxatril.,Candoxatril,DB00041
DB00629,Aldesleukin may increase the hypotensive activities of Guanabenz.,Guanabenz,DB00041
DB00765,Aldesleukin may increase the hypotensive activities of Metyrosine.,Metyrosine,DB00041
DB00785,Aldesleukin may increase the hypotensive activities of Cryptenamine.,Cryptenamine,DB00041
DB00866,Aldesleukin may increase the hypotensive activities of Alprenolol.,Alprenolol,DB00041
DB00886,Aldesleukin may increase the hypotensive activities of Omapatrilat.,Omapatrilat,DB00041
DB01089,Aldesleukin may increase the hypotensive activities of Deserpidine.,Deserpidine,DB00041
DB01090,Aldesleukin may increase the hypotensive activities of Pentolinium.,Pentolinium,DB00041
DB01116,Aldesleukin may increase the hypotensive activities of Trimethaphan.,Trimethaphan,DB00041
DB01180,Aldesleukin may increase the hypotensive activities of Rescinnamine.,Rescinnamine,DB00041
DB01295,Aldesleukin may increase the hypotensive activities of Bevantolol.,Bevantolol,DB00041
DB01297,Aldesleukin may increase the hypotensive activities of Practolol.,Practolol,DB00041
DB01347,Aldesleukin may increase the hypotensive activities of Saprisartan.,Saprisartan,DB00041
DB01348,Aldesleukin may increase the hypotensive activities of Spirapril.,Spirapril,DB00041
DB03322,Aldesleukin may increase the hypotensive activities of Dexpropranolol.,Dexpropranolol,DB00041
DB04840,Aldesleukin may increase the hypotensive activities of Debrisoquine.,Debrisoquine,DB00041
DB04846,Aldesleukin may increase the hypotensive activities of Celiprolol.,Celiprolol,DB00041
DB06268,Aldesleukin may increase the hypotensive activities of Sitaxentan.,Sitaxentan,DB00041
DB06445,Aldesleukin may increase the hypotensive activities of Diethylnorspermine.,Diethylnorspermine,DB00041
DB08808,Aldesleukin may increase the hypotensive activities of Bupranolol.,Bupranolol,DB00041
DB08836,Aldesleukin may increase the hypotensive activities of Temocapril.,Temocapril,DB00041
DB08952,Aldesleukin may increase the hypotensive activities of Indenolol.,Indenolol,DB00041
DB08960,Aldesleukin may increase the hypotensive activities of Hexamethonium.,Hexamethonium,DB00041
DB09206,Aldesleukin may increase the hypotensive activities of Trimazosin.,Trimazosin,DB00041
DB09363,Aldesleukin may increase the hypotensive activities of Rauwolfia serpentina root.,Rauwolfia serpentina root,DB00041
DB11720,Aldesleukin may increase the hypotensive activities of Angiotensin 1-7.,Angiotensin 1-7,DB00041
DB11738,Aldesleukin may increase the hypotensive activities of Rilmenidine.,Rilmenidine,DB00041
DB11770,Aldesleukin may increase the hypotensive activities of Talinolol.,Talinolol,DB00041
DB12054,Aldesleukin may increase the hypotensive activities of BQ-123.,BQ-123,DB00041
DB12212,Aldesleukin may increase the hypotensive activities of Landiolol.,Landiolol,DB00041
DB12661,Aldesleukin may increase the hypotensive activities of Urapidil.,Urapidil,DB00041
DB12945,Aldesleukin may increase the hypotensive activities of Dihydralazine.,Dihydralazine,DB00041
DB13166,Aldesleukin may increase the hypotensive activities of Zofenopril.,Zofenopril,DB00041
DB13211,Aldesleukin may increase the hypotensive activities of Guanoxan.,Guanoxan,DB00041
DB13312,Aldesleukin may increase the hypotensive activities of Delapril.,Delapril,DB00041
DB13374,Aldesleukin may increase the hypotensive activities of Vincamine.,Vincamine,DB00041
DB13410,Aldesleukin may increase the hypotensive activities of Guanoxabenz.,Guanoxabenz,DB00041
DB13429,Aldesleukin may increase the hypotensive activities of Tolonidine.,Tolonidine,DB00041
DB13435,Aldesleukin may increase the hypotensive activities of Endralazine.,Endralazine,DB00041
DB13443,Aldesleukin may increase the hypotensive activities of Esatenolol.,Esatenolol,DB00041
DB13452,Aldesleukin may increase the hypotensive activities of Cadralazine.,Cadralazine,DB00041
DB13508,Aldesleukin may increase the hypotensive activities of Cloranolol.,Cloranolol,DB00041
DB13575,Aldesleukin may increase the hypotensive activities of Bietaserpine.,Bietaserpine,DB00041
DB13604,Aldesleukin may increase the hypotensive activities of Guanazodine.,Guanazodine,DB00041
DB13631,Aldesleukin may increase the hypotensive activities of Methoserpidine.,Methoserpidine,DB00041
DB13757,Aldesleukin may increase the hypotensive activities of Epanolol.,Epanolol,DB00041
DB13779,Aldesleukin may increase the hypotensive activities of Guanoclor.,Guanoclor,DB00041
DB13919,Aldesleukin may increase the hypotensive activities of Candesartan.,Candesartan,DB00041
DB14125,Aldesleukin may increase the hypotensive activities of Benazeprilat.,Benazeprilat,DB00041
DB14207,Aldesleukin may increase the hypotensive activities of Fosinoprilat.,Fosinoprilat,DB00041
DB14208,Aldesleukin may increase the hypotensive activities of Ramiprilat.,Ramiprilat,DB00041
DB14213,Aldesleukin may increase the hypotensive activities of Perindoprilat.,Perindoprilat,DB00041
DB14217,Aldesleukin may increase the hypotensive activities of Quinaprilat.,Quinaprilat,DB00041
DB00559,Aldesleukin may increase the hypotensive activities of Bosentan.,Bosentan,DB00041
DB01388,Aldesleukin may increase the hypotensive activities of Mibefradil.,Mibefradil,DB00041
DB06403,Aldesleukin may increase the hypotensive activities of Ambrisentan.,Ambrisentan,DB00041
DB06762,Aldesleukin may increase the hypotensive activities of Pinacidil.,Pinacidil,DB00041
DB09238,Aldesleukin may increase the hypotensive activities of Manidipine.,Manidipine,DB00041
DB09239,Aldesleukin may increase the hypotensive activities of Niguldipine.,Niguldipine,DB00041
DB11362,Aldesleukin may increase the hypotensive activities of Selexipag.,Selexipag,DB00041
DB12093,Aldesleukin may increase the hypotensive activities of Tetrahydropalmatine.,Tetrahydropalmatine,DB00041
DB14068,Aldesleukin may increase the hypotensive activities of Dexniguldipine.,Dexniguldipine,DB00041
DB14975,The serum concentration of Voxelotor can be increased when it is combined with Aldesleukin.,Voxelotor,DB00041
DB09237,The serum concentration of Levamlodipine can be increased when it is combined with Aldesleukin.,Levamlodipine,DB00041
DB00193,The metabolism of Tramadol can be decreased when combined with Aldesleukin.,Tramadol,DB00041
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Aldesleukin.,Magnesium,DB00041
DB01601,The serum concentration of Aldesleukin can be increased when it is combined with Lopinavir.,Lopinavir,DB00041
DB00502,The serum concentration of Haloperidol can be increased when it is combined with Aldesleukin.,Haloperidol,DB00041
DB12530,The risk or severity of infection can be increased when Aldesleukin is combined with Inebilizumab.,Inebilizumab,DB00041
DB00186,The metabolism of Lorazepam can be decreased when combined with Aldesleukin.,Lorazepam,DB00041
DB00208,The metabolism of Ticlopidine can be decreased when combined with Aldesleukin.,Ticlopidine,DB00041
DB00264,The metabolism of Metoprolol can be decreased when combined with Aldesleukin.,Metoprolol,DB00041
DB00477,The metabolism of Chlorpromazine can be decreased when combined with Aldesleukin.,Chlorpromazine,DB00041
DB01039,The metabolism of Fenofibrate can be decreased when combined with Aldesleukin.,Fenofibrate,DB00041
DB01431,The metabolism of Allylestrenol can be decreased when combined with Aldesleukin.,Allylestrenol,DB00041
DB09071,The metabolism of Tasimelteon can be decreased when combined with Aldesleukin.,Tasimelteon,DB00041
DB00191,The metabolism of Phentermine can be decreased when combined with Aldesleukin.,Phentermine,DB00041
DB00207,The metabolism of Azithromycin can be decreased when combined with Aldesleukin.,Azithromycin,DB00041
DB00246,The metabolism of Ziprasidone can be decreased when combined with Aldesleukin.,Ziprasidone,DB00041
DB00426,The metabolism of Famciclovir can be decreased when combined with Aldesleukin.,Famciclovir,DB00041
DB00433,The metabolism of Prochlorperazine can be decreased when combined with Aldesleukin.,Prochlorperazine,DB00041
DB00518,The metabolism of Albendazole can be decreased when combined with Aldesleukin.,Albendazole,DB00041
DB00590,The metabolism of Doxazosin can be decreased when combined with Aldesleukin.,Doxazosin,DB00041
DB00717,The metabolism of Norethisterone can be decreased when combined with Aldesleukin.,Norethisterone,DB00041
DB01098,The metabolism of Rosuvastatin can be decreased when combined with Aldesleukin.,Rosuvastatin,DB00041
DB01323,The metabolism of St. John's Wort can be decreased when combined with Aldesleukin.,St. John's Wort,DB00041
DB01395,The metabolism of Drospirenone can be decreased when combined with Aldesleukin.,Drospirenone,DB00041
DB01411,The metabolism of Pranlukast can be decreased when combined with Aldesleukin.,Pranlukast,DB00041
DB01624,The metabolism of Zuclopenthixol can be decreased when combined with Aldesleukin.,Zuclopenthixol,DB00041
DB06201,The metabolism of Rufinamide can be decreased when combined with Aldesleukin.,Rufinamide,DB00041
DB06218,The metabolism of Lacosamide can be decreased when combined with Aldesleukin.,Lacosamide,DB00041
DB08882,The metabolism of Linagliptin can be decreased when combined with Aldesleukin.,Linagliptin,DB00041
DB09030,The metabolism of Vorapaxar can be decreased when combined with Aldesleukin.,Vorapaxar,DB00041
DB09034,The metabolism of Suvorexant can be decreased when combined with Aldesleukin.,Suvorexant,DB00041
DB09048,The metabolism of Netupitant can be decreased when combined with Aldesleukin.,Netupitant,DB00041
DB09079,The metabolism of Nintedanib can be decreased when combined with Aldesleukin.,Nintedanib,DB00041
DB09330,The metabolism of Osimertinib can be decreased when combined with Aldesleukin.,Osimertinib,DB00041
DB11094,The metabolism of Vitamin D can be decreased when combined with Aldesleukin.,Vitamin D,DB00041
DB11273,The metabolism of Dihydroergocornine can be decreased when combined with Aldesleukin.,Dihydroergocornine,DB00041
DB11730,The metabolism of Ribociclib can be decreased when combined with Aldesleukin.,Ribociclib,DB00041
DB11952,The metabolism of Duvelisib can be decreased when combined with Aldesleukin.,Duvelisib,DB00041
DB12141,The metabolism of Gilteritinib can be decreased when combined with Aldesleukin.,Gilteritinib,DB00041
DB12515,The metabolism of 9-aminocamptothecin can be decreased when combined with Aldesleukin.,9-aminocamptothecin,DB00041
DB12952,The metabolism of Methylprednisone can be decreased when combined with Aldesleukin.,Methylprednisone,DB00041
DB13345,The metabolism of Dihydroergocristine can be decreased when combined with Aldesleukin.,Dihydroergocristine,DB00041
DB13385,The metabolism of Dihydroergocryptine can be decreased when combined with Aldesleukin.,Dihydroergocryptine,DB00041
DB14009,The metabolism of Medical Cannabis can be decreased when combined with Aldesleukin.,Medical Cannabis,DB00041
DB00549,The metabolism of Zafirlukast can be decreased when combined with Aldesleukin.,Zafirlukast,DB00041
DB15444,The metabolism of Elexacaftor can be decreased when combined with Aldesleukin.,Elexacaftor,DB00041
DB12887,The metabolism of Tazemetostat can be decreased when combined with Aldesleukin.,Tazemetostat,DB00041
DB06717,The metabolism of Fosaprepitant can be decreased when combined with Aldesleukin.,Fosaprepitant,DB00041
DB12825,The metabolism of Lefamulin can be decreased when combined with Aldesleukin.,Lefamulin,DB00041
DB01151,The metabolism of Desipramine can be decreased when combined with Aldesleukin.,Desipramine,DB00041
DB00454,The metabolism of Meperidine can be decreased when combined with Aldesleukin.,Meperidine,DB00041
DB00247,The metabolism of Methysergide can be decreased when combined with Aldesleukin.,Methysergide,DB00041
DB00637,The metabolism of Astemizole can be decreased when combined with Aldesleukin.,Astemizole,DB00041
DB08827,The metabolism of Lomitapide can be decreased when combined with Aldesleukin.,Lomitapide,DB00041
DB11742,The metabolism of Ebastine can be decreased when combined with Aldesleukin.,Ebastine,DB00041
DB00188,The metabolism of Bortezomib can be decreased when combined with Aldesleukin.,Bortezomib,DB00041
DB00309,The metabolism of Vindesine can be decreased when combined with Aldesleukin.,Vindesine,DB00041
DB00361,The metabolism of Vinorelbine can be decreased when combined with Aldesleukin.,Vinorelbine,DB00041
DB00398,The metabolism of Sorafenib can be decreased when combined with Aldesleukin.,Sorafenib,DB00041
DB00444,The metabolism of Teniposide can be decreased when combined with Aldesleukin.,Teniposide,DB00041
DB00541,The metabolism of Vincristine can be decreased when combined with Aldesleukin.,Vincristine,DB00041
DB00563,The metabolism of Methotrexate can be decreased when combined with Aldesleukin.,Methotrexate,DB00041
DB00570,The metabolism of Vinblastine can be decreased when combined with Aldesleukin.,Vinblastine,DB00041
DB00619,The metabolism of Imatinib can be decreased when combined with Aldesleukin.,Imatinib,DB00041
DB00694,The metabolism of Daunorubicin can be decreased when combined with Aldesleukin.,Daunorubicin,DB00041
DB00773,The metabolism of Etoposide can be decreased when combined with Aldesleukin.,Etoposide,DB00041
DB00987,The metabolism of Cytarabine can be decreased when combined with Aldesleukin.,Cytarabine,DB00041
DB00997,The metabolism of Doxorubicin can be decreased when combined with Aldesleukin.,Doxorubicin,DB00041
DB01108,The metabolism of Trilostane can be decreased when combined with Aldesleukin.,Trilostane,DB00041
DB01181,The metabolism of Ifosfamide can be decreased when combined with Aldesleukin.,Ifosfamide,DB00041
DB01248,The metabolism of Docetaxel can be decreased when combined with Aldesleukin.,Docetaxel,DB00041
DB01268,The metabolism of Sunitinib can be decreased when combined with Aldesleukin.,Sunitinib,DB00041
DB04572,The metabolism of Thiotepa can be decreased when combined with Aldesleukin.,Thiotepa,DB00041
DB04845,The metabolism of Ixabepilone can be decreased when combined with Aldesleukin.,Ixabepilone,DB00041
DB04868,The metabolism of Nilotinib can be decreased when combined with Aldesleukin.,Nilotinib,DB00041
DB05015,The metabolism of Belinostat can be decreased when combined with Aldesleukin.,Belinostat,DB00041
DB05109,The metabolism of Trabectedin can be decreased when combined with Aldesleukin.,Trabectedin,DB00041
DB06589,The metabolism of Pazopanib can be decreased when combined with Aldesleukin.,Pazopanib,DB00041
DB06603,The metabolism of Panobinostat can be decreased when combined with Aldesleukin.,Panobinostat,DB00041
DB06616,The metabolism of Bosutinib can be decreased when combined with Aldesleukin.,Bosutinib,DB00041
DB08870,The metabolism of Brentuximab vedotin can be decreased when combined with Aldesleukin.,Brentuximab vedotin,DB00041
DB08877,The metabolism of Ruxolitinib can be decreased when combined with Aldesleukin.,Ruxolitinib,DB00041
DB08901,The metabolism of Ponatinib can be decreased when combined with Aldesleukin.,Ponatinib,DB00041
DB09054,The metabolism of Idelalisib can be decreased when combined with Aldesleukin.,Idelalisib,DB00041
DB09073,The metabolism of Palbociclib can be decreased when combined with Aldesleukin.,Palbociclib,DB00041
DB09570,The metabolism of Ixazomib can be decreased when combined with Aldesleukin.,Ixazomib,DB00041
DB00564,The metabolism of Carbamazepine can be decreased when combined with Aldesleukin.,Carbamazepine,DB00041
DB00204,The metabolism of Dofetilide can be decreased when combined with Aldesleukin.,Dofetilide,DB00041
DB00277,The metabolism of Theophylline can be decreased when combined with Aldesleukin.,Theophylline,DB00041
DB00342,The metabolism of Terfenadine can be decreased when combined with Aldesleukin.,Terfenadine,DB00041
DB00604,The metabolism of Cisapride can be decreased when combined with Aldesleukin.,Cisapride,DB00041
DB00877,The metabolism of Sirolimus can be decreased when combined with Aldesleukin.,Sirolimus,DB00041
DB00946,The metabolism of Phenprocoumon can be decreased when combined with Aldesleukin.,Phenprocoumon,DB00041
DB01008,The metabolism of Busulfan can be decreased when combined with Aldesleukin.,Busulfan,DB00041
DB01100,The metabolism of Pimozide can be decreased when combined with Aldesleukin.,Pimozide,DB00041
DB01118,The metabolism of Amiodarone can be decreased when combined with Aldesleukin.,Amiodarone,DB00041
DB01223,The metabolism of Aminophylline can be decreased when combined with Aldesleukin.,Aminophylline,DB00041
DB01229,The metabolism of Paclitaxel can be decreased when combined with Aldesleukin.,Paclitaxel,DB00041
DB01254,The metabolism of Dasatinib can be decreased when combined with Aldesleukin.,Dasatinib,DB00041
DB01320,The metabolism of Fosphenytoin can be decreased when combined with Aldesleukin.,Fosphenytoin,DB00041
DB01396,The metabolism of Digitoxin can be decreased when combined with Aldesleukin.,Digitoxin,DB00041
DB01590,The metabolism of Everolimus can be decreased when combined with Aldesleukin.,Everolimus,DB00041
DB03410,The metabolism of 4-hydroxycoumarin can be decreased when combined with Aldesleukin.,4-hydroxycoumarin,DB00041
DB04855,The metabolism of Dronedarone can be decreased when combined with Aldesleukin.,Dronedarone,DB00041
DB05239,The metabolism of Cobimetinib can be decreased when combined with Aldesleukin.,Cobimetinib,DB00041
DB06287,The metabolism of Temsirolimus can be decreased when combined with Aldesleukin.,Temsirolimus,DB00041
DB09063,The metabolism of Ceritinib can be decreased when combined with Aldesleukin.,Ceritinib,DB00041
DB09289,The metabolism of Tianeptine can be decreased when combined with Aldesleukin.,Tianeptine,DB00041
DB11633,The metabolism of Isavuconazole can be decreased when combined with Aldesleukin.,Isavuconazole,DB00041
DB11963,The metabolism of Dacomitinib can be decreased when combined with Aldesleukin.,Dacomitinib,DB00041
DB12015,The metabolism of Alpelisib can be decreased when combined with Aldesleukin.,Alpelisib,DB00041
DB13136,The metabolism of Fluindione can be decreased when combined with Aldesleukin.,Fluindione,DB00041
DB13275,The metabolism of Clorindione can be decreased when combined with Aldesleukin.,Clorindione,DB00041
DB00675,The metabolism of Tamoxifen can be decreased when combined with Aldesleukin.,Tamoxifen,DB00041
DB05294,The metabolism of Vandetanib can be decreased when combined with Aldesleukin.,Vandetanib,DB00041
DB05812,The metabolism of Abiraterone can be decreased when combined with Aldesleukin.,Abiraterone,DB00041
DB08881,The metabolism of Vemurafenib can be decreased when combined with Aldesleukin.,Vemurafenib,DB00041
DB11363,The metabolism of Alectinib can be decreased when combined with Aldesleukin.,Alectinib,DB00041
DB11581,The metabolism of Venetoclax can be decreased when combined with Aldesleukin.,Venetoclax,DB00041
DB11641,The metabolism of Vinflunine can be decreased when combined with Aldesleukin.,Vinflunine,DB00041
DB11703,The metabolism of Acalabrutinib can be decreased when combined with Aldesleukin.,Acalabrutinib,DB00041
DB13874,The metabolism of Enasidenib can be decreased when combined with Aldesleukin.,Enasidenib,DB00041
DB15035,The metabolism of Zanubrutinib can be decreased when combined with Aldesleukin.,Zanubrutinib,DB00041
DB00248,The metabolism of Cabergoline can be decreased when combined with Aldesleukin.,Cabergoline,DB00041
DB00530,The metabolism of Erlotinib can be decreased when combined with Aldesleukin.,Erlotinib,DB00041
DB06595,The metabolism of Midostaurin can be decreased when combined with Aldesleukin.,Midostaurin,DB00041
DB06626,The metabolism of Axitinib can be decreased when combined with Aldesleukin.,Axitinib,DB00041
DB08865,The metabolism of Crizotinib can be decreased when combined with Aldesleukin.,Crizotinib,DB00041
DB08912,The metabolism of Dabrafenib can be decreased when combined with Aldesleukin.,Dabrafenib,DB00041
DB09143,The metabolism of Sonidegib can be decreased when combined with Aldesleukin.,Sonidegib,DB00041
DB11718,The metabolism of Encorafenib can be decreased when combined with Aldesleukin.,Encorafenib,DB00041
DB11828,The metabolism of Neratinib can be decreased when combined with Aldesleukin.,Neratinib,DB00041
DB12147,The metabolism of Erdafitinib can be decreased when combined with Aldesleukin.,Erdafitinib,DB00041
DB12267,The metabolism of Brigatinib can be decreased when combined with Aldesleukin.,Brigatinib,DB00041
DB12483,The metabolism of Copanlisib can be decreased when combined with Aldesleukin.,Copanlisib,DB00041
DB12978,The metabolism of Pexidartinib can be decreased when combined with Aldesleukin.,Pexidartinib,DB00041
DB14568,The metabolism of Ivosidenib can be decreased when combined with Aldesleukin.,Ivosidenib,DB00041
DB11986,The metabolism of Entrectinib can be decreased when combined with Aldesleukin.,Entrectinib,DB00041
DB00921,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,Buprenorphine,DB00042
DB00366,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Doxylamine,DB00042
DB00470,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Dronabinol,DB00042
DB00450,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Droperidol,DB00042
DB00956,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,Hydrocodone,DB00042
DB00557,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Hydroxyzine,DB00042
DB00653,The therapeutic efficacy of Botulinum Toxin Type B can be increased when used in combination with Magnesium sulfate.,Magnesium sulfate,DB00042
DB01403,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,Methotrimeprazine,DB00042
DB00765,Botulinum Toxin Type B may increase the sedative activities of Metyrosine.,Metyrosine,DB00042
DB01017,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Minocycline,DB00042
DB00370,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,Mirtazapine,DB00042
DB00486,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Nabilone,DB00042
DB01173,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,Orphenadrine,DB00042
DB09117,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,Paraldehyde,DB00042
DB08883,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Perampanel,DB00042
DB00413,Botulinum Toxin Type B may increase the sedative activities of Pramipexole.,Pramipexole,DB00042
DB00268,Botulinum Toxin Type B may increase the sedative activities of Ropinirole.,Ropinirole,DB00042
DB05271,Botulinum Toxin Type B may increase the sedative activities of Rotigotine.,Rotigotine,DB00042
DB06201,The risk or severity of adverse effects can be increased when Rufinamide is combined with Botulinum Toxin Type B.,Rufinamide,DB00042
DB09072,Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Sodium oxybate,DB00042
DB09034,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,Suvorexant,DB00042
DB06204,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Tapentadol,DB00042
DB01041,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.,Thalidomide,DB00042
DB00425,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,Zolpidem,DB00042
DB00202,The therapeutic efficacy of Succinylcholine can be increased when used in combination with Botulinum Toxin Type B.,Succinylcholine,DB00042
DB01245,The therapeutic efficacy of Decamethonium can be increased when used in combination with Botulinum Toxin Type B.,Decamethonium,DB00042
DB11156,The therapeutic efficacy of Pyrantel can be increased when used in combination with Botulinum Toxin Type B.,Pyrantel,DB00042
DB12989,The therapeutic efficacy of Neosaxitoxin can be increased when used in combination with Botulinum Toxin Type B.,Neosaxitoxin,DB00042
DB00333,The risk or severity of adverse effects can be increased when Methadone is combined with Botulinum Toxin Type B.,Methadone,DB00042
DB00209,The risk or severity of adverse effects can be increased when Trospium is combined with Botulinum Toxin Type B.,Trospium,DB00042
DB00219,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Botulinum Toxin Type B.,Oxyphenonium,DB00042
DB00237,The risk or severity of adverse effects can be increased when Butabarbital is combined with Botulinum Toxin Type B.,Butabarbital,DB00042
DB00241,The risk or severity of adverse effects can be increased when Butalbital is combined with Botulinum Toxin Type B.,Butalbital,DB00042
DB00245,The risk or severity of adverse effects can be increased when Benzatropine is combined with Botulinum Toxin Type B.,Benzatropine,DB00042
DB00280,The risk or severity of adverse effects can be increased when Disopyramide is combined with Botulinum Toxin Type B.,Disopyramide,DB00042
DB00306,The risk or severity of adverse effects can be increased when Talbutal is combined with Botulinum Toxin Type B.,Talbutal,DB00042
DB00312,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Botulinum Toxin Type B.,Pentobarbital,DB00042
DB00321,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Botulinum Toxin Type B.,Amitriptyline,DB00042
DB00332,The risk or severity of adverse effects can be increased when Ipratropium is combined with Botulinum Toxin Type B.,Ipratropium,DB00042
DB00334,The risk or severity of adverse effects can be increased when Olanzapine is combined with Botulinum Toxin Type B.,Olanzapine,DB00042
DB00340,The risk or severity of adverse effects can be increased when Metixene is combined with Botulinum Toxin Type B.,Metixene,DB00042
DB00342,The risk or severity of adverse effects can be increased when Terfenadine is combined with Botulinum Toxin Type B.,Terfenadine,DB00042
DB00354,The risk or severity of adverse effects can be increased when Buclizine is combined with Botulinum Toxin Type B.,Buclizine,DB00042
DB00363,The risk or severity of adverse effects can be increased when Clozapine is combined with Botulinum Toxin Type B.,Clozapine,DB00042
DB00376,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Botulinum Toxin Type B.,Trihexyphenidyl,DB00042
DB00383,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Botulinum Toxin Type B.,Oxyphencyclimine,DB00042
DB00387,The risk or severity of adverse effects can be increased when Procyclidine is combined with Botulinum Toxin Type B.,Procyclidine,DB00042
DB00392,The risk or severity of adverse effects can be increased when Profenamine is combined with Botulinum Toxin Type B.,Profenamine,DB00042
DB00416,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Botulinum Toxin Type B.,Metocurine iodide,DB00042
DB00418,The risk or severity of adverse effects can be increased when Secobarbital is combined with Botulinum Toxin Type B.,Secobarbital,DB00042
DB00420,The risk or severity of adverse effects can be increased when Promazine is combined with Botulinum Toxin Type B.,Promazine,DB00042
DB00424,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Botulinum Toxin Type B.,Hyoscyamine,DB00042
DB00434,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Botulinum Toxin Type B.,Cyproheptadine,DB00042
DB00458,The risk or severity of adverse effects can be increased when Imipramine is combined with Botulinum Toxin Type B.,Imipramine,DB00042
DB00462,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Botulinum Toxin Type B.,Methscopolamine bromide,DB00042
DB00463,The risk or severity of adverse effects can be increased when Metharbital is combined with Botulinum Toxin Type B.,Metharbital,DB00042
DB00477,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Botulinum Toxin Type B.,Chlorpromazine,DB00042
DB00483,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Botulinum Toxin Type B.,Gallamine triethiodide,DB00042
DB00496,The risk or severity of adverse effects can be increased when Darifenacin is combined with Botulinum Toxin Type B.,Darifenacin,DB00042
DB00505,The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Botulinum Toxin Type B.,Tridihexethyl,DB00042
DB00508,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Botulinum Toxin Type B.,Triflupromazine,DB00042
DB00514,The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Botulinum Toxin Type B.,Dextromethorphan,DB00042
DB00517,The risk or severity of adverse effects can be increased when Anisotropine methylbromide is combined with Botulinum Toxin Type B.,Anisotropine methylbromide,DB00042
DB00540,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Botulinum Toxin Type B.,Nortriptyline,DB00042
DB00543,The risk or severity of adverse effects can be increased when Amoxapine is combined with Botulinum Toxin Type B.,Amoxapine,DB00042
DB00555,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Botulinum Toxin Type B.,Lamotrigine,DB00042
DB00565,The risk or severity of adverse effects can be increased when Cisatracurium is combined with Botulinum Toxin Type B.,Cisatracurium,DB00042
DB00572,The risk or severity of adverse effects can be increased when Atropine is combined with Botulinum Toxin Type B.,Atropine,DB00042
DB00599,The risk or severity of adverse effects can be increased when Thiopental is combined with Botulinum Toxin Type B.,Thiopental,DB00042
DB00622,The risk or severity of adverse effects can be increased when Nicardipine is combined with Botulinum Toxin Type B.,Nicardipine,DB00042
DB00657,The risk or severity of adverse effects can be increased when Mecamylamine is combined with Botulinum Toxin Type B.,Mecamylamine,DB00042
DB00670,The risk or severity of adverse effects can be increased when Pirenzepine is combined with Botulinum Toxin Type B.,Pirenzepine,DB00042
DB00715,The risk or severity of adverse effects can be increased when Paroxetine is combined with Botulinum Toxin Type B.,Paroxetine,DB00042
DB00721,The risk or severity of adverse effects can be increased when Procaine is combined with Botulinum Toxin Type B.,Procaine,DB00042
DB00725,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Botulinum Toxin Type B.,Homatropine methylbromide,DB00042
DB00728,The risk or severity of adverse effects can be increased when Rocuronium is combined with Botulinum Toxin Type B.,Rocuronium,DB00042
DB00732,The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Botulinum Toxin Type B.,Atracurium besylate,DB00042
DB00747,The risk or severity of adverse effects can be increased when Scopolamine is combined with Botulinum Toxin Type B.,Scopolamine,DB00042
DB00753,The risk or severity of adverse effects can be increased when Isoflurane is combined with Botulinum Toxin Type B.,Isoflurane,DB00042
DB00767,The risk or severity of adverse effects can be increased when Benzquinamide is combined with Botulinum Toxin Type B.,Benzquinamide,DB00042
DB00771,The risk or severity of adverse effects can be increased when Clidinium is combined with Botulinum Toxin Type B.,Clidinium,DB00042
DB00777,The risk or severity of adverse effects can be increased when Propiomazine is combined with Botulinum Toxin Type B.,Propiomazine,DB00042
DB00782,The risk or severity of adverse effects can be increased when Propantheline is combined with Botulinum Toxin Type B.,Propantheline,DB00042
DB00794,The risk or severity of adverse effects can be increased when Primidone is combined with Botulinum Toxin Type B.,Primidone,DB00042
DB00804,The risk or severity of adverse effects can be increased when Dicyclomine is combined with Botulinum Toxin Type B.,Dicyclomine,DB00042
DB00810,The risk or severity of adverse effects can be increased when Biperiden is combined with Botulinum Toxin Type B.,Biperiden,DB00042
DB00835,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Botulinum Toxin Type B.,Brompheniramine,DB00042
DB00849,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Botulinum Toxin Type B.,Methylphenobarbital,DB00042
DB00875,The risk or severity of adverse effects can be increased when Flupentixol is combined with Botulinum Toxin Type B.,Flupentixol,DB00042
DB00907,The risk or severity of adverse effects can be increased when Cocaine is combined with Botulinum Toxin Type B.,Cocaine,DB00042
DB00908,The risk or severity of adverse effects can be increased when Quinidine is combined with Botulinum Toxin Type B.,Quinidine,DB00042
DB00915,The risk or severity of adverse effects can be increased when Amantadine is combined with Botulinum Toxin Type B.,Amantadine,DB00042
DB00934,The risk or severity of adverse effects can be increased when Maprotiline is combined with Botulinum Toxin Type B.,Maprotiline,DB00042
DB00940,The risk or severity of adverse effects can be increased when Methantheline is combined with Botulinum Toxin Type B.,Methantheline,DB00042
DB00941,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Botulinum Toxin Type B.,Hexafluronium,DB00042
DB00942,The risk or severity of adverse effects can be increased when Cycrimine is combined with Botulinum Toxin Type B.,Cycrimine,DB00042
DB00967,The risk or severity of adverse effects can be increased when Desloratadine is combined with Botulinum Toxin Type B.,Desloratadine,DB00042
DB00986,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Botulinum Toxin Type B.,Glycopyrronium,DB00042
DB01036,The risk or severity of adverse effects can be increased when Tolterodine is combined with Botulinum Toxin Type B.,Tolterodine,DB00042
DB01062,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Botulinum Toxin Type B.,Oxybutynin,DB00042
DB01069,The risk or severity of adverse effects can be increased when Promethazine is combined with Botulinum Toxin Type B.,Promethazine,DB00042
DB01075,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Botulinum Toxin Type B.,Diphenhydramine,DB00042
DB01090,The risk or severity of adverse effects can be increased when Pentolinium is combined with Botulinum Toxin Type B.,Pentolinium,DB00042
DB01116,The risk or severity of adverse effects can be increased when Trimethaphan is combined with Botulinum Toxin Type B.,Trimethaphan,DB00042
DB01135,The risk or severity of adverse effects can be increased when Doxacurium is combined with Botulinum Toxin Type B.,Doxacurium,DB00042
DB01142,The risk or severity of adverse effects can be increased when Doxepin is combined with Botulinum Toxin Type B.,Doxepin,DB00042
DB01148,The risk or severity of adverse effects can be increased when Flavoxate is combined with Botulinum Toxin Type B.,Flavoxate,DB00042
DB01151,The risk or severity of adverse effects can be increased when Desipramine is combined with Botulinum Toxin Type B.,Desipramine,DB00042
DB01161,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Botulinum Toxin Type B.,Chloroprocaine,DB00042
DB01174,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Botulinum Toxin Type B.,Phenobarbital,DB00042
DB01175,The risk or severity of adverse effects can be increased when Escitalopram is combined with Botulinum Toxin Type B.,Escitalopram,DB00042
DB01199,The risk or severity of adverse effects can be increased when Tubocurarine is combined with Botulinum Toxin Type B.,Tubocurarine,DB00042
DB01224,The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum Toxin Type B.,Quetiapine,DB00042
DB01226,The risk or severity of adverse effects can be increased when Mivacurium is combined with Botulinum Toxin Type B.,Mivacurium,DB00042
DB01227,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Botulinum Toxin Type B.,Levacetylmethadol,DB00042
DB01231,The risk or severity of adverse effects can be increased when Diphenidol is combined with Botulinum Toxin Type B.,Diphenidol,DB00042
DB01238,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Botulinum Toxin Type B.,Aripiprazole,DB00042
DB01239,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Botulinum Toxin Type B.,Chlorprothixene,DB00042
DB01288,The risk or severity of adverse effects can be increased when Fenoterol is combined with Botulinum Toxin Type B.,Fenoterol,DB00042
DB01336,The risk or severity of adverse effects can be increased when Metocurine is combined with Botulinum Toxin Type B.,Metocurine,DB00042
DB01337,The risk or severity of adverse effects can be increased when Pancuronium is combined with Botulinum Toxin Type B.,Pancuronium,DB00042
DB01338,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Botulinum Toxin Type B.,Pipecuronium,DB00042
DB01339,The risk or severity of adverse effects can be increased when Vecuronium is combined with Botulinum Toxin Type B.,Vecuronium,DB00042
DB01351,The risk or severity of adverse effects can be increased when Amobarbital is combined with Botulinum Toxin Type B.,Amobarbital,DB00042
DB01352,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Botulinum Toxin Type B.,Aprobarbital,DB00042
DB01353,The risk or severity of adverse effects can be increased when Butobarbital is combined with Botulinum Toxin Type B.,Butobarbital,DB00042
DB01354,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Botulinum Toxin Type B.,Heptabarbital,DB00042
DB01355,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Botulinum Toxin Type B.,Hexobarbital,DB00042
DB01409,The risk or severity of adverse effects can be increased when Tiotropium is combined with Botulinum Toxin Type B.,Tiotropium,DB00042
DB01483,The risk or severity of adverse effects can be increased when Barbital is combined with Botulinum Toxin Type B.,Barbital,DB00042
DB01496,"The risk or severity of adverse effects can be increased when Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione is combined with Botulinum Toxin Type B.","Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione",DB00042
DB01591,The risk or severity of adverse effects can be increased when Solifenacin is combined with Botulinum Toxin Type B.,Solifenacin,DB00042
DB01625,The risk or severity of adverse effects can be increased when Isopropamide is combined with Botulinum Toxin Type B.,Isopropamide,DB00042
DB04834,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Botulinum Toxin Type B.,Rapacuronium,DB00042
DB04843,The risk or severity of adverse effects can be increased when Mepenzolate is combined with Botulinum Toxin Type B.,Mepenzolate,DB00042
DB05710,The risk or severity of adverse effects can be increased when Gantacurium is combined with Botulinum Toxin Type B.,Gantacurium,DB00042
DB06153,The risk or severity of adverse effects can be increased when Pizotifen is combined with Botulinum Toxin Type B.,Pizotifen,DB00042
DB06702,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Botulinum Toxin Type B.,Fesoterodine,DB00042
DB06787,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Botulinum Toxin Type B.,Hexocyclium,DB00042
DB08801,The risk or severity of adverse effects can be increased when Dimetindene is combined with Botulinum Toxin Type B.,Dimetindene,DB00042
DB08838,The risk or severity of adverse effects can be increased when Agmatine is combined with Botulinum Toxin Type B.,Agmatine,DB00042
DB08897,The risk or severity of adverse effects can be increased when Aclidinium is combined with Botulinum Toxin Type B.,Aclidinium,DB00042
DB08960,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Botulinum Toxin Type B.,Hexamethonium,DB00042
DB08997,The risk or severity of adverse effects can be increased when Dexetimide is combined with Botulinum Toxin Type B.,Dexetimide,DB00042
DB09007,The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Botulinum Toxin Type B.,Chlorphenoxamine,DB00042
DB09023,The risk or severity of adverse effects can be increased when Benactyzine is combined with Botulinum Toxin Type B.,Benactyzine,DB00042
DB09076,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Botulinum Toxin Type B.,Umeclidinium,DB00042
DB09089,The risk or severity of adverse effects can be increased when Trimebutine is combined with Botulinum Toxin Type B.,Trimebutine,DB00042
DB09167,The risk or severity of adverse effects can be increased when Dosulepin is combined with Botulinum Toxin Type B.,Dosulepin,DB00042
DB09262,The risk or severity of adverse effects can be increased when Imidafenacin is combined with Botulinum Toxin Type B.,Imidafenacin,DB00042
DB09300,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Botulinum Toxin Type B.,Butylscopolamine,DB00042
DB11235,The risk or severity of adverse effects can be increased when Thonzylamine is combined with Botulinum Toxin Type B.,Thonzylamine,DB00042
DB11315,The risk or severity of adverse effects can be increased when Methscopolamine is combined with Botulinum Toxin Type B.,Methscopolamine,DB00042
DB11855,The risk or severity of adverse effects can be increased when Revefenacin is combined with Botulinum Toxin Type B.,Revefenacin,DB00042
DB12086,The risk or severity of adverse effects can be increased when Oxitropium is combined with Botulinum Toxin Type B.,Oxitropium,DB00042
DB12278,The risk or severity of adverse effects can be increased when Propiverine is combined with Botulinum Toxin Type B.,Propiverine,DB00042
DB12526,The risk or severity of adverse effects can be increased when Batefenterol is combined with Botulinum Toxin Type B.,Batefenterol,DB00042
DB12554,The risk or severity of adverse effects can be increased when Mebeverine is combined with Botulinum Toxin Type B.,Mebeverine,DB00042
DB13252,The risk or severity of adverse effects can be increased when Tropatepine is combined with Botulinum Toxin Type B.,Tropatepine,DB00042
DB13254,The risk or severity of adverse effects can be increased when Prifinium is combined with Botulinum Toxin Type B.,Prifinium,DB00042
DB13295,The risk or severity of adverse effects can be increased when Atracurium is combined with Botulinum Toxin Type B.,Atracurium,DB00042
DB13351,The risk or severity of adverse effects can be increased when Piperidolate is combined with Botulinum Toxin Type B.,Piperidolate,DB00042
DB13369,The risk or severity of adverse effects can be increased when Benzilone is combined with Botulinum Toxin Type B.,Benzilone,DB00042
DB13380,The risk or severity of adverse effects can be increased when Difemerine is combined with Botulinum Toxin Type B.,Difemerine,DB00042
DB13413,The risk or severity of adverse effects can be increased when Phenglutarimide is combined with Botulinum Toxin Type B.,Phenglutarimide,DB00042
DB13448,The risk or severity of adverse effects can be increased when Mazaticol is combined with Botulinum Toxin Type B.,Mazaticol,DB00042
DB13468,The risk or severity of adverse effects can be increased when Etybenzatropine is combined with Botulinum Toxin Type B.,Etybenzatropine,DB00042
DB13500,The risk or severity of adverse effects can be increased when Otilonium is combined with Botulinum Toxin Type B.,Otilonium,DB00042
DB13505,The risk or severity of adverse effects can be increased when Emepronium is combined with Botulinum Toxin Type B.,Emepronium,DB00042
DB13507,The risk or severity of adverse effects can be increased when Poldine is combined with Botulinum Toxin Type B.,Poldine,DB00042
DB13542,The risk or severity of adverse effects can be increased when Bevonium is combined with Botulinum Toxin Type B.,Bevonium,DB00042
DB13581,The risk or severity of adverse effects can be increased when Rociverine is combined with Botulinum Toxin Type B.,Rociverine,DB00042
DB13584,The risk or severity of adverse effects can be increased when Gallamine is combined with Botulinum Toxin Type B.,Gallamine,DB00042
DB13619,The risk or severity of adverse effects can be increased when Bornaprine is combined with Botulinum Toxin Type B.,Bornaprine,DB00042
DB13636,The risk or severity of adverse effects can be increased when Etanautine is combined with Botulinum Toxin Type B.,Etanautine,DB00042
DB13648,The risk or severity of adverse effects can be increased when Alcuronium is combined with Botulinum Toxin Type B.,Alcuronium,DB00042
DB13666,The risk or severity of adverse effects can be increased when Tiemonium iodide is combined with Botulinum Toxin Type B.,Tiemonium iodide,DB00042
DB13678,The risk or severity of adverse effects can be increased when Dihexyverine is combined with Botulinum Toxin Type B.,Dihexyverine,DB00042
DB13695,The risk or severity of adverse effects can be increased when Penthienate is combined with Botulinum Toxin Type B.,Penthienate,DB00042
DB13720,The risk or severity of adverse effects can be increased when Diphemanil is combined with Botulinum Toxin Type B.,Diphemanil,DB00042
DB13738,The risk or severity of adverse effects can be increased when Camylofin is combined with Botulinum Toxin Type B.,Camylofin,DB00042
DB13759,The risk or severity of adverse effects can be increased when Fenpiverinium is combined with Botulinum Toxin Type B.,Fenpiverinium,DB00042
DB13769,The risk or severity of adverse effects can be increased when Emetonium iodide is combined with Botulinum Toxin Type B.,Emetonium iodide,DB00042
DB13844,The risk or severity of adverse effects can be increased when Pipenzolate is combined with Botulinum Toxin Type B.,Pipenzolate,DB00042
DB13850,The risk or severity of adverse effects can be increased when Timepidium is combined with Botulinum Toxin Type B.,Timepidium,DB00042
DB00898,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,Ethanol,DB00042
DB00972,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,Azelastine,DB00042
DB00484,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Brimonidine,DB00042
DB00176,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluvoxamine.,Fluvoxamine,DB00042
DB00215,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Citalopram.,Citalopram,DB00042
DB00476,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Duloxetine.,Duloxetine,DB00042
DB00656,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trazodone.,Trazodone,DB00042
DB01104,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sertraline.,Sertraline,DB00042
DB01105,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sibutramine.,Sibutramine,DB00042
DB01149,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nefazodone.,Nefazodone,DB00042
DB04832,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zimelidine.,Zimelidine,DB00042
DB04884,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dapoxetine.,Dapoxetine,DB00042
DB04896,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Milnacipran.,Milnacipran,DB00042
DB06700,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Desvenlafaxine.,Desvenlafaxine,DB00042
DB06731,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Seproxetine.,Seproxetine,DB00042
DB08918,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levomilnacipran.,Levomilnacipran,DB00042
DB08953,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Indalpine.,Indalpine,DB00042
DB12693,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ritanserin.,Ritanserin,DB00042
DB13233,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alaproclate.,Alaproclate,DB00042
DB01198,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zopiclone.,Zopiclone,DB00042
DB00150,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tryptophan.,Tryptophan,DB00042
DB00181,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Baclofen.,Baclofen,DB00042
DB00182,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amphetamine.,Amphetamine,DB00042
DB00186,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lorazepam.,Lorazepam,DB00042
DB00189,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethchlorvynol.,Ethchlorvynol,DB00042
DB00206,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Reserpine.,Reserpine,DB00042
DB00216,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eletriptan.,Eletriptan,DB00042
DB00228,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Enflurane.,Enflurane,DB00042
DB00231,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Temazepam.,Temazepam,DB00042
DB00234,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Reboxetine.,Reboxetine,DB00042
DB00247,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methysergide.,Methysergide,DB00042
DB00248,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cabergoline.,Cabergoline,DB00042
DB00252,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenytoin.,Phenytoin,DB00042
DB00273,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Topiramate.,Topiramate,DB00042
DB00283,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clemastine.,Clemastine,DB00042
DB00285,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Venlafaxine.,Venlafaxine,DB00042
DB00289,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Atomoxetine.,Atomoxetine,DB00042
DB00292,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etomidate.,Etomidate,DB00042
DB00295,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Morphine.,Morphine,DB00042
DB00313,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Valproic acid.,Valproic acid,DB00042
DB00315,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zolmitriptan.,Zolmitriptan,DB00042
DB00318,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Codeine.,Codeine,DB00042
DB00320,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dihydroergotamine.,Dihydroergotamine,DB00042
DB00323,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tolcapone.,Tolcapone,DB00042
DB00327,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Hydromorphone.,Hydromorphone,DB00042
DB00341,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cetirizine.,Cetirizine,DB00042
DB00344,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Protriptyline.,Protriptyline,DB00042
DB00347,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trimethadione.,Trimethadione,DB00042
DB00349,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clobazam.,Clobazam,DB00042
DB00356,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlorzoxazone.,Chlorzoxazone,DB00042
DB00371,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Meprobamate.,Meprobamate,DB00042
DB00372,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiethylperazine.,Thiethylperazine,DB00042
DB00377,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Palonosetron.,Palonosetron,DB00042
DB00391,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sulpiride.,Sulpiride,DB00042
DB00404,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alprazolam.,Alprazolam,DB00042
DB00405,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dexbrompheniramine.,Dexbrompheniramine,DB00042
DB00408,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Loxapine.,Loxapine,DB00042
DB00409,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Remoxipride.,Remoxipride,DB00042
DB00423,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methocarbamol.,Methocarbamol,DB00042
DB00427,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Triprolidine.,Triprolidine,DB00042
DB00433,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Prochlorperazine.,Prochlorperazine,DB00042
DB00454,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Meperidine.,Meperidine,DB00042
DB00474,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methohexital.,Methohexital,DB00042
DB00475,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlordiazepoxide.,Chlordiazepoxide,DB00042
DB00494,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Entacapone.,Entacapone,DB00042
DB00497,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxycodone.,Oxycodone,DB00042
DB00532,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mephenytoin.,Mephenytoin,DB00042
DB00546,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Adinazolam.,Adinazolam,DB00042
DB00564,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carbamazepine.,Carbamazepine,DB00042
DB00574,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fenfluramine.,Fenfluramine,DB00042
DB00579,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mazindol.,Mazindol,DB00042
DB00588,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluticasone propionate.,Fluticasone propionate,DB00042
DB00589,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lisuride.,Lisuride,DB00042
DB00593,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethosuximide.,Ethosuximide,DB00042
DB00601,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Linezolid.,Linezolid,DB00042
DB00604,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cisapride.,Cisapride,DB00042
DB00611,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Butorphanol.,Butorphanol,DB00042
DB00614,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Furazolidone.,Furazolidone,DB00042
DB00617,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Paramethadione.,Paramethadione,DB00042
DB00623,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluphenazine.,Fluphenazine,DB00042
DB00625,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Efavirenz.,Efavirenz,DB00042
DB00628,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clorazepic acid.,Clorazepic acid,DB00042
DB00633,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dexmedetomidine.,Dexmedetomidine,DB00042
DB00645,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dyclonine.,Dyclonine,DB00042
DB00647,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dextropropoxyphene.,Dextropropoxyphene,DB00042
DB00652,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pentazocine.,Pentazocine,DB00042
DB00660,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Metaxalone.,Metaxalone,DB00042
DB00662,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trimethobenzamide.,Trimethobenzamide,DB00042
DB00669,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sumatriptan.,Sumatriptan,DB00042
DB00679,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thioridazine.,Thioridazine,DB00042
DB00680,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Moricizine.,Moricizine,DB00042
DB00683,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Midazolam.,Midazolam,DB00042
DB00690,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Flurazepam.,Flurazepam,DB00042
DB00696,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ergotamine.,Ergotamine,DB00042
DB00697,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tizanidine.,Tizanidine,DB00042
DB00708,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sufentanil.,Sufentanil,DB00042
DB00714,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Apomorphine.,Apomorphine,DB00042
DB00726,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trimipramine.,Trimipramine,DB00042
DB00734,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Risperidone.,Risperidone,DB00042
DB00737,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Meclizine.,Meclizine,DB00042
DB00740,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Riluzole.,Riluzole,DB00042
DB00748,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carbinoxamine.,Carbinoxamine,DB00042
DB00752,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tranylcypromine.,Tranylcypromine,DB00042
DB00754,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethotoin.,Ethotoin,DB00042
DB00757,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dolasetron.,Dolasetron,DB00042
DB00776,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxcarbazepine.,Oxcarbazepine,DB00042
DB00780,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenelzine.,Phenelzine,DB00042
DB00801,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Halazepam.,Halazepam,DB00042
DB00802,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alfentanil.,Alfentanil,DB00042
DB00805,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Minaprine.,Minaprine,DB00042
DB00813,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fentanyl.,Fentanyl,DB00042
DB00818,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Propofol.,Propofol,DB00042
DB00819,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Acetazolamide.,Acetazolamide,DB00042
DB00829,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diazepam.,Diazepam,DB00042
DB00831,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trifluoperazine.,Trifluoperazine,DB00042
DB00832,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phensuximide.,Phensuximide,DB00042
DB00837,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Progabide.,Progabide,DB00042
DB00842,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxazepam.,Oxazepam,DB00042
DB00843,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Donepezil.,Donepezil,DB00042
DB00844,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nalbuphine.,Nalbuphine,DB00042
DB00850,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Perphenazine.,Perphenazine,DB00042
DB00854,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levorphanol.,Levorphanol,DB00042
DB00865,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benzphetamine.,Benzphetamine,DB00042
DB00866,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alprenolol.,Alprenolol,DB00042
DB00889,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Granisetron.,Granisetron,DB00042
DB00897,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Triazolam.,Triazolam,DB00042
DB00899,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Remifentanil.,Remifentanil,DB00042
DB00904,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ondansetron.,Ondansetron,DB00042
DB00906,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tiagabine.,Tiagabine,DB00042
DB00909,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zonisamide.,Zonisamide,DB00042
DB00918,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Almotriptan.,Almotriptan,DB00042
DB00933,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mesoridazine.,Mesoridazine,DB00042
DB00937,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diethylpropion.,Diethylpropion,DB00042
DB00949,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Felbamate.,Felbamate,DB00042
DB00952,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Naratriptan.,Naratriptan,DB00042
DB00953,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Rizatriptan.,Rizatriptan,DB00042
DB00960,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pindolol.,Pindolol,DB00042
DB00962,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zaleplon.,Zaleplon,DB00042
DB00969,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alosetron.,Alosetron,DB00042
DB00980,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ramelteon.,Ramelteon,DB00042
DB00985,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dimenhydrinate.,Dimenhydrinate,DB00042
DB00996,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gabapentin.,Gabapentin,DB00042
DB00998,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Frovatriptan.,Frovatriptan,DB00042
DB01018,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Guanfacine.,Guanfacine,DB00042
DB01028,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methoxyflurane.,Methoxyflurane,DB00042
DB01037,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Selegiline.,Selegiline,DB00042
DB01049,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ergoloid mesylate.,Ergoloid mesylate,DB00042
DB01063,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Acetophenazine.,Acetophenazine,DB00042
DB01065,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Melatonin.,Melatonin,DB00042
DB01068,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clonazepam.,Clonazepam,DB00042
DB01080,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vigabatrin.,Vigabatrin,DB00042
DB01081,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diphenoxylate.,Diphenoxylate,DB00042
DB01100,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pimozide.,Pimozide,DB00042
DB01107,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methyprylon.,Methyprylon,DB00042
DB01114,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlorpheniramine.,Chlorpheniramine,DB00042
DB01121,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenacemide.,Phenacemide,DB00042
DB01154,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiamylal.,Thiamylal,DB00042
DB01156,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bupropion.,Bupropion,DB00042
DB01159,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Halothane.,Halothane,DB00042
DB01168,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Procarbazine.,Procarbazine,DB00042
DB01171,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Moclobemide.,Moclobemide,DB00042
DB01176,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyclizine.,Cyclizine,DB00042
DB01178,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlormezanone.,Chlormezanone,DB00042
DB01186,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pergolide.,Pergolide,DB00042
DB01189,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Desflurane.,Desflurane,DB00042
DB01192,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxymorphone.,Oxymorphone,DB00042
DB01200,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bromocriptine.,Bromocriptine,DB00042
DB01202,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levetiracetam.,Levetiracetam,DB00042
DB01209,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dezocine.,Dezocine,DB00042
DB01215,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Estazolam.,Estazolam,DB00042
DB01221,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ketamine.,Ketamine,DB00042
DB01235,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levodopa.,Levodopa,DB00042
DB01236,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sevoflurane.,Sevoflurane,DB00042
DB01242,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clomipramine.,Clomipramine,DB00042
DB01246,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alimemazine.,Alimemazine,DB00042
DB01247,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Isocarboxazid.,Isocarboxazid,DB00042
DB01253,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ergometrine.,Ergometrine,DB00042
DB01267,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Paliperidone.,Paliperidone,DB00042
DB01320,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fosphenytoin.,Fosphenytoin,DB00042
DB01323,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with St. John's Wort.,St. John's Wort,DB00042
DB01356,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lithium cation.,Lithium cation,DB00042
DB01359,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Penbutolol.,Penbutolol,DB00042
DB01367,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Rasagiline.,Rasagiline,DB00042
DB01392,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Yohimbine.,Yohimbine,DB00042
DB01433,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methadyl acetate.,Methadyl acetate,DB00042
DB01437,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Glutethimide.,Glutethimide,DB00042
DB01440,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with gamma-Hydroxybutyric acid.,gamma-Hydroxybutyric acid,DB00042
DB01442,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with MMDA.,MMDA,DB00042
DB01445,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bufotenine.,Bufotenine,DB00042
DB01450,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dihydroetorphine.,Dihydroetorphine,DB00042
DB01452,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diamorphine.,Diamorphine,DB00042
DB01454,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Midomafetamine.,Midomafetamine,DB00042
DB01463,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fencamfamin.,Fencamfamin,DB00042
DB01466,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethylmorphine.,Ethylmorphine,DB00042
DB01472,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 4-Methoxyamphetamine.,4-Methoxyamphetamine,DB00042
DB01484,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 4-Bromo-2,5-dimethoxyamphetamine.","4-Bromo-2,5-dimethoxyamphetamine",DB00042
DB01488,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dimethyltryptamine.,Dimethyltryptamine,DB00042
DB01489,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Camazepam.,Camazepam,DB00042
DB01495,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dichloralphenazone.,Dichloralphenazone,DB00042
DB01497,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etorphine.,Etorphine,DB00042
DB01501,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Difenoxin.,Difenoxin,DB00042
DB01509,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tenamfetamine.,Tenamfetamine,DB00042
DB01511,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Delorazepam.,Delorazepam,DB00042
DB01529,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dextromoramide.,Dextromoramide,DB00042
DB01531,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Desomorphine.,Desomorphine,DB00042
DB01534,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlorhexadol.,Chlorhexadol,DB00042
DB01535,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carfentanil.,Carfentanil,DB00042
DB01544,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Flunitrazepam.,Flunitrazepam,DB00042
DB01545,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethyl loflazepate.,Ethyl loflazepate,DB00042
DB01547,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Drotebanol.,Drotebanol,DB00042
DB01551,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dihydrocodeine.,Dihydrocodeine,DB00042
DB01553,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cloxazolam.,Cloxazolam,DB00042
DB01555,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alphacetylmethadol.,Alphacetylmethadol,DB00042
DB01558,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bromazepam.,Bromazepam,DB00042
DB01559,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clotiazepam.,Clotiazepam,DB00042
DB01560,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cathinone.,Cathinone,DB00042
DB01563,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chloral hydrate.,Chloral hydrate,DB00042
DB01565,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dihydromorphine.,Dihydromorphine,DB00042
DB01567,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fludiazepam.,Fludiazepam,DB00042
DB01577,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Metamfetamine.,Metamfetamine,DB00042
DB01580,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxprenolol.,Oxprenolol,DB00042
DB01587,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ketazolam.,Ketazolam,DB00042
DB01588,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Prazepam.,Prazepam,DB00042
DB01589,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Quazepam.,Quazepam,DB00042
DB01594,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cinolazepam.,Cinolazepam,DB00042
DB01595,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nitrazepam.,Nitrazepam,DB00042
DB01608,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Periciazine.,Periciazine,DB00042
DB01614,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Acepromazine.,Acepromazine,DB00042
DB01615,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Aceprometazine.,Aceprometazine,DB00042
DB01616,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alverine.,Alverine,DB00042
DB01618,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Molindone.,Molindone,DB00042
DB01621,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pipotiazine.,Pipotiazine,DB00042
DB01622,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thioproperazine.,Thioproperazine,DB00042
DB01623,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiothixene.,Thiothixene,DB00042
DB01624,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zuclopenthixol.,Zuclopenthixol,DB00042
DB01626,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pargyline.,Pargyline,DB00042
DB01954,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Rolipram.,Rolipram,DB00042
DB02207,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 7-Nitroindazole.,7-Nitroindazole,DB00042
DB02234,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with S-Ethylisothiourea.,S-Ethylisothiourea,DB00042
DB02852,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Domoic Acid.,Domoic Acid,DB00042
DB02959,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxitriptan.,Oxitriptan,DB00042
DB03575,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phencyclidine.,Phencyclidine,DB00042
DB04017,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clorgiline.,Clorgiline,DB00042
DB04165,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Valpromide.,Valpromide,DB00042
DB04325,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenethylamine.,Phenethylamine,DB00042
DB04599,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Aniracetam.,Aniracetam,DB00042
DB04818,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iproniazid.,Iproniazid,DB00042
DB04819,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methapyrilene.,Methapyrilene,DB00042
DB04820,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nialamide.,Nialamide,DB00042
DB04821,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nomifensine.,Nomifensine,DB00042
DB04827,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Urethane.,Urethane,DB00042
DB04829,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lysergic acid diethylamide.,Lysergic acid diethylamide,DB00042
DB04833,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methaqualone.,Methaqualone,DB00042
DB04836,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amineptine.,Amineptine,DB00042
DB04841,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Flunarizine.,Flunarizine,DB00042
DB04842,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluspirilene.,Fluspirilene,DB00042
DB04871,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lorcaserin.,Lorcaserin,DB00042
DB04872,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Osanetant.,Osanetant,DB00042
DB04885,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cilansetron.,Cilansetron,DB00042
DB04888,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bifeprunox.,Bifeprunox,DB00042
DB04903,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pagoclone.,Pagoclone,DB00042
DB04908,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Flibanserin.,Flibanserin,DB00042
DB04917,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Renzapride.,Renzapride,DB00042
DB04946,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iloperidone.,Iloperidone,DB00042
DB04953,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ezogabine.,Ezogabine,DB00042
DB05227,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with APD791.,APD791,DB00042
DB05232,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetrodotoxin.,Tetrodotoxin,DB00042
DB05246,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methsuximide.,Methsuximide,DB00042
DB05316,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pimavanserin.,Pimavanserin,DB00042
DB05541,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brivaracetam.,Brivaracetam,DB00042
DB05542,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Naronapride.,Naronapride,DB00042
DB05562,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Naluzotan.,Naluzotan,DB00042
DB05607,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with PRX-08066.,PRX-08066,DB00042
DB05687,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with BL-1020.,BL-1020,DB00042
DB06016,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cariprazine.,Cariprazine,DB00042
DB06077,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lumateperone.,Lumateperone,DB00042
DB06109,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with YKP-1358.,YKP-1358,DB00042
DB06144,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sertindole.,Sertindole,DB00042
DB06148,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mianserin.,Mianserin,DB00042
DB06216,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Asenapine.,Asenapine,DB00042
DB06218,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lacosamide.,Lacosamide,DB00042
DB06264,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tolperisone.,Tolperisone,DB00042
DB06282,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levocetirizine.,Levocetirizine,DB00042
DB06283,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ziconotide.,Ziconotide,DB00042
DB06288,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amisulpride.,Amisulpride,DB00042
DB06446,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dotarizine.,Dotarizine,DB00042
DB06458,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Remacemide.,Remacemide,DB00042
DB06470,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clomethiazole.,Clomethiazole,DB00042
DB06512,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Deramciclane.,Deramciclane,DB00042
DB06527,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tramiprosate.,Tramiprosate,DB00042
DB06529,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ocinaplon.,Ocinaplon,DB00042
DB06554,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gaboxadol.,Gaboxadol,DB00042
DB06579,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Adipiplon.,Adipiplon,DB00042
DB06582,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dextofisopam.,Dextofisopam,DB00042
DB06594,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Agomelatine.,Agomelatine,DB00042
DB06654,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Safinamide.,Safinamide,DB00042
DB06660,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Saredutant.,Saredutant,DB00042
DB06678,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Esmirtazapine.,Esmirtazapine,DB00042
DB06684,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vilazodone.,Vilazodone,DB00042
DB06690,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nitrous oxide.,Nitrous oxide,DB00042
DB06691,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mepyramine.,Mepyramine,DB00042
DB06701,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dexmethylphenidate.,Dexmethylphenidate,DB00042
DB06716,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fospropofol.,Fospropofol,DB00042
DB06738,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ketobemidone.,Ketobemidone,DB00042
DB06753,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Triclofos.,Triclofos,DB00042
DB06770,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benzyl alcohol.,Benzyl alcohol,DB00042
DB06797,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mebutamate.,Mebutamate,DB00042
DB08059,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Wortmannin.,Wortmannin,DB00042
DB08329,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sulthiame.,Sulthiame,DB00042
DB08550,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",DB00042
DB08810,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cinitapride.,Cinitapride,DB00042
DB08811,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tofisopam.,Tofisopam,DB00042
DB08815,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lurasidone.,Lurasidone,DB00042
DB08839,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Serotonin.,Serotonin,DB00042
DB08861,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with DPDPE.,DPDPE,DB00042
DB08872,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gabapentin enacarbil.,Gabapentin enacarbil,DB00042
DB08892,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Arbaclofen Placarbil.,Arbaclofen Placarbil,DB00042
DB08910,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pomalidomide.,Pomalidomide,DB00042
DB08922,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Perospirone.,Perospirone,DB00042
DB08927,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amperozide.,Amperozide,DB00042
DB08954,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ifenprodil.,Ifenprodil,DB00042
DB08986,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etifoxine.,Etifoxine,DB00042
DB08992,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eperisone.,Eperisone,DB00042
DB08996,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dimetacrine.,Dimetacrine,DB00042
DB09000,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyamemazine.,Cyamemazine,DB00042
DB09001,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Barbexaclone.,Barbexaclone,DB00042
DB09011,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Beclamide.,Beclamide,DB00042
DB09014,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Captodiame.,Captodiame,DB00042
DB09016,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Butriptyline.,Butriptyline,DB00042
DB09017,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brotizolam.,Brotizolam,DB00042
DB09021,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benzoctamine.,Benzoctamine,DB00042
DB09068,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vortioxetine.,Vortioxetine,DB00042
DB09071,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tasimelteon.,Tasimelteon,DB00042
DB09118,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Stiripentol.,Stiripentol,DB00042
DB09119,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eslicarbazepine acetate.,Eslicarbazepine acetate,DB00042
DB09128,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brexpiprazole.,Brexpiprazole,DB00042
DB09166,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etizolam.,Etizolam,DB00042
DB09174,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lofentanil.,Lofentanil,DB00042
DB09184,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Edivoxetine.,Edivoxetine,DB00042
DB09185,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Viloxazine.,Viloxazine,DB00042
DB09186,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nisoxetine.,Nisoxetine,DB00042
DB09187,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lortalamine.,Lortalamine,DB00042
DB09190,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Talopram.,Talopram,DB00042
DB09194,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etoperidone.,Etoperidone,DB00042
DB09223,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Blonanserin.,Blonanserin,DB00042
DB09224,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Melperone.,Melperone,DB00042
DB09225,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zotepine.,Zotepine,DB00042
DB09226,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brilaroxazine.,Brilaroxazine,DB00042
DB09241,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methylene blue.,Methylene blue,DB00042
DB09243,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Hydracarbazine.,Hydracarbazine,DB00042
DB09244,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pirlindole.,Pirlindole,DB00042
DB09245,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Toloxatone.,Toloxatone,DB00042
DB09246,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benmoxin.,Benmoxin,DB00042
DB09247,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iproclozide.,Iproclozide,DB00042
DB09248,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mebanazine.,Mebanazine,DB00042
DB09249,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Octamoxin.,Octamoxin,DB00042
DB09250,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pheniprazine.,Pheniprazine,DB00042
DB09251,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenoxypropazine.,Phenoxypropazine,DB00042
DB09252,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pivhydrazine.,Pivhydrazine,DB00042
DB09253,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Safrazine.,Safrazine,DB00042
DB09254,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Caroxazone.,Caroxazone,DB00042
DB09286,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pipamperone.,Pipamperone,DB00042
DB09289,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tianeptine.,Tianeptine,DB00042
DB09290,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ramosetron.,Ramosetron,DB00042
DB09307,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxaprotiline.,Oxaprotiline,DB00042
DB11130,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Opium.,Opium,DB00042
DB11371,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alfaxalone.,Alfaxalone,DB00042
DB11376,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Azaperone.,Azaperone,DB00042
DB11400,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Doramectin.,Doramectin,DB00042
DB11428,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Medetomidine.,Medetomidine,DB00042
DB11477,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Xylazine.,Xylazine,DB00042
DB11540,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Propiopromazine.,Propiopromazine,DB00042
DB11543,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Romifidine.,Romifidine,DB00042
DB11549,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tiletamine.,Tiletamine,DB00042
DB11552,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tricaine.,Tricaine,DB00042
DB11555,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zolazepam.,Zolazepam,DB00042
DB11556,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Detomidine.,Detomidine,DB00042
DB11582,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiocolchicoside.,Thiocolchicoside,DB00042
DB11609,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Normethadone.,Normethadone,DB00042
DB11664,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Psilocybin.,Psilocybin,DB00042
DB11675,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mosapride.,Mosapride,DB00042
DB11686,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iferanserin.,Iferanserin,DB00042
DB11699,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tropisetron.,Tropisetron,DB00042
DB11755,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetrahydrocannabivarin.,Tetrahydrocannabivarin,DB00042
DB11859,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brexanolone.,Brexanolone,DB00042
DB11868,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etiracetam.,Etiracetam,DB00042
DB11889,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lanicemine.,Lanicemine,DB00042
DB11957,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Idalopirdine.,Idalopirdine,DB00042
DB12071,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vabicaserin.,Vabicaserin,DB00042
DB12093,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetrahydropalmatine.,Tetrahydropalmatine,DB00042
DB12105,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Imagabalin.,Imagabalin,DB00042
DB12110,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with m-Chlorophenylpiperazine.,m-Chlorophenylpiperazine,DB00042
DB12111,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with MK-212.,MK-212,DB00042
DB12131,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vinpocetine.,Vinpocetine,DB00042
DB12163,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sarpogrelate.,Sarpogrelate,DB00042
DB12177,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eplivanserin.,Eplivanserin,DB00042
DB12184,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gepirone.,Gepirone,DB00042
DB12229,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cerlapirdine.,Cerlapirdine,DB00042
DB12273,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ecopipam.,Ecopipam,DB00042
DB12308,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eltanolone.,Eltanolone,DB00042
DB12327,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Salvinorin A.,Salvinorin A,DB00042
DB12338,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carisbamate.,Carisbamate,DB00042
DB12361,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Piclozotan.,Piclozotan,DB00042
DB12395,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Esreboxetine.,Esreboxetine,DB00042
DB12401,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bromperidol.,Bromperidol,DB00042
DB12427,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Orvepitant.,Orvepitant,DB00042
DB12465,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ketanserin.,Ketanserin,DB00042
DB12492,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Piritramide.,Piritramide,DB00042
DB12518,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Raclopride.,Raclopride,DB00042
DB12537,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benzodiazepine.,Benzodiazepine,DB00042
DB12576,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with AZD-3043.,AZD-3043,DB00042
DB12590,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Indiplon.,Indiplon,DB00042
DB12661,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Urapidil.,Urapidil,DB00042
DB12710,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Perazine.,Perazine,DB00042
DB12725,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with TD-8954.,TD-8954,DB00042
DB12833,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tandospirone.,Tandospirone,DB00042
DB12867,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benperidol.,Benperidol,DB00042
DB12883,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eltoprazine.,Eltoprazine,DB00042
DB12930,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Opipramol.,Opipramol,DB00042
DB12951,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pivagabine.,Pivagabine,DB00042
DB12958,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Prothipendyl.,Prothipendyl,DB00042
DB13014,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Hypericin.,Hypericin,DB00042
DB13025,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tiapride.,Tiapride,DB00042
DB13082,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nefiracetam.,Nefiracetam,DB00042
DB13099,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Valnoctamide.,Valnoctamide,DB00042
DB13114,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amitriptylinoxide.,Amitriptylinoxide,DB00042
DB13160,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alphaprodine.,Alphaprodine,DB00042
DB13213,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Butaperazine.,Butaperazine,DB00042
DB13219,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Medifoxamine.,Medifoxamine,DB00042
DB13221,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Apronalide.,Apronalide,DB00042
DB13225,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dibenzepin.,Dibenzepin,DB00042
DB13234,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Propanidid.,Propanidid,DB00042
DB13246,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Quinupramine.,Quinupramine,DB00042
DB13253,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Proxibarbal.,Proxibarbal,DB00042
DB13256,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clothiapine.,Clothiapine,DB00042
DB13273,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sultopride.,Sultopride,DB00042
DB13303,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Febarbamate.,Febarbamate,DB00042
DB13323,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trichloroethylene.,Trichloroethylene,DB00042
DB13324,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetrazepam.,Tetrazepam,DB00042
DB13331,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pyrithyldione.,Pyrithyldione,DB00042
DB13335,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pinazepam.,Pinazepam,DB00042
DB13352,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Deanol.,Deanol,DB00042
DB13354,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenprobamate.,Phenprobamate,DB00042
DB13357,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Styramate.,Styramate,DB00042
DB13362,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pheneturide.,Pheneturide,DB00042
DB13370,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bromisoval.,Bromisoval,DB00042
DB13377,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vinbarbital.,Vinbarbital,DB00042
DB13382,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlorproethazine.,Chlorproethazine,DB00042
DB13384,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Melitracen.,Melitracen,DB00042
DB13396,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Neocitrullamon.,Neocitrullamon,DB00042
DB13402,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Acetylglycinamide chloral hydrate.,Acetylglycinamide chloral hydrate,DB00042
DB13403,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxypertine.,Oxypertine,DB00042
DB13411,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lofepramine.,Lofepramine,DB00042
DB13414,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fenyramidol.,Fenyramidol,DB00042
DB13420,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiazinam.,Thiazinam,DB00042
DB13437,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Medazepam.,Medazepam,DB00042
DB13455,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenibut.,Phenibut,DB00042
DB13457,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxaflozane.,Oxaflozane,DB00042
DB13478,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Meptazinol.,Meptazinol,DB00042
DB13496,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iprindole.,Iprindole,DB00042
DB13520,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Metergoline.,Metergoline,DB00042
DB13522,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mebicar.,Mebicar,DB00042
DB13523,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Veralipride.,Veralipride,DB00042
DB13534,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gedocarnil.,Gedocarnil,DB00042
DB13541,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iprazochrome.,Iprazochrome,DB00042
DB13550,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bifemelane.,Bifemelane,DB00042
DB13552,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trifluperidol.,Trifluperidol,DB00042
DB13554,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Moperone.,Moperone,DB00042
DB13557,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiopropazate.,Thiopropazate,DB00042
DB13572,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Emylcamate.,Emylcamate,DB00042
DB13577,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Allobarbital.,Allobarbital,DB00042
DB13588,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Naftidrofuryl.,Naftidrofuryl,DB00042
DB13598,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diethyl ether.,Diethyl ether,DB00042
DB13601,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxiracetam.,Oxiracetam,DB00042
DB13605,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenoperidine.,Phenoperidine,DB00042
DB13606,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenazocine.,Phenazocine,DB00042
DB13623,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fabomotizole.,Fabomotizole,DB00042
DB13642,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pridinol.,Pridinol,DB00042
DB13643,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Loprazolam.,Loprazolam,DB00042
DB13662,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Hexapropymate.,Hexapropymate,DB00042
DB13665,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluanisone.,Fluanisone,DB00042
DB13676,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mosapramine.,Mosapramine,DB00042
DB13687,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Niaprazine.,Niaprazine,DB00042
DB13690,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vinyl ether.,Vinyl ether,DB00042
DB13733,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methylpentynol.,Methylpentynol,DB00042
DB13737,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyclobarbital.,Cyclobarbital,DB00042
DB13745,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fazadinium bromide.,Fazadinium bromide,DB00042
DB13754,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mephenoxalone.,Mephenoxalone,DB00042
DB13770,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vinylbital.,Vinylbital,DB00042
DB13782,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Imipramine oxide.,Imipramine oxide,DB00042
DB13784,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dixyrazine.,Dixyrazine,DB00042
DB13787,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tilidine.,Tilidine,DB00042
DB13791,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Penfluridol.,Penfluridol,DB00042
DB13799,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethadione.,Ethadione,DB00042
DB13805,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Reposal.,Reposal,DB00042
DB13817,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carbromal.,Carbromal,DB00042
DB13837,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Doxefazepam.,Doxefazepam,DB00042
DB13841,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clopenthixol.,Clopenthixol,DB00042
DB13872,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lormetazepam.,Lormetazepam,DB00042
DB13875,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Harmaline.,Harmaline,DB00042
DB13876,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brofaromine.,Brofaromine,DB00042
DB13940,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.","2,5-Dimethoxy-4-ethylthioamphetamine",DB00042
DB13948,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine.","N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine",DB00042
DB13984,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyclopropane.,Cyclopropane,DB00042
DB13993,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with MRK-409.,MRK-409,DB00042
DB14010,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 5-methoxy-N,N-dimethyltryptamine.","5-methoxy-N,N-dimethyltryptamine",DB00042
DB14028,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nordazepam.,Nordazepam,DB00042
DB14050,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cannabidivarin.,Cannabidivarin,DB00042
DB14185,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Aripiprazole lauroxil.,Aripiprazole lauroxil,DB00042
DB14509,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lithium carbonate.,Lithium carbonate,DB00042
DB14575,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eslicarbazepine.,Eslicarbazepine,DB00042
DB14651,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Perphenazine enanthate.,Perphenazine enanthate,DB00042
DB14672,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxazepam acetate.,Oxazepam acetate,DB00042
DB14715,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cinazepam.,Cinazepam,DB00042
DB14718,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pyrazolam.,Pyrazolam,DB00042
DB14719,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bentazepam.,Bentazepam,DB00042
DB14754,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Solriamfetol.,Solriamfetol,DB00042
DB15203,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with JNJ-26489112.,JNJ-26489112,DB00042
DB15360,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carfentanil, C-11.","Carfentanil, C-11",DB00042
DB11951,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lemborexant.,Lemborexant,DB00042
DB00230,The therapeutic efficacy of Botulinum Toxin Type B can be increased when used in combination with Pregabalin.,Pregabalin,DB00042
DB04948,The therapeutic efficacy of Botulinum Toxin Type B can be increased when used in combination with Lofexidine.,Lofexidine,DB00042
DB00083,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Botulinum toxin type A.,Botulinum toxin type A,DB00042
DB00184,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nicotine.,Nicotine,DB00042
DB08837,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetraethylammonium.,Tetraethylammonium,DB00042
DB08999,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyclopentamine.,Cyclopentamine,DB00042
DB00091,The risk or severity of adverse effects can be increased when Cyclosporine is combined with Botulinum Toxin Type B.,Cyclosporine,DB00042
DB00254,The risk or severity of adverse effects can be increased when Doxycycline is combined with Botulinum Toxin Type B.,Doxycycline,DB00042
DB00256,The risk or severity of adverse effects can be increased when Lymecycline is combined with Botulinum Toxin Type B.,Lymecycline,DB00042
DB00314,The risk or severity of adverse effects can be increased when Capreomycin is combined with Botulinum Toxin Type B.,Capreomycin,DB00042
DB00319,The risk or severity of adverse effects can be increased when Piperacillin is combined with Botulinum Toxin Type B.,Piperacillin,DB00042
DB00452,The risk or severity of adverse effects can be increased when Framycetin is combined with Botulinum Toxin Type B.,Framycetin,DB00042
DB00453,The risk or severity of adverse effects can be increased when Clomocycline is combined with Botulinum Toxin Type B.,Clomocycline,DB00042
DB00468,The risk or severity of adverse effects can be increased when Quinine is combined with Botulinum Toxin Type B.,Quinine,DB00042
DB00512,The risk or severity of adverse effects can be increased when Vancomycin is combined with Botulinum Toxin Type B.,Vancomycin,DB00042
DB00560,The risk or severity of adverse effects can be increased when Tigecycline is combined with Botulinum Toxin Type B.,Tigecycline,DB00042
DB00595,The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Botulinum Toxin Type B.,Oxytetracycline,DB00042
DB00608,The risk or severity of adverse effects can be increased when Chloroquine is combined with Botulinum Toxin Type B.,Chloroquine,DB00042
DB00618,The risk or severity of adverse effects can be increased when Demeclocycline is combined with Botulinum Toxin Type B.,Demeclocycline,DB00042
DB00684,The risk or severity of adverse effects can be increased when Tobramycin is combined with Botulinum Toxin Type B.,Tobramycin,DB00042
DB00759,The risk or severity of adverse effects can be increased when Tetracycline is combined with Botulinum Toxin Type B.,Tetracycline,DB00042
DB00798,The risk or severity of adverse effects can be increased when Gentamicin is combined with Botulinum Toxin Type B.,Gentamicin,DB00042
DB00903,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Botulinum Toxin Type B.,Etacrynic acid,DB00042
DB00931,The risk or severity of adverse effects can be increased when Metacycline is combined with Botulinum Toxin Type B.,Metacycline,DB00042
DB00955,The risk or severity of adverse effects can be increased when Netilmicin is combined with Botulinum Toxin Type B.,Netilmicin,DB00042
DB00994,The risk or severity of adverse effects can be increased when Neomycin is combined with Botulinum Toxin Type B.,Neomycin,DB00042
DB01035,The risk or severity of adverse effects can be increased when Procainamide is combined with Botulinum Toxin Type B.,Procainamide,DB00042
DB01082,The risk or severity of adverse effects can be increased when Streptomycin is combined with Botulinum Toxin Type B.,Streptomycin,DB00042
DB01111,The risk or severity of adverse effects can be increased when Colistimethate is combined with Botulinum Toxin Type B.,Colistimethate,DB00042
DB01172,The risk or severity of adverse effects can be increased when Kanamycin is combined with Botulinum Toxin Type B.,Kanamycin,DB00042
DB01190,The risk or severity of adverse effects can be increased when Clindamycin is combined with Botulinum Toxin Type B.,Clindamycin,DB00042
DB01219,The risk or severity of adverse effects can be increased when Dantrolene is combined with Botulinum Toxin Type B.,Dantrolene,DB00042
DB01301,The risk or severity of adverse effects can be increased when Rolitetracycline is combined with Botulinum Toxin Type B.,Rolitetracycline,DB00042
DB01377,The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Botulinum Toxin Type B.,Magnesium oxide,DB00042
DB01378,The risk or severity of adverse effects can be increased when Magnesium cation is combined with Botulinum Toxin Type B.,Magnesium cation,DB00042
DB01421,The risk or severity of adverse effects can be increased when Paromomycin is combined with Botulinum Toxin Type B.,Paromomycin,DB00042
DB01627,The risk or severity of adverse effects can be increased when Lincomycin is combined with Botulinum Toxin Type B.,Lincomycin,DB00042
DB03615,The risk or severity of adverse effects can be increased when Ribostamycin is combined with Botulinum Toxin Type B.,Ribostamycin,DB00042
DB04263,The risk or severity of adverse effects can be increased when Geneticin is combined with Botulinum Toxin Type B.,Geneticin,DB00042
DB04626,The risk or severity of adverse effects can be increased when Apramycin is combined with Botulinum Toxin Type B.,Apramycin,DB00042
DB04729,The risk or severity of adverse effects can be increased when Gentamicin C1a is combined with Botulinum Toxin Type B.,Gentamicin C1a,DB00042
DB04808,The risk or severity of adverse effects can be increased when Neamine is combined with Botulinum Toxin Type B.,Neamine,DB00042
DB06696,The risk or severity of adverse effects can be increased when Arbekacin is combined with Botulinum Toxin Type B.,Arbekacin,DB00042
DB06827,The risk or severity of adverse effects can be increased when Viomycin is combined with Botulinum Toxin Type B.,Viomycin,DB00042
DB08437,The risk or severity of adverse effects can be increased when Puromycin is combined with Botulinum Toxin Type B.,Puromycin,DB00042
DB09104,The risk or severity of adverse effects can be increased when Magnesium hydroxide is combined with Botulinum Toxin Type B.,Magnesium hydroxide,DB00042
DB09281,The risk or severity of adverse effects can be increased when Magnesium trisilicate is combined with Botulinum Toxin Type B.,Magnesium trisilicate,DB00042
DB09407,The risk or severity of adverse effects can be increased when Magnesium chloride is combined with Botulinum Toxin Type B.,Magnesium chloride,DB00042
DB09409,The risk or severity of adverse effects can be increased when Magnesium acetate tetrahydrate is combined with Botulinum Toxin Type B.,Magnesium acetate tetrahydrate,DB00042
DB09481,The risk or severity of adverse effects can be increased when Magnesium carbonate is combined with Botulinum Toxin Type B.,Magnesium carbonate,DB00042
DB11110,The risk or severity of adverse effects can be increased when Magnesium citrate is combined with Botulinum Toxin Type B.,Magnesium citrate,DB00042
DB11189,The risk or severity of adverse effects can be increased when Magnesium glycinate is combined with Botulinum Toxin Type B.,Magnesium glycinate,DB00042
DB11230,The risk or severity of adverse effects can be increased when Magnesium Aluminum Silicate is combined with Botulinum Toxin Type B.,Magnesium Aluminum Silicate,DB00042
DB11512,The risk or severity of adverse effects can be increased when Dihydrostreptomycin is combined with Botulinum Toxin Type B.,Dihydrostreptomycin,DB00042
DB11520,The risk or severity of adverse effects can be increased when Hygromycin B is combined with Botulinum Toxin Type B.,Hygromycin B,DB00042
DB12604,The risk or severity of adverse effects can be increased when Sisomicin is combined with Botulinum Toxin Type B.,Sisomicin,DB00042
DB12615,The risk or severity of adverse effects can be increased when Plazomicin is combined with Botulinum Toxin Type B.,Plazomicin,DB00042
DB13249,The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Botulinum Toxin Type B.,Magnesium silicate,DB00042
DB13264,The risk or severity of adverse effects can be increased when Penimepicycline is combined with Botulinum Toxin Type B.,Penimepicycline,DB00042
DB13270,The risk or severity of adverse effects can be increased when Dibekacin is combined with Botulinum Toxin Type B.,Dibekacin,DB00042
DB13274,The risk or severity of adverse effects can be increased when Micronomicin is combined with Botulinum Toxin Type B.,Micronomicin,DB00042
DB13359,The risk or severity of adverse effects can be increased when Magnesium aspartate is combined with Botulinum Toxin Type B.,Magnesium aspartate,DB00042
DB13540,The risk or severity of adverse effects can be increased when Isepamicin is combined with Botulinum Toxin Type B.,Isepamicin,DB00042
DB13673,The risk or severity of adverse effects can be increased when Bekanamycin is combined with Botulinum Toxin Type B.,Bekanamycin,DB00042
DB13749,The risk or severity of adverse effects can be increased when Magnesium gluconate is combined with Botulinum Toxin Type B.,Magnesium gluconate,DB00042
DB13786,The risk or severity of adverse effects can be increased when Magnesium orotate is combined with Botulinum Toxin Type B.,Magnesium orotate,DB00042
DB13862,The risk or severity of adverse effects can be increased when Magnesium phosphate is combined with Botulinum Toxin Type B.,Magnesium phosphate,DB00042
DB13996,The risk or severity of adverse effects can be increased when Magnesium acetate is combined with Botulinum Toxin Type B.,Magnesium acetate,DB00042
DB05077,The risk or severity of adverse effects can be increased when SLV319 is combined with Botulinum Toxin Type B.,SLV319,DB00042
DB06155,The risk or severity of adverse effects can be increased when Rimonabant is combined with Botulinum Toxin Type B.,Rimonabant,DB00042
DB06624,The risk or severity of adverse effects can be increased when Taranabant is combined with Botulinum Toxin Type B.,Taranabant,DB00042
DB09061,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Botulinum Toxin Type B.,Cannabidiol,DB00042
DB11903,The risk or severity of adverse effects can be increased when GW842166 is combined with Botulinum Toxin Type B.,GW842166,DB00042
DB12193,The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Botulinum Toxin Type B.,Ajulemic acid,DB00042
DB12649,The risk or severity of adverse effects can be increased when Ibipinabant is combined with Botulinum Toxin Type B.,Ibipinabant,DB00042
DB13070,The risk or severity of adverse effects can be increased when Surinabant is combined with Botulinum Toxin Type B.,Surinabant,DB00042
DB13950,The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Botulinum Toxin Type B.,WIN 55212-2,DB00042
DB14011,The risk or severity of adverse effects can be increased when Nabiximols is combined with Botulinum Toxin Type B.,Nabiximols,DB00042
DB14043,The risk or severity of adverse effects can be increased when Palmidrol is combined with Botulinum Toxin Type B.,Palmidrol,DB00042
DB14737,The risk or severity of adverse effects can be increased when Cannabinol is combined with Botulinum Toxin Type B.,Cannabinol,DB00042
DB11823,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Esketamine.,Esketamine,DB00042
DB00395,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Botulinum Toxin Type B.,Carisoprodol,DB00042
DB00704,The risk or severity of respiratory depression can be increased when Naltrexone is combined with Botulinum Toxin Type B.,Naltrexone,DB00042
DB01459,The risk or severity of respiratory depression can be increased when Bezitramide is combined with Botulinum Toxin Type B.,Bezitramide,DB00042
DB09272,The risk or severity of respiratory depression can be increased when Eluxadoline is combined with Botulinum Toxin Type B.,Eluxadoline,DB00042
DB13454,The risk or severity of respiratory depression can be increased when Nicomorphine is combined with Botulinum Toxin Type B.,Nicomorphine,DB00042
DB15465,The risk or severity of respiratory depression can be increased when Benzhydrocodone is combined with Botulinum Toxin Type B.,Benzhydrocodone,DB00042
DB00402,The risk or severity of CNS depression can be increased when Botulinum Toxin Type B is combined with Eszopiclone.,Eszopiclone,DB00042
DB00575,The risk or severity of sedation can be increased when Clonidine is combined with Botulinum Toxin Type B.,Clonidine,DB00042
DB00924,The risk or severity of CNS depression can be increased when Botulinum Toxin Type B is combined with Cyclobenzaprine.,Cyclobenzaprine,DB00042
DB01233,The risk or severity of sedation can be increased when Metoclopramide is combined with Botulinum Toxin Type B.,Metoclopramide,DB00042
DB11732,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lasmiditan.,Lasmiditan,DB00042
DB00193,The risk or severity of CNS depression can be increased when Tramadol is combined with Botulinum Toxin Type B.,Tramadol,DB00042
DB00246,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Botulinum Toxin Type B.,Ziprasidone,DB00042
DB00502,The risk or severity of CNS depression can be increased when Botulinum Toxin Type B is combined with Haloperidol.,Haloperidol,DB00042
DB00472,Fluoxetine may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Fluoxetine,DB00042
DB00408,The therapeutic efficacy of Omalizumab can be decreased when used in combination with Loxapine.,Loxapine,DB00043
DB00255,Diethylstilbestrol may increase the thrombogenic activities of Omalizumab.,Diethylstilbestrol,DB00043
DB00269,Chlorotrianisene may increase the thrombogenic activities of Omalizumab.,Chlorotrianisene,DB00043
DB00286,Conjugated estrogens may increase the thrombogenic activities of Omalizumab.,Conjugated estrogens,DB00043
DB00655,Estrone may increase the thrombogenic activities of Omalizumab.,Estrone,DB00043
DB00783,Estradiol may increase the thrombogenic activities of Omalizumab.,Estradiol,DB00043
DB00890,Dienestrol may increase the thrombogenic activities of Omalizumab.,Dienestrol,DB00043
DB00977,Ethinylestradiol may increase the thrombogenic activities of Omalizumab.,Ethinylestradiol,DB00043
DB01357,Mestranol may increase the thrombogenic activities of Omalizumab.,Mestranol,DB00043
DB04573,Estriol may increase the thrombogenic activities of Omalizumab.,Estriol,DB00043
DB04574,Estrone sulfate may increase the thrombogenic activities of Omalizumab.,Estrone sulfate,DB00043
DB04575,Quinestrol may increase the thrombogenic activities of Omalizumab.,Quinestrol,DB00043
DB07931,Hexestrol may increase the thrombogenic activities of Omalizumab.,Hexestrol,DB00043
DB09070,Tibolone may increase the thrombogenic activities of Omalizumab.,Tibolone,DB00043
DB09317,"Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Omalizumab.","Synthetic Conjugated Estrogens, A",DB00043
DB09318,"Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Omalizumab.","Synthetic Conjugated Estrogens, B",DB00043
DB09369,Polyestradiol phosphate may increase the thrombogenic activities of Omalizumab.,Polyestradiol phosphate,DB00043
DB09381,Esterified estrogens may increase the thrombogenic activities of Omalizumab.,Esterified estrogens,DB00043
DB11478,Zeranol may increase the thrombogenic activities of Omalizumab.,Zeranol,DB00043
DB11674,Equol may increase the thrombogenic activities of Omalizumab.,Equol,DB00043
DB12487,Promestriene may increase the thrombogenic activities of Omalizumab.,Promestriene,DB00043
DB13143,Methallenestril may increase the thrombogenic activities of Omalizumab.,Methallenestril,DB00043
DB13386,Epimestrol may increase the thrombogenic activities of Omalizumab.,Epimestrol,DB00043
DB13418,Moxestrol may increase the thrombogenic activities of Omalizumab.,Moxestrol,DB00043
DB13952,Estradiol acetate may increase the thrombogenic activities of Omalizumab.,Estradiol acetate,DB00043
DB13953,Estradiol benzoate may increase the thrombogenic activities of Omalizumab.,Estradiol benzoate,DB00043
DB13954,Estradiol cypionate may increase the thrombogenic activities of Omalizumab.,Estradiol cypionate,DB00043
DB13956,Estradiol valerate may increase the thrombogenic activities of Omalizumab.,Estradiol valerate,DB00043
DB15334,Biochanin A may increase the thrombogenic activities of Omalizumab.,Biochanin A,DB00043
DB15335,Formononetin may increase the thrombogenic activities of Omalizumab.,Formononetin,DB00043
DB00002,The risk or severity of adverse effects can be increased when Cetuximab is combined with Omalizumab.,Cetuximab,DB00043
DB00028,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Omalizumab.,Human immunoglobulin G,DB00043
DB00051,The risk or severity of adverse effects can be increased when Omalizumab is combined with Adalimumab.,Adalimumab,DB00043
DB00054,The risk or severity of adverse effects can be increased when Omalizumab is combined with Abciximab.,Abciximab,DB00043
DB00056,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00043
DB00057,The risk or severity of adverse effects can be increased when Omalizumab is combined with Indium In-111 satumomab pendetide.,Indium In-111 satumomab pendetide,DB00043
DB00065,The risk or severity of adverse effects can be increased when Omalizumab is combined with Infliximab.,Infliximab,DB00043
DB00072,The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab.,Trastuzumab,DB00043
DB00073,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rituximab.,Rituximab,DB00043
DB00074,The risk or severity of adverse effects can be increased when Omalizumab is combined with Basiliximab.,Basiliximab,DB00043
DB00075,The risk or severity of adverse effects can be increased when Omalizumab is combined with Muromonab.,Muromonab,DB00043
DB00076,The risk or severity of adverse effects can be increased when Omalizumab is combined with Digoxin Immune Fab (Ovine).,Digoxin Immune Fab (Ovine),DB00043
DB00078,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00043
DB00081,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tositumomab.,Tositumomab,DB00043
DB00087,The risk or severity of adverse effects can be increased when Omalizumab is combined with Alemtuzumab.,Alemtuzumab,DB00043
DB00089,The risk or severity of adverse effects can be increased when Omalizumab is combined with Capromab pendetide.,Capromab pendetide,DB00043
DB00095,The risk or severity of adverse effects can be increased when Omalizumab is combined with Efalizumab.,Efalizumab,DB00043
DB00098,The risk or severity of adverse effects can be increased when Omalizumab is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit),DB00043
DB00108,The risk or severity of adverse effects can be increased when Omalizumab is combined with Natalizumab.,Natalizumab,DB00043
DB00110,The risk or severity of adverse effects can be increased when Omalizumab is combined with Palivizumab.,Palivizumab,DB00043
DB00111,The risk or severity of adverse effects can be increased when Omalizumab is combined with Daclizumab.,Daclizumab,DB00043
DB00112,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bevacizumab.,Bevacizumab,DB00043
DB00113,The risk or severity of adverse effects can be increased when Omalizumab is combined with Technetium Tc-99m arcitumomab.,Technetium Tc-99m arcitumomab,DB00043
DB01257,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eculizumab.,Eculizumab,DB00043
DB01269,The risk or severity of adverse effects can be increased when Omalizumab is combined with Panitumumab.,Panitumumab,DB00043
DB01270,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ranibizumab.,Ranibizumab,DB00043
DB04901,The risk or severity of adverse effects can be increased when Omalizumab is combined with Galiximab.,Galiximab,DB00043
DB04949,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pexelizumab.,Pexelizumab,DB00043
DB04956,The risk or severity of adverse effects can be increased when Omalizumab is combined with Afelimomab.,Afelimomab,DB00043
DB04958,The risk or severity of adverse effects can be increased when Omalizumab is combined with Epratuzumab.,Epratuzumab,DB00043
DB04962,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bectumomab.,Bectumomab,DB00043
DB04964,The risk or severity of adverse effects can be increased when Omalizumab is combined with Oregovomab.,Oregovomab,DB00043
DB04988,The risk or severity of adverse effects can be increased when Omalizumab is combined with IGN311.,IGN311,DB00043
DB05006,The risk or severity of adverse effects can be increased when Omalizumab is combined with Adecatumumab.,Adecatumumab,DB00043
DB05097,The risk or severity of adverse effects can be increased when Omalizumab is combined with Labetuzumab.,Labetuzumab,DB00043
DB05101,The risk or severity of adverse effects can be increased when Omalizumab is combined with Matuzumab.,Matuzumab,DB00043
DB05111,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fontolizumab.,Fontolizumab,DB00043
DB05136,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bavituximab.,Bavituximab,DB00043
DB05139,The risk or severity of adverse effects can be increased when Omalizumab is combined with CR002.,CR002,DB00043
DB05209,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rozrolimupab.,Rozrolimupab,DB00043
DB05304,The risk or severity of adverse effects can be increased when Omalizumab is combined with Girentuximab.,Girentuximab,DB00043
DB05336,The risk or severity of adverse effects can be increased when Omalizumab is combined with Obiltoxaximab.,Obiltoxaximab,DB00043
DB05405,The risk or severity of adverse effects can be increased when Omalizumab is combined with XTL-001.,XTL-001,DB00043
DB05437,The risk or severity of adverse effects can be increased when Omalizumab is combined with NAV 1800.,NAV 1800,DB00043
DB05459,The risk or severity of adverse effects can be increased when Omalizumab is combined with Briakinumab.,Briakinumab,DB00043
DB05496,The risk or severity of adverse effects can be increased when Omalizumab is combined with Otelixizumab.,Otelixizumab,DB00043
DB05545,The risk or severity of adverse effects can be increased when Omalizumab is combined with AMG 108.,AMG 108,DB00043
DB05550,The risk or severity of adverse effects can be increased when Omalizumab is combined with Iratumumab.,Iratumumab,DB00043
DB05555,The risk or severity of adverse effects can be increased when Omalizumab is combined with Enokizumab.,Enokizumab,DB00043
DB05578,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ramucirumab.,Ramucirumab,DB00043
DB05595,The risk or severity of adverse effects can be increased when Omalizumab is combined with Farletuzumab.,Farletuzumab,DB00043
DB05656,The risk or severity of adverse effects can be increased when Omalizumab is combined with Veltuzumab.,Veltuzumab,DB00043
DB05679,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ustekinumab.,Ustekinumab,DB00043
DB05773,The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00043
DB05793,The risk or severity of adverse effects can be increased when Omalizumab is combined with PRO-542.,PRO-542,DB00043
DB05797,The risk or severity of adverse effects can be increased when Omalizumab is combined with TNX-901.,TNX-901,DB00043
DB05889,The risk or severity of adverse effects can be increased when Omalizumab is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin,DB00043
DB05892,The risk or severity of adverse effects can be increased when Omalizumab is combined with RI 624.,RI 624,DB00043
DB05915,The risk or severity of adverse effects can be increased when Omalizumab is combined with MYO-029.,MYO-029,DB00043
DB05916,The risk or severity of adverse effects can be increased when Omalizumab is combined with CT-011.,CT-011,DB00043
DB05941,The risk or severity of adverse effects can be increased when Omalizumab is combined with Leronlimab.,Leronlimab,DB00043
DB05996,The risk or severity of adverse effects can be increased when Omalizumab is combined with Glembatumumab vedotin.,Glembatumumab vedotin,DB00043
DB06043,The risk or severity of adverse effects can be increased when Omalizumab is combined with Olaratumab.,Olaratumab,DB00043
DB06049,The risk or severity of adverse effects can be increased when Omalizumab is combined with IPH 2101.,IPH 2101,DB00043
DB06050,The risk or severity of adverse effects can be increased when Omalizumab is combined with TB-402.,TB-402,DB00043
DB06081,The risk or severity of adverse effects can be increased when Omalizumab is combined with Caplacizumab.,Caplacizumab,DB00043
DB06101,The risk or severity of adverse effects can be increased when Omalizumab is combined with IMC-1C11.,IMC-1C11,DB00043
DB06116,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eldelumab.,Eldelumab,DB00043
DB06162,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lumiliximab.,Lumiliximab,DB00043
DB06168,The risk or severity of adverse effects can be increased when Omalizumab is combined with Canakinumab.,Canakinumab,DB00043
DB06186,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ipilimumab.,Ipilimumab,DB00043
DB06192,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nimotuzumab.,Nimotuzumab,DB00043
DB06241,The risk or severity of adverse effects can be increased when Omalizumab is combined with Clenoliximab.,Clenoliximab,DB00043
DB06273,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tocilizumab.,Tocilizumab,DB00043
DB06304,The risk or severity of adverse effects can be increased when Omalizumab is combined with BIIB015.,BIIB015,DB00043
DB06305,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sonepcizumab.,Sonepcizumab,DB00043
DB06310,The risk or severity of adverse effects can be increased when Omalizumab is combined with Motavizumab.,Motavizumab,DB00043
DB06317,The risk or severity of adverse effects can be increased when Omalizumab is combined with Elotuzumab.,Elotuzumab,DB00043
DB06318,The risk or severity of adverse effects can be increased when Omalizumab is combined with AVE9633.,AVE9633,DB00043
DB06322,The risk or severity of adverse effects can be increased when Omalizumab is combined with Carotuximab.,Carotuximab,DB00043
DB06324,The risk or severity of adverse effects can be increased when Omalizumab is combined with XmAb 2513.,XmAb 2513,DB00043
DB06342,The risk or severity of adverse effects can be increased when Omalizumab is combined with Coltuximab ravtansine.,Coltuximab ravtansine,DB00043
DB06343,The risk or severity of adverse effects can be increased when Omalizumab is combined with Teprotumumab.,Teprotumumab,DB00043
DB06360,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lucatumumab.,Lucatumumab,DB00043
DB06366,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pertuzumab.,Pertuzumab,DB00043
DB06371,The risk or severity of adverse effects can be increased when Omalizumab is combined with Siplizumab.,Siplizumab,DB00043
DB06467,The risk or severity of adverse effects can be increased when Omalizumab is combined with Apolizumab.,Apolizumab,DB00043
DB06474,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sibrotuzumab.,Sibrotuzumab,DB00043
DB06550,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bivatuzumab.,Bivatuzumab,DB00043
DB06557,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lerdelimumab.,Lerdelimumab,DB00043
DB06599,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lexatumumab.,Lexatumumab,DB00043
DB06602,The risk or severity of adverse effects can be increased when Omalizumab is combined with Reslizumab.,Reslizumab,DB00043
DB06606,The risk or severity of adverse effects can be increased when Omalizumab is combined with Teplizumab.,Teplizumab,DB00043
DB06607,The risk or severity of adverse effects can be increased when Omalizumab is combined with Catumaxomab.,Catumaxomab,DB00043
DB06612,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mepolizumab.,Mepolizumab,DB00043
DB06643,The risk or severity of adverse effects can be increased when Omalizumab is combined with Denosumab.,Denosumab,DB00043
DB06647,The risk or severity of adverse effects can be increased when Omalizumab is combined with Volociximab.,Volociximab,DB00043
DB06650,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ofatumumab.,Ofatumumab,DB00043
DB06674,The risk or severity of adverse effects can be increased when Omalizumab is combined with Golimumab.,Golimumab,DB00043
DB08870,The risk or severity of adverse effects can be increased when Omalizumab is combined with Brentuximab vedotin.,Brentuximab vedotin,DB00043
DB08879,The risk or severity of adverse effects can be increased when Omalizumab is combined with Belimumab.,Belimumab,DB00043
DB08902,The risk or severity of adverse effects can be increased when Omalizumab is combined with Raxibacumab.,Raxibacumab,DB00043
DB08904,The risk or severity of adverse effects can be increased when Omalizumab is combined with Certolizumab pegol.,Certolizumab pegol,DB00043
DB08935,The risk or severity of adverse effects can be increased when Omalizumab is combined with Obinutuzumab.,Obinutuzumab,DB00043
DB09029,The risk or severity of adverse effects can be increased when Omalizumab is combined with Secukinumab.,Secukinumab,DB00043
DB09033,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vedolizumab.,Vedolizumab,DB00043
DB09035,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nivolumab.,Nivolumab,DB00043
DB09036,The risk or severity of adverse effects can be increased when Omalizumab is combined with Siltuximab.,Siltuximab,DB00043
DB09037,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pembrolizumab.,Pembrolizumab,DB00043
DB09045,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dulaglutide.,Dulaglutide,DB00043
DB09052,The risk or severity of adverse effects can be increased when Omalizumab is combined with Blinatumomab.,Blinatumomab,DB00043
DB09057,The risk or severity of adverse effects can be increased when Omalizumab is combined with Anthrax immune globulin human.,Anthrax immune globulin human,DB00043
DB09077,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dinutuximab.,Dinutuximab,DB00043
DB09105,The risk or severity of adverse effects can be increased when Omalizumab is combined with Asfotase alfa.,Asfotase alfa,DB00043
DB09264,The risk or severity of adverse effects can be increased when Omalizumab is combined with Idarucizumab.,Idarucizumab,DB00043
DB09302,The risk or severity of adverse effects can be increased when Omalizumab is combined with Alirocumab.,Alirocumab,DB00043
DB09303,The risk or severity of adverse effects can be increased when Omalizumab is combined with Evolocumab.,Evolocumab,DB00043
DB09312,The risk or severity of adverse effects can be increased when Omalizumab is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse),DB00043
DB09331,The risk or severity of adverse effects can be increased when Omalizumab is combined with Daratumumab.,Daratumumab,DB00043
DB09559,The risk or severity of adverse effects can be increased when Omalizumab is combined with Necitumumab.,Necitumumab,DB00043
DB11569,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ixekizumab.,Ixekizumab,DB00043
DB11580,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ravulizumab.,Ravulizumab,DB00043
DB11595,The risk or severity of adverse effects can be increased when Omalizumab is combined with Atezolizumab.,Atezolizumab,DB00043
DB11604,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tetanus Immune Globulin.,Tetanus Immune Globulin,DB00043
DB11608,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eftrenonacog alfa.,Eftrenonacog alfa,DB00043
DB11621,The risk or severity of adverse effects can be increased when Omalizumab is combined with Human Varicella-Zoster Immune Globulin.,Human Varicella-Zoster Immune Globulin,DB00043
DB11646,The risk or severity of adverse effects can be increased when Omalizumab is combined with Conatumumab.,Conatumumab,DB00043
DB11657,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tabalumab.,Tabalumab,DB00043
DB11680,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ficlatuzumab.,Ficlatuzumab,DB00043
DB11685,The risk or severity of adverse effects can be increased when Omalizumab is combined with Figitumumab.,Figitumumab,DB00043
DB11714,The risk or severity of adverse effects can be increased when Omalizumab is combined with Durvalumab.,Durvalumab,DB00043
DB11715,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bapineuzumab.,Bapineuzumab,DB00043
DB11731,The risk or severity of adverse effects can be increased when Omalizumab is combined with Depatuxizumab mafodotin.,Depatuxizumab mafodotin,DB00043
DB11746,The risk or severity of adverse effects can be increased when Omalizumab is combined with Onartuzumab.,Onartuzumab,DB00043
DB11756,The risk or severity of adverse effects can be increased when Omalizumab is combined with Solanezumab.,Solanezumab,DB00043
DB11767,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sarilumab.,Sarilumab,DB00043
DB11771,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tremelimumab.,Tremelimumab,DB00043
DB11776,The risk or severity of adverse effects can be increased when Omalizumab is combined with Brodalumab.,Brodalumab,DB00043
DB11803,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sirukumab.,Sirukumab,DB00043
DB11826,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lampalizumab.,Lampalizumab,DB00043
DB11834,The risk or severity of adverse effects can be increased when Omalizumab is combined with Guselkumab.,Guselkumab,DB00043
DB11840,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dalotuzumab.,Dalotuzumab,DB00043
DB11849,The risk or severity of adverse effects can be increased when Omalizumab is combined with Emibetuzumab.,Emibetuzumab,DB00043
DB11850,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ublituximab.,Ublituximab,DB00043
DB11856,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ligelizumab.,Ligelizumab,DB00043
DB11857,The risk or severity of adverse effects can be increased when Omalizumab is combined with Seribantumab.,Seribantumab,DB00043
DB11862,The risk or severity of adverse effects can be increased when Omalizumab is combined with Landogrozumab.,Landogrozumab,DB00043
DB11866,The risk or severity of adverse effects can be increased when Omalizumab is combined with Romosozumab.,Romosozumab,DB00043
DB11884,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vadastuximab Talirine.,Vadastuximab Talirine,DB00043
DB11914,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lebrikizumab.,Lebrikizumab,DB00043
DB11930,The risk or severity of adverse effects can be increased when Omalizumab is combined with Varlilumab.,Varlilumab,DB00043
DB11945,The risk or severity of adverse effects can be increased when Omalizumab is combined with Avelumab.,Avelumab,DB00043
DB11959,The risk or severity of adverse effects can be increased when Omalizumab is combined with Crenezumab.,Crenezumab,DB00043
DB11972,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rilotumumab.,Rilotumumab,DB00043
DB11976,The risk or severity of adverse effects can be increased when Omalizumab is combined with Anifrolumab.,Anifrolumab,DB00043
DB11988,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ocrelizumab.,Ocrelizumab,DB00043
DB12023,The risk or severity of adverse effects can be increased when Omalizumab is combined with Benralizumab.,Benralizumab,DB00043
DB12034,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gantenerumab.,Gantenerumab,DB00043
DB12053,The risk or severity of adverse effects can be increased when Omalizumab is combined with Visilizumab.,Visilizumab,DB00043
DB12077,The risk or severity of adverse effects can be increased when Omalizumab is combined with Urelumab.,Urelumab,DB00043
DB12089,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine,DB00043
DB12090,The risk or severity of adverse effects can be increased when Omalizumab is combined with Patritumab.,Patritumab,DB00043
DB12102,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fulranumab.,Fulranumab,DB00043
DB12104,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tarextumab.,Tarextumab,DB00043
DB12118,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sotatercept.,Sotatercept,DB00043
DB12119,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gevokizumab.,Gevokizumab,DB00043
DB12142,The risk or severity of adverse effects can be increased when Omalizumab is combined with Duligotuzumab.,Duligotuzumab,DB00043
DB12152,The risk or severity of adverse effects can be increased when Omalizumab is combined with Simtuzumab.,Simtuzumab,DB00043
DB12157,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fasinumab.,Fasinumab,DB00043
DB12159,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dupilumab.,Dupilumab,DB00043
DB12169,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tralokinumab.,Tralokinumab,DB00043
DB12189,The risk or severity of adverse effects can be increased when Omalizumab is combined with Etrolizumab.,Etrolizumab,DB00043
DB12202,The risk or severity of adverse effects can be increased when Omalizumab is combined with Zalutumumab.,Zalutumumab,DB00043
DB12205,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ganitumab.,Ganitumab,DB00043
DB12213,The risk or severity of adverse effects can be increased when Omalizumab is combined with Etaracizumab.,Etaracizumab,DB00043
DB12240,The risk or severity of adverse effects can be increased when Omalizumab is combined with Polatuzumab vedotin.,Polatuzumab vedotin,DB00043
DB12246,The risk or severity of adverse effects can be increased when Omalizumab is combined with Inclacumab.,Inclacumab,DB00043
DB12250,The risk or severity of adverse effects can be increased when Omalizumab is combined with Cixutumumab.,Cixutumumab,DB00043
DB12261,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ascrinvacumab.,Ascrinvacumab,DB00043
DB12274,The risk or severity of adverse effects can be increased when Omalizumab is combined with Aducanumab.,Aducanumab,DB00043
DB12281,The risk or severity of adverse effects can be increased when Omalizumab is combined with Luspatercept.,Luspatercept,DB00043
DB12296,The risk or severity of adverse effects can be increased when Omalizumab is combined with GS-5745.,GS-5745,DB00043
DB12317,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vanucizumab.,Vanucizumab,DB00043
DB12331,The risk or severity of adverse effects can be increased when Omalizumab is combined with Labetuzumab govitecan.,Labetuzumab govitecan,DB00043
DB12335,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tanezumab.,Tanezumab,DB00043
DB12342,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ensituximab.,Ensituximab,DB00043
DB12344,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fezakinumab.,Fezakinumab,DB00043
DB12363,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dusigitumab.,Dusigitumab,DB00043
DB12396,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fresolimumab.,Fresolimumab,DB00043
DB12413,The risk or severity of adverse effects can be increased when Omalizumab is combined with Indusatumab vedotin.,Indusatumab vedotin,DB00043
DB12456,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bococizumab.,Bococizumab,DB00043
DB12489,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mirvetuximab Soravtansine.,Mirvetuximab Soravtansine,DB00043
DB12498,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mogamulizumab.,Mogamulizumab,DB00043
DB12520,The risk or severity of adverse effects can be increased when Omalizumab is combined with Plozalizumab.,Plozalizumab,DB00043
DB12530,The risk or severity of adverse effects can be increased when Omalizumab is combined with Inebilizumab.,Inebilizumab,DB00043
DB12534,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mavrilimumab.,Mavrilimumab,DB00043
DB12560,The risk or severity of adverse effects can be increased when Omalizumab is combined with Blosozumab.,Blosozumab,DB00043
DB12584,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bimagrumab.,Bimagrumab,DB00043
DB12589,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dacetuzumab.,Dacetuzumab,DB00043
DB12609,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tovetumab.,Tovetumab,DB00043
DB12683,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lumretuzumab.,Lumretuzumab,DB00043
DB12698,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ibalizumab.,Ibalizumab,DB00043
DB12701,The risk or severity of adverse effects can be increased when Omalizumab is combined with Intetumumab.,Intetumumab,DB00043
DB12718,The risk or severity of adverse effects can be increased when Omalizumab is combined with Carlumab.,Carlumab,DB00043
DB12734,The risk or severity of adverse effects can be increased when Omalizumab is combined with Demcizumab.,Demcizumab,DB00043
DB12773,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sifalimumab.,Sifalimumab,DB00043
DB12775,The risk or severity of adverse effects can be increased when Omalizumab is combined with Abituzumab.,Abituzumab,DB00043
DB12797,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ecromeximab.,Ecromeximab,DB00043
DB12807,The risk or severity of adverse effects can be increased when Omalizumab is combined with Naptumomab Estafenatox.,Naptumomab Estafenatox,DB00043
DB12815,The risk or severity of adverse effects can be increased when Omalizumab is combined with Crotedumab.,Crotedumab,DB00043
DB12820,The risk or severity of adverse effects can be increased when Omalizumab is combined with Concizumab.,Concizumab,DB00043
DB12826,The risk or severity of adverse effects can be increased when Omalizumab is combined with Depatuxizumab.,Depatuxizumab,DB00043
DB12844,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rontalizumab.,Rontalizumab,DB00043
DB12845,The risk or severity of adverse effects can be increased when Omalizumab is combined with Amatuximab.,Amatuximab,DB00043
DB12849,The risk or severity of adverse effects can be increased when Omalizumab is combined with Clazakizumab.,Clazakizumab,DB00043
DB12891,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ozanezumab.,Ozanezumab,DB00043
DB12893,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sacituzumab govitecan.,Sacituzumab govitecan,DB00043
DB12917,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bimekizumab.,Bimekizumab,DB00043
DB12943,The risk or severity of adverse effects can be increased when Omalizumab is combined with Milatuzumab.,Milatuzumab,DB00043
DB12976,The risk or severity of adverse effects can be increased when Omalizumab is combined with Robatumumab.,Robatumumab,DB00043
DB13017,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rovalpituzumab Tesirine.,Rovalpituzumab Tesirine,DB00043
DB13037,The risk or severity of adverse effects can be increased when Omalizumab is combined with Namilumab.,Namilumab,DB00043
DB13045,The risk or severity of adverse effects can be increased when Omalizumab is combined with Racotumomab.,Racotumomab,DB00043
DB13073,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tregalizumab.,Tregalizumab,DB00043
DB13127,The risk or severity of adverse effects can be increased when Omalizumab is combined with Olokizumab.,Olokizumab,DB00043
DB13140,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bezlotoxumab.,Bezlotoxumab,DB00043
DB13375,The risk or severity of adverse effects can be increased when Omalizumab is combined with Edrecolomab.,Edrecolomab,DB00043
DB13535,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nebacumab.,Nebacumab,DB00043
DB13886,The risk or severity of adverse effects can be increased when Omalizumab is combined with Human cytomegalovirus immune globulin.,Human cytomegalovirus immune globulin,DB00043
DB13923,The risk or severity of adverse effects can be increased when Omalizumab is combined with Emicizumab.,Emicizumab,DB00043
DB13976,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sulesomab.,Sulesomab,DB00043
DB13979,The risk or severity of adverse effects can be increased when Omalizumab is combined with Besilesomab.,Besilesomab,DB00043
DB14004,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tildrakizumab.,Tildrakizumab,DB00043
DB14012,The risk or severity of adverse effects can be increased when Omalizumab is combined with Burosumab.,Burosumab,DB00043
DB14039,The risk or severity of adverse effects can be increased when Omalizumab is combined with Erenumab.,Erenumab,DB00043
DB14040,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eptinezumab.,Eptinezumab,DB00043
DB14041,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fremanezumab.,Fremanezumab,DB00043
DB14042,The risk or severity of adverse effects can be increased when Omalizumab is combined with Galcanezumab.,Galcanezumab,DB00043
DB14211,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fanolesomab.,Fanolesomab,DB00043
DB14580,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lecanemab.,Lecanemab,DB00043
DB14597,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lanadelumab.,Lanadelumab,DB00043
DB14707,The risk or severity of adverse effects can be increased when Omalizumab is combined with Cemiplimab.,Cemiplimab,DB00043
DB14724,The risk or severity of adverse effects can be increased when Omalizumab is combined with Emapalumab.,Emapalumab,DB00043
DB14762,The risk or severity of adverse effects can be increased when Omalizumab is combined with Risankizumab.,Risankizumab,DB00043
DB14776,The risk or severity of adverse effects can be increased when Omalizumab is combined with Camrelizumab.,Camrelizumab,DB00043
DB14778,The risk or severity of adverse effects can be increased when Omalizumab is combined with Setrusumab.,Setrusumab,DB00043
DB14784,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gancotamab.,Gancotamab,DB00043
DB14809,The risk or severity of adverse effects can be increased when Omalizumab is combined with Anetumab ravtansine.,Anetumab ravtansine,DB00043
DB14811,The risk or severity of adverse effects can be increased when Omalizumab is combined with Isatuximab.,Isatuximab,DB00043
DB14824,The risk or severity of adverse effects can be increased when Omalizumab is combined with Icrucumab.,Icrucumab,DB00043
DB14843,The risk or severity of adverse effects can be increased when Omalizumab is combined with Codrituzumab.,Codrituzumab,DB00043
DB14864,The risk or severity of adverse effects can be increased when Omalizumab is combined with Brolucizumab.,Brolucizumab,DB00043
DB14871,The risk or severity of adverse effects can be increased when Omalizumab is combined with Xentuzumab.,Xentuzumab,DB00043
DB14877,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lintuzumab.,Lintuzumab,DB00043
DB14891,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vobarilizumab.,Vobarilizumab,DB00043
DB14897,The risk or severity of adverse effects can be increased when Omalizumab is combined with Parsatuzumab.,Parsatuzumab,DB00043
DB14905,The risk or severity of adverse effects can be increased when Omalizumab is combined with Emactuzumab.,Emactuzumab,DB00043
DB14907,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bevacizumab zirconium Zr-89.,Bevacizumab zirconium Zr-89,DB00043
DB14908,The risk or severity of adverse effects can be increased when Omalizumab is combined with Refanezumab.,Refanezumab,DB00043
DB14919,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rozanolixizumab.,Rozanolixizumab,DB00043
DB14947,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bermekimab.,Bermekimab,DB00043
DB14952,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pamrevlumab.,Pamrevlumab,DB00043
DB14959,The risk or severity of adverse effects can be increased when Omalizumab is combined with Opicinumab.,Opicinumab,DB00043
DB14962,The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab deruxtecan.,Trastuzumab deruxtecan,DB00043
DB14967,The risk or severity of adverse effects can be increased when Omalizumab is combined with Margetuximab.,Margetuximab,DB00043
DB14988,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dalantercept.,Dalantercept,DB00043
DB14997,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pateclizumab.,Pateclizumab,DB00043
DB15014,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gremubamab.,Gremubamab,DB00043
DB15022,The risk or severity of adverse effects can be increased when Omalizumab is combined with Apomab.,Apomab,DB00043
DB15044,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tafasitamab.,Tafasitamab,DB00043
DB15045,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ipafricept.,Ipafricept,DB00043
DB15076,The risk or severity of adverse effects can be increased when Omalizumab is combined with Abrilumab.,Abrilumab,DB00043
DB15089,The risk or severity of adverse effects can be increased when Omalizumab is combined with Frovocimab.,Frovocimab,DB00043
DB15090,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tezepelumab.,Tezepelumab,DB00043
DB15101,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tigatuzumab.,Tigatuzumab,DB00043
DB15104,The risk or severity of adverse effects can be increased when Omalizumab is combined with Telisotuzumab vedotin.,Telisotuzumab vedotin,DB00043
DB15113,The risk or severity of adverse effects can be increased when Omalizumab is combined with Utomilumab.,Utomilumab,DB00043
DB15118,The risk or severity of adverse effects can be increased when Omalizumab is combined with Zolbetuximab.,Zolbetuximab,DB00043
DB15135,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ponezumab.,Ponezumab,DB00043
DB15160,The risk or severity of adverse effects can be increased when Omalizumab is combined with Asunercept.,Asunercept,DB00043
DB15172,The risk or severity of adverse effects can be increased when Omalizumab is combined with Suvratoxumab.,Suvratoxumab,DB00043
DB15225,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mitazalimab.,Mitazalimab,DB00043
DB15252,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nemolizumab.,Nemolizumab,DB00043
DB15253,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bleselumab.,Bleselumab,DB00043
DB15277,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gedivumab.,Gedivumab,DB00043
DB15336,The risk or severity of adverse effects can be increased when Omalizumab is combined with Valanafusp alfa.,Valanafusp alfa,DB00043
DB15349,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sofituzumab vedotin.,Sofituzumab vedotin,DB00043
DB15354,The risk or severity of adverse effects can be increased when Omalizumab is combined with Evinacumab.,Evinacumab,DB00043
DB15363,The risk or severity of adverse effects can be increased when Omalizumab is combined with Istiratumab.,Istiratumab,DB00043
DB15383,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pidilizumab.,Pidilizumab,DB00043
DB15397,The risk or severity of adverse effects can be increased when Omalizumab is combined with GMA-161.,GMA-161,DB00043
DB15409,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ladiratuzumab vedotin.,Ladiratuzumab vedotin,DB00043
DB15415,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tomaralimab.,Tomaralimab,DB00043
DB15428,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vesencumab.,Vesencumab,DB00043
DB15432,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pinatuzumab vedotin.,Pinatuzumab vedotin,DB00043
DB15441,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lulizumab pegol.,Lulizumab pegol,DB00043
DB15443,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lorukafusp alfa.,Lorukafusp alfa,DB00043
DB15453,The risk or severity of adverse effects can be increased when Omalizumab is combined with Naratuximab emtansine.,Naratuximab emtansine,DB00043
DB15559,The risk or severity of adverse effects can be increased when Omalizumab is combined with Zenocutuzumab.,Zenocutuzumab,DB00043
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Omalizumab.","Ebola Zaire vaccine (live, attenuated)",DB00043
DB06655,Liraglutide may increase the hypoglycemic activities of Insulin lispro.,Liraglutide,DB00046
DB09046,Metreleptin may increase the hypoglycemic activities of Insulin lispro.,Metreleptin,DB00046
DB00082,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Insulin lispro.,Pegvisomant,DB00046
DB01132,The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin lispro.,Pioglitazone,DB00046
DB01278,Pramlintide may increase the hypoglycemic activities of Insulin lispro.,Pramlintide,DB00046
DB00412,The risk or severity of congestive heart failure can be increased when Insulin lispro is combined with Rosiglitazone.,Rosiglitazone,DB00046
DB00166,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Insulin lispro.,Lipoic acid,DB00046
DB00974,Edetic acid may increase the hypoglycemic activities of Insulin lispro.,Edetic acid,DB00046
DB00187,Esmolol may increase the hypoglycemic activities of Insulin lispro.,Esmolol,DB00046
DB00218,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Moxifloxacin.,Moxifloxacin,DB00046
DB00365,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Grepafloxacin.,Grepafloxacin,DB00046
DB00467,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Enoxacin.,Enoxacin,DB00046
DB00487,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Pefloxacin.,Pefloxacin,DB00046
DB00537,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ciprofloxacin.,Ciprofloxacin,DB00046
DB00685,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Trovafloxacin.,Trovafloxacin,DB00046
DB00779,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Nalidixic acid.,Nalidixic acid,DB00046
DB00817,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Rosoxacin.,Rosoxacin,DB00046
DB00827,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Cinoxacin.,Cinoxacin,DB00046
DB00978,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Lomefloxacin.,Lomefloxacin,DB00046
DB01044,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Gatifloxacin.,Gatifloxacin,DB00046
DB01059,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Norfloxacin.,Norfloxacin,DB00046
DB01137,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Levofloxacin.,Levofloxacin,DB00046
DB01155,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Gemifloxacin.,Gemifloxacin,DB00046
DB01165,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ofloxacin.,Ofloxacin,DB00046
DB01208,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sparfloxacin.,Sparfloxacin,DB00046
DB01405,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Temafloxacin.,Temafloxacin,DB00046
DB04576,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Fleroxacin.,Fleroxacin,DB00046
DB05488,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,Technetium Tc-99m ciprofloxacin,DB00046
DB06160,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Garenoxacin.,Garenoxacin,DB00046
DB06600,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Nemonoxacin.,Nemonoxacin,DB00046
DB08972,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Flumequine.,Flumequine,DB00046
DB11404,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Enrofloxacin.,Enrofloxacin,DB00046
DB11443,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Orbifloxacin.,Orbifloxacin,DB00046
DB11491,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sarafloxacin.,Sarafloxacin,DB00046
DB11511,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Difloxacin.,Difloxacin,DB00046
DB11774,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Pazufloxacin.,Pazufloxacin,DB00046
DB11892,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Prulifloxacin.,Prulifloxacin,DB00046
DB11943,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Delafloxacin.,Delafloxacin,DB00046
DB13261,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sitafloxacin.,Sitafloxacin,DB00046
DB13627,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Oxolinic acid.,Oxolinic acid,DB00046
DB13772,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Rufloxacin.,Rufloxacin,DB00046
DB13823,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Pipemidic acid.,Pipemidic acid,DB00046
DB00232,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Methyclothiazide.,Methyclothiazide,DB00046
DB00310,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Chlorthalidone.,Chlorthalidone,DB00046
DB00436,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide,DB00046
DB00524,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Metolazone.,Metolazone,DB00046
DB00562,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Benzthiazide.,Benzthiazide,DB00046
DB00774,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide,DB00046
DB00808,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Indapamide.,Indapamide,DB00046
DB00880,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Chlorothiazide.,Chlorothiazide,DB00046
DB00999,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide,DB00046
DB01021,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide,DB00046
DB01324,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Polythiazide.,Polythiazide,DB00046
DB01325,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Quinethazone.,Quinethazone,DB00046
DB13532,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide,DB00046
DB13989,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Epitizide.,Epitizide,DB00046
DB00344,Protriptyline may decrease the hypoglycemic activities of Insulin lispro.,Protriptyline,DB00046
DB00543,Amoxapine may decrease the hypoglycemic activities of Insulin lispro.,Amoxapine,DB00046
DB00726,Trimipramine may decrease the hypoglycemic activities of Insulin lispro.,Trimipramine,DB00046
DB04836,Amineptine may decrease the hypoglycemic activities of Insulin lispro.,Amineptine,DB00046
DB08996,Dimetacrine may decrease the hypoglycemic activities of Insulin lispro.,Dimetacrine,DB00046
DB09016,Butriptyline may decrease the hypoglycemic activities of Insulin lispro.,Butriptyline,DB00046
DB09167,Dosulepin may decrease the hypoglycemic activities of Insulin lispro.,Dosulepin,DB00046
DB09289,Tianeptine may decrease the hypoglycemic activities of Insulin lispro.,Tianeptine,DB00046
DB09307,Oxaprotiline may decrease the hypoglycemic activities of Insulin lispro.,Oxaprotiline,DB00046
DB12930,Opipramol may decrease the hypoglycemic activities of Insulin lispro.,Opipramol,DB00046
DB13114,Amitriptylinoxide may decrease the hypoglycemic activities of Insulin lispro.,Amitriptylinoxide,DB00046
DB13225,Dibenzepin may decrease the hypoglycemic activities of Insulin lispro.,Dibenzepin,DB00046
DB13246,Quinupramine may decrease the hypoglycemic activities of Insulin lispro.,Quinupramine,DB00046
DB13384,Melitracen may decrease the hypoglycemic activities of Insulin lispro.,Melitracen,DB00046
DB13411,Lofepramine may decrease the hypoglycemic activities of Insulin lispro.,Lofepramine,DB00046
DB13496,Iprindole may decrease the hypoglycemic activities of Insulin lispro.,Iprindole,DB00046
DB13782,Imipramine oxide may decrease the hypoglycemic activities of Insulin lispro.,Imipramine oxide,DB00046
DB06292,Dapagliflozin may increase the hypoglycemic activities of Insulin lispro.,Dapagliflozin,DB00046
DB08907,Canagliflozin may increase the hypoglycemic activities of Insulin lispro.,Canagliflozin,DB00046
DB00007,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Leuprolide.,Leuprolide,DB00046
DB00014,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Goserelin.,Goserelin,DB00046
DB00104,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Octreotide.,Octreotide,DB00046
DB00220,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Nelfinavir.,Nelfinavir,DB00046
DB00224,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Indinavir.,Indinavir,DB00046
DB00246,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ziprasidone.,Ziprasidone,DB00046
DB00294,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Etonogestrel.,Etonogestrel,DB00046
DB00304,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Desogestrel.,Desogestrel,DB00046
DB00334,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Olanzapine.,Olanzapine,DB00046
DB00351,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Megestrol acetate.,Megestrol acetate,DB00046
DB00363,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Clozapine.,Clozapine,DB00046
DB00367,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Levonorgestrel.,Levonorgestrel,DB00046
DB00396,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Progesterone.,Progesterone,DB00046
DB00477,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Chlorpromazine.,Chlorpromazine,DB00046
DB00502,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Haloperidol.,Haloperidol,DB00046
DB00503,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ritonavir.,Ritonavir,DB00046
DB00592,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Piperazine.,Piperazine,DB00046
DB00603,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Medroxyprogesterone acetate.,Medroxyprogesterone acetate,DB00046
DB00627,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Niacin.,Niacin,DB00046
DB00668,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Epinephrine.,Epinephrine,DB00046
DB00717,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Norethisterone.,Norethisterone,DB00046
DB00734,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Risperidone.,Risperidone,DB00046
DB00738,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Pentamidine.,Pentamidine,DB00046
DB00823,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ethynodiol diacetate.,Ethynodiol diacetate,DB00046
DB00852,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Pseudoephedrine.,Pseudoephedrine,DB00046
DB00864,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Tacrolimus.,Tacrolimus,DB00046
DB00877,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Sirolimus.,Sirolimus,DB00046
DB00903,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Etacrynic acid.,Etacrynic acid,DB00046
DB00932,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Tipranavir.,Tipranavir,DB00046
DB00957,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Norgestimate.,Norgestimate,DB00046
DB00977,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ethinylestradiol.,Ethinylestradiol,DB00046
DB01072,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Atazanavir.,Atazanavir,DB00046
DB01169,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Arsenic trioxide.,Arsenic trioxide,DB00046
DB01224,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Quetiapine.,Quetiapine,DB00046
DB01232,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Saquinavir.,Saquinavir,DB00046
DB01238,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Aripiprazole.,Aripiprazole,DB00046
DB01267,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Paliperidone.,Paliperidone,DB00046
DB01319,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Fosamprenavir.,Fosamprenavir,DB00046
DB01323,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with St. John's Wort.,St. John's Wort,DB00046
DB01357,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Mestranol.,Mestranol,DB00046
DB01363,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ephedra sinica root.,Ephedra sinica root,DB00046
DB01395,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Drospirenone.,Drospirenone,DB00046
DB01403,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Methotrimeprazine.,Methotrimeprazine,DB00046
DB01406,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Danazol.,Danazol,DB00046
DB01590,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Everolimus.,Everolimus,DB00046
DB01601,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Lopinavir.,Lopinavir,DB00046
DB01621,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Pipotiazine.,Pipotiazine,DB00046
DB02546,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Vorinostat.,Vorinostat,DB00046
DB04574,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Estrone sulfate.,Estrone sulfate,DB00046
DB04839,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Cyproterone acetate.,Cyproterone acetate,DB00046
DB04868,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Nilotinib.,Nilotinib,DB00046
DB04946,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Iloperidone.,Iloperidone,DB00046
DB06216,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Asenapine.,Asenapine,DB00046
DB06287,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Temsirolimus.,Temsirolimus,DB00046
DB06663,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Pasireotide.,Pasireotide,DB00046
DB06719,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Buserelin.,Buserelin,DB00046
DB06788,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Histrelin.,Histrelin,DB00046
DB06789,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Hydroxyprogesterone caproate.,Hydroxyprogesterone caproate,DB00046
DB06791,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Lanreotide.,Lanreotide,DB00046
DB06825,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Triptorelin.,Triptorelin,DB00046
DB08815,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Lurasidone.,Lurasidone,DB00046
DB08912,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Dabrafenib.,Dabrafenib,DB00046
DB09009,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Articaine.,Articaine,DB00046
DB09063,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ceritinib.,Ceritinib,DB00046
DB09123,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Dienogest.,Dienogest,DB00046
DB09128,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Brexpiprazole.,Brexpiprazole,DB00046
DB06343,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Teprotumumab.,Teprotumumab,DB00046
DB00621,Oxandrolone may increase the hypoglycemic activities of Insulin lispro.,Oxandrolone,DB00046
DB00624,Testosterone may increase the hypoglycemic activities of Insulin lispro.,Testosterone,DB00046
DB00984,Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin lispro.,Nandrolone phenpropionate,DB00046
DB01185,Fluoxymesterone may increase the hypoglycemic activities of Insulin lispro.,Fluoxymesterone,DB00046
DB01420,Testosterone propionate may increase the hypoglycemic activities of Insulin lispro.,Testosterone propionate,DB00046
DB02901,Stanolone may increase the hypoglycemic activities of Insulin lispro.,Stanolone,DB00046
DB06412,Oxymetholone may increase the hypoglycemic activities of Insulin lispro.,Oxymetholone,DB00046
DB06710,Methyltestosterone may increase the hypoglycemic activities of Insulin lispro.,Methyltestosterone,DB00046
DB06718,Stanozolol may increase the hypoglycemic activities of Insulin lispro.,Stanozolol,DB00046
DB08804,Nandrolone decanoate may increase the hypoglycemic activities of Insulin lispro.,Nandrolone decanoate,DB00046
DB12461,GLPG-0492 may increase the hypoglycemic activities of Insulin lispro.,GLPG-0492,DB00046
DB13169,Nandrolone may increase the hypoglycemic activities of Insulin lispro.,Nandrolone,DB00046
DB13587,Mesterolone may increase the hypoglycemic activities of Insulin lispro.,Mesterolone,DB00046
DB13943,Testosterone cypionate may increase the hypoglycemic activities of Insulin lispro.,Testosterone cypionate,DB00046
DB13944,Testosterone enanthate may increase the hypoglycemic activities of Insulin lispro.,Testosterone enanthate,DB00046
DB00215,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Citalopram.,Citalopram,DB00046
DB00230,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Pregabalin.,Pregabalin,DB00046
DB00285,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Venlafaxine.,Venlafaxine,DB00046
DB00328,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Indomethacin.,Indomethacin,DB00046
DB01104,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Sertraline.,Sertraline,DB00046
DB01149,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Nefazodone.,Nefazodone,DB00046
DB01175,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Escitalopram.,Escitalopram,DB00046
DB04832,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Zimelidine.,Zimelidine,DB00046
DB04884,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Dapoxetine.,Dapoxetine,DB00046
DB04896,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Milnacipran.,Milnacipran,DB00046
DB06700,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Desvenlafaxine.,Desvenlafaxine,DB00046
DB08918,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Levomilnacipran.,Levomilnacipran,DB00046
DB08953,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Indalpine.,Indalpine,DB00046
DB09270,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Ubidecarenone.,Ubidecarenone,DB00046
DB12693,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Ritanserin.,Ritanserin,DB00046
DB13233,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Alaproclate.,Alaproclate,DB00046
DB13358,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Cibenzoline.,Cibenzoline,DB00046
DB14025,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Clinafloxacin.,Clinafloxacin,DB00046
DB09038,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Empagliflozin.,Empagliflozin,DB00046
DB00233,Aminosalicylic acid may increase the hypoglycemic activities of Insulin lispro.,Aminosalicylic acid,DB00046
DB00244,Mesalazine may increase the hypoglycemic activities of Insulin lispro.,Mesalazine,DB00046
DB00795,Sulfasalazine may increase the hypoglycemic activities of Insulin lispro.,Sulfasalazine,DB00046
DB00861,Diflunisal may increase the hypoglycemic activities of Insulin lispro.,Diflunisal,DB00046
DB00936,Salicylic acid may increase the hypoglycemic activities of Insulin lispro.,Salicylic acid,DB00046
DB01014,Balsalazide may increase the hypoglycemic activities of Insulin lispro.,Balsalazide,DB00046
DB01250,Olsalazine may increase the hypoglycemic activities of Insulin lispro.,Olsalazine,DB00046
DB01294,Bismuth subsalicylate may increase the hypoglycemic activities of Insulin lispro.,Bismuth subsalicylate,DB00046
DB06251,Dersalazine may increase the hypoglycemic activities of Insulin lispro.,Dersalazine,DB00046
DB06807,Phenyl aminosalicylate may increase the hypoglycemic activities of Insulin lispro.,Phenyl aminosalicylate,DB00046
DB09543,Methyl salicylate may increase the hypoglycemic activities of Insulin lispro.,Methyl salicylate,DB00046
DB11079,Trolamine salicylate may increase the hypoglycemic activities of Insulin lispro.,Trolamine salicylate,DB00046
DB12445,Nitroaspirin may increase the hypoglycemic activities of Insulin lispro.,Nitroaspirin,DB00046
DB13509,Aloxiprin may increase the hypoglycemic activities of Insulin lispro.,Aloxiprin,DB00046
DB13538,Guacetisal may increase the hypoglycemic activities of Insulin lispro.,Guacetisal,DB00046
DB13612,Carbaspirin calcium may increase the hypoglycemic activities of Insulin lispro.,Carbaspirin calcium,DB00046
DB14006,Choline salicylate may increase the hypoglycemic activities of Insulin lispro.,Choline salicylate,DB00046
DB14026,Thiosalicylic acid may increase the hypoglycemic activities of Insulin lispro.,Thiosalicylic acid,DB00046
DB01261,Sitagliptin may increase the hypoglycemic activities of Insulin lispro.,Sitagliptin,DB00046
DB04876,Vildagliptin may increase the hypoglycemic activities of Insulin lispro.,Vildagliptin,DB00046
DB06011,AMG-222 may increase the hypoglycemic activities of Insulin lispro.,AMG-222,DB00046
DB06127,Bisegliptin may increase the hypoglycemic activities of Insulin lispro.,Bisegliptin,DB00046
DB06203,Alogliptin may increase the hypoglycemic activities of Insulin lispro.,Alogliptin,DB00046
DB06335,Saxagliptin may increase the hypoglycemic activities of Insulin lispro.,Saxagliptin,DB00046
DB08382,Gosogliptin may increase the hypoglycemic activities of Insulin lispro.,Gosogliptin,DB00046
DB08882,Linagliptin may increase the hypoglycemic activities of Insulin lispro.,Linagliptin,DB00046
DB11723,Dutogliptin may increase the hypoglycemic activities of Insulin lispro.,Dutogliptin,DB00046
DB11950,Teneligliptin may increase the hypoglycemic activities of Insulin lispro.,Teneligliptin,DB00046
DB11992,Omarigliptin may increase the hypoglycemic activities of Insulin lispro.,Omarigliptin,DB00046
DB12268,Carmegliptin may increase the hypoglycemic activities of Insulin lispro.,Carmegliptin,DB00046
DB12412,Gemigliptin may increase the hypoglycemic activities of Insulin lispro.,Gemigliptin,DB00046
DB12417,Anagliptin may increase the hypoglycemic activities of Insulin lispro.,Anagliptin,DB00046
DB12625,Evogliptin may increase the hypoglycemic activities of Insulin lispro.,Evogliptin,DB00046
DB01276,Exenatide may increase the hypoglycemic activities of Insulin lispro.,Exenatide,DB00046
DB09043,Albiglutide may increase the hypoglycemic activities of Insulin lispro.,Albiglutide,DB00046
DB09045,Dulaglutide may increase the hypoglycemic activities of Insulin lispro.,Dulaglutide,DB00046
DB09265,Lixisenatide may increase the hypoglycemic activities of Insulin lispro.,Lixisenatide,DB00046
DB13928,Semaglutide may increase the hypoglycemic activities of Insulin lispro.,Semaglutide,DB00046
DB14027,Taspoglutide may increase the hypoglycemic activities of Insulin lispro.,Taspoglutide,DB00046
DB00752,Tranylcypromine may increase the hypoglycemic activities of Insulin lispro.,Tranylcypromine,DB00046
DB00780,Phenelzine may increase the hypoglycemic activities of Insulin lispro.,Phenelzine,DB00046
DB01171,Moclobemide may increase the hypoglycemic activities of Insulin lispro.,Moclobemide,DB00046
DB01247,Isocarboxazid may increase the hypoglycemic activities of Insulin lispro.,Isocarboxazid,DB00046
DB01626,Pargyline may increase the hypoglycemic activities of Insulin lispro.,Pargyline,DB00046
DB00805,Minaprine may increase the hypoglycemic activities of Insulin lispro.,Minaprine,DB00046
DB04818,Iproniazid may increase the hypoglycemic activities of Insulin lispro.,Iproniazid,DB00046
DB04820,Nialamide may increase the hypoglycemic activities of Insulin lispro.,Nialamide,DB00046
DB09244,Pirlindole may increase the hypoglycemic activities of Insulin lispro.,Pirlindole,DB00046
DB09245,Toloxatone may increase the hypoglycemic activities of Insulin lispro.,Toloxatone,DB00046
DB09243,Hydracarbazine may increase the hypoglycemic activities of Insulin lispro.,Hydracarbazine,DB00046
DB09241,Methylene blue may increase the hypoglycemic activities of Insulin lispro.,Methylene blue,DB00046
DB09246,Benmoxin may increase the hypoglycemic activities of Insulin lispro.,Benmoxin,DB00046
DB09248,Mebanazine may increase the hypoglycemic activities of Insulin lispro.,Mebanazine,DB00046
DB09249,Octamoxin may increase the hypoglycemic activities of Insulin lispro.,Octamoxin,DB00046
DB09250,Pheniprazine may increase the hypoglycemic activities of Insulin lispro.,Pheniprazine,DB00046
DB09251,Phenoxypropazine may increase the hypoglycemic activities of Insulin lispro.,Phenoxypropazine,DB00046
DB09252,Pivhydrazine may increase the hypoglycemic activities of Insulin lispro.,Pivhydrazine,DB00046
DB09253,Safrazine may increase the hypoglycemic activities of Insulin lispro.,Safrazine,DB00046
DB09254,Caroxazone may increase the hypoglycemic activities of Insulin lispro.,Caroxazone,DB00046
DB00614,Furazolidone may increase the hypoglycemic activities of Insulin lispro.,Furazolidone,DB00046
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Insulin lispro.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",DB00046
DB13875,Harmaline may increase the hypoglycemic activities of Insulin lispro.,Harmaline,DB00046
DB13876,Brofaromine may increase the hypoglycemic activities of Insulin lispro.,Brofaromine,DB00046
DB00721,Procaine may increase the hypoglycemic activities of Insulin lispro.,Procaine,DB00046
DB00182,Amphetamine may increase the hypoglycemic activities of Insulin lispro.,Amphetamine,DB00046
DB01168,Procarbazine may increase the hypoglycemic activities of Insulin lispro.,Procarbazine,DB00046
DB00601,Linezolid may increase the hypoglycemic activities of Insulin lispro.,Linezolid,DB00046
DB06654,Safinamide may increase the hypoglycemic activities of Insulin lispro.,Safinamide,DB00046
DB04017,Clorgiline may increase the hypoglycemic activities of Insulin lispro.,Clorgiline,DB00046
DB11827,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ertugliflozin.,Ertugliflozin,DB00046
DB00203,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sildenafil.,Sildenafil,DB00046
DB00214,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Torasemide.,Torasemide,DB00046
DB00263,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfisoxazole.,Sulfisoxazole,DB00046
DB00311,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ethoxzolamide.,Ethoxzolamide,DB00046
DB00359,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfadiazine.,Sulfadiazine,DB00046
DB00482,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Celecoxib.,Celecoxib,DB00046
DB00559,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bosentan.,Bosentan,DB00046
DB00576,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamethizole.,Sulfamethizole,DB00046
DB00606,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Cyclothiazide.,Cyclothiazide,DB00046
DB00664,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfametopyrazine.,Sulfametopyrazine,DB00046
DB00669,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sumatriptan.,Sumatriptan,DB00046
DB00695,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Furosemide.,Furosemide,DB00046
DB00706,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Tamsulosin.,Tamsulosin,DB00046
DB00819,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Acetazolamide.,Acetazolamide,DB00046
DB00887,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bumetanide.,Bumetanide,DB00046
DB00891,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfapyridine.,Sulfapyridine,DB00046
DB00909,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Zonisamide.,Zonisamide,DB00046
DB01015,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamethoxazole.,Sulfamethoxazole,DB00046
DB01032,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Probenecid.,Probenecid,DB00046
DB01098,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Rosuvastatin.,Rosuvastatin,DB00046
DB01119,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Diazoxide.,Diazoxide,DB00046
DB01144,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Diclofenamide.,Diclofenamide,DB00046
DB01264,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Darunavir.,Darunavir,DB00046
DB01298,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfacytine.,Sulfacytine,DB00046
DB01299,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfadoxine.,Sulfadoxine,DB00046
DB01382,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Glymidine.,Glymidine,DB00046
DB01581,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamerazine.,Sulfamerazine,DB00046
DB01582,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamethazine.,Sulfamethazine,DB00046
DB02925,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Piretanide.,Piretanide,DB00046
DB04707,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Hydroxyfasudil.,Hydroxyfasudil,DB00046
DB06150,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfadimethoxine.,Sulfadimethoxine,DB00046
DB06290,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Simeprevir.,Simeprevir,DB00046
DB06729,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaphenazole.,Sulfaphenazole,DB00046
DB06821,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfameter.,Sulfameter,DB00046
DB07996,The therapeutic efficacy of Insulin lispro can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,DB00046
DB08162,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Fasudil.,Fasudil,DB00046
DB08798,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamoxole.,Sulfamoxole,DB00046
DB08881,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Vemurafenib.,Vemurafenib,DB00046
DB08961,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Azosemide.,Azosemide,DB00046
DB11389,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Clorsulon.,Clorsulon,DB00046
DB11461,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfachlorpyridazine.,Sulfachlorpyridazine,DB00046
DB11462,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaethoxypyridazine.,Sulfaethoxypyridazine,DB00046
DB11463,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfanitran.,Sulfanitran,DB00046
DB11464,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaquinoxaline.,Sulfaquinoxaline,DB00046
DB12051,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Setrobuvir.,Setrobuvir,DB00046
DB12921,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Chlorsulfaquinoxaline.,Chlorsulfaquinoxaline,DB00046
DB13214,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfadicramide.,Sulfadicramide,DB00046
DB13248,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Phthalylsulfathiazole.,Phthalylsulfathiazole,DB00046
DB13283,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaisodimidine.,Sulfaisodimidine,DB00046
DB13284,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Meticrane.,Meticrane,DB00046
DB13320,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaperin.,Sulfaperin,DB00046
DB13405,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Mefruside.,Mefruside,DB00046
DB13430,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Mebutizide.,Mebutizide,DB00046
DB13485,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfametomidine.,Sulfametomidine,DB00046
DB13547,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfatolamide.,Sulfatolamide,DB00046
DB13556,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamazone.,Sulfamazone,DB00046
DB13580,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Succinylsulfathiazole.,Succinylsulfathiazole,DB00046
DB13617,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Clorexolone.,Clorexolone,DB00046
DB13663,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Clofenamide.,Clofenamide,DB00046
DB13699,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfathiourea.,Sulfathiourea,DB00046
DB13708,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Fenquizone.,Fenquizone,DB00046
DB13726,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaguanidine.,Sulfaguanidine,DB00046
DB13773,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamethoxypyridazine.,Sulfamethoxypyridazine,DB00046
DB13792,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Clopamide.,Clopamide,DB00046
DB13803,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Xipamide.,Xipamide,DB00046
DB14033,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Acetyl sulfisoxazole.,Acetyl sulfisoxazole,DB00046
DB14708,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Tosylchloramide.,Tosylchloramide,DB00046
DB00703,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Methazolamide.,Methazolamide,DB00046
DB06370,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Indisulam.,Indisulam,DB00046
DB00176,The metabolism of Fluvoxamine can be increased when combined with Insulin lispro.,Fluvoxamine,DB00046
DB00184,The metabolism of Nicotine can be increased when combined with Insulin lispro.,Nicotine,DB00046
DB00188,The metabolism of Bortezomib can be increased when combined with Insulin lispro.,Bortezomib,DB00046
DB00201,The metabolism of Caffeine can be increased when combined with Insulin lispro.,Caffeine,DB00046
DB00261,The metabolism of Anagrelide can be increased when combined with Insulin lispro.,Anagrelide,DB00046
DB00262,The metabolism of Carmustine can be increased when combined with Insulin lispro.,Carmustine,DB00046
DB00281,The metabolism of Lidocaine can be increased when combined with Insulin lispro.,Lidocaine,DB00046
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Insulin lispro.,Conjugated estrogens,DB00046
DB00296,The metabolism of Ropivacaine can be increased when combined with Insulin lispro.,Ropivacaine,DB00046
DB00315,The metabolism of Zolmitriptan can be increased when combined with Insulin lispro.,Zolmitriptan,DB00046
DB00316,The metabolism of Acetaminophen can be increased when combined with Insulin lispro.,Acetaminophen,DB00046
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Insulin lispro.,Chlorzoxazone,DB00046
DB00370,The metabolism of Mirtazapine can be increased when combined with Insulin lispro.,Mirtazapine,DB00046
DB00379,The metabolism of Mexiletine can be increased when combined with Insulin lispro.,Mexiletine,DB00046
DB00382,The metabolism of Tacrine can be increased when combined with Insulin lispro.,Tacrine,DB00046
DB00384,The metabolism of Triamterene can be increased when combined with Insulin lispro.,Triamterene,DB00046
DB00420,The metabolism of Promazine can be increased when combined with Insulin lispro.,Promazine,DB00046
DB00425,The metabolism of Zolpidem can be increased when combined with Insulin lispro.,Zolpidem,DB00046
DB00442,The metabolism of Entecavir can be increased when combined with Insulin lispro.,Entecavir,DB00046
DB00461,The metabolism of Nabumetone can be increased when combined with Insulin lispro.,Nabumetone,DB00046
DB00472,The metabolism of Fluoxetine can be increased when combined with Insulin lispro.,Fluoxetine,DB00046
DB00476,The metabolism of Duloxetine can be increased when combined with Insulin lispro.,Duloxetine,DB00046
DB00499,The metabolism of Flutamide can be increased when combined with Insulin lispro.,Flutamide,DB00046
DB00518,The metabolism of Albendazole can be increased when combined with Insulin lispro.,Albendazole,DB00046
DB00533,The metabolism of Rofecoxib can be increased when combined with Insulin lispro.,Rofecoxib,DB00046
DB00544,The metabolism of Fluorouracil can be increased when combined with Insulin lispro.,Fluorouracil,DB00046
DB00568,The metabolism of Cinnarizine can be increased when combined with Insulin lispro.,Cinnarizine,DB00046
DB00586,The metabolism of Diclofenac can be increased when combined with Insulin lispro.,Diclofenac,DB00046
DB00619,The metabolism of Imatinib can be increased when combined with Insulin lispro.,Imatinib,DB00046
DB00629,The metabolism of Guanabenz can be increased when combined with Insulin lispro.,Guanabenz,DB00046
DB00642,The metabolism of Pemetrexed can be increased when combined with Insulin lispro.,Pemetrexed,DB00046
DB00661,The metabolism of Verapamil can be increased when combined with Insulin lispro.,Verapamil,DB00046
DB00715,The metabolism of Paroxetine can be increased when combined with Insulin lispro.,Paroxetine,DB00046
DB00730,The metabolism of Thiabendazole can be increased when combined with Insulin lispro.,Thiabendazole,DB00046
DB00740,The metabolism of Riluzole can be increased when combined with Insulin lispro.,Riluzole,DB00046
DB00744,The metabolism of Zileuton can be increased when combined with Insulin lispro.,Zileuton,DB00046
DB00758,The metabolism of Clopidogrel can be increased when combined with Insulin lispro.,Clopidogrel,DB00046
DB00787,The metabolism of Acyclovir can be increased when combined with Insulin lispro.,Acyclovir,DB00046
DB00788,The metabolism of Naproxen can be increased when combined with Insulin lispro.,Naproxen,DB00046
DB00806,The metabolism of Pentoxifylline can be increased when combined with Insulin lispro.,Pentoxifylline,DB00046
DB00831,The metabolism of Trifluoperazine can be increased when combined with Insulin lispro.,Trifluoperazine,DB00046
DB00850,The metabolism of Perphenazine can be increased when combined with Insulin lispro.,Perphenazine,DB00046
DB00857,The metabolism of Terbinafine can be increased when combined with Insulin lispro.,Terbinafine,DB00046
DB00863,The metabolism of Ranitidine can be increased when combined with Insulin lispro.,Ranitidine,DB00046
DB00898,The metabolism of Ethanol can be increased when combined with Insulin lispro.,Ethanol,DB00046
DB00934,The metabolism of Maprotiline can be increased when combined with Insulin lispro.,Maprotiline,DB00046
DB00969,The metabolism of Alosetron can be increased when combined with Insulin lispro.,Alosetron,DB00046
DB00980,The metabolism of Ramelteon can be increased when combined with Insulin lispro.,Ramelteon,DB00046
DB00993,The metabolism of Azathioprine can be increased when combined with Insulin lispro.,Azathioprine,DB00046
DB00998,The metabolism of Frovatriptan can be increased when combined with Insulin lispro.,Frovatriptan,DB00046
DB01002,The metabolism of Levobupivacaine can be increased when combined with Insulin lispro.,Levobupivacaine,DB00046
DB01012,The metabolism of Cinacalcet can be increased when combined with Insulin lispro.,Cinacalcet,DB00046
DB01037,The metabolism of Selegiline can be increased when combined with Insulin lispro.,Selegiline,DB00046
DB01056,The metabolism of Tocainide can be increased when combined with Insulin lispro.,Tocainide,DB00046
DB01058,The metabolism of Praziquantel can be increased when combined with Insulin lispro.,Praziquantel,DB00046
DB01065,The metabolism of Melatonin can be increased when combined with Insulin lispro.,Melatonin,DB00046
DB01087,The metabolism of Primaquine can be increased when combined with Insulin lispro.,Primaquine,DB00046
DB01094,The metabolism of Hesperetin can be increased when combined with Insulin lispro.,Hesperetin,DB00046
DB01097,The metabolism of Leflunomide can be increased when combined with Insulin lispro.,Leflunomide,DB00046
DB01166,The metabolism of Cilostazol can be increased when combined with Insulin lispro.,Cilostazol,DB00046
DB01184,The metabolism of Domperidone can be increased when combined with Insulin lispro.,Domperidone,DB00046
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Insulin lispro.,Dexfenfluramine,DB00046
DB01303,The metabolism of Oxtriphylline can be increased when combined with Insulin lispro.,Oxtriphylline,DB00046
DB01367,The metabolism of Rasagiline can be increased when combined with Insulin lispro.,Rasagiline,DB00046
DB01412,The metabolism of Theobromine can be increased when combined with Insulin lispro.,Theobromine,DB00046
DB01424,The metabolism of Aminophenazone can be increased when combined with Insulin lispro.,Aminophenazone,DB00046
DB01435,The metabolism of Antipyrine can be increased when combined with Insulin lispro.,Antipyrine,DB00046
DB01482,The metabolism of Fenethylline can be increased when combined with Insulin lispro.,Fenethylline,DB00046
DB01558,The metabolism of Bromazepam can be increased when combined with Insulin lispro.,Bromazepam,DB00046
DB01623,The metabolism of Thiothixene can be increased when combined with Insulin lispro.,Thiothixene,DB00046
DB01628,The metabolism of Etoricoxib can be increased when combined with Insulin lispro.,Etoricoxib,DB00046
DB01645,The metabolism of Genistein can be increased when combined with Insulin lispro.,Genistein,DB00046
DB01667,The metabolism of 8-azaguanine can be increased when combined with Insulin lispro.,8-azaguanine,DB00046
DB02134,The metabolism of Xanthine can be increased when combined with Insulin lispro.,Xanthine,DB00046
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Insulin lispro.,9-Methylguanine,DB00046
DB02568,The metabolism of Peldesine can be increased when combined with Insulin lispro.,Peldesine,DB00046
DB02709,The metabolism of Resveratrol can be increased when combined with Insulin lispro.,Resveratrol,DB00046
DB03783,The metabolism of Phenacetin can be increased when combined with Insulin lispro.,Phenacetin,DB00046
DB04076,The metabolism of Hypoxanthine can be increased when combined with Insulin lispro.,Hypoxanthine,DB00046
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Insulin lispro.,9-Deazaguanine,DB00046
DB04841,The metabolism of Flunarizine can be increased when combined with Insulin lispro.,Flunarizine,DB00046
DB04871,The metabolism of Lorcaserin can be increased when combined with Insulin lispro.,Lorcaserin,DB00046
DB04948,The metabolism of Lofexidine can be increased when combined with Insulin lispro.,Lofexidine,DB00046
DB04951,The metabolism of Pirfenidone can be increased when combined with Insulin lispro.,Pirfenidone,DB00046
DB05676,The metabolism of Apremilast can be increased when combined with Insulin lispro.,Apremilast,DB00046
DB06148,The metabolism of Mianserin can be increased when combined with Insulin lispro.,Mianserin,DB00046
DB06210,The metabolism of Eltrombopag can be increased when combined with Insulin lispro.,Eltrombopag,DB00046
DB06235,The metabolism of Vadimezan can be increased when combined with Insulin lispro.,Vadimezan,DB00046
DB06479,The metabolism of Propentofylline can be increased when combined with Insulin lispro.,Propentofylline,DB00046
DB06589,The metabolism of Pazopanib can be increased when combined with Insulin lispro.,Pazopanib,DB00046
DB06594,The metabolism of Agomelatine can be increased when combined with Insulin lispro.,Agomelatine,DB00046
DB06626,The metabolism of Axitinib can be increased when combined with Insulin lispro.,Axitinib,DB00046
DB06769,The metabolism of Bendamustine can be increased when combined with Insulin lispro.,Bendamustine,DB00046
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Insulin lispro.,Benzyl alcohol,DB00046
DB06774,The metabolism of Capsaicin can be increased when combined with Insulin lispro.,Capsaicin,DB00046
DB08496,The metabolism of (R)-warfarin can be increased when combined with Insulin lispro.,(R)-warfarin,DB00046
DB08883,The metabolism of Perampanel can be increased when combined with Insulin lispro.,Perampanel,DB00046
DB09071,The metabolism of Tasimelteon can be increased when combined with Insulin lispro.,Tasimelteon,DB00046
DB09118,The metabolism of Stiripentol can be increased when combined with Insulin lispro.,Stiripentol,DB00046
DB09225,The metabolism of Zotepine can be increased when combined with Insulin lispro.,Zotepine,DB00046
DB09273,The metabolism of Doxofylline can be increased when combined with Insulin lispro.,Doxofylline,DB00046
DB09288,The metabolism of Propacetamol can be increased when combined with Insulin lispro.,Propacetamol,DB00046
DB09290,The metabolism of Ramosetron can be increased when combined with Insulin lispro.,Ramosetron,DB00046
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Insulin lispro.,6-O-benzylguanine,DB00046
DB11967,The metabolism of Binimetinib can be increased when combined with Insulin lispro.,Binimetinib,DB00046
DB12026,The metabolism of Voxilaprevir can be increased when combined with Insulin lispro.,Voxilaprevir,DB00046
DB12245,The metabolism of Triclabendazole can be increased when combined with Insulin lispro.,Triclabendazole,DB00046
DB12332,The metabolism of Rucaparib can be increased when combined with Insulin lispro.,Rucaparib,DB00046
DB12406,The metabolism of Lisofylline can be increased when combined with Insulin lispro.,Lisofylline,DB00046
DB12531,The metabolism of Lobucavir can be increased when combined with Insulin lispro.,Lobucavir,DB00046
DB12926,The metabolism of Cafedrine can be increased when combined with Insulin lispro.,Cafedrine,DB00046
DB12927,The metabolism of Theodrenaline can be increased when combined with Insulin lispro.,Theodrenaline,DB00046
DB12945,The metabolism of Dihydralazine can be increased when combined with Insulin lispro.,Dihydralazine,DB00046
DB13203,The metabolism of Bamifylline can be increased when combined with Insulin lispro.,Bamifylline,DB00046
DB13449,The metabolism of Proxyphylline can be increased when combined with Insulin lispro.,Proxyphylline,DB00046
DB13573,The metabolism of Acefylline can be increased when combined with Insulin lispro.,Acefylline,DB00046
DB13592,The metabolism of Etamiphylline can be increased when combined with Insulin lispro.,Etamiphylline,DB00046
DB13634,The metabolism of Pentifylline can be increased when combined with Insulin lispro.,Pentifylline,DB00046
DB13812,The metabolism of Bufylline can be increased when combined with Insulin lispro.,Bufylline,DB00046
DB13952,The metabolism of Estradiol acetate can be increased when combined with Insulin lispro.,Estradiol acetate,DB00046
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Insulin lispro.,Estradiol benzoate,DB00046
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Insulin lispro.,Estradiol cypionate,DB00046
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Insulin lispro.,Estradiol dienanthate,DB00046
DB13956,The metabolism of Estradiol valerate can be increased when combined with Insulin lispro.,Estradiol valerate,DB00046
DB14018,The metabolism of Bromotheophylline can be increased when combined with Insulin lispro.,Bromotheophylline,DB00046
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Insulin lispro.,8-chlorotheophylline,DB00046
DB01115,The metabolism of Nifedipine can be increased when combined with Insulin lispro.,Nifedipine,DB00046
DB11757,The metabolism of Istradefylline can be increased when combined with Insulin lispro.,Istradefylline,DB00046
DB00972,The metabolism of Azelastine can be increased when combined with Insulin lispro.,Azelastine,DB00046
DB00625,The metabolism of Efavirenz can be increased when combined with Insulin lispro.,Efavirenz,DB00046
DB04889,The metabolism of Bicifadine can be increased when combined with Insulin lispro.,Bicifadine,DB00046
DB05708,The metabolism of GTS-21 can be increased when combined with Insulin lispro.,GTS-21,DB00046
DB01195,The metabolism of Flecainide can be increased when combined with Insulin lispro.,Flecainide,DB00046
DB00783,The metabolism of Estradiol can be increased when combined with Insulin lispro.,Estradiol,DB00046
DB00321,The metabolism of Amitriptyline can be increased when combined with Insulin lispro.,Amitriptyline,DB00046
DB00458,The metabolism of Imipramine can be increased when combined with Insulin lispro.,Imipramine,DB00046
DB01142,The metabolism of Doxepin can be increased when combined with Insulin lispro.,Doxepin,DB00046
DB00532,The metabolism of Mephenytoin can be increased when combined with Insulin lispro.,Mephenytoin,DB00046
DB00540,The metabolism of Nortriptyline can be increased when combined with Insulin lispro.,Nortriptyline,DB00046
DB00575,The metabolism of Clonidine can be increased when combined with Insulin lispro.,Clonidine,DB00046
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Insulin lispro.,Cyclobenzaprine,DB00046
DB01151,The metabolism of Desipramine can be increased when combined with Insulin lispro.,Desipramine,DB00046
DB01242,The metabolism of Clomipramine can be increased when combined with Insulin lispro.,Clomipramine,DB00046
DB11689,The metabolism of Selumetinib can be increased when combined with Insulin lispro.,Selumetinib,DB00046
DB00277,The metabolism of Theophylline can be increased when combined with Insulin lispro.,Theophylline,DB00046
DB00398,The metabolism of Sorafenib can be increased when combined with Insulin lispro.,Sorafenib,DB00046
DB00530,The metabolism of Erlotinib can be increased when combined with Insulin lispro.,Erlotinib,DB00046
DB00564,The metabolism of Carbamazepine can be increased when combined with Insulin lispro.,Carbamazepine,DB00046
DB00682,The metabolism of Warfarin can be increased when combined with Insulin lispro.,Warfarin,DB00046
DB00697,The metabolism of Tizanidine can be increased when combined with Insulin lispro.,Tizanidine,DB00046
DB00773,The metabolism of Etoposide can be increased when combined with Insulin lispro.,Etoposide,DB00046
DB00851,The metabolism of Dacarbazine can be increased when combined with Insulin lispro.,Dacarbazine,DB00046
DB01100,The metabolism of Pimozide can be increased when combined with Insulin lispro.,Pimozide,DB00046
DB01223,The metabolism of Aminophylline can be increased when combined with Insulin lispro.,Aminophylline,DB00046
DB01254,The metabolism of Dasatinib can be increased when combined with Insulin lispro.,Dasatinib,DB00046
DB01418,The metabolism of Acenocoumarol can be increased when combined with Insulin lispro.,Acenocoumarol,DB00046
DB08910,The metabolism of Pomalidomide can be increased when combined with Insulin lispro.,Pomalidomide,DB00046
DB09256,The metabolism of Tegafur can be increased when combined with Insulin lispro.,Tegafur,DB00046
DB13874,The metabolism of Enasidenib can be increased when combined with Insulin lispro.,Enasidenib,DB00046
DB00675,The metabolism of Tamoxifen can be increased when combined with Insulin lispro.,Tamoxifen,DB00046
DB00030,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin lispro.,Insulin human,DB00046
DB00047,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin glargine.,Insulin glargine,DB00046
DB00071,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin pork.,Insulin pork,DB00046
DB00197,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Troglitazone.,Troglitazone,DB00046
DB00222,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glimepiride.,Glimepiride,DB00046
DB00280,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Disopyramide.,Disopyramide,DB00046
DB00284,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Acarbose.,Acarbose,DB00046
DB00414,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Acetohexamide.,Acetohexamide,DB00046
DB00468,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Quinine.,Quinine,DB00046
DB00491,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Miglitol.,Miglitol,DB00046
DB00672,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Chlorpropamide.,Chlorpropamide,DB00046
DB00731,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Nateglinide.,Nateglinide,DB00046
DB00834,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Mifepristone.,Mifepristone,DB00046
DB00839,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Tolazamide.,Tolazamide,DB00046
DB00912,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Repaglinide.,Repaglinide,DB00046
DB00914,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Phenformin.,Phenformin,DB00046
DB01016,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glyburide.,Glyburide,DB00046
DB01067,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glipizide.,Glipizide,DB00046
DB01120,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Gliclazide.,Gliclazide,DB00046
DB01124,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Tolbutamide.,Tolbutamide,DB00046
DB01200,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Bromocriptine.,Bromocriptine,DB00046
DB01251,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Gliquidone.,Gliquidone,DB00046
DB01252,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Mitiglinide.,Mitiglinide,DB00046
DB01268,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Sunitinib.,Sunitinib,DB00046
DB01277,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Mecasermin.,Mecasermin,DB00046
DB01289,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glisoxepide.,Glisoxepide,DB00046
DB01306,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin aspart.,Insulin aspart,DB00046
DB01307,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin detemir.,Insulin detemir,DB00046
DB01309,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin glulisine.,Insulin glulisine,DB00046
DB01700,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with AICA ribonucleotide.,AICA ribonucleotide,DB00046
DB04830,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Buformin.,Buformin,DB00046
DB04878,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Voglibose.,Voglibose,DB00046
DB05115,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with NN344.,NN344,DB00046
DB05819,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with NBI-6024.,NBI-6024,DB00046
DB08962,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glibornuride.,Glibornuride,DB00046
DB09022,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Benfluorex.,Benfluorex,DB00046
DB09198,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Lobeglitazone.,Lobeglitazone,DB00046
DB09199,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Netoglitazone.,Netoglitazone,DB00046
DB09200,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Rivoglitazone.,Rivoglitazone,DB00046
DB09201,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Ciglitazone.,Ciglitazone,DB00046
DB09456,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin beef.,Insulin beef,DB00046
DB09564,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin degludec.,Insulin degludec,DB00046
DB11567,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin peglispro.,Insulin peglispro,DB00046
DB11568,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin tregopil.,Insulin tregopil,DB00046
DB11698,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Ipragliflozin.,Ipragliflozin,DB00046
DB11780,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Allicin.,Allicin,DB00046
DB11824,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Tofogliflozin.,Tofogliflozin,DB00046
DB11898,"The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with 2,4-thiazolidinedione.","2,4-thiazolidinedione",DB00046
DB12713,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Sotagliflozin.,Sotagliflozin,DB00046
DB12781,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Balaglitazone.,Balaglitazone,DB00046
DB12935,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Remogliflozin etabonate.,Remogliflozin etabonate,DB00046
DB13406,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Carbutamide.,Carbutamide,DB00046
DB13446,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Guar gum.,Guar gum,DB00046
DB13675,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Metahexamide.,Metahexamide,DB00046
DB14035,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Englitazone.,Englitazone,DB00046
DB15171,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Tirzepatide.,Tirzepatide,DB00046
DB15217,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Gastric inhibitory polypeptide.,Gastric inhibitory polypeptide,DB00046
DB00270,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin lispro.,Isradipine,DB00046
DB00343,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Insulin lispro.,Diltiazem,DB00046
DB00347,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Insulin lispro.,Trimethadione,DB00046
DB00381,The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin lispro.,Amlodipine,DB00046
DB00393,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Insulin lispro.,Nimodipine,DB00046
DB00401,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Insulin lispro.,Nisoldipine,DB00046
DB00528,The risk or severity of hypoglycemia can be increased when Lercanidipine is combined with Insulin lispro.,Lercanidipine,DB00046
DB00555,The risk or severity of hypoglycemia can be increased when Lamotrigine is combined with Insulin lispro.,Lamotrigine,DB00046
DB00593,The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Insulin lispro.,Ethosuximide,DB00046
DB00622,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Insulin lispro.,Nicardipine,DB00046
DB00653,The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin lispro.,Magnesium sulfate,DB00046
DB00836,The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin lispro.,Loperamide,DB00046
DB01054,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Insulin lispro.,Nitrendipine,DB00046
DB01074,The risk or severity of hypoglycemia can be increased when Perhexiline is combined with Insulin lispro.,Perhexiline,DB00046
DB01244,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Insulin lispro.,Bepridil,DB00046
DB01388,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Insulin lispro.,Mibefradil,DB00046
DB04743,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Insulin lispro.,Nimesulide,DB00046
DB04825,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Insulin lispro.,Prenylamine,DB00046
DB04838,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Insulin lispro.,Cyclandelate,DB00046
DB04842,The risk or severity of hypoglycemia can be increased when Fluspirilene is combined with Insulin lispro.,Fluspirilene,DB00046
DB04920,The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Insulin lispro.,Clevidipine,DB00046
DB05246,The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Insulin lispro.,Methsuximide,DB00046
DB05885,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Insulin lispro.,Seletracetam,DB00046
DB06152,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Insulin lispro.,Nylidrin,DB00046
DB06283,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Insulin lispro.,Ziconotide,DB00046
DB06446,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Insulin lispro.,Dotarizine,DB00046
DB06694,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Insulin lispro.,Xylometazoline,DB00046
DB06712,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Insulin lispro.,Nilvadipine,DB00046
DB07615,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Insulin lispro.,Tranilast,DB00046
DB08838,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Insulin lispro.,Agmatine,DB00046
DB08980,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Insulin lispro.,Fendiline,DB00046
DB08992,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Insulin lispro.,Eperisone,DB00046
DB09089,The risk or severity of hypoglycemia can be increased when Trimebutine is combined with Insulin lispro.,Trimebutine,DB00046
DB09090,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Insulin lispro.,Pinaverium,DB00046
DB09216,The risk or severity of hypoglycemia can be increased when Tolfenamic acid is combined with Insulin lispro.,Tolfenamic acid,DB00046
DB09227,The risk or severity of hypoglycemia can be increased when Barnidipine is combined with Insulin lispro.,Barnidipine,DB00046
DB09229,The risk or severity of hypoglycemia can be increased when Aranidipine is combined with Insulin lispro.,Aranidipine,DB00046
DB09230,The risk or severity of hypoglycemia can be increased when Azelnidipine is combined with Insulin lispro.,Azelnidipine,DB00046
DB09231,The risk or severity of hypoglycemia can be increased when Benidipine is combined with Insulin lispro.,Benidipine,DB00046
DB09232,The risk or severity of hypoglycemia can be increased when Cilnidipine is combined with Insulin lispro.,Cilnidipine,DB00046
DB09234,The risk or severity of hypoglycemia can be increased when Darodipine is combined with Insulin lispro.,Darodipine,DB00046
DB09235,The risk or severity of hypoglycemia can be increased when Efonidipine is combined with Insulin lispro.,Efonidipine,DB00046
DB09236,The risk or severity of hypoglycemia can be increased when Lacidipine is combined with Insulin lispro.,Lacidipine,DB00046
DB09238,The risk or severity of hypoglycemia can be increased when Manidipine is combined with Insulin lispro.,Manidipine,DB00046
DB09239,The risk or severity of hypoglycemia can be increased when Niguldipine is combined with Insulin lispro.,Niguldipine,DB00046
DB09240,The risk or severity of hypoglycemia can be increased when Niludipine is combined with Insulin lispro.,Niludipine,DB00046
DB11960,The risk or severity of hypoglycemia can be increased when Carboxyamidotriazole is combined with Insulin lispro.,Carboxyamidotriazole,DB00046
DB12092,The risk or severity of hypoglycemia can be increased when Naftopidil is combined with Insulin lispro.,Naftopidil,DB00046
DB12093,The risk or severity of hypoglycemia can be increased when Tetrahydropalmatine is combined with Insulin lispro.,Tetrahydropalmatine,DB00046
DB12131,The risk or severity of hypoglycemia can be increased when Vinpocetine is combined with Insulin lispro.,Vinpocetine,DB00046
DB12923,The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Insulin lispro.,Gallopamil,DB00046
DB13488,The risk or severity of hypoglycemia can be increased when Bencyclane is combined with Insulin lispro.,Bencyclane,DB00046
DB13500,The risk or severity of hypoglycemia can be increased when Otilonium is combined with Insulin lispro.,Otilonium,DB00046
DB13725,The risk or severity of hypoglycemia can be increased when Terodiline is combined with Insulin lispro.,Terodiline,DB00046
DB13766,The risk or severity of hypoglycemia can be increased when Lidoflazine is combined with Insulin lispro.,Lidoflazine,DB00046
DB13791,The risk or severity of hypoglycemia can be increased when Penfluridol is combined with Insulin lispro.,Penfluridol,DB00046
DB13835,The risk or severity of hypoglycemia can be increased when Caroverine is combined with Insulin lispro.,Caroverine,DB00046
DB13950,The risk or severity of hypoglycemia can be increased when WIN 55212-2 is combined with Insulin lispro.,WIN 55212-2,DB00046
DB13961,The risk or severity of hypoglycemia can be increased when Fish oil is combined with Insulin lispro.,Fish oil,DB00046
DB14063,The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Insulin lispro.,Dexverapamil,DB00046
DB14064,The risk or severity of hypoglycemia can be increased when Emopamil is combined with Insulin lispro.,Emopamil,DB00046
DB14065,The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Insulin lispro.,Lomerizine,DB00046
DB14066,The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Insulin lispro.,Tetrandrine,DB00046
DB14068,The risk or severity of hypoglycemia can be increased when Dexniguldipine is combined with Insulin lispro.,Dexniguldipine,DB00046
DB01023,The risk or severity of hypoglycemia can be increased when Felodipine is combined with Insulin lispro.,Felodipine,DB00046
DB01118,The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin lispro.,Amiodarone,DB00046
DB00191,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Phentermine.,Phentermine,DB00046
DB00268,The metabolism of Ropinirole can be increased when combined with Insulin lispro.,Ropinirole,DB00046
DB13074,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Insulin lispro.,Macimorelin,DB00046
DB00279,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Liothyronine.,Liothyronine,DB00046
DB00331,The risk or severity of adverse effects can be increased when Insulin lispro is combined with Metformin.,Metformin,DB00046
DB00542,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Insulin lispro.,Benazepril,DB00046
DB13946,The risk or severity of adverse effects can be increased when Testosterone undecanoate is combined with Insulin lispro.,Testosterone undecanoate,DB00046
DB00945,The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin lispro.,Acetylsalicylic acid,DB00046
DB00181,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Baclofen.,Baclofen,DB00046
DB00489,The risk or severity of hypoglycemia can be increased when Sotalol is combined with Insulin lispro.,Sotalol,DB00046
DB00196,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Fluconazole.,Fluconazole,DB00046
DB00040,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Glucagon.,Glucagon,DB00046
DB00264,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Metoprolol.,Metoprolol,DB00046
DB00335,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Atenolol.,Atenolol,DB00046
DB00373,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Timolol.,Timolol,DB00046
DB00598,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Labetalol.,Labetalol,DB00046
DB00612,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bisoprolol.,Bisoprolol,DB00046
DB00866,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Alprenolol.,Alprenolol,DB00046
DB00960,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Pindolol.,Pindolol,DB00046
DB01193,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Acebutolol.,Acebutolol,DB00046
DB01203,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Nadolol.,Nadolol,DB00046
DB01295,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bevantolol.,Bevantolol,DB00046
DB01297,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Practolol.,Practolol,DB00046
DB01359,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Penbutolol.,Penbutolol,DB00046
DB01580,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Oxprenolol.,Oxprenolol,DB00046
DB03322,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Dexpropranolol.,Dexpropranolol,DB00046
DB04846,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Celiprolol.,Celiprolol,DB00046
DB04861,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Nebivolol.,Nebivolol,DB00046
DB06726,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bufuralol.,Bufuralol,DB00046
DB08807,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bopindolol.,Bopindolol,DB00046
DB08808,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bupranolol.,Bupranolol,DB00046
DB08952,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Indenolol.,Indenolol,DB00046
DB09013,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Befunolol.,Befunolol,DB00046
DB09204,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Arotinolol.,Arotinolol,DB00046
DB09351,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Levobetaxolol.,Levobetaxolol,DB00046
DB11770,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Talinolol.,Talinolol,DB00046
DB11785,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Anisodamine.,Anisodamine,DB00046
DB12212,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Landiolol.,Landiolol,DB00046
DB12752,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bucindolol.,Bucindolol,DB00046
DB13443,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Esatenolol.,Esatenolol,DB00046
DB13508,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Cloranolol.,Cloranolol,DB00046
DB13530,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Mepindolol.,Mepindolol,DB00046
DB13757,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Epanolol.,Epanolol,DB00046
DB13775,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Tertatolol.,Tertatolol,DB00046
DB00195,The therapeutic efficacy of Betaxolol can be increased when used in combination with Insulin lispro.,Betaxolol,DB00046
DB00571,The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin lispro.,Propranolol,DB00046
DB01136,The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin lispro.,Carvedilol,DB00046
DB01182,The therapeutic efficacy of Propafenone can be increased when used in combination with Insulin lispro.,Propafenone,DB00046
DB01611,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Hydroxychloroquine.,Hydroxychloroquine,DB00046
DB01233,The therapeutic efficacy of Metoclopramide can be increased when used in combination with Insulin lispro.,Metoclopramide,DB00046
DB00394,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Insulin lispro.,Beclomethasone dipropionate,DB00046
DB00443,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Insulin lispro.,Betamethasone,DB00046
DB00620,The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Insulin lispro.,Triamcinolone,DB00046
DB00635,The risk or severity of hyperglycemia can be increased when Prednisone is combined with Insulin lispro.,Prednisone,DB00046
DB00687,The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Insulin lispro.,Fludrocortisone,DB00046
DB00741,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin lispro.,Hydrocortisone,DB00046
DB00764,The risk or severity of hyperglycemia can be increased when Mometasone is combined with Insulin lispro.,Mometasone,DB00046
DB00860,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Insulin lispro.,Prednisolone,DB00046
DB00959,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Insulin lispro.,Methylprednisolone,DB00046
DB01234,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin lispro.,Dexamethasone,DB00046
DB01285,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Insulin lispro.,Corticotropin,DB00046
DB01380,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Insulin lispro.,Cortisone acetate,DB00046
DB01384,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Insulin lispro.,Paramethasone,DB00046
DB01410,The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Insulin lispro.,Ciclesonide,DB00046
DB08906,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin lispro.,Fluticasone furoate,DB00046
DB08970,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin lispro.,Fluprednidene,DB00046
DB08971,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin lispro.,Fluocortolone,DB00046
DB09383,The risk or severity of hyperglycemia can be increased when Meprednisone is combined with Insulin lispro.,Meprednisone,DB00046
DB11487,The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin lispro.,Dexamethasone isonicotinate,DB00046
DB11750,The risk or severity of hyperglycemia can be increased when Clobetasol is combined with Insulin lispro.,Clobetasol,DB00046
DB11921,The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Insulin lispro.,Deflazacort,DB00046
DB13003,The risk or severity of hyperglycemia can be increased when Cortivazol is combined with Insulin lispro.,Cortivazol,DB00046
DB13208,The risk or severity of hyperglycemia can be increased when Prednylidene is combined with Insulin lispro.,Prednylidene,DB00046
DB13843,The risk or severity of hyperglycemia can be increased when Cloprednol is combined with Insulin lispro.,Cloprednol,DB00046
DB13867,The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin lispro.,Fluticasone,DB00046
DB14512,The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Insulin lispro.,Mometasone furoate,DB00046
DB00180,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Insulin lispro.,Flunisolide,DB00046
DB01108,The risk or severity of hyperglycemia can be increased when Trilostane is combined with Insulin lispro.,Trilostane,DB00046
DB01222,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin lispro.,Budesonide,DB00046
DB04630,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Insulin lispro.,Aldosterone,DB00046
DB09378,The risk or severity of hyperglycemia can be increased when Fluprednisolone is combined with Insulin lispro.,Fluprednisolone,DB00046
DB11529,The risk or severity of hyperglycemia can be increased when Melengestrol is combined with Insulin lispro.,Melengestrol,DB00046
DB14681,The risk or severity of hyperglycemia can be increased when Cortisone is combined with Insulin lispro.,Cortisone,DB00046
DB00223,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Insulin lispro.,Diflorasone,DB00046
DB00240,The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Insulin lispro.,Alclometasone,DB00046
DB00253,The risk or severity of hyperglycemia can be increased when Medrysone is combined with Insulin lispro.,Medrysone,DB00046
DB00288,The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Insulin lispro.,Amcinonide,DB00046
DB00324,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Insulin lispro.,Fluorometholone,DB00046
DB00547,The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Insulin lispro.,Desoximetasone,DB00046
DB00588,The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin lispro.,Fluticasone propionate,DB00046
DB00591,The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Insulin lispro.,Fluocinolone acetonide,DB00046
DB00596,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin lispro.,Ulobetasol,DB00046
DB00663,The risk or severity of hyperglycemia can be increased when Flumethasone is combined with Insulin lispro.,Flumethasone,DB00046
DB00838,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Insulin lispro.,Clocortolone,DB00046
DB00846,The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Insulin lispro.,Flurandrenolide,DB00046
DB14596,The risk or severity of hyperglycemia can be increased when Loteprednol etabonate is combined with Insulin lispro.,Loteprednol etabonate,DB00046
DB00896,The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Insulin lispro.,Rimexolone,DB00046
DB01013,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Insulin lispro.,Clobetasol propionate,DB00046
DB01047,The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Insulin lispro.,Fluocinonide,DB00046
DB01130,The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Insulin lispro.,Prednicarbate,DB00046
DB01260,The risk or severity of hyperglycemia can be increased when Desonide is combined with Insulin lispro.,Desonide,DB00046
DB06781,The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Insulin lispro.,Difluprednate,DB00046
DB06786,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin lispro.,Halcinonide,DB00046
DB09091,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Insulin lispro.,Tixocortol,DB00046
DB09095,The risk or severity of hyperglycemia can be increased when Difluocortolone is combined with Insulin lispro.,Difluocortolone,DB00046
DB13158,The risk or severity of hyperglycemia can be increased when Clobetasone is combined with Insulin lispro.,Clobetasone,DB00046
DB13223,The risk or severity of hyperglycemia can be increased when Fluocortin is combined with Insulin lispro.,Fluocortin,DB00046
DB13491,The risk or severity of hyperglycemia can be increased when Fluperolone is combined with Insulin lispro.,Fluperolone,DB00046
DB13664,The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin lispro.,Formocortal,DB00046
DB13728,The risk or severity of hyperglycemia can be increased when Halometasone is combined with Insulin lispro.,Halometasone,DB00046
DB13856,The risk or severity of hyperglycemia can be increased when Fluclorolone is combined with Insulin lispro.,Fluclorolone,DB00046
DB14538,The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Insulin lispro.,Hydrocortisone aceponate,DB00046
DB14539,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin lispro.,Hydrocortisone acetate,DB00046
DB14540,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin lispro.,Hydrocortisone butyrate,DB00046
DB14541,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin lispro.,Hydrocortisone cypionate,DB00046
DB14543,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin lispro.,Hydrocortisone probutate,DB00046
DB14544,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin lispro.,Hydrocortisone valerate,DB00046
DB14545,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin lispro.,Hydrocortisone succinate,DB00046
DB00873,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Insulin lispro.,Loteprednol,DB00046
DB14631,The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Insulin lispro.,Prednisolone phosphate,DB00046
DB14633,The risk or severity of hyperglycemia can be increased when Prednisolone hemisuccinate is combined with Insulin lispro.,Prednisolone hemisuccinate,DB00046
DB14634,The risk or severity of hyperglycemia can be increased when Fluprednidene acetate is combined with Insulin lispro.,Fluprednidene acetate,DB00046
DB14643,The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Insulin lispro.,Methylprednisolone aceponate,DB00046
DB14644,The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Insulin lispro.,Methylprednisolone hemisuccinate,DB00046
DB14646,The risk or severity of hyperglycemia can be increased when Prednisone acetate is combined with Insulin lispro.,Prednisone acetate,DB00046
DB14652,The risk or severity of hyperglycemia can be increased when Clocortolone acetate is combined with Insulin lispro.,Clocortolone acetate,DB00046
DB14659,The risk or severity of hyperglycemia can be increased when Melengestrol acetate is combined with Insulin lispro.,Melengestrol acetate,DB00046
DB14669,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Insulin lispro.,Betamethasone phosphate,DB00046
DB15566,The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Insulin lispro.,Prednisolone acetate,DB00046
DB00451,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Levothyroxine.,Levothyroxine,DB00046
DB00024,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin lispro.,Thyrotropin alfa,DB00046
DB01583,Liotrix may decrease the hypoglycemic activities of Insulin lispro.,Liotrix,DB00046
DB03604,Tiratricol may decrease the hypoglycemic activities of Insulin lispro.,Tiratricol,DB00046
DB09100,"Thyroid, porcine may decrease the hypoglycemic activities of Insulin lispro.","Thyroid, porcine",DB00046
DB06655,Liraglutide may increase the hypoglycemic activities of Insulin glargine.,Liraglutide,DB00047
DB09046,Metreleptin may increase the hypoglycemic activities of Insulin glargine.,Metreleptin,DB00047
DB00082,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Insulin glargine.,Pegvisomant,DB00047
DB01132,The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin glargine.,Pioglitazone,DB00047
DB01278,Pramlintide may increase the hypoglycemic activities of Insulin glargine.,Pramlintide,DB00047
DB00412,The risk or severity of congestive heart failure can be increased when Insulin glargine is combined with Rosiglitazone.,Rosiglitazone,DB00047
DB00166,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Insulin glargine.,Lipoic acid,DB00047
DB00974,Edetic acid may increase the hypoglycemic activities of Insulin glargine.,Edetic acid,DB00047
DB00187,Esmolol may increase the hypoglycemic activities of Insulin glargine.,Esmolol,DB00047
DB01044,The therapeutic efficacy of Gatifloxacin can be increased when used in combination with Insulin glargine.,Gatifloxacin,DB00047
DB00218,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Moxifloxacin.,Moxifloxacin,DB00047
DB00467,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Enoxacin.,Enoxacin,DB00047
DB00487,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Pefloxacin.,Pefloxacin,DB00047
DB00537,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ciprofloxacin.,Ciprofloxacin,DB00047
DB00685,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Trovafloxacin.,Trovafloxacin,DB00047
DB00779,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Nalidixic acid.,Nalidixic acid,DB00047
DB00817,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Rosoxacin.,Rosoxacin,DB00047
DB00827,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Cinoxacin.,Cinoxacin,DB00047
DB01059,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Norfloxacin.,Norfloxacin,DB00047
DB01137,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Levofloxacin.,Levofloxacin,DB00047
DB01155,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Gemifloxacin.,Gemifloxacin,DB00047
DB01165,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ofloxacin.,Ofloxacin,DB00047
DB01208,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sparfloxacin.,Sparfloxacin,DB00047
DB04576,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Fleroxacin.,Fleroxacin,DB00047
DB05488,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,Technetium Tc-99m ciprofloxacin,DB00047
DB06160,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Garenoxacin.,Garenoxacin,DB00047
DB06600,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Nemonoxacin.,Nemonoxacin,DB00047
DB08972,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Flumequine.,Flumequine,DB00047
DB11404,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Enrofloxacin.,Enrofloxacin,DB00047
DB11443,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Orbifloxacin.,Orbifloxacin,DB00047
DB11491,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sarafloxacin.,Sarafloxacin,DB00047
DB11511,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Difloxacin.,Difloxacin,DB00047
DB11774,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Pazufloxacin.,Pazufloxacin,DB00047
DB11892,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Prulifloxacin.,Prulifloxacin,DB00047
DB11943,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Delafloxacin.,Delafloxacin,DB00047
DB13261,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sitafloxacin.,Sitafloxacin,DB00047
DB13627,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Oxolinic acid.,Oxolinic acid,DB00047
DB13772,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Rufloxacin.,Rufloxacin,DB00047
DB13823,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Pipemidic acid.,Pipemidic acid,DB00047
DB00232,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Methyclothiazide.,Methyclothiazide,DB00047
DB00310,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Chlorthalidone.,Chlorthalidone,DB00047
DB00436,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide,DB00047
DB00524,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Metolazone.,Metolazone,DB00047
DB00562,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Benzthiazide.,Benzthiazide,DB00047
DB00774,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide,DB00047
DB00808,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Indapamide.,Indapamide,DB00047
DB00880,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Chlorothiazide.,Chlorothiazide,DB00047
DB00999,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide,DB00047
DB01021,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide,DB00047
DB01324,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Polythiazide.,Polythiazide,DB00047
DB01325,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Quinethazone.,Quinethazone,DB00047
DB13532,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide,DB00047
DB13989,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Epitizide.,Epitizide,DB00047
DB00344,Protriptyline may decrease the hypoglycemic activities of Insulin glargine.,Protriptyline,DB00047
DB00543,Amoxapine may decrease the hypoglycemic activities of Insulin glargine.,Amoxapine,DB00047
DB00726,Trimipramine may decrease the hypoglycemic activities of Insulin glargine.,Trimipramine,DB00047
DB04836,Amineptine may decrease the hypoglycemic activities of Insulin glargine.,Amineptine,DB00047
DB08996,Dimetacrine may decrease the hypoglycemic activities of Insulin glargine.,Dimetacrine,DB00047
DB09016,Butriptyline may decrease the hypoglycemic activities of Insulin glargine.,Butriptyline,DB00047
DB09167,Dosulepin may decrease the hypoglycemic activities of Insulin glargine.,Dosulepin,DB00047
DB09289,Tianeptine may decrease the hypoglycemic activities of Insulin glargine.,Tianeptine,DB00047
DB09307,Oxaprotiline may decrease the hypoglycemic activities of Insulin glargine.,Oxaprotiline,DB00047
DB12930,Opipramol may decrease the hypoglycemic activities of Insulin glargine.,Opipramol,DB00047
DB13114,Amitriptylinoxide may decrease the hypoglycemic activities of Insulin glargine.,Amitriptylinoxide,DB00047
DB13225,Dibenzepin may decrease the hypoglycemic activities of Insulin glargine.,Dibenzepin,DB00047
DB13246,Quinupramine may decrease the hypoglycemic activities of Insulin glargine.,Quinupramine,DB00047
DB13384,Melitracen may decrease the hypoglycemic activities of Insulin glargine.,Melitracen,DB00047
DB13411,Lofepramine may decrease the hypoglycemic activities of Insulin glargine.,Lofepramine,DB00047
DB13496,Iprindole may decrease the hypoglycemic activities of Insulin glargine.,Iprindole,DB00047
DB13782,Imipramine oxide may decrease the hypoglycemic activities of Insulin glargine.,Imipramine oxide,DB00047
DB06292,Dapagliflozin may increase the hypoglycemic activities of Insulin glargine.,Dapagliflozin,DB00047
DB08907,Canagliflozin may increase the hypoglycemic activities of Insulin glargine.,Canagliflozin,DB00047
DB00007,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Leuprolide.,Leuprolide,DB00047
DB00014,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Goserelin.,Goserelin,DB00047
DB00104,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Octreotide.,Octreotide,DB00047
DB00214,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Torasemide.,Torasemide,DB00047
DB00220,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Nelfinavir.,Nelfinavir,DB00047
DB00224,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Indinavir.,Indinavir,DB00047
DB00246,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ziprasidone.,Ziprasidone,DB00047
DB00294,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Etonogestrel.,Etonogestrel,DB00047
DB00304,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Desogestrel.,Desogestrel,DB00047
DB00334,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Olanzapine.,Olanzapine,DB00047
DB00351,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Megestrol acetate.,Megestrol acetate,DB00047
DB00363,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Clozapine.,Clozapine,DB00047
DB00367,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Levonorgestrel.,Levonorgestrel,DB00047
DB00396,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Progesterone.,Progesterone,DB00047
DB00477,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Chlorpromazine.,Chlorpromazine,DB00047
DB00502,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Haloperidol.,Haloperidol,DB00047
DB00503,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ritonavir.,Ritonavir,DB00047
DB00592,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Piperazine.,Piperazine,DB00047
DB00603,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Medroxyprogesterone acetate.,Medroxyprogesterone acetate,DB00047
DB00606,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Cyclothiazide.,Cyclothiazide,DB00047
DB00627,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Niacin.,Niacin,DB00047
DB00668,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Epinephrine.,Epinephrine,DB00047
DB00695,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Furosemide.,Furosemide,DB00047
DB00717,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Norethisterone.,Norethisterone,DB00047
DB00734,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Risperidone.,Risperidone,DB00047
DB00738,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Pentamidine.,Pentamidine,DB00047
DB00823,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ethynodiol diacetate.,Ethynodiol diacetate,DB00047
DB00852,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Pseudoephedrine.,Pseudoephedrine,DB00047
DB00864,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Tacrolimus.,Tacrolimus,DB00047
DB00877,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Sirolimus.,Sirolimus,DB00047
DB00887,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Bumetanide.,Bumetanide,DB00047
DB00903,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Etacrynic acid.,Etacrynic acid,DB00047
DB00932,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Tipranavir.,Tipranavir,DB00047
DB00957,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Norgestimate.,Norgestimate,DB00047
DB00977,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ethinylestradiol.,Ethinylestradiol,DB00047
DB01072,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Atazanavir.,Atazanavir,DB00047
DB01119,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Diazoxide.,Diazoxide,DB00047
DB01169,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Arsenic trioxide.,Arsenic trioxide,DB00047
DB01224,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Quetiapine.,Quetiapine,DB00047
DB01232,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Saquinavir.,Saquinavir,DB00047
DB01238,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Aripiprazole.,Aripiprazole,DB00047
DB01264,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Darunavir.,Darunavir,DB00047
DB01267,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Paliperidone.,Paliperidone,DB00047
DB01319,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Fosamprenavir.,Fosamprenavir,DB00047
DB01323,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with St. John's Wort.,St. John's Wort,DB00047
DB01357,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Mestranol.,Mestranol,DB00047
DB01363,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ephedra sinica root.,Ephedra sinica root,DB00047
DB01395,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Drospirenone.,Drospirenone,DB00047
DB01403,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Methotrimeprazine.,Methotrimeprazine,DB00047
DB01406,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Danazol.,Danazol,DB00047
DB01590,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Everolimus.,Everolimus,DB00047
DB01601,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Lopinavir.,Lopinavir,DB00047
DB01621,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Pipotiazine.,Pipotiazine,DB00047
DB02546,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Vorinostat.,Vorinostat,DB00047
DB04574,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Estrone sulfate.,Estrone sulfate,DB00047
DB04839,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Cyproterone acetate.,Cyproterone acetate,DB00047
DB04868,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Nilotinib.,Nilotinib,DB00047
DB04946,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Iloperidone.,Iloperidone,DB00047
DB06216,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Asenapine.,Asenapine,DB00047
DB06287,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Temsirolimus.,Temsirolimus,DB00047
DB06663,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Pasireotide.,Pasireotide,DB00047
DB06719,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Buserelin.,Buserelin,DB00047
DB06788,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Histrelin.,Histrelin,DB00047
DB06789,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Hydroxyprogesterone caproate.,Hydroxyprogesterone caproate,DB00047
DB06791,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Lanreotide.,Lanreotide,DB00047
DB06825,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Triptorelin.,Triptorelin,DB00047
DB08815,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Lurasidone.,Lurasidone,DB00047
DB08912,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Dabrafenib.,Dabrafenib,DB00047
DB09009,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Articaine.,Articaine,DB00047
DB09063,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ceritinib.,Ceritinib,DB00047
DB09123,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Dienogest.,Dienogest,DB00047
DB09128,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Brexpiprazole.,Brexpiprazole,DB00047
DB13430,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Mebutizide.,Mebutizide,DB00047
DB06343,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Teprotumumab.,Teprotumumab,DB00047
DB00621,Oxandrolone may increase the hypoglycemic activities of Insulin glargine.,Oxandrolone,DB00047
DB00624,Testosterone may increase the hypoglycemic activities of Insulin glargine.,Testosterone,DB00047
DB00984,Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin glargine.,Nandrolone phenpropionate,DB00047
DB01185,Fluoxymesterone may increase the hypoglycemic activities of Insulin glargine.,Fluoxymesterone,DB00047
DB01420,Testosterone propionate may increase the hypoglycemic activities of Insulin glargine.,Testosterone propionate,DB00047
DB02901,Stanolone may increase the hypoglycemic activities of Insulin glargine.,Stanolone,DB00047
DB06412,Oxymetholone may increase the hypoglycemic activities of Insulin glargine.,Oxymetholone,DB00047
DB06710,Methyltestosterone may increase the hypoglycemic activities of Insulin glargine.,Methyltestosterone,DB00047
DB06718,Stanozolol may increase the hypoglycemic activities of Insulin glargine.,Stanozolol,DB00047
DB08804,Nandrolone decanoate may increase the hypoglycemic activities of Insulin glargine.,Nandrolone decanoate,DB00047
DB12461,GLPG-0492 may increase the hypoglycemic activities of Insulin glargine.,GLPG-0492,DB00047
DB13169,Nandrolone may increase the hypoglycemic activities of Insulin glargine.,Nandrolone,DB00047
DB13587,Mesterolone may increase the hypoglycemic activities of Insulin glargine.,Mesterolone,DB00047
DB13943,Testosterone cypionate may increase the hypoglycemic activities of Insulin glargine.,Testosterone cypionate,DB00047
DB13944,Testosterone enanthate may increase the hypoglycemic activities of Insulin glargine.,Testosterone enanthate,DB00047
DB00215,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Citalopram.,Citalopram,DB00047
DB00230,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Pregabalin.,Pregabalin,DB00047
DB00285,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Venlafaxine.,Venlafaxine,DB00047
DB00328,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Indomethacin.,Indomethacin,DB00047
DB01104,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Sertraline.,Sertraline,DB00047
DB01149,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Nefazodone.,Nefazodone,DB00047
DB01175,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Escitalopram.,Escitalopram,DB00047
DB04832,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Zimelidine.,Zimelidine,DB00047
DB04884,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Dapoxetine.,Dapoxetine,DB00047
DB04896,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Milnacipran.,Milnacipran,DB00047
DB06700,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Desvenlafaxine.,Desvenlafaxine,DB00047
DB08918,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Levomilnacipran.,Levomilnacipran,DB00047
DB08953,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Indalpine.,Indalpine,DB00047
DB09270,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Ubidecarenone.,Ubidecarenone,DB00047
DB12693,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Ritanserin.,Ritanserin,DB00047
DB13233,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Alaproclate.,Alaproclate,DB00047
DB13358,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Cibenzoline.,Cibenzoline,DB00047
DB14025,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Clinafloxacin.,Clinafloxacin,DB00047
DB09038,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Empagliflozin.,Empagliflozin,DB00047
DB00233,Aminosalicylic acid may increase the hypoglycemic activities of Insulin glargine.,Aminosalicylic acid,DB00047
DB00244,Mesalazine may increase the hypoglycemic activities of Insulin glargine.,Mesalazine,DB00047
DB00795,Sulfasalazine may increase the hypoglycemic activities of Insulin glargine.,Sulfasalazine,DB00047
DB00861,Diflunisal may increase the hypoglycemic activities of Insulin glargine.,Diflunisal,DB00047
DB00936,Salicylic acid may increase the hypoglycemic activities of Insulin glargine.,Salicylic acid,DB00047
DB01014,Balsalazide may increase the hypoglycemic activities of Insulin glargine.,Balsalazide,DB00047
DB01250,Olsalazine may increase the hypoglycemic activities of Insulin glargine.,Olsalazine,DB00047
DB01294,Bismuth subsalicylate may increase the hypoglycemic activities of Insulin glargine.,Bismuth subsalicylate,DB00047
DB06251,Dersalazine may increase the hypoglycemic activities of Insulin glargine.,Dersalazine,DB00047
DB06807,Phenyl aminosalicylate may increase the hypoglycemic activities of Insulin glargine.,Phenyl aminosalicylate,DB00047
DB09543,Methyl salicylate may increase the hypoglycemic activities of Insulin glargine.,Methyl salicylate,DB00047
DB11079,Trolamine salicylate may increase the hypoglycemic activities of Insulin glargine.,Trolamine salicylate,DB00047
DB12445,Nitroaspirin may increase the hypoglycemic activities of Insulin glargine.,Nitroaspirin,DB00047
DB13509,Aloxiprin may increase the hypoglycemic activities of Insulin glargine.,Aloxiprin,DB00047
DB13538,Guacetisal may increase the hypoglycemic activities of Insulin glargine.,Guacetisal,DB00047
DB13612,Carbaspirin calcium may increase the hypoglycemic activities of Insulin glargine.,Carbaspirin calcium,DB00047
DB14006,Choline salicylate may increase the hypoglycemic activities of Insulin glargine.,Choline salicylate,DB00047
DB14026,Thiosalicylic acid may increase the hypoglycemic activities of Insulin glargine.,Thiosalicylic acid,DB00047
DB01261,Sitagliptin may increase the hypoglycemic activities of Insulin glargine.,Sitagliptin,DB00047
DB04876,Vildagliptin may increase the hypoglycemic activities of Insulin glargine.,Vildagliptin,DB00047
DB06011,AMG-222 may increase the hypoglycemic activities of Insulin glargine.,AMG-222,DB00047
DB06127,Bisegliptin may increase the hypoglycemic activities of Insulin glargine.,Bisegliptin,DB00047
DB06203,Alogliptin may increase the hypoglycemic activities of Insulin glargine.,Alogliptin,DB00047
DB06335,Saxagliptin may increase the hypoglycemic activities of Insulin glargine.,Saxagliptin,DB00047
DB08382,Gosogliptin may increase the hypoglycemic activities of Insulin glargine.,Gosogliptin,DB00047
DB08882,Linagliptin may increase the hypoglycemic activities of Insulin glargine.,Linagliptin,DB00047
DB11723,Dutogliptin may increase the hypoglycemic activities of Insulin glargine.,Dutogliptin,DB00047
DB11950,Teneligliptin may increase the hypoglycemic activities of Insulin glargine.,Teneligliptin,DB00047
DB11992,Omarigliptin may increase the hypoglycemic activities of Insulin glargine.,Omarigliptin,DB00047
DB12268,Carmegliptin may increase the hypoglycemic activities of Insulin glargine.,Carmegliptin,DB00047
DB12412,Gemigliptin may increase the hypoglycemic activities of Insulin glargine.,Gemigliptin,DB00047
DB12417,Anagliptin may increase the hypoglycemic activities of Insulin glargine.,Anagliptin,DB00047
DB12625,Evogliptin may increase the hypoglycemic activities of Insulin glargine.,Evogliptin,DB00047
DB01276,Exenatide may increase the hypoglycemic activities of Insulin glargine.,Exenatide,DB00047
DB09043,Albiglutide may increase the hypoglycemic activities of Insulin glargine.,Albiglutide,DB00047
DB09045,Dulaglutide may increase the hypoglycemic activities of Insulin glargine.,Dulaglutide,DB00047
DB13928,Semaglutide may increase the hypoglycemic activities of Insulin glargine.,Semaglutide,DB00047
DB14027,Taspoglutide may increase the hypoglycemic activities of Insulin glargine.,Taspoglutide,DB00047
DB00752,Tranylcypromine may increase the hypoglycemic activities of Insulin glargine.,Tranylcypromine,DB00047
DB00780,Phenelzine may increase the hypoglycemic activities of Insulin glargine.,Phenelzine,DB00047
DB01171,Moclobemide may increase the hypoglycemic activities of Insulin glargine.,Moclobemide,DB00047
DB01247,Isocarboxazid may increase the hypoglycemic activities of Insulin glargine.,Isocarboxazid,DB00047
DB01626,Pargyline may increase the hypoglycemic activities of Insulin glargine.,Pargyline,DB00047
DB00805,Minaprine may increase the hypoglycemic activities of Insulin glargine.,Minaprine,DB00047
DB04818,Iproniazid may increase the hypoglycemic activities of Insulin glargine.,Iproniazid,DB00047
DB04820,Nialamide may increase the hypoglycemic activities of Insulin glargine.,Nialamide,DB00047
DB09244,Pirlindole may increase the hypoglycemic activities of Insulin glargine.,Pirlindole,DB00047
DB09245,Toloxatone may increase the hypoglycemic activities of Insulin glargine.,Toloxatone,DB00047
DB09243,Hydracarbazine may increase the hypoglycemic activities of Insulin glargine.,Hydracarbazine,DB00047
DB09241,Methylene blue may increase the hypoglycemic activities of Insulin glargine.,Methylene blue,DB00047
DB09246,Benmoxin may increase the hypoglycemic activities of Insulin glargine.,Benmoxin,DB00047
DB09248,Mebanazine may increase the hypoglycemic activities of Insulin glargine.,Mebanazine,DB00047
DB09249,Octamoxin may increase the hypoglycemic activities of Insulin glargine.,Octamoxin,DB00047
DB09250,Pheniprazine may increase the hypoglycemic activities of Insulin glargine.,Pheniprazine,DB00047
DB09251,Phenoxypropazine may increase the hypoglycemic activities of Insulin glargine.,Phenoxypropazine,DB00047
DB09252,Pivhydrazine may increase the hypoglycemic activities of Insulin glargine.,Pivhydrazine,DB00047
DB09253,Safrazine may increase the hypoglycemic activities of Insulin glargine.,Safrazine,DB00047
DB09254,Caroxazone may increase the hypoglycemic activities of Insulin glargine.,Caroxazone,DB00047
DB00614,Furazolidone may increase the hypoglycemic activities of Insulin glargine.,Furazolidone,DB00047
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Insulin glargine.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",DB00047
DB13875,Harmaline may increase the hypoglycemic activities of Insulin glargine.,Harmaline,DB00047
DB13876,Brofaromine may increase the hypoglycemic activities of Insulin glargine.,Brofaromine,DB00047
DB00721,Procaine may increase the hypoglycemic activities of Insulin glargine.,Procaine,DB00047
DB00182,Amphetamine may increase the hypoglycemic activities of Insulin glargine.,Amphetamine,DB00047
DB01168,Procarbazine may increase the hypoglycemic activities of Insulin glargine.,Procarbazine,DB00047
DB00601,Linezolid may increase the hypoglycemic activities of Insulin glargine.,Linezolid,DB00047
DB06654,Safinamide may increase the hypoglycemic activities of Insulin glargine.,Safinamide,DB00047
DB04017,Clorgiline may increase the hypoglycemic activities of Insulin glargine.,Clorgiline,DB00047
DB11827,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ertugliflozin.,Ertugliflozin,DB00047
DB00203,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sildenafil.,Sildenafil,DB00047
DB00263,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfisoxazole.,Sulfisoxazole,DB00047
DB00311,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ethoxzolamide.,Ethoxzolamide,DB00047
DB00359,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfadiazine.,Sulfadiazine,DB00047
DB00482,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Celecoxib.,Celecoxib,DB00047
DB00559,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bosentan.,Bosentan,DB00047
DB00576,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamethizole.,Sulfamethizole,DB00047
DB00664,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfametopyrazine.,Sulfametopyrazine,DB00047
DB00669,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sumatriptan.,Sumatriptan,DB00047
DB00706,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Tamsulosin.,Tamsulosin,DB00047
DB00819,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Acetazolamide.,Acetazolamide,DB00047
DB00891,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfapyridine.,Sulfapyridine,DB00047
DB00909,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Zonisamide.,Zonisamide,DB00047
DB01015,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamethoxazole.,Sulfamethoxazole,DB00047
DB01032,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Probenecid.,Probenecid,DB00047
DB01144,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Diclofenamide.,Diclofenamide,DB00047
DB01298,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfacytine.,Sulfacytine,DB00047
DB01299,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfadoxine.,Sulfadoxine,DB00047
DB01382,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Glymidine.,Glymidine,DB00047
DB01581,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamerazine.,Sulfamerazine,DB00047
DB01582,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamethazine.,Sulfamethazine,DB00047
DB02925,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Piretanide.,Piretanide,DB00047
DB04707,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Hydroxyfasudil.,Hydroxyfasudil,DB00047
DB06150,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfadimethoxine.,Sulfadimethoxine,DB00047
DB06290,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Simeprevir.,Simeprevir,DB00047
DB06729,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaphenazole.,Sulfaphenazole,DB00047
DB06821,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfameter.,Sulfameter,DB00047
DB07996,The therapeutic efficacy of Insulin glargine can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,DB00047
DB08162,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Fasudil.,Fasudil,DB00047
DB08798,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamoxole.,Sulfamoxole,DB00047
DB08881,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Vemurafenib.,Vemurafenib,DB00047
DB08961,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Azosemide.,Azosemide,DB00047
DB11389,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Clorsulon.,Clorsulon,DB00047
DB11461,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfachlorpyridazine.,Sulfachlorpyridazine,DB00047
DB11462,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaethoxypyridazine.,Sulfaethoxypyridazine,DB00047
DB11463,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfanitran.,Sulfanitran,DB00047
DB11464,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaquinoxaline.,Sulfaquinoxaline,DB00047
DB12051,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Setrobuvir.,Setrobuvir,DB00047
DB12921,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Chlorsulfaquinoxaline.,Chlorsulfaquinoxaline,DB00047
DB13214,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfadicramide.,Sulfadicramide,DB00047
DB13248,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Phthalylsulfathiazole.,Phthalylsulfathiazole,DB00047
DB13283,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaisodimidine.,Sulfaisodimidine,DB00047
DB13284,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Meticrane.,Meticrane,DB00047
DB13320,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaperin.,Sulfaperin,DB00047
DB13405,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Mefruside.,Mefruside,DB00047
DB13485,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfametomidine.,Sulfametomidine,DB00047
DB13547,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfatolamide.,Sulfatolamide,DB00047
DB13556,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamazone.,Sulfamazone,DB00047
DB13580,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Succinylsulfathiazole.,Succinylsulfathiazole,DB00047
DB13617,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Clorexolone.,Clorexolone,DB00047
DB13663,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Clofenamide.,Clofenamide,DB00047
DB13699,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfathiourea.,Sulfathiourea,DB00047
DB13708,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Fenquizone.,Fenquizone,DB00047
DB13726,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaguanidine.,Sulfaguanidine,DB00047
DB13773,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamethoxypyridazine.,Sulfamethoxypyridazine,DB00047
DB13792,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Clopamide.,Clopamide,DB00047
DB13803,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Xipamide.,Xipamide,DB00047
DB14033,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Acetyl sulfisoxazole.,Acetyl sulfisoxazole,DB00047
DB14708,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Tosylchloramide.,Tosylchloramide,DB00047
DB01098,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Rosuvastatin.,Rosuvastatin,DB00047
DB00703,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Methazolamide.,Methazolamide,DB00047
DB06370,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Indisulam.,Indisulam,DB00047
DB00176,The metabolism of Fluvoxamine can be increased when combined with Insulin glargine.,Fluvoxamine,DB00047
DB00184,The metabolism of Nicotine can be increased when combined with Insulin glargine.,Nicotine,DB00047
DB00188,The metabolism of Bortezomib can be increased when combined with Insulin glargine.,Bortezomib,DB00047
DB00201,The metabolism of Caffeine can be increased when combined with Insulin glargine.,Caffeine,DB00047
DB00261,The metabolism of Anagrelide can be increased when combined with Insulin glargine.,Anagrelide,DB00047
DB00262,The metabolism of Carmustine can be increased when combined with Insulin glargine.,Carmustine,DB00047
DB00281,The metabolism of Lidocaine can be increased when combined with Insulin glargine.,Lidocaine,DB00047
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Insulin glargine.,Conjugated estrogens,DB00047
DB00296,The metabolism of Ropivacaine can be increased when combined with Insulin glargine.,Ropivacaine,DB00047
DB00315,The metabolism of Zolmitriptan can be increased when combined with Insulin glargine.,Zolmitriptan,DB00047
DB00316,The metabolism of Acetaminophen can be increased when combined with Insulin glargine.,Acetaminophen,DB00047
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Insulin glargine.,Chlorzoxazone,DB00047
DB00365,The metabolism of Grepafloxacin can be increased when combined with Insulin glargine.,Grepafloxacin,DB00047
DB00370,The metabolism of Mirtazapine can be increased when combined with Insulin glargine.,Mirtazapine,DB00047
DB00379,The metabolism of Mexiletine can be increased when combined with Insulin glargine.,Mexiletine,DB00047
DB00382,The metabolism of Tacrine can be increased when combined with Insulin glargine.,Tacrine,DB00047
DB00384,The metabolism of Triamterene can be increased when combined with Insulin glargine.,Triamterene,DB00047
DB00420,The metabolism of Promazine can be increased when combined with Insulin glargine.,Promazine,DB00047
DB00425,The metabolism of Zolpidem can be increased when combined with Insulin glargine.,Zolpidem,DB00047
DB00442,The metabolism of Entecavir can be increased when combined with Insulin glargine.,Entecavir,DB00047
DB00461,The metabolism of Nabumetone can be increased when combined with Insulin glargine.,Nabumetone,DB00047
DB00472,The metabolism of Fluoxetine can be increased when combined with Insulin glargine.,Fluoxetine,DB00047
DB00476,The metabolism of Duloxetine can be increased when combined with Insulin glargine.,Duloxetine,DB00047
DB00499,The metabolism of Flutamide can be increased when combined with Insulin glargine.,Flutamide,DB00047
DB00518,The metabolism of Albendazole can be increased when combined with Insulin glargine.,Albendazole,DB00047
DB00533,The metabolism of Rofecoxib can be increased when combined with Insulin glargine.,Rofecoxib,DB00047
DB00544,The metabolism of Fluorouracil can be increased when combined with Insulin glargine.,Fluorouracil,DB00047
DB00568,The metabolism of Cinnarizine can be increased when combined with Insulin glargine.,Cinnarizine,DB00047
DB00586,The metabolism of Diclofenac can be increased when combined with Insulin glargine.,Diclofenac,DB00047
DB00619,The metabolism of Imatinib can be increased when combined with Insulin glargine.,Imatinib,DB00047
DB00629,The metabolism of Guanabenz can be increased when combined with Insulin glargine.,Guanabenz,DB00047
DB00642,The metabolism of Pemetrexed can be increased when combined with Insulin glargine.,Pemetrexed,DB00047
DB00661,The metabolism of Verapamil can be increased when combined with Insulin glargine.,Verapamil,DB00047
DB00715,The metabolism of Paroxetine can be increased when combined with Insulin glargine.,Paroxetine,DB00047
DB00730,The metabolism of Thiabendazole can be increased when combined with Insulin glargine.,Thiabendazole,DB00047
DB00740,The metabolism of Riluzole can be increased when combined with Insulin glargine.,Riluzole,DB00047
DB00744,The metabolism of Zileuton can be increased when combined with Insulin glargine.,Zileuton,DB00047
DB00758,The metabolism of Clopidogrel can be increased when combined with Insulin glargine.,Clopidogrel,DB00047
DB00787,The metabolism of Acyclovir can be increased when combined with Insulin glargine.,Acyclovir,DB00047
DB00788,The metabolism of Naproxen can be increased when combined with Insulin glargine.,Naproxen,DB00047
DB00806,The metabolism of Pentoxifylline can be increased when combined with Insulin glargine.,Pentoxifylline,DB00047
DB00831,The metabolism of Trifluoperazine can be increased when combined with Insulin glargine.,Trifluoperazine,DB00047
DB00850,The metabolism of Perphenazine can be increased when combined with Insulin glargine.,Perphenazine,DB00047
DB00857,The metabolism of Terbinafine can be increased when combined with Insulin glargine.,Terbinafine,DB00047
DB00863,The metabolism of Ranitidine can be increased when combined with Insulin glargine.,Ranitidine,DB00047
DB00898,The metabolism of Ethanol can be increased when combined with Insulin glargine.,Ethanol,DB00047
DB00934,The metabolism of Maprotiline can be increased when combined with Insulin glargine.,Maprotiline,DB00047
DB00969,The metabolism of Alosetron can be increased when combined with Insulin glargine.,Alosetron,DB00047
DB00978,The metabolism of Lomefloxacin can be increased when combined with Insulin glargine.,Lomefloxacin,DB00047
DB00980,The metabolism of Ramelteon can be increased when combined with Insulin glargine.,Ramelteon,DB00047
DB00993,The metabolism of Azathioprine can be increased when combined with Insulin glargine.,Azathioprine,DB00047
DB00998,The metabolism of Frovatriptan can be increased when combined with Insulin glargine.,Frovatriptan,DB00047
DB01002,The metabolism of Levobupivacaine can be increased when combined with Insulin glargine.,Levobupivacaine,DB00047
DB01012,The metabolism of Cinacalcet can be increased when combined with Insulin glargine.,Cinacalcet,DB00047
DB01037,The metabolism of Selegiline can be increased when combined with Insulin glargine.,Selegiline,DB00047
DB01056,The metabolism of Tocainide can be increased when combined with Insulin glargine.,Tocainide,DB00047
DB01058,The metabolism of Praziquantel can be increased when combined with Insulin glargine.,Praziquantel,DB00047
DB01065,The metabolism of Melatonin can be increased when combined with Insulin glargine.,Melatonin,DB00047
DB01087,The metabolism of Primaquine can be increased when combined with Insulin glargine.,Primaquine,DB00047
DB01094,The metabolism of Hesperetin can be increased when combined with Insulin glargine.,Hesperetin,DB00047
DB01097,The metabolism of Leflunomide can be increased when combined with Insulin glargine.,Leflunomide,DB00047
DB01166,The metabolism of Cilostazol can be increased when combined with Insulin glargine.,Cilostazol,DB00047
DB01184,The metabolism of Domperidone can be increased when combined with Insulin glargine.,Domperidone,DB00047
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Insulin glargine.,Dexfenfluramine,DB00047
DB01303,The metabolism of Oxtriphylline can be increased when combined with Insulin glargine.,Oxtriphylline,DB00047
DB01367,The metabolism of Rasagiline can be increased when combined with Insulin glargine.,Rasagiline,DB00047
DB01405,The metabolism of Temafloxacin can be increased when combined with Insulin glargine.,Temafloxacin,DB00047
DB01412,The metabolism of Theobromine can be increased when combined with Insulin glargine.,Theobromine,DB00047
DB01424,The metabolism of Aminophenazone can be increased when combined with Insulin glargine.,Aminophenazone,DB00047
DB01435,The metabolism of Antipyrine can be increased when combined with Insulin glargine.,Antipyrine,DB00047
DB01482,The metabolism of Fenethylline can be increased when combined with Insulin glargine.,Fenethylline,DB00047
DB01558,The metabolism of Bromazepam can be increased when combined with Insulin glargine.,Bromazepam,DB00047
DB01623,The metabolism of Thiothixene can be increased when combined with Insulin glargine.,Thiothixene,DB00047
DB01628,The metabolism of Etoricoxib can be increased when combined with Insulin glargine.,Etoricoxib,DB00047
DB01645,The metabolism of Genistein can be increased when combined with Insulin glargine.,Genistein,DB00047
DB01667,The metabolism of 8-azaguanine can be increased when combined with Insulin glargine.,8-azaguanine,DB00047
DB02134,The metabolism of Xanthine can be increased when combined with Insulin glargine.,Xanthine,DB00047
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Insulin glargine.,9-Methylguanine,DB00047
DB02568,The metabolism of Peldesine can be increased when combined with Insulin glargine.,Peldesine,DB00047
DB02709,The metabolism of Resveratrol can be increased when combined with Insulin glargine.,Resveratrol,DB00047
DB03783,The metabolism of Phenacetin can be increased when combined with Insulin glargine.,Phenacetin,DB00047
DB04076,The metabolism of Hypoxanthine can be increased when combined with Insulin glargine.,Hypoxanthine,DB00047
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Insulin glargine.,9-Deazaguanine,DB00047
DB04841,The metabolism of Flunarizine can be increased when combined with Insulin glargine.,Flunarizine,DB00047
DB04871,The metabolism of Lorcaserin can be increased when combined with Insulin glargine.,Lorcaserin,DB00047
DB04948,The metabolism of Lofexidine can be increased when combined with Insulin glargine.,Lofexidine,DB00047
DB04951,The metabolism of Pirfenidone can be increased when combined with Insulin glargine.,Pirfenidone,DB00047
DB05676,The metabolism of Apremilast can be increased when combined with Insulin glargine.,Apremilast,DB00047
DB06148,The metabolism of Mianserin can be increased when combined with Insulin glargine.,Mianserin,DB00047
DB06210,The metabolism of Eltrombopag can be increased when combined with Insulin glargine.,Eltrombopag,DB00047
DB06235,The metabolism of Vadimezan can be increased when combined with Insulin glargine.,Vadimezan,DB00047
DB06479,The metabolism of Propentofylline can be increased when combined with Insulin glargine.,Propentofylline,DB00047
DB06589,The metabolism of Pazopanib can be increased when combined with Insulin glargine.,Pazopanib,DB00047
DB06594,The metabolism of Agomelatine can be increased when combined with Insulin glargine.,Agomelatine,DB00047
DB06626,The metabolism of Axitinib can be increased when combined with Insulin glargine.,Axitinib,DB00047
DB06769,The metabolism of Bendamustine can be increased when combined with Insulin glargine.,Bendamustine,DB00047
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Insulin glargine.,Benzyl alcohol,DB00047
DB06774,The metabolism of Capsaicin can be increased when combined with Insulin glargine.,Capsaicin,DB00047
DB08496,The metabolism of (R)-warfarin can be increased when combined with Insulin glargine.,(R)-warfarin,DB00047
DB08883,The metabolism of Perampanel can be increased when combined with Insulin glargine.,Perampanel,DB00047
DB09071,The metabolism of Tasimelteon can be increased when combined with Insulin glargine.,Tasimelteon,DB00047
DB09118,The metabolism of Stiripentol can be increased when combined with Insulin glargine.,Stiripentol,DB00047
DB09225,The metabolism of Zotepine can be increased when combined with Insulin glargine.,Zotepine,DB00047
DB09273,The metabolism of Doxofylline can be increased when combined with Insulin glargine.,Doxofylline,DB00047
DB09288,The metabolism of Propacetamol can be increased when combined with Insulin glargine.,Propacetamol,DB00047
DB09290,The metabolism of Ramosetron can be increased when combined with Insulin glargine.,Ramosetron,DB00047
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Insulin glargine.,6-O-benzylguanine,DB00047
DB11967,The metabolism of Binimetinib can be increased when combined with Insulin glargine.,Binimetinib,DB00047
DB12026,The metabolism of Voxilaprevir can be increased when combined with Insulin glargine.,Voxilaprevir,DB00047
DB12245,The metabolism of Triclabendazole can be increased when combined with Insulin glargine.,Triclabendazole,DB00047
DB12332,The metabolism of Rucaparib can be increased when combined with Insulin glargine.,Rucaparib,DB00047
DB12406,The metabolism of Lisofylline can be increased when combined with Insulin glargine.,Lisofylline,DB00047
DB12531,The metabolism of Lobucavir can be increased when combined with Insulin glargine.,Lobucavir,DB00047
DB12926,The metabolism of Cafedrine can be increased when combined with Insulin glargine.,Cafedrine,DB00047
DB12927,The metabolism of Theodrenaline can be increased when combined with Insulin glargine.,Theodrenaline,DB00047
DB12945,The metabolism of Dihydralazine can be increased when combined with Insulin glargine.,Dihydralazine,DB00047
DB13203,The metabolism of Bamifylline can be increased when combined with Insulin glargine.,Bamifylline,DB00047
DB13449,The metabolism of Proxyphylline can be increased when combined with Insulin glargine.,Proxyphylline,DB00047
DB13573,The metabolism of Acefylline can be increased when combined with Insulin glargine.,Acefylline,DB00047
DB13592,The metabolism of Etamiphylline can be increased when combined with Insulin glargine.,Etamiphylline,DB00047
DB13634,The metabolism of Pentifylline can be increased when combined with Insulin glargine.,Pentifylline,DB00047
DB13812,The metabolism of Bufylline can be increased when combined with Insulin glargine.,Bufylline,DB00047
DB13952,The metabolism of Estradiol acetate can be increased when combined with Insulin glargine.,Estradiol acetate,DB00047
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Insulin glargine.,Estradiol benzoate,DB00047
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Insulin glargine.,Estradiol cypionate,DB00047
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Insulin glargine.,Estradiol dienanthate,DB00047
DB13956,The metabolism of Estradiol valerate can be increased when combined with Insulin glargine.,Estradiol valerate,DB00047
DB14018,The metabolism of Bromotheophylline can be increased when combined with Insulin glargine.,Bromotheophylline,DB00047
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Insulin glargine.,8-chlorotheophylline,DB00047
DB01115,The metabolism of Nifedipine can be increased when combined with Insulin glargine.,Nifedipine,DB00047
DB11757,The metabolism of Istradefylline can be increased when combined with Insulin glargine.,Istradefylline,DB00047
DB00972,The metabolism of Azelastine can be increased when combined with Insulin glargine.,Azelastine,DB00047
DB00625,The metabolism of Efavirenz can be increased when combined with Insulin glargine.,Efavirenz,DB00047
DB04889,The metabolism of Bicifadine can be increased when combined with Insulin glargine.,Bicifadine,DB00047
DB05708,The metabolism of GTS-21 can be increased when combined with Insulin glargine.,GTS-21,DB00047
DB01195,The metabolism of Flecainide can be increased when combined with Insulin glargine.,Flecainide,DB00047
DB00783,The metabolism of Estradiol can be increased when combined with Insulin glargine.,Estradiol,DB00047
DB00321,The metabolism of Amitriptyline can be increased when combined with Insulin glargine.,Amitriptyline,DB00047
DB00458,The metabolism of Imipramine can be increased when combined with Insulin glargine.,Imipramine,DB00047
DB01142,The metabolism of Doxepin can be increased when combined with Insulin glargine.,Doxepin,DB00047
DB00532,The metabolism of Mephenytoin can be increased when combined with Insulin glargine.,Mephenytoin,DB00047
DB00540,The metabolism of Nortriptyline can be increased when combined with Insulin glargine.,Nortriptyline,DB00047
DB00575,The metabolism of Clonidine can be increased when combined with Insulin glargine.,Clonidine,DB00047
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Insulin glargine.,Cyclobenzaprine,DB00047
DB01151,The metabolism of Desipramine can be increased when combined with Insulin glargine.,Desipramine,DB00047
DB01242,The metabolism of Clomipramine can be increased when combined with Insulin glargine.,Clomipramine,DB00047
DB11689,The metabolism of Selumetinib can be increased when combined with Insulin glargine.,Selumetinib,DB00047
DB00277,The metabolism of Theophylline can be increased when combined with Insulin glargine.,Theophylline,DB00047
DB00398,The metabolism of Sorafenib can be increased when combined with Insulin glargine.,Sorafenib,DB00047
DB00530,The metabolism of Erlotinib can be increased when combined with Insulin glargine.,Erlotinib,DB00047
DB00564,The metabolism of Carbamazepine can be increased when combined with Insulin glargine.,Carbamazepine,DB00047
DB00682,The metabolism of Warfarin can be increased when combined with Insulin glargine.,Warfarin,DB00047
DB00697,The metabolism of Tizanidine can be increased when combined with Insulin glargine.,Tizanidine,DB00047
DB00773,The metabolism of Etoposide can be increased when combined with Insulin glargine.,Etoposide,DB00047
DB00851,The metabolism of Dacarbazine can be increased when combined with Insulin glargine.,Dacarbazine,DB00047
DB01100,The metabolism of Pimozide can be increased when combined with Insulin glargine.,Pimozide,DB00047
DB01223,The metabolism of Aminophylline can be increased when combined with Insulin glargine.,Aminophylline,DB00047
DB01254,The metabolism of Dasatinib can be increased when combined with Insulin glargine.,Dasatinib,DB00047
DB01418,The metabolism of Acenocoumarol can be increased when combined with Insulin glargine.,Acenocoumarol,DB00047
DB08910,The metabolism of Pomalidomide can be increased when combined with Insulin glargine.,Pomalidomide,DB00047
DB09256,The metabolism of Tegafur can be increased when combined with Insulin glargine.,Tegafur,DB00047
DB13874,The metabolism of Enasidenib can be increased when combined with Insulin glargine.,Enasidenib,DB00047
DB00675,The metabolism of Tamoxifen can be increased when combined with Insulin glargine.,Tamoxifen,DB00047
DB00030,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin glargine.,Insulin human,DB00047
DB00046,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin glargine.,Insulin lispro,DB00047
DB00071,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin pork.,Insulin pork,DB00047
DB00197,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Troglitazone.,Troglitazone,DB00047
DB00222,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glimepiride.,Glimepiride,DB00047
DB00280,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Disopyramide.,Disopyramide,DB00047
DB00284,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Acarbose.,Acarbose,DB00047
DB00414,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Acetohexamide.,Acetohexamide,DB00047
DB00468,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Quinine.,Quinine,DB00047
DB00491,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Miglitol.,Miglitol,DB00047
DB00672,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Chlorpropamide.,Chlorpropamide,DB00047
DB00731,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Nateglinide.,Nateglinide,DB00047
DB00834,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Mifepristone.,Mifepristone,DB00047
DB00839,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Tolazamide.,Tolazamide,DB00047
DB00912,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Repaglinide.,Repaglinide,DB00047
DB00914,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Phenformin.,Phenformin,DB00047
DB01016,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glyburide.,Glyburide,DB00047
DB01067,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glipizide.,Glipizide,DB00047
DB01120,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Gliclazide.,Gliclazide,DB00047
DB01124,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Tolbutamide.,Tolbutamide,DB00047
DB01200,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Bromocriptine.,Bromocriptine,DB00047
DB01251,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Gliquidone.,Gliquidone,DB00047
DB01252,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Mitiglinide.,Mitiglinide,DB00047
DB01268,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Sunitinib.,Sunitinib,DB00047
DB01277,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Mecasermin.,Mecasermin,DB00047
DB01289,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glisoxepide.,Glisoxepide,DB00047
DB01306,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin aspart.,Insulin aspart,DB00047
DB01307,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin detemir.,Insulin detemir,DB00047
DB01309,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin glulisine.,Insulin glulisine,DB00047
DB01700,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with AICA ribonucleotide.,AICA ribonucleotide,DB00047
DB04830,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Buformin.,Buformin,DB00047
DB04878,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Voglibose.,Voglibose,DB00047
DB05115,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with NN344.,NN344,DB00047
DB05819,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with NBI-6024.,NBI-6024,DB00047
DB08962,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glibornuride.,Glibornuride,DB00047
DB09022,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Benfluorex.,Benfluorex,DB00047
DB09198,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Lobeglitazone.,Lobeglitazone,DB00047
DB09199,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Netoglitazone.,Netoglitazone,DB00047
DB09200,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Rivoglitazone.,Rivoglitazone,DB00047
DB09201,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Ciglitazone.,Ciglitazone,DB00047
DB09456,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin beef.,Insulin beef,DB00047
DB09564,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin degludec.,Insulin degludec,DB00047
DB11567,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin peglispro.,Insulin peglispro,DB00047
DB11568,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin tregopil.,Insulin tregopil,DB00047
DB11698,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Ipragliflozin.,Ipragliflozin,DB00047
DB11780,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Allicin.,Allicin,DB00047
DB11824,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Tofogliflozin.,Tofogliflozin,DB00047
DB11898,"The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with 2,4-thiazolidinedione.","2,4-thiazolidinedione",DB00047
DB12713,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Sotagliflozin.,Sotagliflozin,DB00047
DB12781,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Balaglitazone.,Balaglitazone,DB00047
DB12935,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Remogliflozin etabonate.,Remogliflozin etabonate,DB00047
DB13406,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Carbutamide.,Carbutamide,DB00047
DB13446,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Guar gum.,Guar gum,DB00047
DB13675,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Metahexamide.,Metahexamide,DB00047
DB14035,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Englitazone.,Englitazone,DB00047
DB15171,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Tirzepatide.,Tirzepatide,DB00047
DB15217,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Gastric inhibitory polypeptide.,Gastric inhibitory polypeptide,DB00047
DB00270,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin glargine.,Isradipine,DB00047
DB00343,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Insulin glargine.,Diltiazem,DB00047
DB00347,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Insulin glargine.,Trimethadione,DB00047
DB00381,The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin glargine.,Amlodipine,DB00047
DB00393,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Insulin glargine.,Nimodipine,DB00047
DB00401,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Insulin glargine.,Nisoldipine,DB00047
DB00528,The risk or severity of hypoglycemia can be increased when Lercanidipine is combined with Insulin glargine.,Lercanidipine,DB00047
DB00555,The risk or severity of hypoglycemia can be increased when Lamotrigine is combined with Insulin glargine.,Lamotrigine,DB00047
DB00593,The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Insulin glargine.,Ethosuximide,DB00047
DB00622,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Insulin glargine.,Nicardipine,DB00047
DB00653,The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin glargine.,Magnesium sulfate,DB00047
DB00836,The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin glargine.,Loperamide,DB00047
DB01054,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Insulin glargine.,Nitrendipine,DB00047
DB01074,The risk or severity of hypoglycemia can be increased when Perhexiline is combined with Insulin glargine.,Perhexiline,DB00047
DB01244,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Insulin glargine.,Bepridil,DB00047
DB01388,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Insulin glargine.,Mibefradil,DB00047
DB04743,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Insulin glargine.,Nimesulide,DB00047
DB04825,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Insulin glargine.,Prenylamine,DB00047
DB04838,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Insulin glargine.,Cyclandelate,DB00047
DB04842,The risk or severity of hypoglycemia can be increased when Fluspirilene is combined with Insulin glargine.,Fluspirilene,DB00047
DB04920,The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Insulin glargine.,Clevidipine,DB00047
DB05246,The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Insulin glargine.,Methsuximide,DB00047
DB05885,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Insulin glargine.,Seletracetam,DB00047
DB06152,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Insulin glargine.,Nylidrin,DB00047
DB06283,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Insulin glargine.,Ziconotide,DB00047
DB06446,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Insulin glargine.,Dotarizine,DB00047
DB06694,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Insulin glargine.,Xylometazoline,DB00047
DB06712,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Insulin glargine.,Nilvadipine,DB00047
DB07615,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Insulin glargine.,Tranilast,DB00047
DB08838,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Insulin glargine.,Agmatine,DB00047
DB08980,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Insulin glargine.,Fendiline,DB00047
DB08992,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Insulin glargine.,Eperisone,DB00047
DB09089,The risk or severity of hypoglycemia can be increased when Trimebutine is combined with Insulin glargine.,Trimebutine,DB00047
DB09090,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Insulin glargine.,Pinaverium,DB00047
DB09216,The risk or severity of hypoglycemia can be increased when Tolfenamic acid is combined with Insulin glargine.,Tolfenamic acid,DB00047
DB09227,The risk or severity of hypoglycemia can be increased when Barnidipine is combined with Insulin glargine.,Barnidipine,DB00047
DB09229,The risk or severity of hypoglycemia can be increased when Aranidipine is combined with Insulin glargine.,Aranidipine,DB00047
DB09230,The risk or severity of hypoglycemia can be increased when Azelnidipine is combined with Insulin glargine.,Azelnidipine,DB00047
DB09231,The risk or severity of hypoglycemia can be increased when Benidipine is combined with Insulin glargine.,Benidipine,DB00047
DB09232,The risk or severity of hypoglycemia can be increased when Cilnidipine is combined with Insulin glargine.,Cilnidipine,DB00047
DB09234,The risk or severity of hypoglycemia can be increased when Darodipine is combined with Insulin glargine.,Darodipine,DB00047
DB09235,The risk or severity of hypoglycemia can be increased when Efonidipine is combined with Insulin glargine.,Efonidipine,DB00047
DB09236,The risk or severity of hypoglycemia can be increased when Lacidipine is combined with Insulin glargine.,Lacidipine,DB00047
DB09238,The risk or severity of hypoglycemia can be increased when Manidipine is combined with Insulin glargine.,Manidipine,DB00047
DB09239,The risk or severity of hypoglycemia can be increased when Niguldipine is combined with Insulin glargine.,Niguldipine,DB00047
DB09240,The risk or severity of hypoglycemia can be increased when Niludipine is combined with Insulin glargine.,Niludipine,DB00047
DB11960,The risk or severity of hypoglycemia can be increased when Carboxyamidotriazole is combined with Insulin glargine.,Carboxyamidotriazole,DB00047
DB12092,The risk or severity of hypoglycemia can be increased when Naftopidil is combined with Insulin glargine.,Naftopidil,DB00047
DB12093,The risk or severity of hypoglycemia can be increased when Tetrahydropalmatine is combined with Insulin glargine.,Tetrahydropalmatine,DB00047
DB12131,The risk or severity of hypoglycemia can be increased when Vinpocetine is combined with Insulin glargine.,Vinpocetine,DB00047
DB12923,The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Insulin glargine.,Gallopamil,DB00047
DB13488,The risk or severity of hypoglycemia can be increased when Bencyclane is combined with Insulin glargine.,Bencyclane,DB00047
DB13500,The risk or severity of hypoglycemia can be increased when Otilonium is combined with Insulin glargine.,Otilonium,DB00047
DB13725,The risk or severity of hypoglycemia can be increased when Terodiline is combined with Insulin glargine.,Terodiline,DB00047
DB13766,The risk or severity of hypoglycemia can be increased when Lidoflazine is combined with Insulin glargine.,Lidoflazine,DB00047
DB13791,The risk or severity of hypoglycemia can be increased when Penfluridol is combined with Insulin glargine.,Penfluridol,DB00047
DB13835,The risk or severity of hypoglycemia can be increased when Caroverine is combined with Insulin glargine.,Caroverine,DB00047
DB13950,The risk or severity of hypoglycemia can be increased when WIN 55212-2 is combined with Insulin glargine.,WIN 55212-2,DB00047
DB13961,The risk or severity of hypoglycemia can be increased when Fish oil is combined with Insulin glargine.,Fish oil,DB00047
DB14063,The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Insulin glargine.,Dexverapamil,DB00047
DB14064,The risk or severity of hypoglycemia can be increased when Emopamil is combined with Insulin glargine.,Emopamil,DB00047
DB14065,The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Insulin glargine.,Lomerizine,DB00047
DB14066,The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Insulin glargine.,Tetrandrine,DB00047
DB14068,The risk or severity of hypoglycemia can be increased when Dexniguldipine is combined with Insulin glargine.,Dexniguldipine,DB00047
DB01023,The risk or severity of hypoglycemia can be increased when Felodipine is combined with Insulin glargine.,Felodipine,DB00047
DB01118,The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin glargine.,Amiodarone,DB00047
DB00191,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Phentermine.,Phentermine,DB00047
DB00268,The metabolism of Ropinirole can be increased when combined with Insulin glargine.,Ropinirole,DB00047
DB13074,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Insulin glargine.,Macimorelin,DB00047
DB00279,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Liothyronine.,Liothyronine,DB00047
DB00331,The risk or severity of adverse effects can be increased when Insulin glargine is combined with Metformin.,Metformin,DB00047
DB00542,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Insulin glargine.,Benazepril,DB00047
DB13946,The risk or severity of adverse effects can be increased when Testosterone undecanoate is combined with Insulin glargine.,Testosterone undecanoate,DB00047
DB00945,The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin glargine.,Acetylsalicylic acid,DB00047
DB00181,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Baclofen.,Baclofen,DB00047
DB00489,The risk or severity of hypoglycemia can be increased when Sotalol is combined with Insulin glargine.,Sotalol,DB00047
DB00196,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Fluconazole.,Fluconazole,DB00047
DB00040,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Glucagon.,Glucagon,DB00047
DB00264,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Metoprolol.,Metoprolol,DB00047
DB00335,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Atenolol.,Atenolol,DB00047
DB00373,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Timolol.,Timolol,DB00047
DB00598,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Labetalol.,Labetalol,DB00047
DB00612,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bisoprolol.,Bisoprolol,DB00047
DB00866,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Alprenolol.,Alprenolol,DB00047
DB00960,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Pindolol.,Pindolol,DB00047
DB01193,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Acebutolol.,Acebutolol,DB00047
DB01203,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Nadolol.,Nadolol,DB00047
DB01295,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bevantolol.,Bevantolol,DB00047
DB01297,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Practolol.,Practolol,DB00047
DB01359,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Penbutolol.,Penbutolol,DB00047
DB01580,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Oxprenolol.,Oxprenolol,DB00047
DB03322,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Dexpropranolol.,Dexpropranolol,DB00047
DB04846,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Celiprolol.,Celiprolol,DB00047
DB04861,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Nebivolol.,Nebivolol,DB00047
DB06726,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bufuralol.,Bufuralol,DB00047
DB08807,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bopindolol.,Bopindolol,DB00047
DB08808,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bupranolol.,Bupranolol,DB00047
DB08952,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Indenolol.,Indenolol,DB00047
DB09013,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Befunolol.,Befunolol,DB00047
DB09204,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Arotinolol.,Arotinolol,DB00047
DB09351,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Levobetaxolol.,Levobetaxolol,DB00047
DB11770,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Talinolol.,Talinolol,DB00047
DB11785,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Anisodamine.,Anisodamine,DB00047
DB12212,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Landiolol.,Landiolol,DB00047
DB12752,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bucindolol.,Bucindolol,DB00047
DB13443,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Esatenolol.,Esatenolol,DB00047
DB13508,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Cloranolol.,Cloranolol,DB00047
DB13530,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Mepindolol.,Mepindolol,DB00047
DB13757,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Epanolol.,Epanolol,DB00047
DB13775,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Tertatolol.,Tertatolol,DB00047
DB00195,The therapeutic efficacy of Betaxolol can be increased when used in combination with Insulin glargine.,Betaxolol,DB00047
DB00571,The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin glargine.,Propranolol,DB00047
DB01136,The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin glargine.,Carvedilol,DB00047
DB01182,The therapeutic efficacy of Propafenone can be increased when used in combination with Insulin glargine.,Propafenone,DB00047
DB01611,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Hydroxychloroquine.,Hydroxychloroquine,DB00047
DB01233,The therapeutic efficacy of Metoclopramide can be increased when used in combination with Insulin glargine.,Metoclopramide,DB00047
DB00394,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Insulin glargine.,Beclomethasone dipropionate,DB00047
DB00443,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Insulin glargine.,Betamethasone,DB00047
DB00620,The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Insulin glargine.,Triamcinolone,DB00047
DB00635,The risk or severity of hyperglycemia can be increased when Prednisone is combined with Insulin glargine.,Prednisone,DB00047
DB00687,The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Insulin glargine.,Fludrocortisone,DB00047
DB00741,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin glargine.,Hydrocortisone,DB00047
DB00764,The risk or severity of hyperglycemia can be increased when Mometasone is combined with Insulin glargine.,Mometasone,DB00047
DB00860,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Insulin glargine.,Prednisolone,DB00047
DB00959,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Insulin glargine.,Methylprednisolone,DB00047
DB01234,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin glargine.,Dexamethasone,DB00047
DB01285,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Insulin glargine.,Corticotropin,DB00047
DB01380,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Insulin glargine.,Cortisone acetate,DB00047
DB01384,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Insulin glargine.,Paramethasone,DB00047
DB01410,The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Insulin glargine.,Ciclesonide,DB00047
DB08906,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin glargine.,Fluticasone furoate,DB00047
DB08970,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin glargine.,Fluprednidene,DB00047
DB08971,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin glargine.,Fluocortolone,DB00047
DB09383,The risk or severity of hyperglycemia can be increased when Meprednisone is combined with Insulin glargine.,Meprednisone,DB00047
DB11487,The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin glargine.,Dexamethasone isonicotinate,DB00047
DB11750,The risk or severity of hyperglycemia can be increased when Clobetasol is combined with Insulin glargine.,Clobetasol,DB00047
DB11921,The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Insulin glargine.,Deflazacort,DB00047
DB13003,The risk or severity of hyperglycemia can be increased when Cortivazol is combined with Insulin glargine.,Cortivazol,DB00047
DB13208,The risk or severity of hyperglycemia can be increased when Prednylidene is combined with Insulin glargine.,Prednylidene,DB00047
DB13843,The risk or severity of hyperglycemia can be increased when Cloprednol is combined with Insulin glargine.,Cloprednol,DB00047
DB13867,The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin glargine.,Fluticasone,DB00047
DB14512,The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Insulin glargine.,Mometasone furoate,DB00047
DB00180,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Insulin glargine.,Flunisolide,DB00047
DB01108,The risk or severity of hyperglycemia can be increased when Trilostane is combined with Insulin glargine.,Trilostane,DB00047
DB01222,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin glargine.,Budesonide,DB00047
DB04630,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Insulin glargine.,Aldosterone,DB00047
DB09378,The risk or severity of hyperglycemia can be increased when Fluprednisolone is combined with Insulin glargine.,Fluprednisolone,DB00047
DB11529,The risk or severity of hyperglycemia can be increased when Melengestrol is combined with Insulin glargine.,Melengestrol,DB00047
DB14681,The risk or severity of hyperglycemia can be increased when Cortisone is combined with Insulin glargine.,Cortisone,DB00047
DB00223,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Insulin glargine.,Diflorasone,DB00047
DB00240,The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Insulin glargine.,Alclometasone,DB00047
DB00253,The risk or severity of hyperglycemia can be increased when Medrysone is combined with Insulin glargine.,Medrysone,DB00047
DB00288,The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Insulin glargine.,Amcinonide,DB00047
DB00324,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Insulin glargine.,Fluorometholone,DB00047
DB00547,The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Insulin glargine.,Desoximetasone,DB00047
DB00588,The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin glargine.,Fluticasone propionate,DB00047
DB00591,The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Insulin glargine.,Fluocinolone acetonide,DB00047
DB00596,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin glargine.,Ulobetasol,DB00047
DB00663,The risk or severity of hyperglycemia can be increased when Flumethasone is combined with Insulin glargine.,Flumethasone,DB00047
DB00838,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Insulin glargine.,Clocortolone,DB00047
DB00846,The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Insulin glargine.,Flurandrenolide,DB00047
DB14596,The risk or severity of hyperglycemia can be increased when Loteprednol etabonate is combined with Insulin glargine.,Loteprednol etabonate,DB00047
DB00896,The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Insulin glargine.,Rimexolone,DB00047
DB01013,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Insulin glargine.,Clobetasol propionate,DB00047
DB01047,The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Insulin glargine.,Fluocinonide,DB00047
DB01130,The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Insulin glargine.,Prednicarbate,DB00047
DB01260,The risk or severity of hyperglycemia can be increased when Desonide is combined with Insulin glargine.,Desonide,DB00047
DB06781,The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Insulin glargine.,Difluprednate,DB00047
DB06786,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin glargine.,Halcinonide,DB00047
DB09091,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Insulin glargine.,Tixocortol,DB00047
DB09095,The risk or severity of hyperglycemia can be increased when Difluocortolone is combined with Insulin glargine.,Difluocortolone,DB00047
DB13158,The risk or severity of hyperglycemia can be increased when Clobetasone is combined with Insulin glargine.,Clobetasone,DB00047
DB13223,The risk or severity of hyperglycemia can be increased when Fluocortin is combined with Insulin glargine.,Fluocortin,DB00047
DB13491,The risk or severity of hyperglycemia can be increased when Fluperolone is combined with Insulin glargine.,Fluperolone,DB00047
DB13664,The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin glargine.,Formocortal,DB00047
DB13728,The risk or severity of hyperglycemia can be increased when Halometasone is combined with Insulin glargine.,Halometasone,DB00047
DB13856,The risk or severity of hyperglycemia can be increased when Fluclorolone is combined with Insulin glargine.,Fluclorolone,DB00047
DB14538,The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Insulin glargine.,Hydrocortisone aceponate,DB00047
DB14539,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin glargine.,Hydrocortisone acetate,DB00047
DB14540,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin glargine.,Hydrocortisone butyrate,DB00047
DB14541,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin glargine.,Hydrocortisone cypionate,DB00047
DB14543,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin glargine.,Hydrocortisone probutate,DB00047
DB14544,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin glargine.,Hydrocortisone valerate,DB00047
DB14545,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin glargine.,Hydrocortisone succinate,DB00047
DB00873,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Insulin glargine.,Loteprednol,DB00047
DB14631,The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Insulin glargine.,Prednisolone phosphate,DB00047
DB14633,The risk or severity of hyperglycemia can be increased when Prednisolone hemisuccinate is combined with Insulin glargine.,Prednisolone hemisuccinate,DB00047
DB14634,The risk or severity of hyperglycemia can be increased when Fluprednidene acetate is combined with Insulin glargine.,Fluprednidene acetate,DB00047
DB14643,The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Insulin glargine.,Methylprednisolone aceponate,DB00047
DB14644,The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Insulin glargine.,Methylprednisolone hemisuccinate,DB00047
DB14646,The risk or severity of hyperglycemia can be increased when Prednisone acetate is combined with Insulin glargine.,Prednisone acetate,DB00047
DB14652,The risk or severity of hyperglycemia can be increased when Clocortolone acetate is combined with Insulin glargine.,Clocortolone acetate,DB00047
DB14659,The risk or severity of hyperglycemia can be increased when Melengestrol acetate is combined with Insulin glargine.,Melengestrol acetate,DB00047
DB14669,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Insulin glargine.,Betamethasone phosphate,DB00047
DB15566,The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Insulin glargine.,Prednisolone acetate,DB00047
DB00451,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Levothyroxine.,Levothyroxine,DB00047
DB00024,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin glargine.,Thyrotropin alfa,DB00047
DB01583,Liotrix may decrease the hypoglycemic activities of Insulin glargine.,Liotrix,DB00047
DB03604,Tiratricol may decrease the hypoglycemic activities of Insulin glargine.,Tiratricol,DB00047
DB09100,"Thyroid, porcine may decrease the hypoglycemic activities of Insulin glargine.","Thyroid, porcine",DB00047
DB00006,The risk or severity of adverse effects can be increased when Bivalirudin is combined with Collagenase clostridium histolyticum.,Bivalirudin,DB00048
DB00054,The risk or severity of adverse effects can be increased when Abciximab is combined with Collagenase clostridium histolyticum.,Abciximab,DB00048
DB00266,The risk or severity of adverse effects can be increased when Dicoumarol is combined with Collagenase clostridium histolyticum.,Dicoumarol,DB00048
DB00278,The risk or severity of adverse effects can be increased when Argatroban is combined with Collagenase clostridium histolyticum.,Argatroban,DB00048
DB00407,The risk or severity of adverse effects can be increased when Ardeparin is combined with Collagenase clostridium histolyticum.,Ardeparin,DB00048
DB00498,The risk or severity of adverse effects can be increased when Phenindione is combined with Collagenase clostridium histolyticum.,Phenindione,DB00048
DB00569,The risk or severity of adverse effects can be increased when Fondaparinux is combined with Collagenase clostridium histolyticum.,Fondaparinux,DB00048
DB00682,The risk or severity of adverse effects can be increased when Warfarin is combined with Collagenase clostridium histolyticum.,Warfarin,DB00048
DB00686,The risk or severity of adverse effects can be increased when Pentosan polysulfate is combined with Collagenase clostridium histolyticum.,Pentosan polysulfate,DB00048
DB00946,The risk or severity of adverse effects can be increased when Phenprocoumon is combined with Collagenase clostridium histolyticum.,Phenprocoumon,DB00048
DB00974,The risk or severity of adverse effects can be increased when Edetic acid is combined with Collagenase clostridium histolyticum.,Edetic acid,DB00048
DB01109,The risk or severity of adverse effects can be increased when Heparin is combined with Collagenase clostridium histolyticum.,Heparin,DB00048
DB01225,The risk or severity of adverse effects can be increased when Enoxaparin is combined with Collagenase clostridium histolyticum.,Enoxaparin,DB00048
DB01418,The risk or severity of adverse effects can be increased when Acenocoumarol is combined with Collagenase clostridium histolyticum.,Acenocoumarol,DB00048
DB04898,The risk or severity of adverse effects can be increased when Ximelagatran is combined with Collagenase clostridium histolyticum.,Ximelagatran,DB00048
DB05099,The risk or severity of adverse effects can be increased when Ancrod is combined with Collagenase clostridium histolyticum.,Ancrod,DB00048
DB06228,The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Collagenase clostridium histolyticum.,Rivaroxaban,DB00048
DB06271,The risk or severity of adverse effects can be increased when Sulodexide is combined with Collagenase clostridium histolyticum.,Sulodexide,DB00048
DB06406,The risk or severity of adverse effects can be increased when Idraparinux is combined with Collagenase clostridium histolyticum.,Idraparinux,DB00048
DB06605,The risk or severity of adverse effects can be increased when Apixaban is combined with Collagenase clostridium histolyticum.,Apixaban,DB00048
DB06635,The risk or severity of adverse effects can be increased when Otamixaban is combined with Collagenase clostridium histolyticum.,Otamixaban,DB00048
DB06695,The risk or severity of adverse effects can be increased when Dabigatran etexilate is combined with Collagenase clostridium histolyticum.,Dabigatran etexilate,DB00048
DB06754,The risk or severity of adverse effects can be increased when Danaparoid is combined with Collagenase clostridium histolyticum.,Danaparoid,DB00048
DB06779,The risk or severity of adverse effects can be increased when Dalteparin is combined with Collagenase clostridium histolyticum.,Dalteparin,DB00048
DB07767,The risk or severity of adverse effects can be increased when Ferulic acid is combined with Collagenase clostridium histolyticum.,Ferulic acid,DB00048
DB08794,The risk or severity of adverse effects can be increased when Ethyl biscoumacetate is combined with Collagenase clostridium histolyticum.,Ethyl biscoumacetate,DB00048
DB08813,The risk or severity of adverse effects can be increased when Nadroparin is combined with Collagenase clostridium histolyticum.,Nadroparin,DB00048
DB09075,The risk or severity of adverse effects can be increased when Edoxaban is combined with Collagenase clostridium histolyticum.,Edoxaban,DB00048
DB09255,The risk or severity of adverse effects can be increased when Dextran is combined with Collagenase clostridium histolyticum.,Dextran,DB00048
DB09259,The risk or severity of adverse effects can be increased when Reviparin is combined with Collagenase clostridium histolyticum.,Reviparin,DB00048
DB09261,The risk or severity of adverse effects can be increased when Certoparin is combined with Collagenase clostridium histolyticum.,Certoparin,DB00048
DB11095,The risk or severity of adverse effects can be increased when Desirudin is combined with Collagenase clostridium histolyticum.,Desirudin,DB00048
DB11268,The risk or severity of adverse effects can be increased when Protocatechualdehyde is combined with Collagenase clostridium histolyticum.,Protocatechualdehyde,DB00048
DB11312,The risk or severity of adverse effects can be increased when Protein C is combined with Collagenase clostridium histolyticum.,Protein C,DB00048
DB11598,The risk or severity of adverse effects can be increased when Antithrombin III human is combined with Collagenase clostridium histolyticum.,Antithrombin III human,DB00048
DB11984,The risk or severity of adverse effects can be increased when Letaxaban is combined with Collagenase clostridium histolyticum.,Letaxaban,DB00048
DB12289,The risk or severity of adverse effects can be increased when Darexaban is combined with Collagenase clostridium histolyticum.,Darexaban,DB00048
DB12598,The risk or severity of adverse effects can be increased when Nafamostat is combined with Collagenase clostridium histolyticum.,Nafamostat,DB00048
DB12831,The risk or severity of adverse effects can be increased when Gabexate is combined with Collagenase clostridium histolyticum.,Gabexate,DB00048
DB13124,The risk or severity of adverse effects can be increased when Troxerutin is combined with Collagenase clostridium histolyticum.,Troxerutin,DB00048
DB13136,The risk or severity of adverse effects can be increased when Fluindione is combined with Collagenase clostridium histolyticum.,Fluindione,DB00048
DB13149,The risk or severity of adverse effects can be increased when Protein S human is combined with Collagenase clostridium histolyticum.,Protein S human,DB00048
DB13616,The risk or severity of adverse effects can be increased when Melagatran is combined with Collagenase clostridium histolyticum.,Melagatran,DB00048
DB09125,The risk or severity of adverse effects can be increased when Potassium citrate is combined with Collagenase clostridium histolyticum.,Potassium citrate,DB00048
DB09154,The risk or severity of adverse effects can be increased when Sodium citrate is combined with Collagenase clostridium histolyticum.,Sodium citrate,DB00048
DB00031,The risk or severity of adverse effects can be increased when Tenecteplase is combined with Collagenase clostridium histolyticum.,Tenecteplase,DB00048
DB00055,The risk or severity of adverse effects can be increased when Drotrecogin alfa is combined with Collagenase clostridium histolyticum.,Drotrecogin alfa,DB00048
DB04932,The risk or severity of adverse effects can be increased when Defibrotide is combined with Collagenase clostridium histolyticum.,Defibrotide,DB00048
DB06822,The risk or severity of adverse effects can be increased when Tinzaparin is combined with Collagenase clostridium histolyticum.,Tinzaparin,DB00048
DB13199,The risk or severity of adverse effects can be increased when Brinase is combined with Collagenase clostridium histolyticum.,Brinase,DB00048
DB13646,The risk or severity of adverse effects can be increased when Saruplase is combined with Collagenase clostridium histolyticum.,Saruplase,DB00048
DB00086,The risk or severity of adverse effects can be increased when Streptokinase is combined with Collagenase clostridium histolyticum.,Streptokinase,DB00048
DB00945,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Collagenase clostridium histolyticum.,Acetylsalicylic acid,DB00048
DB04925,The risk or severity of adverse effects can be increased when Desmoteplase is combined with Collagenase clostridium histolyticum.,Desmoteplase,DB00048
DB05254,The risk or severity of adverse effects can be increased when Fibrinolysin is combined with Collagenase clostridium histolyticum.,Fibrinolysin,DB00048
DB06543,The risk or severity of adverse effects can be increased when Astaxanthin is combined with Collagenase clostridium histolyticum.,Astaxanthin,DB00048
DB00013,The risk or severity of adverse effects can be increased when Urokinase is combined with Collagenase clostridium histolyticum.,Urokinase,DB00048
DB00975,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Collagenase clostridium histolyticum.,Dipyridamole,DB00048
DB01088,The risk or severity of adverse effects can be increased when Iloprost is combined with Collagenase clostridium histolyticum.,Iloprost,DB00048
DB01240,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Collagenase clostridium histolyticum.,Epoprostenol,DB00048
DB05229,The risk or severity of adverse effects can be increased when Beraprost is combined with Collagenase clostridium histolyticum.,Beraprost,DB00048
DB06209,The risk or severity of adverse effects can be increased when Prasugrel is combined with Collagenase clostridium histolyticum.,Prasugrel,DB00048
DB06441,The risk or severity of adverse effects can be increased when Cangrelor is combined with Collagenase clostridium histolyticum.,Cangrelor,DB00048
DB08814,The risk or severity of adverse effects can be increased when Triflusal is combined with Collagenase clostridium histolyticum.,Triflusal,DB00048
DB08816,The risk or severity of adverse effects can be increased when Ticagrelor is combined with Collagenase clostridium histolyticum.,Ticagrelor,DB00048
DB08994,The risk or severity of adverse effects can be increased when Ditazole is combined with Collagenase clostridium histolyticum.,Ditazole,DB00048
DB09030,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Collagenase clostridium histolyticum.,Vorapaxar,DB00048
DB09258,The risk or severity of adverse effects can be increased when Bemiparin is combined with Collagenase clostridium histolyticum.,Bemiparin,DB00048
DB09260,The risk or severity of adverse effects can be increased when Parnaparin is combined with Collagenase clostridium histolyticum.,Parnaparin,DB00048
DB13275,The risk or severity of adverse effects can be increased when Clorindione is combined with Collagenase clostridium histolyticum.,Clorindione,DB00048
DB13347,The risk or severity of adverse effects can be increased when Diphenadione is combined with Collagenase clostridium histolyticum.,Diphenadione,DB00048
DB13451,The risk or severity of adverse effects can be increased when Tioclomarol is combined with Collagenase clostridium histolyticum.,Tioclomarol,DB00048
DB00001,The risk or severity of adverse effects can be increased when Lepirudin is combined with Collagenase clostridium histolyticum.,Lepirudin,DB00048
DB00009,The risk or severity of adverse effects can be increased when Alteplase is combined with Collagenase clostridium histolyticum.,Alteplase,DB00048
DB00015,The risk or severity of adverse effects can be increased when Reteplase is combined with Collagenase clostridium histolyticum.,Reteplase,DB00048
DB00029,The risk or severity of adverse effects can be increased when Anistreplase is combined with Collagenase clostridium histolyticum.,Anistreplase,DB00048
DB14094,The risk or severity of adverse effects can be increased when Tocopherylquinone is combined with Collagenase clostridium histolyticum.,Tocopherylquinone,DB00048
DB06679,The risk or severity of adverse effects can be increased when Amediplase is combined with Collagenase clostridium histolyticum.,Amediplase,DB00048
DB03410,The risk or severity of adverse effects can be increased when 4-hydroxycoumarin is combined with Collagenase clostridium histolyticum.,4-hydroxycoumarin,DB00048
DB08496,The risk or severity of adverse effects can be increased when (R)-warfarin is combined with Collagenase clostridium histolyticum.,(R)-warfarin,DB00048
DB14055,The risk or severity of adverse effects can be increased when (S)-Warfarin is combined with Collagenase clostridium histolyticum.,(S)-Warfarin,DB00048
DB12364,The risk or severity of adverse effects can be increased when Betrixaban is combined with Collagenase clostridium histolyticum.,Betrixaban,DB00048
DB14598,The risk or severity of adverse effects can be increased when Edetate calcium disodium anhydrous is combined with Collagenase clostridium histolyticum.,Edetate calcium disodium anhydrous,DB00048
DB11154,The risk or severity of adverse effects can be increased when Zinc citrate is combined with Collagenase clostridium histolyticum.,Zinc citrate,DB00048
DB11166,The risk or severity of adverse effects can be increased when Antithrombin Alfa is combined with Collagenase clostridium histolyticum.,Antithrombin Alfa,DB00048
DB04665,The risk or severity of adverse effects can be increased when Coumarin is combined with Collagenase clostridium histolyticum.,Coumarin,DB00048
DB14726,The risk or severity of adverse effects can be increased when Dabigatran is combined with Collagenase clostridium histolyticum.,Dabigatran,DB00048
DB06294,The risk or severity of adverse effects can be increased when Semuloparin is combined with Collagenase clostridium histolyticum.,Semuloparin,DB00048
DB12726,The risk or severity of adverse effects can be increased when Monteplase is combined with Collagenase clostridium histolyticum.,Monteplase,DB00048
DB00232,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Methyclothiazide.,Methyclothiazide,DB00049
DB00436,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide,DB00049
DB00562,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Benzthiazide.,Benzthiazide,DB00049
DB00606,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Cyclothiazide.,Cyclothiazide,DB00049
DB00774,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide,DB00049
DB00880,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Chlorothiazide.,Chlorothiazide,DB00049
DB00999,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide,DB00049
DB01021,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide,DB00049
DB01324,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Polythiazide.,Polythiazide,DB00049
DB13430,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Mebutizide.,Mebutizide,DB00049
DB13532,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide,DB00049
DB01281,The risk or severity of infection can be increased when Adalimumab is combined with Abatacept.,Abatacept,DB00051
DB00026,The risk or severity of adverse effects can be increased when Adalimumab is combined with Anakinra.,Anakinra,DB00051
DB06168,The risk or severity of infection and neutropenia can be increased when Adalimumab is combined with Canakinumab.,Canakinumab,DB00051
DB08904,The risk or severity of infection can be increased when Adalimumab is combined with Certolizumab pegol.,Certolizumab pegol,DB00051
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Adalimumab.,Denosumab,DB00051
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Adalimumab.,Etanercept,DB00051
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Adalimumab.,Peginterferon alfa-2a,DB00051
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Adalimumab.,Interferon alfa-n1,DB00051
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Adalimumab.,Interferon alfa-n3,DB00051
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Adalimumab.,Peginterferon alfa-2b,DB00051
DB00033,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Adalimumab.,Interferon gamma-1b,DB00051
DB00034,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Adalimumab.","Interferon alfa-2a, Recombinant",DB00051
DB00041,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Adalimumab.,Aldesleukin,DB00051
DB00056,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00051
DB00059,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pegaspargase.,Pegaspargase,DB00051
DB00068,The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon beta-1b.,Interferon beta-1b,DB00051
DB00069,The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00051
DB00073,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rituximab.,Rituximab,DB00051
DB00074,The risk or severity of adverse effects can be increased when Adalimumab is combined with Basiliximab.,Basiliximab,DB00051
DB00075,The risk or severity of adverse effects can be increased when Adalimumab is combined with Muromonab.,Muromonab,DB00051
DB00078,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00051
DB00081,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tositumomab.,Tositumomab,DB00051
DB00087,The risk or severity of adverse effects can be increased when Adalimumab is combined with Alemtuzumab.,Alemtuzumab,DB00051
DB00092,The risk or severity of adverse effects can be increased when Adalimumab is combined with Alefacept.,Alefacept,DB00051
DB00095,The risk or severity of adverse effects can be increased when Adalimumab is combined with Efalizumab.,Efalizumab,DB00051
DB00098,The risk or severity of adverse effects can be increased when Adalimumab is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit),DB00051
DB00105,The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00051
DB00111,The risk or severity of adverse effects can be increased when Adalimumab is combined with Daclizumab.,Daclizumab,DB00051
DB00112,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bevacizumab.,Bevacizumab,DB00051
DB00120,The risk or severity of adverse effects can be increased when Adalimumab is combined with Phenylalanine.,Phenylalanine,DB00051
DB00242,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cladribine.,Cladribine,DB00051
DB00276,The risk or severity of adverse effects can be increased when Adalimumab is combined with Amsacrine.,Amsacrine,DB00051
DB00290,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bleomycin.,Bleomycin,DB00051
DB00291,The risk or severity of adverse effects can be increased when Adalimumab is combined with Chlorambucil.,Chlorambucil,DB00051
DB00293,The risk or severity of adverse effects can be increased when Adalimumab is combined with Raltitrexed.,Raltitrexed,DB00051
DB00305,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mitomycin.,Mitomycin,DB00051
DB00322,The risk or severity of adverse effects can be increased when Adalimumab is combined with Floxuridine.,Floxuridine,DB00051
DB00352,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tioguanine.,Tioguanine,DB00051
DB00380,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dexrazoxane.,Dexrazoxane,DB00051
DB00428,The risk or severity of adverse effects can be increased when Adalimumab is combined with Streptozocin.,Streptozocin,DB00051
DB00432,The risk or severity of adverse effects can be increased when Adalimumab is combined with Trifluridine.,Trifluridine,DB00051
DB00441,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gemcitabine.,Gemcitabine,DB00051
DB00445,The risk or severity of adverse effects can be increased when Adalimumab is combined with Epirubicin.,Epirubicin,DB00051
DB00446,The risk or severity of adverse effects can be increased when Adalimumab is combined with Chloramphenicol.,Chloramphenicol,DB00051
DB00480,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lenalidomide.,Lenalidomide,DB00051
DB00488,The risk or severity of adverse effects can be increased when Adalimumab is combined with Altretamine.,Altretamine,DB00051
DB00515,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cisplatin.,Cisplatin,DB00051
DB00526,The risk or severity of adverse effects can be increased when Adalimumab is combined with Oxaliplatin.,Oxaliplatin,DB00051
DB00550,The risk or severity of adverse effects can be increased when Adalimumab is combined with Propylthiouracil.,Propylthiouracil,DB00051
DB00552,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pentostatin.,Pentostatin,DB00051
DB00601,The risk or severity of adverse effects can be increased when Adalimumab is combined with Linezolid.,Linezolid,DB00051
DB00631,The risk or severity of adverse effects can be increased when Adalimumab is combined with Clofarabine.,Clofarabine,DB00051
DB00763,The risk or severity of adverse effects can be increased when Adalimumab is combined with Methimazole.,Methimazole,DB00051
DB00795,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sulfasalazine.,Sulfasalazine,DB00051
DB00853,The risk or severity of adverse effects can be increased when Adalimumab is combined with Temozolomide.,Temozolomide,DB00051
DB00859,The risk or severity of adverse effects can be increased when Adalimumab is combined with Penicillamine.,Penicillamine,DB00051
DB00888,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mechlorethamine.,Mechlorethamine,DB00051
DB00928,The risk or severity of adverse effects can be increased when Adalimumab is combined with Azacitidine.,Azacitidine,DB00051
DB00958,The risk or severity of adverse effects can be increased when Adalimumab is combined with Carboplatin.,Carboplatin,DB00051
DB00970,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dactinomycin.,Dactinomycin,DB00051
DB01005,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hydroxyurea.,Hydroxyurea,DB00051
DB01024,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mycophenolic acid.,Mycophenolic acid,DB00051
DB01030,The risk or severity of adverse effects can be increased when Adalimumab is combined with Topotecan.,Topotecan,DB00051
DB01042,The risk or severity of adverse effects can be increased when Adalimumab is combined with Melphalan.,Melphalan,DB00051
DB01073,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fludarabine.,Fludarabine,DB00051
DB01099,The risk or severity of adverse effects can be increased when Adalimumab is combined with Flucytosine.,Flucytosine,DB00051
DB01168,The risk or severity of adverse effects can be increased when Adalimumab is combined with Procarbazine.,Procarbazine,DB00051
DB01169,The risk or severity of adverse effects can be increased when Adalimumab is combined with Arsenic trioxide.,Arsenic trioxide,DB00051
DB01204,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mitoxantrone.,Mitoxantrone,DB00051
DB01206,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lomustine.,Lomustine,DB00051
DB01257,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eculizumab.,Eculizumab,DB00051
DB01262,The risk or severity of adverse effects can be increased when Adalimumab is combined with Decitabine.,Decitabine,DB00051
DB01280,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nelarabine.,Nelarabine,DB00051
DB01423,The risk or severity of adverse effects can be increased when Adalimumab is combined with Stepronin.,Stepronin,DB00051
DB01816,The risk or severity of adverse effects can be increased when Adalimumab is combined with Castanospermine.,Castanospermine,DB00051
DB02546,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vorinostat.,Vorinostat,DB00051
DB02806,The risk or severity of adverse effects can be increased when Adalimumab is combined with 2-Methoxyethanol.,2-Methoxyethanol,DB00051
DB03523,The risk or severity of adverse effects can be increased when Adalimumab is combined with Brequinar.,Brequinar,DB00051
DB04956,The risk or severity of adverse effects can be increased when Adalimumab is combined with Afelimomab.,Afelimomab,DB00051
DB05258,The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon alfa.,Interferon alfa,DB00051
DB05259,The risk or severity of adverse effects can be increased when Adalimumab is combined with Glatiramer.,Glatiramer,DB00051
DB05260,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gallium nitrate.,Gallium nitrate,DB00051
DB05459,The risk or severity of adverse effects can be increased when Adalimumab is combined with Briakinumab.,Briakinumab,DB00051
DB05472,The risk or severity of adverse effects can be increased when Adalimumab is combined with omega interferon.,omega interferon,DB00051
DB06612,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mepolizumab.,Mepolizumab,DB00051
DB06662,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abetimus.,Abetimus,DB00051
DB06674,The risk or severity of adverse effects can be increased when Adalimumab is combined with Golimumab.,Golimumab,DB00051
DB06681,The risk or severity of adverse effects can be increased when Adalimumab is combined with Belatacept.,Belatacept,DB00051
DB06813,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pralatrexate.,Pralatrexate,DB00051
DB08059,The risk or severity of adverse effects can be increased when Adalimumab is combined with Wortmannin.,Wortmannin,DB00051
DB08871,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eribulin.,Eribulin,DB00051
DB08879,The risk or severity of adverse effects can be increased when Adalimumab is combined with Belimumab.,Belimumab,DB00051
DB08880,The risk or severity of adverse effects can be increased when Adalimumab is combined with Teriflunomide.,Teriflunomide,DB00051
DB08889,The risk or severity of adverse effects can be increased when Adalimumab is combined with Carfilzomib.,Carfilzomib,DB00051
DB08908,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dimethyl fumarate.,Dimethyl fumarate,DB00051
DB08935,The risk or severity of adverse effects can be increased when Adalimumab is combined with Obinutuzumab.,Obinutuzumab,DB00051
DB09029,The risk or severity of adverse effects can be increased when Adalimumab is combined with Secukinumab.,Secukinumab,DB00051
DB09036,The risk or severity of adverse effects can be increased when Adalimumab is combined with Siltuximab.,Siltuximab,DB00051
DB09052,The risk or severity of adverse effects can be increased when Adalimumab is combined with Blinatumomab.,Blinatumomab,DB00051
DB09077,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dinutuximab.,Dinutuximab,DB00051
DB09091,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tixocortol.,Tixocortol,DB00051
DB09122,The risk or severity of adverse effects can be increased when Adalimumab is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00051
DB09312,The risk or severity of adverse effects can be increased when Adalimumab is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse),DB00051
DB11466,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tepoxalin.,Tepoxalin,DB00051
DB11569,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ixekizumab.,Ixekizumab,DB00051
DB11580,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ravulizumab.,Ravulizumab,DB00051
DB11616,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pirarubicin.,Pirarubicin,DB00051
DB11693,The risk or severity of adverse effects can be increased when Adalimumab is combined with Voclosporin.,Voclosporin,DB00051
DB11708,The risk or severity of adverse effects can be increased when Adalimumab is combined with Peficitinib.,Peficitinib,DB00051
DB11767,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sarilumab.,Sarilumab,DB00051
DB11776,The risk or severity of adverse effects can be increased when Adalimumab is combined with Brodalumab.,Brodalumab,DB00051
DB11803,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sirukumab.,Sirukumab,DB00051
DB11834,The risk or severity of adverse effects can be increased when Adalimumab is combined with Guselkumab.,Guselkumab,DB00051
DB11988,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ocrelizumab.,Ocrelizumab,DB00051
DB12025,The risk or severity of adverse effects can be increased when Adalimumab is combined with Triptolide.,Triptolide,DB00051
DB12612,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ozanimod.,Ozanimod,DB00051
DB12617,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mizoribine.,Mizoribine,DB00051
DB12692,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gusperimus.,Gusperimus,DB00051
DB12814,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00051
DB12902,The risk or severity of adverse effects can be increased when Adalimumab is combined with Trofosfamide.,Trofosfamide,DB00051
DB12947,The risk or severity of adverse effects can be increased when Adalimumab is combined with Doxifluridine.,Doxifluridine,DB00051
DB12991,The risk or severity of adverse effects can be increased when Adalimumab is combined with Deoxyspergualin.,Deoxyspergualin,DB00051
DB12996,The risk or severity of adverse effects can be increased when Adalimumab is combined with Acteoside.,Acteoside,DB00051
DB13003,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cortivazol.,Cortivazol,DB00051
DB13014,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hypericin.,Hypericin,DB00051
DB13068,The risk or severity of adverse effects can be increased when Adalimumab is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A,DB00051
DB13223,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluocortin.,Fluocortin,DB00051
DB13241,The risk or severity of adverse effects can be increased when Adalimumab is combined with Begelomab.,Begelomab,DB00051
DB13491,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluperolone.,Fluperolone,DB00051
DB13664,The risk or severity of adverse effects can be increased when Adalimumab is combined with Formocortal.,Formocortal,DB00051
DB13728,The risk or severity of adverse effects can be increased when Adalimumab is combined with Halometasone.,Halometasone,DB00051
DB13843,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cloprednol.,Cloprednol,DB00051
DB13856,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluclorolone.,Fluclorolone,DB00051
DB14219,The risk or severity of adverse effects can be increased when Adalimumab is combined with Monomethyl fumarate.,Monomethyl fumarate,DB00051
DB14724,The risk or severity of adverse effects can be increased when Adalimumab is combined with Emapalumab.,Emapalumab,DB00051
DB14762,The risk or severity of adverse effects can be increased when Adalimumab is combined with Risankizumab.,Risankizumab,DB00051
DB14919,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rozanolixizumab.,Rozanolixizumab,DB00051
DB15253,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bleselumab.,Bleselumab,DB00051
DB00180,The risk or severity of adverse effects can be increased when Adalimumab is combined with Flunisolide.,Flunisolide,DB00051
DB00394,The risk or severity of adverse effects can be increased when Adalimumab is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate,DB00051
DB00443,The risk or severity of adverse effects can be increased when Adalimumab is combined with Betamethasone.,Betamethasone,DB00051
DB00591,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluocinolone acetonide.,Fluocinolone acetonide,DB00051
DB00635,The risk or severity of adverse effects can be increased when Adalimumab is combined with Prednisone.,Prednisone,DB00051
DB00687,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fludrocortisone.,Fludrocortisone,DB00051
DB00764,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mometasone.,Mometasone,DB00051
DB00860,The risk or severity of adverse effects can be increased when Adalimumab is combined with Prednisolone.,Prednisolone,DB00051
DB00959,The risk or severity of adverse effects can be increased when Adalimumab is combined with Methylprednisolone.,Methylprednisolone,DB00051
DB01196,The risk or severity of adverse effects can be increased when Adalimumab is combined with Estramustine.,Estramustine,DB00051
DB01285,The risk or severity of adverse effects can be increased when Adalimumab is combined with Corticotropin.,Corticotropin,DB00051
DB01380,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cortisone acetate.,Cortisone acetate,DB00051
DB01384,The risk or severity of adverse effects can be increased when Adalimumab is combined with Paramethasone.,Paramethasone,DB00051
DB01611,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hydroxychloroquine.,Hydroxychloroquine,DB00051
DB04630,The risk or severity of adverse effects can be increased when Adalimumab is combined with Aldosterone.,Aldosterone,DB00051
DB08970,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluprednidene.,Fluprednidene,DB00051
DB08971,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluocortolone.,Fluocortolone,DB00051
DB09082,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vilanterol.,Vilanterol,DB00051
DB09378,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluprednisolone.,Fluprednisolone,DB00051
DB09383,The risk or severity of adverse effects can be increased when Adalimumab is combined with Meprednisone.,Meprednisone,DB00051
DB11487,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate,DB00051
DB11529,The risk or severity of adverse effects can be increased when Adalimumab is combined with Melengestrol.,Melengestrol,DB00051
DB11750,The risk or severity of adverse effects can be increased when Adalimumab is combined with Clobetasol.,Clobetasol,DB00051
DB11817,The risk or severity of adverse effects can be increased when Adalimumab is combined with Baricitinib.,Baricitinib,DB00051
DB11921,The risk or severity of adverse effects can be increased when Adalimumab is combined with Deflazacort.,Deflazacort,DB00051
DB13208,The risk or severity of adverse effects can be increased when Adalimumab is combined with Prednylidene.,Prednylidene,DB00051
DB14066,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tetrandrine.,Tetrandrine,DB00051
DB14512,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mometasone furoate.,Mometasone furoate,DB00051
DB14545,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hydrocortisone succinate.,Hydrocortisone succinate,DB00051
DB01222,The risk or severity of adverse effects can be increased when Adalimumab is combined with Budesonide.,Budesonide,DB00051
DB01394,The risk or severity of adverse effects can be increased when Adalimumab is combined with Colchicine.,Colchicine,DB00051
DB00108,The risk or severity of adverse effects can be increased when Adalimumab is combined with Natalizumab.,Natalizumab,DB00051
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Adalimumab.,Pimecrolimus,DB00051
DB06372,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rilonacept.,Rilonacept,DB00051
DB01656,Adalimumab may increase the immunosuppressive activities of Roflumilast.,Roflumilast,DB00051
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Adalimumab.,Sipuleucel-T,DB00051
DB06273,Tocilizumab may increase the immunosuppressive activities of Adalimumab.,Tocilizumab,DB00051
DB08895,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tofacitinib.,Tofacitinib,DB00051
DB09033,The risk or severity of infection can be increased when Adalimumab is combined with Vedolizumab.,Vedolizumab,DB00051
DB00065,Adalimumab may increase the immunosuppressive activities of Infliximab.,Infliximab,DB00051
DB00682,The serum concentration of Warfarin can be decreased when it is combined with Adalimumab.,Warfarin,DB00051
DB00091,The serum concentration of Cyclosporine can be decreased when it is combined with Adalimumab.,Cyclosporine,DB00051
DB00651,The serum concentration of Dyphylline can be decreased when it is combined with Adalimumab.,Dyphylline,DB00051
DB01033,The serum concentration of Mercaptopurine can be decreased when it is combined with Adalimumab.,Mercaptopurine,DB00051
DB01978,"The serum concentration of 7,9-Dimethylguanine can be decreased when it is combined with Adalimumab.","7,9-Dimethylguanine",DB00051
DB02245,The serum concentration of 7-Deazaguanine can be decreased when it is combined with Adalimumab.,7-Deazaguanine,DB00051
DB02377,The serum concentration of Guanine can be decreased when it is combined with Adalimumab.,Guanine,DB00051
DB06575,The serum concentration of Valomaciclovir can be decreased when it is combined with Adalimumab.,Valomaciclovir,DB00051
DB07954,The serum concentration of 3-isobutyl-1-methyl-7H-xanthine can be decreased when it is combined with Adalimumab.,3-isobutyl-1-methyl-7H-xanthine,DB00051
DB08844,The serum concentration of Uric acid can be decreased when it is combined with Adalimumab.,Uric acid,DB00051
DB14029,The serum concentration of Furafylline can be decreased when it is combined with Adalimumab.,Furafylline,DB00051
DB15122,The serum concentration of PCS-499 can be decreased when it is combined with Adalimumab.,PCS-499,DB00051
DB00277,The serum concentration of Theophylline can be decreased when it is combined with Adalimumab.,Theophylline,DB00051
DB01223,The serum concentration of Aminophylline can be decreased when it is combined with Adalimumab.,Aminophylline,DB00051
DB00201,The serum concentration of Caffeine can be decreased when it is combined with Adalimumab.,Caffeine,DB00051
DB00806,The serum concentration of Pentoxifylline can be decreased when it is combined with Adalimumab.,Pentoxifylline,DB00051
DB01303,The serum concentration of Oxtriphylline can be decreased when it is combined with Adalimumab.,Oxtriphylline,DB00051
DB01412,The serum concentration of Theobromine can be decreased when it is combined with Adalimumab.,Theobromine,DB00051
DB01482,The serum concentration of Fenethylline can be decreased when it is combined with Adalimumab.,Fenethylline,DB00051
DB01667,The serum concentration of 8-azaguanine can be decreased when it is combined with Adalimumab.,8-azaguanine,DB00051
DB02134,The serum concentration of Xanthine can be decreased when it is combined with Adalimumab.,Xanthine,DB00051
DB02489,The serum concentration of 9-Methylguanine can be decreased when it is combined with Adalimumab.,9-Methylguanine,DB00051
DB02568,The serum concentration of Peldesine can be decreased when it is combined with Adalimumab.,Peldesine,DB00051
DB04076,The serum concentration of Hypoxanthine can be decreased when it is combined with Adalimumab.,Hypoxanthine,DB00051
DB04356,The serum concentration of 9-Deazaguanine can be decreased when it is combined with Adalimumab.,9-Deazaguanine,DB00051
DB06479,The serum concentration of Propentofylline can be decreased when it is combined with Adalimumab.,Propentofylline,DB00051
DB09273,The serum concentration of Doxofylline can be decreased when it is combined with Adalimumab.,Doxofylline,DB00051
DB11919,The serum concentration of 6-O-benzylguanine can be decreased when it is combined with Adalimumab.,6-O-benzylguanine,DB00051
DB12406,The serum concentration of Lisofylline can be decreased when it is combined with Adalimumab.,Lisofylline,DB00051
DB12531,The serum concentration of Lobucavir can be decreased when it is combined with Adalimumab.,Lobucavir,DB00051
DB12926,The serum concentration of Cafedrine can be decreased when it is combined with Adalimumab.,Cafedrine,DB00051
DB12927,The serum concentration of Theodrenaline can be decreased when it is combined with Adalimumab.,Theodrenaline,DB00051
DB13203,The serum concentration of Bamifylline can be decreased when it is combined with Adalimumab.,Bamifylline,DB00051
DB13449,The serum concentration of Proxyphylline can be decreased when it is combined with Adalimumab.,Proxyphylline,DB00051
DB13573,The serum concentration of Acefylline can be decreased when it is combined with Adalimumab.,Acefylline,DB00051
DB13592,The serum concentration of Etamiphylline can be decreased when it is combined with Adalimumab.,Etamiphylline,DB00051
DB13634,The serum concentration of Pentifylline can be decreased when it is combined with Adalimumab.,Pentifylline,DB00051
DB13812,The serum concentration of Bufylline can be decreased when it is combined with Adalimumab.,Bufylline,DB00051
DB14018,The serum concentration of Bromotheophylline can be decreased when it is combined with Adalimumab.,Bromotheophylline,DB00051
DB14132,The serum concentration of 8-chlorotheophylline can be decreased when it is combined with Adalimumab.,8-chlorotheophylline,DB00051
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Adalimumab.,Sulfamethoxazole,DB00051
DB00269,Chlorotrianisene may increase the thrombogenic activities of Adalimumab.,Chlorotrianisene,DB00051
DB00655,Estrone may increase the thrombogenic activities of Adalimumab.,Estrone,DB00051
DB00890,Dienestrol may increase the thrombogenic activities of Adalimumab.,Dienestrol,DB00051
DB04573,Estriol may increase the thrombogenic activities of Adalimumab.,Estriol,DB00051
DB04575,Quinestrol may increase the thrombogenic activities of Adalimumab.,Quinestrol,DB00051
DB07931,Hexestrol may increase the thrombogenic activities of Adalimumab.,Hexestrol,DB00051
DB09070,Tibolone may increase the thrombogenic activities of Adalimumab.,Tibolone,DB00051
DB09369,Polyestradiol phosphate may increase the thrombogenic activities of Adalimumab.,Polyestradiol phosphate,DB00051
DB11478,Zeranol may increase the thrombogenic activities of Adalimumab.,Zeranol,DB00051
DB11674,Equol may increase the thrombogenic activities of Adalimumab.,Equol,DB00051
DB12487,Promestriene may increase the thrombogenic activities of Adalimumab.,Promestriene,DB00051
DB13143,Methallenestril may increase the thrombogenic activities of Adalimumab.,Methallenestril,DB00051
DB13386,Epimestrol may increase the thrombogenic activities of Adalimumab.,Epimestrol,DB00051
DB13418,Moxestrol may increase the thrombogenic activities of Adalimumab.,Moxestrol,DB00051
DB15334,Biochanin A may increase the thrombogenic activities of Adalimumab.,Biochanin A,DB00051
DB15335,Formononetin may increase the thrombogenic activities of Adalimumab.,Formononetin,DB00051
DB09317,"Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Adalimumab.","Synthetic Conjugated Estrogens, A",DB00051
DB09318,"Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Adalimumab.","Synthetic Conjugated Estrogens, B",DB00051
DB09381,Esterified estrogens may increase the thrombogenic activities of Adalimumab.,Esterified estrogens,DB00051
DB01097,The risk or severity of adverse effects can be increased when Adalimumab is combined with Leflunomide.,Leflunomide,DB00051
DB00072,Trastuzumab may increase the neutropenic activities of Adalimumab.,Trastuzumab,DB00051
DB08868,Adalimumab may increase the immunosuppressive activities of Fingolimod.,Fingolimod,DB00051
DB00864,Tacrolimus may increase the immunosuppressive activities of Adalimumab.,Tacrolimus,DB00051
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Adalimumab.,G17DT,DB00051
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Adalimumab.,PEV3A,DB00051
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Adalimumab.,INGN 225,DB00051
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Adalimumab.,Rindopepimut,DB00051
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Adalimumab.,SRP 299,DB00051
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Adalimumab.,GI-5005,DB00051
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Adalimumab.,Vitespen,DB00051
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Adalimumab.,TG4010,DB00051
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Adalimumab.,Anthrax immune globulin human,DB00051
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Adalimumab.","Rabies virus inactivated antigen, B",DB00051
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Adalimumab.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen,DB00051
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Adalimumab.,Rotavirus vaccine,DB00051
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Adalimumab.","Rabies virus inactivated antigen, A",DB00051
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Adalimumab.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen,DB00051
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Clostridium tetani toxoid antigen (formaldehyde inactivated),DB00051
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated),DB00051
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated),DB00051
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),DB00051
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated),DB00051
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Adalimumab.,Typhoid Vi polysaccharide vaccine,DB00051
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Adalimumab.,Hepatitis A Vaccine,DB00051
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Adalimumab.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,DB00051
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated),DB00051
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated),DB00051
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated),DB00051
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated),DB00051
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Adalimumab.,Human rabies virus immune globulin,DB00051
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Adalimumab.,Hepatitis B Vaccine (Recombinant),DB00051
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Adalimumab.,Tecemotide,DB00051
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Adalimumab.,Typhoid vaccine,DB00051
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated),DB00051
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated),DB00051
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Adalimumab.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen,DB00051
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated),DB00051
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Adalimumab.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen,DB00051
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated),DB00051
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated),DB00051
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Adalimumab.,Vaccinia virus strain new york city board of health live antigen,DB00051
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Adalimumab.,Pertussis vaccine,DB00051
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Yersinia pestis 195/p antigen (formaldehyde inactivated),DB00051
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Adalimumab.,Varicella Zoster Vaccine (Recombinant),DB00051
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Adalimumab.,Modified vaccinia ankara,DB00051
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Adalimumab.,Rubella virus vaccine,DB00051
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Adalimumab.,Varicella Zoster Vaccine (Live/attenuated),DB00051
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Adalimumab.,Bacillus calmette-guerin substrain tice live antigen,DB00051
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Adalimumab.,Bacillus calmette-guerin substrain connaught live antigen,DB00051
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Adalimumab.,Yellow Fever Vaccine,DB00051
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Adalimumab.,Anthrax vaccine,DB00051
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Adalimumab.,Typhoid Vaccine Live,DB00051
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Adalimumab.,Bacillus calmette-guerin substrain danish 1331 live antigen,DB00051
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Adalimumab.,BCG vaccine,DB00051
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Adalimumab.,Human adenovirus e serotype 4 strain cl-68578 antigen,DB00051
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Adalimumab.,Vibrio cholerae CVD 103-HgR strain live antigen,DB00051
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Adalimumab.,Adenovirus type 7 vaccine live,DB00051
DB00002,The risk or severity of adverse effects can be increased when Cetuximab is combined with Adalimumab.,Cetuximab,DB00051
DB00028,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Adalimumab.,Human immunoglobulin G,DB00051
DB00043,The risk or severity of adverse effects can be increased when Omalizumab is combined with Adalimumab.,Omalizumab,DB00051
DB00054,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abciximab.,Abciximab,DB00051
DB00057,The risk or severity of adverse effects can be increased when Adalimumab is combined with Indium In-111 satumomab pendetide.,Indium In-111 satumomab pendetide,DB00051
DB00076,The risk or severity of adverse effects can be increased when Adalimumab is combined with Digoxin Immune Fab (Ovine).,Digoxin Immune Fab (Ovine),DB00051
DB00089,The risk or severity of adverse effects can be increased when Adalimumab is combined with Capromab pendetide.,Capromab pendetide,DB00051
DB00110,The risk or severity of adverse effects can be increased when Adalimumab is combined with Palivizumab.,Palivizumab,DB00051
DB00113,The risk or severity of adverse effects can be increased when Adalimumab is combined with Technetium Tc-99m arcitumomab.,Technetium Tc-99m arcitumomab,DB00051
DB01269,The risk or severity of adverse effects can be increased when Adalimumab is combined with Panitumumab.,Panitumumab,DB00051
DB01270,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ranibizumab.,Ranibizumab,DB00051
DB04901,The risk or severity of adverse effects can be increased when Adalimumab is combined with Galiximab.,Galiximab,DB00051
DB04949,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pexelizumab.,Pexelizumab,DB00051
DB04958,The risk or severity of adverse effects can be increased when Adalimumab is combined with Epratuzumab.,Epratuzumab,DB00051
DB04962,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bectumomab.,Bectumomab,DB00051
DB04964,The risk or severity of adverse effects can be increased when Adalimumab is combined with Oregovomab.,Oregovomab,DB00051
DB04988,The risk or severity of adverse effects can be increased when Adalimumab is combined with IGN311.,IGN311,DB00051
DB05006,The risk or severity of adverse effects can be increased when Adalimumab is combined with Adecatumumab.,Adecatumumab,DB00051
DB05097,The risk or severity of adverse effects can be increased when Adalimumab is combined with Labetuzumab.,Labetuzumab,DB00051
DB05101,The risk or severity of adverse effects can be increased when Adalimumab is combined with Matuzumab.,Matuzumab,DB00051
DB05111,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fontolizumab.,Fontolizumab,DB00051
DB05136,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bavituximab.,Bavituximab,DB00051
DB05139,The risk or severity of adverse effects can be increased when Adalimumab is combined with CR002.,CR002,DB00051
DB05209,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rozrolimupab.,Rozrolimupab,DB00051
DB05304,The risk or severity of adverse effects can be increased when Adalimumab is combined with Girentuximab.,Girentuximab,DB00051
DB05336,The risk or severity of adverse effects can be increased when Adalimumab is combined with Obiltoxaximab.,Obiltoxaximab,DB00051
DB05405,The risk or severity of adverse effects can be increased when Adalimumab is combined with XTL-001.,XTL-001,DB00051
DB05437,The risk or severity of adverse effects can be increased when Adalimumab is combined with NAV 1800.,NAV 1800,DB00051
DB05496,The risk or severity of adverse effects can be increased when Adalimumab is combined with Otelixizumab.,Otelixizumab,DB00051
DB05545,The risk or severity of adverse effects can be increased when Adalimumab is combined with AMG 108.,AMG 108,DB00051
DB05550,The risk or severity of adverse effects can be increased when Adalimumab is combined with Iratumumab.,Iratumumab,DB00051
DB05555,The risk or severity of adverse effects can be increased when Adalimumab is combined with Enokizumab.,Enokizumab,DB00051
DB05578,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ramucirumab.,Ramucirumab,DB00051
DB05595,The risk or severity of adverse effects can be increased when Adalimumab is combined with Farletuzumab.,Farletuzumab,DB00051
DB05656,The risk or severity of adverse effects can be increased when Adalimumab is combined with Veltuzumab.,Veltuzumab,DB00051
DB05793,The risk or severity of adverse effects can be increased when Adalimumab is combined with PRO-542.,PRO-542,DB00051
DB05797,The risk or severity of adverse effects can be increased when Adalimumab is combined with TNX-901.,TNX-901,DB00051
DB05889,The risk or severity of adverse effects can be increased when Adalimumab is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin,DB00051
DB05892,The risk or severity of adverse effects can be increased when Adalimumab is combined with RI 624.,RI 624,DB00051
DB05915,The risk or severity of adverse effects can be increased when Adalimumab is combined with MYO-029.,MYO-029,DB00051
DB05916,The risk or severity of adverse effects can be increased when Adalimumab is combined with CT-011.,CT-011,DB00051
DB05941,The risk or severity of adverse effects can be increased when Adalimumab is combined with Leronlimab.,Leronlimab,DB00051
DB05996,The risk or severity of adverse effects can be increased when Adalimumab is combined with Glembatumumab vedotin.,Glembatumumab vedotin,DB00051
DB06043,The risk or severity of adverse effects can be increased when Adalimumab is combined with Olaratumab.,Olaratumab,DB00051
DB06049,The risk or severity of adverse effects can be increased when Adalimumab is combined with IPH 2101.,IPH 2101,DB00051
DB06050,The risk or severity of adverse effects can be increased when Adalimumab is combined with TB-402.,TB-402,DB00051
DB06081,The risk or severity of adverse effects can be increased when Adalimumab is combined with Caplacizumab.,Caplacizumab,DB00051
DB06101,The risk or severity of adverse effects can be increased when Adalimumab is combined with IMC-1C11.,IMC-1C11,DB00051
DB06116,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eldelumab.,Eldelumab,DB00051
DB06162,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lumiliximab.,Lumiliximab,DB00051
DB06186,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ipilimumab.,Ipilimumab,DB00051
DB06192,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nimotuzumab.,Nimotuzumab,DB00051
DB06241,The risk or severity of adverse effects can be increased when Adalimumab is combined with Clenoliximab.,Clenoliximab,DB00051
DB06304,The risk or severity of adverse effects can be increased when Adalimumab is combined with BIIB015.,BIIB015,DB00051
DB06305,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sonepcizumab.,Sonepcizumab,DB00051
DB06310,The risk or severity of adverse effects can be increased when Adalimumab is combined with Motavizumab.,Motavizumab,DB00051
DB06317,The risk or severity of adverse effects can be increased when Adalimumab is combined with Elotuzumab.,Elotuzumab,DB00051
DB06318,The risk or severity of adverse effects can be increased when Adalimumab is combined with AVE9633.,AVE9633,DB00051
DB06322,The risk or severity of adverse effects can be increased when Adalimumab is combined with Carotuximab.,Carotuximab,DB00051
DB06324,The risk or severity of adverse effects can be increased when Adalimumab is combined with XmAb 2513.,XmAb 2513,DB00051
DB06342,The risk or severity of adverse effects can be increased when Adalimumab is combined with Coltuximab ravtansine.,Coltuximab ravtansine,DB00051
DB06343,The risk or severity of adverse effects can be increased when Adalimumab is combined with Teprotumumab.,Teprotumumab,DB00051
DB06360,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lucatumumab.,Lucatumumab,DB00051
DB06366,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pertuzumab.,Pertuzumab,DB00051
DB06371,The risk or severity of adverse effects can be increased when Adalimumab is combined with Siplizumab.,Siplizumab,DB00051
DB06467,The risk or severity of adverse effects can be increased when Adalimumab is combined with Apolizumab.,Apolizumab,DB00051
DB06474,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sibrotuzumab.,Sibrotuzumab,DB00051
DB06550,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bivatuzumab.,Bivatuzumab,DB00051
DB06557,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lerdelimumab.,Lerdelimumab,DB00051
DB06599,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lexatumumab.,Lexatumumab,DB00051
DB06602,The risk or severity of adverse effects can be increased when Adalimumab is combined with Reslizumab.,Reslizumab,DB00051
DB06606,The risk or severity of adverse effects can be increased when Adalimumab is combined with Teplizumab.,Teplizumab,DB00051
DB06607,The risk or severity of adverse effects can be increased when Adalimumab is combined with Catumaxomab.,Catumaxomab,DB00051
DB06647,The risk or severity of adverse effects can be increased when Adalimumab is combined with Volociximab.,Volociximab,DB00051
DB06650,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ofatumumab.,Ofatumumab,DB00051
DB08902,The risk or severity of adverse effects can be increased when Adalimumab is combined with Raxibacumab.,Raxibacumab,DB00051
DB09035,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nivolumab.,Nivolumab,DB00051
DB09037,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pembrolizumab.,Pembrolizumab,DB00051
DB09045,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dulaglutide.,Dulaglutide,DB00051
DB09105,The risk or severity of adverse effects can be increased when Adalimumab is combined with Asfotase alfa.,Asfotase alfa,DB00051
DB09264,The risk or severity of adverse effects can be increased when Adalimumab is combined with Idarucizumab.,Idarucizumab,DB00051
DB09302,The risk or severity of adverse effects can be increased when Adalimumab is combined with Alirocumab.,Alirocumab,DB00051
DB09303,The risk or severity of adverse effects can be increased when Adalimumab is combined with Evolocumab.,Evolocumab,DB00051
DB09331,The risk or severity of adverse effects can be increased when Adalimumab is combined with Daratumumab.,Daratumumab,DB00051
DB09559,The risk or severity of adverse effects can be increased when Adalimumab is combined with Necitumumab.,Necitumumab,DB00051
DB11595,The risk or severity of adverse effects can be increased when Adalimumab is combined with Atezolizumab.,Atezolizumab,DB00051
DB11604,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tetanus Immune Globulin.,Tetanus Immune Globulin,DB00051
DB11608,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eftrenonacog alfa.,Eftrenonacog alfa,DB00051
DB11621,The risk or severity of adverse effects can be increased when Adalimumab is combined with Human Varicella-Zoster Immune Globulin.,Human Varicella-Zoster Immune Globulin,DB00051
DB11646,The risk or severity of adverse effects can be increased when Adalimumab is combined with Conatumumab.,Conatumumab,DB00051
DB11657,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tabalumab.,Tabalumab,DB00051
DB11680,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ficlatuzumab.,Ficlatuzumab,DB00051
DB11685,The risk or severity of adverse effects can be increased when Adalimumab is combined with Figitumumab.,Figitumumab,DB00051
DB11714,The risk or severity of adverse effects can be increased when Adalimumab is combined with Durvalumab.,Durvalumab,DB00051
DB11715,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bapineuzumab.,Bapineuzumab,DB00051
DB11731,The risk or severity of adverse effects can be increased when Adalimumab is combined with Depatuxizumab mafodotin.,Depatuxizumab mafodotin,DB00051
DB11746,The risk or severity of adverse effects can be increased when Adalimumab is combined with Onartuzumab.,Onartuzumab,DB00051
DB11756,The risk or severity of adverse effects can be increased when Adalimumab is combined with Solanezumab.,Solanezumab,DB00051
DB11771,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tremelimumab.,Tremelimumab,DB00051
DB11826,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lampalizumab.,Lampalizumab,DB00051
DB11840,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dalotuzumab.,Dalotuzumab,DB00051
DB11849,The risk or severity of adverse effects can be increased when Adalimumab is combined with Emibetuzumab.,Emibetuzumab,DB00051
DB11850,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ublituximab.,Ublituximab,DB00051
DB11856,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ligelizumab.,Ligelizumab,DB00051
DB11857,The risk or severity of adverse effects can be increased when Adalimumab is combined with Seribantumab.,Seribantumab,DB00051
DB11862,The risk or severity of adverse effects can be increased when Adalimumab is combined with Landogrozumab.,Landogrozumab,DB00051
DB11866,The risk or severity of adverse effects can be increased when Adalimumab is combined with Romosozumab.,Romosozumab,DB00051
DB11884,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vadastuximab Talirine.,Vadastuximab Talirine,DB00051
DB11914,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lebrikizumab.,Lebrikizumab,DB00051
DB11930,The risk or severity of adverse effects can be increased when Adalimumab is combined with Varlilumab.,Varlilumab,DB00051
DB11945,The risk or severity of adverse effects can be increased when Adalimumab is combined with Avelumab.,Avelumab,DB00051
DB11959,The risk or severity of adverse effects can be increased when Adalimumab is combined with Crenezumab.,Crenezumab,DB00051
DB11972,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rilotumumab.,Rilotumumab,DB00051
DB11976,The risk or severity of adverse effects can be increased when Adalimumab is combined with Anifrolumab.,Anifrolumab,DB00051
DB12023,The risk or severity of adverse effects can be increased when Adalimumab is combined with Benralizumab.,Benralizumab,DB00051
DB12034,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gantenerumab.,Gantenerumab,DB00051
DB12053,The risk or severity of adverse effects can be increased when Adalimumab is combined with Visilizumab.,Visilizumab,DB00051
DB12077,The risk or severity of adverse effects can be increased when Adalimumab is combined with Urelumab.,Urelumab,DB00051
DB12089,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine,DB00051
DB12090,The risk or severity of adverse effects can be increased when Adalimumab is combined with Patritumab.,Patritumab,DB00051
DB12102,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fulranumab.,Fulranumab,DB00051
DB12104,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tarextumab.,Tarextumab,DB00051
DB12118,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sotatercept.,Sotatercept,DB00051
DB12119,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gevokizumab.,Gevokizumab,DB00051
DB12142,The risk or severity of adverse effects can be increased when Adalimumab is combined with Duligotuzumab.,Duligotuzumab,DB00051
DB12152,The risk or severity of adverse effects can be increased when Adalimumab is combined with Simtuzumab.,Simtuzumab,DB00051
DB12157,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fasinumab.,Fasinumab,DB00051
DB12159,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dupilumab.,Dupilumab,DB00051
DB12169,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tralokinumab.,Tralokinumab,DB00051
DB12189,The risk or severity of adverse effects can be increased when Adalimumab is combined with Etrolizumab.,Etrolizumab,DB00051
DB12202,The risk or severity of adverse effects can be increased when Adalimumab is combined with Zalutumumab.,Zalutumumab,DB00051
DB12205,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ganitumab.,Ganitumab,DB00051
DB12213,The risk or severity of adverse effects can be increased when Adalimumab is combined with Etaracizumab.,Etaracizumab,DB00051
DB12246,The risk or severity of adverse effects can be increased when Adalimumab is combined with Inclacumab.,Inclacumab,DB00051
DB12250,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cixutumumab.,Cixutumumab,DB00051
DB12261,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ascrinvacumab.,Ascrinvacumab,DB00051
DB12274,The risk or severity of adverse effects can be increased when Adalimumab is combined with Aducanumab.,Aducanumab,DB00051
DB12281,The risk or severity of adverse effects can be increased when Adalimumab is combined with Luspatercept.,Luspatercept,DB00051
DB12296,The risk or severity of adverse effects can be increased when Adalimumab is combined with GS-5745.,GS-5745,DB00051
DB12317,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vanucizumab.,Vanucizumab,DB00051
DB12331,The risk or severity of adverse effects can be increased when Adalimumab is combined with Labetuzumab govitecan.,Labetuzumab govitecan,DB00051
DB12335,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tanezumab.,Tanezumab,DB00051
DB12342,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ensituximab.,Ensituximab,DB00051
DB12344,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fezakinumab.,Fezakinumab,DB00051
DB12363,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dusigitumab.,Dusigitumab,DB00051
DB12396,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fresolimumab.,Fresolimumab,DB00051
DB12413,The risk or severity of adverse effects can be increased when Adalimumab is combined with Indusatumab vedotin.,Indusatumab vedotin,DB00051
DB12456,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bococizumab.,Bococizumab,DB00051
DB12489,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mirvetuximab Soravtansine.,Mirvetuximab Soravtansine,DB00051
DB12498,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mogamulizumab.,Mogamulizumab,DB00051
DB12520,The risk or severity of adverse effects can be increased when Adalimumab is combined with Plozalizumab.,Plozalizumab,DB00051
DB12534,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mavrilimumab.,Mavrilimumab,DB00051
DB12560,The risk or severity of adverse effects can be increased when Adalimumab is combined with Blosozumab.,Blosozumab,DB00051
DB12584,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bimagrumab.,Bimagrumab,DB00051
DB12589,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dacetuzumab.,Dacetuzumab,DB00051
DB12609,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tovetumab.,Tovetumab,DB00051
DB12683,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lumretuzumab.,Lumretuzumab,DB00051
DB12698,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ibalizumab.,Ibalizumab,DB00051
DB12701,The risk or severity of adverse effects can be increased when Adalimumab is combined with Intetumumab.,Intetumumab,DB00051
DB12718,The risk or severity of adverse effects can be increased when Adalimumab is combined with Carlumab.,Carlumab,DB00051
DB12734,The risk or severity of adverse effects can be increased when Adalimumab is combined with Demcizumab.,Demcizumab,DB00051
DB12773,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sifalimumab.,Sifalimumab,DB00051
DB12775,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abituzumab.,Abituzumab,DB00051
DB12797,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ecromeximab.,Ecromeximab,DB00051
DB12807,The risk or severity of adverse effects can be increased when Adalimumab is combined with Naptumomab Estafenatox.,Naptumomab Estafenatox,DB00051
DB12815,The risk or severity of adverse effects can be increased when Adalimumab is combined with Crotedumab.,Crotedumab,DB00051
DB12820,The risk or severity of adverse effects can be increased when Adalimumab is combined with Concizumab.,Concizumab,DB00051
DB12826,The risk or severity of adverse effects can be increased when Adalimumab is combined with Depatuxizumab.,Depatuxizumab,DB00051
DB12844,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rontalizumab.,Rontalizumab,DB00051
DB12845,The risk or severity of adverse effects can be increased when Adalimumab is combined with Amatuximab.,Amatuximab,DB00051
DB12849,The risk or severity of adverse effects can be increased when Adalimumab is combined with Clazakizumab.,Clazakizumab,DB00051
DB12891,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ozanezumab.,Ozanezumab,DB00051
DB12893,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sacituzumab govitecan.,Sacituzumab govitecan,DB00051
DB12917,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bimekizumab.,Bimekizumab,DB00051
DB12943,The risk or severity of adverse effects can be increased when Adalimumab is combined with Milatuzumab.,Milatuzumab,DB00051
DB12976,The risk or severity of adverse effects can be increased when Adalimumab is combined with Robatumumab.,Robatumumab,DB00051
DB13017,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rovalpituzumab Tesirine.,Rovalpituzumab Tesirine,DB00051
DB13037,The risk or severity of adverse effects can be increased when Adalimumab is combined with Namilumab.,Namilumab,DB00051
DB13045,The risk or severity of adverse effects can be increased when Adalimumab is combined with Racotumomab.,Racotumomab,DB00051
DB13073,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tregalizumab.,Tregalizumab,DB00051
DB13127,The risk or severity of adverse effects can be increased when Adalimumab is combined with Olokizumab.,Olokizumab,DB00051
DB13140,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bezlotoxumab.,Bezlotoxumab,DB00051
DB13375,The risk or severity of adverse effects can be increased when Adalimumab is combined with Edrecolomab.,Edrecolomab,DB00051
DB13535,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nebacumab.,Nebacumab,DB00051
DB13886,The risk or severity of adverse effects can be increased when Adalimumab is combined with Human cytomegalovirus immune globulin.,Human cytomegalovirus immune globulin,DB00051
DB13923,The risk or severity of adverse effects can be increased when Adalimumab is combined with Emicizumab.,Emicizumab,DB00051
DB13976,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sulesomab.,Sulesomab,DB00051
DB13979,The risk or severity of adverse effects can be increased when Adalimumab is combined with Besilesomab.,Besilesomab,DB00051
DB14012,The risk or severity of adverse effects can be increased when Adalimumab is combined with Burosumab.,Burosumab,DB00051
DB14039,The risk or severity of adverse effects can be increased when Adalimumab is combined with Erenumab.,Erenumab,DB00051
DB14040,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eptinezumab.,Eptinezumab,DB00051
DB14041,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fremanezumab.,Fremanezumab,DB00051
DB14042,The risk or severity of adverse effects can be increased when Adalimumab is combined with Galcanezumab.,Galcanezumab,DB00051
DB14211,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fanolesomab.,Fanolesomab,DB00051
DB14580,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lecanemab.,Lecanemab,DB00051
DB14597,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lanadelumab.,Lanadelumab,DB00051
DB14707,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cemiplimab.,Cemiplimab,DB00051
DB14776,The risk or severity of adverse effects can be increased when Adalimumab is combined with Camrelizumab.,Camrelizumab,DB00051
DB14778,The risk or severity of adverse effects can be increased when Adalimumab is combined with Setrusumab.,Setrusumab,DB00051
DB14784,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gancotamab.,Gancotamab,DB00051
DB14809,The risk or severity of adverse effects can be increased when Adalimumab is combined with Anetumab ravtansine.,Anetumab ravtansine,DB00051
DB14811,The risk or severity of adverse effects can be increased when Adalimumab is combined with Isatuximab.,Isatuximab,DB00051
DB14824,The risk or severity of adverse effects can be increased when Adalimumab is combined with Icrucumab.,Icrucumab,DB00051
DB14843,The risk or severity of adverse effects can be increased when Adalimumab is combined with Codrituzumab.,Codrituzumab,DB00051
DB14864,The risk or severity of adverse effects can be increased when Adalimumab is combined with Brolucizumab.,Brolucizumab,DB00051
DB14871,The risk or severity of adverse effects can be increased when Adalimumab is combined with Xentuzumab.,Xentuzumab,DB00051
DB14877,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lintuzumab.,Lintuzumab,DB00051
DB14891,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vobarilizumab.,Vobarilizumab,DB00051
DB14897,The risk or severity of adverse effects can be increased when Adalimumab is combined with Parsatuzumab.,Parsatuzumab,DB00051
DB14905,The risk or severity of adverse effects can be increased when Adalimumab is combined with Emactuzumab.,Emactuzumab,DB00051
DB14907,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bevacizumab zirconium Zr-89.,Bevacizumab zirconium Zr-89,DB00051
DB14908,The risk or severity of adverse effects can be increased when Adalimumab is combined with Refanezumab.,Refanezumab,DB00051
DB14947,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bermekimab.,Bermekimab,DB00051
DB14952,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pamrevlumab.,Pamrevlumab,DB00051
DB14959,The risk or severity of adverse effects can be increased when Adalimumab is combined with Opicinumab.,Opicinumab,DB00051
DB14962,The risk or severity of adverse effects can be increased when Adalimumab is combined with Trastuzumab deruxtecan.,Trastuzumab deruxtecan,DB00051
DB14967,The risk or severity of adverse effects can be increased when Adalimumab is combined with Margetuximab.,Margetuximab,DB00051
DB14988,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dalantercept.,Dalantercept,DB00051
DB14997,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pateclizumab.,Pateclizumab,DB00051
DB15014,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gremubamab.,Gremubamab,DB00051
DB15022,The risk or severity of adverse effects can be increased when Adalimumab is combined with Apomab.,Apomab,DB00051
DB15044,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tafasitamab.,Tafasitamab,DB00051
DB15045,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ipafricept.,Ipafricept,DB00051
DB15076,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abrilumab.,Abrilumab,DB00051
DB15089,The risk or severity of adverse effects can be increased when Adalimumab is combined with Frovocimab.,Frovocimab,DB00051
DB15090,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tezepelumab.,Tezepelumab,DB00051
DB15101,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tigatuzumab.,Tigatuzumab,DB00051
DB15104,The risk or severity of adverse effects can be increased when Adalimumab is combined with Telisotuzumab vedotin.,Telisotuzumab vedotin,DB00051
DB15113,The risk or severity of adverse effects can be increased when Adalimumab is combined with Utomilumab.,Utomilumab,DB00051
DB15118,The risk or severity of adverse effects can be increased when Adalimumab is combined with Zolbetuximab.,Zolbetuximab,DB00051
DB15135,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ponezumab.,Ponezumab,DB00051
DB15160,The risk or severity of adverse effects can be increased when Adalimumab is combined with Asunercept.,Asunercept,DB00051
DB15172,The risk or severity of adverse effects can be increased when Adalimumab is combined with Suvratoxumab.,Suvratoxumab,DB00051
DB15225,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mitazalimab.,Mitazalimab,DB00051
DB15252,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nemolizumab.,Nemolizumab,DB00051
DB15277,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gedivumab.,Gedivumab,DB00051
DB15336,The risk or severity of adverse effects can be increased when Adalimumab is combined with Valanafusp alfa.,Valanafusp alfa,DB00051
DB15349,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sofituzumab vedotin.,Sofituzumab vedotin,DB00051
DB15354,The risk or severity of adverse effects can be increased when Adalimumab is combined with Evinacumab.,Evinacumab,DB00051
DB15363,The risk or severity of adverse effects can be increased when Adalimumab is combined with Istiratumab.,Istiratumab,DB00051
DB15383,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pidilizumab.,Pidilizumab,DB00051
DB15397,The risk or severity of adverse effects can be increased when Adalimumab is combined with GMA-161.,GMA-161,DB00051
DB15409,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ladiratuzumab vedotin.,Ladiratuzumab vedotin,DB00051
DB15415,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tomaralimab.,Tomaralimab,DB00051
DB15428,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vesencumab.,Vesencumab,DB00051
DB15432,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pinatuzumab vedotin.,Pinatuzumab vedotin,DB00051
DB15441,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lulizumab pegol.,Lulizumab pegol,DB00051
DB15443,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lorukafusp alfa.,Lorukafusp alfa,DB00051
DB15453,The risk or severity of adverse effects can be increased when Adalimumab is combined with Naratuximab emtansine.,Naratuximab emtansine,DB00051
DB14004,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tildrakizumab.,Tildrakizumab,DB00051
DB05679,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ustekinumab.,Ustekinumab,DB00051
DB12240,The risk or severity of adverse effects can be increased when Adalimumab is combined with Polatuzumab vedotin.,Polatuzumab vedotin,DB00051
DB15559,The risk or severity of adverse effects can be increased when Adalimumab is combined with Zenocutuzumab.,Zenocutuzumab,DB00051
DB00176,The metabolism of Fluvoxamine can be increased when combined with Adalimumab.,Fluvoxamine,DB00051
DB00195,The metabolism of Betaxolol can be increased when combined with Adalimumab.,Betaxolol,DB00051
DB00261,The metabolism of Anagrelide can be increased when combined with Adalimumab.,Anagrelide,DB00051
DB00262,The metabolism of Carmustine can be increased when combined with Adalimumab.,Carmustine,DB00051
DB00268,The metabolism of Ropinirole can be increased when combined with Adalimumab.,Ropinirole,DB00051
DB00280,The metabolism of Disopyramide can be increased when combined with Adalimumab.,Disopyramide,DB00051
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Adalimumab.,Conjugated estrogens,DB00051
DB00296,The metabolism of Ropivacaine can be increased when combined with Adalimumab.,Ropivacaine,DB00051
DB00315,The metabolism of Zolmitriptan can be increased when combined with Adalimumab.,Zolmitriptan,DB00051
DB00316,The metabolism of Acetaminophen can be increased when combined with Adalimumab.,Acetaminophen,DB00051
DB00334,The metabolism of Olanzapine can be increased when combined with Adalimumab.,Olanzapine,DB00051
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Adalimumab.,Chlorzoxazone,DB00051
DB00365,The metabolism of Grepafloxacin can be increased when combined with Adalimumab.,Grepafloxacin,DB00051
DB00370,The metabolism of Mirtazapine can be increased when combined with Adalimumab.,Mirtazapine,DB00051
DB00379,The metabolism of Mexiletine can be increased when combined with Adalimumab.,Mexiletine,DB00051
DB00382,The metabolism of Tacrine can be increased when combined with Adalimumab.,Tacrine,DB00051
DB00384,The metabolism of Triamterene can be increased when combined with Adalimumab.,Triamterene,DB00051
DB00442,The metabolism of Entecavir can be increased when combined with Adalimumab.,Entecavir,DB00051
DB00477,The metabolism of Chlorpromazine can be increased when combined with Adalimumab.,Chlorpromazine,DB00051
DB00518,The metabolism of Albendazole can be increased when combined with Adalimumab.,Albendazole,DB00051
DB00544,The metabolism of Fluorouracil can be increased when combined with Adalimumab.,Fluorouracil,DB00051
DB00629,The metabolism of Guanabenz can be increased when combined with Adalimumab.,Guanabenz,DB00051
DB00642,The metabolism of Pemetrexed can be increased when combined with Adalimumab.,Pemetrexed,DB00051
DB00730,The metabolism of Thiabendazole can be increased when combined with Adalimumab.,Thiabendazole,DB00051
DB00740,The metabolism of Riluzole can be increased when combined with Adalimumab.,Riluzole,DB00051
DB00787,The metabolism of Acyclovir can be increased when combined with Adalimumab.,Acyclovir,DB00051
DB00831,The metabolism of Trifluoperazine can be increased when combined with Adalimumab.,Trifluoperazine,DB00051
DB00863,The metabolism of Ranitidine can be increased when combined with Adalimumab.,Ranitidine,DB00051
DB00898,The metabolism of Ethanol can be increased when combined with Adalimumab.,Ethanol,DB00051
DB00934,The metabolism of Maprotiline can be increased when combined with Adalimumab.,Maprotiline,DB00051
DB00978,The metabolism of Lomefloxacin can be increased when combined with Adalimumab.,Lomefloxacin,DB00051
DB00993,The metabolism of Azathioprine can be increased when combined with Adalimumab.,Azathioprine,DB00051
DB00998,The metabolism of Frovatriptan can be increased when combined with Adalimumab.,Frovatriptan,DB00051
DB01002,The metabolism of Levobupivacaine can be increased when combined with Adalimumab.,Levobupivacaine,DB00051
DB01012,The metabolism of Cinacalcet can be increased when combined with Adalimumab.,Cinacalcet,DB00051
DB01056,The metabolism of Tocainide can be increased when combined with Adalimumab.,Tocainide,DB00051
DB01087,The metabolism of Primaquine can be increased when combined with Adalimumab.,Primaquine,DB00051
DB01094,The metabolism of Hesperetin can be increased when combined with Adalimumab.,Hesperetin,DB00051
DB01182,The metabolism of Propafenone can be increased when combined with Adalimumab.,Propafenone,DB00051
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Adalimumab.,Dexfenfluramine,DB00051
DB01367,The metabolism of Rasagiline can be increased when combined with Adalimumab.,Rasagiline,DB00051
DB01405,The metabolism of Temafloxacin can be increased when combined with Adalimumab.,Temafloxacin,DB00051
DB01558,The metabolism of Bromazepam can be increased when combined with Adalimumab.,Bromazepam,DB00051
DB01623,The metabolism of Thiothixene can be increased when combined with Adalimumab.,Thiothixene,DB00051
DB01645,The metabolism of Genistein can be increased when combined with Adalimumab.,Genistein,DB00051
DB02709,The metabolism of Resveratrol can be increased when combined with Adalimumab.,Resveratrol,DB00051
DB04871,The metabolism of Lorcaserin can be increased when combined with Adalimumab.,Lorcaserin,DB00051
DB04948,The metabolism of Lofexidine can be increased when combined with Adalimumab.,Lofexidine,DB00051
DB04951,The metabolism of Pirfenidone can be increased when combined with Adalimumab.,Pirfenidone,DB00051
DB06148,The metabolism of Mianserin can be increased when combined with Adalimumab.,Mianserin,DB00051
DB06210,The metabolism of Eltrombopag can be increased when combined with Adalimumab.,Eltrombopag,DB00051
DB06216,The metabolism of Asenapine can be increased when combined with Adalimumab.,Asenapine,DB00051
DB06235,The metabolism of Vadimezan can be increased when combined with Adalimumab.,Vadimezan,DB00051
DB06594,The metabolism of Agomelatine can be increased when combined with Adalimumab.,Agomelatine,DB00051
DB06769,The metabolism of Bendamustine can be increased when combined with Adalimumab.,Bendamustine,DB00051
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Adalimumab.,Benzyl alcohol,DB00051
DB06774,The metabolism of Capsaicin can be increased when combined with Adalimumab.,Capsaicin,DB00051
DB08496,The metabolism of (R)-warfarin can be increased when combined with Adalimumab.,(R)-warfarin,DB00051
DB09071,The metabolism of Tasimelteon can be increased when combined with Adalimumab.,Tasimelteon,DB00051
DB09118,The metabolism of Stiripentol can be increased when combined with Adalimumab.,Stiripentol,DB00051
DB09225,The metabolism of Zotepine can be increased when combined with Adalimumab.,Zotepine,DB00051
DB09290,The metabolism of Ramosetron can be increased when combined with Adalimumab.,Ramosetron,DB00051
DB11967,The metabolism of Binimetinib can be increased when combined with Adalimumab.,Binimetinib,DB00051
DB12026,The metabolism of Voxilaprevir can be increased when combined with Adalimumab.,Voxilaprevir,DB00051
DB12245,The metabolism of Triclabendazole can be increased when combined with Adalimumab.,Triclabendazole,DB00051
DB12332,The metabolism of Rucaparib can be increased when combined with Adalimumab.,Rucaparib,DB00051
DB12945,The metabolism of Dihydralazine can be increased when combined with Adalimumab.,Dihydralazine,DB00051
DB11757,The metabolism of Istradefylline can be increased when combined with Adalimumab.,Istradefylline,DB00051
DB04889,The metabolism of Bicifadine can be increased when combined with Adalimumab.,Bicifadine,DB00051
DB05708,The metabolism of GTS-21 can be increased when combined with Adalimumab.,GTS-21,DB00051
DB00977,The metabolism of Adalimumab can be increased when combined with Ethinylestradiol.,Ethinylestradiol,DB00051
DB00425,The metabolism of Zolpidem can be increased when combined with Adalimumab.,Zolpidem,DB00051
DB00458,The metabolism of Imipramine can be increased when combined with Adalimumab.,Imipramine,DB00051
DB00532,The metabolism of Mephenytoin can be increased when combined with Adalimumab.,Mephenytoin,DB00051
DB00540,The metabolism of Nortriptyline can be increased when combined with Adalimumab.,Nortriptyline,DB00051
DB00575,The metabolism of Clonidine can be increased when combined with Adalimumab.,Clonidine,DB00051
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Adalimumab.,Cyclobenzaprine,DB00051
DB01242,The metabolism of Clomipramine can be increased when combined with Adalimumab.,Clomipramine,DB00051
DB11689,The metabolism of Selumetinib can be increased when combined with Adalimumab.,Selumetinib,DB00051
DB00564,The metabolism of Carbamazepine can be increased when combined with Adalimumab.,Carbamazepine,DB00051
DB00697,The metabolism of Tizanidine can be increased when combined with Adalimumab.,Tizanidine,DB00051
DB01100,The metabolism of Pimozide can be increased when combined with Adalimumab.,Pimozide,DB00051
DB01418,The metabolism of Acenocoumarol can be increased when combined with Adalimumab.,Acenocoumarol,DB00051
DB09256,The metabolism of Tegafur can be increased when combined with Adalimumab.,Tegafur,DB00051
DB00851,The metabolism of Dacarbazine can be increased when combined with Adalimumab.,Dacarbazine,DB00051
DB08910,The metabolism of Pomalidomide can be increased when combined with Adalimumab.,Pomalidomide,DB00051
DB00238,The metabolism of Nevirapine can be increased when combined with Adalimumab.,Nevirapine,DB00051
DB00471,The metabolism of Montelukast can be increased when combined with Adalimumab.,Montelukast,DB00051
DB00690,The metabolism of Flurazepam can be increased when combined with Adalimumab.,Flurazepam,DB00051
DB00916,The metabolism of Metronidazole can be increased when combined with Adalimumab.,Metronidazole,DB00051
DB00983,The metabolism of Formoterol can be increased when combined with Adalimumab.,Formoterol,DB00051
DB01006,The metabolism of Letrozole can be increased when combined with Adalimumab.,Letrozole,DB00051
DB01028,The metabolism of Methoxyflurane can be increased when combined with Adalimumab.,Methoxyflurane,DB00051
DB01159,The metabolism of Halothane can be increased when combined with Adalimumab.,Halothane,DB00051
DB01236,The metabolism of Sevoflurane can be increased when combined with Adalimumab.,Sevoflurane,DB00051
DB01274,The metabolism of Arformoterol can be increased when combined with Adalimumab.,Arformoterol,DB00051
DB01544,The metabolism of Flunitrazepam can be increased when combined with Adalimumab.,Flunitrazepam,DB00051
DB06292,The metabolism of Dapagliflozin can be increased when combined with Adalimumab.,Dapagliflozin,DB00051
DB06470,The metabolism of Clomethiazole can be increased when combined with Adalimumab.,Clomethiazole,DB00051
DB09068,The metabolism of Vortioxetine can be increased when combined with Adalimumab.,Vortioxetine,DB00051
DB09327,The metabolism of Tegafur-uracil can be increased when combined with Adalimumab.,Tegafur-uracil,DB00051
DB11586,The metabolism of Asunaprevir can be increased when combined with Adalimumab.,Asunaprevir,DB00051
DB04977,The metabolism of Plitidepsin can be increased when combined with Adalimumab.,Plitidepsin,DB00051
DB06119,The metabolism of Cenobamate can be increased when combined with Adalimumab.,Cenobamate,DB00051
DB00193,The metabolism of Tramadol can be increased when combined with Adalimumab.,Tramadol,DB00051
DB00333,The metabolism of Methadone can be increased when combined with Adalimumab.,Methadone,DB00051
DB00349,The metabolism of Clobazam can be increased when combined with Adalimumab.,Clobazam,DB00051
DB00625,The metabolism of Efavirenz can be increased when combined with Adalimumab.,Efavirenz,DB00051
DB00753,The metabolism of Isoflurane can be increased when combined with Adalimumab.,Isoflurane,DB00051
DB00818,The metabolism of Propofol can be increased when combined with Adalimumab.,Propofol,DB00051
DB00835,The metabolism of Brompheniramine can be increased when combined with Adalimumab.,Brompheniramine,DB00051
DB00836,The metabolism of Loperamide can be increased when combined with Adalimumab.,Loperamide,DB00051
DB00849,The metabolism of Methylphenobarbital can be increased when combined with Adalimumab.,Methylphenobarbital,DB00051
DB00865,The metabolism of Benzphetamine can be increased when combined with Adalimumab.,Benzphetamine,DB00051
DB01069,The metabolism of Promethazine can be increased when combined with Adalimumab.,Promethazine,DB00051
DB01074,The metabolism of Perhexiline can be increased when combined with Adalimumab.,Perhexiline,DB00051
DB01221,The metabolism of Ketamine can be increased when combined with Adalimumab.,Ketamine,DB00051
DB01466,The metabolism of Ethylmorphine can be increased when combined with Adalimumab.,Ethylmorphine,DB00051
DB01559,The metabolism of Clotiazepam can be increased when combined with Adalimumab.,Clotiazepam,DB00051
DB04938,The metabolism of Ospemifene can be increased when combined with Adalimumab.,Ospemifene,DB00051
DB04975,The metabolism of Banoxantrone can be increased when combined with Adalimumab.,Banoxantrone,DB00051
DB05541,The metabolism of Brivaracetam can be increased when combined with Adalimumab.,Brivaracetam,DB00051
DB06176,The metabolism of Romidepsin can be increased when combined with Adalimumab.,Romidepsin,DB00051
DB06209,The metabolism of Prasugrel can be increased when combined with Adalimumab.,Prasugrel,DB00051
DB06697,The metabolism of Artemether can be increased when combined with Adalimumab.,Artemether,DB00051
DB06710,The metabolism of Methyltestosterone can be increased when combined with Adalimumab.,Methyltestosterone,DB00051
DB06738,The metabolism of Ketobemidone can be increased when combined with Adalimumab.,Ketobemidone,DB00051
DB06739,The metabolism of Seratrodast can be increased when combined with Adalimumab.,Seratrodast,DB00051
DB11613,The metabolism of Velpatasvir can be increased when combined with Adalimumab.,Velpatasvir,DB00051
DB13132,The metabolism of Artemisinin can be increased when combined with Adalimumab.,Artemisinin,DB00051
DB13943,The metabolism of Testosterone cypionate can be increased when combined with Adalimumab.,Testosterone cypionate,DB00051
DB13944,The metabolism of Testosterone enanthate can be increased when combined with Adalimumab.,Testosterone enanthate,DB00051
DB13946,The metabolism of Testosterone undecanoate can be increased when combined with Adalimumab.,Testosterone undecanoate,DB00051
DB01156,The metabolism of Bupropion can be increased when combined with Adalimumab.,Bupropion,DB00051
DB00956,The metabolism of Hydrocodone can be increased when combined with Adalimumab.,Hydrocodone,DB00051
DB14975,The metabolism of Voxelotor can be increased when combined with Adalimumab.,Voxelotor,DB00051
DB11837,The metabolism of Osilodrostat can be increased when combined with Adalimumab.,Osilodrostat,DB00051
DB13384,The metabolism of Melitracen can be increased when combined with Adalimumab.,Melitracen,DB00051
DB13411,The metabolism of Lofepramine can be increased when combined with Adalimumab.,Lofepramine,DB00051
DB00714,The metabolism of Apomorphine can be increased when combined with Adalimumab.,Apomorphine,DB00051
DB09167,The metabolism of Dosulepin can be increased when combined with Adalimumab.,Dosulepin,DB00051
DB00213,The metabolism of Pantoprazole can be increased when combined with Adalimumab.,Pantoprazole,DB00051
DB00215,The metabolism of Citalopram can be increased when combined with Adalimumab.,Citalopram,DB00051
DB00312,The metabolism of Pentobarbital can be increased when combined with Adalimumab.,Pentobarbital,DB00051
DB00338,The metabolism of Omeprazole can be increased when combined with Adalimumab.,Omeprazole,DB00051
DB00347,The metabolism of Trimethadione can be increased when combined with Adalimumab.,Trimethadione,DB00051
DB00395,The metabolism of Carisoprodol can be increased when combined with Adalimumab.,Carisoprodol,DB00051
DB00448,The metabolism of Lansoprazole can be increased when combined with Adalimumab.,Lansoprazole,DB00051
DB00474,The metabolism of Methohexital can be increased when combined with Adalimumab.,Methohexital,DB00051
DB00582,The metabolism of Voriconazole can be increased when combined with Adalimumab.,Voriconazole,DB00051
DB00679,The metabolism of Thioridazine can be increased when combined with Adalimumab.,Thioridazine,DB00051
DB00736,The metabolism of Esomeprazole can be increased when combined with Adalimumab.,Esomeprazole,DB00051
DB00794,The metabolism of Primidone can be increased when combined with Adalimumab.,Primidone,DB00051
DB00909,The metabolism of Zonisamide can be increased when combined with Adalimumab.,Zonisamide,DB00051
DB01129,The metabolism of Rabeprazole can be increased when combined with Adalimumab.,Rabeprazole,DB00051
DB01131,The metabolism of Proguanil can be increased when combined with Adalimumab.,Proguanil,DB00051
DB01175,The metabolism of Escitalopram can be increased when combined with Adalimumab.,Escitalopram,DB00051
DB01259,The metabolism of Lapatinib can be increased when combined with Adalimumab.,Lapatinib,DB00051
DB01323,The metabolism of St. John's Wort can be increased when combined with Adalimumab.,St. John's Wort,DB00051
DB01355,The metabolism of Hexobarbital can be increased when combined with Adalimumab.,Hexobarbital,DB00051
DB01483,The metabolism of Barbital can be increased when combined with Adalimumab.,Barbital,DB00051
DB05246,The metabolism of Methsuximide can be increased when combined with Adalimumab.,Methsuximide,DB00051
DB05351,The metabolism of Dexlansoprazole can be increased when combined with Adalimumab.,Dexlansoprazole,DB00051
DB06218,The metabolism of Lacosamide can be increased when combined with Adalimumab.,Lacosamide,DB00051
DB06414,The metabolism of Etravirine can be increased when combined with Adalimumab.,Etravirine,DB00051
DB06605,The metabolism of Apixaban can be increased when combined with Adalimumab.,Apixaban,DB00051
DB09166,The metabolism of Etizolam can be increased when combined with Adalimumab.,Etizolam,DB00051
DB12130,The metabolism of Lorlatinib can be increased when combined with Adalimumab.,Lorlatinib,DB00051
DB12474,The metabolism of Lynestrenol can be increased when combined with Adalimumab.,Lynestrenol,DB00051
DB13762,The metabolism of Dexrabeprazole can be increased when combined with Adalimumab.,Dexrabeprazole,DB00051
DB14055,The metabolism of (S)-Warfarin can be increased when combined with Adalimumab.,(S)-Warfarin,DB00051
DB00715,The metabolism of Paroxetine can be increased when combined with Adalimumab.,Paroxetine,DB00051
DB12500,The metabolism of Fedratinib can be increased when combined with Adalimumab.,Fedratinib,DB00051
DB04861,The metabolism of Nebivolol can be increased when combined with Adalimumab.,Nebivolol,DB00051
DB06684,The metabolism of Vilazodone can be increased when combined with Adalimumab.,Vilazodone,DB00051
DB01104,The metabolism of Sertraline can be increased when combined with Adalimumab.,Sertraline,DB00051
DB11823,The metabolism of Esketamine can be increased when combined with Adalimumab.,Esketamine,DB00051
DB00252,The metabolism of Phenytoin can be increased when combined with Adalimumab.,Phenytoin,DB00051
DB00599,The metabolism of Thiopental can be increased when combined with Adalimumab.,Thiopental,DB00051
DB01174,The metabolism of Phenobarbital can be increased when combined with Adalimumab.,Phenobarbital,DB00051
DB01320,The metabolism of Fosphenytoin can be increased when combined with Adalimumab.,Fosphenytoin,DB00051
DB00613,The metabolism of Amodiaquine can be increased when combined with Adalimumab.,Amodiaquine,DB00051
DB00799,The metabolism of Tazarotene can be increased when combined with Adalimumab.,Tazarotene,DB00051
DB05229,The metabolism of Beraprost can be increased when combined with Adalimumab.,Beraprost,DB00051
DB06510,The metabolism of Muraglitazar can be increased when combined with Adalimumab.,Muraglitazar,DB00051
DB09296,The metabolism of Ombitasvir can be increased when combined with Adalimumab.,Ombitasvir,DB00051
DB01217,The metabolism of Anastrozole can be increased when combined with Adalimumab.,Anastrozole,DB00051
DB00255,The metabolism of Adalimumab can be increased when combined with Diethylstilbestrol.,Diethylstilbestrol,DB00051
DB00295,The metabolism of Morphine can be increased when combined with Adalimumab.,Morphine,DB00051
DB00359,The metabolism of Sulfadiazine can be increased when combined with Adalimumab.,Sulfadiazine,DB00051
DB00402,The metabolism of Eszopiclone can be increased when combined with Adalimumab.,Eszopiclone,DB00051
DB00622,The metabolism of Nicardipine can be increased when combined with Adalimumab.,Nicardipine,DB00051
DB00912,The metabolism of Repaglinide can be increased when combined with Adalimumab.,Repaglinide,DB00051
DB01261,The metabolism of Sitagliptin can be increased when combined with Adalimumab.,Sitagliptin,DB00051
DB06670,The metabolism of Odanacatib can be increased when combined with Adalimumab.,Odanacatib,DB00051
DB08502,The metabolism of Capravirine can be increased when combined with Adalimumab.,Capravirine,DB00051
DB08931,The metabolism of Riociguat can be increased when combined with Adalimumab.,Riociguat,DB00051
DB09198,The metabolism of Lobeglitazone can be increased when combined with Adalimumab.,Lobeglitazone,DB00051
DB09199,The metabolism of Netoglitazone can be increased when combined with Adalimumab.,Netoglitazone,DB00051
DB09200,The metabolism of Rivoglitazone can be increased when combined with Adalimumab.,Rivoglitazone,DB00051
DB09201,The metabolism of Ciglitazone can be increased when combined with Adalimumab.,Ciglitazone,DB00051
DB11362,The metabolism of Selexipag can be increased when combined with Adalimumab.,Selexipag,DB00051
DB11901,The metabolism of Apalutamide can be increased when combined with Adalimumab.,Apalutamide,DB00051
DB11978,The metabolism of Glasdegib can be increased when combined with Adalimumab.,Glasdegib,DB00051
DB12781,The metabolism of Balaglitazone can be increased when combined with Adalimumab.,Balaglitazone,DB00051
DB01132,The metabolism of Pioglitazone can be increased when combined with Adalimumab.,Pioglitazone,DB00051
DB11652,The metabolism of Tucatinib can be increased when combined with Adalimumab.,Tucatinib,DB00051
DB00946,The metabolism of Phenprocoumon can be increased when combined with Adalimumab.,Phenprocoumon,DB00051
DB01229,The metabolism of Paclitaxel can be increased when combined with Adalimumab.,Paclitaxel,DB00051
DB00177,The metabolism of Valsartan can be increased when combined with Adalimumab.,Valsartan,DB00051
DB00184,The metabolism of Nicotine can be increased when combined with Adalimumab.,Nicotine,DB00051
DB00197,The metabolism of Troglitazone can be increased when combined with Adalimumab.,Troglitazone,DB00051
DB00214,The metabolism of Torasemide can be increased when combined with Adalimumab.,Torasemide,DB00051
DB00222,The metabolism of Glimepiride can be increased when combined with Adalimumab.,Glimepiride,DB00051
DB00285,The metabolism of Venlafaxine can be increased when combined with Adalimumab.,Venlafaxine,DB00051
DB00304,The metabolism of Desogestrel can be increased when combined with Adalimumab.,Desogestrel,DB00051
DB00307,The metabolism of Bexarotene can be increased when combined with Adalimumab.,Bexarotene,DB00051
DB00327,The metabolism of Hydromorphone can be increased when combined with Adalimumab.,Hydromorphone,DB00051
DB00328,The metabolism of Indomethacin can be increased when combined with Adalimumab.,Indomethacin,DB00051
DB00343,The metabolism of Diltiazem can be increased when combined with Adalimumab.,Diltiazem,DB00051
DB00374,The metabolism of Treprostinil can be increased when combined with Adalimumab.,Treprostinil,DB00051
DB00412,The metabolism of Rosiglitazone can be increased when combined with Adalimumab.,Rosiglitazone,DB00051
DB00414,The metabolism of Acetohexamide can be increased when combined with Adalimumab.,Acetohexamide,DB00051
DB00420,The metabolism of Promazine can be increased when combined with Adalimumab.,Promazine,DB00051
DB00440,The metabolism of Trimethoprim can be increased when combined with Adalimumab.,Trimethoprim,DB00051
DB00461,The metabolism of Nabumetone can be increased when combined with Adalimumab.,Nabumetone,DB00051
DB00468,The metabolism of Quinine can be increased when combined with Adalimumab.,Quinine,DB00051
DB00469,The metabolism of Tenoxicam can be increased when combined with Adalimumab.,Tenoxicam,DB00051
DB00472,The metabolism of Fluoxetine can be increased when combined with Adalimumab.,Fluoxetine,DB00051
DB00476,The metabolism of Duloxetine can be increased when combined with Adalimumab.,Duloxetine,DB00051
DB00482,The metabolism of Celecoxib can be increased when combined with Adalimumab.,Celecoxib,DB00051
DB00495,The metabolism of Zidovudine can be increased when combined with Adalimumab.,Zidovudine,DB00051
DB00502,The metabolism of Haloperidol can be increased when combined with Adalimumab.,Haloperidol,DB00051
DB00531,The metabolism of Cyclophosphamide can be increased when combined with Adalimumab.,Cyclophosphamide,DB00051
DB00533,The metabolism of Rofecoxib can be increased when combined with Adalimumab.,Rofecoxib,DB00051
DB00549,The metabolism of Zafirlukast can be increased when combined with Adalimumab.,Zafirlukast,DB00051
DB00554,The metabolism of Piroxicam can be increased when combined with Adalimumab.,Piroxicam,DB00051
DB00559,The metabolism of Bosentan can be increased when combined with Adalimumab.,Bosentan,DB00051
DB00568,The metabolism of Cinnarizine can be increased when combined with Adalimumab.,Cinnarizine,DB00051
DB00580,The metabolism of Valdecoxib can be increased when combined with Adalimumab.,Valdecoxib,DB00051
DB00586,The metabolism of Diclofenac can be increased when combined with Adalimumab.,Diclofenac,DB00051
DB00617,The metabolism of Paramethadione can be increased when combined with Adalimumab.,Paramethadione,DB00051
DB00661,The metabolism of Verapamil can be increased when combined with Adalimumab.,Verapamil,DB00051
DB00672,The metabolism of Chlorpropamide can be increased when combined with Adalimumab.,Chlorpropamide,DB00051
DB00678,The metabolism of Losartan can be increased when combined with Adalimumab.,Losartan,DB00051
DB00701,The metabolism of Amprenavir can be increased when combined with Adalimumab.,Amprenavir,DB00051
DB00712,The metabolism of Flurbiprofen can be increased when combined with Adalimumab.,Flurbiprofen,DB00051
DB00731,The metabolism of Nateglinide can be increased when combined with Adalimumab.,Nateglinide,DB00051
DB00744,The metabolism of Zileuton can be increased when combined with Adalimumab.,Zileuton,DB00051
DB00749,The metabolism of Etodolac can be increased when combined with Adalimumab.,Etodolac,DB00051
DB00755,The metabolism of Tretinoin can be increased when combined with Adalimumab.,Tretinoin,DB00051
DB00758,The metabolism of Clopidogrel can be increased when combined with Adalimumab.,Clopidogrel,DB00051
DB00783,The metabolism of Estradiol can be increased when combined with Adalimumab.,Estradiol,DB00051
DB00784,The metabolism of Mefenamic acid can be increased when combined with Adalimumab.,Mefenamic acid,DB00051
DB00788,The metabolism of Naproxen can be increased when combined with Adalimumab.,Naproxen,DB00051
DB00796,The metabolism of Candesartan cilexetil can be increased when combined with Adalimumab.,Candesartan cilexetil,DB00051
DB00812,The metabolism of Phenylbutazone can be increased when combined with Adalimumab.,Phenylbutazone,DB00051
DB00814,The metabolism of Meloxicam can be increased when combined with Adalimumab.,Meloxicam,DB00051
DB00839,The metabolism of Tolazamide can be increased when combined with Adalimumab.,Tolazamide,DB00051
DB00843,The metabolism of Donepezil can be increased when combined with Adalimumab.,Donepezil,DB00051
DB00857,The metabolism of Terbinafine can be increased when combined with Adalimumab.,Terbinafine,DB00051
DB00904,The metabolism of Ondansetron can be increased when combined with Adalimumab.,Ondansetron,DB00051
DB00921,The metabolism of Buprenorphine can be increased when combined with Adalimumab.,Buprenorphine,DB00051
DB00936,The metabolism of Salicylic acid can be increased when combined with Adalimumab.,Salicylic acid,DB00051
DB00945,The metabolism of Acetylsalicylic acid can be increased when combined with Adalimumab.,Acetylsalicylic acid,DB00051
DB00969,The metabolism of Alosetron can be increased when combined with Adalimumab.,Alosetron,DB00051
DB00972,The metabolism of Azelastine can be increased when combined with Adalimumab.,Azelastine,DB00051
DB00980,The metabolism of Ramelteon can be increased when combined with Adalimumab.,Ramelteon,DB00051
DB01016,The metabolism of Glyburide can be increased when combined with Adalimumab.,Glyburide,DB00051
DB01029,The metabolism of Irbesartan can be increased when combined with Adalimumab.,Irbesartan,DB00051
DB01036,The metabolism of Tolterodine can be increased when combined with Adalimumab.,Tolterodine,DB00051
DB01037,The metabolism of Selegiline can be increased when combined with Adalimumab.,Selegiline,DB00051
DB01041,The metabolism of Thalidomide can be increased when combined with Adalimumab.,Thalidomide,DB00051
DB01050,The metabolism of Ibuprofen can be increased when combined with Adalimumab.,Ibuprofen,DB00051
DB01065,The metabolism of Melatonin can be increased when combined with Adalimumab.,Melatonin,DB00051
DB01067,The metabolism of Glipizide can be increased when combined with Adalimumab.,Glipizide,DB00051
DB01072,The metabolism of Atazanavir can be increased when combined with Adalimumab.,Atazanavir,DB00051
DB01075,The metabolism of Diphenhydramine can be increased when combined with Adalimumab.,Diphenhydramine,DB00051
DB01095,The metabolism of Fluvastatin can be increased when combined with Adalimumab.,Fluvastatin,DB00051
DB01098,The metabolism of Rosuvastatin can be increased when combined with Adalimumab.,Rosuvastatin,DB00051
DB01120,The metabolism of Gliclazide can be increased when combined with Adalimumab.,Gliclazide,DB00051
DB01124,The metabolism of Tolbutamide can be increased when combined with Adalimumab.,Tolbutamide,DB00051
DB01136,The metabolism of Carvedilol can be increased when combined with Adalimumab.,Carvedilol,DB00051
DB01154,The metabolism of Thiamylal can be increased when combined with Adalimumab.,Thiamylal,DB00051
DB01171,The metabolism of Moclobemide can be increased when combined with Adalimumab.,Moclobemide,DB00051
DB01177,The metabolism of Idarubicin can be increased when combined with Adalimumab.,Idarubicin,DB00051
DB01198,The metabolism of Zopiclone can be increased when combined with Adalimumab.,Zopiclone,DB00051
DB01251,The metabolism of Gliquidone can be increased when combined with Adalimumab.,Gliquidone,DB00051
DB01283,The metabolism of Lumiracoxib can be increased when combined with Adalimumab.,Lumiracoxib,DB00051
DB01289,The metabolism of Glisoxepide can be increased when combined with Adalimumab.,Glisoxepide,DB00051
DB01357,The metabolism of Mestranol can be increased when combined with Adalimumab.,Mestranol,DB00051
DB01424,The metabolism of Aminophenazone can be increased when combined with Adalimumab.,Aminophenazone,DB00051
DB01435,The metabolism of Antipyrine can be increased when combined with Adalimumab.,Antipyrine,DB00051
DB01589,The metabolism of Quazepam can be increased when combined with Adalimumab.,Quazepam,DB00051
DB01628,The metabolism of Etoricoxib can be increased when combined with Adalimumab.,Etoricoxib,DB00051
DB03756,The metabolism of Doconexent can be increased when combined with Adalimumab.,Doconexent,DB00051
DB03783,The metabolism of Phenacetin can be increased when combined with Adalimumab.,Phenacetin,DB00051
DB04557,The metabolism of Arachidonic Acid can be increased when combined with Adalimumab.,Arachidonic Acid,DB00051
DB04574,The metabolism of Estrone sulfate can be increased when combined with Adalimumab.,Estrone sulfate,DB00051
DB04665,The metabolism of Coumarin can be increased when combined with Adalimumab.,Coumarin,DB00051
DB04725,The metabolism of Licofelone can be increased when combined with Adalimumab.,Licofelone,DB00051
DB04841,The metabolism of Flunarizine can be increased when combined with Adalimumab.,Flunarizine,DB00051
DB04898,The metabolism of Ximelagatran can be increased when combined with Adalimumab.,Ximelagatran,DB00051
DB06204,The metabolism of Tapentadol can be increased when combined with Adalimumab.,Tapentadol,DB00051
DB06268,The metabolism of Sitaxentan can be increased when combined with Adalimumab.,Sitaxentan,DB00051
DB06370,The metabolism of Indisulam can be increased when combined with Adalimumab.,Indisulam,DB00051
DB06652,The metabolism of Vicriviroc can be increased when combined with Adalimumab.,Vicriviroc,DB00051
DB06725,The metabolism of Lornoxicam can be increased when combined with Adalimumab.,Lornoxicam,DB00051
DB06737,The metabolism of Zaltoprofen can be increased when combined with Adalimumab.,Zaltoprofen,DB00051
DB06803,The metabolism of Niclosamide can be increased when combined with Adalimumab.,Niclosamide,DB00051
DB07615,The metabolism of Tranilast can be increased when combined with Adalimumab.,Tranilast,DB00051
DB08439,The metabolism of Parecoxib can be increased when combined with Adalimumab.,Parecoxib,DB00051
DB08828,The metabolism of Vismodegib can be increased when combined with Adalimumab.,Vismodegib,DB00051
DB08860,The metabolism of Pitavastatin can be increased when combined with Adalimumab.,Pitavastatin,DB00051
DB08875,The metabolism of Cabozantinib can be increased when combined with Adalimumab.,Cabozantinib,DB00051
DB08899,The metabolism of Enzalutamide can be increased when combined with Adalimumab.,Enzalutamide,DB00051
DB08962,The metabolism of Glibornuride can be increased when combined with Adalimumab.,Glibornuride,DB00051
DB09048,The metabolism of Netupitant can be increased when combined with Adalimumab.,Netupitant,DB00051
DB09061,The metabolism of Cannabidiol can be increased when combined with Adalimumab.,Cannabidiol,DB00051
DB09080,The metabolism of Olodaterol can be increased when combined with Adalimumab.,Olodaterol,DB00051
DB09288,The metabolism of Propacetamol can be increased when combined with Adalimumab.,Propacetamol,DB00051
DB11560,The metabolism of Lesinurad can be increased when combined with Adalimumab.,Lesinurad,DB00051
DB11614,The metabolism of Rupatadine can be increased when combined with Adalimumab.,Rupatadine,DB00051
DB13406,The metabolism of Carbutamide can be increased when combined with Adalimumab.,Carbutamide,DB00051
DB13675,The metabolism of Metahexamide can be increased when combined with Adalimumab.,Metahexamide,DB00051
DB13919,The metabolism of Candesartan can be increased when combined with Adalimumab.,Candesartan,DB00051
DB13941,The metabolism of Piperaquine can be increased when combined with Adalimumab.,Piperaquine,DB00051
DB13952,The metabolism of Estradiol acetate can be increased when combined with Adalimumab.,Estradiol acetate,DB00051
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Adalimumab.,Estradiol benzoate,DB00051
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Adalimumab.,Estradiol cypionate,DB00051
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Adalimumab.,Estradiol dienanthate,DB00051
DB13956,The metabolism of Estradiol valerate can be increased when combined with Adalimumab.,Estradiol valerate,DB00051
DB14009,The metabolism of Medical Cannabis can be increased when combined with Adalimumab.,Medical Cannabis,DB00051
DB14011,The metabolism of Nabiximols can be increased when combined with Adalimumab.,Nabiximols,DB00051
DB00829,The metabolism of Diazepam can be increased when combined with Adalimumab.,Diazepam,DB00051
DB00514,The metabolism of Dextromethorphan can be increased when combined with Adalimumab.,Dextromethorphan,DB00051
DB00470,The metabolism of Dronabinol can be increased when combined with Adalimumab.,Dronabinol,DB00051
DB09213,The metabolism of Dexibuprofen can be increased when combined with Adalimumab.,Dexibuprofen,DB00051
DB00465,The metabolism of Ketorolac can be increased when combined with Adalimumab.,Ketorolac,DB00051
DB15233,The metabolism of Avapritinib can be increased when combined with Adalimumab.,Avapritinib,DB00051
DB00321,The metabolism of Amitriptyline can be increased when combined with Adalimumab.,Amitriptyline,DB00051
DB01142,The metabolism of Doxepin can be increased when combined with Adalimumab.,Doxepin,DB00051
DB00216,The metabolism of Eletriptan can be increased when combined with Adalimumab.,Eletriptan,DB00051
DB00404,The metabolism of Alprazolam can be increased when combined with Adalimumab.,Alprazolam,DB00051
DB00726,The metabolism of Trimipramine can be increased when combined with Adalimumab.,Trimipramine,DB00051
DB01101,The metabolism of Capecitabine can be increased when combined with Adalimumab.,Capecitabine,DB00051
DB00266,The metabolism of Dicoumarol can be increased when combined with Adalimumab.,Dicoumarol,DB00051
DB00313,The metabolism of Valproic acid can be increased when combined with Adalimumab.,Valproic acid,DB00051
DB00908,The metabolism of Quinidine can be increased when combined with Adalimumab.,Quinidine,DB00051
DB13136,The metabolism of Fluindione can be increased when combined with Adalimumab.,Fluindione,DB00051
DB01224,The metabolism of Quetiapine can be increased when combined with Adalimumab.,Quetiapine,DB00051
DB00182,The metabolism of Amphetamine can be increased when combined with Adalimumab.,Amphetamine,DB00051
DB00187,The metabolism of Esmolol can be increased when combined with Adalimumab.,Esmolol,DB00051
DB00245,The metabolism of Benzatropine can be increased when combined with Adalimumab.,Benzatropine,DB00051
DB00289,The metabolism of Atomoxetine can be increased when combined with Adalimumab.,Atomoxetine,DB00051
DB00335,The metabolism of Atenolol can be increased when combined with Adalimumab.,Atenolol,DB00051
DB00373,The metabolism of Timolol can be increased when combined with Adalimumab.,Timolol,DB00051
DB00409,The metabolism of Remoxipride can be increased when combined with Adalimumab.,Remoxipride,DB00051
DB00592,The metabolism of Piperazine can be increased when combined with Adalimumab.,Piperazine,DB00051
DB00699,The metabolism of Nicergoline can be increased when combined with Adalimumab.,Nicergoline,DB00051
DB00737,The metabolism of Meclizine can be increased when combined with Adalimumab.,Meclizine,DB00051
DB00805,The metabolism of Minaprine can be increased when combined with Adalimumab.,Minaprine,DB00051
DB00866,The metabolism of Alprenolol can be increased when combined with Adalimumab.,Alprenolol,DB00051
DB00914,The metabolism of Phenformin can be increased when combined with Adalimumab.,Phenformin,DB00051
DB00933,The metabolism of Mesoridazine can be increased when combined with Adalimumab.,Mesoridazine,DB00051
DB00960,The metabolism of Pindolol can be increased when combined with Adalimumab.,Pindolol,DB00051
DB01071,The metabolism of Mequitazine can be increased when combined with Adalimumab.,Mequitazine,DB00051
DB01079,The metabolism of Tegaserod can be increased when combined with Adalimumab.,Tegaserod,DB00051
DB01193,The metabolism of Acebutolol can be increased when combined with Adalimumab.,Acebutolol,DB00051
DB01203,The metabolism of Nadolol can be increased when combined with Adalimumab.,Nadolol,DB00051
DB01228,The metabolism of Encainide can be increased when combined with Adalimumab.,Encainide,DB00051
DB01233,The metabolism of Metoclopramide can be increased when combined with Adalimumab.,Metoclopramide,DB00051
DB01255,The metabolism of Lisdexamfetamine can be increased when combined with Adalimumab.,Lisdexamfetamine,DB00051
DB01295,The metabolism of Bevantolol can be increased when combined with Adalimumab.,Bevantolol,DB00051
DB01297,The metabolism of Practolol can be increased when combined with Adalimumab.,Practolol,DB00051
DB01359,The metabolism of Penbutolol can be increased when combined with Adalimumab.,Penbutolol,DB00051
DB01403,The metabolism of Methotrimeprazine can be increased when combined with Adalimumab.,Methotrimeprazine,DB00051
DB01429,The metabolism of Aprindine can be increased when combined with Adalimumab.,Aprindine,DB00051
DB01454,The metabolism of Midomafetamine can be increased when combined with Adalimumab.,Midomafetamine,DB00051
DB01472,The metabolism of 4-Methoxyamphetamine can be increased when combined with Adalimumab.,4-Methoxyamphetamine,DB00051
DB01576,The metabolism of Dextroamphetamine can be increased when combined with Adalimumab.,Dextroamphetamine,DB00051
DB01577,The metabolism of Metamfetamine can be increased when combined with Adalimumab.,Metamfetamine,DB00051
DB01580,The metabolism of Oxprenolol can be increased when combined with Adalimumab.,Oxprenolol,DB00051
DB04840,The metabolism of Debrisoquine can be increased when combined with Adalimumab.,Debrisoquine,DB00051
DB04844,The metabolism of Tetrabenazine can be increased when combined with Adalimumab.,Tetrabenazine,DB00051
DB04846,The metabolism of Celiprolol can be increased when combined with Adalimumab.,Celiprolol,DB00051
DB06217,The metabolism of Vernakalant can be increased when combined with Adalimumab.,Vernakalant,DB00051
DB06506,The metabolism of Repinotan can be increased when combined with Adalimumab.,Repinotan,DB00051
DB06608,The metabolism of Tafenoquine can be increased when combined with Adalimumab.,Tafenoquine,DB00051
DB06678,The metabolism of Esmirtazapine can be increased when combined with Adalimumab.,Esmirtazapine,DB00051
DB06726,The metabolism of Bufuralol can be increased when combined with Adalimumab.,Bufuralol,DB00051
DB06727,The metabolism of Sparteine can be increased when combined with Adalimumab.,Sparteine,DB00051
DB06735,The metabolism of Enclomiphene can be increased when combined with Adalimumab.,Enclomiphene,DB00051
DB08807,The metabolism of Bopindolol can be increased when combined with Adalimumab.,Bopindolol,DB00051
DB08808,The metabolism of Bupranolol can be increased when combined with Adalimumab.,Bupranolol,DB00051
DB08952,The metabolism of Indenolol can be increased when combined with Adalimumab.,Indenolol,DB00051
DB09013,The metabolism of Befunolol can be increased when combined with Adalimumab.,Befunolol,DB00051
DB09076,The metabolism of Umeclidinium can be increased when combined with Adalimumab.,Umeclidinium,DB00051
DB09204,The metabolism of Arotinolol can be increased when combined with Adalimumab.,Arotinolol,DB00051
DB09351,The metabolism of Levobetaxolol can be increased when combined with Adalimumab.,Levobetaxolol,DB00051
DB11770,The metabolism of Talinolol can be increased when combined with Adalimumab.,Talinolol,DB00051
DB11785,The metabolism of Anisodamine can be increased when combined with Adalimumab.,Anisodamine,DB00051
DB11855,The metabolism of Revefenacin can be increased when combined with Adalimumab.,Revefenacin,DB00051
DB11979,The metabolism of Elagolix can be increased when combined with Adalimumab.,Elagolix,DB00051
DB12070,The metabolism of Letermovir can be increased when combined with Adalimumab.,Letermovir,DB00051
DB12212,The metabolism of Landiolol can be increased when combined with Adalimumab.,Landiolol,DB00051
DB12752,The metabolism of Bucindolol can be increased when combined with Adalimumab.,Bucindolol,DB00051
DB13443,The metabolism of Esatenolol can be increased when combined with Adalimumab.,Esatenolol,DB00051
DB13508,The metabolism of Cloranolol can be increased when combined with Adalimumab.,Cloranolol,DB00051
DB13530,The metabolism of Mepindolol can be increased when combined with Adalimumab.,Mepindolol,DB00051
DB13679,The metabolism of Dexchlorpheniramine can be increased when combined with Adalimumab.,Dexchlorpheniramine,DB00051
DB13757,The metabolism of Epanolol can be increased when combined with Adalimumab.,Epanolol,DB00051
DB13775,The metabolism of Tertatolol can be increased when combined with Adalimumab.,Tertatolol,DB00051
DB00850,The metabolism of Perphenazine can be increased when combined with Adalimumab.,Perphenazine,DB00051
DB09173,The metabolism of Butyrfentanyl can be increased when combined with Adalimumab.,Butyrfentanyl,DB00051
DB00281,The metabolism of Lidocaine can be increased when combined with Adalimumab.,Lidocaine,DB00051
DB00598,The metabolism of Labetalol can be increased when combined with Adalimumab.,Labetalol,DB00051
DB14010,"The metabolism of 5-methoxy-N,N-dimethyltryptamine can be increased when combined with Adalimumab.","5-methoxy-N,N-dimethyltryptamine",DB00051
DB01410,The metabolism of Ciclesonide can be increased when combined with Adalimumab.,Ciclesonide,DB00051
DB00918,The metabolism of Almotriptan can be increased when combined with Adalimumab.,Almotriptan,DB00051
DB08918,The metabolism of Levomilnacipran can be increased when combined with Adalimumab.,Levomilnacipran,DB00051
DB08922,The metabolism of Perospirone can be increased when combined with Adalimumab.,Perospirone,DB00051
DB09183,The metabolism of Dasabuvir can be increased when combined with Adalimumab.,Dasabuvir,DB00051
DB00185,The metabolism of Cevimeline can be increased when combined with Adalimumab.,Cevimeline,DB00051
DB00243,The metabolism of Ranolazine can be increased when combined with Adalimumab.,Ranolazine,DB00051
DB00297,The metabolism of Bupivacaine can be increased when combined with Adalimumab.,Bupivacaine,DB00051
DB00318,The metabolism of Codeine can be increased when combined with Adalimumab.,Codeine,DB00051
DB00377,The metabolism of Palonosetron can be increased when combined with Adalimumab.,Palonosetron,DB00051
DB00589,The metabolism of Lisuride can be increased when combined with Adalimumab.,Lisuride,DB00051
DB00647,The metabolism of Dextropropoxyphene can be increased when combined with Adalimumab.,Dextropropoxyphene,DB00051
DB00674,The metabolism of Galantamine can be increased when combined with Adalimumab.,Galantamine,DB00051
DB00705,The metabolism of Delavirdine can be increased when combined with Adalimumab.,Delavirdine,DB00051
DB00706,The metabolism of Tamsulosin can be increased when combined with Adalimumab.,Tamsulosin,DB00051
DB00757,The metabolism of Dolasetron can be increased when combined with Adalimumab.,Dolasetron,DB00051
DB01149,The metabolism of Nefazodone can be increased when combined with Adalimumab.,Nefazodone,DB00051
DB01192,The metabolism of Oxymorphone can be increased when combined with Adalimumab.,Oxymorphone,DB00051
DB01244,The metabolism of Bepridil can be increased when combined with Adalimumab.,Bepridil,DB00051
DB01392,The metabolism of Yohimbine can be increased when combined with Adalimumab.,Yohimbine,DB00051
DB01409,The metabolism of Tiotropium can be increased when combined with Adalimumab.,Tiotropium,DB00051
DB01551,The metabolism of Dihydrocodeine can be increased when combined with Adalimumab.,Dihydrocodeine,DB00051
DB01591,The metabolism of Solifenacin can be increased when combined with Adalimumab.,Solifenacin,DB00051
DB01621,The metabolism of Pipotiazine can be increased when combined with Adalimumab.,Pipotiazine,DB00051
DB02703,The metabolism of Fusidic acid can be increased when combined with Adalimumab.,Fusidic acid,DB00051
DB04829,The metabolism of Lysergic acid diethylamide can be increased when combined with Adalimumab.,Lysergic acid diethylamide,DB00051
DB04884,The metabolism of Dapoxetine can be increased when combined with Adalimumab.,Dapoxetine,DB00051
DB04905,The metabolism of Tesmilifene can be increased when combined with Adalimumab.,Tesmilifene,DB00051
DB04920,The metabolism of Clevidipine can be increased when combined with Adalimumab.,Clevidipine,DB00051
DB05271,The metabolism of Rotigotine can be increased when combined with Adalimumab.,Rotigotine,DB00051
DB06016,The metabolism of Cariprazine can be increased when combined with Adalimumab.,Cariprazine,DB00051
DB06144,The metabolism of Sertindole can be increased when combined with Adalimumab.,Sertindole,DB00051
DB06203,The metabolism of Alogliptin can be increased when combined with Adalimumab.,Alogliptin,DB00051
DB06702,The metabolism of Fesoterodine can be increased when combined with Adalimumab.,Fesoterodine,DB00051
DB08893,The metabolism of Mirabegron can be increased when combined with Adalimumab.,Mirabegron,DB00051
DB09128,The metabolism of Brexpiprazole can be increased when combined with Adalimumab.,Brexpiprazole,DB00051
DB09195,The metabolism of Lorpiprazole can be increased when combined with Adalimumab.,Lorpiprazole,DB00051
DB09555,The metabolism of Dexchlorpheniramine maleate can be increased when combined with Adalimumab.,Dexchlorpheniramine maleate,DB00051
DB11130,The metabolism of Opium can be increased when combined with Adalimumab.,Opium,DB00051
DB11642,The metabolism of Pitolisant can be increased when combined with Adalimumab.,Pitolisant,DB00051
DB13293,The metabolism of Ipecac can be increased when combined with Adalimumab.,Ipecac,DB00051
DB00344,The metabolism of Protriptyline can be increased when combined with Adalimumab.,Protriptyline,DB00051
DB00496,The metabolism of Darifenacin can be increased when combined with Adalimumab.,Darifenacin,DB00051
DB00543,The metabolism of Amoxapine can be increased when combined with Adalimumab.,Amoxapine,DB00051
DB00932,The metabolism of Tipranavir can be increased when combined with Adalimumab.,Tipranavir,DB00051
DB09039,The metabolism of Eliglustat can be increased when combined with Adalimumab.,Eliglustat,DB00051
DB12930,The metabolism of Opipramol can be increased when combined with Adalimumab.,Opipramol,DB00051
DB00489,The metabolism of Sotalol can be increased when combined with Adalimumab.,Sotalol,DB00051
DB01035,The metabolism of Procainamide can be increased when combined with Adalimumab.,Procainamide,DB00051
DB01195,The metabolism of Flecainide can be increased when combined with Adalimumab.,Flecainide,DB00051
DB00228,The metabolism of Enflurane can be increased when combined with Adalimumab.,Enflurane,DB00051
DB06712,The metabolism of Nilvadipine can be increased when combined with Adalimumab.,Nilvadipine,DB00051
DB06728,The metabolism of Aniline can be increased when combined with Adalimumab.,Aniline,DB00051
DB00949,The metabolism of Felbamate can be increased when combined with Adalimumab.,Felbamate,DB00051
DB00593,The metabolism of Ethosuximide can be increased when combined with Adalimumab.,Ethosuximide,DB00051
DB00186,The metabolism of Lorazepam can be increased when combined with Adalimumab.,Lorazepam,DB00051
DB00191,The metabolism of Phentermine can be increased when combined with Adalimumab.,Phentermine,DB00051
DB00207,The metabolism of Azithromycin can be increased when combined with Adalimumab.,Azithromycin,DB00051
DB00208,The metabolism of Ticlopidine can be increased when combined with Adalimumab.,Ticlopidine,DB00051
DB00264,The metabolism of Metoprolol can be increased when combined with Adalimumab.,Metoprolol,DB00051
DB00426,The metabolism of Famciclovir can be increased when combined with Adalimumab.,Famciclovir,DB00051
DB00433,The metabolism of Prochlorperazine can be increased when combined with Adalimumab.,Prochlorperazine,DB00051
DB00567,The metabolism of Cephalexin can be increased when combined with Adalimumab.,Cephalexin,DB00051
DB00590,The metabolism of Doxazosin can be increased when combined with Adalimumab.,Doxazosin,DB00051
DB01039,The metabolism of Fenofibrate can be increased when combined with Adalimumab.,Fenofibrate,DB00051
DB01395,The metabolism of Drospirenone can be increased when combined with Adalimumab.,Drospirenone,DB00051
DB01411,The metabolism of Pranlukast can be increased when combined with Adalimumab.,Pranlukast,DB00051
DB01431,The metabolism of Allylestrenol can be increased when combined with Adalimumab.,Allylestrenol,DB00051
DB01624,The metabolism of Zuclopenthixol can be increased when combined with Adalimumab.,Zuclopenthixol,DB00051
DB06201,The metabolism of Rufinamide can be increased when combined with Adalimumab.,Rufinamide,DB00051
DB06480,The metabolism of Prucalopride can be increased when combined with Adalimumab.,Prucalopride,DB00051
DB08882,The metabolism of Linagliptin can be increased when combined with Adalimumab.,Linagliptin,DB00051
DB09030,The metabolism of Vorapaxar can be increased when combined with Adalimumab.,Vorapaxar,DB00051
DB09034,The metabolism of Suvorexant can be increased when combined with Adalimumab.,Suvorexant,DB00051
DB09079,The metabolism of Nintedanib can be increased when combined with Adalimumab.,Nintedanib,DB00051
DB09299,The metabolism of Tenofovir alafenamide can be increased when combined with Adalimumab.,Tenofovir alafenamide,DB00051
DB09330,The metabolism of Osimertinib can be increased when combined with Adalimumab.,Osimertinib,DB00051
DB11094,The metabolism of Vitamin D can be increased when combined with Adalimumab.,Vitamin D,DB00051
DB11273,The metabolism of Dihydroergocornine can be increased when combined with Adalimumab.,Dihydroergocornine,DB00051
DB11730,The metabolism of Ribociclib can be increased when combined with Adalimumab.,Ribociclib,DB00051
DB11952,The metabolism of Duvelisib can be increased when combined with Adalimumab.,Duvelisib,DB00051
DB12141,The metabolism of Gilteritinib can be increased when combined with Adalimumab.,Gilteritinib,DB00051
DB12515,The metabolism of 9-aminocamptothecin can be increased when combined with Adalimumab.,9-aminocamptothecin,DB00051
DB12952,The metabolism of Methylprednisone can be increased when combined with Adalimumab.,Methylprednisone,DB00051
DB13345,The metabolism of Dihydroergocristine can be increased when combined with Adalimumab.,Dihydroergocristine,DB00051
DB13385,The metabolism of Dihydroergocryptine can be increased when combined with Adalimumab.,Dihydroergocryptine,DB00051
DB14126,The metabolism of Tenofovir can be increased when combined with Adalimumab.,Tenofovir,DB00051
DB15444,The metabolism of Elexacaftor can be increased when combined with Adalimumab.,Elexacaftor,DB00051
DB06717,The metabolism of Fosaprepitant can be increased when combined with Adalimumab.,Fosaprepitant,DB00051
DB12825,The metabolism of Lefamulin can be increased when combined with Adalimumab.,Lefamulin,DB00051
DB12887,The metabolism of Tazemetostat can be increased when combined with Adalimumab.,Tazemetostat,DB00051
DB00454,The metabolism of Meperidine can be increased when combined with Adalimumab.,Meperidine,DB00051
DB01151,The metabolism of Desipramine can be increased when combined with Adalimumab.,Desipramine,DB00051
DB12371,The metabolism of Siponimod can be increased when combined with Adalimumab.,Siponimod,DB00051
DB00247,The metabolism of Methysergide can be increased when combined with Adalimumab.,Methysergide,DB00051
DB08827,The metabolism of Lomitapide can be increased when combined with Adalimumab.,Lomitapide,DB00051
DB11742,The metabolism of Ebastine can be increased when combined with Adalimumab.,Ebastine,DB00051
DB05015,The metabolism of Belinostat can be increased when combined with Adalimumab.,Belinostat,DB00051
DB01118,The metabolism of Amiodarone can be increased when combined with Adalimumab.,Amiodarone,DB00051
DB00675,The metabolism of Tamoxifen can be increased when combined with Adalimumab.,Tamoxifen,DB00051
DB00204,The metabolism of Dofetilide can be increased when combined with Adalimumab.,Dofetilide,DB00051
DB00342,The metabolism of Terfenadine can be increased when combined with Adalimumab.,Terfenadine,DB00051
DB00451,The metabolism of Levothyroxine can be increased when combined with Adalimumab.,Levothyroxine,DB00051
DB00604,The metabolism of Cisapride can be increased when combined with Adalimumab.,Cisapride,DB00051
DB00877,The metabolism of Sirolimus can be increased when combined with Adalimumab.,Sirolimus,DB00051
DB01008,The metabolism of Busulfan can be increased when combined with Adalimumab.,Busulfan,DB00051
DB01254,The metabolism of Dasatinib can be increased when combined with Adalimumab.,Dasatinib,DB00051
DB01396,The metabolism of Digitoxin can be increased when combined with Adalimumab.,Digitoxin,DB00051
DB01590,The metabolism of Everolimus can be increased when combined with Adalimumab.,Everolimus,DB00051
DB03410,The metabolism of 4-hydroxycoumarin can be increased when combined with Adalimumab.,4-hydroxycoumarin,DB00051
DB04855,The metabolism of Dronedarone can be increased when combined with Adalimumab.,Dronedarone,DB00051
DB06287,The metabolism of Temsirolimus can be increased when combined with Adalimumab.,Temsirolimus,DB00051
DB09053,The metabolism of Ibrutinib can be increased when combined with Adalimumab.,Ibrutinib,DB00051
DB09289,The metabolism of Tianeptine can be increased when combined with Adalimumab.,Tianeptine,DB00051
DB11633,The metabolism of Isavuconazole can be increased when combined with Adalimumab.,Isavuconazole,DB00051
DB13275,The metabolism of Clorindione can be increased when combined with Adalimumab.,Clorindione,DB00051
DB00398,The metabolism of Sorafenib can be increased when combined with Adalimumab.,Sorafenib,DB00051
DB00444,The metabolism of Teniposide can be increased when combined with Adalimumab.,Teniposide,DB00051
DB00530,The metabolism of Erlotinib can be increased when combined with Adalimumab.,Erlotinib,DB00051
DB00541,The metabolism of Vincristine can be increased when combined with Adalimumab.,Vincristine,DB00051
DB00619,The metabolism of Imatinib can be increased when combined with Adalimumab.,Imatinib,DB00051
DB00773,The metabolism of Etoposide can be increased when combined with Adalimumab.,Etoposide,DB00051
DB01248,The metabolism of Docetaxel can be increased when combined with Adalimumab.,Docetaxel,DB00051
DB01268,The metabolism of Sunitinib can be increased when combined with Adalimumab.,Sunitinib,DB00051
DB06626,The metabolism of Axitinib can be increased when combined with Adalimumab.,Axitinib,DB00051
DB08865,The metabolism of Crizotinib can be increased when combined with Adalimumab.,Crizotinib,DB00051
DB08901,The metabolism of Ponatinib can be increased when combined with Adalimumab.,Ponatinib,DB00051
DB12483,The metabolism of Copanlisib can be increased when combined with Adalimumab.,Copanlisib,DB00051
DB00188,The metabolism of Bortezomib can be increased when combined with Adalimumab.,Bortezomib,DB00051
DB00363,The metabolism of Clozapine can be increased when combined with Adalimumab.,Clozapine,DB00051
DB01181,The metabolism of Ifosfamide can be increased when combined with Adalimumab.,Ifosfamide,DB00051
DB05109,The metabolism of Trabectedin can be increased when combined with Adalimumab.,Trabectedin,DB00051
DB12147,The metabolism of Erdafitinib can be increased when combined with Adalimumab.,Erdafitinib,DB00051
DB13874,The metabolism of Enasidenib can be increased when combined with Adalimumab.,Enasidenib,DB00051
DB06589,The metabolism of Pazopanib can be increased when combined with Adalimumab.,Pazopanib,DB00051
DB05239,The metabolism of Cobimetinib can be increased when combined with Adalimumab.,Cobimetinib,DB00051
DB09063,The metabolism of Ceritinib can be increased when combined with Adalimumab.,Ceritinib,DB00051
DB11963,The metabolism of Dacomitinib can be increased when combined with Adalimumab.,Dacomitinib,DB00051
DB12015,The metabolism of Alpelisib can be increased when combined with Adalimumab.,Alpelisib,DB00051
DB00309,The metabolism of Vindesine can be increased when combined with Adalimumab.,Vindesine,DB00051
DB00361,The metabolism of Vinorelbine can be increased when combined with Adalimumab.,Vinorelbine,DB00051
DB00570,The metabolism of Vinblastine can be increased when combined with Adalimumab.,Vinblastine,DB00051
DB00694,The metabolism of Daunorubicin can be increased when combined with Adalimumab.,Daunorubicin,DB00051
DB00987,The metabolism of Cytarabine can be increased when combined with Adalimumab.,Cytarabine,DB00051
DB00997,The metabolism of Doxorubicin can be increased when combined with Adalimumab.,Doxorubicin,DB00051
DB01108,The metabolism of Trilostane can be increased when combined with Adalimumab.,Trilostane,DB00051
DB04572,The metabolism of Thiotepa can be increased when combined with Adalimumab.,Thiotepa,DB00051
DB04845,The metabolism of Ixabepilone can be increased when combined with Adalimumab.,Ixabepilone,DB00051
DB04868,The metabolism of Nilotinib can be increased when combined with Adalimumab.,Nilotinib,DB00051
DB06603,The metabolism of Panobinostat can be increased when combined with Adalimumab.,Panobinostat,DB00051
DB06616,The metabolism of Bosutinib can be increased when combined with Adalimumab.,Bosutinib,DB00051
DB08870,The metabolism of Brentuximab vedotin can be increased when combined with Adalimumab.,Brentuximab vedotin,DB00051
DB08877,The metabolism of Ruxolitinib can be increased when combined with Adalimumab.,Ruxolitinib,DB00051
DB09073,The metabolism of Palbociclib can be increased when combined with Adalimumab.,Palbociclib,DB00051
DB08912,The metabolism of Dabrafenib can be increased when combined with Adalimumab.,Dabrafenib,DB00051
DB12267,The metabolism of Brigatinib can be increased when combined with Adalimumab.,Brigatinib,DB00051
DB11718,The metabolism of Encorafenib can be increased when combined with Adalimumab.,Encorafenib,DB00051
DB00563,The metabolism of Methotrexate can be increased when combined with Adalimumab.,Methotrexate,DB00051
DB05294,The metabolism of Vandetanib can be increased when combined with Adalimumab.,Vandetanib,DB00051
DB05812,The metabolism of Abiraterone can be increased when combined with Adalimumab.,Abiraterone,DB00051
DB08881,The metabolism of Vemurafenib can be increased when combined with Adalimumab.,Vemurafenib,DB00051
DB11363,The metabolism of Alectinib can be increased when combined with Adalimumab.,Alectinib,DB00051
DB11581,The metabolism of Venetoclax can be increased when combined with Adalimumab.,Venetoclax,DB00051
DB11641,The metabolism of Vinflunine can be increased when combined with Adalimumab.,Vinflunine,DB00051
DB11703,The metabolism of Acalabrutinib can be increased when combined with Adalimumab.,Acalabrutinib,DB00051
DB15035,The metabolism of Zanubrutinib can be increased when combined with Adalimumab.,Zanubrutinib,DB00051
DB00248,The metabolism of Cabergoline can be increased when combined with Adalimumab.,Cabergoline,DB00051
DB06595,The metabolism of Midostaurin can be increased when combined with Adalimumab.,Midostaurin,DB00051
DB09143,The metabolism of Sonidegib can be increased when combined with Adalimumab.,Sonidegib,DB00051
DB11828,The metabolism of Neratinib can be increased when combined with Adalimumab.,Neratinib,DB00051
DB11986,The metabolism of Entrectinib can be increased when combined with Adalimumab.,Entrectinib,DB00051
DB12978,The metabolism of Pexidartinib can be increased when combined with Adalimumab.,Pexidartinib,DB00051
DB14568,The metabolism of Ivosidenib can be increased when combined with Adalimumab.,Ivosidenib,DB00051
DB09054,The metabolism of Idelalisib can be increased when combined with Adalimumab.,Idelalisib,DB00051
DB09570,The metabolism of Ixazomib can be increased when combined with Adalimumab.,Ixazomib,DB00051
DB00199,The metabolism of Erythromycin can be increased when combined with Adalimumab.,Erythromycin,DB00051
DB00246,The metabolism of Ziprasidone can be increased when combined with Adalimumab.,Ziprasidone,DB00051
DB00439,The metabolism of Cerivastatin can be increased when combined with Adalimumab.,Cerivastatin,DB00051
DB00499,The metabolism of Flutamide can be increased when combined with Adalimumab.,Flutamide,DB00051
DB00528,The metabolism of Lercanidipine can be increased when combined with Adalimumab.,Lercanidipine,DB00051
DB00571,The metabolism of Propranolol can be increased when combined with Adalimumab.,Propranolol,DB00051
DB00588,The metabolism of Fluticasone propionate can be increased when combined with Adalimumab.,Fluticasone propionate,DB00051
DB00608,The metabolism of Chloroquine can be increased when combined with Adalimumab.,Chloroquine,DB00051
DB00688,The metabolism of Mycophenolate mofetil can be increased when combined with Adalimumab.,Mycophenolate mofetil,DB00051
DB00717,The metabolism of Norethisterone can be increased when combined with Adalimumab.,Norethisterone,DB00051
DB00738,The metabolism of Pentamidine can be increased when combined with Adalimumab.,Pentamidine,DB00051
DB00741,The metabolism of Hydrocortisone can be increased when combined with Adalimumab.,Hydrocortisone,DB00051
DB00762,The metabolism of Irinotecan can be increased when combined with Adalimumab.,Irinotecan,DB00051
DB00822,The metabolism of Disulfiram can be increased when combined with Adalimumab.,Disulfiram,DB00051
DB00834,The metabolism of Mifepristone can be increased when combined with Adalimumab.,Mifepristone,DB00051
DB00938,The metabolism of Salmeterol can be increased when combined with Adalimumab.,Salmeterol,DB00051
DB00962,The metabolism of Zaleplon can be increased when combined with Adalimumab.,Zaleplon,DB00051
DB00976,The metabolism of Telithromycin can be increased when combined with Adalimumab.,Telithromycin,DB00051
DB01054,The metabolism of Nitrendipine can be increased when combined with Adalimumab.,Nitrendipine,DB00051
DB01058,The metabolism of Praziquantel can be increased when combined with Adalimumab.,Praziquantel,DB00051
DB01062,The metabolism of Oxybutynin can be increased when combined with Adalimumab.,Oxybutynin,DB00051
DB01076,The metabolism of Atorvastatin can be increased when combined with Adalimumab.,Atorvastatin,DB00051
DB01103,The metabolism of Quinacrine can be increased when combined with Adalimumab.,Quinacrine,DB00051
DB01115,The metabolism of Nifedipine can be increased when combined with Adalimumab.,Nifedipine,DB00051
DB01126,The metabolism of Dutasteride can be increased when combined with Adalimumab.,Dutasteride,DB00051
DB01166,The metabolism of Cilostazol can be increased when combined with Adalimumab.,Cilostazol,DB00051
DB01184,The metabolism of Domperidone can be increased when combined with Adalimumab.,Domperidone,DB00051
DB01211,The metabolism of Clarithromycin can be increased when combined with Adalimumab.,Clarithromycin,DB00051
DB01216,The metabolism of Finasteride can be increased when combined with Adalimumab.,Finasteride,DB00051
DB01218,The metabolism of Halofantrine can be increased when combined with Adalimumab.,Halofantrine,DB00051
DB05521,The metabolism of Telaprevir can be increased when combined with Adalimumab.,Telaprevir,DB00051
DB05773,The metabolism of Trastuzumab emtansine can be increased when combined with Adalimumab.,Trastuzumab emtansine,DB00051
DB06267,The metabolism of Udenafil can be increased when combined with Adalimumab.,Udenafil,DB00051
DB06335,The metabolism of Saxagliptin can be increased when combined with Adalimumab.,Saxagliptin,DB00051
DB06403,The metabolism of Ambrisentan can be increased when combined with Adalimumab.,Ambrisentan,DB00051
DB06419,The metabolism of Cethromycin can be increased when combined with Adalimumab.,Cethromycin,DB00051
DB06772,The metabolism of Cabazitaxel can be increased when combined with Adalimumab.,Cabazitaxel,DB00051
DB06789,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Adalimumab.,Hydroxyprogesterone caproate,DB00051
DB08820,The metabolism of Ivacaftor can be increased when combined with Adalimumab.,Ivacaftor,DB00051
DB08873,The metabolism of Boceprevir can be increased when combined with Adalimumab.,Boceprevir,DB00051
DB08883,The metabolism of Perampanel can be increased when combined with Adalimumab.,Perampanel,DB00051
DB08906,The metabolism of Fluticasone furoate can be increased when combined with Adalimumab.,Fluticasone furoate,DB00051
DB09065,The metabolism of Cobicistat can be increased when combined with Adalimumab.,Cobicistat,DB00051
DB09074,The metabolism of Olaparib can be increased when combined with Adalimumab.,Olaparib,DB00051
DB09102,The metabolism of Daclatasvir can be increased when combined with Adalimumab.,Daclatasvir,DB00051
DB09231,The metabolism of Benidipine can be increased when combined with Adalimumab.,Benidipine,DB00051
DB09297,The metabolism of Paritaprevir can be increased when combined with Adalimumab.,Paritaprevir,DB00051
DB11574,The metabolism of Elbasvir can be increased when combined with Adalimumab.,Elbasvir,DB00051
DB11712,The metabolism of Tezacaftor can be increased when combined with Adalimumab.,Tezacaftor,DB00051
DB11737,The metabolism of Icotinib can be increased when combined with Adalimumab.,Icotinib,DB00051
DB12301,The metabolism of Doravirine can be increased when combined with Adalimumab.,Doravirine,DB00051
DB13867,The metabolism of Fluticasone can be increased when combined with Adalimumab.,Fluticasone,DB00051
DB14538,The metabolism of Hydrocortisone aceponate can be increased when combined with Adalimumab.,Hydrocortisone aceponate,DB00051
DB14539,The metabolism of Hydrocortisone acetate can be increased when combined with Adalimumab.,Hydrocortisone acetate,DB00051
DB14541,The metabolism of Hydrocortisone cypionate can be increased when combined with Adalimumab.,Hydrocortisone cypionate,DB00051
DB14542,The metabolism of Hydrocortisone phosphate can be increased when combined with Adalimumab.,Hydrocortisone phosphate,DB00051
DB00396,The metabolism of Progesterone can be increased when combined with Adalimumab.,Progesterone,DB00051
DB04856,The metabolism of Dexloxiglumide can be increased when combined with Adalimumab.,Dexloxiglumide,DB00051
DB04957,The metabolism of Azimilide can be increased when combined with Adalimumab.,Azimilide,DB00051
DB00250,The metabolism of Dapsone can be increased when combined with Adalimumab.,Dapsone,DB00051
DB00317,The metabolism of Gefitinib can be increased when combined with Adalimumab.,Gefitinib,DB00051
DB00367,The metabolism of Levonorgestrel can be increased when combined with Adalimumab.,Levonorgestrel,DB00051
DB00497,The metabolism of Oxycodone can be increased when combined with Adalimumab.,Oxycodone,DB00051
DB00620,The metabolism of Triamcinolone can be increased when combined with Adalimumab.,Triamcinolone,DB00051
DB00624,The metabolism of Testosterone can be increased when combined with Adalimumab.,Testosterone,DB00051
DB00656,The metabolism of Trazodone can be increased when combined with Adalimumab.,Trazodone,DB00051
DB00734,The metabolism of Risperidone can be increased when combined with Adalimumab.,Risperidone,DB00051
DB01114,The metabolism of Chlorpheniramine can be increased when combined with Adalimumab.,Chlorpheniramine,DB00051
DB01238,The metabolism of Aripiprazole can be increased when combined with Adalimumab.,Aripiprazole,DB00051
DB01267,The metabolism of Paliperidone can be increased when combined with Adalimumab.,Paliperidone,DB00051
DB04946,The metabolism of Iloperidone can be increased when combined with Adalimumab.,Iloperidone,DB00051
DB11915,The metabolism of Valbenazine can be increased when combined with Adalimumab.,Valbenazine,DB00051
DB12161,The metabolism of Deutetrabenazine can be increased when combined with Adalimumab.,Deutetrabenazine,DB00051
DB14185,The metabolism of Aripiprazole lauroxil can be increased when combined with Adalimumab.,Aripiprazole lauroxil,DB00051
DB01234,The metabolism of Dexamethasone can be increased when combined with Adalimumab.,Dexamethasone,DB00051
DB09237,The metabolism of Levamlodipine can be increased when combined with Adalimumab.,Levamlodipine,DB00051
DB11951,The metabolism of Lemborexant can be increased when combined with Adalimumab.,Lemborexant,DB00051
DB00557,The metabolism of Hydroxyzine can be increased when combined with Adalimumab.,Hydroxyzine,DB00051
DB00203,The metabolism of Sildenafil can be increased when combined with Adalimumab.,Sildenafil,DB00051
DB00227,The metabolism of Lovastatin can be increased when combined with Adalimumab.,Lovastatin,DB00051
DB00490,The metabolism of Buspirone can be increased when combined with Adalimumab.,Buspirone,DB00051
DB00641,The metabolism of Simvastatin can be increased when combined with Adalimumab.,Simvastatin,DB00051
DB00673,The metabolism of Aprepitant can be increased when combined with Adalimumab.,Aprepitant,DB00051
DB00820,The metabolism of Tadalafil can be increased when combined with Adalimumab.,Tadalafil,DB00051
DB00862,The metabolism of Vardenafil can be increased when combined with Adalimumab.,Vardenafil,DB00051
DB01190,The metabolism of Clindamycin can be increased when combined with Adalimumab.,Clindamycin,DB00051
DB00503,The metabolism of Ritonavir can be increased when combined with Adalimumab.,Ritonavir,DB00051
DB00224,The metabolism of Indinavir can be increased when combined with Adalimumab.,Indinavir,DB00051
DB00401,The metabolism of Nisoldipine can be increased when combined with Adalimumab.,Nisoldipine,DB00051
DB00637,The metabolism of Astemizole can be increased when combined with Adalimumab.,Astemizole,DB00051
DB00683,The metabolism of Midazolam can be increased when combined with Adalimumab.,Midazolam,DB00051
DB00700,The metabolism of Eplerenone can be increased when combined with Adalimumab.,Eplerenone,DB00051
DB00802,The metabolism of Alfentanil can be increased when combined with Adalimumab.,Alfentanil,DB00051
DB00813,The metabolism of Fentanyl can be increased when combined with Adalimumab.,Fentanyl,DB00051
DB00897,The metabolism of Triazolam can be increased when combined with Adalimumab.,Triazolam,DB00051
DB01023,The metabolism of Felodipine can be increased when combined with Adalimumab.,Felodipine,DB00051
DB01227,The metabolism of Levacetylmethadol can be increased when combined with Adalimumab.,Levacetylmethadol,DB00051
DB01232,The metabolism of Saquinavir can be increased when combined with Adalimumab.,Saquinavir,DB00051
DB06228,The metabolism of Rivaroxaban can be increased when combined with Adalimumab.,Rivaroxaban,DB00051
DB05804,The metabolism of Prasterone sulfate can be increased when combined with Adalimumab.,Prasterone sulfate,DB00051
DB05676,The therapeutic efficacy of Apremilast can be decreased when used in combination with Adalimumab.,Apremilast,DB00051
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Adalimumab.","Ebola Zaire vaccine (live, attenuated)",DB00051
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Adalimumab.,Magnesium,DB00051
DB01601,The serum concentration of Adalimumab can be increased when it is combined with Lopinavir.,Lopinavir,DB00051
DB12530,The risk or severity of infection can be increased when Adalimumab is combined with Inebilizumab.,Inebilizumab,DB00051
DB00635,The serum concentration of the active metabolites of Prednisone can be reduced when Prednisone is used in combination with Somatotropin resulting in a loss in efficacy.,Prednisone,DB00052
DB00255,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Diethylstilbestrol.,Diethylstilbestrol,DB00052
DB00269,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Chlorotrianisene.,Chlorotrianisene,DB00052
DB00286,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Conjugated estrogens.,Conjugated estrogens,DB00052
DB00783,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estradiol.,Estradiol,DB00052
DB00977,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Ethinylestradiol.,Ethinylestradiol,DB00052
DB01357,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Mestranol.,Mestranol,DB00052
DB04573,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estriol.,Estriol,DB00052
DB04574,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estrone sulfate.,Estrone sulfate,DB00052
DB04575,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Quinestrol.,Quinestrol,DB00052
DB07931,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Hexestrol.,Hexestrol,DB00052
DB09070,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Tibolone.,Tibolone,DB00052
DB09317,"The therapeutic efficacy of Somatotropin can be decreased when used in combination with Synthetic Conjugated Estrogens, A.","Synthetic Conjugated Estrogens, A",DB00052
DB09318,"The therapeutic efficacy of Somatotropin can be decreased when used in combination with Synthetic Conjugated Estrogens, B.","Synthetic Conjugated Estrogens, B",DB00052
DB09369,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Polyestradiol phosphate.,Polyestradiol phosphate,DB00052
DB09381,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Esterified estrogens.,Esterified estrogens,DB00052
DB11478,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Zeranol.,Zeranol,DB00052
DB11674,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Equol.,Equol,DB00052
DB12487,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Promestriene.,Promestriene,DB00052
DB13143,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Methallenestril.,Methallenestril,DB00052
DB13386,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Epimestrol.,Epimestrol,DB00052
DB13418,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Moxestrol.,Moxestrol,DB00052
DB13952,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estradiol acetate.,Estradiol acetate,DB00052
DB13956,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estradiol valerate.,Estradiol valerate,DB00052
DB15334,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Biochanin A.,Biochanin A,DB00052
DB15335,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Formononetin.,Formononetin,DB00052
DB01380,The serum concentration of the active metabolites of Cortisone acetate can be reduced when Cortisone acetate is used in combination with Somatotropin resulting in a loss in efficacy.,Cortisone acetate,DB00052
DB00007,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Somatotropin.",Leuprolide,DB00052
DB00065,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Infliximab.",Infliximab,DB00052
DB00080,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Daptomycin.",Daptomycin,DB00052
DB00091,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cyclosporine.",Cyclosporine,DB00052
DB00175,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pravastatin.",Pravastatin,DB00052
DB00181,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Baclofen.",Baclofen,DB00052
DB00203,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Sildenafil.",Sildenafil,DB00052
DB00224,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Indinavir.",Indinavir,DB00052
DB00227,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lovastatin.",Lovastatin,DB00052
DB00242,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cladribine.",Cladribine,DB00052
DB00252,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Phenytoin.",Phenytoin,DB00052
DB00282,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pamidronic acid.",Pamidronic acid,DB00052
DB00358,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mefloquine.",Mefloquine,DB00052
DB00382,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tacrine.",Tacrine,DB00052
DB00389,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Carbimazole.",Carbimazole,DB00052
DB00439,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cerivastatin.",Cerivastatin,DB00052
DB00440,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Trimethoprim.",Trimethoprim,DB00052
DB00471,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Montelukast.",Montelukast,DB00052
DB00495,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Zidovudine.",Zidovudine,DB00052
DB00501,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cimetidine.",Cimetidine,DB00052
DB00503,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ritonavir.",Ritonavir,DB00052
DB00528,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lercanidipine.",Lercanidipine,DB00052
DB00537,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ciprofloxacin.",Ciprofloxacin,DB00052
DB00541,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Vincristine.",Vincristine,DB00052
DB00550,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Propylthiouracil.",Propylthiouracil,DB00052
DB00563,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Methotrexate.",Methotrexate,DB00052
DB00584,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Enalapril.",Enalapril,DB00052
DB00585,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Nizatidine.",Nizatidine,DB00052
DB00602,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ivermectin.",Ivermectin,DB00052
DB00608,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Chloroquine.",Chloroquine,DB00052
DB00627,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Niacin.",Niacin,DB00052
DB00630,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Alendronic acid.",Alendronic acid,DB00052
DB00636,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Clofibrate.",Clofibrate,DB00052
DB00641,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Simvastatin.",Simvastatin,DB00052
DB00649,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Stavudine.",Stavudine,DB00052
DB00666,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Nafarelin.",Nafarelin,DB00052
DB00681,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Amphotericin B.",Amphotericin B,DB00052
DB00688,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mycophenolate mofetil.",Mycophenolate mofetil,DB00052
DB00704,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Naltrexone.",Naltrexone,DB00052
DB00709,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lamivudine.",Lamivudine,DB00052
DB00710,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ibandronate.",Ibandronate,DB00052
DB00818,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Propofol.",Propofol,DB00052
DB00857,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Terbinafine.",Terbinafine,DB00052
DB00859,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Penicillamine.",Penicillamine,DB00052
DB00863,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ranitidine.",Ranitidine,DB00052
DB00864,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tacrolimus.",Tacrolimus,DB00052
DB00876,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Eprosartan.",Eprosartan,DB00052
DB00884,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Risedronic acid.",Risedronic acid,DB00052
DB00887,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Bumetanide.",Bumetanide,DB00052
DB00897,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Triazolam.",Triazolam,DB00052
DB00898,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ethanol.",Ethanol,DB00052
DB00938,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Salmeterol.",Salmeterol,DB00052
DB00951,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Isoniazid.",Isoniazid,DB00052
DB00968,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Methyldopa.",Methyldopa,DB00052
DB00982,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Isotretinoin.",Isotretinoin,DB00052
DB00987,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cytarabine.",Cytarabine,DB00052
DB01004,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ganciclovir.",Ganciclovir,DB00052
DB01006,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Letrozole.",Letrozole,DB00052
DB01015,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Sulfamethoxazole.",Sulfamethoxazole,DB00052
DB01017,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Minocycline.",Minocycline,DB00052
DB01035,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Procainamide.",Procainamide,DB00052
DB01039,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fenofibrate.",Fenofibrate,DB00052
DB01059,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Norfloxacin.",Norfloxacin,DB00052
DB01076,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Atorvastatin.",Atorvastatin,DB00052
DB01088,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Iloprost.",Iloprost,DB00052
DB01095,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fluvastatin.",Fluvastatin,DB00052
DB01097,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Leflunomide.",Leflunomide,DB00052
DB01098,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Rosuvastatin.",Rosuvastatin,DB00052
DB01118,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Amiodarone.",Amiodarone,DB00052
DB01165,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ofloxacin.",Ofloxacin,DB00052
DB01168,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Procarbazine.",Procarbazine,DB00052
DB01197,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Captopril.",Captopril,DB00052
DB01229,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Paclitaxel.",Paclitaxel,DB00052
DB01232,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Saquinavir.",Saquinavir,DB00052
DB01233,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Metoclopramide.",Metoclopramide,DB00052
DB01234,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Dexamethasone.",Dexamethasone,DB00052
DB01241,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Gemfibrozil.",Gemfibrozil,DB00052
DB01248,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Docetaxel.",Docetaxel,DB00052
DB01393,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Bezafibrate.",Bezafibrate,DB00052
DB01394,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Colchicine.",Colchicine,DB00052
DB02703,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fusidic acid.",Fusidic acid,DB00052
DB05109,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Trabectedin.",Trabectedin,DB00052
DB06693,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mevastatin.",Mevastatin,DB00052
DB06817,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Raltegravir.",Raltegravir,DB00052
DB08860,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pitavastatin.",Pitavastatin,DB00052
DB08983,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Etofibrate.",Etofibrate,DB00052
DB09055,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Acipimox.",Acipimox,DB00052
DB09064,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ciprofibrate.",Ciprofibrate,DB00052
DB09270,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ubidecarenone.",Ubidecarenone,DB00052
DB09289,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tianeptine.",Tianeptine,DB00052
DB12554,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mebeverine.",Mebeverine,DB00052
DB13293,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ipecac.",Ipecac,DB00052
DB13393,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Emetine.",Emetine,DB00052
DB13433,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Simfibrate.",Simfibrate,DB00052
DB13460,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ronifibrate.",Ronifibrate,DB00052
DB13780,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Aluminium clofibrate.",Aluminium clofibrate,DB00052
DB13849,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Clofibride.",Clofibride,DB00052
DB13873,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fenofibric acid.",Fenofibric acid,DB00052
DB13074,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Somatotropin.,Macimorelin,DB00052
DB00443,The therapeutic efficacy of Betamethasone can be decreased when used in combination with Somatotropin.,Betamethasone,DB00052
DB00620,The therapeutic efficacy of Triamcinolone can be decreased when used in combination with Somatotropin.,Triamcinolone,DB00052
DB00253,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Medrysone.,Medrysone,DB00052
DB00324,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluorometholone.,Fluorometholone,DB00052
DB00394,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Beclomethasone dipropionate.,Beclomethasone dipropionate,DB00052
DB00764,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Mometasone.,Mometasone,DB00052
DB00896,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Rimexolone.,Rimexolone,DB00052
DB01384,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Paramethasone.,Paramethasone,DB00052
DB01410,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Ciclesonide.,Ciclesonide,DB00052
DB08906,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluticasone furoate.,Fluticasone furoate,DB00052
DB08970,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluprednidene.,Fluprednidene,DB00052
DB08971,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluocortolone.,Fluocortolone,DB00052
DB09383,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Meprednisone.,Meprednisone,DB00052
DB11487,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Dexamethasone isonicotinate.,Dexamethasone isonicotinate,DB00052
DB11750,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Clobetasol.,Clobetasol,DB00052
DB11921,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Deflazacort.,Deflazacort,DB00052
DB13003,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Cortivazol.,Cortivazol,DB00052
DB13208,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Prednylidene.,Prednylidene,DB00052
DB13728,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Halometasone.,Halometasone,DB00052
DB13843,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Cloprednol.,Cloprednol,DB00052
DB13867,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluticasone.,Fluticasone,DB00052
DB14512,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Mometasone furoate.,Mometasone furoate,DB00052
DB14631,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Prednisolone phosphate.,Prednisolone phosphate,DB00052
DB14633,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Prednisolone hemisuccinate.,Prednisolone hemisuccinate,DB00052
DB14634,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluprednidene acetate.,Fluprednidene acetate,DB00052
DB14644,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Methylprednisolone hemisuccinate.,Methylprednisolone hemisuccinate,DB00052
DB14646,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Prednisone acetate.,Prednisone acetate,DB00052
DB14652,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Clocortolone acetate.,Clocortolone acetate,DB00052
DB14659,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Melengestrol acetate.,Melengestrol acetate,DB00052
DB14669,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Betamethasone phosphate.,Betamethasone phosphate,DB00052
DB14681,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Cortisone.,Cortisone,DB00052
DB06605,Apixaban may increase the anticoagulant activities of Abciximab.,Apixaban,DB00054
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Abciximab.,Dabigatran etexilate,DB00054
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Abciximab.,Dasatinib,DB00054
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Abciximab is combined with Deferasirox.,Deferasirox,DB00054
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Abciximab.,Edoxaban,DB00054
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Abciximab.,Ibrutinib,DB00054
DB06228,Abciximab may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban,DB00054
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Abciximab is combined with Sugammadex.,Sugammadex,DB00054
DB09070,Tibolone may increase the anticoagulant activities of Abciximab.,Tibolone,DB00054
DB00013,Urokinase may increase the anticoagulant activities of Abciximab.,Urokinase,DB00054
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Abciximab.,Vorapaxar,DB00054
DB06692,The therapeutic efficacy of Abciximab can be decreased when used in combination with Aprotinin.,Aprotinin,DB00054
DB01586,The risk or severity of adverse effects can be increased when Abciximab is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid,DB00054
DB02123,The risk or severity of adverse effects can be increased when Abciximab is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid,DB00054
DB02659,The risk or severity of adverse effects can be increased when Abciximab is combined with Cholic Acid.,Cholic Acid,DB00054
DB02691,The risk or severity of adverse effects can be increased when Abciximab is combined with Glycocholic acid.,Glycocholic acid,DB00054
DB03619,The risk or severity of adverse effects can be increased when Abciximab is combined with Deoxycholic acid.,Deoxycholic acid,DB00054
DB04348,The risk or severity of adverse effects can be increased when Abciximab is combined with Taurocholic acid.,Taurocholic acid,DB00054
DB05990,The risk or severity of adverse effects can be increased when Abciximab is combined with Obeticholic acid.,Obeticholic acid,DB00054
DB06777,The risk or severity of adverse effects can be increased when Abciximab is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid,DB00054
DB08833,The risk or severity of adverse effects can be increased when Abciximab is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid,DB00054
DB08834,The risk or severity of adverse effects can be increased when Abciximab is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid,DB00054
DB08857,The risk or severity of adverse effects can be increased when Abciximab is combined with Bamet-UD2.,Bamet-UD2,DB00054
DB11622,The risk or severity of adverse effects can be increased when Abciximab is combined with Dehydrocholic acid.,Dehydrocholic acid,DB00054
DB11789,The risk or severity of adverse effects can be increased when Abciximab is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid,DB00054
DB01296,Glucosamine may increase the antiplatelet activities of Abciximab.,Glucosamine,DB00054
DB00078,The risk or severity of adverse effects can be increased when Abciximab is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan,DB00054
DB08935,The risk or severity of adverse effects can be increased when Abciximab is combined with Obinutuzumab.,Obinutuzumab,DB00054
DB00932,Tipranavir may increase the antiplatelet activities of Abciximab.,Tipranavir,DB00054
DB00163,Vitamin E may increase the antiplatelet activities of Abciximab.,Vitamin E,DB00054
DB01381,The therapeutic efficacy of Abciximab can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba,DB00054
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Abciximab.,Ifosfamide,DB00054
DB00468,The therapeutic efficacy of Abciximab can be increased when used in combination with Quinine.,Quinine,DB00054
DB00908,The therapeutic efficacy of Abciximab can be increased when used in combination with Quinidine.,Quinidine,DB00054
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Abciximab.,Tamoxifen,DB00054
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Abciximab.,Toremifene,DB00054
DB00806,The therapeutic efficacy of Abciximab can be increased when used in combination with Pentoxifylline.,Pentoxifylline,DB00054
DB00686,The risk or severity of adverse effects can be increased when Pentosan polysulfate is combined with Abciximab.,Pentosan polysulfate,DB00054
DB00583,The therapeutic efficacy of Abciximab can be increased when used in combination with Levocarnitine.,Levocarnitine,DB00054
DB00655,Estrone may increase the thrombogenic activities of Abciximab.,Estrone,DB00054
DB00890,Dienestrol may increase the thrombogenic activities of Abciximab.,Dienestrol,DB00054
DB09255,Dextran may increase the anticoagulant activities of Abciximab.,Dextran,DB00054
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Abciximab.,Diethylstilbestrol,DB00054
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Abciximab.,Chlorotrianisene,DB00054
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Abciximab.,Conjugated estrogens,DB00054
DB00783,Estradiol may decrease the anticoagulant activities of Abciximab.,Estradiol,DB00054
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Abciximab.,Ethinylestradiol,DB00054
DB01357,Mestranol may decrease the anticoagulant activities of Abciximab.,Mestranol,DB00054
DB04573,Estriol may decrease the anticoagulant activities of Abciximab.,Estriol,DB00054
DB04574,Estrone sulfate may decrease the anticoagulant activities of Abciximab.,Estrone sulfate,DB00054
DB04575,Quinestrol may decrease the anticoagulant activities of Abciximab.,Quinestrol,DB00054
DB07931,Hexestrol may decrease the anticoagulant activities of Abciximab.,Hexestrol,DB00054
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Abciximab.","Synthetic Conjugated Estrogens, A",DB00054
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Abciximab.","Synthetic Conjugated Estrogens, B",DB00054
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Abciximab.,Polyestradiol phosphate,DB00054
DB09381,Esterified estrogens may decrease the anticoagulant activities of Abciximab.,Esterified estrogens,DB00054
DB11478,Zeranol may decrease the anticoagulant activities of Abciximab.,Zeranol,DB00054
DB11674,Equol may decrease the anticoagulant activities of Abciximab.,Equol,DB00054
DB12487,Promestriene may decrease the anticoagulant activities of Abciximab.,Promestriene,DB00054
DB13143,Methallenestril may decrease the anticoagulant activities of Abciximab.,Methallenestril,DB00054
DB13386,Epimestrol may decrease the anticoagulant activities of Abciximab.,Epimestrol,DB00054
DB13418,Moxestrol may decrease the anticoagulant activities of Abciximab.,Moxestrol,DB00054
DB13952,Estradiol acetate may decrease the anticoagulant activities of Abciximab.,Estradiol acetate,DB00054
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Abciximab.,Estradiol benzoate,DB00054
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Abciximab.,Estradiol cypionate,DB00054
DB13956,Estradiol valerate may decrease the anticoagulant activities of Abciximab.,Estradiol valerate,DB00054
DB15334,Biochanin A may decrease the anticoagulant activities of Abciximab.,Biochanin A,DB00054
DB15335,Formononetin may decrease the anticoagulant activities of Abciximab.,Formononetin,DB00054
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Abciximab.,Icosapent,DB00054
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Abciximab.,Mesalazine,DB00054
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Abciximab.,Indomethacin,DB00054
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Abciximab.,Nabumetone,DB00054
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Abciximab.,Ketorolac,DB00054
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Abciximab.,Tenoxicam,DB00054
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Abciximab.,Celecoxib,DB00054
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Abciximab.,Tolmetin,DB00054
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Abciximab.,Rofecoxib,DB00054
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Abciximab.,Piroxicam,DB00054
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Abciximab.,Fenoprofen,DB00054
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Abciximab.,Valdecoxib,DB00054
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Abciximab.,Diclofenac,DB00054
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Abciximab.,Sulindac,DB00054
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Abciximab.,Flurbiprofen,DB00054
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Abciximab.,Etodolac,DB00054
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Abciximab.,Mefenamic acid,DB00054
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Abciximab.,Naproxen,DB00054
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Abciximab.,Sulfasalazine,DB00054
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Abciximab.,Phenylbutazone,DB00054
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Abciximab.,Meloxicam,DB00054
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Abciximab.,Carprofen,DB00054
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Abciximab.,Diflunisal,DB00054
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Abciximab.,Salicylic acid,DB00054
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Abciximab.,Meclofenamic acid,DB00054
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Abciximab.,Oxaprozin,DB00054
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Abciximab.,Ketoprofen,DB00054
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Abciximab.,Balsalazide,DB00054
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Abciximab.,Olsalazine,DB00054
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Abciximab.,Lumiracoxib,DB00054
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Abciximab.,Magnesium salicylate,DB00054
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Abciximab.,Salsalate,DB00054
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Abciximab.,Choline magnesium trisalicylate,DB00054
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Abciximab.,Antrafenine,DB00054
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Abciximab.,Aminophenazone,DB00054
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Abciximab.,Antipyrine,DB00054
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Abciximab.,Tiaprofenic acid,DB00054
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Abciximab.,Etoricoxib,DB00054
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Abciximab.,Taxifolin,DB00054
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Abciximab.,Oxyphenbutazone,DB00054
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Abciximab.,Niflumic acid,DB00054
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Abciximab.,Licofelone,DB00054
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Abciximab.,Benoxaprofen,DB00054
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Abciximab.,Metamizole,DB00054
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Abciximab.,Zomepirac,DB00054
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Abciximab.,Cimicoxib,DB00054
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Abciximab.,Lornoxicam,DB00054
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Abciximab.,Aceclofenac,DB00054
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Abciximab.,Zaltoprofen,DB00054
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Abciximab.,Azapropazone,DB00054
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Abciximab.,Felbinac,DB00054
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Abciximab.,Parecoxib,DB00054
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Abciximab.,Salicylamide,DB00054
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Abciximab.,Kebuzone,DB00054
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Abciximab.,Isoxicam,DB00054
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Abciximab.,Indoprofen,DB00054
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Abciximab.,Ibuproxam,DB00054
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Abciximab.,Floctafenine,DB00054
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Abciximab.,Fenbufen,DB00054
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Abciximab.,Etofenamate,DB00054
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Abciximab.,Epirizole,DB00054
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Abciximab.,Benzydamine,DB00054
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Abciximab.,Loxoprofen,DB00054
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Abciximab.,Dexketoprofen,DB00054
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Abciximab.,Droxicam,DB00054
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Abciximab.,Tolfenamic acid,DB00054
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Abciximab.,Firocoxib,DB00054
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Abciximab.,Clonixin,DB00054
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Abciximab.,Morniflumate,DB00054
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Abciximab.,Propacetamol,DB00054
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Abciximab.,Talniflumate,DB00054
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Abciximab.,Robenacoxib,DB00054
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Abciximab.,Tepoxalin,DB00054
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Abciximab.,Flunixin,DB00054
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Abciximab.,Polmacoxib,DB00054
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Abciximab.,Betulinic Acid,DB00054
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Abciximab.,Ebselen,DB00054
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Abciximab.,Tinoridine,DB00054
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Abciximab.,Alclofenac,DB00054
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Abciximab.,Fentiazac,DB00054
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Abciximab.,Suxibuzone,DB00054
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Abciximab.,Bumadizone,DB00054
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Abciximab.,Alminoprofen,DB00054
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Abciximab.,Flunoxaprofen,DB00054
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Abciximab.,Feprazone,DB00054
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Abciximab.,Difenpiramide,DB00054
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Abciximab.,Nifenazone,DB00054
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Abciximab.,Lonazolac,DB00054
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Abciximab.,Tenidap,DB00054
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Abciximab.,Bendazac,DB00054
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Abciximab.,Pranoprofen,DB00054
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Abciximab.,Propyphenazone,DB00054
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Abciximab.,Proglumetacin,DB00054
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Abciximab.,Guacetisal,DB00054
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Abciximab.,Ethenzamide,DB00054
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Abciximab.,Carbaspirin calcium,DB00054
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Abciximab.,Mofebutazone,DB00054
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Abciximab.,Proquazone,DB00054
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Abciximab.,Benorilate,DB00054
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Abciximab.,Pirprofen,DB00054
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Abciximab.,Imidazole salicylate,DB00054
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Abciximab.,SC-236,DB00054
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Abciximab.,NS-398,DB00054
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Abciximab.,Flurbiprofen axetil,DB00054
DB04865,The risk or severity of bleeding can be increased when Abciximab is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate,DB00054
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Abciximab.,Limaprost,DB00054
DB00048,The risk or severity of adverse effects can be increased when Abciximab is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum,DB00054
DB11133,Omega-3 fatty acids may increase the antiplatelet activities of Abciximab.,Omega-3 fatty acids,DB00054
DB00081,The risk or severity of adverse effects can be increased when Abciximab is combined with Tositumomab.,Tositumomab,DB00054
DB00389,Carbimazole may increase the anticoagulant activities of Abciximab.,Carbimazole,DB00054
DB00550,Propylthiouracil may increase the anticoagulant activities of Abciximab.,Propylthiouracil,DB00054
DB00763,Methimazole may increase the anticoagulant activities of Abciximab.,Methimazole,DB00054
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Abciximab.","3,5-Diiodotyrosine",DB00054
DB06715,Potassium Iodide may increase the anticoagulant activities of Abciximab.,Potassium Iodide,DB00054
DB07637,Dibromotyrosine may increase the anticoagulant activities of Abciximab.,Dibromotyrosine,DB00054
DB09418,Potassium perchlorate may increase the anticoagulant activities of Abciximab.,Potassium perchlorate,DB00054
DB13644,Methylthiouracil may increase the anticoagulant activities of Abciximab.,Methylthiouracil,DB00054
DB13804,Benzylthiouracil may increase the anticoagulant activities of Abciximab.,Benzylthiouracil,DB00054
DB00834,The therapeutic efficacy of Abciximab can be decreased when used in combination with Mifepristone.,Mifepristone,DB00054
DB04066,The therapeutic efficacy of Abciximab can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid,DB00054
DB04682,The therapeutic efficacy of Abciximab can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol,DB00054
DB05830,The therapeutic efficacy of Abciximab can be decreased when used in combination with Trestolone.,Trestolone,DB00054
DB06266,The therapeutic efficacy of Abciximab can be decreased when used in combination with Lonidamine.,Lonidamine,DB00054
DB08867,The therapeutic efficacy of Abciximab can be decreased when used in combination with Ulipristal.,Ulipristal,DB00054
DB09401,The therapeutic efficacy of Abciximab can be decreased when used in combination with Isosorbide.,Isosorbide,DB00054
DB11507,The therapeutic efficacy of Abciximab can be decreased when used in combination with Cloprostenol.,Cloprostenol,DB00054
DB12025,The therapeutic efficacy of Abciximab can be decreased when used in combination with Triptolide.,Triptolide,DB00054
DB13044,The therapeutic efficacy of Abciximab can be decreased when used in combination with Gossypol.,Gossypol,DB00054
DB13310,The therapeutic efficacy of Abciximab can be decreased when used in combination with Ormeloxifene.,Ormeloxifene,DB00054
DB00294,Etonogestrel may decrease the anticoagulant activities of Abciximab.,Etonogestrel,DB00054
DB00304,Desogestrel may decrease the anticoagulant activities of Abciximab.,Desogestrel,DB00054
DB00351,Megestrol acetate may decrease the anticoagulant activities of Abciximab.,Megestrol acetate,DB00054
DB00367,Levonorgestrel may decrease the anticoagulant activities of Abciximab.,Levonorgestrel,DB00054
DB00378,Dydrogesterone may decrease the anticoagulant activities of Abciximab.,Dydrogesterone,DB00054
DB00396,Progesterone may decrease the anticoagulant activities of Abciximab.,Progesterone,DB00054
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Abciximab.,Medroxyprogesterone acetate,DB00054
DB00717,Norethisterone may decrease the anticoagulant activities of Abciximab.,Norethisterone,DB00054
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Abciximab.,Ethynodiol diacetate,DB00054
DB00957,Norgestimate may decrease the anticoagulant activities of Abciximab.,Norgestimate,DB00054
DB01395,Drospirenone may decrease the anticoagulant activities of Abciximab.,Drospirenone,DB00054
DB01431,Allylestrenol may decrease the anticoagulant activities of Abciximab.,Allylestrenol,DB00054
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Abciximab.,Cyproterone acetate,DB00054
DB06713,Norelgestromin may decrease the anticoagulant activities of Abciximab.,Norelgestromin,DB00054
DB06730,Gestodene may decrease the anticoagulant activities of Abciximab.,Gestodene,DB00054
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Abciximab.,Hydroxyprogesterone caproate,DB00054
DB09123,Dienogest may decrease the anticoagulant activities of Abciximab.,Dienogest,DB00054
DB09124,Medrogestone may decrease the anticoagulant activities of Abciximab.,Medrogestone,DB00054
DB09371,Norethynodrel may decrease the anticoagulant activities of Abciximab.,Norethynodrel,DB00054
DB09389,Norgestrel may decrease the anticoagulant activities of Abciximab.,Norgestrel,DB00054
DB11372,Altrenogest may decrease the anticoagulant activities of Abciximab.,Altrenogest,DB00054
DB11619,Gestrinone may decrease the anticoagulant activities of Abciximab.,Gestrinone,DB00054
DB11636,Nomegestrol may decrease the anticoagulant activities of Abciximab.,Nomegestrol,DB00054
DB12474,Lynestrenol may decrease the anticoagulant activities of Abciximab.,Lynestrenol,DB00054
DB13230,Gestonorone may decrease the anticoagulant activities of Abciximab.,Gestonorone,DB00054
DB13528,Chlormadinone may decrease the anticoagulant activities of Abciximab.,Chlormadinone,DB00054
DB13533,Methylestrenolone may decrease the anticoagulant activities of Abciximab.,Methylestrenolone,DB00054
DB13563,Norgestrienone may decrease the anticoagulant activities of Abciximab.,Norgestrienone,DB00054
DB13602,Promegestone may decrease the anticoagulant activities of Abciximab.,Promegestone,DB00054
DB13685,Quingestanol may decrease the anticoagulant activities of Abciximab.,Quingestanol,DB00054
DB13857,Demegestone may decrease the anticoagulant activities of Abciximab.,Demegestone,DB00054
DB13866,Etynodiol may decrease the anticoagulant activities of Abciximab.,Etynodiol,DB00054
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Abciximab.,Nomegestrol acetate,DB00054
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Abciximab.,Hydroxyprogesterone,DB00054
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Abciximab.,Norethindrone enanthate,DB00054
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Abciximab.,Quingestanol acetate,DB00054
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Abciximab.,Aminosalicylic acid,DB00054
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Abciximab.,Bismuth subsalicylate,DB00054
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Abciximab.,Dersalazine,DB00054
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Abciximab.,Phenyl aminosalicylate,DB00054
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Abciximab.,Methyl salicylate,DB00054
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Abciximab.,Trolamine salicylate,DB00054
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Abciximab.,Aloxiprin,DB00054
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Abciximab.,Choline salicylate,DB00054
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Abciximab.,Thiosalicylic acid,DB00054
DB00001,The risk or severity of bleeding can be increased when Abciximab is combined with Lepirudin.,Lepirudin,DB00054
DB00006,The risk or severity of bleeding can be increased when Abciximab is combined with Bivalirudin.,Bivalirudin,DB00054
DB00009,The risk or severity of bleeding can be increased when Abciximab is combined with Alteplase.,Alteplase,DB00054
DB00015,The risk or severity of bleeding can be increased when Abciximab is combined with Reteplase.,Reteplase,DB00054
DB00029,The risk or severity of bleeding can be increased when Abciximab is combined with Anistreplase.,Anistreplase,DB00054
DB00031,The risk or severity of bleeding can be increased when Abciximab is combined with Tenecteplase.,Tenecteplase,DB00054
DB00055,The risk or severity of bleeding can be increased when Abciximab is combined with Drotrecogin alfa.,Drotrecogin alfa,DB00054
DB00086,The risk or severity of bleeding can be increased when Abciximab is combined with Streptokinase.,Streptokinase,DB00054
DB00261,The risk or severity of bleeding can be increased when Abciximab is combined with Anagrelide.,Anagrelide,DB00054
DB00266,The risk or severity of bleeding can be increased when Abciximab is combined with Dicoumarol.,Dicoumarol,DB00054
DB00278,The risk or severity of bleeding can be increased when Abciximab is combined with Argatroban.,Argatroban,DB00054
DB00407,The risk or severity of bleeding can be increased when Abciximab is combined with Ardeparin.,Ardeparin,DB00054
DB00498,The risk or severity of bleeding can be increased when Abciximab is combined with Phenindione.,Phenindione,DB00054
DB00569,The risk or severity of bleeding can be increased when Abciximab is combined with Fondaparinux.,Fondaparinux,DB00054
DB00682,The risk or severity of bleeding can be increased when Abciximab is combined with Warfarin.,Warfarin,DB00054
DB00946,The risk or severity of bleeding can be increased when Abciximab is combined with Phenprocoumon.,Phenprocoumon,DB00054
DB00975,The risk or severity of bleeding can be increased when Abciximab is combined with Dipyridamole.,Dipyridamole,DB00054
DB01088,The risk or severity of bleeding can be increased when Abciximab is combined with Iloprost.,Iloprost,DB00054
DB01109,The risk or severity of bleeding can be increased when Abciximab is combined with Heparin.,Heparin,DB00054
DB01225,The risk or severity of bleeding can be increased when Abciximab is combined with Enoxaparin.,Enoxaparin,DB00054
DB01240,The risk or severity of bleeding can be increased when Abciximab is combined with Epoprostenol.,Epoprostenol,DB00054
DB01418,The risk or severity of bleeding can be increased when Abciximab is combined with Acenocoumarol.,Acenocoumarol,DB00054
DB03410,The risk or severity of bleeding can be increased when Abciximab is combined with 4-hydroxycoumarin.,4-hydroxycoumarin,DB00054
DB04665,The risk or severity of bleeding can be increased when Abciximab is combined with Coumarin.,Coumarin,DB00054
DB04898,The risk or severity of bleeding can be increased when Abciximab is combined with Ximelagatran.,Ximelagatran,DB00054
DB04925,The risk or severity of bleeding can be increased when Abciximab is combined with Desmoteplase.,Desmoteplase,DB00054
DB04932,The risk or severity of bleeding can be increased when Abciximab is combined with Defibrotide.,Defibrotide,DB00054
DB05099,The risk or severity of bleeding can be increased when Abciximab is combined with Ancrod.,Ancrod,DB00054
DB05229,The risk or severity of bleeding can be increased when Abciximab is combined with Beraprost.,Beraprost,DB00054
DB05254,The risk or severity of bleeding can be increased when Abciximab is combined with Fibrinolysin.,Fibrinolysin,DB00054
DB06209,The risk or severity of bleeding can be increased when Abciximab is combined with Prasugrel.,Prasugrel,DB00054
DB06271,The risk or severity of bleeding can be increased when Abciximab is combined with Sulodexide.,Sulodexide,DB00054
DB06294,The risk or severity of bleeding can be increased when Abciximab is combined with Semuloparin.,Semuloparin,DB00054
DB06406,The risk or severity of bleeding can be increased when Abciximab is combined with Idraparinux.,Idraparinux,DB00054
DB06441,The risk or severity of bleeding can be increased when Abciximab is combined with Cangrelor.,Cangrelor,DB00054
DB06543,The risk or severity of bleeding can be increased when Abciximab is combined with Astaxanthin.,Astaxanthin,DB00054
DB06635,The risk or severity of bleeding can be increased when Abciximab is combined with Otamixaban.,Otamixaban,DB00054
DB06679,The risk or severity of bleeding can be increased when Abciximab is combined with Amediplase.,Amediplase,DB00054
DB06754,The risk or severity of bleeding can be increased when Abciximab is combined with Danaparoid.,Danaparoid,DB00054
DB06779,The risk or severity of bleeding can be increased when Abciximab is combined with Dalteparin.,Dalteparin,DB00054
DB06822,The risk or severity of bleeding can be increased when Abciximab is combined with Tinzaparin.,Tinzaparin,DB00054
DB07767,The risk or severity of bleeding can be increased when Abciximab is combined with Ferulic acid.,Ferulic acid,DB00054
DB08496,The risk or severity of bleeding can be increased when Abciximab is combined with (R)-warfarin.,(R)-warfarin,DB00054
DB08794,The risk or severity of bleeding can be increased when Abciximab is combined with Ethyl biscoumacetate.,Ethyl biscoumacetate,DB00054
DB08813,The risk or severity of bleeding can be increased when Abciximab is combined with Nadroparin.,Nadroparin,DB00054
DB08814,The risk or severity of bleeding can be increased when Abciximab is combined with Triflusal.,Triflusal,DB00054
DB08816,The risk or severity of bleeding can be increased when Abciximab is combined with Ticagrelor.,Ticagrelor,DB00054
DB08994,The risk or severity of bleeding can be increased when Abciximab is combined with Ditazole.,Ditazole,DB00054
DB09125,The risk or severity of bleeding can be increased when Abciximab is combined with Potassium citrate.,Potassium citrate,DB00054
DB09154,The risk or severity of bleeding can be increased when Abciximab is combined with Sodium citrate.,Sodium citrate,DB00054
DB09258,The risk or severity of bleeding can be increased when Abciximab is combined with Bemiparin.,Bemiparin,DB00054
DB09259,The risk or severity of bleeding can be increased when Abciximab is combined with Reviparin.,Reviparin,DB00054
DB09260,The risk or severity of bleeding can be increased when Abciximab is combined with Parnaparin.,Parnaparin,DB00054
DB09261,The risk or severity of bleeding can be increased when Abciximab is combined with Certoparin.,Certoparin,DB00054
DB11095,The risk or severity of bleeding can be increased when Abciximab is combined with Desirudin.,Desirudin,DB00054
DB11154,The risk or severity of bleeding can be increased when Abciximab is combined with Zinc citrate.,Zinc citrate,DB00054
DB11166,The risk or severity of bleeding can be increased when Abciximab is combined with Antithrombin Alfa.,Antithrombin Alfa,DB00054
DB11312,The risk or severity of bleeding can be increased when Abciximab is combined with Protein C.,Protein C,DB00054
DB11598,The risk or severity of bleeding can be increased when Abciximab is combined with Antithrombin III human.,Antithrombin III human,DB00054
DB11984,The risk or severity of bleeding can be increased when Abciximab is combined with Letaxaban.,Letaxaban,DB00054
DB12289,The risk or severity of bleeding can be increased when Abciximab is combined with Darexaban.,Darexaban,DB00054
DB12364,The risk or severity of bleeding can be increased when Abciximab is combined with Betrixaban.,Betrixaban,DB00054
DB12598,The risk or severity of bleeding can be increased when Abciximab is combined with Nafamostat.,Nafamostat,DB00054
DB12726,The risk or severity of bleeding can be increased when Abciximab is combined with Monteplase.,Monteplase,DB00054
DB12831,The risk or severity of bleeding can be increased when Abciximab is combined with Gabexate.,Gabexate,DB00054
DB13136,The risk or severity of bleeding can be increased when Abciximab is combined with Fluindione.,Fluindione,DB00054
DB13149,The risk or severity of bleeding can be increased when Abciximab is combined with Protein S human.,Protein S human,DB00054
DB13199,The risk or severity of bleeding can be increased when Abciximab is combined with Brinase.,Brinase,DB00054
DB13275,The risk or severity of bleeding can be increased when Abciximab is combined with Clorindione.,Clorindione,DB00054
DB13347,The risk or severity of bleeding can be increased when Abciximab is combined with Diphenadione.,Diphenadione,DB00054
DB13451,The risk or severity of bleeding can be increased when Abciximab is combined with Tioclomarol.,Tioclomarol,DB00054
DB13616,The risk or severity of bleeding can be increased when Abciximab is combined with Melagatran.,Melagatran,DB00054
DB13646,The risk or severity of bleeding can be increased when Abciximab is combined with Saruplase.,Saruplase,DB00054
DB14055,The risk or severity of bleeding can be increased when Abciximab is combined with (S)-Warfarin.,(S)-Warfarin,DB00054
DB14094,The risk or severity of bleeding can be increased when Abciximab is combined with Tocopherylquinone.,Tocopherylquinone,DB00054
DB14598,The risk or severity of bleeding can be increased when Abciximab is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous,DB00054
DB14726,The risk or severity of bleeding can be increased when Abciximab is combined with Dabigatran.,Dabigatran,DB00054
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Abciximab.,Eptifibatide,DB00054
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Abciximab.,Ticlopidine,DB00054
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Abciximab.,Clopidogrel,DB00054
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Abciximab.,Tirofiban,DB00054
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Abciximab.,Sulfinpyrazone,DB00054
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Abciximab.,Cilostazol,DB00054
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Abciximab.,Ridogrel,DB00054
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Abciximab.,Sevoflurane,DB00054
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Abciximab.,Resveratrol,DB00054
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Abciximab.,Nimesulide,DB00054
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Abciximab.,Tesmilifene,DB00054
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Abciximab.,Ibudilast,DB00054
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Abciximab.,Andrographolide,DB00054
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Abciximab.,Caplacizumab,DB00054
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Abciximab.,Tranilast,DB00054
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Abciximab.,Icosapent ethyl,DB00054
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Abciximab.,Trapidil,DB00054
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Abciximab.,Naftopidil,DB00054
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Abciximab.,Sarpogrelate,DB00054
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Abciximab.,Ifetroban,DB00054
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Abciximab.,Nitroaspirin,DB00054
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Abciximab.,Ketanserin,DB00054
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Abciximab.,Indobufen,DB00054
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Abciximab.,Butylphthalide,DB00054
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Abciximab.,Hydroxytyrosol,DB00054
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Abciximab.,Ramatroban,DB00054
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Abciximab.,Picotamide,DB00054
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Abciximab.,Cloricromen,DB00054
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Abciximab.,Linsidomine,DB00054
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Abciximab.,Buflomedil,DB00054
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Abciximab.,Relcovaptan,DB00054
DB00374,The risk or severity of adverse effects can be increased when Abciximab is combined with Treprostinil.,Treprostinil,DB00054
DB00008,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a,DB00054
DB00011,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-n1.,Interferon alfa-n1,DB00054
DB00018,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-n3.,Interferon alfa-n3,DB00054
DB00022,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b,DB00054
DB00033,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon gamma-1b.,Interferon gamma-1b,DB00054
DB00034,"The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant",DB00054
DB00041,The risk or severity of bleeding can be increased when Abciximab is combined with Aldesleukin.,Aldesleukin,DB00054
DB00068,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon beta-1b.,Interferon beta-1b,DB00054
DB00069,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfacon-1.,Interferon alfacon-1,DB00054
DB00105,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-2b.,Interferon alfa-2b,DB00054
DB00120,The risk or severity of bleeding can be increased when Abciximab is combined with Phenylalanine.,Phenylalanine,DB00054
DB00188,The risk or severity of bleeding can be increased when Abciximab is combined with Bortezomib.,Bortezomib,DB00054
DB00242,The risk or severity of bleeding can be increased when Abciximab is combined with Cladribine.,Cladribine,DB00054
DB00262,The risk or severity of bleeding can be increased when Abciximab is combined with Carmustine.,Carmustine,DB00054
DB00276,The risk or severity of bleeding can be increased when Abciximab is combined with Amsacrine.,Amsacrine,DB00054
DB00291,The risk or severity of bleeding can be increased when Abciximab is combined with Chlorambucil.,Chlorambucil,DB00054
DB00293,The risk or severity of bleeding can be increased when Abciximab is combined with Raltitrexed.,Raltitrexed,DB00054
DB00305,The risk or severity of bleeding can be increased when Abciximab is combined with Mitomycin.,Mitomycin,DB00054
DB00307,The risk or severity of bleeding can be increased when Abciximab is combined with Bexarotene.,Bexarotene,DB00054
DB00309,The risk or severity of bleeding can be increased when Abciximab is combined with Vindesine.,Vindesine,DB00054
DB00322,The risk or severity of bleeding can be increased when Abciximab is combined with Floxuridine.,Floxuridine,DB00054
DB00352,The risk or severity of bleeding can be increased when Abciximab is combined with Tioguanine.,Tioguanine,DB00054
DB00361,The risk or severity of bleeding can be increased when Abciximab is combined with Vinorelbine.,Vinorelbine,DB00054
DB00380,The risk or severity of bleeding can be increased when Abciximab is combined with Dexrazoxane.,Dexrazoxane,DB00054
DB00398,The risk or severity of bleeding can be increased when Abciximab is combined with Sorafenib.,Sorafenib,DB00054
DB00428,The risk or severity of bleeding can be increased when Abciximab is combined with Streptozocin.,Streptozocin,DB00054
DB00441,The risk or severity of bleeding can be increased when Abciximab is combined with Gemcitabine.,Gemcitabine,DB00054
DB00444,The risk or severity of bleeding can be increased when Abciximab is combined with Teniposide.,Teniposide,DB00054
DB00445,The risk or severity of bleeding can be increased when Abciximab is combined with Epirubicin.,Epirubicin,DB00054
DB00446,The risk or severity of bleeding can be increased when Abciximab is combined with Chloramphenicol.,Chloramphenicol,DB00054
DB00480,The risk or severity of bleeding can be increased when Abciximab is combined with Lenalidomide.,Lenalidomide,DB00054
DB00488,The risk or severity of bleeding can be increased when Abciximab is combined with Altretamine.,Altretamine,DB00054
DB00495,The risk or severity of bleeding can be increased when Abciximab is combined with Zidovudine.,Zidovudine,DB00054
DB00515,The risk or severity of bleeding can be increased when Abciximab is combined with Cisplatin.,Cisplatin,DB00054
DB00526,The risk or severity of bleeding can be increased when Abciximab is combined with Oxaliplatin.,Oxaliplatin,DB00054
DB00531,The risk or severity of bleeding can be increased when Abciximab is combined with Cyclophosphamide.,Cyclophosphamide,DB00054
DB00544,The risk or severity of bleeding can be increased when Abciximab is combined with Fluorouracil.,Fluorouracil,DB00054
DB00552,The risk or severity of bleeding can be increased when Abciximab is combined with Pentostatin.,Pentostatin,DB00054
DB00563,The risk or severity of bleeding can be increased when Abciximab is combined with Methotrexate.,Methotrexate,DB00054
DB00564,The risk or severity of bleeding can be increased when Abciximab is combined with Carbamazepine.,Carbamazepine,DB00054
DB00570,The risk or severity of bleeding can be increased when Abciximab is combined with Vinblastine.,Vinblastine,DB00054
DB00619,The risk or severity of bleeding can be increased when Abciximab is combined with Imatinib.,Imatinib,DB00054
DB00631,The risk or severity of bleeding can be increased when Abciximab is combined with Clofarabine.,Clofarabine,DB00054
DB00642,The risk or severity of bleeding can be increased when Abciximab is combined with Pemetrexed.,Pemetrexed,DB00054
DB00694,The risk or severity of bleeding can be increased when Abciximab is combined with Daunorubicin.,Daunorubicin,DB00054
DB00762,The risk or severity of bleeding can be increased when Abciximab is combined with Irinotecan.,Irinotecan,DB00054
DB00773,The risk or severity of bleeding can be increased when Abciximab is combined with Etoposide.,Etoposide,DB00054
DB00851,The risk or severity of bleeding can be increased when Abciximab is combined with Dacarbazine.,Dacarbazine,DB00054
DB00853,The risk or severity of bleeding can be increased when Abciximab is combined with Temozolomide.,Temozolomide,DB00054
DB00859,The risk or severity of bleeding can be increased when Abciximab is combined with Penicillamine.,Penicillamine,DB00054
DB00864,The risk or severity of bleeding can be increased when Abciximab is combined with Tacrolimus.,Tacrolimus,DB00054
DB00877,The risk or severity of bleeding can be increased when Abciximab is combined with Sirolimus.,Sirolimus,DB00054
DB00888,The risk or severity of bleeding can be increased when Abciximab is combined with Mechlorethamine.,Mechlorethamine,DB00054
DB00928,The risk or severity of bleeding can be increased when Abciximab is combined with Azacitidine.,Azacitidine,DB00054
DB00958,The risk or severity of bleeding can be increased when Abciximab is combined with Carboplatin.,Carboplatin,DB00054
DB00970,The risk or severity of bleeding can be increased when Abciximab is combined with Dactinomycin.,Dactinomycin,DB00054
DB00987,The risk or severity of bleeding can be increased when Abciximab is combined with Cytarabine.,Cytarabine,DB00054
DB00997,The risk or severity of bleeding can be increased when Abciximab is combined with Doxorubicin.,Doxorubicin,DB00054
DB01005,The risk or severity of bleeding can be increased when Abciximab is combined with Hydroxyurea.,Hydroxyurea,DB00054
DB01008,The risk or severity of bleeding can be increased when Abciximab is combined with Busulfan.,Busulfan,DB00054
DB01030,The risk or severity of bleeding can be increased when Abciximab is combined with Topotecan.,Topotecan,DB00054
DB01033,The risk or severity of bleeding can be increased when Abciximab is combined with Mercaptopurine.,Mercaptopurine,DB00054
DB01041,The risk or severity of bleeding can be increased when Abciximab is combined with Thalidomide.,Thalidomide,DB00054
DB01042,The risk or severity of bleeding can be increased when Abciximab is combined with Melphalan.,Melphalan,DB00054
DB01073,The risk or severity of bleeding can be increased when Abciximab is combined with Fludarabine.,Fludarabine,DB00054
DB01099,The risk or severity of bleeding can be increased when Abciximab is combined with Flucytosine.,Flucytosine,DB00054
DB01101,The risk or severity of bleeding can be increased when Abciximab is combined with Capecitabine.,Capecitabine,DB00054
DB01169,The risk or severity of bleeding can be increased when Abciximab is combined with Arsenic trioxide.,Arsenic trioxide,DB00054
DB01177,The risk or severity of bleeding can be increased when Abciximab is combined with Idarubicin.,Idarubicin,DB00054
DB01204,The risk or severity of bleeding can be increased when Abciximab is combined with Mitoxantrone.,Mitoxantrone,DB00054
DB01206,The risk or severity of bleeding can be increased when Abciximab is combined with Lomustine.,Lomustine,DB00054
DB01229,The risk or severity of bleeding can be increased when Abciximab is combined with Paclitaxel.,Paclitaxel,DB00054
DB01248,The risk or severity of bleeding can be increased when Abciximab is combined with Docetaxel.,Docetaxel,DB00054
DB01262,The risk or severity of bleeding can be increased when Abciximab is combined with Decitabine.,Decitabine,DB00054
DB01280,The risk or severity of bleeding can be increased when Abciximab is combined with Nelarabine.,Nelarabine,DB00054
DB01590,The risk or severity of bleeding can be increased when Abciximab is combined with Everolimus.,Everolimus,DB00054
DB02546,The risk or severity of bleeding can be increased when Abciximab is combined with Vorinostat.,Vorinostat,DB00054
DB04572,The risk or severity of bleeding can be increased when Abciximab is combined with Thiotepa.,Thiotepa,DB00054
DB04845,The risk or severity of bleeding can be increased when Abciximab is combined with Ixabepilone.,Ixabepilone,DB00054
DB04868,The risk or severity of bleeding can be increased when Abciximab is combined with Nilotinib.,Nilotinib,DB00054
DB05015,The risk or severity of bleeding can be increased when Abciximab is combined with Belinostat.,Belinostat,DB00054
DB05109,The risk or severity of bleeding can be increased when Abciximab is combined with Trabectedin.,Trabectedin,DB00054
DB05258,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa.,Interferon alfa,DB00054
DB05472,The risk or severity of bleeding can be increased when Abciximab is combined with omega interferon.,omega interferon,DB00054
DB06287,The risk or severity of bleeding can be increased when Abciximab is combined with Temsirolimus.,Temsirolimus,DB00054
DB06616,The risk or severity of bleeding can be increased when Abciximab is combined with Bosutinib.,Bosutinib,DB00054
DB06769,The risk or severity of bleeding can be increased when Abciximab is combined with Bendamustine.,Bendamustine,DB00054
DB06772,The risk or severity of bleeding can be increased when Abciximab is combined with Cabazitaxel.,Cabazitaxel,DB00054
DB08871,The risk or severity of bleeding can be increased when Abciximab is combined with Eribulin.,Eribulin,DB00054
DB08877,The risk or severity of bleeding can be increased when Abciximab is combined with Ruxolitinib.,Ruxolitinib,DB00054
DB08889,The risk or severity of bleeding can be increased when Abciximab is combined with Carfilzomib.,Carfilzomib,DB00054
DB08895,The risk or severity of bleeding can be increased when Abciximab is combined with Tofacitinib.,Tofacitinib,DB00054
DB08901,The risk or severity of bleeding can be increased when Abciximab is combined with Ponatinib.,Ponatinib,DB00054
DB08910,The risk or severity of bleeding can be increased when Abciximab is combined with Pomalidomide.,Pomalidomide,DB00054
DB09042,The risk or severity of bleeding can be increased when Abciximab is combined with Tedizolid phosphate.,Tedizolid phosphate,DB00054
DB09073,The risk or severity of bleeding can be increased when Abciximab is combined with Palbociclib.,Palbociclib,DB00054
DB09074,The risk or severity of bleeding can be increased when Abciximab is combined with Olaparib.,Olaparib,DB00054
DB09122,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon beta-1a.,Peginterferon beta-1a,DB00054
DB12814,The risk or severity of bleeding can be increased when Abciximab is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B,DB00054
DB03404,Hemin may increase the anticoagulant activities of Abciximab.,Hemin,DB00054
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Abciximab.,Acemetacin,DB00054
DB00624,Testosterone may increase the anticoagulant activities of Abciximab.,Testosterone,DB00054
DB01420,Testosterone propionate may increase the anticoagulant activities of Abciximab.,Testosterone propionate,DB00054
DB01481,1-Testosterone may increase the anticoagulant activities of Abciximab.,1-Testosterone,DB00054
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Abciximab.,4-Hydroxytestosterone,DB00054
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Abciximab.,Dehydrochloromethyltestosterone,DB00054
DB01541,Boldenone may increase the anticoagulant activities of Abciximab.,Boldenone,DB00054
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Abciximab.,18-methyl-19-nortestosterone,DB00054
DB01564,Calusterone may increase the anticoagulant activities of Abciximab.,Calusterone,DB00054
DB01569,Formebolone may increase the anticoagulant activities of Abciximab.,Formebolone,DB00054
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Abciximab.,Methyl-1-testosterone,DB00054
DB02901,Stanolone may increase the anticoagulant activities of Abciximab.,Stanolone,DB00054
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Abciximab.,5beta-dihydrotestosterone,DB00054
DB08619,Testosterone succinate may increase the anticoagulant activities of Abciximab.,Testosterone succinate,DB00054
DB11429,Mibolerone may increase the anticoagulant activities of Abciximab.,Mibolerone,DB00054
DB13943,Testosterone cypionate may increase the anticoagulant activities of Abciximab.,Testosterone cypionate,DB00054
DB13944,Testosterone enanthate may increase the anticoagulant activities of Abciximab.,Testosterone enanthate,DB00054
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Abciximab.,Testosterone undecanoate,DB00054
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Abciximab.,Testosterone enantate benzilic acid hydrazone,DB00054
DB13951,Stanolone acetate may increase the anticoagulant activities of Abciximab.,Stanolone acetate,DB00054
DB13958,Trestolone acetate may increase the anticoagulant activities of Abciximab.,Trestolone acetate,DB00054
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Abciximab.","(1,2,6,7-3H)Testosterone",DB00054
DB14655,Drostanolone propionate may increase the anticoagulant activities of Abciximab.,Drostanolone propionate,DB00054
DB11051,The risk or severity of adverse effects can be increased when Abciximab is combined with Azficel-T.,Azficel-T,DB00054
DB09568,The therapeutic efficacy of Abciximab can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids,DB00054
DB00002,The risk or severity of adverse effects can be increased when Cetuximab is combined with Abciximab.,Cetuximab,DB00054
DB00028,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abciximab.,Human immunoglobulin G,DB00054
DB00043,The risk or severity of adverse effects can be increased when Omalizumab is combined with Abciximab.,Omalizumab,DB00054
DB00051,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abciximab.,Adalimumab,DB00054
DB00056,The risk or severity of adverse effects can be increased when Abciximab is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin,DB00054
DB00057,The risk or severity of adverse effects can be increased when Abciximab is combined with Indium In-111 satumomab pendetide.,Indium In-111 satumomab pendetide,DB00054
DB00065,The risk or severity of adverse effects can be increased when Abciximab is combined with Infliximab.,Infliximab,DB00054
DB00072,The risk or severity of adverse effects can be increased when Abciximab is combined with Trastuzumab.,Trastuzumab,DB00054
DB00073,The risk or severity of adverse effects can be increased when Abciximab is combined with Rituximab.,Rituximab,DB00054
DB00074,The risk or severity of adverse effects can be increased when Abciximab is combined with Basiliximab.,Basiliximab,DB00054
DB00075,The risk or severity of adverse effects can be increased when Abciximab is combined with Muromonab.,Muromonab,DB00054
DB00076,The risk or severity of adverse effects can be increased when Abciximab is combined with Digoxin Immune Fab (Ovine).,Digoxin Immune Fab (Ovine),DB00054
DB00087,The risk or severity of adverse effects can be increased when Abciximab is combined with Alemtuzumab.,Alemtuzumab,DB00054
DB00089,The risk or severity of adverse effects can be increased when Abciximab is combined with Capromab pendetide.,Capromab pendetide,DB00054
DB00095,The risk or severity of adverse effects can be increased when Abciximab is combined with Efalizumab.,Efalizumab,DB00054
DB00098,The risk or severity of adverse effects can be increased when Abciximab is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit),DB00054
DB00108,The risk or severity of adverse effects can be increased when Abciximab is combined with Natalizumab.,Natalizumab,DB00054
DB00110,The risk or severity of adverse effects can be increased when Abciximab is combined with Palivizumab.,Palivizumab,DB00054
DB00111,The risk or severity of adverse effects can be increased when Abciximab is combined with Daclizumab.,Daclizumab,DB00054
DB00112,The risk or severity of adverse effects can be increased when Abciximab is combined with Bevacizumab.,Bevacizumab,DB00054
DB00113,The risk or severity of adverse effects can be increased when Abciximab is combined with Technetium Tc-99m arcitumomab.,Technetium Tc-99m arcitumomab,DB00054
DB01257,The risk or severity of adverse effects can be increased when Abciximab is combined with Eculizumab.,Eculizumab,DB00054
DB01269,The risk or severity of adverse effects can be increased when Abciximab is combined with Panitumumab.,Panitumumab,DB00054
DB01270,The risk or severity of adverse effects can be increased when Abciximab is combined with Ranibizumab.,Ranibizumab,DB00054
DB04901,The risk or severity of adverse effects can be increased when Abciximab is combined with Galiximab.,Galiximab,DB00054
DB04949,The risk or severity of adverse effects can be increased when Abciximab is combined with Pexelizumab.,Pexelizumab,DB00054
DB04956,The risk or severity of adverse effects can be increased when Abciximab is combined with Afelimomab.,Afelimomab,DB00054
DB04958,The risk or severity of adverse effects can be increased when Abciximab is combined with Epratuzumab.,Epratuzumab,DB00054
DB04962,The risk or severity of adverse effects can be increased when Abciximab is combined with Bectumomab.,Bectumomab,DB00054
DB04964,The risk or severity of adverse effects can be increased when Abciximab is combined with Oregovomab.,Oregovomab,DB00054
DB04988,The risk or severity of adverse effects can be increased when Abciximab is combined with IGN311.,IGN311,DB00054
DB05006,The risk or severity of adverse effects can be increased when Abciximab is combined with Adecatumumab.,Adecatumumab,DB00054
DB05097,The risk or severity of adverse effects can be increased when Abciximab is combined with Labetuzumab.,Labetuzumab,DB00054
DB05101,The risk or severity of adverse effects can be increased when Abciximab is combined with Matuzumab.,Matuzumab,DB00054
DB05111,The risk or severity of adverse effects can be increased when Abciximab is combined with Fontolizumab.,Fontolizumab,DB00054
DB05136,The risk or severity of adverse effects can be increased when Abciximab is combined with Bavituximab.,Bavituximab,DB00054
DB05139,The risk or severity of adverse effects can be increased when Abciximab is combined with CR002.,CR002,DB00054
DB05209,The risk or severity of adverse effects can be increased when Abciximab is combined with Rozrolimupab.,Rozrolimupab,DB00054
DB05304,The risk or severity of adverse effects can be increased when Abciximab is combined with Girentuximab.,Girentuximab,DB00054
DB05336,The risk or severity of adverse effects can be increased when Abciximab is combined with Obiltoxaximab.,Obiltoxaximab,DB00054
DB05405,The risk or severity of adverse effects can be increased when Abciximab is combined with XTL-001.,XTL-001,DB00054
DB05437,The risk or severity of adverse effects can be increased when Abciximab is combined with NAV 1800.,NAV 1800,DB00054
DB05459,The risk or severity of adverse effects can be increased when Abciximab is combined with Briakinumab.,Briakinumab,DB00054
DB05496,The risk or severity of adverse effects can be increased when Abciximab is combined with Otelixizumab.,Otelixizumab,DB00054
DB05545,The risk or severity of adverse effects can be increased when Abciximab is combined with AMG 108.,AMG 108,DB00054
DB05550,The risk or severity of adverse effects can be increased when Abciximab is combined with Iratumumab.,Iratumumab,DB00054
DB05555,The risk or severity of adverse effects can be increased when Abciximab is combined with Enokizumab.,Enokizumab,DB00054
DB05578,The risk or severity of adverse effects can be increased when Abciximab is combined with Ramucirumab.,Ramucirumab,DB00054
DB05595,The risk or severity of adverse effects can be increased when Abciximab is combined with Farletuzumab.,Farletuzumab,DB00054
DB05656,The risk or severity of adverse effects can be increased when Abciximab is combined with Veltuzumab.,Veltuzumab,DB00054
DB05679,The risk or severity of adverse effects can be increased when Abciximab is combined with Ustekinumab.,Ustekinumab,DB00054
DB05773,The risk or severity of adverse effects can be increased when Abciximab is combined with Trastuzumab emtansine.,Trastuzumab emtansine,DB00054
DB05793,The risk or severity of adverse effects can be increased when Abciximab is combined with PRO-542.,PRO-542,DB00054
DB05797,The risk or severity of adverse effects can be increased when Abciximab is combined with TNX-901.,TNX-901,DB00054
DB05889,The risk or severity of adverse effects can be increased when Abciximab is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin,DB00054
DB05892,The risk or severity of adverse effects can be increased when Abciximab is combined with RI 624.,RI 624,DB00054
DB05915,The risk or severity of adverse effects can be increased when Abciximab is combined with MYO-029.,MYO-029,DB00054
DB05916,The risk or severity of adverse effects can be increased when Abciximab is combined with CT-011.,CT-011,DB00054
DB05941,The risk or severity of adverse effects can be increased when Abciximab is combined with Leronlimab.,Leronlimab,DB00054
DB05996,The risk or severity of adverse effects can be increased when Abciximab is combined with Glembatumumab vedotin.,Glembatumumab vedotin,DB00054
DB06043,The risk or severity of adverse effects can be increased when Abciximab is combined with Olaratumab.,Olaratumab,DB00054
DB06049,The risk or severity of adverse effects can be increased when Abciximab is combined with IPH 2101.,IPH 2101,DB00054
DB06050,The risk or severity of adverse effects can be increased when Abciximab is combined with TB-402.,TB-402,DB00054
DB06101,The risk or severity of adverse effects can be increased when Abciximab is combined with IMC-1C11.,IMC-1C11,DB00054
DB06116,The risk or severity of adverse effects can be increased when Abciximab is combined with Eldelumab.,Eldelumab,DB00054
DB06162,The risk or severity of adverse effects can be increased when Abciximab is combined with Lumiliximab.,Lumiliximab,DB00054
DB06168,The risk or severity of adverse effects can be increased when Abciximab is combined with Canakinumab.,Canakinumab,DB00054
DB06186,The risk or severity of adverse effects can be increased when Abciximab is combined with Ipilimumab.,Ipilimumab,DB00054
DB06192,The risk or severity of adverse effects can be increased when Abciximab is combined with Nimotuzumab.,Nimotuzumab,DB00054
DB06241,The risk or severity of adverse effects can be increased when Abciximab is combined with Clenoliximab.,Clenoliximab,DB00054
DB06273,The risk or severity of adverse effects can be increased when Abciximab is combined with Tocilizumab.,Tocilizumab,DB00054
DB06304,The risk or severity of adverse effects can be increased when Abciximab is combined with BIIB015.,BIIB015,DB00054
DB06305,The risk or severity of adverse effects can be increased when Abciximab is combined with Sonepcizumab.,Sonepcizumab,DB00054
DB06310,The risk or severity of adverse effects can be increased when Abciximab is combined with Motavizumab.,Motavizumab,DB00054
DB06317,The risk or severity of adverse effects can be increased when Abciximab is combined with Elotuzumab.,Elotuzumab,DB00054
DB06318,The risk or severity of adverse effects can be increased when Abciximab is combined with AVE9633.,AVE9633,DB00054
DB06322,The risk or severity of adverse effects can be increased when Abciximab is combined with Carotuximab.,Carotuximab,DB00054
DB06324,The risk or severity of adverse effects can be increased when Abciximab is combined with XmAb 2513.,XmAb 2513,DB00054
DB06342,The risk or severity of adverse effects can be increased when Abciximab is combined with Coltuximab ravtansine.,Coltuximab ravtansine,DB00054
DB06343,The risk or severity of adverse effects can be increased when Abciximab is combined with Teprotumumab.,Teprotumumab,DB00054
DB06360,The risk or severity of adverse effects can be increased when Abciximab is combined with Lucatumumab.,Lucatumumab,DB00054
DB06366,The risk or severity of adverse effects can be increased when Abciximab is combined with Pertuzumab.,Pertuzumab,DB00054
DB06371,The risk or severity of adverse effects can be increased when Abciximab is combined with Siplizumab.,Siplizumab,DB00054
DB06467,The risk or severity of adverse effects can be increased when Abciximab is combined with Apolizumab.,Apolizumab,DB00054
DB06474,The risk or severity of adverse effects can be increased when Abciximab is combined with Sibrotuzumab.,Sibrotuzumab,DB00054
DB06550,The risk or severity of adverse effects can be increased when Abciximab is combined with Bivatuzumab.,Bivatuzumab,DB00054
DB06557,The risk or severity of adverse effects can be increased when Abciximab is combined with Lerdelimumab.,Lerdelimumab,DB00054
DB06599,The risk or severity of adverse effects can be increased when Abciximab is combined with Lexatumumab.,Lexatumumab,DB00054
DB06602,The risk or severity of adverse effects can be increased when Abciximab is combined with Reslizumab.,Reslizumab,DB00054
DB06606,The risk or severity of adverse effects can be increased when Abciximab is combined with Teplizumab.,Teplizumab,DB00054
DB06607,The risk or severity of adverse effects can be increased when Abciximab is combined with Catumaxomab.,Catumaxomab,DB00054
DB06612,The risk or severity of adverse effects can be increased when Abciximab is combined with Mepolizumab.,Mepolizumab,DB00054
DB06643,The risk or severity of adverse effects can be increased when Abciximab is combined with Denosumab.,Denosumab,DB00054
DB06647,The risk or severity of adverse effects can be increased when Abciximab is combined with Volociximab.,Volociximab,DB00054
DB06650,The risk or severity of adverse effects can be increased when Abciximab is combined with Ofatumumab.,Ofatumumab,DB00054
DB06674,The risk or severity of adverse effects can be increased when Abciximab is combined with Golimumab.,Golimumab,DB00054
DB08870,The risk or severity of adverse effects can be increased when Abciximab is combined with Brentuximab vedotin.,Brentuximab vedotin,DB00054
DB08879,The risk or severity of adverse effects can be increased when Abciximab is combined with Belimumab.,Belimumab,DB00054
DB08902,The risk or severity of adverse effects can be increased when Abciximab is combined with Raxibacumab.,Raxibacumab,DB00054
DB08904,The risk or severity of adverse effects can be increased when Abciximab is combined with Certolizumab pegol.,Certolizumab pegol,DB00054
DB09029,The risk or severity of adverse effects can be increased when Abciximab is combined with Secukinumab.,Secukinumab,DB00054
DB09033,The risk or severity of adverse effects can be increased when Abciximab is combined with Vedolizumab.,Vedolizumab,DB00054
DB09035,The risk or severity of adverse effects can be increased when Abciximab is combined with Nivolumab.,Nivolumab,DB00054
DB09036,The risk or severity of adverse effects can be increased when Abciximab is combined with Siltuximab.,Siltuximab,DB00054
DB09037,The risk or severity of adverse effects can be increased when Abciximab is combined with Pembrolizumab.,Pembrolizumab,DB00054
DB09045,The risk or severity of adverse effects can be increased when Abciximab is combined with Dulaglutide.,Dulaglutide,DB00054
DB09052,The risk or severity of adverse effects can be increased when Abciximab is combined with Blinatumomab.,Blinatumomab,DB00054
DB09057,The risk or severity of adverse effects can be increased when Abciximab is combined with Anthrax immune globulin human.,Anthrax immune globulin human,DB00054
DB09077,The risk or severity of adverse effects can be increased when Abciximab is combined with Dinutuximab.,Dinutuximab,DB00054
DB09105,The risk or severity of adverse effects can be increased when Abciximab is combined with Asfotase alfa.,Asfotase alfa,DB00054
DB09264,The risk or severity of adverse effects can be increased when Abciximab is combined with Idarucizumab.,Idarucizumab,DB00054
DB09302,The risk or severity of adverse effects can be increased when Abciximab is combined with Alirocumab.,Alirocumab,DB00054
DB09303,The risk or severity of adverse effects can be increased when Abciximab is combined with Evolocumab.,Evolocumab,DB00054
DB09312,The risk or severity of adverse effects can be increased when Abciximab is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse),DB00054
DB09331,The risk or severity of adverse effects can be increased when Abciximab is combined with Daratumumab.,Daratumumab,DB00054
DB09559,The risk or severity of adverse effects can be increased when Abciximab is combined with Necitumumab.,Necitumumab,DB00054
DB11569,The risk or severity of adverse effects can be increased when Abciximab is combined with Ixekizumab.,Ixekizumab,DB00054
DB11580,The risk or severity of adverse effects can be increased when Abciximab is combined with Ravulizumab.,Ravulizumab,DB00054
DB11595,The risk or severity of adverse effects can be increased when Abciximab is combined with Atezolizumab.,Atezolizumab,DB00054
DB11604,The risk or severity of adverse effects can be increased when Abciximab is combined with Tetanus Immune Globulin.,Tetanus Immune Globulin,DB00054
DB11621,The risk or severity of adverse effects can be increased when Abciximab is combined with Human Varicella-Zoster Immune Globulin.,Human Varicella-Zoster Immune Globulin,DB00054
DB11646,The risk or severity of adverse effects can be increased when Abciximab is combined with Conatumumab.,Conatumumab,DB00054
DB11657,The risk or severity of adverse effects can be increased when Abciximab is combined with Tabalumab.,Tabalumab,DB00054
DB11680,The risk or severity of adverse effects can be increased when Abciximab is combined with Ficlatuzumab.,Ficlatuzumab,DB00054
DB11685,The risk or severity of adverse effects can be increased when Abciximab is combined with Figitumumab.,Figitumumab,DB00054
DB11714,The risk or severity of adverse effects can be increased when Abciximab is combined with Durvalumab.,Durvalumab,DB00054
DB11715,The risk or severity of adverse effects can be increased when Abciximab is combined with Bapineuzumab.,Bapineuzumab,DB00054
DB11731,The risk or severity of adverse effects can be increased when Abciximab is combined with Depatuxizumab mafodotin.,Depatuxizumab mafodotin,DB00054
DB11746,The risk or severity of adverse effects can be increased when Abciximab is combined with Onartuzumab.,Onartuzumab,DB00054
DB11756,The risk or severity of adverse effects can be increased when Abciximab is combined with Solanezumab.,Solanezumab,DB00054
DB11767,The risk or severity of adverse effects can be increased when Abciximab is combined with Sarilumab.,Sarilumab,DB00054
DB11771,The risk or severity of adverse effects can be increased when Abciximab is combined with Tremelimumab.,Tremelimumab,DB00054
DB11776,The risk or severity of adverse effects can be increased when Abciximab is combined with Brodalumab.,Brodalumab,DB00054
DB11803,The risk or severity of adverse effects can be increased when Abciximab is combined with Sirukumab.,Sirukumab,DB00054
DB11826,The risk or severity of adverse effects can be increased when Abciximab is combined with Lampalizumab.,Lampalizumab,DB00054
DB11834,The risk or severity of adverse effects can be increased when Abciximab is combined with Guselkumab.,Guselkumab,DB00054
DB11840,The risk or severity of adverse effects can be increased when Abciximab is combined with Dalotuzumab.,Dalotuzumab,DB00054
DB11849,The risk or severity of adverse effects can be increased when Abciximab is combined with Emibetuzumab.,Emibetuzumab,DB00054
DB11850,The risk or severity of adverse effects can be increased when Abciximab is combined with Ublituximab.,Ublituximab,DB00054
DB11856,The risk or severity of adverse effects can be increased when Abciximab is combined with Ligelizumab.,Ligelizumab,DB00054
DB11857,The risk or severity of adverse effects can be increased when Abciximab is combined with Seribantumab.,Seribantumab,DB00054
DB11862,The risk or severity of adverse effects can be increased when Abciximab is combined with Landogrozumab.,Landogrozumab,DB00054
DB11866,The risk or severity of adverse effects can be increased when Abciximab is combined with Romosozumab.,Romosozumab,DB00054
DB11884,The risk or severity of adverse effects can be increased when Abciximab is combined with Vadastuximab Talirine.,Vadastuximab Talirine,DB00054
DB11914,The risk or severity of adverse effects can be increased when Abciximab is combined with Lebrikizumab.,Lebrikizumab,DB00054
DB11930,The risk or severity of adverse effects can be increased when Abciximab is combined with Varlilumab.,Varlilumab,DB00054
DB11945,The risk or severity of adverse effects can be increased when Abciximab is combined with Avelumab.,Avelumab,DB00054
DB11959,The risk or severity of adverse effects can be increased when Abciximab is combined with Crenezumab.,Crenezumab,DB00054
DB11972,The risk or severity of adverse effects can be increased when Abciximab is combined with Rilotumumab.,Rilotumumab,DB00054
DB11976,The risk or severity of adverse effects can be increased when Abciximab is combined with Anifrolumab.,Anifrolumab,DB00054
DB11988,The risk or severity of adverse effects can be increased when Abciximab is combined with Ocrelizumab.,Ocrelizumab,DB00054
DB12023,The risk or severity of adverse effects can be increased when Abciximab is combined with Benralizumab.,Benralizumab,DB00054
DB12034,The risk or severity of adverse effects can be increased when Abciximab is combined with Gantenerumab.,Gantenerumab,DB00054
DB12053,The risk or severity of adverse effects can be increased when Abciximab is combined with Visilizumab.,Visilizumab,DB00054
DB12077,The risk or severity of adverse effects can be increased when Abciximab is combined with Urelumab.,Urelumab,DB00054
DB12089,The risk or severity of adverse effects can be increased when Abciximab is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine,DB00054
DB12090,The risk or severity of adverse effects can be increased when Abciximab is combined with Patritumab.,Patritumab,DB00054
DB12102,The risk or severity of adverse effects can be increased when Abciximab is combined with Fulranumab.,Fulranumab,DB00054
DB12104,The risk or severity of adverse effects can be increased when Abciximab is combined with Tarextumab.,Tarextumab,DB00054
DB12118,The risk or severity of adverse effects can be increased when Abciximab is combined with Sotatercept.,Sotatercept,DB00054
DB12119,The risk or severity of adverse effects can be increased when Abciximab is combined with Gevokizumab.,Gevokizumab,DB00054
DB12142,The risk or severity of adverse effects can be increased when Abciximab is combined with Duligotuzumab.,Duligotuzumab,DB00054
DB12152,The risk or severity of adverse effects can be increased when Abciximab is combined with Simtuzumab.,Simtuzumab,DB00054
DB12157,The risk or severity of adverse effects can be increased when Abciximab is combined with Fasinumab.,Fasinumab,DB00054
DB12159,The risk or severity of adverse effects can be increased when Abciximab is combined with Dupilumab.,Dupilumab,DB00054
DB12169,The risk or severity of adverse effects can be increased when Abciximab is combined with Tralokinumab.,Tralokinumab,DB00054
DB12189,The risk or severity of adverse effects can be increased when Abciximab is combined with Etrolizumab.,Etrolizumab,DB00054
DB12202,The risk or severity of adverse effects can be increased when Abciximab is combined with Zalutumumab.,Zalutumumab,DB00054
DB12205,The risk or severity of adverse effects can be increased when Abciximab is combined with Ganitumab.,Ganitumab,DB00054
DB12213,The risk or severity of adverse effects can be increased when Abciximab is combined with Etaracizumab.,Etaracizumab,DB00054
DB12240,The risk or severity of adverse effects can be increased when Abciximab is combined with Polatuzumab vedotin.,Polatuzumab vedotin,DB00054
DB12246,The risk or severity of adverse effects can be increased when Abciximab is combined with Inclacumab.,Inclacumab,DB00054
DB12250,The risk or severity of adverse effects can be increased when Abciximab is combined with Cixutumumab.,Cixutumumab,DB00054
DB12261,The risk or severity of adverse effects can be increased when Abciximab is combined with Ascrinvacumab.,Ascrinvacumab,DB00054
DB12274,The risk or severity of adverse effects can be increased when Abciximab is combined with Aducanumab.,Aducanumab,DB00054
DB12281,The risk or severity of adverse effects can be increased when Abciximab is combined with Luspatercept.,Luspatercept,DB00054
DB12296,The risk or severity of adverse effects can be increased when Abciximab is combined with GS-5745.,GS-5745,DB00054
DB12317,The risk or severity of adverse effects can be increased when Abciximab is combined with Vanucizumab.,Vanucizumab,DB00054
DB12331,The risk or severity of adverse effects can be increased when Abciximab is combined with Labetuzumab govitecan.,Labetuzumab govitecan,DB00054
DB12335,The risk or severity of adverse effects can be increased when Abciximab is combined with Tanezumab.,Tanezumab,DB00054
DB12342,The risk or severity of adverse effects can be increased when Abciximab is combined with Ensituximab.,Ensituximab,DB00054
DB12344,The risk or severity of adverse effects can be increased when Abciximab is combined with Fezakinumab.,Fezakinumab,DB00054
DB12363,The risk or severity of adverse effects can be increased when Abciximab is combined with Dusigitumab.,Dusigitumab,DB00054
DB12396,The risk or severity of adverse effects can be increased when Abciximab is combined with Fresolimumab.,Fresolimumab,DB00054
DB12413,The risk or severity of adverse effects can be increased when Abciximab is combined with Indusatumab vedotin.,Indusatumab vedotin,DB00054
DB12456,The risk or severity of adverse effects can be increased when Abciximab is combined with Bococizumab.,Bococizumab,DB00054
DB12489,The risk or severity of adverse effects can be increased when Abciximab is combined with Mirvetuximab Soravtansine.,Mirvetuximab Soravtansine,DB00054
DB12498,The risk or severity of adverse effects can be increased when Abciximab is combined with Mogamulizumab.,Mogamulizumab,DB00054
DB12520,The risk or severity of adverse effects can be increased when Abciximab is combined with Plozalizumab.,Plozalizumab,DB00054
DB12530,The risk or severity of adverse effects can be increased when Abciximab is combined with Inebilizumab.,Inebilizumab,DB00054
DB12534,The risk or severity of adverse effects can be increased when Abciximab is combined with Mavrilimumab.,Mavrilimumab,DB00054
DB12560,The risk or severity of adverse effects can be increased when Abciximab is combined with Blosozumab.,Blosozumab,DB00054
DB12584,The risk or severity of adverse effects can be increased when Abciximab is combined with Bimagrumab.,Bimagrumab,DB00054
DB12589,The risk or severity of adverse effects can be increased when Abciximab is combined with Dacetuzumab.,Dacetuzumab,DB00054
DB12609,The risk or severity of adverse effects can be increased when Abciximab is combined with Tovetumab.,Tovetumab,DB00054
DB12683,The risk or severity of adverse effects can be increased when Abciximab is combined with Lumretuzumab.,Lumretuzumab,DB00054
DB12698,The risk or severity of adverse effects can be increased when Abciximab is combined with Ibalizumab.,Ibalizumab,DB00054
DB12701,The risk or severity of adverse effects can be increased when Abciximab is combined with Intetumumab.,Intetumumab,DB00054
DB12718,The risk or severity of adverse effects can be increased when Abciximab is combined with Carlumab.,Carlumab,DB00054
DB12734,The risk or severity of adverse effects can be increased when Abciximab is combined with Demcizumab.,Demcizumab,DB00054
DB12773,The risk or severity of adverse effects can be increased when Abciximab is combined with Sifalimumab.,Sifalimumab,DB00054
DB12775,The risk or severity of adverse effects can be increased when Abciximab is combined with Abituzumab.,Abituzumab,DB00054
DB12797,The risk or severity of adverse effects can be increased when Abciximab is combined with Ecromeximab.,Ecromeximab,DB00054
DB12807,The risk or severity of adverse effects can be increased when Abciximab is combined with Naptumomab Estafenatox.,Naptumomab Estafenatox,DB00054
DB12815,The risk or severity of adverse effects can be increased when Abciximab is combined with Crotedumab.,Crotedumab,DB00054
DB12820,The risk or severity of adverse effects can be increased when Abciximab is combined with Concizumab.,Concizumab,DB00054
DB12826,The risk or severity of adverse effects can be increased when Abciximab is combined with Depatuxizumab.,Depatuxizumab,DB00054
DB12844,The risk or severity of adverse effects can be increased when Abciximab is combined with Rontalizumab.,Rontalizumab,DB00054
DB12845,The risk or severity of adverse effects can be increased when Abciximab is combined with Amatuximab.,Amatuximab,DB00054
DB12849,The risk or severity of adverse effects can be increased when Abciximab is combined with Clazakizumab.,Clazakizumab,DB00054
DB12891,The risk or severity of adverse effects can be increased when Abciximab is combined with Ozanezumab.,Ozanezumab,DB00054
DB12893,The risk or severity of adverse effects can be increased when Abciximab is combined with Sacituzumab govitecan.,Sacituzumab govitecan,DB00054
DB12917,The risk or severity of adverse effects can be increased when Abciximab is combined with Bimekizumab.,Bimekizumab,DB00054
DB12943,The risk or severity of adverse effects can be increased when Abciximab is combined with Milatuzumab.,Milatuzumab,DB00054
DB12976,The risk or severity of adverse effects can be increased when Abciximab is combined with Robatumumab.,Robatumumab,DB00054
DB13017,The risk or severity of adverse effects can be increased when Abciximab is combined with Rovalpituzumab Tesirine.,Rovalpituzumab Tesirine,DB00054
DB13037,The risk or severity of adverse effects can be increased when Abciximab is combined with Namilumab.,Namilumab,DB00054
DB13045,The risk or severity of adverse effects can be increased when Abciximab is combined with Racotumomab.,Racotumomab,DB00054
DB13073,The risk or severity of adverse effects can be increased when Abciximab is combined with Tregalizumab.,Tregalizumab,DB00054
DB13127,The risk or severity of adverse effects can be increased when Abciximab is combined with Olokizumab.,Olokizumab,DB00054
DB13140,The risk or severity of adverse effects can be increased when Abciximab is combined with Bezlotoxumab.,Bezlotoxumab,DB00054
DB13375,The risk or severity of adverse effects can be increased when Abciximab is combined with Edrecolomab.,Edrecolomab,DB00054
DB13535,The risk or severity of adverse effects can be increased when Abciximab is combined with Nebacumab.,Nebacumab,DB00054
DB13886,The risk or severity of adverse effects can be increased when Abciximab is combined with Human cytomegalovirus immune globulin.,Human cytomegalovirus immune globulin,DB00054
DB13976,The risk or severity of adverse effects can be increased when Abciximab is combined with Sulesomab.,Sulesomab,DB00054
DB13979,The risk or severity of adverse effects can be increased when Abciximab is combined with Besilesomab.,Besilesomab,DB00054
DB14004,The risk or severity of adverse effects can be increased when Abciximab is combined with Tildrakizumab.,Tildrakizumab,DB00054
DB14012,The risk or severity of adverse effects can be increased when Abciximab is combined with Burosumab.,Burosumab,DB00054
DB14039,The risk or severity of adverse effects can be increased when Abciximab is combined with Erenumab.,Erenumab,DB00054
DB14040,The risk or severity of adverse effects can be increased when Abciximab is combined with Eptinezumab.,Eptinezumab,DB00054
DB14041,The risk or severity of adverse effects can be increased when Abciximab is combined with Fremanezumab.,Fremanezumab,DB00054
DB14042,The risk or severity of adverse effects can be increased when Abciximab is combined with Galcanezumab.,Galcanezumab,DB00054
DB14211,The risk or severity of adverse effects can be increased when Abciximab is combined with Fanolesomab.,Fanolesomab,DB00054
DB14580,The risk or severity of adverse effects can be increased when Abciximab is combined with Lecanemab.,Lecanemab,DB00054
DB14597,The risk or severity of adverse effects can be increased when Abciximab is combined with Lanadelumab.,Lanadelumab,DB00054
DB14707,The risk or severity of adverse effects can be increased when Abciximab is combined with Cemiplimab.,Cemiplimab,DB00054
DB14724,The risk or severity of adverse effects can be increased when Abciximab is combined with Emapalumab.,Emapalumab,DB00054
DB14762,The risk or severity of adverse effects can be increased when Abciximab is combined with Risankizumab.,Risankizumab,DB00054
DB14776,The risk or severity of adverse effects can be increased when Abciximab is combined with Camrelizumab.,Camrelizumab,DB00054
DB14778,The risk or severity of adverse effects can be increased when Abciximab is combined with Setrusumab.,Setrusumab,DB00054
DB14784,The risk or severity of adverse effects can be increased when Abciximab is combined with Gancotamab.,Gancotamab,DB00054
DB14809,The risk or severity of adverse effects can be increased when Abciximab is combined with Anetumab ravtansine.,Anetumab ravtansine,DB00054
DB14811,The risk or severity of adverse effects can be increased when Abciximab is combined with Isatuximab.,Isatuximab,DB00054
DB14824,The risk or severity of adverse effects can be increased when Abciximab is combined with Icrucumab.,Icrucumab,DB00054
DB14843,The risk or severity of adverse effects can be increased when Abciximab is combined with Codrituzumab.,Codrituzumab,DB00054
DB14864,The risk or severity of adverse effects can be increased when Abciximab is combined with Brolucizumab.,Brolucizumab,DB00054
DB14871,The risk or severity of adverse effects can be increased when Abciximab is combined with Xentuzumab.,Xentuzumab,DB00054
DB14877,The risk or severity of adverse effects can be increased when Abciximab is combined with Lintuzumab.,Lintuzumab,DB00054
DB14891,The risk or severity of adverse effects can be increased when Abciximab is combined with Vobarilizumab.,Vobarilizumab,DB00054
DB14897,The risk or severity of adverse effects can be increased when Abciximab is combined with Parsatuzumab.,Parsatuzumab,DB00054
DB14905,The risk or severity of adverse effects can be increased when Abciximab is combined with Emactuzumab.,Emactuzumab,DB00054
DB14907,The risk or severity of adverse effects can be increased when Abciximab is combined with Bevacizumab zirconium Zr-89.,Bevacizumab zirconium Zr-89,DB00054
DB14908,The risk or severity of adverse effects can be increased when Abciximab is combined with Refanezumab.,Refanezumab,DB00054
DB14919,The risk or severity of adverse effects can be increased when Abciximab is combined with Rozanolixizumab.,Rozanolixizumab,DB00054
DB14947,The risk or severity of adverse effects can be increased when Abciximab is combined with Bermekimab.,Bermekimab,DB00054
DB14952,The risk or severity of adverse effects can be increased when Abciximab is combined with Pamrevlumab.,Pamrevlumab,DB00054
DB14959,The risk or severity of adverse effects can be increased when Abciximab is combined with Opicinumab.,Opicinumab,DB00054
DB14962,The risk or severity of adverse effects can be increased when Abciximab is combined with Trastuzumab deruxtecan.,Trastuzumab deruxtecan,DB00054
DB14967,The risk or severity of adverse effects can be increased when Abciximab is combined with Margetuximab.,Margetuximab,DB00054
DB14988,The risk or severity of adverse effects can be increased when Abciximab is combined with Dalantercept.,Dalantercept,DB00054
DB14997,The risk or severity of adverse effects can be increased when Abciximab is combined with Pateclizumab.,Pateclizumab,DB00054
DB15014,The risk or severity of adverse effects can be increased when Abciximab is combined with Gremubamab.,Gremubamab,DB00054
DB15022,The risk or severity of adverse effects can be increased when Abciximab is combined with Apomab.,Apomab,DB00054
DB15044,The risk or severity of adverse effects can be increased when Abciximab is combined with Tafasitamab.,Tafasitamab,DB00054
DB15045,The risk or severity of adverse effects can be increased when Abciximab is combined with Ipafricept.,Ipafricept,DB00054
DB15076,The risk or severity of adverse effects can be increased when Abciximab is combined with Abrilumab.,Abrilumab,DB00054
DB15089,The risk or severity of adverse effects can be increased when Abciximab is combined with Frovocimab.,Frovocimab,DB00054
DB15090,The risk or severity of adverse effects can be increased when Abciximab is combined with Tezepelumab.,Tezepelumab,DB00054
DB15101,The risk or severity of adverse effects can be increased when Abciximab is combined with Tigatuzumab.,Tigatuzumab,DB00054
DB15104,The risk or severity of adverse effects can be increased when Abciximab is combined with Telisotuzumab vedotin.,Telisotuzumab vedotin,DB00054
DB15113,The risk or severity of adverse effects can be increased when Abciximab is combined with Utomilumab.,Utomilumab,DB00054
DB15118,The risk or severity of adverse effects can be increased when Abciximab is combined with Zolbetuximab.,Zolbetuximab,DB00054
DB15135,The risk or severity of adverse effects can be increased when Abciximab is combined with Ponezumab.,Ponezumab,DB00054
DB15160,The risk or severity of adverse effects can be increased when Abciximab is combined with Asunercept.,Asunercept,DB00054
DB15172,The risk or severity of adverse effects can be increased when Abciximab is combined with Suvratoxumab.,Suvratoxumab,DB00054
DB15225,The risk or severity of adverse effects can be increased when Abciximab is combined with Mitazalimab.,Mitazalimab,DB00054
DB15252,The risk or severity of adverse effects can be increased when Abciximab is combined with Nemolizumab.,Nemolizumab,DB00054
DB15253,The risk or severity of adverse effects can be increased when Abciximab is combined with Bleselumab.,Bleselumab,DB00054
DB15277,The risk or severity of adverse effects can be increased when Abciximab is combined with Gedivumab.,Gedivumab,DB00054
DB15336,The risk or severity of adverse effects can be increased when Abciximab is combined with Valanafusp alfa.,Valanafusp alfa,DB00054
DB15349,The risk or severity of adverse effects can be increased when Abciximab is combined with Sofituzumab vedotin.,Sofituzumab vedotin,DB00054
DB15354,The risk or severity of adverse effects can be increased when Abciximab is combined with Evinacumab.,Evinacumab,DB00054
DB15363,The risk or severity of adverse effects can be increased when Abciximab is combined with Istiratumab.,Istiratumab,DB00054
DB15383,The risk or severity of adverse effects can be increased when Abciximab is combined with Pidilizumab.,Pidilizumab,DB00054
DB15397,The risk or severity of adverse effects can be increased when Abciximab is combined with GMA-161.,GMA-161,DB00054
DB15409,The risk or severity of adverse effects can be increased when Abciximab is combined with Ladiratuzumab vedotin.,Ladiratuzumab vedotin,DB00054
DB15415,The risk or severity of adverse effects can be increased when Abciximab is combined with Tomaralimab.,Tomaralimab,DB00054
DB15428,The risk or severity of adverse effects can be increased when Abciximab is combined with Vesencumab.,Vesencumab,DB00054
DB15432,The risk or severity of adverse effects can be increased when Abciximab is combined with Pinatuzumab vedotin.,Pinatuzumab vedotin,DB00054
DB15441,The risk or severity of adverse effects can be increased when Abciximab is combined with Lulizumab pegol.,Lulizumab pegol,DB00054
DB15443,The risk or severity of adverse effects can be increased when Abciximab is combined with Lorukafusp alfa.,Lorukafusp alfa,DB00054
DB15453,The risk or severity of adverse effects can be increased when Abciximab is combined with Naratuximab emtansine.,Naratuximab emtansine,DB00054
DB15559,The risk or severity of adverse effects can be increased when Abciximab is combined with Zenocutuzumab.,Zenocutuzumab,DB00054
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Abciximab.,Calcium acetate,DB00054
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Abciximab.,Calcium chloride,DB00054
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Abciximab.,Calcium,DB00054
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Abciximab.,Calcium gluconate,DB00054
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Abciximab.,Eftrenonacog alfa,DB00054
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Abciximab.,Albutrepenonacog alfa,DB00054
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Abciximab.,Emicizumab,DB00054
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Abciximab.,Turoctocog alfa pegol,DB00054
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Abciximab.","Antihemophilic factor, human recombinant",DB00054
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Abciximab.,Coagulation factor VIIa Recombinant Human,DB00054
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Abciximab.,Coagulation Factor IX (Recombinant),DB00054
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Abciximab.,Pantothenic acid,DB00054
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Abciximab.,Formic acid,DB00054
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Abciximab.,Platelet Activating Factor,DB00054
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Abciximab.,Calcium carbonate,DB00054
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Abciximab.,Turoctocog alfa,DB00054
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Abciximab.,Fibrinogen human,DB00054
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Abciximab.,Catridecacog,DB00054
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Abciximab.","Antihemophilic Factor (Recombinant), PEGylated",DB00054
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Abciximab.,Calcium citrate,DB00054
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Abciximab.,Calcium threonate,DB00054
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Abciximab.,Prothrombin,DB00054
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Abciximab.,Factor IX Complex (Human),DB00054
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Abciximab.,Calcium Phosphate,DB00054
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Abciximab.,Susoctocog alfa,DB00054
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Abciximab.,Rusalatide acetate,DB00054
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Abciximab.,Vatreptacog alfa,DB00054
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Abciximab.,Factor XIII (human),DB00054
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Abciximab.,Von Willebrand Factor Human,DB00054
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Abciximab.,Coagulation factor X human,DB00054
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Abciximab.,Coagulation factor VII human,DB00054
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Abciximab.,Anti-inhibitor coagulant complex,DB00054
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Abciximab.,Coagulation Factor IX Human,DB00054
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Abciximab.,Antihemophilic factor human,DB00054
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Abciximab.,Kallidinogenase,DB00054
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Abciximab.,Trenonacog alfa,DB00054
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Abciximab.,Nonacog beta pegol,DB00054
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Abciximab.,Moroctocog alfa,DB00054
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Abciximab.,Beroctocog alfa,DB00054
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Abciximab.,Andexanet alfa,DB00054
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Abciximab.,Calcium cation,DB00054
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Abciximab.,Damoctocog alfa pegol,DB00054
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Abciximab.,Seproxetine,DB00054
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Abciximab.,Fluvoxamine,DB00054
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Abciximab.,Citalopram,DB00054
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Abciximab.,Fluoxetine,DB00054
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Abciximab.,Duloxetine,DB00054
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Abciximab.,Paroxetine,DB00054
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Abciximab.,Sibutramine,DB00054
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Abciximab.,Nefazodone,DB00054
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Abciximab.,Zimelidine,DB00054
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Abciximab.,Dapoxetine,DB00054
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Abciximab.,Milnacipran,DB00054
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Abciximab.,Desvenlafaxine,DB00054
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Abciximab.,Levomilnacipran,DB00054
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Abciximab.,Indalpine,DB00054
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Abciximab.,Ritanserin,DB00054
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Abciximab.,Alaproclate,DB00054
DB00285,Venlafaxine may increase the antiplatelet activities of Abciximab.,Venlafaxine,DB00054
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Abciximab.,Amphetamine,DB00054
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Abciximab.,Linezolid,DB00054
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Abciximab.,Furazolidone,DB00054
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Abciximab.,Procaine,DB00054
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Abciximab.,Tranylcypromine,DB00054
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Abciximab.,Phenelzine,DB00054
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Abciximab.,Minaprine,DB00054
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Abciximab.,Selegiline,DB00054
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Abciximab.,Procarbazine,DB00054
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Abciximab.,Moclobemide,DB00054
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Abciximab.,Isocarboxazid,DB00054
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Abciximab.,Rasagiline,DB00054
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Abciximab.,Pargyline,DB00054
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Abciximab.,Clorgiline,DB00054
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Abciximab.,Iproniazid,DB00054
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Abciximab.,Nialamide,DB00054
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Abciximab.,Safinamide,DB00054
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Abciximab.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",DB00054
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Abciximab.,Methylene blue,DB00054
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Abciximab.,Hydracarbazine,DB00054
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Abciximab.,Pirlindole,DB00054
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Abciximab.,Toloxatone,DB00054
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Abciximab.,Benmoxin,DB00054
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Abciximab.,Mebanazine,DB00054
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Abciximab.,Octamoxin,DB00054
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Abciximab.,Pheniprazine,DB00054
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Abciximab.,Phenoxypropazine,DB00054
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Abciximab.,Pivhydrazine,DB00054
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Abciximab.,Safrazine,DB00054
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Abciximab.,Caroxazone,DB00054
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Abciximab.,Harmaline,DB00054
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Abciximab.,Brofaromine,DB00054
DB00974,The risk or severity of bleeding can be increased when Abciximab is combined with Edetic acid.,Edetic acid,DB00054
DB11268,The risk or severity of bleeding can be increased when Abciximab is combined with Protocatechualdehyde.,Protocatechualdehyde,DB00054
DB13124,The risk or severity of bleeding can be increased when Abciximab is combined with Troxerutin.,Troxerutin,DB00054
DB00203,The risk or severity of hemorrhage can be increased when Abciximab is combined with Sildenafil.,Sildenafil,DB00054
DB00229,The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefotiam.,Cefotiam,DB00054
